data_2n8l_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2n8l _Structure_validation_residue.Date_analyzed 2017-01-20 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 83.2 mm-40 . . . . . 0 N--CA 1.45 -0.471 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -73.74 120.37 19.24 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.081 0.467 . . . . 0.0 110.879 -177.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.621 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 53.1 m -122.87 114.77 20.93 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.61 -176.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.566 HG21 ' NE2' ' A' ' 167' ' ' GLN . 27.2 m -132.8 161.72 41.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.636 -179.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.558 ' HB3' ' HB3' ' A' ' 70' ' ' MET . 13.1 m170 -107.74 113.61 27.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.747 -173.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.615 ' O ' ' HA ' ' A' ' 70' ' ' MET . 40.2 t -90.83 123.36 42.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.909 0.385 . . . . 0.0 110.557 -176.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.726 ' CZ ' HG13 ' A' ' 68' ' ' VAL . 2.3 t80 -85.13 104.67 15.23 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.527 -168.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.561 ' C ' HG21 ' A' ' 68' ' ' VAL . 18.9 pt -130.3 117.09 17.75 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.424 0.63 . . . . 0.0 110.892 174.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.596 ' HB2' ' HG2' ' A' ' 32' ' ' GLN . 51.0 Cg_exo -54.42 153.87 21.33 Favored 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 123.315 2.677 . . . . 0.0 112.505 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.53 ' HA ' HG11 ' A' ' 34' ' ' VAL . . . -56.89 -18.22 12.41 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 114.848 -1.069 . . . . 0.0 112.423 -176.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.596 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 30.1 pt20 -72.05 -18.62 61.93 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.94 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.499 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -123.09 -31.82 3.55 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 120.52 -0.472 . . . . 0.0 111.869 -176.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.53 HG11 ' HA ' ' A' ' 31' ' ' ALA . 9.1 p -52.56 -34.28 19.07 Favored 'Isoleucine or valine' 0 C--O 1.242 0.675 0 CA-C-O 120.922 0.391 . . . . 0.0 111.715 -172.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.19 -57.11 21.5 Favored Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.355 -178.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.52 -13.46 60.09 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.928 -174.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.609 HD11 ' CG ' ' A' ' 90' ' ' LYS . 3.3 mm -64.28 -39.98 87.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 116.313 -0.403 . . . . 0.0 109.97 176.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.598 HG23 HG22 ' A' ' 45' ' ' ILE . 9.1 mt -61.16 -60.05 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.929 176.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.566 ' HA3' ' NE2' ' A' ' 44' ' ' HIS . . . 86.48 119.12 1.12 Allowed Glycine 0 CA--C 1.525 0.713 0 C-N-CA 120.288 -0.958 . . . . 0.0 115.393 169.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm 40.43 89.52 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.278 1.431 . . . . 0.0 114.259 169.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.4 ttpt 61.54 5.25 1.18 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.958 175.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.3 29.83 69.88 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.749 -0.738 . . . . 0.0 111.859 -176.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 54.9 tp60 -86.51 -54.71 4.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.532 0.206 . . . . 0.0 111.214 -176.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.566 ' NE2' ' HA3' ' A' ' 39' ' ' GLY . 17.4 p80 -71.64 -21.76 61.78 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.483 -176.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.598 HG22 HG23 ' A' ' 38' ' ' ILE . 10.6 tt -68.07 -33.52 61.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 121.131 0.491 . . . . 0.0 110.006 175.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.457 ' HE2' ' HA ' ' A' ' 46' ' ' LYS . 0.8 OUTLIER -81.32 -31.62 33.43 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 174.808 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.479 ' HB3' ' HA ' ' A' ' 44' ' ' HIS . 34.1 tt0 -58.58 -36.57 74.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.349 171.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.781 HD23 HG12 ' A' ' 56' ' ' ILE . 6.7 tt -61.43 -39.17 89.82 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.271 177.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.67 ' HA ' HD13 ' A' ' 56' ' ' ILE . 17.1 m -61.55 -29.28 69.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.301 177.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 43.8 mtp180 -79.57 -50.89 10.03 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.617 -177.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.733 ' CZ ' ' HA ' ' A' ' 48' ' ' LEU . 1.7 p90 -75.18 -18.99 60.06 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.853 -177.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -92.05 -22.47 19.92 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.829 175.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.2 t 65.85 37.2 5.67 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.616 -177.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -132.36 173.41 11.31 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.17 -178.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.778 ' HB3' ' HB ' ' A' ' 74' ' ' THR . 18.6 t -100.5 101.8 12.82 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.781 HG12 HD23 ' A' ' 48' ' ' LEU . 2.1 mp -98.23 111.9 29.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.814 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.477 ' HB2' ' HB ' ' A' ' 72' ' ' VAL . 41.7 mtpt -128.75 154.31 46.5 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.849 -178.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.486 HG13 HD11 ' A' ' 38' ' ' ILE . 42.4 mm -110.1 113.31 43.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 174.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.718 ' HB1' HG21 ' A' ' 72' ' ' VAL . . . -71.69 126.16 91.58 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.396 -175.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -65.03 143.81 80.05 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.404 2.069 . . . . 0.0 110.341 171.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo . . . . . 0 C--N 1.351 0.694 0 C-N-CA 124.098 3.199 . . . . 0.0 113.497 -176.556 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.4 tmtp? . . . . . 0 C--O 1.232 0.133 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.726 HG13 ' CZ ' ' A' ' 28' ' ' PHE . 2.7 p -154.02 150.91 11.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.327 -167.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.476 ' HB2' HG21 ' A' ' 34' ' ' VAL . 61.2 mtp180 -125.83 129.9 50.31 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 175.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.615 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 3.6 mpp? -94.27 136.88 34.08 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.824 -172.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.583 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 84.6 t -83.61 120.48 34.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 175.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.718 HG21 ' HB1' ' A' ' 59' ' ' ALA . 74.4 t -86.88 96.43 5.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.621 ' O ' ' HA ' ' A' ' 24' ' ' THR . 10.2 tp -93.48 114.57 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 CA-C-O 121.422 0.63 . . . . 0.0 110.162 178.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.778 ' HB ' ' HB3' ' A' ' 55' ' ' SER . 75.3 m -113.27 103.25 11.14 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 173.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -168.75 162.91 36.7 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.046 -1.073 . . . . 0.0 112.934 -176.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.81 147.66 75.5 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.285 1.99 . . . . 0.0 110.361 169.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -49.85 -27.27 15.44 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 124.092 3.194 . . . . 0.0 113.722 -177.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -61.38 -43.06 99.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.425 0.631 . . . . 0.0 110.23 175.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.36 -38.77 41.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.798 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -59.04 -30.58 68.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.14 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.568 ' HA ' ' NE2' ' A' ' 164' ' ' GLN . 55.5 t80 -59.72 -48.92 79.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.53 178.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 17.3 mttt -68.39 -50.78 50.46 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.242 0.544 . . . . 0.0 109.682 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.91 -54.06 49.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.968 -1.014 . . . . 0.0 111.93 -174.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.512 ' HB2' HE21 ' A' ' 164' ' ' GLN . 23.8 mt-30 -76.27 -31.07 58.07 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.95 -0.3 . . . . 0.0 111.135 -178.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -59.2 -42.06 97.02 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.295 -0.955 . . . . 0.0 111.589 175.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.453 ' HA ' ' HD3' ' A' ' 86' ' ' ARG . 21.6 mmt180 -79.79 -27.92 40.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.861 -0.169 . . . . 0.0 111.156 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.509 HG21 ' O ' ' A' ' 84' ' ' GLN . 0.3 OUTLIER -68.57 -39.49 80.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.069 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.585 ' HB3' HG21 ' A' ' 103' ' ' VAL . 9.1 m-85 -68.11 -30.17 69.27 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.148 0.499 . . . . 0.0 109.886 173.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -65.69 -28.88 74.05 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.773 175.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.609 ' CG ' HD11 ' A' ' 37' ' ' ILE . 10.9 mptt -70.31 -29.96 66.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.822 0.344 . . . . 0.0 110.372 176.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.468 ' HB2' ' O ' ' A' ' 88' ' ' TYR . 4.6 mm? -61.99 -44.97 95.61 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 169.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 1.099 ' HE3' ' HB ' ' A' ' 103' ' ' VAL . 1.8 mptm? -63.44 -30.23 71.39 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.637 176.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -55.31 -46.02 76.27 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.522 -178.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -109.63 -5.78 15.56 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -178.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 61.87 40.53 12.53 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.223 174.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 . . . . . 0 N--CA 1.467 0.397 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -178.014 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.436 -1.172 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 1.099 ' HB ' ' HE3' ' A' ' 92' ' ' LYS . 7.6 p -57.28 124.29 10.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 122.136 0.969 . . . . 0.0 111.734 -170.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 35.6 mmtm -126.03 90.44 3.19 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 113.976 -1.466 . . . . 0.0 108.43 176.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.538 ' HB3' ' CE2' ' A' ' 88' ' ' TYR . 2.0 tm? -128.12 125.64 39.58 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.508 0.67 . . . . 0.0 110.525 -175.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.477 ' HG3' HG13 ' A' ' 157' ' ' ILE . 2.5 mp0 -71.35 132.11 44.38 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.58 -1.191 . . . . 0.0 112.064 -177.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 20.3 m -119.56 135.16 54.9 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 169.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 10.2 m170 -108.75 120.86 43.71 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.731 0.301 . . . . 0.0 110.329 -177.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.466 HD11 ' HA ' ' A' ' 167' ' ' GLN . 37.4 pt -114.1 136.06 51.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.135 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.574 HH11 HG13 ' A' ' 153' ' ' ILE . 19.5 mmm180 -87.17 119.16 27.12 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.862 -176.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.6 HG11 HD11 ' A' ' 174' ' ' LEU . 19.2 m -123.04 153.33 64.26 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.827 176.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.5 ' HD2' HD22 ' A' ' 174' ' ' LEU . 51.8 Cg_exo -54.33 142.89 67.64 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.221 1.948 . . . . 0.0 111.098 176.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.549 ' HA ' HG21 ' A' ' 152' ' ' VAL . . . -50.17 -47.41 54.42 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -170.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 43.8 t -75.1 -28.95 60.47 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.523 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.39 -32.26 73.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.14 -178.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.657 ' O ' HG13 ' A' ' 119' ' ' VAL . . . -64.56 -32.76 74.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.368 0.604 . . . . 0.0 110.231 175.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -74.74 -25.32 70.0 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.548 177.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 56.3 ttt180 -92.95 -15.09 26.68 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.722 0.267 . . . . 0.0 111.722 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.657 HG13 ' O ' ' A' ' 116' ' ' ALA . 9.5 p -71.31 -20.88 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 173.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 1.057 ' HA ' ' HB ' ' A' ' 127' ' ' VAL . 71.9 mt -66.35 -25.98 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.953 170.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.03 0 CA-C-N 114.993 -1.003 . . . . 0.0 112.219 178.185 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 31.0 mtmm . . . . . 0 N--CA 1.462 0.157 0 CA-C-O 120.979 0.419 . . . . 0.0 110.948 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 23.5 m -65.09 -39.19 92.83 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.642 -170.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 1.057 ' HB ' ' HA ' ' A' ' 120' ' ' ILE . 14.4 p -63.71 -32.73 58.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.028 0.442 . . . . 0.0 111.082 -177.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -71.9 -40.56 68.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.241 0.544 . . . . 0.0 110.237 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -78.67 -25.4 44.87 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.394 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.465 HD22 HG11 ' A' ' 138' ' ' VAL . 25.8 tp -58.59 -45.53 88.89 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 174.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -60.55 -36.03 77.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.068 0.461 . . . . 0.0 110.693 176.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -67.51 -33.03 74.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.407 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -88.16 -43.95 11.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.852 0.358 . . . . 0.0 110.755 -178.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.606 ' HB ' ' HB2' ' A' ' 166' ' ' ALA . 62.0 p -73.65 -22.57 59.93 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.956 -174.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 65.08 15.74 10.17 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.044 -178.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.48 ' HB2' ' HB3' ' A' ' 162' ' ' ALA . . . -120.84 168.75 11.12 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.124 -178.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.437 ' HB3' ' HB ' ' A' ' 157' ' ' ILE . 23.5 tt0 -93.84 109.71 21.39 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 177.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.465 HG11 HD22 ' A' ' 130' ' ' LEU . 55.0 t -106.29 105.89 19.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.879 -177.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.623 HG11 ' HD3' ' A' ' 155' ' ' LYS . 4.8 p -108.76 115.1 48.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.464 0.649 . . . . 0.0 110.605 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 47.0 t -101.68 115.33 65.04 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.125 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.513 ' HG3' ' HE3' ' A' ' 155' ' ' LYS . 84.0 Cg_endo -82.87 155.25 15.28 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.724 2.283 . . . . 0.0 112.608 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 39.8 mmt180 -86.52 -12.65 48.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.071 176.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -116.93 -89.17 0.58 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.795 -178.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.897 ' HG2' ' H ' ' A' ' 153' ' ' ILE . 23.8 tp60 67.43 -77.39 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.04 0.536 . . . . 0.0 111.624 -178.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.1 p -145.31 139.51 15.06 Favored Pre-proline 0 C--N 1.316 -0.851 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -57.19 148.77 67.88 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 122.641 2.227 . . . . 0.0 111.97 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -72.95 8.64 1.46 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.025 -178.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -61.55 -29.22 69.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.574 0.702 . . . . 0.0 109.571 169.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -95.94 0.46 51.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.515 177.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 46.46 23.82 0.25 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.91 1.284 . . . . 0.0 112.323 -175.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -152.97 139.49 18.71 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 120.871 0.367 . . . . 0.0 110.706 -171.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.549 HG21 ' HA ' ' A' ' 113' ' ' ALA . 17.5 m -132.19 -177.04 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.951 -178.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.897 ' H ' ' HG2' ' A' ' 144' ' ' GLN . 20.5 mt -126.27 141.0 47.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.889 0.376 . . . . 0.0 111.462 -178.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.443 ' N ' HG21 ' A' ' 153' ' ' ILE . 5.6 p -109.88 138.93 35.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 165.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.623 ' HD3' HG11 ' A' ' 139' ' ' VAL . 0.0 OUTLIER -99.6 129.09 45.72 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.915 -173.668 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.495 HG21 ' HA ' ' A' ' 163' ' ' SER . 59.9 mt -110.86 117.69 55.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.221 179.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.477 HG13 ' HG3' ' A' ' 106' ' ' GLU . 3.9 mp -112.27 139.62 36.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.658 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 142.38 -153.2 24.3 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.351 -0.928 . . . . 0.0 112.897 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 17.9 m80 -85.69 158.22 20.11 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -177.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.463 ' HB3' ' CG ' ' A' ' 88' ' ' TYR . 51.4 p90 -63.64 -36.73 84.8 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.459 -175.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -54.58 -46.82 73.82 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.384 0.611 . . . . 0.0 110.371 175.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.48 ' HB3' ' HB2' ' A' ' 136' ' ' ALA . . . -68.76 -48.31 64.04 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.854 -178.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.495 ' HA ' HG21 ' A' ' 156' ' ' ILE . 41.9 m -56.63 -49.95 73.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.173 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . 0.568 ' NE2' ' HA ' ' A' ' 81' ' ' PHE . 93.4 mt-30 -59.64 -39.43 84.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.93 0.395 . . . . 0.0 111.289 -178.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 35.9 ttp -72.8 -37.23 67.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.774 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.606 ' HB2' ' HB ' ' A' ' 134' ' ' THR . . . -66.56 -48.68 68.87 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.805 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.566 ' NE2' HG21 ' A' ' 25' ' ' VAL . 42.2 mt-30 -51.82 -55.79 17.8 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.953 -178.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -64.32 -30.44 71.49 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.635 -174.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . 0.933 ' HA ' ' HE2' ' A' ' 169' ' ' LYS . 3.5 mmpt? -76.82 -40.99 46.02 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.367 -177.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.414 ' O ' ' HG ' ' A' ' 174' ' ' LEU . 17.0 mt -70.89 -42.21 77.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.006 0.431 . . . . 0.0 110.132 176.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -61.46 -27.0 68.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.891 175.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -77.02 -40.43 46.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.4 -177.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.425 ' O ' HG21 ' A' ' 177' ' ' VAL . 18.2 pt -69.46 -26.75 31.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.602 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.6 HD11 HG11 ' A' ' 111' ' ' VAL . 19.3 mt -50.46 -47.74 56.79 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.831 0.348 . . . . 0.0 111.138 177.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.73 -40.52 97.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.787 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -73.68 -30.08 62.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.102 -178.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.425 HG21 ' O ' ' A' ' 173' ' ' ILE . 53.3 t -67.38 -45.82 84.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.27 175.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -63.3 -19.54 64.68 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.678 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 . . . . . 0 CA--C 1.535 0.391 0 CA-C-O 120.895 0.379 . . . . 0.0 111.229 179.888 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 . . . . . 0 C--O 1.235 0.324 0 CA-C-O 121.299 0.571 . . . . 0.0 111.22 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.455 ' HG2' HE22 ' A' ' 80' ' ' GLN . 30.4 tt0 -85.08 103.53 14.17 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.145 -178.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.652 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 8.0 t -120.05 123.12 42.65 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 121.556 0.693 . . . . 0.0 109.572 173.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.53 ' HB ' HG23 ' A' ' 109' ' ' ILE . 27.2 m -126.44 160.94 33.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -106.07 121.41 44.07 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 121.009 -0.277 . . . . 0.0 110.785 -171.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.605 ' O ' ' HA ' ' A' ' 70' ' ' MET . 21.6 t -96.93 128.43 48.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.614 -174.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.428 ' CZ ' HG12 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -90.65 104.84 17.38 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 122.326 0.25 . . . . 0.0 111.232 -171.622 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.464 ' C ' HG21 ' A' ' 68' ' ' VAL . 20.4 pt -126.97 120.06 22.53 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.179 0.514 . . . . 0.0 110.682 175.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -58.92 152.38 58.41 Favored 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 122.955 2.437 . . . . 0.0 112.8 -177.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.582 ' HA ' HG13 ' A' ' 34' ' ' VAL . . . -60.01 -19.98 55.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.89 -1.05 . . . . 0.0 112.889 -173.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -68.54 -24.81 64.68 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.616 ' HB2' ' HE2' ' A' ' 96' ' ' PHE . . . -116.28 -31.03 5.76 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.939 -176.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.582 HG13 ' HA ' ' A' ' 31' ' ' ALA . 10.2 p -51.44 -34.96 15.92 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 CA-C-O 120.93 0.395 . . . . 0.0 111.432 -174.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -55.84 -55.91 26.62 Favored Glycine 0 N--CA 1.438 -1.231 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.268 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.25 -14.89 60.55 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 120.987 0.422 . . . . 0.0 111.099 -175.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.598 HD13 ' HB3' ' A' ' 90' ' ' LYS . 3.7 mm -65.98 -39.96 86.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.16 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.574 HG23 HG23 ' A' ' 45' ' ' ILE . 17.7 mt -61.94 -37.8 79.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-O 121.074 0.464 . . . . 0.0 111.392 177.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.66 141.21 9.07 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.063 178.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -46.52 -34.18 4.65 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.342 0.657 . . . . 0.0 112.132 -172.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.476 ' HE2' ' HB3' ' A' ' 43' ' ' GLN . 15.4 ptmt -123.09 93.2 3.88 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 166.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.43 ' HA2' HG22 ' A' ' 38' ' ' ILE . . . -33.23 88.8 0.01 OUTLIER Glycine 0 C--N 1.338 0.671 0 O-C-N 124.355 1.034 . . . . 0.0 113.673 172.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.476 ' HB3' ' HE2' ' A' ' 41' ' ' LYS . 5.4 tp-100 -176.19 -34.91 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -175.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -56.89 -41.8 78.72 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.023 169.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.574 HG23 HG23 ' A' ' 38' ' ' ILE . 8.5 tt -56.99 -34.16 44.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.036 173.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 23.5 mmmt -82.35 -29.96 30.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.594 -178.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.4 ' OE1' ' HD3' ' A' ' 50' ' ' ARG . 46.9 tp60 -62.85 -35.46 80.05 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 170.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.809 ' HG ' ' HE1' ' A' ' 51' ' ' PHE . 7.3 tt -60.98 -42.38 98.24 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.513 173.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 14.9 m -56.74 -34.95 68.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.609 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.4 ' HD3' ' OE1' ' A' ' 47' ' ' GLN . 76.1 mtp180 -72.31 -51.87 18.77 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.693 -176.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.809 ' HE1' ' HG ' ' A' ' 48' ' ' LEU . 3.2 p90 -77.0 -29.98 55.71 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.728 -173.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.588 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -81.73 -12.56 58.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.244 -178.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.7 t 61.27 30.07 18.98 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.541 178.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -131.91 159.66 38.0 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.345 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.688 ' HB2' ' HB ' ' A' ' 74' ' ' THR . 19.6 m -91.12 100.46 13.29 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -178.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.4 mm -88.4 111.53 22.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.319 -177.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -130.6 137.76 49.8 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.39 176.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.8 mm -94.27 112.35 26.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 172.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.664 ' HB2' HG21 ' A' ' 72' ' ' VAL . . . -67.73 117.73 50.76 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.452 -174.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.07 132.02 17.56 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.798 2.332 . . . . 0.0 111.406 176.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo . . . . . 0 N--CA 1.456 -0.703 0 C-N-CA 122.706 2.271 . . . . 0.0 111.531 177.149 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.6 tmtp? . . . . . 0 C--O 1.234 0.251 0 CA-C-O 121.566 0.698 . . . . 0.0 110.475 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.464 HG21 ' C ' ' A' ' 29' ' ' ILE . 2.4 p -144.78 151.91 15.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.724 -171.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.444 ' HD3' HG12 ' A' ' 34' ' ' VAL . 59.3 mtp180 -126.18 132.23 51.83 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 177.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.605 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 76.7 mtm -92.26 147.47 22.9 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.873 -175.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.528 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 86.4 t -96.09 124.42 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 172.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.664 HG21 ' HB2' ' A' ' 59' ' ' ALA . 97.5 t -86.8 102.13 11.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 174.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.652 ' O ' ' HA ' ' A' ' 24' ' ' THR . 8.8 tp -101.34 100.18 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 CA-C-O 121.882 0.849 . . . . 0.0 110.252 -177.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.688 ' HB ' ' HB2' ' A' ' 55' ' ' SER . 9.4 m -102.61 105.83 16.4 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.688 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -160.35 163.62 34.03 Favored Glycine 0 CA--C 1.497 -1.088 0 C-N-CA 119.674 -1.25 . . . . 0.0 113.254 -174.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.489 ' HD2' ' HB3' ' A' ' 79' ' ' ALA . 7.1 Cg_exo -67.23 136.77 41.55 Favored 'Trans proline' 0 N--CA 1.446 -1.273 0 C-N-CA 121.944 1.763 . . . . 0.0 109.859 170.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.556 ' HA ' ' NH2' ' A' ' 168' ' ' ARG . 3.7 Cg_exo -36.78 -50.93 1.4 Allowed 'Trans proline' 0 C--O 1.24 0.614 0 C-N-CA 124.59 3.527 . . . . 0.0 113.684 -176.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -63.81 -49.82 71.39 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.942 0.401 . . . . 0.0 111.174 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.551 ' HB1' ' O ' ' A' ' 52' ' ' ALA . . . -66.87 -34.4 77.72 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.407 -177.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.455 HE22 ' HG2' ' A' ' 23' ' ' GLU . 34.2 tt0 -61.91 -31.22 71.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.73 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -65.77 -42.17 91.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.603 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.3 mtmt -63.02 -37.98 89.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.548 0.689 . . . . 0.0 109.952 -178.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.588 ' HB3' ' HB2' ' A' ' 52' ' ' ALA . . . -69.76 -49.05 56.74 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.534 179.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.439 ' O ' HG23 ' A' ' 87' ' ' ILE . 41.6 mt-30 -67.14 -30.81 70.91 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -177.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -56.99 -35.19 67.7 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.848 175.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.4 mmt180 -79.44 -36.76 38.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.576 0.227 . . . . 0.0 111.154 177.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.543 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 0.3 OUTLIER -67.75 -40.87 84.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.738 -174.93 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.738 ' HA ' HD21 ' A' ' 91' ' ' LEU . 6.7 m-85 -68.33 -32.04 71.88 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.056 0.455 . . . . 0.0 110.292 175.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -61.44 -28.91 70.29 Favored Glycine 0 C--O 1.224 -0.526 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.709 174.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.598 ' HB3' HD13 ' A' ' 37' ' ' ILE . 69.3 mmtt -66.99 -38.87 86.82 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 122.827 0.451 . . . . 0.0 111.002 174.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.738 HD21 ' HA ' ' A' ' 88' ' ' TYR . 3.2 mm? -60.49 -38.36 84.04 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.157 0.504 . . . . 0.0 110.555 173.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.954 ' HE3' ' HB ' ' A' ' 103' ' ' VAL . 3.6 mmtp -76.44 -26.54 55.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.502 178.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -68.43 -30.92 69.91 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.472 -175.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.568 ' OE1' ' HA ' ' A' ' 94' ' ' GLU . 4.4 mm-40 -96.42 10.7 37.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.307 0.575 . . . . 0.0 110.799 177.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 63.2 t30 57.2 45.52 20.37 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 114.757 -1.11 . . . . 0.0 112.143 172.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.616 ' HE2' ' HB2' ' A' ' 33' ' ' ALA . 61.2 m-85 . . . . . 0 C--N 1.324 -0.54 0 CA-C-O 121.148 0.499 . . . . 0.0 110.243 174.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 . . . . . 0 N--CA 1.454 -0.268 0 CA-C-O 120.726 0.298 . . . . 0.0 110.726 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.954 ' HB ' ' HE3' ' A' ' 92' ' ' LYS . 7.1 p -76.45 122.83 31.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 172.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -124.53 90.31 3.23 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 176.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.579 ' HB3' ' CE2' ' A' ' 88' ' ' TYR . 1.8 tm? -118.86 130.81 55.95 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.869 -173.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.835 ' HG2' HG13 ' A' ' 157' ' ' ILE . 32.0 mt-10 -73.5 126.89 31.25 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.188 -0.915 . . . . 0.0 112.743 -176.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.473 HG22 ' NE2' ' A' ' 167' ' ' GLN . 0.2 OUTLIER -113.81 125.5 54.16 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 167.012 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 21.5 m170 -107.81 121.49 44.83 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -177.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.53 HG23 ' HB ' ' A' ' 25' ' ' VAL . 10.4 pt -113.83 147.24 17.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 177.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.88 ' HG3' ' HG2' ' A' ' 151' ' ' GLN . 4.2 tpt180 -97.88 118.65 34.92 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -176.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.608 HG11 HD22 ' A' ' 174' ' ' LEU . 11.1 m -116.82 150.1 45.2 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 178.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.62 ' CD ' HD12 ' A' ' 174' ' ' LEU . 44.8 Cg_exo -49.77 149.66 10.42 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 123.217 2.612 . . . . 0.0 112.341 177.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -48.6 -49.15 38.11 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -171.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 23.1 t -85.93 -19.74 30.04 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.839 0.352 . . . . 0.0 110.921 -176.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.439 ' O ' HG21 ' A' ' 119' ' ' VAL . . . -65.66 -26.08 67.63 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.521 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.501 ' O ' ' HB ' ' A' ' 119' ' ' VAL . . . -63.51 -34.44 77.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.59 177.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -67.66 -32.91 79.34 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.852 -0.689 . . . . 0.0 111.473 177.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.457 ' HD3' HG23 ' A' ' 177' ' ' VAL . 26.1 mtp180 -83.77 -6.8 59.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.488 -0.356 . . . . 0.0 110.609 176.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.72 HG23 HD13 ' A' ' 173' ' ' ILE . 12.0 t -75.11 -51.19 22.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.331 0.586 . . . . 0.0 109.788 172.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 1.011 ' HA ' ' HB ' ' A' ' 127' ' ' VAL . 20.2 pt -81.12 -34.22 13.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.946 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.456 ' HA3' HG22 ' A' ' 126' ' ' THR . . . . . . . . 0 N--CA 1.444 -0.825 0 C-N-CA 120.98 -0.628 . . . . 0.0 111.891 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? . . . . . 0 N--CA 1.456 -0.165 0 CA-C-O 120.669 0.271 . . . . 0.0 111.25 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.619 ' O ' ' HG ' ' A' ' 130' ' ' LEU . 8.1 t -76.79 -20.22 56.68 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.756 -174.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 1.011 ' HB ' ' HA ' ' A' ' 120' ' ' ILE . 8.8 p -69.25 -29.21 41.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 176.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -65.95 -41.04 91.77 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.494 174.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.33 -48.76 80.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.761 173.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' A' ' 126' ' ' THR . 87.7 mt -58.02 -50.47 73.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.457 -177.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -62.0 -49.69 75.04 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -176.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -77.81 -11.3 59.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.794 -173.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 59.5 tp -97.46 -49.34 4.94 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.749 0.309 . . . . 0.0 110.96 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 82.1 p -79.62 -20.2 47.39 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.85 -173.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 66.2 27.47 10.31 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.875 0.735 . . . . 0.0 110.168 -174.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -127.33 176.21 7.6 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.528 -177.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.547 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 7.3 tp10 -108.74 111.4 23.14 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.845 177.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.48 HG23 HD12 ' A' ' 170' ' ' ILE . 46.2 t -108.41 106.24 20.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 177.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.662 HG13 ' HD3' ' A' ' 155' ' ' LYS . 5.1 p -123.16 125.33 71.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.351 0.596 . . . . 0.0 111.819 -175.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 89.3 t -92.8 118.1 67.8 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 173.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -50.72 137.71 41.78 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 123.811 3.007 . . . . 0.0 113.25 -171.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.534 ' HA ' ' NE ' ' A' ' 142' ' ' ARG . 4.6 mmp_? -81.64 -28.99 33.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.309 178.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -93.56 62.89 3.37 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 163.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -57.93 139.31 54.6 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.607 -1.179 . . . . 0.0 111.438 -171.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 30.2 p -59.13 130.47 86.83 Favored Pre-proline 0 N--CA 1.448 -0.542 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.292 173.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.488 ' C ' ' H ' ' A' ' 148' ' ' GLU . 17.8 Cg_endo -58.27 150.98 63.2 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.684 2.256 . . . . 0.0 112.226 -175.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -78.24 35.32 0.22 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.321 0.582 . . . . 0.0 110.751 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.488 ' H ' ' C ' ' A' ' 146' ' ' PRO . 24.0 tt0 -52.26 -47.15 65.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.019 177.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -109.15 25.01 12.3 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.314 178.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 49.48 31.34 3.95 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.854 1.262 . . . . 0.0 112.544 178.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.88 ' HG2' ' HG3' ' A' ' 110' ' ' ARG . 7.8 tt0 -156.68 136.12 12.22 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.141 -177.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 32.6 m -122.41 169.32 13.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.007 0.432 . . . . 0.0 111.716 -172.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 10.7 mm -102.27 142.76 15.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.098 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 4.1 p -127.97 140.04 50.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.939 171.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.662 ' HD3' HG13 ' A' ' 139' ' ' VAL . 0.0 OUTLIER -96.77 130.4 44.03 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.738 -174.685 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.547 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 76.0 mt -114.43 111.53 36.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 172.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.835 HG13 ' HG2' ' A' ' 106' ' ' GLU . 4.2 mp -110.05 131.69 60.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.12 -177.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 163.82 -164.0 36.14 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.313 -0.946 . . . . 0.0 112.53 177.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.562 ' HA ' HG13 ' A' ' 103' ' ' VAL . 5.1 m80 -79.07 160.07 27.25 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.533 ' HB3' ' CG ' ' A' ' 88' ' ' TYR . 13.5 p90 -57.43 -33.3 67.75 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 118.561 0.619 . . . . 0.0 112.028 -175.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -61.86 -52.95 62.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.522 0.677 . . . . 0.0 110.112 175.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -65.59 -41.65 92.59 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.808 -175.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.484 ' O ' ' HG3' ' A' ' 167' ' ' GLN . 26.2 p -68.08 -49.13 63.16 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.318 -176.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.62 -31.63 71.72 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.708 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 25.6 ttt -66.83 -45.66 77.56 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.036 0.446 . . . . 0.0 110.301 176.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.547 ' HB3' HG22 ' A' ' 156' ' ' ILE . . . -71.16 -35.31 71.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.833 -177.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.484 ' HG3' ' O ' ' A' ' 163' ' ' SER . 66.4 mt-30 -51.54 -56.58 12.64 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.005 0.431 . . . . 0.0 110.807 -179.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.65 ' HA ' ' HB2' ' A' ' 171' ' ' ARG . 0.4 OUTLIER -74.09 -27.18 60.77 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.498 178.812 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . 0.577 ' HA ' ' HE3' ' A' ' 169' ' ' LYS . 0.2 OUTLIER -64.52 -49.76 70.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.064 0.459 . . . . 0.0 109.992 -179.245 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.526 HG23 HG23 ' A' ' 119' ' ' VAL . 2.0 mp -71.87 -35.24 53.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.755 177.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.65 ' HB2' ' HA ' ' A' ' 168' ' ' ARG . 1.0 OUTLIER -56.58 -33.82 66.55 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.38 172.894 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.49 -44.13 45.53 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.73 0.271 . . . . 0.0 111.73 -178.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.72 HD13 HG23 ' A' ' 119' ' ' VAL . 2.7 pp -68.58 -30.86 48.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.61 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.62 HD12 ' CD ' ' A' ' 112' ' ' PRO . 0.3 OUTLIER -71.89 -37.59 70.11 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.624 0.726 . . . . 0.0 109.278 174.191 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -58.01 -32.21 67.7 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.981 -1.008 . . . . 0.0 111.067 176.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -61.36 -33.74 74.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.082 0.468 . . . . 0.0 110.113 174.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.457 HG23 ' HD3' ' A' ' 118' ' ' ARG . 22.0 t -73.8 -29.41 26.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.358 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -63.83 -34.85 78.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.005 0.431 . . . . 0.0 110.44 175.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 . . . . . 0 C--N 1.326 -0.436 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.238 -174.672 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.48 ' HB3' HG23 ' A' ' 74' ' ' THR . 97.1 mt-30 . . . . . 0 N--CA 1.452 -0.326 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -73.27 143.67 46.96 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.679 -174.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 44.8 m -115.16 107.45 15.32 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.509 0.671 . . . . 0.0 110.774 -176.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.0 t -106.96 148.41 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.422 ' HB3' ' SD ' ' A' ' 70' ' ' MET . 15.9 m-70 -113.74 146.51 39.77 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -174.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.677 ' HB ' HG22 ' A' ' 71' ' ' VAL . 7.4 t -124.26 142.79 39.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 120.912 0.387 . . . . 0.0 111.173 -174.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.744 ' CE2' HG12 ' A' ' 68' ' ' VAL . 45.4 t80 -97.58 105.27 17.39 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.088 0.955 . . . . 0.0 110.269 -176.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.528 ' C ' HG22 ' A' ' 68' ' ' VAL . 17.6 pt -124.07 120.22 26.43 Favored Pre-proline 0 C--N 1.324 -0.53 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.766 174.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.552 ' HA ' ' HA ' ' A' ' 68' ' ' VAL . 18.0 Cg_endo -57.96 150.73 62.19 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 122.966 2.444 . . . . 0.0 112.05 -176.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.483 ' HA ' HG13 ' A' ' 34' ' ' VAL . . . -60.17 -19.64 54.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.082 -174.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -69.96 -22.99 63.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.214 177.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.466 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -113.59 -31.79 6.39 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 120.889 -0.325 . . . . 0.0 111.625 -175.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.596 HG23 ' HB3' ' A' ' 69' ' ' ARG . 11.7 p -55.58 -31.23 28.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 O-C-N 123.431 0.457 . . . . 0.0 111.714 -171.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.71 -57.58 18.84 Favored Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.019 -178.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.43 -13.73 59.7 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 120.673 0.273 . . . . 0.0 111.368 -175.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.536 HD12 ' CG ' ' A' ' 90' ' ' LYS . 2.1 mm -65.49 -36.43 77.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 177.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.481 HG22 ' HA2' ' A' ' 42' ' ' GLY . 37.8 mt -63.99 -52.64 53.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.012 173.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 81.7 106.37 0.37 Allowed Glycine 0 CA--C 1.523 0.549 0 N-CA-C 115.131 0.812 . . . . 0.0 115.131 168.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.404 ' HD2' ' HA ' ' A' ' 40' ' ' LYS . 41.0 tptt 42.16 89.51 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.841 1.256 . . . . 0.0 113.757 169.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 41' ' ' LYS . 21.0 ttpt 66.85 -0.35 1.68 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.702 0.801 . . . . 0.0 111.947 176.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.481 ' HA2' HG22 ' A' ' 38' ' ' ILE . . . 84.96 18.92 60.27 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.274 -0.965 . . . . 0.0 111.398 -175.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -67.84 -47.21 69.61 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.989 0.423 . . . . 0.0 110.076 178.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 64.0 m-70 -68.29 -39.59 82.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.753 -172.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.0 tt -62.51 -47.31 93.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.719 0.295 . . . . 0.0 111.775 -178.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.2 ptmm? -81.43 -22.87 37.89 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.924 -177.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -64.81 -39.21 93.22 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 169.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.622 ' HA ' ' CZ ' ' A' ' 51' ' ' PHE . 7.8 tt -61.95 -42.12 98.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.931 177.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.621 ' HA ' HD11 ' A' ' 56' ' ' ILE . 44.0 t -53.98 -34.85 60.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.687 177.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -76.85 -50.96 12.17 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.661 -177.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.622 ' CZ ' ' HA ' ' A' ' 48' ' ' LEU . 2.4 p90 -76.77 -11.42 59.83 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 119.995 -0.682 . . . . 0.0 111.85 -175.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 79' ' ' ALA . . . -96.36 -18.53 19.88 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.73 0.3 . . . . 0.0 110.975 176.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.7 t 65.32 34.36 8.35 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.698 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -141.18 168.93 18.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.291 -176.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.654 ' HB2' ' HB ' ' A' ' 74' ' ' THR . 29.9 m -90.71 103.26 15.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.743 0.306 . . . . 0.0 110.679 -178.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.621 HD11 ' HA ' ' A' ' 49' ' ' SER . 2.4 mp -107.21 113.13 42.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.035 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -134.64 157.76 45.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.794 -177.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 40.8 mm -97.6 135.7 31.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 174.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.852 ' HB1' HG21 ' A' ' 72' ' ' VAL . . . -92.5 140.58 24.08 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-O 120.642 0.258 . . . . 0.0 110.772 -178.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -65.63 120.8 8.04 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.794 2.33 . . . . 0.0 111.495 175.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo . . . . . 0 N--CA 1.461 -0.436 0 C-N-CA 122.325 2.017 . . . . 0.0 111.733 -179.058 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.738 0.304 . . . . 0.0 111.74 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.744 HG12 ' CE2' ' A' ' 28' ' ' PHE . 7.7 p -137.23 150.99 26.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-O 120.925 0.393 . . . . 0.0 110.602 -175.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.596 ' HB3' HG23 ' A' ' 34' ' ' VAL . 18.6 ttm180 -122.21 121.88 37.86 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 174.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.425 ' O ' ' HB2' ' A' ' 59' ' ' ALA . 44.5 ttp -79.83 148.11 31.51 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.134 -178.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.677 HG22 ' HB ' ' A' ' 27' ' ' VAL . 21.8 m -115.19 145.64 20.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.716 0.293 . . . . 0.0 110.555 175.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.852 HG21 ' HB1' ' A' ' 59' ' ' ALA . 58.3 t -107.8 111.11 34.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.15 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.573 ' O ' HD12 ' A' ' 73' ' ' ILE . 2.7 pp -118.77 125.32 74.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.817 0.818 . . . . 0.0 111.133 176.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.654 ' HB ' ' HB2' ' A' ' 55' ' ' SER . 59.4 m -107.04 106.03 16.35 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.786 176.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.03 134.58 7.4 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 119.995 -1.098 . . . . 0.0 113.464 -172.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -69.42 151.03 70.95 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.057 1.838 . . . . 0.0 110.247 167.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -38.13 -49.07 2.28 Favored 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 124.862 3.708 . . . . 0.0 115.407 -173.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -71.3 -49.97 37.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.875 0.369 . . . . 0.0 110.132 -178.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' A' ' 52' ' ' ALA . . . -64.59 -27.19 68.78 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.806 -177.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -53.9 -42.56 68.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.307 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -72.5 -34.65 67.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.844 -177.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 15.4 tppt? -64.99 -47.83 76.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.714 -178.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.0 -53.13 19.06 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.868 -177.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.525 ' O ' HG23 ' A' ' 87' ' ' ILE . 6.5 tt0 -72.18 -30.23 64.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.386 -173.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -56.29 -34.76 63.48 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.508 177.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -76.7 -36.85 56.95 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.996 ' HA ' ' HD3' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -70.41 -30.31 42.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.804 -174.492 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.401 ' O ' ' HB2' ' A' ' 91' ' ' LEU . 7.4 m-85 -66.94 -30.67 70.87 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.166 0.508 . . . . 0.0 109.752 171.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -61.87 -29.22 71.76 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.867 175.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.996 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 5.2 mptp? -60.0 -45.79 91.58 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.909 0.385 . . . . 0.0 109.999 173.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.421 ' HG ' ' HG ' ' A' ' 105' ' ' LEU . 3.6 mm? -57.23 -37.67 72.62 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.591 176.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.965 ' HE3' ' HB ' ' A' ' 103' ' ' VAL . 11.4 mmtp -75.26 -24.43 57.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.028 -176.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -69.47 -44.39 71.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.705 0.288 . . . . 0.0 111.407 -176.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.664 ' HB2' ' CE2' ' A' ' 96' ' ' PHE . 22.7 mm-40 -108.2 1.81 22.37 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 52.27 47.9 23.77 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.269 177.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.664 ' CE2' ' HB2' ' A' ' 94' ' ' GLU . 71.8 m-85 . . . . . 0 N--CA 1.467 0.405 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.442 -177.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 . . . . . 0 CA--C 1.519 -0.243 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.965 ' HB ' ' HE3' ' A' ' 92' ' ' LYS . 9.8 p -68.12 123.37 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 C-N-CA 118.392 -1.323 . . . . 0.0 109.328 174.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 158' ' ' GLY . 30.3 mmtp -130.75 89.68 2.79 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.43 177.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.421 ' HG ' ' HG ' ' A' ' 91' ' ' LEU . 0.9 OUTLIER -109.02 115.94 31.04 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -177.473 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.452 ' O ' ' HB3' ' A' ' 28' ' ' PHE . 33.5 tt0 -71.26 116.52 11.67 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.021 -176.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -101.66 144.25 30.61 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.053 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 -124.84 120.98 33.25 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.083 0.468 . . . . 0.0 110.785 -177.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 16.2 pt -121.17 138.15 52.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.144 0.497 . . . . 0.0 111.062 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.607 ' HD3' HG12 ' A' ' 153' ' ' ILE . 9.6 mmt85 -82.66 119.02 23.76 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.442 177.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.852 HG21 HD11 ' A' ' 174' ' ' LEU . 6.0 p -121.69 143.11 37.39 Favored Pre-proline 0 C--N 1.318 -0.783 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.472 ' HD2' HG23 ' A' ' 111' ' ' VAL . 50.7 Cg_exo -53.42 140.03 64.16 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.259 1.972 . . . . 0.0 110.111 177.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.68 -28.51 68.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.179 0.514 . . . . 0.0 110.761 -174.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.2 p -75.89 -34.5 59.97 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.461 176.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.565 ' HB1' HG23 ' A' ' 111' ' ' VAL . . . -71.89 -20.35 61.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.973 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.48 -32.65 70.45 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.236 0.541 . . . . 0.0 110.446 176.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -73.43 -39.63 50.17 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.576 175.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.495 ' HD3' HG23 ' A' ' 177' ' ' VAL . 45.5 mtp180 -73.41 -34.64 65.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.486 0.184 . . . . 0.0 111.459 -177.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.481 HG13 HG21 ' A' ' 140' ' ' VAL . 14.0 p -69.73 -36.43 70.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.923 0.392 . . . . 0.0 110.376 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.982 ' HA ' ' HB ' ' A' ' 127' ' ' VAL . 75.5 mt -75.11 -31.4 24.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.651 0.739 . . . . 0.0 109.449 174.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.096 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 179.637 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt . . . . . 0 C--O 1.234 0.283 0 CA-C-O 120.884 0.373 . . . . 0.0 110.422 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 11.0 m -60.09 -46.15 90.55 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.246 -175.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.982 ' HB ' ' HA ' ' A' ' 120' ' ' ILE . 9.9 p -68.82 -33.89 61.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.266 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -60.71 -42.56 97.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.346 0.593 . . . . 0.0 109.533 176.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -61.08 -48.89 79.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.844 175.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 91.4 mt -58.6 -49.37 77.73 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.09 -177.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -58.52 -43.88 89.31 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 123.14 0.275 . . . . 0.0 111.575 -174.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -81.13 -33.26 33.33 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 121.061 -0.256 . . . . 0.0 111.344 -178.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.34 -48.74 74.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.098 0.475 . . . . 0.0 110.009 178.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.649 HG23 ' HA ' ' A' ' 166' ' ' ALA . 66.7 p -85.6 -18.06 34.41 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.762 -174.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 63.6 29.32 15.19 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.523 -175.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -127.44 170.17 12.84 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.4 -177.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.428 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 10.1 tp10 -95.77 113.61 25.26 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 177.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 59.1 t -110.8 105.97 19.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.939 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.644 HG23 ' HD3' ' A' ' 141' ' ' PRO . 6.3 p -125.25 128.34 72.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.348 177.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.877 HG22 HG11 ' A' ' 154' ' ' VAL . 2.3 t -130.75 81.55 67.08 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 121.02 0.438 . . . . 0.0 110.723 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.783 ' HD2' ' HE3' ' A' ' 155' ' ' LYS . 51.6 Cg_exo -57.1 142.18 94.28 Favored 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 123.083 2.522 . . . . 0.0 112.113 176.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -78.17 -19.34 54.15 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.545 -176.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -97.3 16.56 19.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.035 -172.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.911 HE21 ' HB ' ' A' ' 153' ' ' ILE . 14.4 mm100 -50.79 -70.26 0.09 Allowed 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -177.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -137.98 159.94 66.49 Favored Pre-proline 0 C--N 1.311 -1.079 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.587 -174.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -56.44 144.31 84.08 Favored 'Trans proline' 0 C--O 1.238 0.503 0 C-N-CA 123.084 2.523 . . . . 0.0 112.902 -176.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -67.23 -7.45 24.03 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.407 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -49.96 -47.73 52.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.483 169.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . 0.471 ' O ' ' HG2' ' A' ' 150' ' ' GLU . 10.8 t-20 -87.52 -7.16 57.92 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.792 -178.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 149' ' ' ASN . 11.1 pt-20 48.13 33.26 3.46 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.712 1.205 . . . . 0.0 111.457 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -149.55 144.0 25.96 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.436 -173.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 25.2 m -128.47 -176.54 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.965 -178.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.911 ' HB ' HE21 ' A' ' 144' ' ' GLN . 39.3 mt -122.41 131.24 73.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.588 0.233 . . . . 0.0 111.6 -177.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.877 HG11 HG22 ' A' ' 140' ' ' VAL . 32.4 t -92.77 140.2 16.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 172.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.783 ' HE3' ' HD2' ' A' ' 141' ' ' PRO . 0.0 OUTLIER -107.39 126.19 52.16 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 177.397 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.428 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 60.2 mt -110.04 111.21 35.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.089 178.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.413 ' HB ' ' HB3' ' A' ' 137' ' ' GLU . 3.8 mp -109.1 119.75 59.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 176.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 104' ' ' LYS . . . 177.53 -157.4 21.95 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 119.62 -1.276 . . . . 0.0 113.1 -174.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -102.63 173.25 6.42 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 -173.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -59.96 -46.24 90.08 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 121.172 -0.211 . . . . 0.0 111.22 -177.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -60.89 -51.76 67.92 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.931 0.396 . . . . 0.0 110.516 175.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -59.22 -49.04 79.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.259 -174.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.449 ' O ' ' HG3' ' A' ' 167' ' ' GLN . 32.4 t -62.16 -47.44 84.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.058 -175.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -56.41 -37.82 70.7 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.923 0.392 . . . . 0.0 111.001 178.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 89.9 mtp -71.92 -38.72 69.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.653 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.649 ' HA ' HG23 ' A' ' 134' ' ' THR . . . -66.83 -49.53 65.47 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.33 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.449 ' HG3' ' O ' ' A' ' 163' ' ' SER . 75.7 mt-30 -51.87 -52.46 49.44 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.233 -177.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 18.4 ptt180 -66.85 -38.15 85.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.146 -177.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . 0.634 ' HA ' ' HE2' ' A' ' 169' ' ' LYS . 0.1 OUTLIER -68.09 -39.17 82.93 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.706 0.289 . . . . 0.0 111.299 -172.798 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.516 ' O ' HD13 ' A' ' 174' ' ' LEU . 1.9 mp -74.98 -44.19 44.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 177.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 -55.83 -25.59 42.57 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.2 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -60.77 -55.55 31.84 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.463 175.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.495 ' O ' HG21 ' A' ' 177' ' ' VAL . 42.5 pt -67.57 -23.94 30.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.446 -172.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.852 HD11 HG21 ' A' ' 111' ' ' VAL . 10.9 mp -58.33 -37.69 75.65 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.843 176.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -65.74 -34.97 79.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.058 0.456 . . . . 0.0 110.378 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -71.37 -38.1 71.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.508 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.495 HG21 ' O ' ' A' ' 173' ' ' ILE . 58.0 t -66.7 -37.28 79.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.5 177.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 174' ' ' LEU . 98.2 mttt -66.06 -41.38 90.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.185 176.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.395 177.807 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 . . . . . 0 CA--C 1.516 -0.329 0 CA-C-O 121.1 0.476 . . . . 0.0 111.36 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -94.83 102.4 14.25 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.054 174.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 56.1 m -104.59 114.25 28.35 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.214 -177.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 42.1 t -126.42 149.94 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 176.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -108.52 146.45 33.2 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 122.086 -0.384 . . . . 0.0 110.138 -174.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.666 ' HB ' ' CG1' ' A' ' 71' ' ' VAL . 21.1 t -120.76 133.16 68.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.232 -174.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.773 ' CE1' HG13 ' A' ' 68' ' ' VAL . 32.5 t80 -93.56 104.15 16.29 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.483 0.713 . . . . 0.0 110.048 -176.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.486 ' CD1' HG23 ' A' ' 34' ' ' VAL . 8.8 pt -126.74 124.69 24.19 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.283 0.563 . . . . 0.0 111.13 178.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.449 ' HG2' ' HB2' ' A' ' 33' ' ' ALA . 3.0 Cg_endo -45.82 140.65 9.5 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 124.474 3.449 . . . . 0.0 114.064 -174.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.74 -18.71 22.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.958 -176.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -89.71 -29.47 18.72 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.11 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.566 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -96.47 -30.84 13.12 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -175.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.81 HG21 ' HB3' ' A' ' 69' ' ' ARG . 10.6 p -54.09 -29.91 19.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.707 179.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.76 -57.0 22.17 Favored Glycine 0 N--CA 1.432 -1.633 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.242 176.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.36 -14.16 59.78 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.552 -0.324 . . . . 0.0 111.201 -174.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.584 HD13 ' HB3' ' A' ' 90' ' ' LYS . 9.5 mm -63.16 -39.29 84.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 172.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.448 ' CG2' ' HA2' ' A' ' 42' ' ' GLY . 38.4 mt -61.83 -52.34 61.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.566 177.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.7 111.87 2.82 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 120.27 -0.967 . . . . 0.0 114.855 170.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt 59.23 -89.43 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.286 1.034 . . . . 0.0 113.561 173.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.484 ' CD ' ' HB2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -129.28 23.94 5.55 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.18 0.514 . . . . 0.0 111.156 -177.478 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.448 ' HA2' ' CG2' ' A' ' 38' ' ' ILE . . . 82.37 28.79 38.78 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.441 -0.885 . . . . 0.0 110.992 -175.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.484 ' HB2' ' CD ' ' A' ' 41' ' ' LYS . 25.4 tm0? -91.02 -47.61 7.46 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.024 0.44 . . . . 0.0 109.855 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -70.52 -32.78 70.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.492 -174.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.599 HG23 ' HG3' ' A' ' 46' ' ' LYS . 6.2 tt -61.04 -44.59 98.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.176 0.512 . . . . 0.0 111.145 177.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.599 ' HG3' HG23 ' A' ' 45' ' ' ILE . 55.0 mtpt -81.41 -30.92 33.41 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.428 -177.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -63.11 -33.46 75.51 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 172.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.815 ' HA ' ' HD1' ' A' ' 51' ' ' PHE . 6.1 tt -62.95 -49.26 75.44 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.422 174.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.623 ' HA ' HD13 ' A' ' 56' ' ' ILE . 14.4 t -55.52 -40.84 72.31 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.704 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.821 ' HE ' ' HA ' ' A' ' 50' ' ' ARG . 0.9 OUTLIER -78.84 -40.54 32.47 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -177.68 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.815 ' HD1' ' HA ' ' A' ' 48' ' ' LEU . 0.4 OUTLIER -74.51 -30.84 61.96 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 121.829 -0.545 . . . . 0.0 110.484 -178.03 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -84.59 -12.96 53.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.529 -177.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.9 m 66.9 30.13 7.88 Favored 'General case' 0 N--CA 1.463 0.223 0 O-C-N 123.644 0.59 . . . . 0.0 110.854 -179.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -134.54 166.95 21.7 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.539 -176.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.435 ' HB2' ' HB ' ' A' ' 74' ' ' THR . 18.4 m -92.53 108.1 19.72 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.567 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.709 HG13 HG22 ' A' ' 73' ' ' ILE . 1.9 mp -110.47 115.03 48.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.224 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -137.66 135.75 36.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.234 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 37.6 mm -80.38 124.42 38.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 177.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.713 ' HB1' HG22 ' A' ' 72' ' ' VAL . . . -90.05 129.75 44.87 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.606 -177.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.34 140.61 95.29 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 122.942 2.428 . . . . 0.0 111.897 176.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.448 ' HD3' ' HG3' ' A' ' 69' ' ' ARG . 40.2 Cg_endo . . . . . 0 C--O 1.233 0.26 0 C-N-CA 122.796 2.33 . . . . 0.0 112.054 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.507 ' O ' ' HD2' ' A' ' 67' ' ' LYS . 1.0 OUTLIER . . . . . 0 CA--C 1.536 0.417 0 CA-C-O 121.786 0.803 . . . . 0.0 110.578 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.773 HG13 ' CE1' ' A' ' 28' ' ' PHE . 11.2 p -146.54 154.64 12.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.798 -175.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.81 ' HB3' HG21 ' A' ' 34' ' ' VAL . 11.7 ttm180 -129.94 129.38 43.75 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 170.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.499 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 42.2 mtt -96.48 134.63 39.42 Favored 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.236 -173.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.666 ' CG1' ' HB ' ' A' ' 27' ' ' VAL . 3.9 p -99.98 140.21 19.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 177.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.713 HG22 ' HB1' ' A' ' 59' ' ' ALA . 63.9 t -101.56 120.5 51.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.112 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.709 HG22 HG13 ' A' ' 56' ' ' ILE . 2.6 pp -114.76 127.31 72.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.499 0.666 . . . . 0.0 110.522 176.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.435 ' HB ' ' HB2' ' A' ' 55' ' ' SER . 91.3 m -125.55 113.21 17.12 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.674 178.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.62 161.14 34.65 Favored Glycine 0 CA--C 1.498 -1.03 0 C-N-CA 119.811 -1.185 . . . . 0.0 113.115 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.31 153.07 71.54 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 122.5 2.133 . . . . 0.0 110.964 169.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.437 ' HA ' ' NH2' ' A' ' 168' ' ' ARG . 35.8 Cg_exo -38.18 -51.59 2.0 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 124.804 3.669 . . . . 0.0 114.85 -176.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -66.61 -36.02 81.61 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.264 0.554 . . . . 0.0 110.994 -177.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.88 -49.82 27.53 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.724 -178.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.545 ' HG3' HD12 ' A' ' 73' ' ' ILE . 19.9 tt0 -63.47 -31.9 73.19 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.955 -178.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -54.21 -54.62 37.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.513 -177.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.6 pttm -72.93 -33.09 65.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.378 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.05 -53.03 62.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.224 177.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.402 ' O ' ' HD1' ' A' ' 88' ' ' TYR . 35.0 mt-30 -72.76 -31.16 64.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.38 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -54.12 -42.33 71.72 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.957 176.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -81.19 -28.81 34.79 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 178.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.24 -41.25 91.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 120.981 -0.287 . . . . 0.0 110.49 -176.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.579 ' HA ' HD22 ' A' ' 91' ' ' LEU . 26.5 m-85 -67.39 -31.67 72.05 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.249 0.547 . . . . 0.0 110.239 176.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.08 -29.38 74.22 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.913 176.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.584 ' HB3' HD13 ' A' ' 37' ' ' ILE . 67.0 mmtt -77.3 -21.06 54.11 Favored 'General case' 0 N--CA 1.442 -0.87 0 O-C-N 122.62 -0.341 . . . . 0.0 110.491 178.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.579 HD22 ' HA ' ' A' ' 88' ' ' TYR . 3.8 mm? -66.05 -33.27 75.43 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.239 0.542 . . . . 0.0 109.847 167.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.772 ' HE3' ' HB ' ' A' ' 103' ' ' VAL . 13.8 mmtp -75.94 -21.8 56.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.117 176.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.489 ' HB2' ' HA ' ' A' ' 90' ' ' LYS . 5.2 tp10 -62.78 -33.05 74.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.772 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.595 ' HG2' ' CE2' ' A' ' 96' ' ' PHE . 6.5 tp10 -88.96 -1.38 58.08 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.957 0.884 . . . . 0.0 109.605 178.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 12.5 m120 65.87 29.09 10.57 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.423 177.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.595 ' CE2' ' HG2' ' A' ' 94' ' ' GLU . 14.2 m-85 . . . . . 0 C--N 1.331 -0.216 0 CA-C-O 121.072 0.463 . . . . 0.0 111.149 178.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 . . . . . 0 CA--C 1.52 -0.197 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.772 ' HB ' ' HE3' ' A' ' 92' ' ' LYS . 7.1 p -65.95 122.23 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 175.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -116.79 88.23 2.86 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 174.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.576 ' HG ' ' HG ' ' A' ' 91' ' ' LEU . 1.6 tm? -112.02 124.66 52.87 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.973 -173.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -65.23 118.32 9.09 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.642 -178.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.491 HG22 ' NE2' ' A' ' 167' ' ' GLN . 1.2 m -109.92 136.9 48.47 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -108.0 118.76 37.6 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.286 0.565 . . . . 0.0 111.102 -174.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.509 HG13 ' HB ' ' A' ' 154' ' ' VAL . 12.4 pt -110.76 112.66 41.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.689 175.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.913 ' HG3' ' HG2' ' A' ' 151' ' ' GLN . 5.6 tpt180 -77.96 117.51 19.36 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.636 HG12 HD22 ' A' ' 174' ' ' LEU . 13.0 m -116.2 150.85 45.96 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -177.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -49.44 155.82 3.16 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.864 2.376 . . . . 0.0 111.461 175.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -52.83 -49.92 64.73 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.111 0.482 . . . . 0.0 111.513 -172.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 13.7 m -78.65 -8.26 58.48 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.913 -177.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.24 -29.99 61.95 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 122.215 -0.303 . . . . 0.0 111.453 -175.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.588 ' O ' HG11 ' A' ' 119' ' ' VAL . . . -65.26 -37.84 88.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.2 0.524 . . . . 0.0 110.684 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -69.41 -28.29 72.65 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.912 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 37.1 mtp85 -92.02 -18.12 24.1 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 111.555 0.206 . . . . 0.0 111.555 -178.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.588 HG11 ' O ' ' A' ' 116' ' ' ALA . 8.4 p -76.64 -29.2 18.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 175.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.557 ' HA ' ' HB ' ' A' ' 127' ' ' VAL . 69.3 mt -65.79 -40.62 88.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 170.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.969 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.931 174.207 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? . . . . . 0 C--O 1.233 0.207 0 CA-C-O 120.989 0.423 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 15.1 m -64.69 -37.76 88.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.691 -175.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.557 ' HB ' ' HA ' ' A' ' 120' ' ' ILE . 14.0 p -63.24 -33.48 61.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-O 120.872 0.368 . . . . 0.0 110.731 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -65.95 -42.59 89.78 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 177.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -63.93 -40.96 97.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.233 177.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 79.3 mt -57.85 -50.77 72.17 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.202 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -68.4 -35.35 77.54 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.941 0.401 . . . . 0.0 110.881 -177.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -67.36 -36.99 82.51 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.385 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -84.9 -47.72 10.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.099 -175.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.519 ' HA ' ' HE3' ' A' ' 165' ' ' MET . 76.9 p -79.88 -21.08 44.45 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -172.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 66.17 21.39 11.12 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.53 -174.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -120.13 164.15 16.62 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.002 177.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.505 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 49.0 mt-10 -101.07 113.02 25.65 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.188 0.518 . . . . 0.0 111.033 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 60.0 t -104.85 106.45 20.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.912 -178.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.463 ' O ' ' HD2' ' A' ' 155' ' ' LYS . 7.2 p -128.46 130.88 69.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.065 0.46 . . . . 0.0 111.136 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.67 ' HB ' HG22 ' A' ' 154' ' ' VAL . 8.5 p -125.94 131.04 23.86 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 116.136 -0.483 . . . . 0.0 109.855 178.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 140' ' ' VAL . 36.7 Cg_exo -60.89 121.01 9.03 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.7 2.267 . . . . 0.0 111.631 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.614 ' H ' ' HD2' ' A' ' 142' ' ' ARG . 0.3 OUTLIER -83.19 14.78 3.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.586 0.708 . . . . 0.0 110.102 -175.043 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -117.84 -1.74 11.47 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.346 176.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.416 ' HB2' ' HB2' ' A' ' 141' ' ' PRO . 6.4 tp-100 -98.11 115.11 27.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.07 -172.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.1 t -175.29 70.53 0.27 Allowed Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.381 176.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -91.55 143.96 3.06 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.384 2.056 . . . . 0.0 112.568 -178.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -70.0 -16.62 63.2 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.981 178.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -52.3 -48.67 65.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.974 -1.012 . . . . 0.0 112.204 -178.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . 0.421 ' O ' ' HG2' ' A' ' 150' ' ' GLU . 4.4 t-20 -119.62 -10.4 9.61 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.014 -175.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 149' ' ' ASN . 12.2 pt-20 47.33 29.68 1.33 Allowed 'General case' 0 N--CA 1.475 0.799 0 O-C-N 124.31 1.007 . . . . 0.0 111.097 -173.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.913 ' HG2' ' HG3' ' A' ' 110' ' ' ARG . 30.5 tt0 -155.71 128.31 7.86 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.15 -174.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.412 HG23 ' HB1' ' A' ' 116' ' ' ALA . 33.1 m -114.41 -177.1 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.338 -171.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 53.9 mt -122.16 131.39 73.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -173.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.67 HG22 ' HB ' ' A' ' 140' ' ' VAL . 46.2 t -107.29 140.77 24.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 168.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.463 ' HD2' ' O ' ' A' ' 139' ' ' VAL . 0.0 OUTLIER -104.12 122.39 45.22 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.07 178.898 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.505 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 51.6 mt -102.71 112.67 36.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 173.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 4.4 mp -103.6 129.86 54.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.82 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 161.3 -172.07 37.45 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.436 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.483 ' HA ' HG12 ' A' ' 103' ' ' VAL . 6.3 p80 -88.68 153.68 20.91 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.43 ' HB3' ' CG ' ' A' ' 88' ' ' TYR . 10.2 p90 -50.82 -46.59 59.99 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -165.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . 0.406 ' O ' ' HG3' ' A' ' 164' ' ' GLN . 16.8 m-85 -59.67 -48.94 79.7 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 118.85 0.75 . . . . 0.0 111.174 -178.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.59 -42.91 86.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.603 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.476 ' O ' ' HG3' ' A' ' 167' ' ' GLN . 35.7 t -63.59 -50.37 69.68 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.418 -177.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . 0.406 ' HG3' ' O ' ' A' ' 161' ' ' TYR . 5.1 pp0? -59.37 -35.48 73.97 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.478 0.18 . . . . 0.0 111.034 -177.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' MET . . . . . 0.519 ' HE3' ' HA ' ' A' ' 134' ' ' THR . 49.0 ttp -73.76 -33.45 64.28 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 120.621 -0.431 . . . . 0.0 110.806 177.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.494 ' HB3' ' HB ' ' A' ' 134' ' ' THR . . . -69.96 -43.61 71.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.103 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.491 ' NE2' HG22 ' A' ' 107' ' ' THR . 71.9 mt-30 -51.94 -52.81 47.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.953 -178.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.812 ' HA ' ' HB2' ' A' ' 171' ' ' ARG . 1.3 ptp180 -70.85 -27.36 63.78 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.455 178.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . 0.646 ' HA ' ' HE2' ' A' ' 169' ' ' LYS . 0.1 OUTLIER -67.55 -37.85 83.29 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.753 -178.688 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.482 ' O ' HG13 ' A' ' 173' ' ' ILE . 1.9 mp -75.24 -39.88 42.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 173.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.812 ' HB2' ' HA ' ' A' ' 168' ' ' ARG . 1.1 mpt_? -51.74 -28.0 13.74 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.072 171.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 169' ' ' LYS . 1.3 m-20 -68.66 -56.14 9.16 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 122.679 0.392 . . . . 0.0 111.499 178.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.482 HG13 ' O ' ' A' ' 170' ' ' ILE . 2.7 pp -66.59 -18.64 24.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.525 -174.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.636 HD22 HG12 ' A' ' 111' ' ' VAL . 6.7 mp -66.41 -33.86 76.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.093 174.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.99 -31.82 73.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.107 0.48 . . . . 0.0 110.28 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -69.6 -33.45 72.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.923 176.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 48.7 t -66.06 -46.4 88.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.796 176.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -61.18 -40.89 95.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.845 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.016 -179.515 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.442 ' HB3' HG21 ' A' ' 74' ' ' THR . 48.5 mt-30 . . . . . 0 CA--C 1.514 -0.407 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.525 ' O ' ' HA ' ' A' ' 74' ' ' THR . 7.1 tp10 -81.05 147.67 30.04 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.399 -0.818 . . . . 0.0 111.101 -174.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.627 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 39.8 m -116.15 107.16 14.54 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.492 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.419 HG12 HG21 ' A' ' 109' ' ' ILE . 37.0 t -119.14 150.02 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.723 -177.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -111.69 125.15 53.66 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-O 120.773 0.32 . . . . 0.0 110.776 -175.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.479 ' HB ' ' HB ' ' A' ' 71' ' ' VAL . 13.6 t -94.09 139.69 17.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.48 ' CZ ' HG11 ' A' ' 68' ' ' VAL . 1.0 OUTLIER -103.54 104.89 15.01 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.406 -175.704 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.434 ' C ' HG22 ' A' ' 68' ' ' VAL . 21.7 pt -129.68 123.36 21.15 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 121.169 0.509 . . . . 0.0 111.291 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.4 ' HA ' ' HA ' ' A' ' 68' ' ' VAL . 50.5 Cg_exo -53.5 149.12 31.86 Favored 'Trans proline' 0 C--O 1.238 0.501 0 C-N-CA 123.439 2.76 . . . . 0.0 112.643 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.578 ' HA ' HG11 ' A' ' 34' ' ' VAL . . . -57.7 -23.57 52.33 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 114.9 -1.046 . . . . 0.0 112.529 -173.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -66.12 -30.01 70.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.235 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.51 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -108.25 -31.07 8.03 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.663 -175.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.731 HG23 ' HB3' ' A' ' 69' ' ' ARG . 13.3 p -53.98 -32.48 22.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-O 120.945 0.402 . . . . 0.0 110.968 -175.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.81 -56.36 25.71 Favored Glycine 0 N--CA 1.434 -1.448 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.959 178.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.44 -14.54 59.67 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.621 0.248 . . . . 0.0 111.298 -175.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.617 HD13 ' HB3' ' A' ' 90' ' ' LYS . 2.4 mm -67.44 -36.96 77.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.369 -0.378 . . . . 0.0 109.99 177.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.433 HG22 HG22 ' A' ' 45' ' ' ILE . 24.6 mt -61.45 -32.72 54.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-O 121.528 0.68 . . . . 0.0 110.337 174.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.18 153.72 30.18 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.627 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.57 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 34.1 mtpt -66.02 131.38 46.08 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -175.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.57 ' HG2' ' O ' ' A' ' 40' ' ' LYS . 19.8 pttt 73.63 4.21 4.69 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.051 1.34 . . . . 0.0 112.198 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 61.05 38.64 95.88 Favored Glycine 0 CA--C 1.523 0.545 0 CA-C-N 116.253 -0.431 . . . . 0.0 113.607 176.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.422 ' HB3' ' HE2' ' A' ' 41' ' ' LYS . 19.4 tt0 -109.1 -36.65 6.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 117.322 0.561 . . . . 0.0 110.985 175.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 77.7 m-70 -55.87 -41.62 74.67 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.393 0.616 . . . . 0.0 109.778 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.46 ' O ' HG22 ' A' ' 56' ' ' ILE . 4.5 tt -56.52 -44.13 79.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 114.515 -1.221 . . . . 0.0 112.231 176.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.43 ' HG2' HG21 ' A' ' 45' ' ' ILE . 28.4 mmmt -81.45 -29.09 33.91 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 121.984 -0.447 . . . . 0.0 110.779 -173.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -60.47 -40.55 91.65 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 172.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.688 HD21 ' HZ ' ' A' ' 51' ' ' PHE . 0.2 OUTLIER -49.72 -47.8 50.35 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.048 175.898 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.837 ' HB2' ' HB ' ' A' ' 56' ' ' ILE . 14.5 t -61.77 -35.88 79.43 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.629 -176.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -78.81 -41.35 30.53 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -169.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.688 ' HZ ' HD21 ' A' ' 48' ' ' LEU . 10.2 p90 -79.56 -17.02 54.89 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 120.167 -0.613 . . . . 0.0 111.609 -177.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -94.09 -16.89 23.38 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.199 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.2 t 67.3 13.97 9.55 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.544 -177.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -108.73 153.57 23.27 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.838 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.497 ' HB2' ' HB ' ' A' ' 74' ' ' THR . 60.4 m -80.27 102.41 9.48 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.018 0.437 . . . . 0.0 110.185 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.837 ' HB ' ' HB2' ' A' ' 49' ' ' SER . 1.5 mp -92.98 117.64 36.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.147 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -144.77 151.13 38.37 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.891 -175.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 38.8 mm -102.43 129.1 54.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.58 ' HB2' ' HB2' ' A' ' 70' ' ' MET . . . -95.86 108.55 41.23 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.841 -178.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -69.59 146.0 59.89 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 123.061 2.507 . . . . 0.0 112.338 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.848 ' HD3' ' HG3' ' A' ' 69' ' ' ARG . 98.6 Cg_endo . . . . . 0 N--CA 1.459 -0.527 0 C-N-CA 122.874 2.383 . . . . 0.0 112.396 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? . . . . . 0 CA--C 1.528 0.113 0 CA-C-O 121.353 0.597 . . . . 0.0 110.417 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.48 HG11 ' CZ ' ' A' ' 28' ' ' PHE . 1.5 p -145.83 150.53 15.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.457 -172.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.848 ' HG3' ' HD3' ' A' ' 61' ' ' PRO . 22.9 ttm180 -127.05 151.3 48.79 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 177.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.58 ' HB2' ' HB2' ' A' ' 59' ' ' ALA . 63.6 mtt -100.13 149.41 23.55 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.269 0.557 . . . . 0.0 112.127 -173.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.479 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 86.8 t -105.44 120.34 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 168.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.6 p -109.23 115.54 49.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-O 121.563 0.697 . . . . 0.0 110.451 -176.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.627 ' O ' ' HA ' ' A' ' 24' ' ' THR . 2.1 pp -120.34 140.84 43.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.598 -176.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 58.9 m -123.76 108.77 12.88 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.934 177.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -163.95 162.03 34.8 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.098 -1.049 . . . . 0.0 113.326 -176.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -64.39 142.61 79.58 Favored 'Trans proline' 0 CA--C 1.533 0.427 0 C-N-CA 123.079 2.519 . . . . 0.0 111.908 175.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.474 ' O ' ' HB2' ' A' ' 80' ' ' GLN . 97.4 Cg_exo -46.14 -35.39 14.89 Favored 'Trans proline' 0 N--CA 1.478 0.565 0 C-N-CA 125.013 3.808 . . . . 0.0 115.298 -174.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.3 -46.87 69.14 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.115 0.483 . . . . 0.0 109.849 177.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.56 -22.44 63.54 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.894 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.474 ' HB2' ' O ' ' A' ' 77' ' ' PRO . 71.3 mm-40 -52.76 -52.0 58.31 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.787 176.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -66.74 -33.15 74.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.832 -179.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 47.1 tttp -61.5 -52.95 62.38 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.189 0.519 . . . . 0.0 110.334 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.4 -53.74 13.07 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.854 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.502 ' O ' HG21 ' A' ' 87' ' ' ILE . 9.5 tt0 -69.15 -31.03 69.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.68 -173.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -58.13 -32.54 67.4 Favored Glycine 0 CA--C 1.518 0.219 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.884 177.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.52 ' HA ' ' NE ' ' A' ' 86' ' ' ARG . 3.5 mmp_? -79.69 -26.83 40.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.654 0.264 . . . . 0.0 111.054 178.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.502 HG21 ' O ' ' A' ' 84' ' ' GLN . 0.4 OUTLIER -66.33 -35.16 74.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.646 -177.307 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.662 ' CE2' ' HB3' ' A' ' 105' ' ' LEU . 10.0 m-85 -68.66 -34.57 75.93 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.361 176.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -62.26 -30.43 75.96 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.524 176.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.617 ' HB3' HD13 ' A' ' 37' ' ' ILE . 75.0 mmtt -59.96 -52.96 63.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.7 0.286 . . . . 0.0 110.612 175.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.521 HD21 HD11 ' A' ' 105' ' ' LEU . 3.8 mm? -61.35 -39.66 91.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.606 178.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.866 ' HE3' ' HB ' ' A' ' 103' ' ' VAL . 0.3 OUTLIER -61.65 -41.17 97.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.821 0.343 . . . . 0.0 110.92 174.711 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -71.18 -23.45 62.05 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.028 -176.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.491 ' HB3' ' CE2' ' A' ' 96' ' ' PHE . 58.7 mm-40 -88.26 4.23 46.65 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.927 -179.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 63.56 21.04 12.56 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.742 172.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.491 ' CE2' ' HB3' ' A' ' 94' ' ' GLU . 78.2 m-85 . . . . . 0 C--N 1.326 -0.453 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 168.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 . . . . . 0 CA--C 1.514 -0.409 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.866 ' HB ' ' HE3' ' A' ' 92' ' ' LYS . 15.0 p -54.6 123.94 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 CA-C-O 121.819 0.819 . . . . 0.0 111.995 -172.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -123.02 90.81 3.36 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 170.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.662 ' HB3' ' CE2' ' A' ' 88' ' ' TYR . 2.5 tt -117.17 114.89 24.32 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -177.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.843 ' HG3' HG13 ' A' ' 157' ' ' ILE . 1.7 mp0 -71.86 128.73 36.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.694 -175.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.1 m -114.69 128.06 56.1 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 170.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 16.2 m170 -102.26 119.62 39.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.14 0.495 . . . . 0.0 110.064 -178.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.449 HG13 ' HB ' ' A' ' 154' ' ' VAL . 34.8 pt -112.33 157.52 13.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.231 -178.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -102.26 133.64 46.83 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.879 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.697 HG12 HD21 ' A' ' 174' ' ' LEU . 10.4 m -133.15 148.24 68.43 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 173.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.724 ' HD2' ' HG ' ' A' ' 174' ' ' LEU . 51.6 Cg_exo -53.96 146.27 48.01 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.139 1.893 . . . . 0.0 110.596 175.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.15 -27.77 65.95 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.616 -175.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 44.0 t -81.5 -33.11 32.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.3 0.571 . . . . 0.0 110.281 175.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.56 -21.05 61.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.011 -178.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.549 ' O ' HG12 ' A' ' 119' ' ' VAL . . . -61.45 -50.82 71.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.071 0.462 . . . . 0.0 110.59 177.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.93 -29.39 67.14 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.562 177.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.535 ' HD3' HG21 ' A' ' 177' ' ' VAL . 13.7 ttt85 -73.04 -36.1 66.86 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.832 -0.184 . . . . 0.0 111.316 -178.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.549 HG12 ' O ' ' A' ' 116' ' ' ALA . 7.0 p -69.89 -26.21 29.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-O 121.014 0.435 . . . . 0.0 109.905 178.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.937 ' HA ' ' HB ' ' A' ' 127' ' ' VAL . 73.7 mt -68.12 -33.36 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 CA-C-O 121.495 0.664 . . . . 0.0 109.347 171.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.557 ' HA3' ' H ' ' A' ' 126' ' ' THR . . . . . . . . 0 N--CA 1.446 -0.672 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.182 176.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 53.2 tptt . . . . . 0 C--O 1.231 0.089 0 CA-C-O 121.069 0.461 . . . . 0.0 110.623 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.557 ' H ' ' HA3' ' A' ' 121' ' ' GLY . 21.7 m -60.16 -34.62 73.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.905 -177.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.937 ' HB ' ' HA ' ' A' ' 120' ' ' ILE . 10.2 p -63.11 -29.24 46.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.7 0.286 . . . . 0.0 110.856 -178.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -63.77 -45.49 89.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.149 0.5 . . . . 0.0 109.835 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -72.35 -37.36 68.84 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.946 178.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.62 HD23 HD13 ' A' ' 170' ' ' ILE . 23.1 tp -58.98 -49.43 77.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.937 178.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.498 ' HG3' HG12 ' A' ' 138' ' ' VAL . 16.4 tt0 -63.12 -36.24 82.94 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.195 -178.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -75.11 -37.0 61.63 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.783 -178.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 21.8 mt -79.98 -22.08 42.97 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -178.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 38.5 p -96.7 -22.03 17.23 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.747 -177.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 65.25 18.53 11.43 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.623 -178.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -118.95 168.93 10.33 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.585 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 21.8 tt0 -105.1 122.05 45.08 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.987 0.423 . . . . 0.0 110.225 -178.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.498 HG12 ' HG3' ' A' ' 131' ' ' GLN . 2.4 p -121.09 122.01 66.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.067 -172.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 13.5 p -130.66 133.23 63.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.54 176.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.809 ' HB ' HG21 ' A' ' 154' ' ' VAL . 6.7 p -137.49 97.68 10.32 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-O 121.824 0.821 . . . . 0.0 111.14 177.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.493 ' HG2' ' HZ2' ' A' ' 155' ' ' LYS . 51.3 Cg_exo -60.57 166.45 9.75 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 123.427 2.751 . . . . 0.0 112.656 175.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -79.05 -50.31 11.26 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.399 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -94.27 102.19 14.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.438 178.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.747 ' HB2' ' HB ' ' A' ' 152' ' ' VAL . 23.7 mm-40 -127.78 93.23 3.64 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.551 176.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.892 ' HB ' ' HD2' ' A' ' 146' ' ' PRO . 60.8 p 58.67 172.91 0.05 OUTLIER Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 123.615 0.766 . . . . 0.0 111.519 -176.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.892 ' HD2' ' HB ' ' A' ' 145' ' ' THR . 35.1 Cg_endo -65.8 154.71 72.75 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.07 1.847 . . . . 0.0 111.965 178.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -78.88 36.3 0.27 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.527 0.68 . . . . 0.0 110.544 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.457 ' H ' ' C ' ' A' ' 146' ' ' PRO . 37.8 tt0 -63.21 -33.34 75.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.598 -177.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -118.61 22.63 11.94 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 175.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 48.17 31.62 2.66 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 114.104 -1.407 . . . . 0.0 112.716 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -136.35 158.4 44.51 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.503 0.668 . . . . 0.0 112.434 -177.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.747 ' HB ' ' HB2' ' A' ' 144' ' ' GLN . 27.0 m -123.69 -175.78 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.787 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.432 ' HB ' ' OE1' ' A' ' 144' ' ' GLN . 25.2 mt -115.47 136.93 50.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.098 0.475 . . . . 0.0 112.27 -172.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.809 HG21 ' HB ' ' A' ' 140' ' ' VAL . 59.6 t -114.35 141.09 31.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.259 172.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.493 ' HZ2' ' HG2' ' A' ' 141' ' ' PRO . 6.5 mttt -113.22 121.27 43.97 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.333 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.496 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 64.4 mt -104.85 116.34 48.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.177 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.843 HG13 ' HG3' ' A' ' 106' ' ' GLU . 3.9 mp -110.57 133.19 56.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.523 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 153.8 -156.17 26.63 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.114 -1.041 . . . . 0.0 112.757 176.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.629 ' HA ' HG12 ' A' ' 103' ' ' VAL . 74.3 m80 -86.95 160.08 18.8 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -178.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.512 ' HB3' ' CG ' ' A' ' 88' ' ' TYR . 19.7 p90 -68.67 -24.47 64.52 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -170.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -73.26 -41.28 63.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.219 0.533 . . . . 0.0 109.981 172.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -73.27 -39.73 65.15 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.452 -176.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.447 ' O ' ' HG3' ' A' ' 167' ' ' GLN . 29.0 p -65.07 -50.08 67.54 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.223 -177.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -62.23 -34.55 76.71 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.723 0.297 . . . . 0.0 110.627 178.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 26.6 ttt -63.79 -43.46 96.27 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.09 0.472 . . . . 0.0 110.266 177.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.442 ' HB1' HD12 ' A' ' 156' ' ' ILE . . . -68.65 -46.46 69.1 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.02 178.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.447 ' HG3' ' O ' ' A' ' 163' ' ' SER . 72.4 mt-30 -51.52 -51.36 55.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.26 -178.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -70.07 -30.82 68.16 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.151 -178.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -71.49 -40.64 70.07 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.945 0.402 . . . . 0.0 110.92 -178.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.643 ' O ' HD13 ' A' ' 174' ' ' LEU . 1.9 mp -73.01 -51.0 28.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.434 178.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.589 ' HA ' HD22 ' A' ' 174' ' ' LEU . 25.8 mmm180 -56.98 -24.82 56.1 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.727 0.298 . . . . 0.0 110.909 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -69.4 -51.35 37.4 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.638 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.409 ' O ' HG22 ' A' ' 177' ' ' VAL . 34.4 pt -68.5 -19.82 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 121.017 0.437 . . . . 0.0 110.722 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.724 ' HG ' ' HD2' ' A' ' 112' ' ' PRO . 3.5 mp -64.08 -29.15 70.3 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.133 178.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.78 -31.89 72.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.26 0.553 . . . . 0.0 110.146 175.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -73.44 -47.09 44.44 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.161 177.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.535 HG21 ' HD3' ' A' ' 118' ' ' ARG . 29.6 t -67.33 -32.51 57.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.657 -178.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -57.25 -49.01 77.4 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 174.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 . . . . . 0 C--N 1.327 -0.385 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.821 178.189 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 . . . . . 0 N--CA 1.453 -0.297 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.601 ' O ' ' HA ' ' A' ' 74' ' ' THR . 22.1 mm-40 -72.64 130.53 40.77 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.255 -174.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.601 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 29.6 m -131.7 109.94 10.54 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.61 -178.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.73 HG21 HD11 ' A' ' 73' ' ' ILE . 14.3 m -127.73 161.24 35.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.237 178.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 10.0 m170 -111.47 127.95 55.85 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 -174.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.611 ' O ' ' HA ' ' A' ' 70' ' ' MET . 10.4 t -105.87 123.87 60.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.821 -174.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.779 ' CZ ' HG13 ' A' ' 68' ' ' VAL . 3.7 t80 -82.33 103.2 11.73 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.313 -174.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.527 ' C ' HG22 ' A' ' 68' ' ' VAL . 39.6 pt -126.52 113.14 23.03 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.701 0.762 . . . . 0.0 110.724 174.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.929 ' HB2' ' HG2' ' A' ' 32' ' ' GLN . 88.8 Cg_exo -50.45 150.95 10.66 Favored 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 123.513 2.808 . . . . 0.0 113.325 -179.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.577 ' HA ' HG11 ' A' ' 34' ' ' VAL . . . -58.73 -18.73 33.98 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.909 -175.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.929 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 3.5 pt20 -51.65 -36.53 46.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.021 176.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.762 ' HB1' ' HZ2' ' A' ' 90' ' ' LYS . . . -126.4 -25.35 3.48 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -169.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.577 HG11 ' HA ' ' A' ' 31' ' ' ALA . 14.4 p -49.94 -34.53 9.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 O-C-N 123.355 0.409 . . . . 0.0 111.622 -173.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.22 -55.8 28.42 Favored Glycine 0 N--CA 1.44 -1.084 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.155 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.87 -15.05 62.11 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 120.906 0.384 . . . . 0.0 111.057 -175.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.594 HG12 ' O ' ' A' ' 33' ' ' ALA . 6.5 mm -71.74 -36.0 57.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.683 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.53 HG21 ' HA2' ' A' ' 42' ' ' GLY . 8.2 mt -63.51 -32.12 55.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-O 121.41 0.624 . . . . 0.0 110.265 173.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.53 ' HA3' ' HB2' ' A' ' 44' ' ' HIS . . . 86.72 163.48 38.66 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.443 176.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -61.36 128.15 34.94 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 120.927 0.394 . . . . 0.0 110.039 -178.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.442 ' O ' ' HE3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER 72.62 1.84 4.13 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.178 179.149 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.53 ' HA2' HG21 ' A' ' 38' ' ' ILE . . . 69.94 19.86 75.68 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.395 -0.907 . . . . 0.0 110.889 -173.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -73.86 -41.85 61.62 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.427 -0.386 . . . . 0.0 110.227 -178.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.53 ' HB2' ' HA3' ' A' ' 39' ' ' GLY . 18.8 m-70 -64.6 -40.52 95.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.539 -173.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.445 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 13.8 tt -64.46 -45.45 95.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.887 0.375 . . . . 0.0 111.442 -179.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.401 ' O ' ' HB3' ' A' ' 49' ' ' SER . 13.9 ptmm? -82.26 -22.32 35.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.671 0.272 . . . . 0.0 111.324 -178.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -69.34 -34.78 75.14 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 172.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.839 ' HG ' ' HE1' ' A' ' 51' ' ' PHE . 6.4 tt -60.1 -41.97 93.68 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.052 -0.976 . . . . 0.0 108.983 173.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.634 ' HA ' HD13 ' A' ' 56' ' ' ILE . 34.0 t -54.99 -35.31 64.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.931 178.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -73.53 -51.28 17.55 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.839 ' HE1' ' HG ' ' A' ' 48' ' ' LEU . 1.5 p90 -72.49 -32.18 65.99 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.823 -174.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.53 -19.02 36.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.858 0.361 . . . . 0.0 110.804 179.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.5 m 63.95 31.05 14.03 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.078 178.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -132.4 171.16 14.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.992 -177.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.482 ' HB3' ' HB ' ' A' ' 74' ' ' THR . 33.2 t -93.19 115.85 28.45 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.88 HG13 HG21 ' A' ' 73' ' ' ILE . 3.2 mp -115.58 119.15 61.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.238 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -148.43 136.69 21.19 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.012 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.606 HG12 HG23 ' A' ' 71' ' ' VAL . 10.4 mt -88.8 128.48 40.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.189 0.518 . . . . 0.0 111.224 -177.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.541 ' HB3' HG23 ' A' ' 72' ' ' VAL . . . -71.19 141.79 86.57 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.239 -176.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 59' ' ' ALA . 2.4 Cg_endo -80.36 137.46 11.84 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.933 2.422 . . . . 0.0 111.956 177.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo . . . . . 0 N--CA 1.461 -0.405 0 C-N-CA 122.853 2.369 . . . . 0.0 111.782 176.913 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? . . . . . 0 N--CA 1.457 -0.105 0 CA-C-O 121.135 0.493 . . . . 0.0 109.734 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.779 HG13 ' CZ ' ' A' ' 28' ' ' PHE . 3.7 p -154.65 153.64 7.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.788 -167.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.549 ' HB2' HG21 ' A' ' 34' ' ' VAL . 30.4 mtp180 -128.59 130.2 47.02 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 171.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.611 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 4.1 mpp? -92.35 125.88 37.19 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.803 0.335 . . . . 0.0 110.846 -175.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.606 HG23 HG12 ' A' ' 58' ' ' ILE . 93.1 t -84.47 127.11 40.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 120.924 0.393 . . . . 0.0 110.244 178.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.541 HG23 ' HB3' ' A' ' 59' ' ' ALA . 81.9 t -99.29 118.05 45.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.929 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.88 HG21 HG13 ' A' ' 56' ' ' ILE . 2.4 pp -118.58 133.45 65.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.271 0.557 . . . . 0.0 110.938 178.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.601 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 30.0 m -126.08 106.26 9.46 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.068 -179.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.63 164.38 37.29 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.859 -173.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -61.33 138.9 79.83 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 122.488 2.126 . . . . 0.0 111.665 173.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -40.05 -48.36 3.86 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 124.449 3.433 . . . . 0.0 115.316 -173.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -72.9 -32.22 65.2 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 121.031 -0.268 . . . . 0.0 111.617 -175.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.42 -32.21 69.72 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.231 0.539 . . . . 0.0 109.966 177.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -57.85 -41.57 82.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.774 177.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -64.99 -35.03 79.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.409 -175.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.7 mtmt -66.09 -44.02 85.63 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.405 0.621 . . . . 0.0 109.699 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.463 ' HB3' HD22 ' A' ' 48' ' ' LEU . . . -69.77 -41.55 75.02 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.058 178.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.482 ' O ' HG21 ' A' ' 87' ' ' ILE . 49.0 tt0 -64.48 -34.44 78.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.242 -177.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -56.79 -42.07 91.37 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.197 177.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 32.7 mmt180 -76.78 -33.38 58.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.788 0.328 . . . . 0.0 111.497 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.482 HG21 ' O ' ' A' ' 84' ' ' GLN . 0.4 OUTLIER -65.53 -37.29 79.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -177.909 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.679 ' HA ' HD22 ' A' ' 91' ' ' LEU . 10.7 m-85 -69.39 -30.66 68.69 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.201 0.524 . . . . 0.0 110.795 174.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -58.02 -33.81 70.38 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.759 175.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.762 ' HZ2' ' HB1' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -61.33 -36.51 80.34 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 117.435 0.617 . . . . 0.0 109.646 177.774 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.708 HD21 ' HG3' ' A' ' 90' ' ' LYS . 2.8 mm? -61.79 -44.87 96.02 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.772 175.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 1.046 ' HE3' ' HB ' ' A' ' 103' ' ' VAL . 3.6 mmtp -76.67 -34.96 58.21 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -176.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -63.1 -33.05 74.62 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.768 -171.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -97.68 18.79 14.8 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.169 -0.613 . . . . 0.0 110.763 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 65.8 t30 58.07 40.5 25.24 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.186 174.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 . . . . . 0 C--N 1.324 -0.542 0 C-N-CA 120.591 -0.443 . . . . 0.0 109.986 176.956 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 . . . . . 0 N--CA 1.454 -0.236 0 CA-C-O 120.569 0.223 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 1.046 ' HB ' ' HE3' ' A' ' 92' ' ' LYS . 13.3 p -60.45 123.3 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 173.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -126.27 89.89 3.09 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.773 0.797 . . . . 0.0 109.335 176.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 tt -101.22 126.92 47.99 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.467 -1.242 . . . . 0.0 108.191 -176.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -81.56 103.32 11.19 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.247 0.546 . . . . 0.0 110.383 -177.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.3 m -95.07 130.77 41.63 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.865 0.364 . . . . 0.0 110.036 177.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 -103.65 120.18 40.39 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.813 0.34 . . . . 0.0 110.643 -177.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 32.9 pt -115.63 134.41 58.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.174 0.512 . . . . 0.0 110.191 178.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.549 HH11 HD12 ' A' ' 153' ' ' ILE . 12.7 tpt180 -86.84 118.98 26.58 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.254 -174.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.687 HG23 ' CD2' ' A' ' 174' ' ' LEU . 7.1 p -121.51 145.04 41.73 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -177.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.819 ' HA ' ' HG2' ' A' ' 151' ' ' GLN . 32.7 Cg_exo -55.67 144.54 75.08 Favored 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 122.586 2.191 . . . . 0.0 110.871 173.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.21 -32.15 70.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.692 -175.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.5 p -79.75 -26.04 40.86 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.778 178.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.681 ' HB2' HG22 ' A' ' 111' ' ' VAL . . . -75.51 -20.41 58.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.315 -177.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.42 -35.1 79.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.11 0.481 . . . . 0.0 110.098 175.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -81.52 -11.3 83.33 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.909 176.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.418 ' HD2' HG23 ' A' ' 177' ' ' VAL . 18.3 ttm180 -93.09 -38.36 11.65 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.723 0.296 . . . . 0.0 111.037 179.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.6 p -65.66 -29.83 48.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.353 -177.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.993 ' HA ' ' HB ' ' A' ' 127' ' ' VAL . 34.9 pt -77.28 -19.48 14.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.005 0.431 . . . . 0.0 110.485 178.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.663 ' HA3' HG23 ' A' ' 126' ' ' THR . . . . . . . . 0 N--CA 1.445 -0.706 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.213 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 64.2 mttp . . . . . 0 CA--C 1.523 -0.067 0 CA-C-O 120.568 0.223 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.663 HG23 ' HA3' ' A' ' 121' ' ' GLY . 14.4 t -69.24 -14.98 63.26 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.961 -0.295 . . . . 0.0 111.129 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.993 ' HB ' ' HA ' ' A' ' 120' ' ' ILE . 12.7 p -66.76 -32.44 58.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.015 0.435 . . . . 0.0 109.964 174.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -66.29 -45.98 78.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.337 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -63.85 -39.06 93.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.242 175.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.692 HD21 HD12 ' A' ' 170' ' ' ILE . 33.4 tp -56.68 -49.44 75.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.147 -176.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.593 ' HG2' ' H ' ' A' ' 138' ' ' VAL . 48.2 mt-30 -61.42 -47.4 85.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.599 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -66.99 -40.09 87.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.855 0.36 . . . . 0.0 111.349 -178.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 34.3 tp -73.13 -42.0 63.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.318 -176.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.418 ' HB ' ' HB1' ' A' ' 166' ' ' ALA . 68.2 p -76.52 -16.26 59.67 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.86 0.362 . . . . 0.0 110.888 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 64.96 26.34 12.74 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.837 -178.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -137.96 162.96 32.71 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.106 -177.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.563 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 8.6 mm-40 -90.23 110.01 21.07 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-O 120.957 0.408 . . . . 0.0 110.395 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.593 ' H ' ' HG2' ' A' ' 131' ' ' GLN . 43.2 t -101.52 104.9 17.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.92 176.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.542 HG13 ' HE3' ' A' ' 155' ' ' LYS . 4.9 p -113.81 111.85 37.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.466 0.65 . . . . 0.0 111.059 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.603 HG12 HG22 ' A' ' 154' ' ' VAL . 9.2 m -90.59 139.14 26.43 Favored Pre-proline 0 N--CA 1.446 -0.631 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 172.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -76.43 122.12 6.37 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 121.845 1.697 . . . . 0.0 112.525 -174.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 11.2 mpt_? -81.53 -13.79 57.67 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 174.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -80.2 -52.13 8.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.933 -1.031 . . . . 0.0 109.44 175.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.532 ' HG2' HG13 ' A' ' 152' ' ' VAL . 40.6 mt-30 73.36 151.1 0.11 Allowed 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 172.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.542 ' HB ' ' HD2' ' A' ' 146' ' ' PRO . 2.2 p -90.95 165.37 22.15 Favored Pre-proline 0 N--CA 1.448 -0.529 0 CA-C-N 114.427 -1.26 . . . . 0.0 110.358 177.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.542 ' HD2' ' HB ' ' A' ' 145' ' ' THR . 20.0 Cg_endo -59.97 159.92 23.88 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.105 2.537 . . . . 0.0 113.601 -177.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -70.83 1.51 5.4 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.096 -0.957 . . . . 0.0 111.207 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -50.13 -35.88 27.58 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.721 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -119.73 7.45 11.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.453 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 44.69 29.86 0.47 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.149 0.98 . . . . 0.0 111.808 -173.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.819 ' HG2' ' HA ' ' A' ' 112' ' ' PRO . 73.9 mt-30 -143.97 153.15 41.96 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 121.069 0.462 . . . . 0.0 111.249 -174.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.532 HG13 ' HG2' ' A' ' 144' ' ' GLN . 33.7 m -126.16 177.91 4.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 176.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.549 HD12 HH11 ' A' ' 110' ' ' ARG . 15.1 mt -121.89 129.62 75.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 O-C-N 121.718 -0.614 . . . . 0.0 111.747 -178.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.603 HG22 HG12 ' A' ' 140' ' ' VAL . 59.4 t -93.1 138.67 19.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 173.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.542 ' HE3' HG13 ' A' ' 139' ' ' VAL . 4.9 mtmt -107.21 123.6 48.53 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.764 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.563 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 52.7 mt -108.0 111.69 36.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 176.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 4.7 mp -107.66 118.45 55.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.904 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 171.7 -165.78 38.69 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.127 -1.035 . . . . 0.0 113.102 178.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.728 ' HA ' HG11 ' A' ' 103' ' ' VAL . 0.3 OUTLIER -77.81 157.24 30.03 Favored 'General case' 0 C--O 1.223 -0.334 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.185 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.495 ' HB3' ' CG ' ' A' ' 88' ' ' TYR . 44.8 p90 -64.24 -23.35 67.27 Favored 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -175.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . 0.556 ' O ' ' HG3' ' A' ' 164' ' ' GLN . 91.1 m-85 -68.73 -51.61 39.55 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.737 0.78 . . . . 0.0 109.543 173.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.15 -41.42 67.11 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.563 -174.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 62.0 p -64.59 -44.28 91.16 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.941 -176.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . 0.605 ' O ' ' HG2' ' A' ' 168' ' ' ARG . 1.2 pp0? -61.09 -38.04 84.84 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.605 177.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' MET . . . . . 0.426 ' HG3' ' O ' ' A' ' 161' ' ' TYR . 81.9 mtp -61.24 -42.4 98.56 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.864 0.364 . . . . 0.0 110.818 177.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.418 ' HB1' ' HB ' ' A' ' 134' ' ' THR . . . -70.67 -43.52 68.92 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.748 178.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -51.99 -55.76 18.44 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.728 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.605 ' HG2' ' O ' ' A' ' 164' ' ' GLN . 9.3 ptt180 -65.38 -29.88 70.64 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.824 -179.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -70.96 -51.12 27.65 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.949 -178.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.692 HD12 HD21 ' A' ' 130' ' ' LEU . 2.3 mp -68.09 -44.83 84.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.574 ' HA ' ' HG ' ' A' ' 174' ' ' LEU . 20.3 mmm180 -58.62 -26.27 63.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.811 0.339 . . . . 0.0 111.352 177.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -69.49 -46.4 66.69 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.655 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.53 HG13 HD21 ' A' ' 174' ' ' LEU . 32.7 pt -72.16 -19.74 19.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.691 -179.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.687 ' CD2' HG23 ' A' ' 111' ' ' VAL . 5.6 mt -66.99 -34.5 77.88 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 177.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.4 -31.72 72.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.18 176.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -71.6 -42.27 67.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.988 177.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.418 HG23 ' HD2' ' A' ' 118' ' ' ARG . 88.9 t -67.5 -35.01 71.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.507 176.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -57.48 -46.59 83.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.165 0.507 . . . . 0.0 110.328 175.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 . . . . . 0 C--N 1.327 -0.387 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.393 177.802 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.235 0.298 0 CA-C-O 121.016 0.436 . . . . 0.0 110.301 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.518 ' O ' ' HA ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -107.65 161.58 14.74 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.663 178.7 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.8 m -139.84 108.63 5.96 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.765 0.317 . . . . 0.0 110.99 -178.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.434 HG22 HD12 ' A' ' 73' ' ' ILE . 35.5 m -127.77 161.02 36.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.128 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -114.97 130.2 56.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.274 -174.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.534 ' HB ' ' HB ' ' A' ' 71' ' ' VAL . 21.4 t -105.06 132.81 50.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.823 -174.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.673 ' CZ ' HG12 ' A' ' 68' ' ' VAL . 5.0 t80 -94.12 104.58 16.6 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.012 0.525 . . . . 0.0 110.846 -174.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.474 ' C ' HG23 ' A' ' 68' ' ' VAL . 26.7 pt -124.66 120.57 25.77 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.391 0.615 . . . . 0.0 110.404 174.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.502 ' HA ' ' HA ' ' A' ' 68' ' ' VAL . 36.5 Cg_endo -64.82 153.1 79.61 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 123.045 2.497 . . . . 0.0 112.541 -174.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.539 ' HA ' HG13 ' A' ' 34' ' ' VAL . . . -60.48 -18.95 54.88 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.052 -176.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -74.09 -13.98 60.92 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.828 177.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.547 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -123.47 -30.75 3.6 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.914 -177.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.562 HG21 ' HB3' ' A' ' 69' ' ' ARG . 11.1 p -54.47 -31.54 23.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -172.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.59 -59.26 11.1 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.174 -1.012 . . . . 0.0 111.642 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.4 -13.48 59.92 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 120.788 0.327 . . . . 0.0 111.007 -174.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.635 HD12 ' HB3' ' A' ' 90' ' ' LYS . 2.0 mm -67.79 -34.4 67.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.75 178.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.468 ' HA ' HD13 ' A' ' 45' ' ' ILE . 19.2 mt -63.23 -59.45 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.962 177.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.431 ' HA3' ' NE2' ' A' ' 44' ' ' HIS . . . 118.8 90.55 1.34 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 119.761 -1.209 . . . . 0.0 115.311 168.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 43.9 tptt 57.38 -79.13 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.655 1.182 . . . . 0.0 113.805 171.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.522 ' HE2' ' HB3' ' A' ' 43' ' ' GLN . 19.2 pttm -117.36 7.68 12.89 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.749 0.309 . . . . 0.0 111.389 -175.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 62.9 39.25 97.8 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.995 -0.622 . . . . 0.0 112.942 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.522 ' HB3' ' HE2' ' A' ' 41' ' ' LYS . 23.0 tt0 -114.82 -48.79 2.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 117.158 0.479 . . . . 0.0 111.384 178.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.431 ' NE2' ' HA3' ' A' ' 39' ' ' GLY . 4.6 p80 -63.56 -19.19 64.6 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.075 0.464 . . . . 0.0 110.703 178.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.468 HD13 ' HA ' ' A' ' 38' ' ' ILE . 10.2 tt -67.26 -32.2 56.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.385 174.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -81.54 -22.25 37.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.287 0.565 . . . . 0.0 110.159 178.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -66.79 -30.57 70.8 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 173.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.626 HD21 ' HE1' ' A' ' 51' ' ' PHE . 0.3 OUTLIER -55.58 -49.31 73.06 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.173 173.822 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.65 ' HA ' HD11 ' A' ' 56' ' ' ILE . 8.6 m -57.87 -37.03 73.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.186 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.8 mtp180 -73.48 -50.92 19.09 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -176.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.626 ' HE1' HD21 ' A' ' 48' ' ' LEU . 0.6 OUTLIER -68.63 -27.46 66.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.938 0.399 . . . . 0.0 110.223 -176.43 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.561 ' O ' ' HB3' ' A' ' 79' ' ' ALA . . . -86.82 -10.64 53.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.892 0.377 . . . . 0.0 110.864 177.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 31.5 m 57.62 38.22 27.7 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.148 178.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -138.65 173.46 11.56 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.623 -174.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 26.4 m -94.7 101.6 13.45 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.179 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.802 HG13 HG23 ' A' ' 73' ' ' ILE . 1.9 mp -106.14 123.12 60.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.129 178.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -138.65 150.97 46.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.23 176.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.2 mm -89.97 120.83 39.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 169.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.807 ' HB1' HG23 ' A' ' 72' ' ' VAL . . . -65.24 122.45 80.0 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.552 -175.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.41 127.29 19.91 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.987 2.458 . . . . 0.0 111.746 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo . . . . . 0 C--O 1.235 0.358 0 C-N-CA 123.204 2.603 . . . . 0.0 112.56 -177.893 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.474 ' O ' ' HD2' ' A' ' 67' ' ' LYS . 24.4 tptp . . . . . 0 C--O 1.232 0.143 0 CA-C-O 121.219 0.533 . . . . 0.0 110.282 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.673 HG12 ' CZ ' ' A' ' 28' ' ' PHE . 10.8 p -139.29 148.8 23.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.857 175.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.562 ' HB3' HG21 ' A' ' 34' ' ' VAL . 17.6 ttm180 -127.09 133.8 50.36 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 175.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.628 ' HE3' ' HB2' ' A' ' 108' ' ' HIS . 41.0 mtp -100.42 149.33 23.77 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 119.863 -0.735 . . . . 0.0 111.14 -171.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.534 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 89.9 t -99.05 127.95 51.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.953 175.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.807 HG23 ' HB1' ' A' ' 59' ' ' ALA . 92.3 t -103.28 110.0 28.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 177.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.802 HG23 HG13 ' A' ' 56' ' ' ILE . 2.6 pp -117.0 129.23 73.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.307 0.575 . . . . 0.0 111.072 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.518 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 35.4 m -125.14 109.44 12.89 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.922 -1.036 . . . . 0.0 109.889 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.45 162.04 35.43 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.363 -0.922 . . . . 0.0 112.601 -177.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.465 ' HG2' ' HB2' ' A' ' 79' ' ' ALA . 19.3 Cg_endo -59.67 137.01 74.53 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.754 2.303 . . . . 0.0 111.339 174.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_exo -40.03 -49.85 3.56 Favored 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 124.314 3.342 . . . . 0.0 114.683 -174.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -68.16 -36.32 79.46 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.888 0.375 . . . . 0.0 111.373 -176.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' A' ' 52' ' ' ALA . . . -74.83 -31.7 61.75 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.425 0.631 . . . . 0.0 110.206 177.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -62.87 -33.45 75.3 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.239 175.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -53.75 -54.73 34.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.673 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.533 ' HE2' ' HA ' ' A' ' 79' ' ' ALA . 37.0 pttt -70.9 -33.77 70.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.677 0.275 . . . . 0.0 111.444 -177.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.35 -45.65 86.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.997 0.427 . . . . 0.0 111.011 177.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.653 ' HB3' ' HE1' ' A' ' 160' ' ' PHE . 23.6 tt0 -71.41 -31.69 67.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.318 -177.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -58.0 -32.7 67.11 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.829 176.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -76.65 -27.63 55.72 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.56 0.219 . . . . 0.0 111.197 178.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.515 HG23 ' O ' ' A' ' 84' ' ' GLN . 0.4 OUTLIER -70.26 -39.73 77.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -177.739 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.439 ' CE2' ' HB3' ' A' ' 105' ' ' LEU . 18.3 m-85 -69.68 -30.81 68.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.095 0.474 . . . . 0.0 109.999 174.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -58.48 -28.6 62.49 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.91 173.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.635 ' HB3' HD12 ' A' ' 37' ' ' ILE . 34.8 mmtp -67.97 -44.39 76.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.082 0.468 . . . . 0.0 109.893 175.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -60.46 -41.71 94.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.851 174.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 1.047 ' HE3' ' HB ' ' A' ' 103' ' ' VAL . 0.6 OUTLIER -65.73 -31.78 72.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.379 178.46 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -52.72 -47.52 67.26 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.575 -176.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.738 ' HB2' ' CE2' ' A' ' 96' ' ' PHE . 10.4 mm-40 -110.14 0.3 18.22 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.665 -177.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 55.72 43.58 27.7 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.751 178.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.738 ' CE2' ' HB2' ' A' ' 94' ' ' GLU . 92.9 m-85 . . . . . 0 N--CA 1.467 0.387 0 CA-C-O 121.101 0.477 . . . . 0.0 111.342 -178.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.431 ' HB3' ' NE2' ' A' ' 159' ' ' HIS . 38.5 mt-10 . . . . . 0 N--CA 1.453 -0.308 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 1.047 ' HB ' ' HE3' ' A' ' 92' ' ' LYS . 12.6 p -59.03 129.84 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.149 175.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.41 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 74.3 mmtt -136.86 91.25 2.62 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.423 -177.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.439 ' HB3' ' CE2' ' A' ' 88' ' ' TYR . 2.4 tt -115.88 117.01 29.0 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -76.95 113.93 15.19 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.311 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.5 m -104.99 143.73 32.78 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . 0.628 ' HB2' ' HE3' ' A' ' 70' ' ' MET . 22.1 m170 -114.41 120.28 39.78 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 120.962 0.411 . . . . 0.0 110.346 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.418 ' CD1' ' HB ' ' A' ' 170' ' ' ILE . 16.6 pt -107.97 138.37 34.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 176.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -90.82 118.68 30.42 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.363 -174.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.575 HG11 HD12 ' A' ' 174' ' ' LEU . 11.1 m -116.95 154.34 49.64 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.769 178.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.617 ' HD2' HD23 ' A' ' 174' ' ' LEU . 38.4 Cg_exo -58.62 146.06 92.98 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.05 1.833 . . . . 0.0 110.891 173.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.415 ' HA ' HG23 ' A' ' 152' ' ' VAL . . . -48.65 -52.21 24.37 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -172.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.5 m -76.34 -17.82 59.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.676 -176.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.19 -24.66 62.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.652 0.263 . . . . 0.0 111.24 -177.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.553 ' HB2' HG11 ' A' ' 140' ' ' VAL . . . -64.17 -29.86 70.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.23 0.538 . . . . 0.0 110.357 177.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -77.01 -23.88 67.95 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.827 177.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.45 ' HD2' HG22 ' A' ' 177' ' ' VAL . 78.8 mtt-85 -83.72 -27.79 28.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.568 0.223 . . . . 0.0 110.592 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.704 HG22 HD12 ' A' ' 130' ' ' LEU . 9.9 p -77.47 -32.34 18.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.086 -178.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.415 ' O ' HG12 ' A' ' 127' ' ' VAL . 47.1 mm -74.34 -38.64 47.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.427 0.632 . . . . 0.0 109.944 177.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.065 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.384 -178.77 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 23.5 tptm . . . . . 0 N--CA 1.468 0.458 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 26.4 m -68.75 -37.34 79.31 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.891 0.377 . . . . 0.0 110.784 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.415 HG12 ' O ' ' A' ' 120' ' ' ILE . 6.4 m -65.21 -20.95 28.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.669 175.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -63.81 -33.43 75.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.969 0.414 . . . . 0.0 109.954 178.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -79.15 -40.31 31.3 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.642 -0.423 . . . . 0.0 109.957 175.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.704 HD12 HG22 ' A' ' 119' ' ' VAL . 66.4 mt -55.57 -52.01 65.17 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -174.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -84.34 -31.92 24.55 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.361 -0.535 . . . . 0.0 112.233 -173.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -72.26 -38.3 68.89 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.785 0.326 . . . . 0.0 111.083 -178.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 42.7 tp -83.03 -46.59 12.67 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.514 -176.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.585 HG23 ' HA ' ' A' ' 166' ' ' ALA . 39.6 p -75.88 -28.01 57.96 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.526 -174.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 67.36 15.48 9.92 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.546 -175.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -112.59 172.1 7.12 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.75 -178.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.466 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 35.2 tt0 -99.99 110.74 23.06 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 177.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 59.8 t -108.42 106.65 21.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.822 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 6.2 p -119.71 115.82 48.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.288 0.566 . . . . 0.0 111.428 -177.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.599 HG21 ' HB ' ' A' ' 154' ' ' VAL . 86.3 t -93.56 110.82 49.43 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.388 173.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.588 ' HG3' ' HE2' ' A' ' 155' ' ' LYS . 21.1 Cg_exo -67.5 149.9 80.16 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 123.104 2.536 . . . . 0.0 112.639 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.35 118.71 22.23 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.581 177.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 65.93 97.34 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.422 0.629 . . . . 0.0 112.004 -178.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.604 ' OE1' ' HB ' ' A' ' 153' ' ' ILE . 20.8 mm-40 -102.96 -66.94 0.9 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.545 176.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -145.61 144.61 23.11 Favored Pre-proline 0 C--N 1.314 -0.978 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.957 -179.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -67.43 168.33 18.26 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 123.23 2.62 . . . . 0.0 113.531 -174.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -58.84 -15.77 14.07 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.904 -177.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -55.41 -43.17 75.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.9 0.381 . . . . 0.0 110.497 172.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.48 -16.75 33.87 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 46.35 28.91 0.77 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.948 1.299 . . . . 0.0 111.731 -178.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -145.29 149.11 34.26 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.381 -174.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.415 HG23 ' HA ' ' A' ' 113' ' ' ALA . 11.2 m -137.59 177.65 5.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 O-C-N 123.362 0.414 . . . . 0.0 110.203 178.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.604 ' HB ' ' OE1' ' A' ' 144' ' ' GLN . 96.7 mt -119.92 144.81 27.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.188 -173.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.599 ' HB ' HG21 ' A' ' 140' ' ' VAL . 1.5 p -135.46 139.43 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-O 121.251 0.548 . . . . 0.0 110.342 168.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.588 ' HE2' ' HG3' ' A' ' 141' ' ' PRO . 19.6 mttm -101.88 133.55 46.46 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.342 -172.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.466 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 68.2 mt -115.3 112.12 38.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.901 177.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.411 ' N ' HD11 ' A' ' 157' ' ' ILE . 4.5 mp -109.63 132.51 57.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.816 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 156.33 -158.43 28.67 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.222 -0.99 . . . . 0.0 112.866 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.832 ' HA ' HG11 ' A' ' 103' ' ' VAL . 13.6 m-70 -76.7 166.08 23.86 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 123.729 0.311 . . . . 0.0 110.64 -177.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.653 ' HE1' ' HB3' ' A' ' 84' ' ' GLN . 10.4 t80 -61.99 -49.04 77.67 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.59 0.233 . . . . 0.0 110.534 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -69.46 -33.61 73.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.894 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.06 -49.85 53.79 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.028 0.442 . . . . 0.0 110.672 178.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.542 ' O ' ' HG3' ' A' ' 167' ' ' GLN . 49.7 m -66.49 -38.43 87.24 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.704 -177.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -64.16 -36.67 84.79 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.708 178.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 90.1 mtp -66.01 -34.08 77.27 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.951 0.405 . . . . 0.0 110.357 176.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.585 ' HA ' HG23 ' A' ' 134' ' ' THR . . . -71.68 -44.16 64.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.493 177.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.542 ' HG3' ' O ' ' A' ' 163' ' ' SER . 75.0 mt-30 -52.46 -51.6 58.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.624 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.747 ' O ' ' HB2' ' A' ' 172' ' ' ASP . 5.9 ptm180 -67.05 -31.74 72.46 Favored 'General case' 0 C--O 1.217 -0.651 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.376 -178.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . 0.435 ' N ' ' HG3' ' A' ' 168' ' ' ARG . 16.2 tppt? -65.25 -53.14 48.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.828 0.347 . . . . 0.0 111.208 -176.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.464 ' O ' ' HG ' ' A' ' 174' ' ' LEU . 3.0 mp -72.29 -44.23 63.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.321 -177.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -61.46 -25.5 67.28 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.916 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.747 ' HB2' ' O ' ' A' ' 168' ' ' ARG . 2.1 t0 -71.16 -47.98 54.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.914 -177.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 18.1 pt -70.12 -19.73 22.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.925 -176.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.617 HD23 ' HD2' ' A' ' 112' ' ' PRO . 19.1 mt -57.73 -32.34 67.33 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.883 0.373 . . . . 0.0 110.733 175.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.71 -31.8 73.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.743 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -67.57 -35.69 79.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.998 177.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.45 HG22 ' HD2' ' A' ' 118' ' ' ARG . 42.1 t -74.82 -27.37 20.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.902 177.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 52.1 tptt -65.66 -45.01 84.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.508 172.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.64 175.159 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 . . . . . 0 N--CA 1.454 -0.227 0 CA-C-O 121.101 0.477 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.43 110.14 15.6 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.126 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 66.0 m -106.62 107.62 18.72 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 173.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.639 ' HB ' HG23 ' A' ' 109' ' ' ILE . 22.2 m -132.14 160.96 42.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.166 -177.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.505 ' HB3' ' HE2' ' A' ' 70' ' ' MET . 12.8 m-70 -116.96 132.0 56.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.615 0.245 . . . . 0.0 110.777 -173.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 70' ' ' MET . 9.6 t -101.52 137.39 29.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.571 -176.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.612 ' HD1' ' HE3' ' A' ' 70' ' ' MET . 1.7 t80 -102.05 105.0 15.67 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.253 -177.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.608 HD11 HD11 ' A' ' 87' ' ' ILE . 18.9 pt -132.4 125.83 19.93 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-O 121.288 0.566 . . . . 0.0 111.676 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.487 ' HA ' ' HA ' ' A' ' 68' ' ' VAL . 52.0 Cg_exo -55.85 148.27 57.41 Favored 'Trans proline' 0 C--O 1.239 0.553 0 C-N-CA 123.31 2.674 . . . . 0.0 112.504 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.608 ' HA ' HG13 ' A' ' 34' ' ' VAL . . . -57.83 -23.8 54.41 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.762 -1.108 . . . . 0.0 112.916 -171.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.661 ' HB2' ' HZ ' ' A' ' 96' ' ' PHE . 62.6 mm-40 -64.67 -21.74 66.81 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -175.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.656 ' HB1' ' HE2' ' A' ' 96' ' ' PHE . . . -121.86 -28.97 4.38 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.521 -175.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.608 HG13 ' HA ' ' A' ' 31' ' ' ALA . 14.3 p -57.28 -29.21 32.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-O 121.24 0.543 . . . . 0.0 110.166 -178.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.6 -55.32 31.42 Favored Glycine 0 N--CA 1.438 -1.216 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.627 176.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.45 -13.88 61.15 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 120.891 0.377 . . . . 0.0 110.585 -177.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.623 HG12 ' O ' ' A' ' 33' ' ' ALA . 7.8 mm -66.29 -37.38 79.56 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.149 175.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.405 HG12 HD11 ' A' ' 45' ' ' ILE . 19.6 mt -66.94 -43.9 88.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.628 174.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 83.78 -173.86 51.14 Favored Glycine 0 C--O 1.224 -0.525 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.957 174.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -47.83 91.07 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.509 0.723 . . . . 0.0 112.486 -177.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.6 ttpt 49.28 37.41 11.34 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.984 0.913 . . . . 0.0 111.544 -175.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.443 ' HA2' HG22 ' A' ' 45' ' ' ILE . . . 83.01 26.85 43.09 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.233 -0.984 . . . . 0.0 112.557 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -56.1 -71.57 0.09 Allowed 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -76.78 -20.6 56.25 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.208 0.448 . . . . 0.0 112.208 -173.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.443 HG22 ' HA2' ' A' ' 42' ' ' GLY . 10.3 tt -68.8 -37.07 76.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.904 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.631 ' HA ' ' HZ1' ' A' ' 46' ' ' LYS . 1.9 mmmp? -82.23 -22.42 35.89 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 121.939 -0.476 . . . . 0.0 110.679 177.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -69.96 -30.38 67.73 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 172.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.691 ' HA ' ' HE1' ' A' ' 51' ' ' PHE . 0.2 OUTLIER -51.38 -50.46 59.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.996 175.733 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.498 ' HA ' HD13 ' A' ' 56' ' ' ILE . 1.6 p -63.91 -23.26 67.28 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.231 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -74.38 -51.75 14.11 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.691 ' HE1' ' HA ' ' A' ' 48' ' ' LEU . 13.1 p90 -83.97 -22.71 31.35 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.512 -173.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -95.7 -16.53 21.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.85 0.357 . . . . 0.0 111.095 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 73.2 m 56.29 26.46 10.54 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.482 -178.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -106.64 171.55 7.3 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.824 -179.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.5 m -95.7 107.38 19.59 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 178.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.81 HG13 HG21 ' A' ' 73' ' ' ILE . 2.9 mp -108.02 121.31 60.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.782 -176.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -139.51 155.75 47.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.828 175.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 48.5 mm -99.92 129.56 50.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 173.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.72 ' HB3' HG23 ' A' ' 72' ' ' VAL . . . -81.74 119.08 74.51 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.137 -175.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -73.25 125.65 10.43 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 123.037 2.491 . . . . 0.0 112.055 176.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.426 ' HD3' ' HG3' ' A' ' 69' ' ' ARG . 72.3 Cg_endo . . . . . 0 N--CA 1.458 -0.56 0 C-N-CA 122.242 1.961 . . . . 0.0 111.658 176.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? . . . . . 0 N--CA 1.456 -0.146 0 CA-C-O 121.542 0.687 . . . . 0.0 110.171 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.511 HG13 ' CE2' ' A' ' 28' ' ' PHE . 1.4 p -137.46 148.66 25.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.723 -174.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.426 ' HG3' ' HD3' ' A' ' 61' ' ' PRO . 19.8 ttm180 -126.1 144.35 50.77 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 177.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.619 ' HE1' ' HB2' ' A' ' 108' ' ' HIS . 42.0 mtp -98.58 149.45 22.74 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.429 -173.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 26' ' ' HIS . 90.9 t -105.98 137.92 33.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.828 174.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.72 HG23 ' HB3' ' A' ' 59' ' ' ALA . 58.6 t -111.57 109.36 28.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 178.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.81 HG21 HG13 ' A' ' 56' ' ' ILE . 2.0 pp -124.6 140.32 48.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.143 0.497 . . . . 0.0 111.31 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 90.1 m -131.28 113.92 14.39 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.132 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.65 162.75 36.14 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.37 -177.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.415 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 45.3 Cg_endo -68.42 140.44 48.13 Favored 'Trans proline' 0 CA--C 1.531 0.346 0 C-N-CA 122.698 2.265 . . . . 0.0 111.371 175.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 76' ' ' PRO . 80.4 Cg_exo -45.98 -36.37 15.73 Favored 'Trans proline' 0 N--CA 1.477 0.543 0 C-N-CA 124.746 3.631 . . . . 0.0 114.897 -172.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -72.37 -39.37 68.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.84 0.352 . . . . 0.0 110.813 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.535 ' HA ' ' HE2' ' A' ' 82' ' ' LYS . . . -75.44 -29.31 59.65 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.235 0.54 . . . . 0.0 110.186 176.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -64.72 -35.38 80.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.3 178.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -53.34 -51.0 63.84 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.14 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.535 ' HE2' ' HA ' ' A' ' 79' ' ' ALA . 47.2 pttt -72.71 -33.85 66.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.465 -177.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.496 ' HB1' HD13 ' A' ' 48' ' ' LEU . . . -67.14 -53.8 27.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.866 0.365 . . . . 0.0 111.097 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.443 ' O ' HG23 ' A' ' 87' ' ' ILE . 45.1 tt0 -65.82 -29.72 70.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.107 -178.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -53.85 -35.73 53.81 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.737 177.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -75.81 -40.06 55.7 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 120.855 0.36 . . . . 0.0 110.852 178.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.608 HD11 HD11 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -65.33 -38.5 82.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.052 -177.343 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.818 ' HA ' HD23 ' A' ' 91' ' ' LEU . 2.2 m-30 -69.62 -27.34 64.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.763 0.316 . . . . 0.0 111.166 173.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -57.81 -41.14 93.86 Favored Glycine 0 CA--C 1.52 0.402 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.567 177.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.629 ' HZ1' ' HB2' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -65.29 -24.64 67.35 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.68 0.276 . . . . 0.0 111.038 179.171 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.818 HD23 ' HA ' ' A' ' 88' ' ' TYR . 1.6 mp -58.37 -50.57 73.2 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.443 0.639 . . . . 0.0 110.392 177.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.871 ' HE3' ' HB ' ' A' ' 103' ' ' VAL . 0.6 OUTLIER -73.67 -37.89 65.11 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.434 177.711 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.464 ' HB3' ' HA ' ' A' ' 90' ' ' LYS . 3.7 tp10 -58.74 -38.46 78.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.525 -177.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -96.74 8.81 43.43 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -176.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 54.98 34.61 22.77 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.911 175.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.661 ' HZ ' ' HB2' ' A' ' 32' ' ' GLN . 44.4 m-85 . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 121.404 0.621 . . . . 0.0 109.555 174.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 . . . . . 0 N--CA 1.454 -0.236 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.871 ' HB ' ' HE3' ' A' ' 92' ' ' LYS . 7.2 p -79.68 129.65 37.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.177 0.513 . . . . 0.0 110.227 174.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.552 ' HD2' ' HA2' ' A' ' 158' ' ' GLY . 21.1 mmmt -139.14 89.48 2.35 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 174.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.779 ' HG ' HD22 ' A' ' 91' ' ' LEU . 3.4 tm? -110.94 130.48 55.57 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.489 -169.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.434 ' HA ' HG13 ' A' ' 157' ' ' ILE . 6.8 tp10 -64.88 118.91 9.73 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.394 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.0 m -126.39 114.93 18.86 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 177.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . 0.619 ' HB2' ' HE1' ' A' ' 70' ' ' MET . 49.9 m170 -99.66 120.42 39.67 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.942 0.401 . . . . 0.0 110.792 -177.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.639 HG23 ' HB ' ' A' ' 25' ' ' VAL . 39.8 pt -110.22 149.38 13.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.063 176.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 13.7 mmt180 -96.76 119.48 35.32 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.336 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.574 HG13 HD22 ' A' ' 174' ' ' LEU . 16.8 m -111.79 152.23 44.01 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 177.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.799 ' HD2' ' HG ' ' A' ' 174' ' ' LEU . 32.4 Cg_exo -56.22 147.73 64.38 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.435 2.09 . . . . 0.0 111.043 176.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -50.11 -52.1 37.63 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -171.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 18.6 m -72.25 -25.4 61.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.795 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.5 -26.52 65.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.798 0.333 . . . . 0.0 110.881 -178.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.62 ' O ' HG13 ' A' ' 119' ' ' VAL . . . -64.96 -28.84 69.79 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.967 178.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -81.43 -18.97 67.44 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.613 -0.804 . . . . 0.0 111.838 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.56 ' HD3' HG21 ' A' ' 177' ' ' VAL . 17.8 mtp85 -92.38 -19.53 21.99 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 122.733 -0.275 . . . . 0.0 111.23 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.62 HG13 ' O ' ' A' ' 116' ' ' ALA . 7.6 p -69.52 -29.16 40.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.066 0.46 . . . . 0.0 110.236 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.932 ' HA ' ' HB ' ' A' ' 127' ' ' VAL . 7.7 pt -86.5 -33.62 7.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.59 175.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.562 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.913 179.264 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.401 ' HD3' ' N ' ' A' ' 126' ' ' THR . 1.2 tmtp? . . . . . 0 CA--C 1.538 0.509 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.401 ' N ' ' HD3' ' A' ' 125' ' ' LYS . 95.1 m -60.16 -46.07 90.95 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -175.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.932 ' HB ' ' HA ' ' A' ' 120' ' ' ILE . 7.1 p -64.62 -40.4 88.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.813 0.34 . . . . 0.0 111.322 -178.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -68.61 -33.96 74.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.258 0.551 . . . . 0.0 109.94 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -64.24 -41.71 96.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.864 175.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 80.9 mt -59.45 -50.04 75.49 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.567 175.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -62.76 -40.55 97.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.292 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -68.03 -27.69 66.76 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.401 -177.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -93.18 -43.19 8.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.886 0.375 . . . . 0.0 110.961 -176.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 76.1 p -84.66 -20.47 31.22 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -175.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 67.04 20.64 10.37 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 123.724 0.64 . . . . 0.0 110.998 -178.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -118.43 157.46 27.15 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.167 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.568 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 36.4 tt0 -88.35 110.55 20.88 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 59.2 t -108.74 106.8 21.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.321 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.411 ' C ' HG21 ' A' ' 154' ' ' VAL . 6.7 p -132.28 120.74 44.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.38 0.61 . . . . 0.0 111.482 -178.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.61 HG21 ' HB3' ' A' ' 116' ' ' ALA . 2.6 p -99.82 113.16 64.95 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.01 177.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.516 ' HD2' ' O ' ' A' ' 153' ' ' ILE . 36.1 Cg_exo -60.78 125.64 17.74 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.439 2.092 . . . . 0.0 111.55 175.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -83.75 -15.22 49.34 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.26 0.553 . . . . 0.0 109.814 178.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -106.66 59.28 0.64 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.03 172.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.656 ' HG2' ' HB ' ' A' ' 152' ' ' VAL . 57.5 tp60 -100.52 171.75 7.54 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.147 -174.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.452 ' N ' ' HG3' ' A' ' 144' ' ' GLN . 31.7 p -45.21 153.82 0.52 Allowed Pre-proline 0 C--N 1.325 -0.499 0 C-N-CA 123.564 0.746 . . . . 0.0 112.346 174.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -54.61 153.85 22.3 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 123.398 2.732 . . . . 0.0 112.914 -176.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -78.33 9.34 3.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.544 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -53.05 -43.61 66.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.627 175.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . 0.406 ' O ' ' HG2' ' A' ' 150' ' ' GLU . 0.2 OUTLIER -79.74 1.02 28.19 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.668 -175.149 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 149' ' ' ASN . 9.2 pt-20 46.42 29.06 0.81 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.074 0.95 . . . . 0.0 110.484 -171.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -164.5 130.39 2.88 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.17 -169.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.656 ' HB ' ' HG2' ' A' ' 144' ' ' GLN . 23.7 m -128.26 -176.55 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.899 -175.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.516 ' O ' ' HD2' ' A' ' 141' ' ' PRO . 49.2 mt -104.85 142.52 17.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.03 -174.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.411 HG21 ' C ' ' A' ' 139' ' ' VAL . 2.1 p -135.0 140.0 46.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.074 164.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.9 mttt -95.24 145.6 24.94 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.424 -172.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.568 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 70.6 mt -131.42 110.79 18.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.476 174.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.434 HG13 ' HA ' ' A' ' 106' ' ' GLU . 3.8 mp -120.32 118.44 56.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 178.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.552 ' HA2' ' HD2' ' A' ' 104' ' ' LYS . . . -170.87 -170.17 34.77 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.489 -0.863 . . . . 0.0 112.164 -174.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.539 ' HA ' ' O ' ' A' ' 103' ' ' VAL . 24.6 m170 -80.35 169.99 17.0 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -53.26 -45.89 69.01 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -174.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . 0.465 ' O ' ' HG3' ' A' ' 165' ' ' MET . 36.3 p90 -73.88 -33.85 64.21 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.92 0.391 . . . . 0.0 110.762 178.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.79 -50.97 37.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.133 -174.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 26.5 m -58.1 -48.57 79.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.64 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . 0.491 ' O ' ' HG2' ' A' ' 168' ' ' ARG . 65.7 mt-30 -61.74 -32.03 72.24 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.665 -178.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' MET . . . . . 0.465 ' HG3' ' O ' ' A' ' 161' ' ' TYR . 77.0 mtp -70.04 -48.54 57.54 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.382 175.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.43 -42.07 98.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.534 -177.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.499 HE21 HG21 ' A' ' 25' ' ' VAL . 39.0 mt-30 -51.4 -54.65 24.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.279 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.491 ' HG2' ' O ' ' A' ' 164' ' ' GLN . 19.4 ptt180 -75.7 -30.81 59.43 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . 0.885 ' HA ' ' HE3' ' A' ' 169' ' ' LYS . 0.1 OUTLIER -70.85 -36.79 73.03 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 122.195 -0.316 . . . . 0.0 111.292 -177.342 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.636 ' O ' HD13 ' A' ' 174' ' ' LEU . 1.8 mp -75.29 -43.04 43.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 174.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.579 ' HA ' HD23 ' A' ' 174' ' ' LEU . 10.7 mmm180 -54.85 -25.74 30.67 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.994 0.426 . . . . 0.0 110.883 175.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.465 ' HB3' ' O ' ' A' ' 169' ' ' LYS . 6.7 t70 -63.13 -55.66 23.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.415 -0.812 . . . . 0.0 111.11 178.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.525 ' O ' HG22 ' A' ' 177' ' ' VAL . 37.8 pt -67.31 -21.95 28.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.882 -176.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.799 ' HG ' ' HD2' ' A' ' 112' ' ' PRO . 6.7 mp -57.18 -41.69 79.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.825 176.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.469 ' O ' ' HG2' ' A' ' 179' ' ' GLN . . . -68.16 -35.59 78.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.321 178.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -67.56 -32.58 73.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.457 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.56 HG21 ' HD3' ' A' ' 118' ' ' ARG . 60.0 t -72.86 -38.21 56.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.881 0.372 . . . . 0.0 110.535 178.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -69.17 -11.14 60.54 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.298 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 0.469 ' HG2' ' O ' ' A' ' 175' ' ' ALA . 33.1 mm-40 . . . . . 0 N--CA 1.464 0.261 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.143 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 . . . . . 0 N--CA 1.454 -0.265 0 CA-C-O 120.911 0.386 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.666 ' OE1' ' HG3' ' A' ' 171' ' ' ARG . 58.4 mt-10 -102.44 132.14 48.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.585 176.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.8 m -100.82 106.73 18.14 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 172.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.669 HG11 HG23 ' A' ' 109' ' ' ILE . 4.6 t -136.08 146.61 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.07 -174.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.445 ' HB2' ' O ' ' A' ' 108' ' ' HIS . 11.5 m170 -104.19 128.58 51.91 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-O 120.932 0.396 . . . . 0.0 110.483 -176.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.486 ' HB ' ' CG1' ' A' ' 71' ' ' VAL . 2.3 t -108.7 142.4 21.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -99.13 112.77 24.83 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -174.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.569 HG22 HD23 ' A' ' 91' ' ' LEU . 6.5 pt -126.81 120.11 22.78 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.846 176.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.536 ' HA ' ' HA ' ' A' ' 68' ' ' VAL . 68.6 Cg_exo -51.46 144.56 31.6 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.395 2.73 . . . . 0.0 112.58 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.584 ' HA ' HG12 ' A' ' 34' ' ' VAL . . . -59.85 -22.94 62.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.974 -1.012 . . . . 0.0 112.218 -173.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -84.2 0.3 49.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.38 -178.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.902 ' HB1' ' HE2' ' A' ' 96' ' ' PHE . . . -125.07 -32.75 2.97 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.594 174.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.584 HG12 ' HA ' ' A' ' 31' ' ' ALA . 11.2 p -57.01 -26.99 25.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-O 121.206 0.527 . . . . 0.0 110.075 -178.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.58 -56.95 22.32 Favored Glycine 0 N--CA 1.431 -1.649 0 CA-C-N 115.344 -0.843 . . . . 0.0 111.566 176.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.34 -13.53 59.8 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.826 0.346 . . . . 0.0 111.227 -174.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.638 HD13 ' HG2' ' A' ' 90' ' ' LYS . 3.3 mm -66.35 -39.47 84.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 176.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.712 HG23 ' HA2' ' A' ' 42' ' ' GLY . 32.5 mt -64.37 -44.78 97.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 172.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 70.6 104.45 0.04 OUTLIER Glycine 0 CA--C 1.519 0.309 0 N-CA-C 115.706 1.042 . . . . 0.0 115.706 163.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.434 ' C ' ' H ' ' A' ' 42' ' ' GLY . 66.7 mttm 40.54 98.39 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.598 1.159 . . . . 0.0 113.707 167.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.678 ' HE2' ' HB3' ' A' ' 43' ' ' GLN . 24.6 ttpt 76.13 -23.21 0.25 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.209 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.712 ' HA2' HG23 ' A' ' 38' ' ' ILE . . . 92.31 23.06 27.82 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.977 -178.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.678 ' HB3' ' HE2' ' A' ' 41' ' ' LYS . 19.2 pt20 -87.95 -24.71 23.5 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.15 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 81.3 m-70 -66.11 -44.53 84.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.783 0.325 . . . . 0.0 110.775 -178.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.559 ' CD1' HG12 ' A' ' 58' ' ' ILE . 3.0 tt -61.75 -49.06 85.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.242 -177.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -77.55 -21.36 52.67 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.849 0.356 . . . . 0.0 111.033 -175.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -68.43 -36.67 79.4 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 172.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.932 HD22 HG12 ' A' ' 56' ' ' ILE . 1.2 tp -56.73 -40.69 76.15 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.209 177.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.67 ' HA ' HD11 ' A' ' 56' ' ' ILE . 2.1 m -56.85 -38.46 72.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.984 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -70.7 -51.27 28.67 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -175.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.648 ' CZ ' ' HA ' ' A' ' 48' ' ' LEU . 10.6 p90 -79.14 -6.88 57.55 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 120.274 -0.57 . . . . 0.0 111.553 -176.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -97.55 -13.12 21.83 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.863 0.363 . . . . 0.0 110.703 173.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.7 m 56.62 39.61 29.72 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.054 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' A' ' 74' ' ' THR . . . -141.28 174.62 10.36 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.469 -174.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.595 ' HB3' ' HB ' ' A' ' 74' ' ' THR . 32.3 t -92.78 104.34 16.61 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.932 HG12 HD22 ' A' ' 48' ' ' LEU . 1.9 mp -110.97 115.52 50.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.778 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -143.49 151.36 40.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.938 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.559 HG12 ' CD1' ' A' ' 45' ' ' ILE . 25.1 mm -86.88 134.64 27.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.719 0.295 . . . . 0.0 110.347 178.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.723 ' HB2' HG21 ' A' ' 72' ' ' VAL . . . -95.27 116.77 66.62 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.397 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -62.37 128.61 24.22 Favored 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 122.698 2.265 . . . . 0.0 112.053 178.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.733 ' HD3' ' HG3' ' A' ' 69' ' ' ARG . 57.2 Cg_endo . . . . . 0 C--O 1.237 0.437 0 C-N-CA 122.449 2.099 . . . . 0.0 111.635 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? . . . . . 0 C--O 1.23 0.076 0 CA-C-O 121.047 0.451 . . . . 0.0 110.747 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.536 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 2.0 p -134.16 147.15 30.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.192 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.733 ' HG3' ' HD3' ' A' ' 61' ' ' PRO . 27.2 ttm180 -119.18 145.87 45.64 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.62 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 55.3 mtt -87.6 149.07 24.55 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.817 0.342 . . . . 0.0 110.321 -178.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.486 ' CG1' ' HB ' ' A' ' 27' ' ' VAL . 2.8 p -118.5 131.97 69.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 169.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.723 HG21 ' HB2' ' A' ' 59' ' ' ALA . 58.3 t -86.81 102.62 12.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.096 0.474 . . . . 0.0 109.977 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.446 HD12 HG13 ' A' ' 56' ' ' ILE . 1.9 mm -94.97 117.63 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.987 175.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.646 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 25.0 m -130.02 106.26 8.52 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.656 175.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.13 162.0 35.31 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.748 -176.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -69.51 155.41 66.83 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.356 2.038 . . . . 0.0 111.144 171.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -38.92 -42.92 2.11 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 124.041 3.161 . . . . 0.0 114.231 -177.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.453 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 30.4 tt0 -55.99 -50.3 71.24 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.149 0.5 . . . . 0.0 110.561 176.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.429 ' HA ' ' CE ' ' A' ' 82' ' ' LYS . . . -63.54 -36.68 84.57 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.689 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -55.96 -35.58 66.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.942 177.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -69.7 -55.66 9.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.767 -174.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.453 ' HD3' ' O ' ' A' ' 78' ' ' GLU . 0.4 OUTLIER -74.62 -34.16 62.74 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 120.119 -0.632 . . . . 0.0 111.879 -176.36 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.31 -52.59 64.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.93 0.395 . . . . 0.0 110.617 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.428 ' HA ' HG23 ' A' ' 87' ' ' ILE . 47.6 mt-30 -76.38 -31.25 57.9 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.216 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -53.95 -43.65 71.84 Favored Glycine 0 CA--C 1.512 -0.153 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.02 177.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.446 ' HG2' ' O ' ' A' ' 82' ' ' LYS . 12.6 mmt180 -74.84 -43.04 56.73 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.989 0.423 . . . . 0.0 110.076 176.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.874 ' HA ' ' HD3' ' A' ' 90' ' ' LYS . 0.4 OUTLIER -63.8 -35.79 74.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.994 -171.189 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -64.48 -30.51 71.55 Favored 'General case' 0 C--N 1.333 -0.114 0 O-C-N 121.866 -0.522 . . . . 0.0 109.688 176.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -65.0 -29.03 74.31 Favored Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.666 173.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.874 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 4.3 mptp? -68.84 -33.36 73.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.148 0.499 . . . . 0.0 110.103 175.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.758 ' HG ' ' HG ' ' A' ' 105' ' ' LEU . 4.1 mm? -64.55 -40.24 95.21 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.523 172.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.843 ' HE3' ' HB ' ' A' ' 103' ' ' VAL . 0.1 OUTLIER -71.71 -22.0 61.7 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.564 176.659 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -53.52 -47.27 70.06 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.302 178.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -112.81 3.79 16.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.902 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 43.09 59.99 2.7 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 172.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.902 ' HE2' ' HB1' ' A' ' 33' ' ' ALA . 82.8 m-85 . . . . . 0 C--N 1.327 -0.41 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.955 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.464 ' O ' ' HG2' ' A' ' 104' ' ' LYS . 6.7 mm-40 . . . . . 0 CA--C 1.515 -0.4 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.843 ' HB ' ' HE3' ' A' ' 92' ' ' LYS . 14.9 p -52.39 125.37 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 CA-C-O 121.576 0.703 . . . . 0.0 111.258 -173.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 47.1 mmtm -120.13 91.16 3.47 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.563 -1.198 . . . . 0.0 108.755 178.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.758 ' HG ' ' HG ' ' A' ' 91' ' ' LEU . 1.5 tt -108.27 124.9 51.01 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.658 -173.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -74.5 120.93 20.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.627 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.4 m -107.33 108.47 19.86 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 173.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . 0.445 ' O ' ' HB2' ' A' ' 26' ' ' HIS . 12.1 m-70 -104.01 121.07 42.39 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.159 0.504 . . . . 0.0 109.921 -177.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.669 HG23 HG11 ' A' ' 25' ' ' VAL . 23.0 pt -122.88 152.22 27.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 C-N-CA 120.534 -0.466 . . . . 0.0 112.138 -173.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.682 ' HD3' HG12 ' A' ' 153' ' ' ILE . 1.7 mmt180 -100.05 116.83 32.99 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.435 174.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 151' ' ' GLN . 31.2 m -104.93 162.31 20.15 Favored Pre-proline 0 C--N 1.316 -0.858 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 173.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -51.83 139.69 49.25 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 121.442 1.428 . . . . 0.0 109.856 170.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -55.18 -30.5 60.03 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.492 -170.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.5 m -93.02 -15.64 25.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.75 0.31 . . . . 0.0 111.439 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.62 -24.72 61.93 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.913 -172.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.564 ' O ' HG11 ' A' ' 119' ' ' VAL . . . -57.99 -28.84 64.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.145 0.498 . . . . 0.0 110.787 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.92 -27.76 73.52 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.997 -0.62 . . . . 0.0 113.014 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.569 ' HD3' HG21 ' A' ' 177' ' ' VAL . 69.3 mtp180 -92.12 -22.79 19.69 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 122.385 -0.479 . . . . 0.0 111.488 -178.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.564 HG11 ' O ' ' A' ' 116' ' ' ALA . 9.8 p -73.31 -27.98 24.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 174.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.922 ' HA ' ' HB ' ' A' ' 127' ' ' VAL . 67.7 mt -78.56 -39.44 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 CA-C-O 121.708 0.766 . . . . 0.0 109.339 171.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.588 ' HA3' ' HB ' ' A' ' 126' ' ' THR . . . . . . . . 0 N--CA 1.442 -0.933 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.312 175.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 41.3 tptt . . . . . 0 C--O 1.232 0.177 0 CA-C-O 121.103 0.477 . . . . 0.0 110.621 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.588 ' HB ' ' HA3' ' A' ' 121' ' ' GLY . 84.2 m -65.2 -46.93 78.72 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.306 -176.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.922 ' HB ' ' HA ' ' A' ' 120' ' ' ILE . 11.6 p -67.83 -35.84 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 121.029 -0.268 . . . . 0.0 111.219 -176.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -65.26 -43.57 90.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.2 0.524 . . . . 0.0 109.989 178.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -68.49 -35.68 77.87 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.102 177.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.668 HD23 HD13 ' A' ' 170' ' ' ILE . 39.4 tp -60.74 -49.53 77.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.817 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.496 ' NE2' ' HA ' ' A' ' 137' ' ' GLU . 39.3 mt-30 -66.65 -32.37 73.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.777 0.322 . . . . 0.0 111.129 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -64.05 -43.6 95.04 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.996 0.427 . . . . 0.0 110.703 175.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 6.7 tt -73.88 -48.11 33.3 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.805 -177.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.631 ' HB ' ' HB2' ' A' ' 166' ' ' ALA . 70.5 p -77.65 -29.98 51.9 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -172.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 65.03 28.17 12.48 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.601 -175.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -121.02 169.37 10.56 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.441 177.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.496 ' HA ' ' NE2' ' A' ' 131' ' ' GLN . 9.0 tp10 -96.18 111.86 23.78 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.835 -178.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.451 ' H ' ' NE2' ' A' ' 131' ' ' GLN . 45.3 t -113.63 107.33 22.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 O-C-N 123.82 0.7 . . . . 0.0 109.391 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.641 HG12 ' HD3' ' A' ' 155' ' ' LYS . 14.9 p -125.87 126.9 70.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.231 0.539 . . . . 0.0 111.63 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.416 HG22 ' HB ' ' A' ' 154' ' ' VAL . 59.9 t -104.94 112.95 65.26 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.906 176.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.603 ' HG3' ' HE3' ' A' ' 155' ' ' LYS . 34.6 Cg_exo -62.01 156.98 46.32 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 123.1 2.533 . . . . 0.0 112.325 177.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -87.4 -26.1 23.48 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.076 -178.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -120.2 115.97 24.68 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.133 178.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.512 ' OE1' ' HB ' ' A' ' 153' ' ' ILE . 22.4 mm-40 -127.77 -86.9 0.57 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.012 0.434 . . . . 0.0 112.034 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -152.77 154.65 31.65 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.299 -175.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.76 165.17 26.59 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.731 2.288 . . . . 0.0 111.2 175.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -69.98 -3.96 18.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.96 -177.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -53.84 -42.57 68.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.277 0.56 . . . . 0.0 110.239 169.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -84.21 -14.12 50.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.832 -179.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 47.27 23.46 0.33 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.024 1.33 . . . . 0.0 112.058 -175.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.457 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 57.8 mt-30 -143.27 142.26 31.3 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 120.994 0.426 . . . . 0.0 111.16 -175.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 19.7 m -131.93 163.46 37.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 174.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.682 HG12 ' HD3' ' A' ' 110' ' ' ARG . 12.8 mt -107.39 141.71 21.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.365 0.602 . . . . 0.0 112.393 -176.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.416 ' HB ' HG22 ' A' ' 140' ' ' VAL . 2.5 p -128.49 139.44 51.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.379 163.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.641 ' HD3' HG12 ' A' ' 139' ' ' VAL . 0.0 OUTLIER -99.44 137.76 37.48 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -176.27 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 65.1 mt -113.5 111.18 34.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 169.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 4.7 mp -113.69 140.84 31.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 156.28 -168.52 33.62 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.113 -1.041 . . . . 0.0 112.636 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.413 ' CD2' HG13 ' A' ' 103' ' ' VAL . 12.1 t-80 -75.55 160.85 29.7 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.602 -0.299 . . . . 0.0 110.374 -178.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.531 ' O ' ' HG2' ' A' ' 164' ' ' GLN . 30.4 t80 -49.39 -50.0 42.28 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -172.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -71.47 -47.44 55.63 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.194 -177.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -59.27 -44.62 92.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.911 0.386 . . . . 0.0 110.845 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.652 ' O ' ' HG3' ' A' ' 167' ' ' GLN . 31.9 t -63.79 -52.1 61.79 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.173 -177.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . 0.531 ' HG2' ' O ' ' A' ' 160' ' ' PHE . 4.0 pt20 -66.96 -35.21 79.46 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.406 -177.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' MET . . . . . 0.526 ' HE2' ' HA ' ' A' ' 134' ' ' THR . 47.1 ttp -64.85 -36.72 85.27 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.068 0.461 . . . . 0.0 109.912 177.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.631 ' HB2' ' HB ' ' A' ' 134' ' ' THR . . . -69.47 -43.11 73.88 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.241 174.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.669 ' O ' ' HG2' ' A' ' 171' ' ' ARG . 80.7 mt-30 -51.47 -56.71 11.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.341 -176.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.4 -29.78 66.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.036 -179.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . 0.804 ' HA ' ' HE2' ' A' ' 169' ' ' LYS . 0.6 OUTLIER -75.17 -36.39 61.5 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 120.862 0.363 . . . . 0.0 110.399 -172.903 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.668 HD13 HD23 ' A' ' 130' ' ' LEU . 1.8 mp -74.61 -42.46 48.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.469 178.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.669 ' HG2' ' O ' ' A' ' 167' ' ' GLN . 0.8 OUTLIER -64.25 -25.62 68.14 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.391 0.615 . . . . 0.0 109.419 179.284 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -73.06 -44.24 60.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.583 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.548 HG13 ' O ' ' A' ' 170' ' ' ILE . 2.8 pp -70.95 -19.22 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.904 -178.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 170' ' ' ILE . 39.3 mt -58.82 -34.82 71.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.035 0.445 . . . . 0.0 110.365 174.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.17 -34.53 78.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.767 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -66.44 -39.06 88.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.22 0.533 . . . . 0.0 109.973 176.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.569 HG21 ' HD3' ' A' ' 118' ' ' ARG . 39.6 t -63.53 -38.96 83.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.229 176.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -63.58 -44.49 93.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.271 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.197 -179.308 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 . . . . . 0 C--O 1.236 0.362 0 CA-C-O 120.972 0.415 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -98.1 117.74 33.14 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.183 -178.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 48.3 m -110.57 107.72 17.43 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.82 176.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.528 ' HB ' HD12 ' A' ' 73' ' ' ILE . 34.8 t -117.9 147.87 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.424 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 13.8 m-70 -110.04 123.36 49.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.862 0.363 . . . . 0.0 110.71 -173.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.564 ' HB ' ' HB ' ' A' ' 71' ' ' VAL . 44.4 t -90.36 142.03 13.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.59 -176.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.24 105.16 14.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.469 -177.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.549 ' C ' ' HB ' ' A' ' 68' ' ' VAL . 13.9 pt -127.9 123.47 22.81 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 120.938 0.399 . . . . 0.0 110.929 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.43 ' HA ' HG11 ' A' ' 68' ' ' VAL . 81.4 Cg_exo -48.53 143.53 15.75 Favored 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 123.531 2.821 . . . . 0.0 112.638 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.421 ' HA ' HG12 ' A' ' 34' ' ' VAL . . . -58.08 -18.79 27.14 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.101 -176.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.5 mp0 -65.25 -44.28 88.64 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.401 177.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.733 ' HB2' ' HE2' ' A' ' 96' ' ' PHE . . . -93.71 -29.64 15.3 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.196 -171.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.582 ' HA ' HG12 ' A' ' 37' ' ' ILE . 12.2 p -56.92 -27.64 26.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 O-C-N 123.253 0.346 . . . . 0.0 111.201 -174.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.83 -56.82 22.84 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.235 -0.983 . . . . 0.0 111.076 177.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.95 -15.71 60.13 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.607 -176.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.643 HD11 ' HB3' ' A' ' 90' ' ' LYS . 4.8 mm -61.66 -47.16 94.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.242 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.852 HG23 ' HA2' ' A' ' 42' ' ' GLY . 28.9 mt -63.64 -38.61 82.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.203 177.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 81.83 105.34 0.39 Allowed Glycine 0 CA--C 1.52 0.397 0 N-CA-C 115.554 0.982 . . . . 0.0 115.554 164.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.438 ' HA ' ' HD3' ' A' ' 40' ' ' LYS . 30.0 mmtp 63.64 -81.29 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 168.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.8 ptmt -123.02 10.12 9.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.931 0.396 . . . . 0.0 110.932 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.852 ' HA2' HG23 ' A' ' 38' ' ' ILE . . . 83.34 16.19 69.67 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.408 -0.901 . . . . 0.0 111.786 -177.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -76.4 -28.6 56.77 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.096 0.474 . . . . 0.0 110.048 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.461 ' HB2' ' O ' ' A' ' 38' ' ' ILE . 38.7 m170 -67.04 -30.67 70.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.699 -173.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.783 HD11 HG12 ' A' ' 58' ' ' ILE . 8.9 tt -76.12 -40.33 36.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -175.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.64 -30.98 41.48 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.124 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.453 ' OE1' ' HD2' ' A' ' 50' ' ' ARG . 6.3 tp60 -64.48 -33.84 76.83 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 173.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.825 HD12 HG12 ' A' ' 56' ' ' ILE . 0.5 OUTLIER -58.73 -47.14 85.65 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.987 176.407 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.616 ' HA ' HD11 ' A' ' 56' ' ' ILE . 57.1 m -58.26 -31.89 67.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.046 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.453 ' HD2' ' OE1' ' A' ' 47' ' ' GLN . 99.6 mtt180 -73.64 -33.66 64.62 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.584 -178.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.722 ' CD2' ' HA ' ' A' ' 48' ' ' LEU . 24.2 m-85 -62.21 -48.12 81.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.108 0.48 . . . . 0.0 110.761 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -94.42 -10.58 32.05 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.362 -172.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 75.6 m 60.39 40.22 17.66 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.479 0.657 . . . . 0.0 110.259 -173.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -130.7 174.3 10.07 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.533 -178.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.2 t -95.44 107.01 19.14 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.777 0.322 . . . . 0.0 110.262 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.825 HG12 HD12 ' A' ' 48' ' ' LEU . 2.0 mp -110.12 113.1 43.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.032 179.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.41 ' HA ' HD13 ' A' ' 45' ' ' ILE . 53.2 mtmt -138.14 153.31 49.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.291 -179.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.783 HG12 HD11 ' A' ' 45' ' ' ILE . 44.9 mm -90.44 127.32 43.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.924 0.392 . . . . 0.0 110.25 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.906 ' HB1' HG21 ' A' ' 72' ' ' VAL . . . -92.41 115.8 65.39 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.759 -178.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -67.87 131.18 23.41 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.538 2.159 . . . . 0.0 111.371 176.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.405 ' HD3' ' HD3' ' A' ' 69' ' ' ARG . 18.6 Cg_endo . . . . . 0 N--CA 1.462 -0.361 0 C-N-CA 122.54 2.16 . . . . 0.0 110.814 176.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? . . . . . 0 C--O 1.233 0.225 0 CA-C-O 120.943 0.401 . . . . 0.0 111.505 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.549 ' HB ' ' C ' ' A' ' 29' ' ' ILE . 1.3 m -123.35 174.79 7.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 121.191 0.52 . . . . 0.0 110.947 -174.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.568 ' HB3' HG21 ' A' ' 34' ' ' VAL . 2.0 tpp85 -118.19 132.54 56.32 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 174.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.48 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 56.1 mtm -91.14 149.5 21.77 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.891 -175.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.564 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 94.3 t -113.17 132.2 62.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 175.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.906 HG21 ' HB1' ' A' ' 59' ' ' ALA . 77.6 t -99.92 111.83 30.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 177.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.8 HG22 HG13 ' A' ' 56' ' ' ILE . 2.5 pp -110.93 128.51 67.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.746 173.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 83.3 m -128.18 106.0 8.75 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.968 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -166.78 164.39 37.74 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.041 -178.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -56.81 136.84 78.71 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 121.859 1.706 . . . . 0.0 109.987 170.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -49.67 -19.58 3.6 Favored 'Trans proline' 0 N--CA 1.48 0.68 0 C-N-CA 123.897 3.065 . . . . 0.0 114.515 -172.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -70.72 -33.07 70.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.0 0.428 . . . . 0.0 110.563 177.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.4 -21.82 48.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.809 -177.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.51 -36.22 64.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.47 176.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.608 ' HA ' ' NE2' ' A' ' 164' ' ' GLN . 69.1 t80 -59.3 -47.09 86.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.469 177.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 36.0 tptt -63.89 -52.56 59.36 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.048 -176.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.69 -53.64 14.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.474 -174.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -71.38 -29.36 64.85 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -172.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -53.59 -36.81 55.13 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 120.365 -0.922 . . . . 0.0 111.739 175.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.44 ' HD2' ' N ' ' A' ' 86' ' ' ARG . 4.5 mpt_? -80.11 -32.02 39.11 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.532 0.197 . . . . 0.0 111.532 177.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -68.5 -44.43 83.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 121.119 -0.232 . . . . 0.0 110.422 -176.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.684 ' HA ' HD23 ' A' ' 91' ' ' LEU . 6.9 m-85 -66.38 -32.97 74.68 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.189 0.519 . . . . 0.0 110.274 177.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -66.02 -28.66 73.85 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.051 177.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.643 ' HB3' HD11 ' A' ' 37' ' ' ILE . 30.7 mmtp -78.43 -17.62 56.09 Favored 'General case' 0 N--CA 1.443 -0.787 0 O-C-N 122.388 -0.478 . . . . 0.0 111.332 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.684 HD23 ' HA ' ' A' ' 88' ' ' TYR . 2.6 mm? -65.34 -34.04 77.38 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 120.223 -0.591 . . . . 0.0 109.876 166.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.882 ' HE3' HG21 ' A' ' 103' ' ' VAL . 10.4 mmtp -72.79 -26.07 61.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.37 177.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.401 ' HB2' ' HA ' ' A' ' 90' ' ' LYS . 8.3 tp10 -63.47 -31.29 72.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.394 178.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.481 ' HG3' ' HA ' ' A' ' 33' ' ' ALA . 20.9 mm-40 -97.65 9.22 43.09 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.039 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 65.3 t30 56.8 41.88 27.42 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.654 176.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.733 ' HE2' ' HB2' ' A' ' 33' ' ' ALA . 41.9 m-85 . . . . . 0 C--N 1.327 -0.396 0 CA-C-O 121.04 0.448 . . . . 0.0 110.237 174.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 . . . . . 0 CA--C 1.523 -0.094 0 CA-C-O 120.772 0.32 . . . . 0.0 111.402 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.882 HG21 ' HE3' ' A' ' 92' ' ' LYS . 1.0 OUTLIER -73.96 129.08 36.59 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 172.608 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.6 mmmm -129.4 87.01 2.49 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 172.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.659 ' HB3' ' CE2' ' A' ' 88' ' ' TYR . 2.1 tm? -125.04 141.45 52.12 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -176.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.57 ' H ' HD23 ' A' ' 105' ' ' LEU . 39.8 tt0 -95.47 127.51 41.56 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.578 -170.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.515 HG22 ' NE2' ' A' ' 167' ' ' GLN . 0.1 OUTLIER -108.39 147.66 31.24 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 171.519 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -114.05 119.53 37.48 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.887 0.375 . . . . 0.0 110.088 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.414 ' CG1' ' HB ' ' A' ' 154' ' ' VAL . 23.1 pt -107.43 128.09 62.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.121 177.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.665 ' HD3' HG12 ' A' ' 153' ' ' ILE . 8.8 mmt180 -74.34 123.78 25.25 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.19 177.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.684 HG23 ' HB1' ' A' ' 115' ' ' ALA . 6.4 p -134.07 142.35 42.94 Favored Pre-proline 0 N--CA 1.444 -0.773 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.566 -175.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.459 ' HD2' HG23 ' A' ' 111' ' ' VAL . 31.7 Cg_exo -56.16 149.3 54.78 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 123.114 2.543 . . . . 0.0 111.978 179.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.62 -47.88 69.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.2 0.524 . . . . 0.0 111.066 -178.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.4 m -67.43 -28.9 68.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.661 -177.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.712 ' HB2' HD22 ' A' ' 174' ' ' LEU . . . -67.01 -28.83 68.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.933 -175.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.501 ' HB1' HG21 ' A' ' 152' ' ' VAL . . . -64.66 -27.0 68.63 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.099 0.476 . . . . 0.0 111.225 177.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -79.25 -31.09 43.41 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.664 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.495 ' HD3' HG23 ' A' ' 177' ' ' VAL . 23.1 ttt85 -91.63 -28.63 17.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.081 0.441 . . . . 0.0 111.711 -176.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.2 p -61.14 -24.38 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 121.13 0.491 . . . . 0.0 110.826 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.709 ' HA ' ' HB ' ' A' ' 127' ' ' VAL . 47.1 mm -77.85 -51.43 17.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.158 176.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.592 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.18 -175.986 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.526 ' HD2' ' HB2' ' A' ' 129' ' ' GLU . 3.7 pptp? . . . . . 0 CA--C 1.521 -0.142 0 CA-C-O 121.03 0.443 . . . . 0.0 110.048 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.507 ' O ' ' HG ' ' A' ' 130' ' ' LEU . 9.3 t -63.27 -34.58 77.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.022 -173.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.709 ' HB ' ' HA ' ' A' ' 120' ' ' ILE . 9.5 p -67.47 -37.69 79.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-O 121.044 0.449 . . . . 0.0 110.549 177.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.477 ' HA ' ' OE1' ' A' ' 131' ' ' GLN . 3.6 t-20 -74.09 -34.55 64.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.515 0.674 . . . . 0.0 109.579 178.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.526 ' HB2' ' HD2' ' A' ' 125' ' ' LYS . 69.4 tt0 -65.33 -37.46 87.15 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.059 177.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 126' ' ' THR . 87.0 mt -56.78 -48.83 77.0 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.406 173.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.477 ' OE1' ' HA ' ' A' ' 128' ' ' ASN . 80.8 mt-30 -57.35 -45.95 83.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.34 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -71.59 -36.15 70.75 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.834 0.349 . . . . 0.0 111.146 -177.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -73.03 -46.4 52.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.791 -177.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.584 HG21 ' HA ' ' A' ' 166' ' ' ALA . 77.0 p -88.07 -18.07 29.71 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.033 0.382 . . . . 0.0 112.033 -174.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 65.98 22.26 11.26 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 123.847 0.717 . . . . 0.0 110.491 -175.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.523 ' HB2' ' HB2' ' A' ' 162' ' ' ALA . . . -122.3 160.8 24.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.63 -177.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.638 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 10.9 tp10 -88.95 111.73 22.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.487 178.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 54.2 t -104.22 106.04 19.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.582 178.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.446 ' O ' ' HD2' ' A' ' 155' ' ' LYS . 5.0 p -128.7 124.45 61.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.322 0.582 . . . . 0.0 111.156 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.503 ' HB ' HG21 ' A' ' 154' ' ' VAL . 11.2 p -122.14 128.85 25.35 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.71 178.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.618 ' HG3' ' HE3' ' A' ' 155' ' ' LYS . 13.1 Cg_exo -68.24 154.92 71.14 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.552 2.168 . . . . 0.0 111.565 -178.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 -93.8 15.8 15.65 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 176.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.594 ' CG ' ' H ' ' A' ' 144' ' ' GLN . 6.6 p-10 -136.24 -91.06 0.28 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.8 177.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.875 ' HG2' ' H ' ' A' ' 153' ' ' ILE . 6.0 tp-100 58.13 88.88 0.06 Allowed 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.613 0.765 . . . . 0.0 112.351 174.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.602 ' HB ' ' HD2' ' A' ' 146' ' ' PRO . 59.5 p 61.35 161.18 0.11 Allowed Pre-proline 0 N--CA 1.473 0.689 0 C-N-CA 124.225 1.01 . . . . 0.0 112.51 176.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.602 ' HD2' ' HB ' ' A' ' 145' ' ' THR . 57.7 Cg_endo -72.21 157.86 53.03 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.261 1.974 . . . . 0.0 112.285 178.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -73.06 8.87 1.39 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.566 -176.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -57.0 -47.48 80.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.232 0.539 . . . . 0.0 110.143 174.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . 0.485 ' O ' ' HG2' ' A' ' 150' ' ' GLU . 56.1 t30 -90.85 -8.75 48.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.149 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.485 ' HG2' ' O ' ' A' ' 149' ' ' ASN . 9.9 pt-20 45.03 36.82 2.14 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 114.44 -1.254 . . . . 0.0 111.642 178.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -148.2 138.97 23.02 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.573 -176.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.501 HG21 ' HB1' ' A' ' 116' ' ' ALA . 21.3 m -120.22 -176.15 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.92 -174.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.875 ' H ' ' HG2' ' A' ' 144' ' ' GLN . 49.9 mt -134.45 128.89 52.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.306 -176.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.503 HG21 ' HB ' ' A' ' 140' ' ' VAL . 53.9 t -95.82 140.28 17.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 173.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.618 ' HE3' ' HG3' ' A' ' 141' ' ' PRO . 0.0 OUTLIER -104.13 134.92 46.56 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 177.657 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.638 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 70.6 mt -118.95 112.06 36.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.914 177.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.422 HD11 ' N ' ' A' ' 157' ' ' ILE . 4.4 mp -110.47 138.62 37.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.793 -178.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 149.72 -157.13 27.1 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.372 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -81.45 159.8 24.16 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 -177.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.496 ' HB3' ' CB ' ' A' ' 88' ' ' TYR . 7.6 p90 -57.89 -47.86 81.56 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.719 -175.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . 0.414 ' O ' ' HG3' ' A' ' 165' ' ' MET . 19.0 m-85 -54.37 -49.89 68.78 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.626 0.251 . . . . 0.0 110.721 177.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.523 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -58.25 -53.47 57.88 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.578 -178.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.467 ' O ' ' HG3' ' A' ' 167' ' ' GLN . 30.0 m -59.84 -49.69 76.73 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.979 -179.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . 0.608 ' NE2' ' HA ' ' A' ' 81' ' ' PHE . 21.6 mt-30 -56.51 -30.84 63.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.764 178.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' MET . . . . . 0.414 ' HG3' ' O ' ' A' ' 161' ' ' TYR . 91.0 mtp -77.96 -42.67 32.09 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.743 0.306 . . . . 0.0 110.798 175.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.584 ' HA ' HG21 ' A' ' 134' ' ' THR . . . -69.4 -41.56 76.27 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -174.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.515 ' NE2' HG22 ' A' ' 107' ' ' THR . 71.9 mt-30 -51.93 -57.77 8.44 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.961 0.41 . . . . 0.0 111.215 -176.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 21.5 ptt180 -68.21 -28.15 67.0 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.533 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . 0.754 ' HA ' ' HE3' ' A' ' 169' ' ' LYS . 0.1 OUTLIER -69.56 -44.9 69.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.851 0.358 . . . . 0.0 110.393 -177.832 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.576 ' O ' ' HG ' ' A' ' 174' ' ' LEU . 1.8 mp -71.54 -40.46 71.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 177.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 27.2 mmm-85 -58.88 -26.23 64.07 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.147 0.499 . . . . 0.0 110.974 174.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -77.87 -46.55 21.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.966 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.543 HG13 ' O ' ' A' ' 170' ' ' ILE . 2.7 pp -66.28 -18.88 24.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-O 121.0 0.429 . . . . 0.0 110.823 -177.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.712 HD22 ' HB2' ' A' ' 115' ' ' ALA . 17.7 mt -57.37 -27.55 62.39 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.247 175.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.684 ' HA ' ' HD3' ' A' ' 178' ' ' LYS . . . -54.87 -33.46 61.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.515 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -70.22 -33.19 71.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.927 0.394 . . . . 0.0 110.568 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.495 HG23 ' HD3' ' A' ' 118' ' ' ARG . 40.3 t -69.32 -40.39 80.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.389 0.614 . . . . 0.0 109.736 178.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.684 ' HD3' ' HA ' ' A' ' 175' ' ' ALA . 50.9 mtpt -59.95 -50.52 73.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.073 176.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.312 -177.73 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.499 ' HB2' HG21 ' A' ' 74' ' ' THR . 64.2 mt-30 . . . . . 0 N--CA 1.45 -0.441 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.424 ' OE1' ' HD3' ' A' ' 77' ' ' PRO . 1.5 mp0 -73.57 113.26 10.48 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.354 0.597 . . . . 0.0 111.619 -174.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.604 ' HG1' HG23 ' A' ' 74' ' ' THR . 4.9 m -92.66 109.56 20.98 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.134 177.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.8 m -124.14 152.9 30.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 10.2 m170 -113.81 132.03 56.02 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -174.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.708 ' HB ' ' CG1' ' A' ' 71' ' ' VAL . 20.8 t -108.2 141.02 24.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.559 -177.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.669 ' CE2' HG12 ' A' ' 68' ' ' VAL . 47.2 t80 -97.6 104.87 16.94 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 123.531 0.732 . . . . 0.0 110.198 -174.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.544 ' C ' HG21 ' A' ' 68' ' ' VAL . 11.1 pt -124.5 116.58 26.68 Favored Pre-proline 0 C--N 1.326 -0.435 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.264 176.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.442 ' HA ' ' HA ' ' A' ' 68' ' ' VAL . 18.7 Cg_endo -58.9 147.98 86.61 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.57 2.847 . . . . 0.0 112.572 -177.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.509 ' HA ' HG12 ' A' ' 34' ' ' VAL . . . -54.08 -25.71 23.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.579 -1.191 . . . . 0.0 112.854 -175.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -70.3 -23.65 62.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.909 0.385 . . . . 0.0 111.182 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.574 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -114.12 -30.8 6.54 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.577 -177.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.516 HG22 ' HB3' ' A' ' 69' ' ' ARG . 13.0 p -51.95 -33.8 16.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 O-C-N 123.24 0.337 . . . . 0.0 111.661 -173.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.65 -56.94 22.43 Favored Glycine 0 N--CA 1.439 -1.129 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.974 -179.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.74 -14.19 59.41 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.79 -0.205 . . . . 0.0 111.318 -175.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.574 HG12 ' O ' ' A' ' 33' ' ' ALA . 8.3 mm -61.71 -43.01 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 175.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.455 HG21 HG22 ' A' ' 45' ' ' ILE . 26.3 mt -55.88 -53.48 37.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.532 176.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.32 113.63 0.45 Allowed Glycine 0 CA--C 1.521 0.462 0 C-N-CA 120.515 -0.85 . . . . 0.0 114.942 168.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 46.4 tptt 48.82 77.64 0.1 Allowed 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.191 0.996 . . . . 0.0 113.009 170.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.424 ' HB3' ' HG3' ' A' ' 43' ' ' GLN . 0.0 OUTLIER 62.68 7.81 2.68 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.945 173.893 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.557 ' O ' HG23 ' A' ' 45' ' ' ILE . . . 76.58 8.67 86.15 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.122 -1.037 . . . . 0.0 111.759 -177.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.484 ' HA ' ' HE3' ' A' ' 46' ' ' LYS . 50.8 mt-30 -62.87 -43.55 98.5 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.061 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 40.7 m-70 -78.74 -26.62 44.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.695 -177.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.557 HG23 ' O ' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -72.1 -42.52 67.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 120.995 -0.282 . . . . 0.0 110.721 -176.629 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.484 ' HE3' ' HA ' ' A' ' 43' ' ' GLN . 18.9 pttp -81.43 -24.54 36.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.151 0.5 . . . . 0.0 110.425 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -69.26 -30.86 69.07 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.261 174.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.772 ' HA ' ' CE2' ' A' ' 51' ' ' PHE . 6.4 tt -60.77 -38.14 84.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.719 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.619 ' HA ' HD13 ' A' ' 56' ' ' ILE . 22.7 m -62.4 -36.15 81.43 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.035 177.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -69.41 -47.98 62.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.139 -173.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.772 ' CE2' ' HA ' ' A' ' 48' ' ' LEU . 14.2 p90 -71.32 -24.6 62.15 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.235 -174.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -90.78 -9.35 46.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.008 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.2 t 60.58 32.81 20.46 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.724 -178.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -128.17 174.41 9.28 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.305 -176.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.419 ' HB2' ' HB ' ' A' ' 74' ' ' THR . 20.2 m -104.51 101.73 11.38 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.629 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.619 HD13 ' HA ' ' A' ' 49' ' ' SER . 3.2 mp -111.38 122.49 65.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.844 178.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -147.09 142.41 27.36 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.209 178.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 35.2 mm -75.07 124.45 32.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 177.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.908 ' HB1' HG22 ' A' ' 72' ' ' VAL . . . -77.72 133.64 66.2 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.127 -174.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 59' ' ' ALA . 22.8 Cg_exo -65.33 127.01 17.32 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.817 2.345 . . . . 0.0 112.242 178.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo . . . . . 0 N--CA 1.462 -0.334 0 C-N-CA 122.605 2.203 . . . . 0.0 111.6 177.849 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? . . . . . 0 C--O 1.23 0.077 0 CA-C-O 121.147 0.499 . . . . 0.0 110.697 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.669 HG12 ' CE2' ' A' ' 28' ' ' PHE . 7.4 p -139.01 147.74 24.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 175.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.516 ' HB3' HG22 ' A' ' 34' ' ' VAL . 12.6 ttm180 -123.1 126.62 47.39 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 175.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.847 ' HG3' ' HB2' ' A' ' 59' ' ' ALA . 18.7 ptt? -83.18 146.67 28.49 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.316 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.708 ' CG1' ' HB ' ' A' ' 27' ' ' VAL . 3.5 p -110.08 135.68 48.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 173.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.908 HG22 ' HB1' ' A' ' 59' ' ' ALA . 51.4 t -100.47 110.17 26.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.4 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 10.0 pt -113.23 142.45 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.802 174.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.604 HG23 ' HG1' ' A' ' 24' ' ' THR . 20.5 m -137.34 105.95 5.85 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.987 -176.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -166.96 162.51 36.3 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.93 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -59.71 137.26 75.91 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.398 2.065 . . . . 0.0 110.411 172.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.424 ' HD3' ' OE1' ' A' ' 23' ' ' GLU . 63.8 Cg_exo -40.04 -37.99 1.9 Allowed 'Trans proline' 0 N--CA 1.478 0.584 0 C-N-CA 124.352 3.368 . . . . 0.0 115.517 -171.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -72.29 -43.02 64.85 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 121.798 -0.564 . . . . 0.0 111.275 -178.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.38 -27.72 61.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.449 0.643 . . . . 0.0 109.693 175.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -61.43 -48.51 80.86 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.012 173.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.762 ' HD1' ' HG3' ' A' ' 164' ' ' GLN . 80.6 t80 -59.16 -39.67 83.17 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.833 176.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.6 tptp -53.42 -53.04 57.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.398 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.566 ' HB2' HD22 ' A' ' 48' ' ' LEU . . . -72.0 -47.36 52.59 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.107 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.574 ' O ' HG22 ' A' ' 87' ' ' ILE . 24.5 tt0 -66.93 -31.95 72.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.552 -172.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -57.38 -36.78 78.19 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.285 175.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.447 ' HA ' ' HD3' ' A' ' 86' ' ' ARG . 27.8 mmt180 -80.4 -27.21 38.16 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.668 -0.266 . . . . 0.0 111.239 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.574 HG22 ' O ' ' A' ' 84' ' ' GLN . 0.3 OUTLIER -67.82 -41.78 85.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 178.941 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.603 ' HA ' HD22 ' A' ' 91' ' ' LEU . 7.0 m-85 -68.51 -31.13 70.16 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-O 121.164 0.507 . . . . 0.0 109.889 173.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -61.71 -29.28 71.66 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.474 -0.784 . . . . 0.0 112.119 177.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.483 ' HB3' HD13 ' A' ' 37' ' ' ILE . 73.9 mmtt -66.69 -37.71 85.3 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 177.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.603 HD22 ' HA ' ' A' ' 88' ' ' TYR . 3.4 mm? -59.55 -36.75 76.77 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.41 0.624 . . . . 0.0 110.597 174.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.743 ' HE3' ' HB ' ' A' ' 103' ' ' VAL . 0.1 OUTLIER -75.35 -37.82 60.45 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.277 -177.565 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -67.93 -27.48 66.65 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.182 -178.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.428 ' HB3' ' CE2' ' A' ' 96' ' ' PHE . 17.3 mm-40 -89.27 5.27 45.65 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.189 0.519 . . . . 0.0 110.859 178.338 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 58.69 41.14 22.45 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.986 172.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.428 ' CE2' ' HB3' ' A' ' 94' ' ' GLU . 70.2 m-85 . . . . . 0 C--N 1.326 -0.448 0 CA-C-O 121.2 0.524 . . . . 0.0 109.921 172.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 . . . . . 0 N--CA 1.437 -1.119 0 CA-C-O 120.867 0.365 . . . . 0.0 111.014 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.743 ' HB ' ' HE3' ' A' ' 92' ' ' LYS . 14.8 p -80.46 138.58 19.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.644 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -128.2 90.81 3.14 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 175.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.603 ' HB3' ' CE2' ' A' ' 88' ' ' TYR . 2.3 tm? -133.38 126.3 30.99 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.261 0.553 . . . . 0.0 110.408 -173.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.766 ' HG3' HG13 ' A' ' 157' ' ' ILE . 41.1 mp0 -66.81 133.52 50.27 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.963 -1.017 . . . . 0.0 113.612 -175.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.535 HG22 ' NE2' ' A' ' 167' ' ' GLN . 0.2 OUTLIER -111.97 140.43 46.64 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.142 165.852 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -121.69 119.8 32.84 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 32.8 pt -125.9 153.64 34.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.112 0.482 . . . . 0.0 111.292 -178.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.453 ' HD3' HG12 ' A' ' 153' ' ' ILE . 59.2 mmt-85 -87.31 132.24 34.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.872 -175.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.487 ' O ' ' HG3' ' A' ' 151' ' ' GLN . 5.2 m -129.77 147.09 63.96 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 171.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.676 ' HD2' HD22 ' A' ' 174' ' ' LEU . 31.4 Cg_exo -57.43 145.23 89.2 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.28 1.986 . . . . 0.0 110.911 175.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -51.09 -49.61 60.35 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.787 0.327 . . . . 0.0 111.552 -173.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 36.3 t -65.52 -33.25 75.49 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.137 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.18 -26.69 67.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.007 -178.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.402 ' O ' HG13 ' A' ' 120' ' ' ILE . . . -63.19 -29.18 70.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.268 0.556 . . . . 0.0 110.392 177.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -75.12 -38.21 40.68 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.666 177.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.504 ' HD2' HG21 ' A' ' 177' ' ' VAL . 25.3 ttm180 -74.66 -34.23 62.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.371 0.129 . . . . 0.0 110.997 -178.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.475 HG13 HG22 ' A' ' 140' ' ' VAL . 10.2 p -66.8 -32.17 56.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-O 120.834 0.35 . . . . 0.0 110.579 179.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.402 HG13 ' O ' ' A' ' 116' ' ' ALA . 76.3 mt -72.43 -43.73 63.37 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 CA-C-O 121.277 0.561 . . . . 0.0 109.656 173.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.897 ' HA3' ' HB ' ' A' ' 126' ' ' THR . . . . . . . . 0 N--CA 1.44 -1.047 0 C-N-CA 119.918 -1.134 . . . . 0.0 110.639 -174.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 22.8 pttp . . . . . 0 N--CA 1.463 0.198 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.897 ' HB ' ' HA3' ' A' ' 121' ' ' GLY . 26.1 m -62.91 -46.51 87.48 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -175.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.0 p -67.85 -29.91 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-O 121.017 0.437 . . . . 0.0 110.663 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -63.72 -40.61 97.19 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 177.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -64.45 -41.56 96.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.003 177.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 73.6 mt -60.13 -49.31 78.13 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.621 178.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -64.2 -30.13 71.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.631 -177.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -72.55 -42.59 64.53 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.886 0.375 . . . . 0.0 110.298 177.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 94.4 mt -68.61 -49.67 57.47 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.27 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.4 HG21 ' HA ' ' A' ' 166' ' ' ALA . 74.1 p -82.26 -35.37 28.16 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.317 -171.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 66.97 27.49 8.82 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 123.894 0.746 . . . . 0.0 109.9 -170.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.66 ' HB1' ' HB3' ' A' ' 162' ' ' ALA . . . -122.92 163.95 19.38 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.707 -178.024 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.482 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 9.7 mm-40 -88.25 111.58 21.83 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.421 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 42.8 t -97.75 105.83 17.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.411 ' O ' ' HD2' ' A' ' 155' ' ' LYS . 54.0 t -112.81 111.6 36.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.232 -175.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.475 HG22 HG13 ' A' ' 119' ' ' VAL . 34.8 t -106.03 126.5 30.46 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 177.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.413 ' HG2' ' HB3' ' A' ' 144' ' ' GLN . 88.1 Cg_endo -83.81 143.23 10.51 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.766 2.311 . . . . 0.0 113.358 -174.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 39.7 mmt180 -94.1 -26.88 16.55 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.467 173.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -69.78 -35.44 74.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.036 -0.983 . . . . 0.0 110.567 178.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.413 ' HB3' ' HG2' ' A' ' 141' ' ' PRO . 60.2 tt0 -92.86 90.83 7.16 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 175.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.418 ' N ' ' HD3' ' A' ' 146' ' ' PRO . 16.0 p -145.98 58.01 4.43 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.75 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.471 ' HB2' ' HB3' ' A' ' 148' ' ' GLU . 49.5 Cg_endo -92.8 133.07 1.03 Allowed 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.548 2.165 . . . . 0.0 112.986 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -71.07 -12.88 61.75 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 172.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.471 ' HB3' ' HB2' ' A' ' 146' ' ' PRO . 30.9 tt0 -44.78 -48.55 10.91 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 114.315 -1.312 . . . . 0.0 112.599 178.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -114.75 -0.07 13.67 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.174 -175.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 44.41 32.45 0.72 Allowed 'General case' 0 N--CA 1.474 0.748 0 O-C-N 124.469 1.105 . . . . 0.0 111.045 -172.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.487 ' HG3' ' O ' ' A' ' 111' ' ' VAL . 28.4 tt0 -157.86 142.74 16.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.402 -174.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 31.0 m -133.88 -177.01 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.792 -178.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.453 HG12 ' HD3' ' A' ' 110' ' ' ARG . 55.8 mt -120.48 137.99 52.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.922 0.391 . . . . 0.0 111.726 -178.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.5 p -104.49 138.41 29.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.565 169.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.42 ' HD2' ' H ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -101.23 126.31 47.95 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.664 -177.109 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.509 HD12 ' HB2' ' A' ' 166' ' ' ALA . 58.9 mt -109.24 118.71 57.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.107 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.766 HG13 ' HG3' ' A' ' 106' ' ' GLU . 4.0 mp -114.36 138.33 44.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 143.92 -163.01 27.75 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.525 178.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.523 ' HA ' HG13 ' A' ' 103' ' ' VAL . 10.6 p-80 -83.73 145.1 28.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.73 0.3 . . . . 0.0 110.41 178.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.493 ' HD1' HG11 ' A' ' 103' ' ' VAL . 46.0 p90 -57.72 -24.44 56.91 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -168.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . 0.401 ' HB2' ' HD2' ' A' ' 159' ' ' HIS . 94.2 m-85 -61.43 -44.5 97.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.408 0.623 . . . . 0.0 109.625 174.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.66 ' HB3' ' HB1' ' A' ' 136' ' ' ALA . . . -74.6 -40.27 61.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.073 178.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.457 ' O ' ' HG3' ' A' ' 167' ' ' GLN . 19.3 m -55.21 -51.33 66.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.511 178.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . 0.762 ' HG3' ' HD1' ' A' ' 81' ' ' PHE . 7.8 mm100 -57.79 -45.02 86.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.604 177.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 68.8 mtp -61.45 -40.7 95.44 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.8 0.333 . . . . 0.0 110.893 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.509 ' HB2' HD12 ' A' ' 156' ' ' ILE . . . -69.31 -46.2 67.7 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.163 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.535 ' NE2' HG22 ' A' ' 107' ' ' THR . 62.7 mt-30 -55.31 -52.18 64.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.241 -178.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' A' ' 164' ' ' GLN . 6.7 ptp85 -66.42 -32.32 73.63 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.18 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . 0.975 ' HA ' ' HE3' ' A' ' 169' ' ' LYS . 0.6 OUTLIER -77.24 -42.82 35.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.91 0.386 . . . . 0.0 110.965 -173.58 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.508 ' O ' ' HG ' ' A' ' 174' ' ' LEU . 1.8 mp -70.4 -44.71 77.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.923 177.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -59.26 -25.9 64.47 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.819 0.343 . . . . 0.0 110.566 175.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -73.82 -48.29 32.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.175 -179.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 36.1 pt -66.92 -20.53 27.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.112 -177.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.676 HD22 ' HD2' ' A' ' 112' ' ' PRO . 15.5 mt -59.23 -40.5 86.07 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.911 0.386 . . . . 0.0 110.252 176.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.487 ' O ' ' HG2' ' A' ' 179' ' ' GLN . . . -65.91 -37.39 85.95 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.216 178.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -65.99 -32.19 73.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.887 177.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.504 HG21 ' HD2' ' A' ' 118' ' ' ARG . 75.2 t -73.34 -35.57 46.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.056 0.455 . . . . 0.0 110.207 175.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -64.58 -31.03 72.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.158 0.504 . . . . 0.0 109.904 175.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 0.487 ' HG2' ' O ' ' A' ' 175' ' ' ALA . 73.3 mm-40 . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.622 175.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 81.9 mm-40 . . . . . 0 C--O 1.235 0.339 0 N-CA-C 109.128 -0.694 . . . . 0.0 109.128 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -78.98 141.88 37.12 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.076 -171.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.463 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 29.2 m -131.69 112.45 12.56 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.496 -177.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 28.4 m -125.14 161.68 28.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.839 -178.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -117.44 128.1 54.67 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.618 -175.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.548 ' HB ' ' HB ' ' A' ' 71' ' ' VAL . 8.9 t -97.45 143.14 13.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.198 -179.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.468 ' HE1' ' HE1' ' A' ' 70' ' ' MET . 0.3 OUTLIER -103.86 106.06 16.45 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 122.623 0.369 . . . . 0.0 111.723 -172.573 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.608 ' C ' ' HB ' ' A' ' 68' ' ' VAL . 8.7 pt -130.4 121.41 19.39 Favored Pre-proline 0 C--N 1.326 -0.433 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.856 176.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.651 ' HB2' ' HG2' ' A' ' 32' ' ' GLN . 10.6 Cg_endo -53.27 147.67 35.14 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.699 2.933 . . . . 0.0 112.485 -176.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.46 -21.98 40.57 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.509 -0.768 . . . . 0.0 112.096 -175.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.651 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 11.4 pt20 -71.38 -26.2 62.69 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.589 178.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.569 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -111.8 -30.37 7.33 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 121.167 -0.213 . . . . 0.0 111.545 -172.099 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.663 HG23 ' HB3' ' A' ' 69' ' ' ARG . 9.3 p -52.25 -32.86 16.36 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 O-C-N 123.605 0.566 . . . . 0.0 111.392 -174.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -55.7 -57.93 16.45 Favored Glycine 0 N--CA 1.438 -1.193 0 C-N-CA 120.318 -0.944 . . . . 0.0 111.858 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.32 -14.11 59.8 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 120.744 0.307 . . . . 0.0 111.074 -174.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.569 HG12 ' O ' ' A' ' 33' ' ' ALA . 7.9 mm -64.71 -38.87 83.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.116 176.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.527 HG23 ' HB ' ' A' ' 45' ' ' ILE . 5.0 mt -54.5 -59.42 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -178.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 131.04 77.82 0.17 Allowed Glycine 0 CA--C 1.52 0.357 0 C-N-CA 119.616 -1.278 . . . . 0.0 114.43 175.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 45.9 tttp 54.13 -80.77 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 170.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -101.1 -6.22 24.64 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.821 0.344 . . . . 0.0 111.048 -173.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.541 ' O ' HG21 ' A' ' 45' ' ' ILE . . . 84.86 -1.88 88.57 Favored Glycine 0 C--O 1.229 -0.215 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.152 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -78.78 -32.26 46.39 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 176.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.412 ' HA ' ' HB3' ' A' ' 47' ' ' GLN . 2.2 m-70 -73.62 -22.12 60.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.066 -176.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.541 HG21 ' O ' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -73.65 -42.89 55.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.728 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.9 pttp -81.68 -22.5 37.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.286 0.565 . . . . 0.0 109.744 177.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.412 ' HB3' ' HA ' ' A' ' 44' ' ' HIS . 49.2 tt0 -66.44 -33.44 75.72 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 171.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.418 ' HA ' ' HB3' ' A' ' 51' ' ' PHE . 7.0 tt -66.09 -38.5 88.39 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.371 175.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.628 ' HA ' HD11 ' A' ' 56' ' ' ILE . 8.1 t -60.04 -39.17 85.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.628 176.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -68.87 -47.47 65.85 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.062 174.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.418 ' HB3' ' HA ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -58.41 -39.03 78.62 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.984 -1.007 . . . . 0.0 112.007 -178.163 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -91.16 0.89 57.44 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 121.185 -0.206 . . . . 0.0 111.325 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 72.5 p 50.89 31.39 6.1 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.667 0.787 . . . . 0.0 111.964 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -140.14 174.25 10.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.886 -175.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 35.5 m -86.25 101.29 12.92 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.675 0.274 . . . . 0.0 110.596 -178.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.628 HD11 ' HA ' ' A' ' 49' ' ' SER . 2.2 mp -108.6 117.1 53.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.892 178.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -134.28 146.81 50.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.562 -177.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 40.0 mm -90.17 107.47 18.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 173.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.455 ' HB3' ' CG1' ' A' ' 72' ' ' VAL . . . -86.33 126.4 64.78 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.854 -173.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.65 141.04 53.49 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.879 2.386 . . . . 0.0 110.805 172.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo . . . . . 0 C--O 1.233 0.248 0 C-N-CA 122.906 2.404 . . . . 0.0 111.994 -179.745 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.233 0.219 0 CA-C-O 121.113 0.482 . . . . 0.0 111.505 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.608 ' HB ' ' C ' ' A' ' 29' ' ' ILE . 1.4 m -127.41 176.08 8.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-O 121.225 0.536 . . . . 0.0 111.316 -172.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.663 ' HB3' HG23 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -120.01 139.79 51.96 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 106.471 -1.678 . . . . 0.0 106.471 172.837 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.53 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 61.4 mtt -97.43 149.15 22.46 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.282 -0.567 . . . . 0.0 111.397 -169.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.548 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 70.1 t -104.35 116.22 47.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 171.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.455 ' CG1' ' HB3' ' A' ' 59' ' ' ALA . 11.1 p -108.73 121.6 62.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.357 0.598 . . . . 0.0 110.472 -177.033 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 24' ' ' THR . 0.1 OUTLIER -130.63 142.42 43.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.768 0.794 . . . . 0.0 111.135 179.675 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 47.3 m -122.47 111.57 17.0 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.191 -1.368 . . . . 0.0 109.034 176.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.67 162.36 35.78 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 119.845 -1.169 . . . . 0.0 113.158 -175.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.24 148.54 84.91 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.379 2.052 . . . . 0.0 110.824 170.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -38.35 -46.85 2.4 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 124.152 3.235 . . . . 0.0 114.441 -176.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.507 ' HG3' ' N ' ' A' ' 79' ' ' ALA . 7.6 pt-20 -56.8 -43.97 81.48 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.156 0.503 . . . . 0.0 111.203 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.596 ' HA ' ' HD3' ' A' ' 82' ' ' LYS . . . -71.73 -37.64 70.57 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.006 -175.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -68.93 -26.03 64.88 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.946 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.779 ' HA ' HE22 ' A' ' 164' ' ' GLN . 89.8 t80 -64.4 -54.94 24.86 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.709 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.644 ' H ' ' HD2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -70.02 -32.6 70.84 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.459 -0.497 . . . . 0.0 110.726 -177.681 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.3 -51.54 69.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.753 0.311 . . . . 0.0 110.985 177.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.63 ' HA ' HG22 ' A' ' 87' ' ' ILE . 54.1 mt-30 -66.46 -31.89 72.91 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.269 179.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -59.57 -40.04 95.84 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.332 178.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -80.21 -37.83 32.36 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 122.742 -0.269 . . . . 0.0 111.637 -177.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.63 HG22 ' HA ' ' A' ' 84' ' ' GLN . 0.0 OUTLIER -65.21 -43.83 95.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.662 -176.632 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.579 ' CE2' ' HB3' ' A' ' 105' ' ' LEU . 15.2 m-85 -67.13 -30.15 70.07 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.142 0.496 . . . . 0.0 110.148 176.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -60.04 -32.84 76.88 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.213 176.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.504 ' HB3' HD13 ' A' ' 37' ' ' ILE . 31.7 mmtp -72.63 -26.76 61.78 Favored 'General case' 0 N--CA 1.455 -0.213 0 O-C-N 122.541 -0.388 . . . . 0.0 110.624 177.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.58 ' HG ' ' HG ' ' A' ' 105' ' ' LEU . 4.3 mm? -66.35 -38.55 87.85 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.853 0.359 . . . . 0.0 110.156 171.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.854 ' HE3' ' HB ' ' A' ' 103' ' ' VAL . 0.5 OUTLIER -68.78 -26.52 65.25 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.373 176.124 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -64.32 -40.66 96.34 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.995 -176.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.571 ' HB2' ' CE2' ' A' ' 96' ' ' PHE . 10.4 mm-40 -105.94 0.24 25.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.964 0.411 . . . . 0.0 112.079 -178.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 57.34 47.83 15.96 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.307 -0.86 . . . . 0.0 112.695 171.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.571 ' CE2' ' HB2' ' A' ' 94' ' ' GLU . 80.1 m-85 . . . . . 0 N--CA 1.467 0.418 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -176.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.479 ' HB3' ' CD2' ' A' ' 159' ' ' HIS . 5.2 tt0 . . . . . 0 N--CA 1.439 -1.0 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.854 ' HB ' ' HE3' ' A' ' 92' ' ' LYS . 11.5 p -54.52 122.84 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.404 0 CA-C-O 121.733 0.778 . . . . 0.0 112.037 -168.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp -117.68 91.29 3.53 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.568 -1.196 . . . . 0.0 108.865 176.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.58 ' HG ' ' HG ' ' A' ' 91' ' ' LEU . 2.0 tm? -128.58 123.81 34.33 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.208 0.527 . . . . 0.0 109.959 -176.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -58.92 129.46 42.26 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.821 -1.081 . . . . 0.0 112.016 -174.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.44 142.51 46.27 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.16 175.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -122.22 120.11 33.2 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.306 0.574 . . . . 0.0 111.546 -179.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.48 HD13 HD11 ' A' ' 156' ' ' ILE . 22.9 pt -114.61 134.16 58.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.872 176.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.556 ' HD3' HG12 ' A' ' 153' ' ' ILE . 6.9 tpp180 -78.48 138.25 38.35 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.249 -176.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.827 HG21 HD21 ' A' ' 174' ' ' LEU . 6.4 p -141.93 143.0 26.75 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 177.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.421 ' HD2' HG23 ' A' ' 111' ' ' VAL . 24.6 Cg_exo -59.84 150.1 79.57 Favored 'Trans proline' 0 N--CA 1.465 -0.18 0 C-N-CA 122.399 2.066 . . . . 0.0 111.296 176.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -56.3 -51.06 69.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.022 0.439 . . . . 0.0 111.007 -175.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.7 m -68.54 -12.3 61.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.544 -178.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.653 ' HB2' HG23 ' A' ' 111' ' ' VAL . . . -84.68 -14.87 47.2 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.347 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.441 ' O ' HG13 ' A' ' 120' ' ' ILE . . . -65.42 -40.96 93.98 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.039 176.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.32 -32.9 83.37 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.615 -0.802 . . . . 0.0 111.55 176.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.444 ' HD2' HG22 ' A' ' 177' ' ' VAL . 15.2 ttm180 -74.2 -42.42 59.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.673 0.273 . . . . 0.0 110.788 -179.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.487 HG13 HG13 ' A' ' 140' ' ' VAL . 7.4 p -68.93 -30.56 47.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.025 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.668 ' HA ' HG22 ' A' ' 127' ' ' VAL . 72.6 mt -69.62 -39.26 78.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.818 0.818 . . . . 0.0 109.558 171.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.184 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.551 179.889 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 23.4 pttp . . . . . 0 N--CA 1.463 0.177 0 CA-C-O 120.967 0.413 . . . . 0.0 111.614 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.565 ' O ' ' HG ' ' A' ' 130' ' ' LEU . 50.0 m -88.3 -32.7 18.33 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.268 -174.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.668 HG22 ' HA ' ' A' ' 120' ' ' ILE . 82.0 t -59.81 -37.9 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-O 121.38 0.61 . . . . 0.0 109.809 173.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -56.09 -42.98 77.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.944 177.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.14 -42.83 72.05 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.145 -179.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.565 ' HG ' ' O ' ' A' ' 126' ' ' THR . 77.6 mt -58.29 -52.05 67.23 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.702 -178.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -66.01 -37.97 87.25 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.928 -175.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -65.27 -36.7 84.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.276 -177.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 60.6 tp -88.11 -48.89 7.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.722 0.296 . . . . 0.0 111.525 -176.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.404 HG23 ' HA ' ' A' ' 166' ' ' ALA . 64.2 p -74.67 -25.19 59.01 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.985 -172.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 60.74 20.94 10.98 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.159 -174.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -113.61 173.12 6.57 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.309 -174.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.621 ' HB3' ' HB ' ' A' ' 157' ' ' ILE . 8.6 tp10 -96.95 114.07 25.66 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.04 175.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 57.3 t -114.84 106.98 21.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.758 -176.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.602 HG11 ' HB2' ' A' ' 155' ' ' LYS . 1.5 p -121.22 121.25 64.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.408 0.623 . . . . 0.0 110.991 177.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.635 ' HB ' HG23 ' A' ' 154' ' ' VAL . 7.7 p -127.12 113.01 21.68 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.631 176.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 1.074 ' HG2' ' HB2' ' A' ' 144' ' ' GLN . 96.1 Cg_endo -90.2 138.0 2.71 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.238 2.625 . . . . 0.0 113.526 -174.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -75.41 -23.31 57.02 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 113.636 -1.62 . . . . 0.0 109.418 175.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -97.67 17.29 18.2 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.951 -178.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 1.074 ' HB2' ' HG2' ' A' ' 141' ' ' PRO . 8.9 tp60 -63.83 -63.28 1.21 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.22 0.533 . . . . 0.0 111.54 -177.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.1 p -146.45 150.6 41.15 Favored Pre-proline 0 C--N 1.316 -0.85 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.124 -174.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.57 165.25 32.49 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.189 2.593 . . . . 0.0 112.309 178.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -78.43 23.83 0.29 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.948 -175.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -70.87 -47.6 58.41 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.487 0.661 . . . . 0.0 109.465 176.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -101.82 0.46 35.72 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.744 177.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 44.88 37.86 2.6 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.441 1.096 . . . . 0.0 112.034 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -147.9 141.0 24.98 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.027 0.441 . . . . 0.0 111.779 -174.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.403 HG23 ' CG1' ' A' ' 111' ' ' VAL . 23.3 m -126.95 -176.02 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.186 -178.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.556 HG12 ' HD3' ' A' ' 110' ' ' ARG . 58.2 mt -132.81 134.94 57.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 O-C-N 122.247 -0.283 . . . . 0.0 110.69 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.635 HG23 ' HB ' ' A' ' 140' ' ' VAL . 89.7 t -92.4 139.09 18.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 174.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.702 ' HE3' ' HG3' ' A' ' 141' ' ' PRO . 0.0 OUTLIER -105.57 117.18 33.37 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.997 0.427 . . . . 0.0 109.964 179.258 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.554 HD13 ' HB1' ' A' ' 166' ' ' ALA . 53.4 mt -100.49 116.66 44.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.072 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.621 ' HB ' ' HB3' ' A' ' 137' ' ' GLU . 3.2 mp -107.32 131.8 56.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 175.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 153.36 -152.68 24.27 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.446 -178.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.479 ' CD2' ' HB3' ' A' ' 102' ' ' GLU . 4.1 m80 -102.7 155.12 18.52 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -175.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.437 ' O ' ' HG3' ' A' ' 164' ' ' GLN . 25.0 p90 -56.0 -36.36 67.83 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.037 0.835 . . . . 0.0 111.797 -172.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . 0.448 ' O ' ' HG2' ' A' ' 165' ' ' MET . 35.8 m-85 -60.2 -48.02 83.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.82 0.343 . . . . 0.0 110.746 175.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -70.39 -36.94 74.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.611 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.425 ' HA ' HG23 ' A' ' 156' ' ' ILE . 68.7 m -57.54 -45.78 84.69 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.413 176.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . 0.779 HE22 ' HA ' ' A' ' 81' ' ' PHE . 96.8 mt-30 -64.39 -33.66 76.37 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.777 0.322 . . . . 0.0 111.152 179.082 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' MET . . . . . 0.448 ' HG2' ' O ' ' A' ' 161' ' ' TYR . 95.9 mmm -63.02 -40.57 98.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.173 176.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.554 ' HB1' HD13 ' A' ' 156' ' ' ILE . . . -74.83 -37.99 62.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.826 178.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -53.33 -56.2 18.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.751 177.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -65.88 -31.45 72.4 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.035 -178.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . 0.708 ' HA ' ' HE3' ' A' ' 169' ' ' LYS . 0.2 OUTLIER -72.95 -54.94 7.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.152 -172.886 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 2.4 mp -72.0 -46.77 58.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.8 0.333 . . . . 0.0 110.424 -177.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.582 ' HA ' ' HG ' ' A' ' 174' ' ' LEU . 24.6 mmm180 -60.99 -24.93 66.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.175 -178.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -71.44 -47.36 56.35 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 111.547 0.203 . . . . 0.0 111.547 177.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.459 HG13 HD23 ' A' ' 174' ' ' LEU . 18.3 pt -66.62 -19.26 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.671 -177.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.827 HD21 HG21 ' A' ' 111' ' ' VAL . 6.7 mt -60.92 -28.78 69.18 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.817 177.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.443 ' O ' ' HG3' ' A' ' 179' ' ' GLN . . . -59.0 -43.12 91.45 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.037 176.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 71.3 mm-40 -60.81 -45.43 94.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.656 176.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.636 HG11 ' HB1' ' A' ' 115' ' ' ALA . 46.7 t -61.38 -41.26 89.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.576 179.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -63.0 -44.44 96.0 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.557 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 0.443 ' HG3' ' O ' ' A' ' 175' ' ' ALA . 96.9 mt-30 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.755 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.777 0 N-CA-C 112.201 -0.359 . . . . 0.0 112.201 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.22 123.21 6.36 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 60.8 mtt -77.13 96.11 4.4 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.953 0.406 . . . . 0.0 111.291 -178.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.86 128.88 9.43 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.857 -0.687 . . . . 0.0 111.417 175.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.2 107.19 0.22 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.223 2.615 . . . . 0.0 112.617 -177.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.8 m 61.12 20.07 10.58 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.108 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.9 t -103.07 35.47 2.53 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.563 0.697 . . . . 0.0 110.093 -177.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 18.8 m -102.83 130.79 52.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.134 178.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.8 m -143.35 -176.92 5.13 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.083 0.468 . . . . 0.0 111.263 -176.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 169.12 -88.28 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -177.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 55.95 83.14 0.1 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.158 0.504 . . . . 0.0 111.819 177.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -119.79 82.29 27.17 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.727 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -99.29 35.54 0.09 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 123.547 2.831 . . . . 0.0 112.781 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -104.99 77.35 1.32 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.247 0.546 . . . . 0.0 110.709 -178.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.1 p -112.98 -173.63 2.29 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.614 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.2 m 72.0 138.94 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 O-C-N 123.863 0.727 . . . . 0.0 111.392 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -106.12 87.14 2.5 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.291 177.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 17.1 tpt -92.43 110.07 42.42 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.197 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.96 109.6 1.96 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.794 2.329 . . . . 0.0 112.017 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -90.44 43.58 0.53 Allowed 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 123.048 2.499 . . . . 0.0 112.454 -176.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -94.44 21.05 7.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.228 0.537 . . . . 0.0 110.889 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 83.2 mm-40 -90.27 151.09 21.66 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 174.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -73.74 120.37 19.24 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.081 0.467 . . . . 0.0 110.879 -177.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.621 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 53.1 m -122.87 114.77 20.93 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.61 -176.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.566 HG21 ' NE2' ' A' ' 167' ' ' GLN . 27.2 m -132.8 161.72 41.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.636 -179.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.558 ' HB3' ' HB3' ' A' ' 70' ' ' MET . 13.1 m170 -107.74 113.61 27.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.747 -173.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.615 ' O ' ' HA ' ' A' ' 70' ' ' MET . 40.2 t -90.83 123.36 42.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.909 0.385 . . . . 0.0 110.557 -176.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.726 ' CZ ' HG13 ' A' ' 68' ' ' VAL . 2.3 t80 -85.13 104.67 15.23 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.527 -168.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.561 ' C ' HG21 ' A' ' 68' ' ' VAL . 18.9 pt -130.3 117.09 17.75 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.424 0.63 . . . . 0.0 110.892 174.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.596 ' HB2' ' HG2' ' A' ' 32' ' ' GLN . 51.0 Cg_exo -54.42 153.87 21.33 Favored 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 123.315 2.677 . . . . 0.0 112.505 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.53 ' HA ' HG11 ' A' ' 34' ' ' VAL . . . -56.89 -18.22 12.41 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 114.848 -1.069 . . . . 0.0 112.423 -176.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.596 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 30.1 pt20 -72.05 -18.62 61.93 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.94 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.499 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -123.09 -31.82 3.55 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 120.52 -0.472 . . . . 0.0 111.869 -176.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.53 HG11 ' HA ' ' A' ' 31' ' ' ALA . 9.1 p -52.56 -34.28 19.07 Favored 'Isoleucine or valine' 0 C--O 1.242 0.675 0 CA-C-O 120.922 0.391 . . . . 0.0 111.715 -172.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.907 ' HA2' ' N4 ' ' B' ' 4' ' ' ' C' . . . -57.19 -57.11 21.5 Favored Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.355 -178.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.513 ' HB3' " O2'" ' B' ' 2' ' ' ' C' . . . -76.52 -13.46 60.09 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.928 -174.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.609 HD11 ' CG ' ' A' ' 90' ' ' LYS . 3.3 mm -64.28 -39.98 87.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 116.313 -0.403 . . . . 0.0 109.97 176.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.809 HD12 ' C5 ' ' B' ' 4' ' ' ' C' . 9.1 mt -61.16 -60.05 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.929 176.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.592 ' HA2' ' OP1' ' B' ' 3' ' ' ' A' . . . 86.48 119.12 1.12 Allowed Glycine 0 CA--C 1.525 0.713 0 C-N-CA 120.288 -0.958 . . . . 0.0 115.393 169.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm 40.43 89.52 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.278 1.431 . . . . 0.0 114.259 169.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.509 ' HA ' ' OP2' ' B' ' 4' ' ' ' C' . 10.4 ttpt 61.54 5.25 1.18 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.958 175.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.3 29.83 69.88 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.749 -0.738 . . . . 0.0 111.859 -176.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 54.9 tp60 -86.51 -54.71 4.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.532 0.206 . . . . 0.0 111.214 -176.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.566 ' NE2' ' HA3' ' A' ' 39' ' ' GLY . 17.4 p80 -71.64 -21.76 61.78 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.483 -176.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.598 HG22 HG23 ' A' ' 38' ' ' ILE . 10.6 tt -68.07 -33.52 61.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 121.131 0.491 . . . . 0.0 110.006 175.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.457 ' HE2' ' HA ' ' A' ' 46' ' ' LYS . 0.8 OUTLIER -81.32 -31.62 33.43 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 174.808 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.479 ' HB3' ' HA ' ' A' ' 44' ' ' HIS . 34.1 tt0 -58.58 -36.57 74.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.349 171.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.781 HD23 HG12 ' A' ' 56' ' ' ILE . 6.7 tt -61.43 -39.17 89.82 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.271 177.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.67 ' HA ' HD13 ' A' ' 56' ' ' ILE . 17.1 m -61.55 -29.28 69.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.301 177.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 43.8 mtp180 -79.57 -50.89 10.03 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.617 -177.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.733 ' CZ ' ' HA ' ' A' ' 48' ' ' LEU . 1.7 p90 -75.18 -18.99 60.06 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.853 -177.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -92.05 -22.47 19.92 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.829 175.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.2 t 65.85 37.2 5.67 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.616 -177.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -132.36 173.41 11.31 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.17 -178.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.778 ' HB3' ' HB ' ' A' ' 74' ' ' THR . 18.6 t -100.5 101.8 12.82 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.781 HG12 HD23 ' A' ' 48' ' ' LEU . 2.1 mp -98.23 111.9 29.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.814 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.477 ' HB2' ' HB ' ' A' ' 72' ' ' VAL . 41.7 mtpt -128.75 154.31 46.5 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.849 -178.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.653 ' HB ' ' N1 ' ' B' ' 5' ' ' ' A' . 42.4 mm -110.1 113.31 43.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 174.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.718 ' HB1' HG21 ' A' ' 72' ' ' VAL . . . -71.69 126.16 91.58 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.396 -175.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -65.03 143.81 80.05 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.404 2.069 . . . . 0.0 110.341 171.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -37.89 107.33 0.06 OUTLIER 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 124.098 3.199 . . . . 0.0 113.497 -176.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -66.93 -27.8 67.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.57 -178.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.454 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 19.0 p -126.91 139.2 34.36 Favored Pre-proline 0 C--N 1.324 -0.539 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 172.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 63' ' ' THR . 21.4 Cg_exo -65.89 -7.84 17.98 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.933 2.422 . . . . 0.0 112.652 -177.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -104.01 12.29 34.33 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.218 -179.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 53.4 p -82.47 139.18 34.09 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.317 0.58 . . . . 0.0 111.32 -177.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.4 tmtp? -106.37 26.84 9.36 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 175.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.726 HG13 ' CZ ' ' A' ' 28' ' ' PHE . 2.7 p -154.02 150.91 11.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.327 -167.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.476 ' HB2' HG21 ' A' ' 34' ' ' VAL . 61.2 mtp180 -125.83 129.9 50.31 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 175.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.615 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 3.6 mpp? -94.27 136.88 34.08 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.824 -172.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.583 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 84.6 t -83.61 120.48 34.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 175.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.718 HG21 ' HB1' ' A' ' 59' ' ' ALA . 74.4 t -86.88 96.43 5.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.621 ' O ' ' HA ' ' A' ' 24' ' ' THR . 10.2 tp -93.48 114.57 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 CA-C-O 121.422 0.63 . . . . 0.0 110.162 178.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.778 ' HB ' ' HB3' ' A' ' 55' ' ' SER . 75.3 m -113.27 103.25 11.14 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 173.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -168.75 162.91 36.7 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.046 -1.073 . . . . 0.0 112.934 -176.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.81 147.66 75.5 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.285 1.99 . . . . 0.0 110.361 169.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -49.85 -27.27 15.44 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 124.092 3.194 . . . . 0.0 113.722 -177.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -61.38 -43.06 99.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.425 0.631 . . . . 0.0 110.23 175.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.36 -38.77 41.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.798 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -59.04 -30.58 68.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.14 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.568 ' HA ' ' NE2' ' A' ' 164' ' ' GLN . 55.5 t80 -59.72 -48.92 79.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.53 178.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 17.3 mttt -68.39 -50.78 50.46 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.242 0.544 . . . . 0.0 109.682 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.91 -54.06 49.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.968 -1.014 . . . . 0.0 111.93 -174.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.512 ' HB2' HE21 ' A' ' 164' ' ' GLN . 23.8 mt-30 -76.27 -31.07 58.07 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.95 -0.3 . . . . 0.0 111.135 -178.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -59.2 -42.06 97.02 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.295 -0.955 . . . . 0.0 111.589 175.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.453 ' HA ' ' HD3' ' A' ' 86' ' ' ARG . 21.6 mmt180 -79.79 -27.92 40.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.861 -0.169 . . . . 0.0 111.156 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.509 HG21 ' O ' ' A' ' 84' ' ' GLN . 0.3 OUTLIER -68.57 -39.49 80.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.069 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.585 ' HB3' HG21 ' A' ' 103' ' ' VAL . 9.1 m-85 -68.11 -30.17 69.27 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.148 0.499 . . . . 0.0 109.886 173.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -65.69 -28.88 74.05 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.773 175.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.609 ' CG ' HD11 ' A' ' 37' ' ' ILE . 10.9 mptt -70.31 -29.96 66.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.822 0.344 . . . . 0.0 110.372 176.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.468 ' HB2' ' O ' ' A' ' 88' ' ' TYR . 4.6 mm? -61.99 -44.97 95.61 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 169.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 1.099 ' HE3' ' HB ' ' A' ' 103' ' ' VAL . 1.8 mptm? -63.44 -30.23 71.39 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.637 176.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -55.31 -46.02 76.27 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.522 -178.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -109.63 -5.78 15.56 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -178.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 61.87 40.53 12.53 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.223 174.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -66.84 -46.58 74.63 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -178.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.518 ' CZ ' ' HE2' ' A' ' 92' ' ' LYS . 26.0 p90 -64.71 -29.84 70.83 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.172 -177.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.432 ' HA3' ' HB2' ' A' ' 101' ' ' GLU . . . 157.58 130.91 1.25 Allowed Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -178.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.45 -51.48 5.19 Favored 'Trans proline' 0 CA--C 1.529 0.239 0 C-N-CA 122.824 2.349 . . . . 0.0 113.078 -178.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -92.18 -18.85 22.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.895 0.379 . . . . 0.0 111.166 -178.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.432 ' HB2' ' HA3' ' A' ' 98' ' ' GLY . 5.3 mm-40 -61.98 144.93 54.39 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.06 -179.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.47 156.76 37.89 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 168.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 1.099 ' HB ' ' HE3' ' A' ' 92' ' ' LYS . 7.6 p -57.28 124.29 10.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 122.136 0.969 . . . . 0.0 111.734 -170.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 35.6 mmtm -126.03 90.44 3.19 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 113.976 -1.466 . . . . 0.0 108.43 176.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.538 ' HB3' ' CE2' ' A' ' 88' ' ' TYR . 2.0 tm? -128.12 125.64 39.58 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.508 0.67 . . . . 0.0 110.525 -175.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.477 ' HG3' HG13 ' A' ' 157' ' ' ILE . 2.5 mp0 -71.35 132.11 44.38 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.58 -1.191 . . . . 0.0 112.064 -177.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 20.3 m -119.56 135.16 54.9 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 169.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 10.2 m170 -108.75 120.86 43.71 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.731 0.301 . . . . 0.0 110.329 -177.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.466 HD11 ' HA ' ' A' ' 167' ' ' GLN . 37.4 pt -114.1 136.06 51.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.135 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.574 HH11 HG13 ' A' ' 153' ' ' ILE . 19.5 mmm180 -87.17 119.16 27.12 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.862 -176.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.6 HG11 HD11 ' A' ' 174' ' ' LEU . 19.2 m -123.04 153.33 64.26 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.827 176.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.5 ' HD2' HD22 ' A' ' 174' ' ' LEU . 51.8 Cg_exo -54.33 142.89 67.64 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.221 1.948 . . . . 0.0 111.098 176.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.549 ' HA ' HG21 ' A' ' 152' ' ' VAL . . . -50.17 -47.41 54.42 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -170.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 43.8 t -75.1 -28.95 60.47 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.523 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.39 -32.26 73.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.14 -178.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.657 ' O ' HG13 ' A' ' 119' ' ' VAL . . . -64.56 -32.76 74.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.368 0.604 . . . . 0.0 110.231 175.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -74.74 -25.32 70.0 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.548 177.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 56.3 ttt180 -92.95 -15.09 26.68 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.722 0.267 . . . . 0.0 111.722 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.657 HG13 ' O ' ' A' ' 116' ' ' ALA . 9.5 p -71.31 -20.88 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 173.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 1.057 ' HA ' ' HB ' ' A' ' 127' ' ' VAL . 71.9 mt -66.35 -25.98 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.953 170.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 111.67 151.86 11.96 Favored Glycine 0 N--CA 1.441 -1.03 0 CA-C-N 114.993 -1.003 . . . . 0.0 112.219 178.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -64.67 -26.37 68.35 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 175.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -103.36 -14.81 16.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.902 176.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.56 ' HA2' HG23 ' A' ' 120' ' ' ILE . . . 91.34 -1.64 76.89 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.447 -176.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 31.0 mtmm -85.51 -23.63 27.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.979 0.419 . . . . 0.0 110.948 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 23.5 m -65.09 -39.19 92.83 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.642 -170.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 1.057 ' HB ' ' HA ' ' A' ' 120' ' ' ILE . 14.4 p -63.71 -32.73 58.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.028 0.442 . . . . 0.0 111.082 -177.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -71.9 -40.56 68.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.241 0.544 . . . . 0.0 110.237 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -78.67 -25.4 44.87 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.394 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.465 HD22 HG11 ' A' ' 138' ' ' VAL . 25.8 tp -58.59 -45.53 88.89 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 174.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -60.55 -36.03 77.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.068 0.461 . . . . 0.0 110.693 176.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -67.51 -33.03 74.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.407 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -88.16 -43.95 11.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.852 0.358 . . . . 0.0 110.755 -178.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.606 ' HB ' ' HB2' ' A' ' 166' ' ' ALA . 62.0 p -73.65 -22.57 59.93 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.956 -174.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 65.08 15.74 10.17 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.044 -178.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.48 ' HB2' ' HB3' ' A' ' 162' ' ' ALA . . . -120.84 168.75 11.12 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.124 -178.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.437 ' HB3' ' HB ' ' A' ' 157' ' ' ILE . 23.5 tt0 -93.84 109.71 21.39 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 177.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.465 HG11 HD22 ' A' ' 130' ' ' LEU . 55.0 t -106.29 105.89 19.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.879 -177.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.623 HG11 ' HD3' ' A' ' 155' ' ' LYS . 4.8 p -108.76 115.1 48.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.464 0.649 . . . . 0.0 110.605 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 47.0 t -101.68 115.33 65.04 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.125 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.513 ' HG3' ' HE3' ' A' ' 155' ' ' LYS . 84.0 Cg_endo -82.87 155.25 15.28 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.724 2.283 . . . . 0.0 112.608 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 39.8 mmt180 -86.52 -12.65 48.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.071 176.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -116.93 -89.17 0.58 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.795 -178.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.897 ' HG2' ' H ' ' A' ' 153' ' ' ILE . 23.8 tp60 67.43 -77.39 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.04 0.536 . . . . 0.0 111.624 -178.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.1 p -145.31 139.51 15.06 Favored Pre-proline 0 C--N 1.316 -0.851 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -57.19 148.77 67.88 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 122.641 2.227 . . . . 0.0 111.97 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -72.95 8.64 1.46 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.025 -178.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -61.55 -29.22 69.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.574 0.702 . . . . 0.0 109.571 169.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -95.94 0.46 51.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.515 177.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 46.46 23.82 0.25 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.91 1.284 . . . . 0.0 112.323 -175.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -152.97 139.49 18.71 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 120.871 0.367 . . . . 0.0 110.706 -171.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.549 HG21 ' HA ' ' A' ' 113' ' ' ALA . 17.5 m -132.19 -177.04 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.951 -178.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.897 ' H ' ' HG2' ' A' ' 144' ' ' GLN . 20.5 mt -126.27 141.0 47.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.889 0.376 . . . . 0.0 111.462 -178.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.443 ' N ' HG21 ' A' ' 153' ' ' ILE . 5.6 p -109.88 138.93 35.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 165.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.623 ' HD3' HG11 ' A' ' 139' ' ' VAL . 0.0 OUTLIER -99.6 129.09 45.72 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.915 -173.668 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.495 HG21 ' HA ' ' A' ' 163' ' ' SER . 59.9 mt -110.86 117.69 55.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.221 179.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.477 HG13 ' HG3' ' A' ' 106' ' ' GLU . 3.9 mp -112.27 139.62 36.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.658 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 142.38 -153.2 24.3 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.351 -0.928 . . . . 0.0 112.897 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 17.9 m80 -85.69 158.22 20.11 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -177.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.463 ' HB3' ' CG ' ' A' ' 88' ' ' TYR . 51.4 p90 -63.64 -36.73 84.8 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.459 -175.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -54.58 -46.82 73.82 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.384 0.611 . . . . 0.0 110.371 175.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.48 ' HB3' ' HB2' ' A' ' 136' ' ' ALA . . . -68.76 -48.31 64.04 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.854 -178.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.495 ' HA ' HG21 ' A' ' 156' ' ' ILE . 41.9 m -56.63 -49.95 73.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.173 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.568 ' NE2' ' HA ' ' A' ' 81' ' ' PHE . 93.4 mt-30 -59.64 -39.43 84.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.93 0.395 . . . . 0.0 111.289 -178.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 35.9 ttp -72.8 -37.23 67.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.774 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.606 ' HB2' ' HB ' ' A' ' 134' ' ' THR . . . -66.56 -48.68 68.87 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.805 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.566 ' NE2' HG21 ' A' ' 25' ' ' VAL . 42.2 mt-30 -51.82 -55.79 17.8 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.953 -178.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -64.32 -30.44 71.49 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.635 -174.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.933 ' HA ' ' HE2' ' A' ' 169' ' ' LYS . 3.5 mmpt? -76.82 -40.99 46.02 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.367 -177.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.414 ' O ' ' HG ' ' A' ' 174' ' ' LEU . 17.0 mt -70.89 -42.21 77.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.006 0.431 . . . . 0.0 110.132 176.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -61.46 -27.0 68.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.891 175.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -77.02 -40.43 46.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.4 -177.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.425 ' O ' HG21 ' A' ' 177' ' ' VAL . 18.2 pt -69.46 -26.75 31.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.602 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.6 HD11 HG11 ' A' ' 111' ' ' VAL . 19.3 mt -50.46 -47.74 56.79 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.831 0.348 . . . . 0.0 111.138 177.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.73 -40.52 97.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.787 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -73.68 -30.08 62.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.102 -178.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.425 HG21 ' O ' ' A' ' 173' ' ' ILE . 53.3 t -67.38 -45.82 84.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.27 175.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.478 ' O ' ' HD2' ' A' ' 181' ' ' HIS . 54.8 mtpt -63.3 -19.54 64.68 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.678 -178.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -60.57 -12.12 9.09 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 120.895 0.379 . . . . 0.0 111.229 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -55.3 -20.9 12.68 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.389 176.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . 0.478 ' HD2' ' O ' ' A' ' 178' ' ' LYS . 16.9 p80 -59.28 -25.58 64.22 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.385 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 52.1 tp60 -67.91 -49.12 63.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt 53.86 87.8 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 O-C-N 123.937 0.773 . . . . 0.0 111.547 177.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 159.75 98.08 0.13 Allowed Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -77.94 78.0 4.44 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.05 0.452 . . . . 0.0 110.735 -178.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 15.3 m -83.14 45.18 1.0 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.74 174.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 170.41 164.31 25.92 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.442 -176.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -94.92 172.88 7.88 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.241 0.543 . . . . 0.0 111.645 -177.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 55.6 tp -152.78 138.56 17.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.315 -0.857 . . . . 0.0 108.949 177.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -78.95 71.25 5.4 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.059 0.457 . . . . 0.0 110.72 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.441 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.376 179.086 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' ' G' . . . . . 0.994 " O2'" ' H6 ' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.424 -0.99 0 C4'-C3'-C2' 106.293 3.593 OUTLIER-EPSILON 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . 0.994 ' H6 ' " O2'" ' B' ' 1' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.423 -1.031 0 C3'-C2'-C1' 99.136 -2.627 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . 0.712 " H1'" ' C5 ' ' B' ' 4' ' ' ' C' . . . . . . . . 0 C2'--C1' 1.516 -1.229 0 C5'-C4'-O4' 112.519 2.37 . 0.0 OUTLIER '7D dist 1[' 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' ' C' . . . . . 0.907 ' N4 ' ' HA2' ' A' ' 35' ' ' GLY . . . . . . . . 0 O3'--C3' 1.432 0.653 0 C4'-C3'-C2' 105.887 3.187 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.776 " O5'" " H4'" ' B' ' 4' ' ' ' C' . . . . . . . . 0 P--O3' 1.614 0.597 0 P-O3'-C3' 122.623 2.436 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' ' C' . . . . . 0.739 ' H6 ' " O5'" ' B' ' 6' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.427 -0.84 0 C3'-C2'-C1' 103.484 2.205 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.425 -0.919 0 O4'-C1'-C2' 107.77 0.979 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.867 0 C3'-C2'-C1' 100.233 -1.408 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.695 0 N-CA-C 111.907 -0.477 . . . . 0.0 111.907 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -131.48 149.64 52.45 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.702 0.287 . . . . 0.0 110.473 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.4 mmt -101.9 76.6 1.64 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.267 0.556 . . . . 0.0 110.236 178.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -152.9 117.98 0.85 Allowed Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.81 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.03 149.08 86.49 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 123.039 2.493 . . . . 0.0 112.686 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 24.9 m -88.49 79.27 7.69 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.231 -176.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.7 t -154.39 30.47 0.43 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.061 0.458 . . . . 0.0 110.265 177.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.8 p -157.15 77.31 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 122.271 1.034 . . . . 0.0 110.485 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.2 p -147.36 21.63 1.19 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.237 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.94 88.82 0.9 Allowed Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.937 -177.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -100.75 -30.07 11.92 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.812 0.339 . . . . 0.0 111.047 -176.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -127.72 83.93 64.73 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 120.921 0.391 . . . . 0.0 110.7 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -81.03 -61.46 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 123.044 2.496 . . . . 0.0 113.157 -177.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -108.82 126.41 53.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.654 -173.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.4 p -155.47 174.67 14.93 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.146 -178.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 31.1 m 70.21 -69.67 0.17 Allowed 'General case' 0 N--CA 1.468 0.428 0 O-C-N 123.914 0.759 . . . . 0.0 112.038 176.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -81.73 148.73 28.8 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.463 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -155.23 142.79 13.98 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.06 175.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 18' ' ' MET . 1.6 Cg_endo -86.84 113.84 1.08 Allowed 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 123.149 2.566 . . . . 0.0 111.372 174.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.34 56.82 5.16 Favored 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 123.142 2.561 . . . . 0.0 113.388 -174.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -85.24 63.38 8.06 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 172.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -65.51 134.52 53.56 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.22 -175.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.455 ' HG2' HE22 ' A' ' 80' ' ' GLN . 30.4 tt0 -85.08 103.53 14.17 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.145 -178.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.652 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 8.0 t -120.05 123.12 42.65 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 121.556 0.693 . . . . 0.0 109.572 173.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.53 ' HB ' HG23 ' A' ' 109' ' ' ILE . 27.2 m -126.44 160.94 33.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -106.07 121.41 44.07 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 121.009 -0.277 . . . . 0.0 110.785 -171.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.605 ' O ' ' HA ' ' A' ' 70' ' ' MET . 21.6 t -96.93 128.43 48.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.614 -174.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.428 ' CZ ' HG12 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -90.65 104.84 17.38 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 122.326 0.25 . . . . 0.0 111.232 -171.622 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.464 ' C ' HG21 ' A' ' 68' ' ' VAL . 20.4 pt -126.97 120.06 22.53 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.179 0.514 . . . . 0.0 110.682 175.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -58.92 152.38 58.41 Favored 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 122.955 2.437 . . . . 0.0 112.8 -177.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.582 ' HA ' HG13 ' A' ' 34' ' ' VAL . . . -60.01 -19.98 55.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.89 -1.05 . . . . 0.0 112.889 -173.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -68.54 -24.81 64.68 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.616 ' HB2' ' HE2' ' A' ' 96' ' ' PHE . . . -116.28 -31.03 5.76 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.939 -176.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.582 HG13 ' HA ' ' A' ' 31' ' ' ALA . 10.2 p -51.44 -34.96 15.92 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 CA-C-O 120.93 0.395 . . . . 0.0 111.432 -174.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.946 ' HA2' ' N4 ' ' B' ' 4' ' ' ' C' . . . -55.84 -55.91 26.62 Favored Glycine 0 N--CA 1.438 -1.231 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.268 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.426 ' HB3' " O2'" ' B' ' 2' ' ' ' C' . . . -75.25 -14.89 60.55 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 120.987 0.422 . . . . 0.0 111.099 -175.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.598 HD13 ' HB3' ' A' ' 90' ' ' LYS . 3.7 mm -65.98 -39.96 86.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.16 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.718 HD11 ' C5 ' ' B' ' 4' ' ' ' C' . 17.7 mt -61.94 -37.8 79.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-O 121.074 0.464 . . . . 0.0 111.392 177.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.66 141.21 9.07 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.063 178.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -46.52 -34.18 4.65 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.342 0.657 . . . . 0.0 112.132 -172.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.476 ' HE2' ' HB3' ' A' ' 43' ' ' GLN . 15.4 ptmt -123.09 93.2 3.88 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 166.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.552 ' HA3' " H5'" ' B' ' 4' ' ' ' C' . . . -33.23 88.8 0.01 OUTLIER Glycine 0 C--N 1.338 0.671 0 O-C-N 124.355 1.034 . . . . 0.0 113.673 172.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.476 ' HB3' ' HE2' ' A' ' 41' ' ' LYS . 5.4 tp-100 -176.19 -34.91 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -175.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -56.89 -41.8 78.72 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.023 169.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.574 HG23 HG23 ' A' ' 38' ' ' ILE . 8.5 tt -56.99 -34.16 44.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.036 173.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.519 ' HE2' " H4'" ' B' ' 6' ' ' ' C' . 23.5 mmmt -82.35 -29.96 30.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.594 -178.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.4 ' OE1' ' HD3' ' A' ' 50' ' ' ARG . 46.9 tp60 -62.85 -35.46 80.05 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 170.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.809 ' HG ' ' HE1' ' A' ' 51' ' ' PHE . 7.3 tt -60.98 -42.38 98.24 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.513 173.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 14.9 m -56.74 -34.95 68.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.609 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.4 ' HD3' ' OE1' ' A' ' 47' ' ' GLN . 76.1 mtp180 -72.31 -51.87 18.77 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.693 -176.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.809 ' HE1' ' HG ' ' A' ' 48' ' ' LEU . 3.2 p90 -77.0 -29.98 55.71 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.728 -173.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.588 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -81.73 -12.56 58.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.244 -178.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.7 t 61.27 30.07 18.98 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.541 178.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -131.91 159.66 38.0 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.345 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.688 ' HB2' ' HB ' ' A' ' 74' ' ' THR . 19.6 m -91.12 100.46 13.29 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -178.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.4 mm -88.4 111.53 22.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.319 -177.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -130.6 137.76 49.8 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.39 176.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.62 ' HB ' ' N1 ' ' B' ' 5' ' ' ' A' . 46.8 mm -94.27 112.35 26.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 172.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.664 ' HB2' HG21 ' A' ' 72' ' ' VAL . . . -67.73 117.73 50.76 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.452 -174.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.07 132.02 17.56 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.798 2.332 . . . . 0.0 111.406 176.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -78.24 146.28 22.27 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.706 2.271 . . . . 0.0 111.531 177.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -70.48 -44.55 67.47 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 176.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.414 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 32.5 p -96.32 129.74 32.72 Favored Pre-proline 0 N--CA 1.446 -0.669 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.738 177.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 63' ' ' THR . 11.9 Cg_exo -70.41 -6.06 18.05 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 123.284 2.656 . . . . 0.0 111.987 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -82.07 -10.92 59.05 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.634 -179.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.2 t -57.43 126.03 25.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.501 0.667 . . . . 0.0 111.505 -177.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.6 tmtp? -79.21 -11.01 59.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.475 -176.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.464 HG21 ' C ' ' A' ' 29' ' ' ILE . 2.4 p -144.78 151.91 15.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.724 -171.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.444 ' HD3' HG12 ' A' ' 34' ' ' VAL . 59.3 mtp180 -126.18 132.23 51.83 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 177.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.605 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 76.7 mtm -92.26 147.47 22.9 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.873 -175.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.528 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 86.4 t -96.09 124.42 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 172.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.664 HG21 ' HB2' ' A' ' 59' ' ' ALA . 97.5 t -86.8 102.13 11.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 174.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.652 ' O ' ' HA ' ' A' ' 24' ' ' THR . 8.8 tp -101.34 100.18 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 CA-C-O 121.882 0.849 . . . . 0.0 110.252 -177.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.688 ' HB ' ' HB2' ' A' ' 55' ' ' SER . 9.4 m -102.61 105.83 16.4 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.688 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -160.35 163.62 34.03 Favored Glycine 0 CA--C 1.497 -1.088 0 C-N-CA 119.674 -1.25 . . . . 0.0 113.254 -174.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.489 ' HD2' ' HB3' ' A' ' 79' ' ' ALA . 7.1 Cg_exo -67.23 136.77 41.55 Favored 'Trans proline' 0 N--CA 1.446 -1.273 0 C-N-CA 121.944 1.763 . . . . 0.0 109.859 170.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.556 ' HA ' ' NH2' ' A' ' 168' ' ' ARG . 3.7 Cg_exo -36.78 -50.93 1.4 Allowed 'Trans proline' 0 C--O 1.24 0.614 0 C-N-CA 124.59 3.527 . . . . 0.0 113.684 -176.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -63.81 -49.82 71.39 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.942 0.401 . . . . 0.0 111.174 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.551 ' HB1' ' O ' ' A' ' 52' ' ' ALA . . . -66.87 -34.4 77.72 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.407 -177.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.455 HE22 ' HG2' ' A' ' 23' ' ' GLU . 34.2 tt0 -61.91 -31.22 71.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.73 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -65.77 -42.17 91.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.603 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.3 mtmt -63.02 -37.98 89.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.548 0.689 . . . . 0.0 109.952 -178.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.588 ' HB3' ' HB2' ' A' ' 52' ' ' ALA . . . -69.76 -49.05 56.74 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.534 179.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.439 ' O ' HG23 ' A' ' 87' ' ' ILE . 41.6 mt-30 -67.14 -30.81 70.91 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -177.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -56.99 -35.19 67.7 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.848 175.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.4 mmt180 -79.44 -36.76 38.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.576 0.227 . . . . 0.0 111.154 177.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.543 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 0.3 OUTLIER -67.75 -40.87 84.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.738 -174.93 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.738 ' HA ' HD21 ' A' ' 91' ' ' LEU . 6.7 m-85 -68.33 -32.04 71.88 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.056 0.455 . . . . 0.0 110.292 175.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -61.44 -28.91 70.29 Favored Glycine 0 C--O 1.224 -0.526 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.709 174.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.598 ' HB3' HD13 ' A' ' 37' ' ' ILE . 69.3 mmtt -66.99 -38.87 86.82 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 122.827 0.451 . . . . 0.0 111.002 174.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.738 HD21 ' HA ' ' A' ' 88' ' ' TYR . 3.2 mm? -60.49 -38.36 84.04 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.157 0.504 . . . . 0.0 110.555 173.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.954 ' HE3' ' HB ' ' A' ' 103' ' ' VAL . 3.6 mmtp -76.44 -26.54 55.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.502 178.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -68.43 -30.92 69.91 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.472 -175.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.568 ' OE1' ' HA ' ' A' ' 94' ' ' GLU . 4.4 mm-40 -96.42 10.7 37.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.307 0.575 . . . . 0.0 110.799 177.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 63.2 t30 57.2 45.52 20.37 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 114.757 -1.11 . . . . 0.0 112.143 172.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.616 ' HE2' ' HB2' ' A' ' 33' ' ' ALA . 61.2 m-85 -90.16 -21.94 21.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.148 0.499 . . . . 0.0 110.243 174.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.736 ' O ' ' HB3' ' A' ' 101' ' ' GLU . 12.0 m-85 -131.0 26.38 4.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.037 -179.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 59.72 175.52 0.97 Allowed Glycine 0 CA--C 1.525 0.693 0 C-N-CA 121.277 -0.487 . . . . 0.0 113.219 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -82.19 -35.23 0.37 Allowed 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.856 2.371 . . . . 0.0 112.534 174.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -106.98 -23.18 12.42 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.654 0.264 . . . . 0.0 111.429 -175.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.736 ' HB3' ' O ' ' A' ' 97' ' ' PHE . 10.6 tp10 -61.4 151.65 31.81 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.463 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -62.6 126.58 27.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.726 -177.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.954 ' HB ' ' HE3' ' A' ' 92' ' ' LYS . 7.1 p -76.45 122.83 31.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 172.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -124.53 90.31 3.23 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 176.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.579 ' HB3' ' CE2' ' A' ' 88' ' ' TYR . 1.8 tm? -118.86 130.81 55.95 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.869 -173.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.835 ' HG2' HG13 ' A' ' 157' ' ' ILE . 32.0 mt-10 -73.5 126.89 31.25 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.188 -0.915 . . . . 0.0 112.743 -176.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.473 HG22 ' NE2' ' A' ' 167' ' ' GLN . 0.2 OUTLIER -113.81 125.5 54.16 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 167.012 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 21.5 m170 -107.81 121.49 44.83 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -177.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.53 HG23 ' HB ' ' A' ' 25' ' ' VAL . 10.4 pt -113.83 147.24 17.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 177.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.88 ' HG3' ' HG2' ' A' ' 151' ' ' GLN . 4.2 tpt180 -97.88 118.65 34.92 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -176.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.608 HG11 HD22 ' A' ' 174' ' ' LEU . 11.1 m -116.82 150.1 45.2 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 178.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.62 ' CD ' HD12 ' A' ' 174' ' ' LEU . 44.8 Cg_exo -49.77 149.66 10.42 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 123.217 2.612 . . . . 0.0 112.341 177.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -48.6 -49.15 38.11 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -171.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 23.1 t -85.93 -19.74 30.04 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.839 0.352 . . . . 0.0 110.921 -176.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.439 ' O ' HG21 ' A' ' 119' ' ' VAL . . . -65.66 -26.08 67.63 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.521 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.501 ' O ' ' HB ' ' A' ' 119' ' ' VAL . . . -63.51 -34.44 77.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.59 177.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -67.66 -32.91 79.34 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.852 -0.689 . . . . 0.0 111.473 177.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.457 ' HD3' HG23 ' A' ' 177' ' ' VAL . 26.1 mtp180 -83.77 -6.8 59.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.488 -0.356 . . . . 0.0 110.609 176.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.72 HG23 HD13 ' A' ' 173' ' ' ILE . 12.0 t -75.11 -51.19 22.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.331 0.586 . . . . 0.0 109.788 172.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 1.011 ' HA ' ' HB ' ' A' ' 127' ' ' VAL . 20.2 pt -81.12 -34.22 13.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.946 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.456 ' HA3' HG22 ' A' ' 126' ' ' THR . . . 89.39 58.49 1.64 Allowed Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.98 -0.628 . . . . 0.0 111.891 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 59.9 -88.25 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.16 0.584 . . . . 0.0 111.797 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -86.87 -25.63 24.38 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.734 -178.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 135.26 39.63 0.17 Allowed Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.306 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -79.31 -63.18 1.47 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.669 0.271 . . . . 0.0 111.25 -177.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.619 ' O ' ' HG ' ' A' ' 130' ' ' LEU . 8.1 t -76.79 -20.22 56.68 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.756 -174.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 1.011 ' HB ' ' HA ' ' A' ' 120' ' ' ILE . 8.8 p -69.25 -29.21 41.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 176.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -65.95 -41.04 91.77 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.494 174.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.33 -48.76 80.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.761 173.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' A' ' 126' ' ' THR . 87.7 mt -58.02 -50.47 73.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.457 -177.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -62.0 -49.69 75.04 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -176.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -77.81 -11.3 59.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.794 -173.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 59.5 tp -97.46 -49.34 4.94 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.749 0.309 . . . . 0.0 110.96 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 82.1 p -79.62 -20.2 47.39 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.85 -173.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 66.2 27.47 10.31 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.875 0.735 . . . . 0.0 110.168 -174.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -127.33 176.21 7.6 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.528 -177.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.547 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 7.3 tp10 -108.74 111.4 23.14 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.845 177.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.48 HG23 HD12 ' A' ' 170' ' ' ILE . 46.2 t -108.41 106.24 20.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 177.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.662 HG13 ' HD3' ' A' ' 155' ' ' LYS . 5.1 p -123.16 125.33 71.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.351 0.596 . . . . 0.0 111.819 -175.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 89.3 t -92.8 118.1 67.8 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 173.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -50.72 137.71 41.78 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 123.811 3.007 . . . . 0.0 113.25 -171.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.534 ' HA ' ' NE ' ' A' ' 142' ' ' ARG . 4.6 mmp_? -81.64 -28.99 33.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.309 178.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -93.56 62.89 3.37 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 163.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -57.93 139.31 54.6 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.607 -1.179 . . . . 0.0 111.438 -171.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 30.2 p -59.13 130.47 86.83 Favored Pre-proline 0 N--CA 1.448 -0.542 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.292 173.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.488 ' C ' ' H ' ' A' ' 148' ' ' GLU . 17.8 Cg_endo -58.27 150.98 63.2 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.684 2.256 . . . . 0.0 112.226 -175.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -78.24 35.32 0.22 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.321 0.582 . . . . 0.0 110.751 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.488 ' H ' ' C ' ' A' ' 146' ' ' PRO . 24.0 tt0 -52.26 -47.15 65.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.019 177.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -109.15 25.01 12.3 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.314 178.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 49.48 31.34 3.95 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.854 1.262 . . . . 0.0 112.544 178.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.88 ' HG2' ' HG3' ' A' ' 110' ' ' ARG . 7.8 tt0 -156.68 136.12 12.22 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.141 -177.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 32.6 m -122.41 169.32 13.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.007 0.432 . . . . 0.0 111.716 -172.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 10.7 mm -102.27 142.76 15.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.098 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 4.1 p -127.97 140.04 50.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.939 171.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.662 ' HD3' HG13 ' A' ' 139' ' ' VAL . 0.0 OUTLIER -96.77 130.4 44.03 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.738 -174.685 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.547 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 76.0 mt -114.43 111.53 36.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 172.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.835 HG13 ' HG2' ' A' ' 106' ' ' GLU . 4.2 mp -110.05 131.69 60.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.12 -177.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 163.82 -164.0 36.14 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.313 -0.946 . . . . 0.0 112.53 177.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.562 ' HA ' HG13 ' A' ' 103' ' ' VAL . 5.1 m80 -79.07 160.07 27.25 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.533 ' HB3' ' CG ' ' A' ' 88' ' ' TYR . 13.5 p90 -57.43 -33.3 67.75 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 118.561 0.619 . . . . 0.0 112.028 -175.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -61.86 -52.95 62.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.522 0.677 . . . . 0.0 110.112 175.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -65.59 -41.65 92.59 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.808 -175.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.484 ' O ' ' HG3' ' A' ' 167' ' ' GLN . 26.2 p -68.08 -49.13 63.16 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.318 -176.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.62 -31.63 71.72 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.708 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 25.6 ttt -66.83 -45.66 77.56 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.036 0.446 . . . . 0.0 110.301 176.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.547 ' HB3' HG22 ' A' ' 156' ' ' ILE . . . -71.16 -35.31 71.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.833 -177.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.484 ' HG3' ' O ' ' A' ' 163' ' ' SER . 66.4 mt-30 -51.54 -56.58 12.64 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.005 0.431 . . . . 0.0 110.807 -179.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.65 ' HA ' ' HB2' ' A' ' 171' ' ' ARG . 0.4 OUTLIER -74.09 -27.18 60.77 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.498 178.812 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.577 ' HA ' ' HE3' ' A' ' 169' ' ' LYS . 0.2 OUTLIER -64.52 -49.76 70.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.064 0.459 . . . . 0.0 109.992 -179.245 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.526 HG23 HG23 ' A' ' 119' ' ' VAL . 2.0 mp -71.87 -35.24 53.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.755 177.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.65 ' HB2' ' HA ' ' A' ' 168' ' ' ARG . 1.0 OUTLIER -56.58 -33.82 66.55 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.38 172.894 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.49 -44.13 45.53 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.73 0.271 . . . . 0.0 111.73 -178.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.72 HD13 HG23 ' A' ' 119' ' ' VAL . 2.7 pp -68.58 -30.86 48.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.61 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.62 HD12 ' CD ' ' A' ' 112' ' ' PRO . 0.3 OUTLIER -71.89 -37.59 70.11 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.624 0.726 . . . . 0.0 109.278 174.191 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -58.01 -32.21 67.7 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.981 -1.008 . . . . 0.0 111.067 176.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -61.36 -33.74 74.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.082 0.468 . . . . 0.0 110.113 174.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.701 ' O ' ' HG2' ' A' ' 180' ' ' GLN . 22.0 t -73.8 -29.41 26.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.358 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -63.83 -34.85 78.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.005 0.431 . . . . 0.0 110.44 175.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -67.93 -21.24 65.12 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.238 -174.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.701 ' HG2' ' O ' ' A' ' 177' ' ' VAL . 24.5 pt20 -74.43 -20.88 59.88 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.064 178.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -79.05 -44.29 22.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.94 176.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -70.1 -36.02 74.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.753 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 180' ' ' GLN . 32.3 mmtp 60.73 83.94 0.14 Allowed 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.266 0.555 . . . . 0.0 110.644 -178.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -80.4 107.17 2.6 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.905 -178.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -69.97 96.48 1.04 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.761 0.315 . . . . 0.0 110.2 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 8.1 t 61.38 34.84 18.15 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.328 -178.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 114.06 -89.9 0.52 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.335 178.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . 0.738 HE21 ' HA ' ' A' ' 188' ' ' GLN . 0.0 OUTLIER 64.09 33.46 12.01 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.083 0.468 . . . . 0.0 110.928 -178.476 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 1.5 pp -91.25 164.3 13.93 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.619 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 79.4 mm-40 -99.36 -12.64 20.12 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.124 -175.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.334 0 O-C-N 123.811 0.694 . . . . 0.0 111.663 177.855 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' ' G' . . . . . 0.976 " O2'" ' H6 ' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.424 -0.977 0 C4'-C3'-C2' 106.455 3.755 OUTLIER-EPSILON 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . 0.976 ' H6 ' " O2'" ' B' ' 1' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.425 -0.915 0 C3'-C2'-C1' 99.567 -2.148 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . 0.67 " H1'" ' C5 ' ' B' ' 4' ' ' ' C' . . . . . . . . 0 C2'--C1' 1.516 -1.166 0 O4'-C1'-C2' 103.257 -2.245 . 0.0 OUTLIER '7D dist 1z' 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' ' C' . . . . . 0.946 ' N4 ' ' HA2' ' A' ' 35' ' ' GLY . . . . . . . . 0 O5'--C5' 1.428 -0.73 0 C4'-C3'-C2' 105.997 3.297 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.81 " O5'" " H4'" ' B' ' 4' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.43 -0.623 0 P-O3'-C3' 122.222 2.101 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' ' C' . . . . . 0.523 ' H6 ' " O5'" ' B' ' 6' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.429 -0.703 0 C4'-C3'-C2' 104.961 2.261 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.852 0 O4'-C4'-C3' 104.628 -0.623 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.425 -0.953 0 C3'-C2'-C1' 100.49 -1.122 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.445 0 N-CA-C 112.113 -0.395 . . . . 0.0 112.113 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -119.77 156.4 30.68 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 51.6 ttp -88.51 123.77 33.35 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.543 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 104.53 173.28 24.88 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.171 176.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.19 62.05 7.43 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.887 2.391 . . . . 0.0 111.839 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.0 m -62.91 107.27 0.96 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.292 178.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.1 m -69.48 136.48 51.54 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.068 -177.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.3 t -78.67 82.06 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 176.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.2 m -56.84 130.43 45.7 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.696 -176.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.43 4.95 29.74 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 177.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.25 79.66 7.85 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.163 0.506 . . . . 0.0 110.726 177.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.463 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . . . -72.39 133.24 83.24 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.63 175.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 12' ' ' ALA . 13.3 Cg_exo -69.84 70.66 1.61 Allowed 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 123.099 2.533 . . . . 0.0 112.855 -177.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -89.58 -42.22 11.54 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 174.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 37.1 m -130.13 -57.18 1.09 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.766 174.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.41 ' OG ' ' HA ' ' A' ' 13' ' ' PRO . 42.6 m 51.41 65.15 1.57 Allowed 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.297 0.57 . . . . 0.0 111.949 177.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -97.03 117.95 32.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.356 178.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.733 ' HB3' ' HD3' ' A' ' 19' ' ' PRO . 51.1 ttp -96.41 -58.82 0.18 Allowed Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.852 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.733 ' HD3' ' HB3' ' A' ' 18' ' ' MET . 25.4 Cg_exo -62.62 108.87 0.78 Allowed 'Trans proline' 0 C--N 1.36 1.155 0 C-N-CA 122.233 1.955 . . . . 0.0 112.199 -177.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 19' ' ' PRO . 5.2 Cg_exo -79.35 78.51 3.69 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 123.36 2.707 . . . . 0.0 113.066 -173.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 54.32 66.2 1.3 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.687 171.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.48 ' HB3' HG23 ' A' ' 74' ' ' THR . 97.1 mt-30 -92.35 104.42 16.76 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 171.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -73.27 143.67 46.96 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.679 -174.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 44.8 m -115.16 107.45 15.32 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.509 0.671 . . . . 0.0 110.774 -176.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.0 t -106.96 148.41 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.422 ' HB3' ' SD ' ' A' ' 70' ' ' MET . 15.9 m-70 -113.74 146.51 39.77 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -174.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.677 ' HB ' HG22 ' A' ' 71' ' ' VAL . 7.4 t -124.26 142.79 39.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 120.912 0.387 . . . . 0.0 111.173 -174.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.744 ' CE2' HG12 ' A' ' 68' ' ' VAL . 45.4 t80 -97.58 105.27 17.39 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.088 0.955 . . . . 0.0 110.269 -176.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.528 ' C ' HG22 ' A' ' 68' ' ' VAL . 17.6 pt -124.07 120.22 26.43 Favored Pre-proline 0 C--N 1.324 -0.53 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.766 174.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.552 ' HA ' ' HA ' ' A' ' 68' ' ' VAL . 18.0 Cg_endo -57.96 150.73 62.19 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 122.966 2.444 . . . . 0.0 112.05 -176.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.483 ' HA ' HG13 ' A' ' 34' ' ' VAL . . . -60.17 -19.64 54.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.082 -174.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -69.96 -22.99 63.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.214 177.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.466 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -113.59 -31.79 6.39 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 120.889 -0.325 . . . . 0.0 111.625 -175.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.596 HG23 ' HB3' ' A' ' 69' ' ' ARG . 11.7 p -55.58 -31.23 28.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 O-C-N 123.431 0.457 . . . . 0.0 111.714 -171.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 1.118 ' HA2' ' H42' ' B' ' 4' ' ' ' C' . . . -56.71 -57.58 18.84 Favored Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.019 -178.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.43 -13.73 59.7 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 120.673 0.273 . . . . 0.0 111.368 -175.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.536 HD12 ' CG ' ' A' ' 90' ' ' LYS . 2.1 mm -65.49 -36.43 77.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 177.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.803 HD11 ' C5 ' ' B' ' 4' ' ' ' C' . 37.8 mt -63.99 -52.64 53.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.012 173.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 81.7 106.37 0.37 Allowed Glycine 0 CA--C 1.523 0.549 0 N-CA-C 115.131 0.812 . . . . 0.0 115.131 168.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.404 ' HD2' ' HA ' ' A' ' 40' ' ' LYS . 41.0 tptt 42.16 89.51 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.841 1.256 . . . . 0.0 113.757 169.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.445 ' HA ' ' OP2' ' B' ' 4' ' ' ' C' . 21.0 ttpt 66.85 -0.35 1.68 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.702 0.801 . . . . 0.0 111.947 176.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.481 ' HA2' HG22 ' A' ' 38' ' ' ILE . . . 84.96 18.92 60.27 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.274 -0.965 . . . . 0.0 111.398 -175.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -67.84 -47.21 69.61 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.989 0.423 . . . . 0.0 110.076 178.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 64.0 m-70 -68.29 -39.59 82.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.753 -172.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.0 tt -62.51 -47.31 93.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.719 0.295 . . . . 0.0 111.775 -178.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.2 ptmm? -81.43 -22.87 37.89 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.924 -177.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -64.81 -39.21 93.22 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 169.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.622 ' HA ' ' CZ ' ' A' ' 51' ' ' PHE . 7.8 tt -61.95 -42.12 98.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.931 177.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.621 ' HA ' HD11 ' A' ' 56' ' ' ILE . 44.0 t -53.98 -34.85 60.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.687 177.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -76.85 -50.96 12.17 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.661 -177.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.622 ' CZ ' ' HA ' ' A' ' 48' ' ' LEU . 2.4 p90 -76.77 -11.42 59.83 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 119.995 -0.682 . . . . 0.0 111.85 -175.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 79' ' ' ALA . . . -96.36 -18.53 19.88 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.73 0.3 . . . . 0.0 110.975 176.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.7 t 65.32 34.36 8.35 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.698 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -141.18 168.93 18.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.291 -176.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.654 ' HB2' ' HB ' ' A' ' 74' ' ' THR . 29.9 m -90.71 103.26 15.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.743 0.306 . . . . 0.0 110.679 -178.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.621 HD11 ' HA ' ' A' ' 49' ' ' SER . 2.4 mp -107.21 113.13 42.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.035 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -134.64 157.76 45.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.794 -177.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.672 ' HB ' ' N1 ' ' B' ' 5' ' ' ' A' . 40.8 mm -97.6 135.7 31.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 174.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.852 ' HB1' HG21 ' A' ' 72' ' ' VAL . . . -92.5 140.58 24.08 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-O 120.642 0.258 . . . . 0.0 110.772 -178.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -65.63 120.8 8.04 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.794 2.33 . . . . 0.0 111.495 175.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -73.5 -176.38 2.48 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.325 2.017 . . . . 0.0 111.733 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -59.61 -61.61 2.5 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.477 0.656 . . . . 0.0 109.715 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.432 ' HB ' ' HD2' ' A' ' 64' ' ' PRO . 32.0 p -143.44 173.86 4.12 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.934 178.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.432 ' HD2' ' HB ' ' A' ' 63' ' ' THR . 39.7 Cg_exo -62.39 -21.5 72.79 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 121.901 1.734 . . . . 0.0 111.421 173.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -92.97 17.08 11.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.095 -177.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.8 t -85.02 143.91 28.61 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -72.65 -24.92 61.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.74 -174.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.744 HG12 ' CE2' ' A' ' 28' ' ' PHE . 7.7 p -137.23 150.99 26.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-O 120.925 0.393 . . . . 0.0 110.602 -175.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.596 ' HB3' HG23 ' A' ' 34' ' ' VAL . 18.6 ttm180 -122.21 121.88 37.86 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 174.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.425 ' O ' ' HB2' ' A' ' 59' ' ' ALA . 44.5 ttp -79.83 148.11 31.51 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.134 -178.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.677 HG22 ' HB ' ' A' ' 27' ' ' VAL . 21.8 m -115.19 145.64 20.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.716 0.293 . . . . 0.0 110.555 175.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.852 HG21 ' HB1' ' A' ' 59' ' ' ALA . 58.3 t -107.8 111.11 34.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.15 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.573 ' O ' HD12 ' A' ' 73' ' ' ILE . 2.7 pp -118.77 125.32 74.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.817 0.818 . . . . 0.0 111.133 176.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.654 ' HB ' ' HB2' ' A' ' 55' ' ' SER . 59.4 m -107.04 106.03 16.35 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.786 176.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.03 134.58 7.4 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 119.995 -1.098 . . . . 0.0 113.464 -172.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -69.42 151.03 70.95 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.057 1.838 . . . . 0.0 110.247 167.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -38.13 -49.07 2.28 Favored 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 124.862 3.708 . . . . 0.0 115.407 -173.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -71.3 -49.97 37.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.875 0.369 . . . . 0.0 110.132 -178.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' A' ' 52' ' ' ALA . . . -64.59 -27.19 68.78 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.806 -177.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -53.9 -42.56 68.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.307 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -72.5 -34.65 67.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.844 -177.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 15.4 tppt? -64.99 -47.83 76.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.714 -178.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.0 -53.13 19.06 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.868 -177.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.525 ' O ' HG23 ' A' ' 87' ' ' ILE . 6.5 tt0 -72.18 -30.23 64.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.386 -173.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -56.29 -34.76 63.48 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.508 177.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -76.7 -36.85 56.95 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.996 ' HA ' ' HD3' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -70.41 -30.31 42.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.804 -174.492 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.401 ' O ' ' HB2' ' A' ' 91' ' ' LEU . 7.4 m-85 -66.94 -30.67 70.87 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.166 0.508 . . . . 0.0 109.752 171.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -61.87 -29.22 71.76 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.867 175.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.996 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 5.2 mptp? -60.0 -45.79 91.58 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.909 0.385 . . . . 0.0 109.999 173.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.421 ' HG ' ' HG ' ' A' ' 105' ' ' LEU . 3.6 mm? -57.23 -37.67 72.62 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.591 176.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.965 ' HE3' ' HB ' ' A' ' 103' ' ' VAL . 11.4 mmtp -75.26 -24.43 57.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.028 -176.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -69.47 -44.39 71.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.705 0.288 . . . . 0.0 111.407 -176.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.664 ' HB2' ' CE2' ' A' ' 96' ' ' PHE . 22.7 mm-40 -108.2 1.81 22.37 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 52.27 47.9 23.77 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.269 177.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.664 ' CE2' ' HB2' ' A' ' 94' ' ' GLU . 71.8 m-85 -63.52 -27.41 69.24 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.442 -177.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.468 ' HD2' ' HB3' ' A' ' 101' ' ' GLU . 10.9 p90 -72.39 -28.09 62.78 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.217 -177.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 131.95 158.17 8.93 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.11 -178.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -73.78 -30.62 9.24 Favored 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 122.447 2.098 . . . . 0.0 113.149 -178.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -106.13 23.89 13.32 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.953 0.406 . . . . 0.0 111.157 -174.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.468 ' HB3' ' HD2' ' A' ' 97' ' ' PHE . 12.2 tp10 -123.86 157.41 34.24 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.265 -176.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.42 ' O ' ' HG3' ' A' ' 101' ' ' GLU . 46.7 mt-10 -83.29 -174.86 5.53 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 170.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.965 ' HB ' ' HE3' ' A' ' 92' ' ' LYS . 9.8 p -68.12 123.37 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 C-N-CA 118.392 -1.323 . . . . 0.0 109.328 174.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 158' ' ' GLY . 30.3 mmtp -130.75 89.68 2.79 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.43 177.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.421 ' HG ' ' HG ' ' A' ' 91' ' ' LEU . 0.9 OUTLIER -109.02 115.94 31.04 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -177.473 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.452 ' O ' ' HB3' ' A' ' 28' ' ' PHE . 33.5 tt0 -71.26 116.52 11.67 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.021 -176.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -101.66 144.25 30.61 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.053 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 -124.84 120.98 33.25 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.083 0.468 . . . . 0.0 110.785 -177.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 16.2 pt -121.17 138.15 52.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.144 0.497 . . . . 0.0 111.062 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.607 ' HD3' HG12 ' A' ' 153' ' ' ILE . 9.6 mmt85 -82.66 119.02 23.76 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.442 177.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.852 HG21 HD11 ' A' ' 174' ' ' LEU . 6.0 p -121.69 143.11 37.39 Favored Pre-proline 0 C--N 1.318 -0.783 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.472 ' HD2' HG23 ' A' ' 111' ' ' VAL . 50.7 Cg_exo -53.42 140.03 64.16 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.259 1.972 . . . . 0.0 110.111 177.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.68 -28.51 68.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.179 0.514 . . . . 0.0 110.761 -174.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.2 p -75.89 -34.5 59.97 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.461 176.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.565 ' HB1' HG23 ' A' ' 111' ' ' VAL . . . -71.89 -20.35 61.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.973 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.48 -32.65 70.45 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.236 0.541 . . . . 0.0 110.446 176.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -73.43 -39.63 50.17 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.576 175.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.495 ' HD3' HG23 ' A' ' 177' ' ' VAL . 45.5 mtp180 -73.41 -34.64 65.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.486 0.184 . . . . 0.0 111.459 -177.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.481 HG13 HG21 ' A' ' 140' ' ' VAL . 14.0 p -69.73 -36.43 70.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.923 0.392 . . . . 0.0 110.376 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.982 ' HA ' ' HB ' ' A' ' 127' ' ' VAL . 75.5 mt -75.11 -31.4 24.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.651 0.739 . . . . 0.0 109.449 174.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 118.58 -33.75 4.67 Favored Glycine 0 N--CA 1.44 -1.096 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.9 t70 65.48 -72.61 0.07 Allowed 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.548 0.739 . . . . 0.0 110.96 178.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -107.13 -11.32 15.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.957 0.408 . . . . 0.0 110.237 176.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -113.75 -168.96 16.75 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.082 -176.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -109.11 35.94 3.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.884 0.373 . . . . 0.0 110.422 -176.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 11.0 m -60.09 -46.15 90.55 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.246 -175.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.982 ' HB ' ' HA ' ' A' ' 120' ' ' ILE . 9.9 p -68.82 -33.89 61.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.266 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -60.71 -42.56 97.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.346 0.593 . . . . 0.0 109.533 176.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -61.08 -48.89 79.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.844 175.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 91.4 mt -58.6 -49.37 77.73 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.09 -177.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -58.52 -43.88 89.31 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 123.14 0.275 . . . . 0.0 111.575 -174.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -81.13 -33.26 33.33 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 121.061 -0.256 . . . . 0.0 111.344 -178.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.34 -48.74 74.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.098 0.475 . . . . 0.0 110.009 178.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.649 HG23 ' HA ' ' A' ' 166' ' ' ALA . 66.7 p -85.6 -18.06 34.41 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.762 -174.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 63.6 29.32 15.19 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.523 -175.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -127.44 170.17 12.84 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.4 -177.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.428 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 10.1 tp10 -95.77 113.61 25.26 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 177.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 59.1 t -110.8 105.97 19.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.939 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.644 HG23 ' HD3' ' A' ' 141' ' ' PRO . 6.3 p -125.25 128.34 72.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.348 177.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.877 HG22 HG11 ' A' ' 154' ' ' VAL . 2.3 t -130.75 81.55 67.08 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 121.02 0.438 . . . . 0.0 110.723 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.783 ' HD2' ' HE3' ' A' ' 155' ' ' LYS . 51.6 Cg_exo -57.1 142.18 94.28 Favored 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 123.083 2.522 . . . . 0.0 112.113 176.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -78.17 -19.34 54.15 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.545 -176.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -97.3 16.56 19.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.035 -172.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.911 HE21 ' HB ' ' A' ' 153' ' ' ILE . 14.4 mm100 -50.79 -70.26 0.09 Allowed 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -177.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -137.98 159.94 66.49 Favored Pre-proline 0 C--N 1.311 -1.079 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.587 -174.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -56.44 144.31 84.08 Favored 'Trans proline' 0 C--O 1.238 0.503 0 C-N-CA 123.084 2.523 . . . . 0.0 112.902 -176.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -67.23 -7.45 24.03 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.407 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -49.96 -47.73 52.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.483 169.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . 0.471 ' O ' ' HG2' ' A' ' 150' ' ' GLU . 10.8 t-20 -87.52 -7.16 57.92 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.792 -178.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 149' ' ' ASN . 11.1 pt-20 48.13 33.26 3.46 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.712 1.205 . . . . 0.0 111.457 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -149.55 144.0 25.96 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.436 -173.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 25.2 m -128.47 -176.54 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.965 -178.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.911 ' HB ' HE21 ' A' ' 144' ' ' GLN . 39.3 mt -122.41 131.24 73.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.588 0.233 . . . . 0.0 111.6 -177.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.877 HG11 HG22 ' A' ' 140' ' ' VAL . 32.4 t -92.77 140.2 16.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 172.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.783 ' HE3' ' HD2' ' A' ' 141' ' ' PRO . 0.0 OUTLIER -107.39 126.19 52.16 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 177.397 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.428 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 60.2 mt -110.04 111.21 35.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.089 178.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.413 ' HB ' ' HB3' ' A' ' 137' ' ' GLU . 3.8 mp -109.1 119.75 59.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 176.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 104' ' ' LYS . . . 177.53 -157.4 21.95 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 119.62 -1.276 . . . . 0.0 113.1 -174.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -102.63 173.25 6.42 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 -173.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -59.96 -46.24 90.08 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 121.172 -0.211 . . . . 0.0 111.22 -177.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -60.89 -51.76 67.92 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.931 0.396 . . . . 0.0 110.516 175.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -59.22 -49.04 79.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.259 -174.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.449 ' O ' ' HG3' ' A' ' 167' ' ' GLN . 32.4 t -62.16 -47.44 84.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.058 -175.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -56.41 -37.82 70.7 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.923 0.392 . . . . 0.0 111.001 178.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 89.9 mtp -71.92 -38.72 69.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.653 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.649 ' HA ' HG23 ' A' ' 134' ' ' THR . . . -66.83 -49.53 65.47 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.33 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.449 ' HG3' ' O ' ' A' ' 163' ' ' SER . 75.7 mt-30 -51.87 -52.46 49.44 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.233 -177.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 18.4 ptt180 -66.85 -38.15 85.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.146 -177.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.634 ' HA ' ' HE2' ' A' ' 169' ' ' LYS . 0.1 OUTLIER -68.09 -39.17 82.93 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.706 0.289 . . . . 0.0 111.299 -172.798 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.516 ' O ' HD13 ' A' ' 174' ' ' LEU . 1.9 mp -74.98 -44.19 44.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 177.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 -55.83 -25.59 42.57 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.2 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -60.77 -55.55 31.84 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.463 175.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.495 ' O ' HG21 ' A' ' 177' ' ' VAL . 42.5 pt -67.57 -23.94 30.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.446 -172.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.852 HD11 HG21 ' A' ' 111' ' ' VAL . 10.9 mp -58.33 -37.69 75.65 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.843 176.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -65.74 -34.97 79.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.058 0.456 . . . . 0.0 110.378 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -71.37 -38.1 71.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.508 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.495 HG21 ' O ' ' A' ' 173' ' ' ILE . 58.0 t -66.7 -37.28 79.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.5 177.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 174' ' ' LEU . 98.2 mttt -66.06 -41.38 90.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.185 176.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -63.3 -37.68 88.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.395 177.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -60.15 -32.09 70.71 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.672 177.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 52.6 m170 -85.21 -25.92 27.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.096 0.474 . . . . 0.0 110.568 178.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -74.94 -41.96 58.62 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.709 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -87.35 73.72 9.57 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.744 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -122.5 137.7 11.49 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.068 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -142.8 143.64 32.25 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.769 0.319 . . . . 0.0 110.352 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 14.9 p -91.28 -10.07 42.79 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.464 -176.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 82.82 -152.3 29.96 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.52 177.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -142.05 140.58 32.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.771 0.319 . . . . 0.0 110.951 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 60.3 tp -104.78 88.37 2.89 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.827 178.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -123.58 152.83 41.46 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.297 -178.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.57 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.593 178.059 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' ' G' . . . . . 0.898 " O2'" ' H6 ' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.426 -0.9 0 C3'-C2'-C1' 105.08 3.978 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . 0.898 ' H6 ' " O2'" ' B' ' 1' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.424 -0.981 0 C3'-C2'-C1' 99.674 -2.029 . 0.0 OUTLIER '7D dist 2a' 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . 0.807 " H1'" ' C5 ' ' B' ' 4' ' ' ' C' . . . . . . . . 0 C2'--C1' 1.517 -1.144 0 C5'-C4'-O4' 112.289 2.207 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' ' C' . . . . . 1.118 ' H42' ' HA2' ' A' ' 35' ' ' GLY . . . . . . . . 0 O5'--C5' 1.429 -0.687 0 C4'-C3'-C2' 105.631 2.931 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.86 " O4'" " H4'" ' B' ' 4' ' ' ' C' . . . . . . . . 0 P--O3' 1.616 0.79 0 O4'-C1'-N19 110.251 2.051 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' ' C' . . . . . 0.63 ' H6 ' " O5'" ' B' ' 6' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.428 -0.723 0 C4'-C3'-C2' 106.409 3.709 OUTLIER-DELTA 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . 0.441 ' H42' ' N4 ' ' B' ' 6' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.425 -0.939 0 C4'-C3'-C2' 103.456 0.756 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.424 -0.981 0 O4'-C1'-N19 108.776 0.576 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.72 0 N-CA-C 111.748 -0.541 . . . . 0.0 111.748 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.78 66.7 9.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.787 0.327 . . . . 0.0 110.716 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 17.1 tpt 62.58 -89.14 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.295 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.25 115.5 0.47 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.012 -177.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.78 51.36 3.02 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.269 2.646 . . . . 0.0 112.506 -179.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.2 m -128.81 140.42 51.71 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 177.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.4 t 59.89 42.52 16.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.612 0.72 . . . . 0.0 109.407 -176.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.4 p -68.64 141.15 17.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.747 -177.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.5 p -74.99 75.53 2.2 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.274 0.559 . . . . 0.0 111.092 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -117.79 -145.92 8.07 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.86 178.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.668 ' HB1' ' HA ' ' A' ' 15' ' ' SER . . . 56.02 37.92 29.38 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.121 0.486 . . . . 0.0 110.595 -177.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.66 ' HB2' ' HD3' ' A' ' 13' ' ' PRO . . . -71.38 -54.4 6.93 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.343 -174.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.66 ' HD3' ' HB2' ' A' ' 12' ' ' ALA . 17.0 Cg_exo -67.98 -32.7 27.88 Favored 'Trans proline' 0 C--N 1.356 0.921 0 C-N-CA 121.982 1.788 . . . . 0.0 111.778 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.401 ' CD1' ' HB2' ' A' ' 13' ' ' PRO . 19.9 p90 -155.72 122.19 5.21 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.495 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.668 ' HA ' ' HB1' ' A' ' 11' ' ' ALA . 16.6 m -95.39 -24.04 16.89 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.414 0.626 . . . . 0.0 109.656 175.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.4 m -112.56 135.71 52.95 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.62 177.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -98.42 113.95 26.14 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.437 -175.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 87.8 mtp 61.0 85.31 0.18 Allowed Pre-proline 0 N--CA 1.466 0.344 0 O-C-N 123.538 0.524 . . . . 0.0 111.097 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.415 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 83.8 Cg_endo -78.75 139.4 15.71 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.364 2.043 . . . . 0.0 112.424 -178.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 19' ' ' PRO . 3.7 Cg_exo -75.49 60.19 5.72 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.935 2.423 . . . . 0.0 110.884 174.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.572 ' HG2' ' HG3' ' A' ' 22' ' ' GLN . 40.0 tt0 -62.02 -75.32 0.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.893 -174.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.572 ' HG3' ' HG2' ' A' ' 21' ' ' GLU . 79.3 mt-30 -133.95 109.73 9.21 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.1 0.476 . . . . 0.0 111.36 -176.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -94.83 102.4 14.25 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.054 174.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 56.1 m -104.59 114.25 28.35 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.214 -177.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 42.1 t -126.42 149.94 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 176.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -108.52 146.45 33.2 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 122.086 -0.384 . . . . 0.0 110.138 -174.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.666 ' HB ' ' CG1' ' A' ' 71' ' ' VAL . 21.1 t -120.76 133.16 68.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.232 -174.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.773 ' CE1' HG13 ' A' ' 68' ' ' VAL . 32.5 t80 -93.56 104.15 16.29 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.483 0.713 . . . . 0.0 110.048 -176.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.486 ' CD1' HG23 ' A' ' 34' ' ' VAL . 8.8 pt -126.74 124.69 24.19 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.283 0.563 . . . . 0.0 111.13 178.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.449 ' HG2' ' HB2' ' A' ' 33' ' ' ALA . 3.0 Cg_endo -45.82 140.65 9.5 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 124.474 3.449 . . . . 0.0 114.064 -174.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.74 -18.71 22.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.958 -176.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -89.71 -29.47 18.72 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.11 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.566 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -96.47 -30.84 13.12 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -175.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.81 HG21 ' HB3' ' A' ' 69' ' ' ARG . 10.6 p -54.09 -29.91 19.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.707 179.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 1.063 ' HA2' ' H42' ' B' ' 4' ' ' ' C' . . . -58.76 -57.0 22.17 Favored Glycine 0 N--CA 1.432 -1.633 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.242 176.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.675 ' HB3' " O2'" ' B' ' 2' ' ' ' C' . . . -77.36 -14.16 59.78 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.552 -0.324 . . . . 0.0 111.201 -174.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.584 HD13 ' HB3' ' A' ' 90' ' ' LYS . 9.5 mm -63.16 -39.29 84.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 172.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.836 HD11 ' C5 ' ' B' ' 4' ' ' ' C' . 38.4 mt -61.83 -52.34 61.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.566 177.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.7 111.87 2.82 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 120.27 -0.967 . . . . 0.0 114.855 170.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt 59.23 -89.43 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.286 1.034 . . . . 0.0 113.561 173.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.743 ' HA ' ' OP2' ' B' ' 4' ' ' ' C' . 0.0 OUTLIER -129.28 23.94 5.55 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.18 0.514 . . . . 0.0 111.156 -177.478 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.448 ' HA2' ' CG2' ' A' ' 38' ' ' ILE . . . 82.37 28.79 38.78 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.441 -0.885 . . . . 0.0 110.992 -175.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.484 ' HB2' ' CD ' ' A' ' 41' ' ' LYS . 25.4 tm0? -91.02 -47.61 7.46 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.024 0.44 . . . . 0.0 109.855 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -70.52 -32.78 70.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.492 -174.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.599 HG23 ' HG3' ' A' ' 46' ' ' LYS . 6.2 tt -61.04 -44.59 98.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.176 0.512 . . . . 0.0 111.145 177.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.599 ' HG3' HG23 ' A' ' 45' ' ' ILE . 55.0 mtpt -81.41 -30.92 33.41 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.428 -177.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -63.11 -33.46 75.51 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 172.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.815 ' HA ' ' HD1' ' A' ' 51' ' ' PHE . 6.1 tt -62.95 -49.26 75.44 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.422 174.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.623 ' HA ' HD13 ' A' ' 56' ' ' ILE . 14.4 t -55.52 -40.84 72.31 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.704 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.821 ' HE ' ' HA ' ' A' ' 50' ' ' ARG . 0.9 OUTLIER -78.84 -40.54 32.47 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -177.68 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.815 ' HD1' ' HA ' ' A' ' 48' ' ' LEU . 0.4 OUTLIER -74.51 -30.84 61.96 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 121.829 -0.545 . . . . 0.0 110.484 -178.03 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -84.59 -12.96 53.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.529 -177.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.9 m 66.9 30.13 7.88 Favored 'General case' 0 N--CA 1.463 0.223 0 O-C-N 123.644 0.59 . . . . 0.0 110.854 -179.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -134.54 166.95 21.7 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.539 -176.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.435 ' HB2' ' HB ' ' A' ' 74' ' ' THR . 18.4 m -92.53 108.1 19.72 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.567 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.709 HG13 HG22 ' A' ' 73' ' ' ILE . 1.9 mp -110.47 115.03 48.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.224 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -137.66 135.75 36.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.234 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.653 ' HB ' ' N1 ' ' B' ' 5' ' ' ' A' . 37.6 mm -80.38 124.42 38.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 177.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.713 ' HB1' HG22 ' A' ' 72' ' ' VAL . . . -90.05 129.75 44.87 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.606 -177.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.34 140.61 95.29 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 122.942 2.428 . . . . 0.0 111.897 176.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.448 ' HD3' ' HG3' ' A' ' 69' ' ' ARG . 40.2 Cg_endo -67.58 159.71 51.32 Favored 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 122.796 2.33 . . . . 0.0 112.054 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -84.75 -47.16 10.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.384 0.611 . . . . 0.0 109.936 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.2 p -129.5 139.06 34.55 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.782 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.66 -8.31 21.96 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 123.541 2.827 . . . . 0.0 112.9 -178.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -87.46 -4.76 59.0 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.405 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.414 ' C ' ' H ' ' A' ' 68' ' ' VAL . 6.4 t -87.93 115.56 25.48 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.507 ' O ' ' HD2' ' A' ' 67' ' ' LYS . 1.0 OUTLIER -78.39 33.34 0.2 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.786 0.803 . . . . 0.0 110.578 -176.294 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.773 HG13 ' CE1' ' A' ' 28' ' ' PHE . 11.2 p -146.54 154.64 12.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.798 -175.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.81 ' HB3' HG21 ' A' ' 34' ' ' VAL . 11.7 ttm180 -129.94 129.38 43.75 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 170.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.499 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 42.2 mtt -96.48 134.63 39.42 Favored 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.236 -173.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.666 ' CG1' ' HB ' ' A' ' 27' ' ' VAL . 3.9 p -99.98 140.21 19.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 177.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.713 HG22 ' HB1' ' A' ' 59' ' ' ALA . 63.9 t -101.56 120.5 51.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.112 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.709 HG22 HG13 ' A' ' 56' ' ' ILE . 2.6 pp -114.76 127.31 72.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.499 0.666 . . . . 0.0 110.522 176.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.435 ' HB ' ' HB2' ' A' ' 55' ' ' SER . 91.3 m -125.55 113.21 17.12 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.674 178.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.62 161.14 34.65 Favored Glycine 0 CA--C 1.498 -1.03 0 C-N-CA 119.811 -1.185 . . . . 0.0 113.115 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.31 153.07 71.54 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 122.5 2.133 . . . . 0.0 110.964 169.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.437 ' HA ' ' NH2' ' A' ' 168' ' ' ARG . 35.8 Cg_exo -38.18 -51.59 2.0 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 124.804 3.669 . . . . 0.0 114.85 -176.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -66.61 -36.02 81.61 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.264 0.554 . . . . 0.0 110.994 -177.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.88 -49.82 27.53 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.724 -178.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.545 ' HG3' HD12 ' A' ' 73' ' ' ILE . 19.9 tt0 -63.47 -31.9 73.19 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.955 -178.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -54.21 -54.62 37.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.513 -177.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.6 pttm -72.93 -33.09 65.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.378 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.05 -53.03 62.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.224 177.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.402 ' O ' ' HD1' ' A' ' 88' ' ' TYR . 35.0 mt-30 -72.76 -31.16 64.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.38 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -54.12 -42.33 71.72 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.957 176.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -81.19 -28.81 34.79 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 178.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.24 -41.25 91.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 120.981 -0.287 . . . . 0.0 110.49 -176.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.579 ' HA ' HD22 ' A' ' 91' ' ' LEU . 26.5 m-85 -67.39 -31.67 72.05 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.249 0.547 . . . . 0.0 110.239 176.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.08 -29.38 74.22 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.913 176.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.584 ' HB3' HD13 ' A' ' 37' ' ' ILE . 67.0 mmtt -77.3 -21.06 54.11 Favored 'General case' 0 N--CA 1.442 -0.87 0 O-C-N 122.62 -0.341 . . . . 0.0 110.491 178.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.579 HD22 ' HA ' ' A' ' 88' ' ' TYR . 3.8 mm? -66.05 -33.27 75.43 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.239 0.542 . . . . 0.0 109.847 167.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.814 ' HE2' ' HB2' ' A' ' 97' ' ' PHE . 13.8 mmtp -75.94 -21.8 56.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.117 176.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.489 ' HB2' ' HA ' ' A' ' 90' ' ' LYS . 5.2 tp10 -62.78 -33.05 74.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.772 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.595 ' HG2' ' CE2' ' A' ' 96' ' ' PHE . 6.5 tp10 -88.96 -1.38 58.08 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.957 0.884 . . . . 0.0 109.605 178.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 12.5 m120 65.87 29.09 10.57 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.423 177.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.595 ' CE2' ' HG2' ' A' ' 94' ' ' GLU . 14.2 m-85 -65.01 -51.36 62.08 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.072 0.463 . . . . 0.0 111.149 178.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.814 ' HB2' ' HE2' ' A' ' 92' ' ' LYS . 17.8 m-85 -105.87 34.76 3.16 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.889 -172.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 56.58 -173.42 1.76 Allowed Glycine 0 CA--C 1.525 0.671 0 CA-C-N 115.976 -0.556 . . . . 0.0 113.708 178.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -85.2 -66.51 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.072 2.515 . . . . 0.0 111.975 175.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 53.2 tptt -76.65 -26.71 55.16 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.027 -177.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.654 ' HB3' ' O ' ' A' ' 97' ' ' PHE . 10.4 tp10 -58.15 134.2 56.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.109 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -61.65 130.1 44.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.303 -177.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.772 ' HB ' ' HE3' ' A' ' 92' ' ' LYS . 7.1 p -65.95 122.23 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 175.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -116.79 88.23 2.86 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 174.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.576 ' HG ' ' HG ' ' A' ' 91' ' ' LEU . 1.6 tm? -112.02 124.66 52.87 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.973 -173.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -65.23 118.32 9.09 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.642 -178.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.491 HG22 ' NE2' ' A' ' 167' ' ' GLN . 1.2 m -109.92 136.9 48.47 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -108.0 118.76 37.6 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.286 0.565 . . . . 0.0 111.102 -174.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.509 HG13 ' HB ' ' A' ' 154' ' ' VAL . 12.4 pt -110.76 112.66 41.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.689 175.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.913 ' HG3' ' HG2' ' A' ' 151' ' ' GLN . 5.6 tpt180 -77.96 117.51 19.36 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.636 HG12 HD22 ' A' ' 174' ' ' LEU . 13.0 m -116.2 150.85 45.96 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -177.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -49.44 155.82 3.16 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.864 2.376 . . . . 0.0 111.461 175.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -52.83 -49.92 64.73 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.111 0.482 . . . . 0.0 111.513 -172.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 13.7 m -78.65 -8.26 58.48 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.913 -177.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.24 -29.99 61.95 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 122.215 -0.303 . . . . 0.0 111.453 -175.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.588 ' O ' HG11 ' A' ' 119' ' ' VAL . . . -65.26 -37.84 88.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.2 0.524 . . . . 0.0 110.684 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -69.41 -28.29 72.65 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.912 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 37.1 mtp85 -92.02 -18.12 24.1 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 111.555 0.206 . . . . 0.0 111.555 -178.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.588 HG11 ' O ' ' A' ' 116' ' ' ALA . 8.4 p -76.64 -29.2 18.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 175.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.835 HG21 ' HA2' ' A' ' 124' ' ' GLY . 69.3 mt -65.79 -40.62 88.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 170.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 117.55 -179.26 17.26 Favored Glycine 0 N--CA 1.441 -0.969 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.931 174.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -42.65 -73.77 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.522 0.729 . . . . 0.0 111.641 178.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -112.12 26.66 10.37 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 122.121 0.963 . . . . 0.0 108.522 171.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.835 ' HA2' HG21 ' A' ' 120' ' ' ILE . . . 88.77 21.39 43.35 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.512 -177.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -83.84 -32.91 25.01 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.989 0.423 . . . . 0.0 110.761 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 15.1 m -64.69 -37.76 88.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.691 -175.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.557 ' HB ' ' HA ' ' A' ' 120' ' ' ILE . 14.0 p -63.24 -33.48 61.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-O 120.872 0.368 . . . . 0.0 110.731 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -65.95 -42.59 89.78 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 177.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -63.93 -40.96 97.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.233 177.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 79.3 mt -57.85 -50.77 72.17 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.202 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -68.4 -35.35 77.54 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.941 0.401 . . . . 0.0 110.881 -177.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -67.36 -36.99 82.51 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.385 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -84.9 -47.72 10.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.099 -175.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.519 ' HA ' ' HE3' ' A' ' 165' ' ' MET . 76.9 p -79.88 -21.08 44.45 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -172.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 66.17 21.39 11.12 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.53 -174.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -120.13 164.15 16.62 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.002 177.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.505 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 49.0 mt-10 -101.07 113.02 25.65 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.188 0.518 . . . . 0.0 111.033 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 60.0 t -104.85 106.45 20.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.912 -178.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.463 ' O ' ' HD2' ' A' ' 155' ' ' LYS . 7.2 p -128.46 130.88 69.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.065 0.46 . . . . 0.0 111.136 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.67 ' HB ' HG22 ' A' ' 154' ' ' VAL . 8.5 p -125.94 131.04 23.86 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 116.136 -0.483 . . . . 0.0 109.855 178.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 140' ' ' VAL . 36.7 Cg_exo -60.89 121.01 9.03 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.7 2.267 . . . . 0.0 111.631 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.614 ' H ' ' HD2' ' A' ' 142' ' ' ARG . 0.3 OUTLIER -83.19 14.78 3.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.586 0.708 . . . . 0.0 110.102 -175.043 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -117.84 -1.74 11.47 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.346 176.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.416 ' HB2' ' HB2' ' A' ' 141' ' ' PRO . 6.4 tp-100 -98.11 115.11 27.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.07 -172.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.1 t -175.29 70.53 0.27 Allowed Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.381 176.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -91.55 143.96 3.06 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.384 2.056 . . . . 0.0 112.568 -178.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -70.0 -16.62 63.2 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.981 178.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -52.3 -48.67 65.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.974 -1.012 . . . . 0.0 112.204 -178.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . 0.421 ' O ' ' HG2' ' A' ' 150' ' ' GLU . 4.4 t-20 -119.62 -10.4 9.61 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.014 -175.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 149' ' ' ASN . 12.2 pt-20 47.33 29.68 1.33 Allowed 'General case' 0 N--CA 1.475 0.799 0 O-C-N 124.31 1.007 . . . . 0.0 111.097 -173.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.913 ' HG2' ' HG3' ' A' ' 110' ' ' ARG . 30.5 tt0 -155.71 128.31 7.86 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.15 -174.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.412 HG23 ' HB1' ' A' ' 116' ' ' ALA . 33.1 m -114.41 -177.1 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.338 -171.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 53.9 mt -122.16 131.39 73.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -173.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.67 HG22 ' HB ' ' A' ' 140' ' ' VAL . 46.2 t -107.29 140.77 24.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 168.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.463 ' HD2' ' O ' ' A' ' 139' ' ' VAL . 0.0 OUTLIER -104.12 122.39 45.22 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.07 178.898 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.505 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 51.6 mt -102.71 112.67 36.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 173.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 4.4 mp -103.6 129.86 54.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.82 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 161.3 -172.07 37.45 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.436 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.483 ' HA ' HG12 ' A' ' 103' ' ' VAL . 6.3 p80 -88.68 153.68 20.91 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.43 ' HB3' ' CG ' ' A' ' 88' ' ' TYR . 10.2 p90 -50.82 -46.59 59.99 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -165.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . 0.406 ' O ' ' HG3' ' A' ' 164' ' ' GLN . 16.8 m-85 -59.67 -48.94 79.7 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 118.85 0.75 . . . . 0.0 111.174 -178.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.59 -42.91 86.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.603 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.476 ' O ' ' HG3' ' A' ' 167' ' ' GLN . 35.7 t -63.59 -50.37 69.68 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.418 -177.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.406 ' HG3' ' O ' ' A' ' 161' ' ' TYR . 5.1 pp0? -59.37 -35.48 73.97 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.478 0.18 . . . . 0.0 111.034 -177.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' MET . . . . . 0.519 ' HE3' ' HA ' ' A' ' 134' ' ' THR . 49.0 ttp -73.76 -33.45 64.28 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 120.621 -0.431 . . . . 0.0 110.806 177.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.494 ' HB3' ' HB ' ' A' ' 134' ' ' THR . . . -69.96 -43.61 71.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.103 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.491 ' NE2' HG22 ' A' ' 107' ' ' THR . 71.9 mt-30 -51.94 -52.81 47.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.953 -178.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.812 ' HA ' ' HB2' ' A' ' 171' ' ' ARG . 1.3 ptp180 -70.85 -27.36 63.78 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.455 178.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.646 ' HA ' ' HE2' ' A' ' 169' ' ' LYS . 0.1 OUTLIER -67.55 -37.85 83.29 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.753 -178.688 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.482 ' O ' HG13 ' A' ' 173' ' ' ILE . 1.9 mp -75.24 -39.88 42.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 173.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.812 ' HB2' ' HA ' ' A' ' 168' ' ' ARG . 1.1 mpt_? -51.74 -28.0 13.74 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.072 171.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 169' ' ' LYS . 1.3 m-20 -68.66 -56.14 9.16 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 122.679 0.392 . . . . 0.0 111.499 178.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.482 HG13 ' O ' ' A' ' 170' ' ' ILE . 2.7 pp -66.59 -18.64 24.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.525 -174.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.636 HD22 HG12 ' A' ' 111' ' ' VAL . 6.7 mp -66.41 -33.86 76.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.093 174.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.99 -31.82 73.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.107 0.48 . . . . 0.0 110.28 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -69.6 -33.45 72.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.923 176.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 48.7 t -66.06 -46.4 88.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.796 176.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -61.18 -40.89 95.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.845 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -59.04 -47.04 86.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.016 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -72.67 -35.45 67.69 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.154 0.502 . . . . 0.0 110.431 -178.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 19.8 t60 -73.86 -53.57 9.9 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.406 -175.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.402 ' O ' ' HB2' ' A' ' 183' ' ' LYS . 76.8 mt-30 -73.04 -51.17 19.17 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 111.59 0.218 . . . . 0.0 111.59 -175.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 182' ' ' GLN . 34.8 mtmm 69.72 -61.87 0.43 Allowed 'General case' 0 N--CA 1.468 0.431 0 O-C-N 123.744 0.652 . . . . 0.0 111.429 -177.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 156.38 -100.81 0.2 Allowed Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.033 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -132.42 79.78 1.87 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.259 0.552 . . . . 0.0 110.031 -178.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 40.7 m -101.99 113.08 25.99 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.265 -178.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 120.53 124.34 3.14 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.693 -0.765 . . . . 0.0 113.444 175.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 50.96 71.75 0.41 Allowed 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.326 0.65 . . . . 0.0 112.373 174.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 7.7 mp -83.58 99.02 9.9 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 177.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -121.8 -53.5 1.97 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.761 -175.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.365 -178.355 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' ' G' . . . . . 0.79 " O2'" ' H6 ' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.429 -0.698 1 C3'-C2'-C1' 105.218 4.131 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . 0.79 ' H6 ' " O2'" ' B' ' 1' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.428 -0.738 0 C3'-C2'-C1' 100.373 -1.252 . 0.0 OUTLIER '7D dist 2a' 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . 0.844 " H1'" ' C5 ' ' B' ' 4' ' ' ' C' . . . . . . . . 0 C2'--C1' 1.516 -1.218 0 C5'-C4'-O4' 113.199 2.857 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' ' C' . . . . . 1.063 ' H42' ' HA2' ' A' ' 35' ' ' GLY . . . . . . . . 0 C4'--C3' 1.516 -0.704 0 C3'-C2'-C1' 104.169 2.965 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.857 " O4'" " H4'" ' B' ' 4' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.431 -0.564 0 O4'-C1'-N19 110.124 1.924 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' ' C' . . . . . 0.509 ' H6 ' " O5'" ' B' ' 6' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.43 -0.645 0 C4'-C3'-C2' 105.114 2.414 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.427 -0.83 0 O4'-C1'-C2' 107.417 0.726 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.427 -0.788 0 C3'-C2'-C1' 99.775 -1.916 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.663 0 N-CA-C 111.688 -0.565 . . . . 0.0 111.688 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.1 84.94 7.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.966 0.412 . . . . 0.0 111.096 -176.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 22.9 ptp -92.88 -16.14 25.58 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.805 176.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -90.62 177.99 42.41 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.117 177.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.0 159.8 47.17 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.692 2.262 . . . . 0.0 112.929 -177.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.4 m -137.19 86.13 2.18 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.825 178.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.427 ' C ' ' H ' ' A' ' 9' ' ' SER . 16.4 p -76.53 -18.79 58.52 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.756 -174.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.8 p -75.48 18.12 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 121.647 0.737 . . . . 0.0 111.405 -177.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.427 ' H ' ' C ' ' A' ' 7' ' ' SER . 46.1 m -131.35 31.06 4.41 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.123 176.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 176.28 -50.31 0.11 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.583 -0.817 . . . . 0.0 112.481 179.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.403 ' HB1' ' HB2' ' A' ' 7' ' ' SER . . . -82.37 83.7 7.39 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.108 0.48 . . . . 0.0 110.96 -178.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -102.02 107.06 51.01 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.388 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -57.9 140.02 92.38 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 123.171 2.581 . . . . 0.0 112.91 -177.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -135.02 46.18 2.46 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.767 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.0 m -78.4 46.51 0.63 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.177 -172.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.1 m -80.89 61.75 4.63 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.209 0.528 . . . . 0.0 109.872 176.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -123.71 -70.72 0.75 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.244 -176.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.534 ' HB3' ' HD3' ' A' ' 19' ' ' PRO . 46.9 ttm -89.14 -48.89 0.41 Allowed Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.615 178.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.534 ' HD3' ' HB3' ' A' ' 18' ' ' MET . 85.0 Cg_exo -50.13 143.0 26.47 Favored 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 122.328 2.019 . . . . 0.0 112.34 176.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 19' ' ' PRO . 6.7 Cg_exo -73.87 59.1 4.22 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.277 2.651 . . . . 0.0 112.864 -176.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -88.74 37.86 0.85 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.507 0.67 . . . . 0.0 109.911 175.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.442 ' HB3' HG21 ' A' ' 74' ' ' THR . 48.5 mt-30 -87.36 98.84 11.58 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.393 177.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.525 ' O ' ' HA ' ' A' ' 74' ' ' THR . 7.1 tp10 -81.05 147.67 30.04 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.399 -0.818 . . . . 0.0 111.101 -174.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.627 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 39.8 m -116.15 107.16 14.54 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.492 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.419 HG12 HG21 ' A' ' 109' ' ' ILE . 37.0 t -119.14 150.02 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.723 -177.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -111.69 125.15 53.66 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-O 120.773 0.32 . . . . 0.0 110.776 -175.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.479 ' HB ' ' HB ' ' A' ' 71' ' ' VAL . 13.6 t -94.09 139.69 17.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.48 ' CZ ' HG11 ' A' ' 68' ' ' VAL . 1.0 OUTLIER -103.54 104.89 15.01 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.406 -175.704 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.434 ' C ' HG22 ' A' ' 68' ' ' VAL . 21.7 pt -129.68 123.36 21.15 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 121.169 0.509 . . . . 0.0 111.291 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.4 ' HA ' ' HA ' ' A' ' 68' ' ' VAL . 50.5 Cg_exo -53.5 149.12 31.86 Favored 'Trans proline' 0 C--O 1.238 0.501 0 C-N-CA 123.439 2.76 . . . . 0.0 112.643 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.578 ' HA ' HG11 ' A' ' 34' ' ' VAL . . . -57.7 -23.57 52.33 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 114.9 -1.046 . . . . 0.0 112.529 -173.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -66.12 -30.01 70.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.235 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.51 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -108.25 -31.07 8.03 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.663 -175.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.731 HG23 ' HB3' ' A' ' 69' ' ' ARG . 13.3 p -53.98 -32.48 22.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-O 120.945 0.402 . . . . 0.0 110.968 -175.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 1.056 ' HA2' ' H42' ' B' ' 4' ' ' ' C' . . . -58.81 -56.36 25.71 Favored Glycine 0 N--CA 1.434 -1.448 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.959 178.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.487 ' HB1' " O2'" ' B' ' 2' ' ' ' C' . . . -77.44 -14.54 59.67 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.621 0.248 . . . . 0.0 111.298 -175.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.617 HD13 ' HB3' ' A' ' 90' ' ' LYS . 2.4 mm -67.44 -36.96 77.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.369 -0.378 . . . . 0.0 109.99 177.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.813 HD11 ' C5 ' ' B' ' 4' ' ' ' C' . 24.6 mt -61.45 -32.72 54.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-O 121.528 0.68 . . . . 0.0 110.337 174.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.18 153.72 30.18 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.627 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.57 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 34.1 mtpt -66.02 131.38 46.08 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -175.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.57 ' HG2' ' O ' ' A' ' 40' ' ' LYS . 19.8 pttt 73.63 4.21 4.69 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.051 1.34 . . . . 0.0 112.198 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.419 ' HA3' " H5'" ' B' ' 4' ' ' ' C' . . . 61.05 38.64 95.88 Favored Glycine 0 CA--C 1.523 0.545 0 CA-C-N 116.253 -0.431 . . . . 0.0 113.607 176.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.422 ' HB3' ' HE2' ' A' ' 41' ' ' LYS . 19.4 tt0 -109.1 -36.65 6.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 117.322 0.561 . . . . 0.0 110.985 175.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 77.7 m-70 -55.87 -41.62 74.67 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.393 0.616 . . . . 0.0 109.778 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.46 ' O ' HG22 ' A' ' 56' ' ' ILE . 4.5 tt -56.52 -44.13 79.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 114.515 -1.221 . . . . 0.0 112.231 176.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.749 ' HE2' " H4'" ' B' ' 6' ' ' ' C' . 28.4 mmmt -81.45 -29.09 33.91 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 121.984 -0.447 . . . . 0.0 110.779 -173.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -60.47 -40.55 91.65 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 172.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.688 HD21 ' HZ ' ' A' ' 51' ' ' PHE . 0.2 OUTLIER -49.72 -47.8 50.35 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.048 175.898 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.837 ' HB2' ' HB ' ' A' ' 56' ' ' ILE . 14.5 t -61.77 -35.88 79.43 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.629 -176.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -78.81 -41.35 30.53 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -169.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.688 ' HZ ' HD21 ' A' ' 48' ' ' LEU . 10.2 p90 -79.56 -17.02 54.89 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 120.167 -0.613 . . . . 0.0 111.609 -177.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -94.09 -16.89 23.38 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.199 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.2 t 67.3 13.97 9.55 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.544 -177.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -108.73 153.57 23.27 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.838 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.497 ' HB2' ' HB ' ' A' ' 74' ' ' THR . 60.4 m -80.27 102.41 9.48 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.018 0.437 . . . . 0.0 110.185 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.837 ' HB ' ' HB2' ' A' ' 49' ' ' SER . 1.5 mp -92.98 117.64 36.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.147 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -144.77 151.13 38.37 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.891 -175.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.635 ' HB ' ' C6 ' ' B' ' 5' ' ' ' A' . 38.8 mm -102.43 129.1 54.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 178.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.58 ' HB2' ' HB2' ' A' ' 70' ' ' MET . . . -95.86 108.55 41.23 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.841 -178.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -69.59 146.0 59.89 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 123.061 2.507 . . . . 0.0 112.338 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.848 ' HD3' ' HG3' ' A' ' 69' ' ' ARG . 98.6 Cg_endo -84.09 141.53 9.37 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.874 2.383 . . . . 0.0 112.396 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -68.37 -25.97 65.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.989 -177.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.402 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 22.6 p -101.99 132.01 22.07 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.938 -179.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 63' ' ' THR . 15.1 Cg_exo -68.84 -21.19 38.36 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 123.249 2.633 . . . . 0.0 112.335 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.87 17.0 21.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.077 -178.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.5 t -65.74 134.6 53.5 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.196 0.522 . . . . 0.0 110.501 -179.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -81.42 -10.22 59.56 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.417 -178.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.48 HG11 ' CZ ' ' A' ' 28' ' ' PHE . 1.5 p -145.83 150.53 15.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.457 -172.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.848 ' HG3' ' HD3' ' A' ' 61' ' ' PRO . 22.9 ttm180 -127.05 151.3 48.79 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 177.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.58 ' HB2' ' HB2' ' A' ' 59' ' ' ALA . 63.6 mtt -100.13 149.41 23.55 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.269 0.557 . . . . 0.0 112.127 -173.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.479 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 86.8 t -105.44 120.34 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 168.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.6 p -109.23 115.54 49.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-O 121.563 0.697 . . . . 0.0 110.451 -176.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.627 ' O ' ' HA ' ' A' ' 24' ' ' THR . 2.1 pp -120.34 140.84 43.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.598 -176.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 58.9 m -123.76 108.77 12.88 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.934 177.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -163.95 162.03 34.8 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.098 -1.049 . . . . 0.0 113.326 -176.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -64.39 142.61 79.58 Favored 'Trans proline' 0 CA--C 1.533 0.427 0 C-N-CA 123.079 2.519 . . . . 0.0 111.908 175.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.474 ' O ' ' HB2' ' A' ' 80' ' ' GLN . 97.4 Cg_exo -46.14 -35.39 14.89 Favored 'Trans proline' 0 N--CA 1.478 0.565 0 C-N-CA 125.013 3.808 . . . . 0.0 115.298 -174.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.3 -46.87 69.14 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.115 0.483 . . . . 0.0 109.849 177.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.56 -22.44 63.54 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.894 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.474 ' HB2' ' O ' ' A' ' 77' ' ' PRO . 71.3 mm-40 -52.76 -52.0 58.31 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.787 176.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -66.74 -33.15 74.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.832 -179.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 47.1 tttp -61.5 -52.95 62.38 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.189 0.519 . . . . 0.0 110.334 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.4 -53.74 13.07 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.854 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.502 ' O ' HG21 ' A' ' 87' ' ' ILE . 9.5 tt0 -69.15 -31.03 69.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.68 -173.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -58.13 -32.54 67.4 Favored Glycine 0 CA--C 1.518 0.219 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.884 177.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.52 ' HA ' ' NE ' ' A' ' 86' ' ' ARG . 3.5 mmp_? -79.69 -26.83 40.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.654 0.264 . . . . 0.0 111.054 178.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.502 HG21 ' O ' ' A' ' 84' ' ' GLN . 0.4 OUTLIER -66.33 -35.16 74.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.646 -177.307 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.662 ' CE2' ' HB3' ' A' ' 105' ' ' LEU . 10.0 m-85 -68.66 -34.57 75.93 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.361 176.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -62.26 -30.43 75.96 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.524 176.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.617 ' HB3' HD13 ' A' ' 37' ' ' ILE . 75.0 mmtt -59.96 -52.96 63.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.7 0.286 . . . . 0.0 110.612 175.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.883 ' HB3' ' CD1' ' A' ' 97' ' ' PHE . 3.8 mm? -61.35 -39.66 91.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.606 178.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.866 ' HE3' ' HB ' ' A' ' 103' ' ' VAL . 0.3 OUTLIER -61.65 -41.17 97.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.821 0.343 . . . . 0.0 110.92 174.711 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -71.18 -23.45 62.05 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.028 -176.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.491 ' HB3' ' CE2' ' A' ' 96' ' ' PHE . 58.7 mm-40 -88.26 4.23 46.65 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.927 -179.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 63.56 21.04 12.56 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.742 172.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.491 ' CE2' ' HB3' ' A' ' 94' ' ' GLU . 78.2 m-85 -85.84 -16.75 37.67 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 168.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.883 ' CD1' ' HB3' ' A' ' 91' ' ' LEU . 67.2 m-85 -135.53 48.82 2.2 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 113.939 -1.482 . . . . 0.0 109.113 -177.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -41.24 157.46 0.04 OUTLIER Glycine 0 CA--C 1.521 0.459 0 O-C-N 124.061 0.851 . . . . 0.0 114.437 -174.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -59.04 -4.57 2.19 Favored 'Trans proline' 0 N--CA 1.478 0.605 0 C-N-CA 123.878 3.052 . . . . 0.0 114.419 -172.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.565 ' HD2' ' N ' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -97.49 -14.5 21.08 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.18 0.514 . . . . 0.0 110.118 -179.862 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -100.33 135.52 41.63 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.491 -172.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -70.28 114.99 8.96 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.362 175.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.866 ' HB ' ' HE3' ' A' ' 92' ' ' LYS . 15.0 p -54.6 123.94 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 CA-C-O 121.819 0.819 . . . . 0.0 111.995 -172.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -123.02 90.81 3.36 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 170.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.662 ' HB3' ' CE2' ' A' ' 88' ' ' TYR . 2.5 tt -117.17 114.89 24.32 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -177.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.843 ' HG3' HG13 ' A' ' 157' ' ' ILE . 1.7 mp0 -71.86 128.73 36.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.694 -175.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.1 m -114.69 128.06 56.1 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 170.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 16.2 m170 -102.26 119.62 39.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.14 0.495 . . . . 0.0 110.064 -178.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.449 HG13 ' HB ' ' A' ' 154' ' ' VAL . 34.8 pt -112.33 157.52 13.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.231 -178.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -102.26 133.64 46.83 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.879 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.697 HG12 HD21 ' A' ' 174' ' ' LEU . 10.4 m -133.15 148.24 68.43 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 173.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.724 ' HD2' ' HG ' ' A' ' 174' ' ' LEU . 51.6 Cg_exo -53.96 146.27 48.01 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.139 1.893 . . . . 0.0 110.596 175.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.15 -27.77 65.95 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.616 -175.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 44.0 t -81.5 -33.11 32.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.3 0.571 . . . . 0.0 110.281 175.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.56 -21.05 61.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.011 -178.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.549 ' O ' HG12 ' A' ' 119' ' ' VAL . . . -61.45 -50.82 71.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.071 0.462 . . . . 0.0 110.59 177.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.93 -29.39 67.14 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.562 177.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.535 ' HD3' HG21 ' A' ' 177' ' ' VAL . 13.7 ttt85 -73.04 -36.1 66.86 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.832 -0.184 . . . . 0.0 111.316 -178.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.549 HG12 ' O ' ' A' ' 116' ' ' ALA . 7.0 p -69.89 -26.21 29.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-O 121.014 0.435 . . . . 0.0 109.905 178.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.937 ' HA ' ' HB ' ' A' ' 127' ' ' VAL . 73.7 mt -68.12 -33.36 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 CA-C-O 121.495 0.664 . . . . 0.0 109.347 171.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.557 ' HA3' ' H ' ' A' ' 126' ' ' THR . . . 127.57 42.57 0.26 Allowed Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.182 176.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.2 t70 65.21 -75.16 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.296 0.638 . . . . 0.0 109.714 -176.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -87.59 -49.69 7.0 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 170.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.747 ' HA2' HG21 ' A' ' 120' ' ' ILE . . . 153.16 101.08 0.2 Allowed Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.78 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 53.2 tptt -173.07 -48.25 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.069 0.461 . . . . 0.0 110.623 -175.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.557 ' H ' ' HA3' ' A' ' 121' ' ' GLY . 21.7 m -60.16 -34.62 73.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.905 -177.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.937 ' HB ' ' HA ' ' A' ' 120' ' ' ILE . 10.2 p -63.11 -29.24 46.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.7 0.286 . . . . 0.0 110.856 -178.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -63.77 -45.49 89.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.149 0.5 . . . . 0.0 109.835 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -72.35 -37.36 68.84 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.946 178.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.62 HD23 HD13 ' A' ' 170' ' ' ILE . 23.1 tp -58.98 -49.43 77.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.937 178.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.498 ' HG3' HG12 ' A' ' 138' ' ' VAL . 16.4 tt0 -63.12 -36.24 82.94 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.195 -178.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -75.11 -37.0 61.63 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.783 -178.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 21.8 mt -79.98 -22.08 42.97 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -178.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 38.5 p -96.7 -22.03 17.23 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.747 -177.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 65.25 18.53 11.43 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.623 -178.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -118.95 168.93 10.33 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.585 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 21.8 tt0 -105.1 122.05 45.08 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.987 0.423 . . . . 0.0 110.225 -178.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.498 HG12 ' HG3' ' A' ' 131' ' ' GLN . 2.4 p -121.09 122.01 66.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.067 -172.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 13.5 p -130.66 133.23 63.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.54 176.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.809 ' HB ' HG21 ' A' ' 154' ' ' VAL . 6.7 p -137.49 97.68 10.32 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-O 121.824 0.821 . . . . 0.0 111.14 177.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.493 ' HG2' ' HZ2' ' A' ' 155' ' ' LYS . 51.3 Cg_exo -60.57 166.45 9.75 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 123.427 2.751 . . . . 0.0 112.656 175.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -79.05 -50.31 11.26 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.399 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -94.27 102.19 14.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.438 178.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.747 ' HB2' ' HB ' ' A' ' 152' ' ' VAL . 23.7 mm-40 -127.78 93.23 3.64 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.551 176.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.892 ' HB ' ' HD2' ' A' ' 146' ' ' PRO . 60.8 p 58.67 172.91 0.05 OUTLIER Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 123.615 0.766 . . . . 0.0 111.519 -176.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.892 ' HD2' ' HB ' ' A' ' 145' ' ' THR . 35.1 Cg_endo -65.8 154.71 72.75 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.07 1.847 . . . . 0.0 111.965 178.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -78.88 36.3 0.27 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.527 0.68 . . . . 0.0 110.544 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.457 ' H ' ' C ' ' A' ' 146' ' ' PRO . 37.8 tt0 -63.21 -33.34 75.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.598 -177.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -118.61 22.63 11.94 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 175.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 48.17 31.62 2.66 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 114.104 -1.407 . . . . 0.0 112.716 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -136.35 158.4 44.51 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.503 0.668 . . . . 0.0 112.434 -177.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.747 ' HB ' ' HB2' ' A' ' 144' ' ' GLN . 27.0 m -123.69 -175.78 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.787 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.432 ' HB ' ' OE1' ' A' ' 144' ' ' GLN . 25.2 mt -115.47 136.93 50.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.098 0.475 . . . . 0.0 112.27 -172.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.809 HG21 ' HB ' ' A' ' 140' ' ' VAL . 59.6 t -114.35 141.09 31.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.259 172.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.493 ' HZ2' ' HG2' ' A' ' 141' ' ' PRO . 6.5 mttt -113.22 121.27 43.97 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.333 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.496 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 64.4 mt -104.85 116.34 48.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.177 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.843 HG13 ' HG3' ' A' ' 106' ' ' GLU . 3.9 mp -110.57 133.19 56.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.523 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 153.8 -156.17 26.63 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.114 -1.041 . . . . 0.0 112.757 176.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.629 ' HA ' HG12 ' A' ' 103' ' ' VAL . 74.3 m80 -86.95 160.08 18.8 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -178.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.512 ' HB3' ' CG ' ' A' ' 88' ' ' TYR . 19.7 p90 -68.67 -24.47 64.52 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -170.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -73.26 -41.28 63.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.219 0.533 . . . . 0.0 109.981 172.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -73.27 -39.73 65.15 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.452 -176.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.447 ' O ' ' HG3' ' A' ' 167' ' ' GLN . 29.0 p -65.07 -50.08 67.54 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.223 -177.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -62.23 -34.55 76.71 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.723 0.297 . . . . 0.0 110.627 178.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 26.6 ttt -63.79 -43.46 96.27 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.09 0.472 . . . . 0.0 110.266 177.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.442 ' HB1' HD12 ' A' ' 156' ' ' ILE . . . -68.65 -46.46 69.1 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.02 178.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.447 ' HG3' ' O ' ' A' ' 163' ' ' SER . 72.4 mt-30 -51.52 -51.36 55.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.26 -178.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -70.07 -30.82 68.16 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.151 -178.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -71.49 -40.64 70.07 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.945 0.402 . . . . 0.0 110.92 -178.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.643 ' O ' HD13 ' A' ' 174' ' ' LEU . 1.9 mp -73.01 -51.0 28.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.434 178.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.589 ' HA ' HD22 ' A' ' 174' ' ' LEU . 25.8 mmm180 -56.98 -24.82 56.1 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.727 0.298 . . . . 0.0 110.909 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -69.4 -51.35 37.4 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.638 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.409 ' O ' HG22 ' A' ' 177' ' ' VAL . 34.4 pt -68.5 -19.82 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 121.017 0.437 . . . . 0.0 110.722 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.724 ' HG ' ' HD2' ' A' ' 112' ' ' PRO . 3.5 mp -64.08 -29.15 70.3 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.133 178.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.78 -31.89 72.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.26 0.553 . . . . 0.0 110.146 175.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -73.44 -47.09 44.44 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.161 177.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.535 HG21 ' HD3' ' A' ' 118' ' ' ARG . 29.6 t -67.33 -32.51 57.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.657 -178.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -57.25 -49.01 77.4 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 174.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -63.99 -38.37 90.82 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.821 178.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -64.47 -50.81 66.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.107 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 12.4 t-160 -66.78 -25.72 66.61 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.025 0.44 . . . . 0.0 110.423 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -73.56 -36.62 65.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.844 177.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -72.89 -58.05 3.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.212 176.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -136.03 145.07 17.02 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.384 -178.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -126.69 158.82 35.43 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 49.6 m -64.2 109.52 1.89 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.106 0.479 . . . . 0.0 111.207 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -130.52 -126.29 2.78 Favored Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.391 176.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 69.39 152.69 0.1 Allowed 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.31 0.644 . . . . 0.0 111.396 -178.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.407 ' HB3' ' H ' ' A' ' 190' ' ' GLN . 8.1 mp 57.78 -161.44 0.23 Allowed 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.783 -178.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . 0.407 ' H ' ' HB3' ' A' ' 189' ' ' LEU . 63.2 tt0 -86.3 -48.27 8.66 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 175.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.449 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.502 177.702 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' ' G' . . . . . 0.916 " O2'" ' H6 ' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.426 -0.891 0 C3'-C2'-C1' 105.092 3.991 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . 0.916 ' H6 ' " O2'" ' B' ' 1' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.426 -0.858 0 C3'-C2'-C1' 100.171 -1.476 . 0.0 OUTLIER '7D dist 2a' 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . 0.77 " H1'" ' C5 ' ' B' ' 4' ' ' ' C' . . . . . . . . 0 C2'--C1' 1.517 -1.074 0 C5'-C4'-O4' 112.581 2.415 . 0.0 OUTLIER '7D dist 1z' 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' ' C' . . . . . 1.056 ' H42' ' HA2' ' A' ' 35' ' ' GLY . . . . . . . . 0 O5'--C5' 1.429 -0.697 0 C4'-C3'-C2' 105.929 3.229 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.788 " O5'" " H4'" ' B' ' 4' ' ' ' C' . . . . . . . . 0 O3'--C3' 1.434 0.801 0 P-O3'-C3' 122.273 2.144 OUTLIER-EPSILON 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' ' C' . . . . . 0.749 " H4'" ' HE2' ' A' ' 46' ' ' LYS . . . . . . . . 0 O5'--C5' 1.427 -0.799 0 P-O3'-C3' 123.395 3.079 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.427 -0.789 0 C4'-C3'-C2' 105.241 2.541 . 0.0 OUTLIER '7D dist 1b' 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.428 -0.741 0 O4'-C1'-N19 108.981 0.781 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.958 0 N-CA-C 112.674 -0.171 . . . . 0.0 112.674 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -127.62 151.47 48.88 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 177.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.82 -8.08 56.66 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.358 -175.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -150.13 -160.05 9.06 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.232 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.74 71.69 5.98 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 123.004 2.469 . . . . 0.0 112.833 -178.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.4 t -146.46 99.59 3.24 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.12 178.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 62.2 m -85.7 104.59 15.55 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.428 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.7 p -164.56 148.37 2.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.561 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.9 t -81.99 69.97 8.8 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.564 0.697 . . . . 0.0 109.488 177.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -136.36 36.38 2.01 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.361 178.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.09 165.88 24.29 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.918 0.39 . . . . 0.0 110.981 -177.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -111.83 97.06 36.18 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.401 178.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -81.23 52.3 4.26 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 123.274 2.65 . . . . 0.0 112.0 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -77.93 2.63 16.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.994 0.426 . . . . 0.0 111.221 -177.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 36.9 m -130.34 68.72 1.45 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.233 0.539 . . . . 0.0 110.267 177.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.7 t -80.41 104.95 11.31 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.383 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -93.32 8.36 40.72 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.716 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 22.5 ptp -100.67 120.17 56.57 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.558 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.458 ' HB2' ' HB2' ' A' ' 22' ' ' GLN . 21.8 Cg_exo -65.84 146.63 83.78 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 123.016 2.477 . . . . 0.0 112.023 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.89 84.78 0.31 Allowed 'Trans proline' 0 C--O 1.237 0.428 0 C-N-CA 122.806 2.337 . . . . 0.0 112.812 -178.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 62.2 56.61 2.17 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.249 176.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.458 ' HB2' ' HB2' ' A' ' 19' ' ' PRO . 94.5 mt-30 -118.67 117.57 29.3 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.759 173.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.601 ' O ' ' HA ' ' A' ' 74' ' ' THR . 22.1 mm-40 -72.64 130.53 40.77 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.255 -174.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.601 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 29.6 m -131.7 109.94 10.54 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.61 -178.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.73 HG21 HD11 ' A' ' 73' ' ' ILE . 14.3 m -127.73 161.24 35.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.237 178.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 10.0 m170 -111.47 127.95 55.85 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 -174.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.611 ' O ' ' HA ' ' A' ' 70' ' ' MET . 10.4 t -105.87 123.87 60.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.821 -174.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.779 ' CZ ' HG13 ' A' ' 68' ' ' VAL . 3.7 t80 -82.33 103.2 11.73 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.313 -174.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.527 ' C ' HG22 ' A' ' 68' ' ' VAL . 39.6 pt -126.52 113.14 23.03 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.701 0.762 . . . . 0.0 110.724 174.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.929 ' HB2' ' HG2' ' A' ' 32' ' ' GLN . 88.8 Cg_exo -50.45 150.95 10.66 Favored 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 123.513 2.808 . . . . 0.0 113.325 -179.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.577 ' HA ' HG11 ' A' ' 34' ' ' VAL . . . -58.73 -18.73 33.98 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.909 -175.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.929 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 3.5 pt20 -51.65 -36.53 46.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.021 176.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.762 ' HB1' ' HZ2' ' A' ' 90' ' ' LYS . . . -126.4 -25.35 3.48 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -169.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.577 HG11 ' HA ' ' A' ' 31' ' ' ALA . 14.4 p -49.94 -34.53 9.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 O-C-N 123.355 0.409 . . . . 0.0 111.622 -173.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.956 ' HA2' ' N4 ' ' B' ' 4' ' ' ' C' . . . -57.22 -55.8 28.42 Favored Glycine 0 N--CA 1.44 -1.084 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.155 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.438 ' HA ' " H5'" ' B' ' 3' ' ' ' A' . . . -71.87 -15.05 62.11 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 120.906 0.384 . . . . 0.0 111.057 -175.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.594 HG12 ' O ' ' A' ' 33' ' ' ALA . 6.5 mm -71.74 -36.0 57.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.683 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.763 HD12 ' C4 ' ' B' ' 4' ' ' ' C' . 8.2 mt -63.51 -32.12 55.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-O 121.41 0.624 . . . . 0.0 110.265 173.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.53 ' HA3' ' HB2' ' A' ' 44' ' ' HIS . . . 86.72 163.48 38.66 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.443 176.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -61.36 128.15 34.94 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 120.927 0.394 . . . . 0.0 110.039 -178.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.442 ' O ' ' HE3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER 72.62 1.84 4.13 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.178 179.149 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.53 ' HA2' HG21 ' A' ' 38' ' ' ILE . . . 69.94 19.86 75.68 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.395 -0.907 . . . . 0.0 110.889 -173.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -73.86 -41.85 61.62 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.427 -0.386 . . . . 0.0 110.227 -178.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.53 ' HB2' ' HA3' ' A' ' 39' ' ' GLY . 18.8 m-70 -64.6 -40.52 95.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.539 -173.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.445 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 13.8 tt -64.46 -45.45 95.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.887 0.375 . . . . 0.0 111.442 -179.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.401 ' O ' ' HB3' ' A' ' 49' ' ' SER . 13.9 ptmm? -82.26 -22.32 35.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.671 0.272 . . . . 0.0 111.324 -178.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -69.34 -34.78 75.14 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 172.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.839 ' HG ' ' HE1' ' A' ' 51' ' ' PHE . 6.4 tt -60.1 -41.97 93.68 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.052 -0.976 . . . . 0.0 108.983 173.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.634 ' HA ' HD13 ' A' ' 56' ' ' ILE . 34.0 t -54.99 -35.31 64.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.931 178.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -73.53 -51.28 17.55 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.839 ' HE1' ' HG ' ' A' ' 48' ' ' LEU . 1.5 p90 -72.49 -32.18 65.99 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.823 -174.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.53 -19.02 36.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.858 0.361 . . . . 0.0 110.804 179.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.5 m 63.95 31.05 14.03 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.078 178.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -132.4 171.16 14.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.992 -177.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.482 ' HB3' ' HB ' ' A' ' 74' ' ' THR . 33.2 t -93.19 115.85 28.45 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.88 HG13 HG21 ' A' ' 73' ' ' ILE . 3.2 mp -115.58 119.15 61.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.238 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.545 ' HG3' " H1'" ' B' ' 6' ' ' ' C' . 37.8 ttpt -148.43 136.69 21.19 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.012 179.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.606 HG12 HG23 ' A' ' 71' ' ' VAL . 10.4 mt -88.8 128.48 40.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.189 0.518 . . . . 0.0 111.224 -177.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.541 ' HB3' HG23 ' A' ' 72' ' ' VAL . . . -71.19 141.79 86.57 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.239 -176.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 59' ' ' ALA . 2.4 Cg_endo -80.36 137.46 11.84 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.933 2.422 . . . . 0.0 111.956 177.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.44 148.54 18.53 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.853 2.369 . . . . 0.0 111.782 176.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -78.39 -32.29 48.77 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.869 -178.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.435 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 9.9 p -122.42 133.4 24.38 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.504 -177.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 63' ' ' THR . 23.8 Cg_exo -65.4 -8.77 19.9 Favored 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 123.441 2.761 . . . . 0.0 112.825 177.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -92.38 17.35 10.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.798 0.332 . . . . 0.0 111.096 176.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 24.9 t -74.73 142.82 44.34 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.164 0.506 . . . . 0.0 110.159 177.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -96.43 2.46 52.6 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.734 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.779 HG13 ' CZ ' ' A' ' 28' ' ' PHE . 3.7 p -154.65 153.64 7.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.788 -167.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.549 ' HB2' HG21 ' A' ' 34' ' ' VAL . 30.4 mtp180 -128.59 130.2 47.02 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 171.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.611 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 4.1 mpp? -92.35 125.88 37.19 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.803 0.335 . . . . 0.0 110.846 -175.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.606 HG23 HG12 ' A' ' 58' ' ' ILE . 93.1 t -84.47 127.11 40.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 120.924 0.393 . . . . 0.0 110.244 178.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.541 HG23 ' HB3' ' A' ' 59' ' ' ALA . 81.9 t -99.29 118.05 45.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.929 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.88 HG21 HG13 ' A' ' 56' ' ' ILE . 2.4 pp -118.58 133.45 65.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.271 0.557 . . . . 0.0 110.938 178.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.601 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 30.0 m -126.08 106.26 9.46 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.068 -179.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.63 164.38 37.29 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.859 -173.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -61.33 138.9 79.83 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 122.488 2.126 . . . . 0.0 111.665 173.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -40.05 -48.36 3.86 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 124.449 3.433 . . . . 0.0 115.316 -173.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -72.9 -32.22 65.2 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 121.031 -0.268 . . . . 0.0 111.617 -175.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.42 -32.21 69.72 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.231 0.539 . . . . 0.0 109.966 177.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -57.85 -41.57 82.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.774 177.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -64.99 -35.03 79.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.409 -175.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.7 mtmt -66.09 -44.02 85.63 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.405 0.621 . . . . 0.0 109.699 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.463 ' HB3' HD22 ' A' ' 48' ' ' LEU . . . -69.77 -41.55 75.02 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.058 178.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.482 ' O ' HG21 ' A' ' 87' ' ' ILE . 49.0 tt0 -64.48 -34.44 78.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.242 -177.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -56.79 -42.07 91.37 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.197 177.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 32.7 mmt180 -76.78 -33.38 58.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.788 0.328 . . . . 0.0 111.497 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.482 HG21 ' O ' ' A' ' 84' ' ' GLN . 0.4 OUTLIER -65.53 -37.29 79.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -177.909 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.679 ' HA ' HD22 ' A' ' 91' ' ' LEU . 10.7 m-85 -69.39 -30.66 68.69 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.201 0.524 . . . . 0.0 110.795 174.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -58.02 -33.81 70.38 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.759 175.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.762 ' HZ2' ' HB1' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -61.33 -36.51 80.34 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 117.435 0.617 . . . . 0.0 109.646 177.774 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.747 ' HB3' ' CE1' ' A' ' 97' ' ' PHE . 2.8 mm? -61.79 -44.87 96.02 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.772 175.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 1.046 ' HE3' ' HB ' ' A' ' 103' ' ' VAL . 3.6 mmtp -76.67 -34.96 58.21 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -176.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -63.1 -33.05 74.62 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.768 -171.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -97.68 18.79 14.8 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.169 -0.613 . . . . 0.0 110.763 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 65.8 t30 58.07 40.5 25.24 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.186 174.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -80.88 -27.66 36.26 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.591 -0.443 . . . . 0.0 109.986 176.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.747 ' CE1' ' HB3' ' A' ' 91' ' ' LEU . 6.7 m-85 -134.99 28.23 3.5 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.915 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 50.43 -164.67 0.69 Allowed Glycine 0 CA--C 1.523 0.552 0 CA-C-N 115.874 -0.603 . . . . 0.0 113.742 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -87.36 -57.63 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.159 2.572 . . . . 0.0 112.142 173.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.429 ' HB3' ' HE3' ' A' ' 100' ' ' LYS . 21.8 mmmt -80.37 -28.14 38.06 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -175.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.701 ' HB3' ' O ' ' A' ' 97' ' ' PHE . 33.9 tt0 -60.89 128.6 37.29 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 178.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -56.37 119.86 6.7 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.126 -175.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 1.046 ' HB ' ' HE3' ' A' ' 92' ' ' LYS . 13.3 p -60.45 123.3 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 173.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -126.27 89.89 3.09 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.773 0.797 . . . . 0.0 109.335 176.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 tt -101.22 126.92 47.99 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.467 -1.242 . . . . 0.0 108.191 -176.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -81.56 103.32 11.19 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.247 0.546 . . . . 0.0 110.383 -177.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.3 m -95.07 130.77 41.63 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.865 0.364 . . . . 0.0 110.036 177.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 -103.65 120.18 40.39 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.813 0.34 . . . . 0.0 110.643 -177.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 32.9 pt -115.63 134.41 58.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.174 0.512 . . . . 0.0 110.191 178.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.549 HH11 HD12 ' A' ' 153' ' ' ILE . 12.7 tpt180 -86.84 118.98 26.58 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.254 -174.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.687 HG23 ' CD2' ' A' ' 174' ' ' LEU . 7.1 p -121.51 145.04 41.73 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -177.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.819 ' HA ' ' HG2' ' A' ' 151' ' ' GLN . 32.7 Cg_exo -55.67 144.54 75.08 Favored 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 122.586 2.191 . . . . 0.0 110.871 173.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.21 -32.15 70.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.692 -175.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.5 p -79.75 -26.04 40.86 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.778 178.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.681 ' HB2' HG22 ' A' ' 111' ' ' VAL . . . -75.51 -20.41 58.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.315 -177.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.42 -35.1 79.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.11 0.481 . . . . 0.0 110.098 175.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -81.52 -11.3 83.33 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.909 176.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.418 ' HD2' HG23 ' A' ' 177' ' ' VAL . 18.3 ttm180 -93.09 -38.36 11.65 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.723 0.296 . . . . 0.0 111.037 179.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.6 p -65.66 -29.83 48.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.353 -177.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.993 ' HA ' ' HB ' ' A' ' 127' ' ' VAL . 34.9 pt -77.28 -19.48 14.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.005 0.431 . . . . 0.0 110.485 178.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.663 ' HA3' HG23 ' A' ' 126' ' ' THR . . . 84.15 -153.96 29.83 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.213 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.405 ' HB3' ' HD2' ' A' ' 125' ' ' LYS . 16.7 t70 -66.38 92.14 0.19 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.696 0.284 . . . . 0.0 111.104 -176.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 30.3 t70 56.3 33.88 23.06 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.826 0.822 . . . . 0.0 110.582 -179.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.664 ' HA2' ' HB ' ' A' ' 120' ' ' ILE . . . 80.26 72.6 1.2 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.545 -0.836 . . . . 0.0 113.008 177.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.405 ' HD2' ' HB3' ' A' ' 122' ' ' ASP . 64.2 mttp -126.05 -56.24 1.45 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.568 0.223 . . . . 0.0 110.538 176.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.663 HG23 ' HA3' ' A' ' 121' ' ' GLY . 14.4 t -69.24 -14.98 63.26 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.961 -0.295 . . . . 0.0 111.129 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.993 ' HB ' ' HA ' ' A' ' 120' ' ' ILE . 12.7 p -66.76 -32.44 58.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.015 0.435 . . . . 0.0 109.964 174.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -66.29 -45.98 78.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.337 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -63.85 -39.06 93.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.242 175.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.692 HD21 HD12 ' A' ' 170' ' ' ILE . 33.4 tp -56.68 -49.44 75.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.147 -176.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.593 ' HG2' ' H ' ' A' ' 138' ' ' VAL . 48.2 mt-30 -61.42 -47.4 85.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.599 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -66.99 -40.09 87.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.855 0.36 . . . . 0.0 111.349 -178.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 34.3 tp -73.13 -42.0 63.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.318 -176.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.418 ' HB ' ' HB1' ' A' ' 166' ' ' ALA . 68.2 p -76.52 -16.26 59.67 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.86 0.362 . . . . 0.0 110.888 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 64.96 26.34 12.74 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.837 -178.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -137.96 162.96 32.71 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.106 -177.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.563 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 8.6 mm-40 -90.23 110.01 21.07 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-O 120.957 0.408 . . . . 0.0 110.395 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.593 ' H ' ' HG2' ' A' ' 131' ' ' GLN . 43.2 t -101.52 104.9 17.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.92 176.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.542 HG13 ' HE3' ' A' ' 155' ' ' LYS . 4.9 p -113.81 111.85 37.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.466 0.65 . . . . 0.0 111.059 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.603 HG12 HG22 ' A' ' 154' ' ' VAL . 9.2 m -90.59 139.14 26.43 Favored Pre-proline 0 N--CA 1.446 -0.631 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 172.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -76.43 122.12 6.37 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 121.845 1.697 . . . . 0.0 112.525 -174.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 11.2 mpt_? -81.53 -13.79 57.67 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 174.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -80.2 -52.13 8.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.933 -1.031 . . . . 0.0 109.44 175.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.532 ' HG2' HG13 ' A' ' 152' ' ' VAL . 40.6 mt-30 73.36 151.1 0.11 Allowed 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 172.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.542 ' HB ' ' HD2' ' A' ' 146' ' ' PRO . 2.2 p -90.95 165.37 22.15 Favored Pre-proline 0 N--CA 1.448 -0.529 0 CA-C-N 114.427 -1.26 . . . . 0.0 110.358 177.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.542 ' HD2' ' HB ' ' A' ' 145' ' ' THR . 20.0 Cg_endo -59.97 159.92 23.88 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.105 2.537 . . . . 0.0 113.601 -177.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -70.83 1.51 5.4 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.096 -0.957 . . . . 0.0 111.207 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -50.13 -35.88 27.58 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.721 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -119.73 7.45 11.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.453 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 44.69 29.86 0.47 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.149 0.98 . . . . 0.0 111.808 -173.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.819 ' HG2' ' HA ' ' A' ' 112' ' ' PRO . 73.9 mt-30 -143.97 153.15 41.96 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 121.069 0.462 . . . . 0.0 111.249 -174.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.532 HG13 ' HG2' ' A' ' 144' ' ' GLN . 33.7 m -126.16 177.91 4.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 176.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.549 HD12 HH11 ' A' ' 110' ' ' ARG . 15.1 mt -121.89 129.62 75.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 O-C-N 121.718 -0.614 . . . . 0.0 111.747 -178.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.603 HG22 HG12 ' A' ' 140' ' ' VAL . 59.4 t -93.1 138.67 19.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 173.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.542 ' HE3' HG13 ' A' ' 139' ' ' VAL . 4.9 mtmt -107.21 123.6 48.53 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.764 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.563 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 52.7 mt -108.0 111.69 36.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 176.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 4.7 mp -107.66 118.45 55.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.904 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 171.7 -165.78 38.69 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.127 -1.035 . . . . 0.0 113.102 178.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.728 ' HA ' HG11 ' A' ' 103' ' ' VAL . 0.3 OUTLIER -77.81 157.24 30.03 Favored 'General case' 0 C--O 1.223 -0.334 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.185 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.495 ' HB3' ' CG ' ' A' ' 88' ' ' TYR . 44.8 p90 -64.24 -23.35 67.27 Favored 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -175.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . 0.556 ' O ' ' HG3' ' A' ' 164' ' ' GLN . 91.1 m-85 -68.73 -51.61 39.55 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.737 0.78 . . . . 0.0 109.543 173.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.15 -41.42 67.11 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.563 -174.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 62.0 p -64.59 -44.28 91.16 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.941 -176.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.605 ' O ' ' HG2' ' A' ' 168' ' ' ARG . 1.2 pp0? -61.09 -38.04 84.84 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.605 177.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' MET . . . . . 0.426 ' HG3' ' O ' ' A' ' 161' ' ' TYR . 81.9 mtp -61.24 -42.4 98.56 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.864 0.364 . . . . 0.0 110.818 177.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.418 ' HB1' ' HB ' ' A' ' 134' ' ' THR . . . -70.67 -43.52 68.92 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.748 178.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -51.99 -55.76 18.44 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.728 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.605 ' HG2' ' O ' ' A' ' 164' ' ' GLN . 9.3 ptt180 -65.38 -29.88 70.64 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.824 -179.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -70.96 -51.12 27.65 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.949 -178.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.692 HD12 HD21 ' A' ' 130' ' ' LEU . 2.3 mp -68.09 -44.83 84.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.574 ' HA ' ' HG ' ' A' ' 174' ' ' LEU . 20.3 mmm180 -58.62 -26.27 63.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.811 0.339 . . . . 0.0 111.352 177.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -69.49 -46.4 66.69 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.655 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.53 HG13 HD21 ' A' ' 174' ' ' LEU . 32.7 pt -72.16 -19.74 19.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.691 -179.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.687 ' CD2' HG23 ' A' ' 111' ' ' VAL . 5.6 mt -66.99 -34.5 77.88 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 177.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.4 -31.72 72.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.18 176.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -71.6 -42.27 67.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.988 177.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.418 HG23 ' HD2' ' A' ' 118' ' ' ARG . 88.9 t -67.5 -35.01 71.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.507 176.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -57.48 -46.59 83.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.165 0.507 . . . . 0.0 110.328 175.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.4 ' O ' ' HB3' ' A' ' 183' ' ' LYS . 43.5 mt-30 -64.3 -39.85 94.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.393 177.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.42 ' O ' ' HA3' ' A' ' 184' ' ' GLY . 7.2 tp60 -66.9 -21.48 65.99 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.073 0.463 . . . . 0.0 110.786 178.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -83.68 -42.5 16.56 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.51 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -84.94 -29.19 25.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.097 0.475 . . . . 0.0 111.036 -179.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.457 ' O ' ' HG2' ' A' ' 183' ' ' LYS . 46.2 tttm -114.69 34.76 4.59 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 122.063 0.935 . . . . 0.0 109.254 -177.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.42 ' HA3' ' O ' ' A' ' 180' ' ' GLN . . . -146.61 132.31 4.37 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.567 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -121.45 -39.85 2.63 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.096 0.474 . . . . 0.0 109.73 177.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 11.5 t -100.89 -174.58 2.66 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.759 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 99.34 26.89 8.43 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 -177.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -95.46 49.5 1.19 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.251 0.548 . . . . 0.0 110.894 -176.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 97.8 mt -88.73 57.62 4.25 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.027 178.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -90.25 125.25 35.43 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.07 -177.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.632 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.1 179.75 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' ' G' . . . . . 0.744 " O2'" ' H6 ' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.427 -0.789 1 C3'-C2'-C1' 105.289 4.21 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . 0.744 ' H6 ' " O2'" ' B' ' 1' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.425 -0.937 0 O4'-C4'-C3' 103.362 -1.527 . 0.0 OUTLIER '7D dist 2a' 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . 0.662 " H1'" ' C5 ' ' B' ' 4' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.424 -1.026 0 O4'-C1'-N19 110.785 2.585 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' ' C' . . . . . 0.956 ' N4 ' ' HA2' ' A' ' 35' ' ' GLY . . . . . . . . 0 O5'--C5' 1.426 -0.866 0 C4'-C3'-C2' 105.774 3.074 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.771 " O5'" " H4'" ' B' ' 4' ' ' ' C' . . . . . . . . 0 P--O3' 1.616 0.782 0 P-O3'-C3' 122.357 2.214 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' ' C' . . . . . 0.545 " H1'" ' HG3' ' A' ' 57' ' ' LYS . . . . . . . . 0 P--O3' 1.613 0.505 0 C4'-C3'-C2' 106.555 3.855 OUTLIER-DELTA 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.901 0 O4'-C1'-N19 109.051 0.851 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.425 -0.937 0 C3'-C2'-C1' 100.468 -1.146 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.791 0 N-CA-C 111.967 -0.453 . . . . 0.0 111.967 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.16 86.8 1.86 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.999 0.428 . . . . 0.0 111.114 -177.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 65.4 mtt -99.07 172.3 7.48 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.74 176.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 127.16 -85.59 0.33 Allowed Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 110.991 -0.843 . . . . 0.0 110.991 -176.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -59.76 98.44 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.594 2.196 . . . . 0.0 110.451 172.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.3 m -94.1 118.97 32.3 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.421 0.629 . . . . 0.0 111.847 -169.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.1 m -131.62 -68.31 0.65 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.005 171.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.3 t 50.4 54.12 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-O 121.677 0.751 . . . . 0.0 110.752 177.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.5 m -85.95 -28.68 24.12 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.089 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.11 140.31 6.38 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.043 178.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -127.39 -59.5 1.23 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.027 0.441 . . . . 0.0 110.234 178.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -147.22 89.81 5.46 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.705 178.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -63.94 -49.6 3.82 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.906 2.404 . . . . 0.0 112.645 -177.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -107.77 99.38 8.86 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.8 t 70.1 136.87 0.04 OUTLIER 'General case' 0 C--O 1.235 0.296 0 O-C-N 123.944 0.778 . . . . 0.0 111.064 -177.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.6 t -79.71 65.06 4.75 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.187 -178.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -152.38 -55.98 0.13 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.177 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 27.6 ttt 60.69 91.86 0.07 OUTLIER Pre-proline 0 N--CA 1.465 0.313 0 O-C-N 123.8 0.688 . . . . 0.0 111.071 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -74.68 108.91 2.81 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 123.196 2.598 . . . . 0.0 111.868 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -95.17 14.13 1.25 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.286 2.658 . . . . 0.0 112.905 -176.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.443 ' O ' ' HA ' ' A' ' 76' ' ' PRO . 37.9 tt0 -144.47 95.51 2.72 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.356 -177.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -122.21 142.46 50.41 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.301 177.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.518 ' O ' ' HA ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -107.65 161.58 14.74 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.663 178.7 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.8 m -139.84 108.63 5.96 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.765 0.317 . . . . 0.0 110.99 -178.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.434 HG22 HD12 ' A' ' 73' ' ' ILE . 35.5 m -127.77 161.02 36.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.128 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -114.97 130.2 56.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.274 -174.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.534 ' HB ' ' HB ' ' A' ' 71' ' ' VAL . 21.4 t -105.06 132.81 50.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.823 -174.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.673 ' CZ ' HG12 ' A' ' 68' ' ' VAL . 5.0 t80 -94.12 104.58 16.6 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.012 0.525 . . . . 0.0 110.846 -174.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.474 ' C ' HG23 ' A' ' 68' ' ' VAL . 26.7 pt -124.66 120.57 25.77 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.391 0.615 . . . . 0.0 110.404 174.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.502 ' HA ' ' HA ' ' A' ' 68' ' ' VAL . 36.5 Cg_endo -64.82 153.1 79.61 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 123.045 2.497 . . . . 0.0 112.541 -174.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.539 ' HA ' HG13 ' A' ' 34' ' ' VAL . . . -60.48 -18.95 54.88 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.052 -176.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -74.09 -13.98 60.92 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.828 177.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.547 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -123.47 -30.75 3.6 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.914 -177.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.562 HG21 ' HB3' ' A' ' 69' ' ' ARG . 11.1 p -54.47 -31.54 23.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -172.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.942 ' HA2' ' H42' ' B' ' 4' ' ' ' C' . . . -56.59 -59.26 11.1 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.174 -1.012 . . . . 0.0 111.642 -178.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.607 ' HA ' " H5'" ' B' ' 3' ' ' ' A' . . . -77.4 -13.48 59.92 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 120.788 0.327 . . . . 0.0 111.007 -174.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.635 HD12 ' HB3' ' A' ' 90' ' ' LYS . 2.0 mm -67.79 -34.4 67.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.75 178.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.765 HD13 ' C5 ' ' B' ' 4' ' ' ' C' . 19.2 mt -63.23 -59.45 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.962 177.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.431 ' HA3' ' NE2' ' A' ' 44' ' ' HIS . . . 118.8 90.55 1.34 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 119.761 -1.209 . . . . 0.0 115.311 168.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 43.9 tptt 57.38 -79.13 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.655 1.182 . . . . 0.0 113.805 171.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.522 ' HE2' ' HB3' ' A' ' 43' ' ' GLN . 19.2 pttm -117.36 7.68 12.89 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.749 0.309 . . . . 0.0 111.389 -175.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 62.9 39.25 97.8 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.995 -0.622 . . . . 0.0 112.942 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.522 ' HB3' ' HE2' ' A' ' 41' ' ' LYS . 23.0 tt0 -114.82 -48.79 2.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 117.158 0.479 . . . . 0.0 111.384 178.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.431 ' NE2' ' HA3' ' A' ' 39' ' ' GLY . 4.6 p80 -63.56 -19.19 64.6 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.075 0.464 . . . . 0.0 110.703 178.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.468 HD13 ' HA ' ' A' ' 38' ' ' ILE . 10.2 tt -67.26 -32.2 56.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.385 174.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.428 ' HD3' " C5'" ' B' ' 6' ' ' ' C' . 56.7 mtmt -81.54 -22.25 37.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.287 0.565 . . . . 0.0 110.159 178.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -66.79 -30.57 70.8 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 173.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.626 HD21 ' HE1' ' A' ' 51' ' ' PHE . 0.3 OUTLIER -55.58 -49.31 73.06 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.173 173.822 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.65 ' HA ' HD11 ' A' ' 56' ' ' ILE . 8.6 m -57.87 -37.03 73.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.186 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.8 mtp180 -73.48 -50.92 19.09 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -176.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.626 ' HE1' HD21 ' A' ' 48' ' ' LEU . 0.6 OUTLIER -68.63 -27.46 66.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.938 0.399 . . . . 0.0 110.223 -176.43 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.561 ' O ' ' HB3' ' A' ' 79' ' ' ALA . . . -86.82 -10.64 53.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.892 0.377 . . . . 0.0 110.864 177.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 31.5 m 57.62 38.22 27.7 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.148 178.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -138.65 173.46 11.56 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.623 -174.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 26.4 m -94.7 101.6 13.45 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.179 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.802 HG13 HG23 ' A' ' 73' ' ' ILE . 1.9 mp -106.14 123.12 60.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.129 178.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -138.65 150.97 46.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.23 176.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.669 ' HB ' ' C6 ' ' B' ' 5' ' ' ' A' . 31.2 mm -89.97 120.83 39.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 169.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.807 ' HB1' HG23 ' A' ' 72' ' ' VAL . . . -65.24 122.45 80.0 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.552 -175.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.41 127.29 19.91 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.987 2.458 . . . . 0.0 111.746 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -49.4 124.62 12.25 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 123.204 2.603 . . . . 0.0 112.56 -177.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -56.66 -39.29 73.46 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.358 177.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.433 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 16.6 p -131.55 144.17 52.25 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 114.812 -1.085 . . . . 0.0 108.81 174.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 63' ' ' THR . 39.0 Cg_exo -61.21 -14.67 35.24 Favored 'Trans proline' 0 N--CA 1.475 0.385 0 C-N-CA 123.137 2.558 . . . . 0.0 113.202 -174.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -116.28 17.66 15.55 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.004 -179.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 27.4 p -49.52 131.47 20.98 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.207 0.527 . . . . 0.0 112.338 -174.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.474 ' O ' ' HD2' ' A' ' 67' ' ' LYS . 24.4 tptp -72.15 -18.96 61.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.282 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.673 HG12 ' CZ ' ' A' ' 28' ' ' PHE . 10.8 p -139.29 148.8 23.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.857 175.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.562 ' HB3' HG21 ' A' ' 34' ' ' VAL . 17.6 ttm180 -127.09 133.8 50.36 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 175.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.628 ' HE3' ' HB2' ' A' ' 108' ' ' HIS . 41.0 mtp -100.42 149.33 23.77 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 119.863 -0.735 . . . . 0.0 111.14 -171.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.534 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 89.9 t -99.05 127.95 51.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.953 175.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.807 HG23 ' HB1' ' A' ' 59' ' ' ALA . 92.3 t -103.28 110.0 28.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 177.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.802 HG23 HG13 ' A' ' 56' ' ' ILE . 2.6 pp -117.0 129.23 73.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.307 0.575 . . . . 0.0 111.072 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.518 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 35.4 m -125.14 109.44 12.89 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.922 -1.036 . . . . 0.0 109.889 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.45 162.04 35.43 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.363 -0.922 . . . . 0.0 112.601 -177.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.465 ' HG2' ' HB2' ' A' ' 79' ' ' ALA . 19.3 Cg_endo -59.67 137.01 74.53 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.754 2.303 . . . . 0.0 111.339 174.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_exo -40.03 -49.85 3.56 Favored 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 124.314 3.342 . . . . 0.0 114.683 -174.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -68.16 -36.32 79.46 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.888 0.375 . . . . 0.0 111.373 -176.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' A' ' 52' ' ' ALA . . . -74.83 -31.7 61.75 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.425 0.631 . . . . 0.0 110.206 177.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -62.87 -33.45 75.3 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.239 175.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -53.75 -54.73 34.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.673 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.533 ' HE2' ' HA ' ' A' ' 79' ' ' ALA . 37.0 pttt -70.9 -33.77 70.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.677 0.275 . . . . 0.0 111.444 -177.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.35 -45.65 86.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.997 0.427 . . . . 0.0 111.011 177.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.653 ' HB3' ' HE1' ' A' ' 160' ' ' PHE . 23.6 tt0 -71.41 -31.69 67.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.318 -177.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -58.0 -32.7 67.11 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.829 176.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -76.65 -27.63 55.72 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.56 0.219 . . . . 0.0 111.197 178.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.515 HG23 ' O ' ' A' ' 84' ' ' GLN . 0.4 OUTLIER -70.26 -39.73 77.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -177.739 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.439 ' CE2' ' HB3' ' A' ' 105' ' ' LEU . 18.3 m-85 -69.68 -30.81 68.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.095 0.474 . . . . 0.0 109.999 174.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -58.48 -28.6 62.49 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.91 173.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.635 ' HB3' HD12 ' A' ' 37' ' ' ILE . 34.8 mmtp -67.97 -44.39 76.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.082 0.468 . . . . 0.0 109.893 175.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -60.46 -41.71 94.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.851 174.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 1.047 ' HE3' ' HB ' ' A' ' 103' ' ' VAL . 0.6 OUTLIER -65.73 -31.78 72.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.379 178.46 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -52.72 -47.52 67.26 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.575 -176.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.738 ' HB2' ' CE2' ' A' ' 96' ' ' PHE . 10.4 mm-40 -110.14 0.3 18.22 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.665 -177.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 55.72 43.58 27.7 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.751 178.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.738 ' CE2' ' HB2' ' A' ' 94' ' ' GLU . 92.9 m-85 -58.71 -38.92 79.36 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.101 0.477 . . . . 0.0 111.342 -178.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.674 ' CZ ' ' HE2' ' A' ' 92' ' ' LYS . 20.5 p90 -66.24 -33.54 75.98 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.679 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.439 ' HA3' ' HB2' ' A' ' 101' ' ' GLU . . . 150.83 147.22 4.5 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.627 -177.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -58.32 -54.22 3.28 Favored 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 122.743 2.296 . . . . 0.0 113.016 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -105.24 -6.52 19.68 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.708 0.289 . . . . 0.0 111.141 -178.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.439 ' HB2' ' HA3' ' A' ' 98' ' ' GLY . 5.9 mp0 -61.41 152.49 29.55 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.338 -177.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.431 ' HB3' ' NE2' ' A' ' 159' ' ' HIS . 38.5 mt-10 -61.57 146.55 48.43 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.01 172.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 1.047 ' HB ' ' HE3' ' A' ' 92' ' ' LYS . 12.6 p -59.03 129.84 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.149 175.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.41 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 74.3 mmtt -136.86 91.25 2.62 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.423 -177.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.439 ' HB3' ' CE2' ' A' ' 88' ' ' TYR . 2.4 tt -115.88 117.01 29.0 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -76.95 113.93 15.19 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.311 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.5 m -104.99 143.73 32.78 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.628 ' HB2' ' HE3' ' A' ' 70' ' ' MET . 22.1 m170 -114.41 120.28 39.78 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 120.962 0.411 . . . . 0.0 110.346 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.418 ' CD1' ' HB ' ' A' ' 170' ' ' ILE . 16.6 pt -107.97 138.37 34.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 176.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -90.82 118.68 30.42 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.363 -174.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.575 HG11 HD12 ' A' ' 174' ' ' LEU . 11.1 m -116.95 154.34 49.64 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.769 178.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.617 ' HD2' HD23 ' A' ' 174' ' ' LEU . 38.4 Cg_exo -58.62 146.06 92.98 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.05 1.833 . . . . 0.0 110.891 173.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.415 ' HA ' HG23 ' A' ' 152' ' ' VAL . . . -48.65 -52.21 24.37 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -172.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.5 m -76.34 -17.82 59.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.676 -176.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.19 -24.66 62.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.652 0.263 . . . . 0.0 111.24 -177.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.553 ' HB2' HG11 ' A' ' 140' ' ' VAL . . . -64.17 -29.86 70.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.23 0.538 . . . . 0.0 110.357 177.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -77.01 -23.88 67.95 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.827 177.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.45 ' HD2' HG22 ' A' ' 177' ' ' VAL . 78.8 mtt-85 -83.72 -27.79 28.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.568 0.223 . . . . 0.0 110.592 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.704 HG22 HD12 ' A' ' 130' ' ' LEU . 9.9 p -77.47 -32.34 18.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.086 -178.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.415 ' O ' HG12 ' A' ' 127' ' ' VAL . 47.1 mm -74.34 -38.64 47.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.427 0.632 . . . . 0.0 109.944 177.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 95.54 153.46 30.06 Favored Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.384 -178.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -78.19 115.47 17.93 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 64.77 21.93 12.46 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 123.705 0.628 . . . . 0.0 110.911 -176.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 98.09 -137.45 13.3 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.915 -0.66 . . . . 0.0 111.847 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 23.5 tptm 72.55 -54.39 0.69 Allowed 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.393 0.677 . . . . 0.0 111.834 177.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 26.4 m -68.75 -37.34 79.31 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.891 0.377 . . . . 0.0 110.784 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.415 HG12 ' O ' ' A' ' 120' ' ' ILE . 6.4 m -65.21 -20.95 28.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.669 175.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -63.81 -33.43 75.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.969 0.414 . . . . 0.0 109.954 178.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -79.15 -40.31 31.3 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.642 -0.423 . . . . 0.0 109.957 175.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.704 HD12 HG22 ' A' ' 119' ' ' VAL . 66.4 mt -55.57 -52.01 65.17 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -174.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -84.34 -31.92 24.55 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.361 -0.535 . . . . 0.0 112.233 -173.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -72.26 -38.3 68.89 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.785 0.326 . . . . 0.0 111.083 -178.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 42.7 tp -83.03 -46.59 12.67 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.514 -176.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.585 HG23 ' HA ' ' A' ' 166' ' ' ALA . 39.6 p -75.88 -28.01 57.96 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.526 -174.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 67.36 15.48 9.92 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.546 -175.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -112.59 172.1 7.12 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.75 -178.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.466 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 35.2 tt0 -99.99 110.74 23.06 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 177.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 59.8 t -108.42 106.65 21.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.822 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 6.2 p -119.71 115.82 48.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.288 0.566 . . . . 0.0 111.428 -177.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.599 HG21 ' HB ' ' A' ' 154' ' ' VAL . 86.3 t -93.56 110.82 49.43 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.388 173.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.588 ' HG3' ' HE2' ' A' ' 155' ' ' LYS . 21.1 Cg_exo -67.5 149.9 80.16 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 123.104 2.536 . . . . 0.0 112.639 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.35 118.71 22.23 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.581 177.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 65.93 97.34 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.422 0.629 . . . . 0.0 112.004 -178.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.604 ' OE1' ' HB ' ' A' ' 153' ' ' ILE . 20.8 mm-40 -102.96 -66.94 0.9 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.545 176.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -145.61 144.61 23.11 Favored Pre-proline 0 C--N 1.314 -0.978 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.957 -179.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -67.43 168.33 18.26 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 123.23 2.62 . . . . 0.0 113.531 -174.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -58.84 -15.77 14.07 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.904 -177.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -55.41 -43.17 75.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.9 0.381 . . . . 0.0 110.497 172.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.48 -16.75 33.87 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 46.35 28.91 0.77 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.948 1.299 . . . . 0.0 111.731 -178.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -145.29 149.11 34.26 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.381 -174.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.415 HG23 ' HA ' ' A' ' 113' ' ' ALA . 11.2 m -137.59 177.65 5.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 O-C-N 123.362 0.414 . . . . 0.0 110.203 178.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.604 ' HB ' ' OE1' ' A' ' 144' ' ' GLN . 96.7 mt -119.92 144.81 27.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.188 -173.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.599 ' HB ' HG21 ' A' ' 140' ' ' VAL . 1.5 p -135.46 139.43 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-O 121.251 0.548 . . . . 0.0 110.342 168.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.588 ' HE2' ' HG3' ' A' ' 141' ' ' PRO . 19.6 mttm -101.88 133.55 46.46 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.342 -172.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.466 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 68.2 mt -115.3 112.12 38.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.901 177.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.411 ' N ' HD11 ' A' ' 157' ' ' ILE . 4.5 mp -109.63 132.51 57.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.816 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 156.33 -158.43 28.67 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.222 -0.99 . . . . 0.0 112.866 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.832 ' HA ' HG11 ' A' ' 103' ' ' VAL . 13.6 m-70 -76.7 166.08 23.86 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 123.729 0.311 . . . . 0.0 110.64 -177.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.653 ' HE1' ' HB3' ' A' ' 84' ' ' GLN . 10.4 t80 -61.99 -49.04 77.67 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.59 0.233 . . . . 0.0 110.534 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -69.46 -33.61 73.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.894 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.06 -49.85 53.79 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.028 0.442 . . . . 0.0 110.672 178.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.542 ' O ' ' HG3' ' A' ' 167' ' ' GLN . 49.7 m -66.49 -38.43 87.24 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.704 -177.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -64.16 -36.67 84.79 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.708 178.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 90.1 mtp -66.01 -34.08 77.27 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.951 0.405 . . . . 0.0 110.357 176.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.585 ' HA ' HG23 ' A' ' 134' ' ' THR . . . -71.68 -44.16 64.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.493 177.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.542 ' HG3' ' O ' ' A' ' 163' ' ' SER . 75.0 mt-30 -52.46 -51.6 58.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.624 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.747 ' O ' ' HB2' ' A' ' 172' ' ' ASP . 5.9 ptm180 -67.05 -31.74 72.46 Favored 'General case' 0 C--O 1.217 -0.651 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.376 -178.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.435 ' N ' ' HG3' ' A' ' 168' ' ' ARG . 16.2 tppt? -65.25 -53.14 48.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.828 0.347 . . . . 0.0 111.208 -176.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.464 ' O ' ' HG ' ' A' ' 174' ' ' LEU . 3.0 mp -72.29 -44.23 63.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.321 -177.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -61.46 -25.5 67.28 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.916 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.747 ' HB2' ' O ' ' A' ' 168' ' ' ARG . 2.1 t0 -71.16 -47.98 54.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.914 -177.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 18.1 pt -70.12 -19.73 22.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.925 -176.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.617 HD23 ' HD2' ' A' ' 112' ' ' PRO . 19.1 mt -57.73 -32.34 67.33 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.883 0.373 . . . . 0.0 110.733 175.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.71 -31.8 73.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.743 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -67.57 -35.69 79.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.998 177.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.45 HG22 ' HD2' ' A' ' 118' ' ' ARG . 42.1 t -74.82 -27.37 20.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.902 177.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 52.1 tptt -65.66 -45.01 84.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.508 172.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -63.54 -33.68 76.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.64 175.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.596 ' HA ' ' HA2' ' A' ' 184' ' ' GLY . 25.5 tp60 -62.72 -33.91 76.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.344 175.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 39.9 m-70 -71.81 -35.82 70.07 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.936 0.398 . . . . 0.0 110.814 174.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -65.09 -48.55 73.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.81 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -161.55 -55.89 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.814 176.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.596 ' HA2' ' HA ' ' A' ' 180' ' ' GLN . . . 142.68 100.92 0.38 Allowed Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.263 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 5.4 tp60 -146.6 110.09 4.84 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.906 0.384 . . . . 0.0 110.369 178.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 16.0 p -105.46 -2.61 23.51 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.686 178.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 109.02 -61.05 0.31 Allowed Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.541 -178.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -103.33 75.47 1.35 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.75 0.309 . . . . 0.0 110.615 178.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 5.1 tt -87.78 99.03 11.8 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 178.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 57.41 35.79 26.35 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.618 -176.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.222 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.236 -177.251 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' ' G' . . . . . 0.955 " O2'" ' H6 ' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.426 -0.849 0 C4'-C3'-C2' 106.626 3.926 OUTLIER-EPSILON 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . 0.955 ' H6 ' " O2'" ' B' ' 1' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.424 -0.996 0 C3'-C2'-C1' 99.605 -2.106 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . 0.771 " H1'" ' C5 ' ' B' ' 4' ' ' ' C' . . . . . . . . 0 C2'--C1' 1.517 -1.084 0 C5'-C4'-O4' 112.524 2.374 . 0.01 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' ' C' . . . . . 0.942 ' H42' ' HA2' ' A' ' 35' ' ' GLY . . . . . . . . 0 O5'--C5' 1.427 -0.787 0 C3'-C2'-C1' 104.196 2.995 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.858 " O4'" " H4'" ' B' ' 4' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.431 -0.579 0 P-O3'-C3' 121.867 1.806 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' ' C' . . . . . 0.481 ' H6 ' " O5'" ' B' ' 6' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.43 -0.656 0 C4'-C3'-C2' 105.523 2.823 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.424 -0.969 0 C4'-C3'-C2' 105.43 2.73 OUTLIER-EPSILON 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.424 -0.989 0 P-O3'-C3' 122.765 2.554 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.649 0 N-CA-C 111.86 -0.496 . . . . 0.0 111.86 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -100.99 -43.26 6.1 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.955 0.407 . . . . 0.0 110.091 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.01 141.91 51.38 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.815 177.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -164.99 77.52 0.14 Allowed Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.164 -177.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.2 72.42 5.38 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 123.26 2.64 . . . . 0.0 111.693 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.9 t 73.47 -46.56 0.64 Allowed 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.608 0.763 . . . . 0.0 110.923 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 35.5 t -122.29 155.55 35.71 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.8 m -120.66 137.06 55.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 176.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.6 m -112.65 13.43 19.92 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.134 0.492 . . . . 0.0 110.677 -177.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -77.11 146.81 32.47 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.156 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.94 117.83 22.48 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.892 0.377 . . . . 0.0 111.326 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.472 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . . . -85.51 133.72 41.56 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.584 175.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 12' ' ' ALA . 13.6 Cg_exo -69.3 111.94 2.86 Favored 'Trans proline' 0 N--CA 1.464 -0.257 0 C-N-CA 122.815 2.343 . . . . 0.0 112.326 -178.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -106.83 18.53 21.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.458 177.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.1 m -74.92 100.64 4.17 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.741 -177.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.5 m -92.97 141.25 28.61 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.372 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 57.71 51.77 8.98 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 123.599 0.562 . . . . 0.0 111.231 178.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.852 ' HB3' ' HD3' ' A' ' 19' ' ' PRO . 22.8 ttt -78.8 -56.04 0.93 Allowed Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.496 176.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.852 ' HD3' ' HB3' ' A' ' 18' ' ' MET . 42.3 Cg_endo -97.96 112.01 0.09 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.877 2.385 . . . . 0.0 112.32 176.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -78.23 175.48 11.06 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.752 2.301 . . . . 0.0 111.662 176.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -65.83 114.7 5.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.495 177.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -86.4 151.34 23.63 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.872 -177.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.43 110.14 15.6 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.126 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 66.0 m -106.62 107.62 18.72 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 173.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.639 ' HB ' HG23 ' A' ' 109' ' ' ILE . 22.2 m -132.14 160.96 42.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.166 -177.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.505 ' HB3' ' HE2' ' A' ' 70' ' ' MET . 12.8 m-70 -116.96 132.0 56.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.615 0.245 . . . . 0.0 110.777 -173.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 70' ' ' MET . 9.6 t -101.52 137.39 29.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.571 -176.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.612 ' HD1' ' HE3' ' A' ' 70' ' ' MET . 1.7 t80 -102.05 105.0 15.67 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.253 -177.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.608 HD11 HD11 ' A' ' 87' ' ' ILE . 18.9 pt -132.4 125.83 19.93 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-O 121.288 0.566 . . . . 0.0 111.676 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.487 ' HA ' ' HA ' ' A' ' 68' ' ' VAL . 52.0 Cg_exo -55.85 148.27 57.41 Favored 'Trans proline' 0 C--O 1.239 0.553 0 C-N-CA 123.31 2.674 . . . . 0.0 112.504 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.608 ' HA ' HG13 ' A' ' 34' ' ' VAL . . . -57.83 -23.8 54.41 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.762 -1.108 . . . . 0.0 112.916 -171.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.661 ' HB2' ' HZ ' ' A' ' 96' ' ' PHE . 62.6 mm-40 -64.67 -21.74 66.81 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -175.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.656 ' HB1' ' HE2' ' A' ' 96' ' ' PHE . . . -121.86 -28.97 4.38 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.521 -175.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.608 HG13 ' HA ' ' A' ' 31' ' ' ALA . 14.3 p -57.28 -29.21 32.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-O 121.24 0.543 . . . . 0.0 110.166 -178.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 1.036 ' HA2' ' H42' ' B' ' 4' ' ' ' C' . . . -58.6 -55.32 31.42 Favored Glycine 0 N--CA 1.438 -1.216 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.627 176.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.451 ' HA ' " H5'" ' B' ' 3' ' ' ' A' . . . -73.45 -13.88 61.15 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 120.891 0.377 . . . . 0.0 110.585 -177.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.623 HG12 ' O ' ' A' ' 33' ' ' ALA . 7.8 mm -66.29 -37.38 79.56 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.149 175.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.715 HD13 ' C5 ' ' B' ' 4' ' ' ' C' . 19.6 mt -66.94 -43.9 88.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.628 174.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 83.78 -173.86 51.14 Favored Glycine 0 C--O 1.224 -0.525 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.957 174.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -47.83 91.07 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.509 0.723 . . . . 0.0 112.486 -177.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.597 ' HA ' " C5'" ' B' ' 4' ' ' ' C' . 12.6 ttpt 49.28 37.41 11.34 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.984 0.913 . . . . 0.0 111.544 -175.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.443 ' HA2' HG22 ' A' ' 45' ' ' ILE . . . 83.01 26.85 43.09 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.233 -0.984 . . . . 0.0 112.557 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -56.1 -71.57 0.09 Allowed 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -76.78 -20.6 56.25 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.208 0.448 . . . . 0.0 112.208 -173.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.443 HG22 ' HA2' ' A' ' 42' ' ' GLY . 10.3 tt -68.8 -37.07 76.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.904 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.631 ' HA ' ' HZ1' ' A' ' 46' ' ' LYS . 1.9 mmmp? -82.23 -22.42 35.89 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 121.939 -0.476 . . . . 0.0 110.679 177.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -69.96 -30.38 67.73 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 172.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.691 ' HA ' ' HE1' ' A' ' 51' ' ' PHE . 0.2 OUTLIER -51.38 -50.46 59.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.996 175.733 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.498 ' HA ' HD13 ' A' ' 56' ' ' ILE . 1.6 p -63.91 -23.26 67.28 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.231 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -74.38 -51.75 14.11 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.691 ' HE1' ' HA ' ' A' ' 48' ' ' LEU . 13.1 p90 -83.97 -22.71 31.35 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.512 -173.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -95.7 -16.53 21.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.85 0.357 . . . . 0.0 111.095 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 73.2 m 56.29 26.46 10.54 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.482 -178.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -106.64 171.55 7.3 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.824 -179.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.5 m -95.7 107.38 19.59 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 178.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.81 HG13 HG21 ' A' ' 73' ' ' ILE . 2.9 mp -108.02 121.31 60.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.782 -176.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -139.51 155.75 47.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.828 175.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.715 ' HB ' ' N6 ' ' B' ' 5' ' ' ' A' . 48.5 mm -99.92 129.56 50.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 173.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.72 ' HB3' HG23 ' A' ' 72' ' ' VAL . . . -81.74 119.08 74.51 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.137 -175.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -73.25 125.65 10.43 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 123.037 2.491 . . . . 0.0 112.055 176.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.426 ' HD3' ' HG3' ' A' ' 69' ' ' ARG . 72.3 Cg_endo -80.06 163.22 22.99 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.242 1.961 . . . . 0.0 111.658 176.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -59.48 -57.56 12.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.017 0.437 . . . . 0.0 110.247 -179.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 34.5 p -118.38 146.77 40.33 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.97 -179.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -69.09 0.64 4.86 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.308 2.672 . . . . 0.0 112.663 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -89.01 13.92 11.79 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 121.111 0.482 . . . . 0.0 111.119 178.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 22.9 t -82.17 132.96 35.24 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 174.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -74.0 -16.37 61.07 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.542 0.687 . . . . 0.0 110.171 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.511 HG13 ' CE2' ' A' ' 28' ' ' PHE . 1.4 p -137.46 148.66 25.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.723 -174.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.426 ' HG3' ' HD3' ' A' ' 61' ' ' PRO . 19.8 ttm180 -126.1 144.35 50.77 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 177.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.619 ' HE1' ' HB2' ' A' ' 108' ' ' HIS . 42.0 mtp -98.58 149.45 22.74 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.429 -173.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 26' ' ' HIS . 90.9 t -105.98 137.92 33.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.828 174.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.72 HG23 ' HB3' ' A' ' 59' ' ' ALA . 58.6 t -111.57 109.36 28.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 178.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.81 HG21 HG13 ' A' ' 56' ' ' ILE . 2.0 pp -124.6 140.32 48.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.143 0.497 . . . . 0.0 111.31 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 90.1 m -131.28 113.92 14.39 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.132 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.65 162.75 36.14 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.37 -177.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.415 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 45.3 Cg_endo -68.42 140.44 48.13 Favored 'Trans proline' 0 CA--C 1.531 0.346 0 C-N-CA 122.698 2.265 . . . . 0.0 111.371 175.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 76' ' ' PRO . 80.4 Cg_exo -45.98 -36.37 15.73 Favored 'Trans proline' 0 N--CA 1.477 0.543 0 C-N-CA 124.746 3.631 . . . . 0.0 114.897 -172.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -72.37 -39.37 68.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.84 0.352 . . . . 0.0 110.813 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.535 ' HA ' ' HE2' ' A' ' 82' ' ' LYS . . . -75.44 -29.31 59.65 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.235 0.54 . . . . 0.0 110.186 176.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -64.72 -35.38 80.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.3 178.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -53.34 -51.0 63.84 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.14 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.535 ' HE2' ' HA ' ' A' ' 79' ' ' ALA . 47.2 pttt -72.71 -33.85 66.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.465 -177.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.496 ' HB1' HD13 ' A' ' 48' ' ' LEU . . . -67.14 -53.8 27.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.866 0.365 . . . . 0.0 111.097 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.443 ' O ' HG23 ' A' ' 87' ' ' ILE . 45.1 tt0 -65.82 -29.72 70.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.107 -178.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -53.85 -35.73 53.81 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.737 177.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -75.81 -40.06 55.7 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 120.855 0.36 . . . . 0.0 110.852 178.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.608 HD11 HD11 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -65.33 -38.5 82.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.052 -177.343 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.818 ' HA ' HD23 ' A' ' 91' ' ' LEU . 2.2 m-30 -69.62 -27.34 64.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.763 0.316 . . . . 0.0 111.166 173.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -57.81 -41.14 93.86 Favored Glycine 0 CA--C 1.52 0.402 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.567 177.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.629 ' HZ1' ' HB2' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -65.29 -24.64 67.35 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.68 0.276 . . . . 0.0 111.038 179.171 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.818 HD23 ' HA ' ' A' ' 88' ' ' TYR . 1.6 mp -58.37 -50.57 73.2 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.443 0.639 . . . . 0.0 110.392 177.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.871 ' HE3' ' HB ' ' A' ' 103' ' ' VAL . 0.6 OUTLIER -73.67 -37.89 65.11 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.434 177.711 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.464 ' HB3' ' HA ' ' A' ' 90' ' ' LYS . 3.7 tp10 -58.74 -38.46 78.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.525 -177.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.481 ' CD ' ' H22' ' B' ' 1' ' ' ' G' . 5.1 mm-40 -96.74 8.81 43.43 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -176.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.447 ' OD1' ' HD3' ' A' ' 99' ' ' PRO . 52.0 m-80 54.98 34.61 22.77 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.911 175.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.661 ' HZ ' ' HB2' ' A' ' 32' ' ' GLN . 44.4 m-85 -70.61 -25.08 62.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.404 0.621 . . . . 0.0 109.555 174.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.545 ' HE1' ' HG ' ' A' ' 91' ' ' LEU . 24.1 m-85 -122.31 -44.72 2.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.668 179.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 135.47 146.37 5.29 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 114.902 -1.044 . . . . 0.0 111.057 -178.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.447 ' HD3' ' OD1' ' A' ' 95' ' ' ASN . 30.6 Cg_endo -65.08 -34.9 44.89 Favored 'Trans proline' 0 N--CA 1.464 -0.232 0 C-N-CA 122.682 2.254 . . . . 0.0 112.366 -178.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -108.12 1.99 22.66 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.207 0.527 . . . . 0.0 111.057 -178.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -88.01 156.53 19.26 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.964 -175.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -63.66 132.56 51.47 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.143 177.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.871 ' HB ' ' HE3' ' A' ' 92' ' ' LYS . 7.2 p -79.68 129.65 37.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.177 0.513 . . . . 0.0 110.227 174.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.552 ' HD2' ' HA2' ' A' ' 158' ' ' GLY . 21.1 mmmt -139.14 89.48 2.35 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 174.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.779 ' HG ' HD22 ' A' ' 91' ' ' LEU . 3.4 tm? -110.94 130.48 55.57 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.489 -169.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.434 ' HA ' HG13 ' A' ' 157' ' ' ILE . 6.8 tp10 -64.88 118.91 9.73 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.394 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.0 m -126.39 114.93 18.86 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 177.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.619 ' HB2' ' HE1' ' A' ' 70' ' ' MET . 49.9 m170 -99.66 120.42 39.67 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.942 0.401 . . . . 0.0 110.792 -177.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.639 HG23 ' HB ' ' A' ' 25' ' ' VAL . 39.8 pt -110.22 149.38 13.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.063 176.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 13.7 mmt180 -96.76 119.48 35.32 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.336 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.574 HG13 HD22 ' A' ' 174' ' ' LEU . 16.8 m -111.79 152.23 44.01 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 177.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.799 ' HD2' ' HG ' ' A' ' 174' ' ' LEU . 32.4 Cg_exo -56.22 147.73 64.38 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.435 2.09 . . . . 0.0 111.043 176.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -50.11 -52.1 37.63 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -171.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 18.6 m -72.25 -25.4 61.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.795 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.5 -26.52 65.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.798 0.333 . . . . 0.0 110.881 -178.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.62 ' O ' HG13 ' A' ' 119' ' ' VAL . . . -64.96 -28.84 69.79 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.967 178.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -81.43 -18.97 67.44 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.613 -0.804 . . . . 0.0 111.838 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.56 ' HD3' HG21 ' A' ' 177' ' ' VAL . 17.8 mtp85 -92.38 -19.53 21.99 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 122.733 -0.275 . . . . 0.0 111.23 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.62 HG13 ' O ' ' A' ' 116' ' ' ALA . 7.6 p -69.52 -29.16 40.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.066 0.46 . . . . 0.0 110.236 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.932 ' HA ' ' HB ' ' A' ' 127' ' ' VAL . 7.7 pt -86.5 -33.62 7.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.59 175.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 117.16 155.45 10.22 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.913 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -57.22 -34.49 68.61 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.009 0.433 . . . . 0.0 110.489 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -141.99 47.0 1.64 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.563 0.697 . . . . 0.0 109.485 174.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.451 ' O ' ' HB3' ' A' ' 125' ' ' LYS . . . 79.09 -155.01 39.87 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.019 -179.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.451 ' HB3' ' O ' ' A' ' 124' ' ' GLY . 1.2 tmtp? 73.68 -49.76 0.69 Allowed 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 176.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.401 ' N ' ' HD3' ' A' ' 125' ' ' LYS . 95.1 m -60.16 -46.07 90.95 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -175.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.932 ' HB ' ' HA ' ' A' ' 120' ' ' ILE . 7.1 p -64.62 -40.4 88.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.813 0.34 . . . . 0.0 111.322 -178.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -68.61 -33.96 74.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.258 0.551 . . . . 0.0 109.94 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -64.24 -41.71 96.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.864 175.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 80.9 mt -59.45 -50.04 75.49 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.567 175.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -62.76 -40.55 97.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.292 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -68.03 -27.69 66.76 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.401 -177.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -93.18 -43.19 8.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.886 0.375 . . . . 0.0 110.961 -176.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 76.1 p -84.66 -20.47 31.22 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -175.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 67.04 20.64 10.37 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 123.724 0.64 . . . . 0.0 110.998 -178.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -118.43 157.46 27.15 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.167 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.568 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 36.4 tt0 -88.35 110.55 20.88 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 59.2 t -108.74 106.8 21.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.321 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.411 ' C ' HG21 ' A' ' 154' ' ' VAL . 6.7 p -132.28 120.74 44.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.38 0.61 . . . . 0.0 111.482 -178.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.61 HG21 ' HB3' ' A' ' 116' ' ' ALA . 2.6 p -99.82 113.16 64.95 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.01 177.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.516 ' HD2' ' O ' ' A' ' 153' ' ' ILE . 36.1 Cg_exo -60.78 125.64 17.74 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.439 2.092 . . . . 0.0 111.55 175.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -83.75 -15.22 49.34 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.26 0.553 . . . . 0.0 109.814 178.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -106.66 59.28 0.64 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.03 172.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.656 ' HG2' ' HB ' ' A' ' 152' ' ' VAL . 57.5 tp60 -100.52 171.75 7.54 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.147 -174.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.452 ' N ' ' HG3' ' A' ' 144' ' ' GLN . 31.7 p -45.21 153.82 0.52 Allowed Pre-proline 0 C--N 1.325 -0.499 0 C-N-CA 123.564 0.746 . . . . 0.0 112.346 174.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -54.61 153.85 22.3 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 123.398 2.732 . . . . 0.0 112.914 -176.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -78.33 9.34 3.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.544 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -53.05 -43.61 66.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.627 175.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . 0.406 ' O ' ' HG2' ' A' ' 150' ' ' GLU . 0.2 OUTLIER -79.74 1.02 28.19 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.668 -175.149 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 149' ' ' ASN . 9.2 pt-20 46.42 29.06 0.81 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.074 0.95 . . . . 0.0 110.484 -171.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -164.5 130.39 2.88 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.17 -169.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.656 ' HB ' ' HG2' ' A' ' 144' ' ' GLN . 23.7 m -128.26 -176.55 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.899 -175.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.516 ' O ' ' HD2' ' A' ' 141' ' ' PRO . 49.2 mt -104.85 142.52 17.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.03 -174.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.411 HG21 ' C ' ' A' ' 139' ' ' VAL . 2.1 p -135.0 140.0 46.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.074 164.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.9 mttt -95.24 145.6 24.94 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.424 -172.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.568 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 70.6 mt -131.42 110.79 18.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.476 174.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.434 HG13 ' HA ' ' A' ' 106' ' ' GLU . 3.8 mp -120.32 118.44 56.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 178.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.552 ' HA2' ' HD2' ' A' ' 104' ' ' LYS . . . -170.87 -170.17 34.77 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.489 -0.863 . . . . 0.0 112.164 -174.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.539 ' HA ' ' O ' ' A' ' 103' ' ' VAL . 24.6 m170 -80.35 169.99 17.0 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -53.26 -45.89 69.01 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -174.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . 0.465 ' O ' ' HG3' ' A' ' 165' ' ' MET . 36.3 p90 -73.88 -33.85 64.21 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.92 0.391 . . . . 0.0 110.762 178.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.79 -50.97 37.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.133 -174.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 26.5 m -58.1 -48.57 79.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.64 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.491 ' O ' ' HG2' ' A' ' 168' ' ' ARG . 65.7 mt-30 -61.74 -32.03 72.24 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.665 -178.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' MET . . . . . 0.465 ' HG3' ' O ' ' A' ' 161' ' ' TYR . 77.0 mtp -70.04 -48.54 57.54 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.382 175.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.43 -42.07 98.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.534 -177.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.499 HE21 HG21 ' A' ' 25' ' ' VAL . 39.0 mt-30 -51.4 -54.65 24.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.279 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.491 ' HG2' ' O ' ' A' ' 164' ' ' GLN . 19.4 ptt180 -75.7 -30.81 59.43 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.885 ' HA ' ' HE3' ' A' ' 169' ' ' LYS . 0.1 OUTLIER -70.85 -36.79 73.03 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 122.195 -0.316 . . . . 0.0 111.292 -177.342 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.636 ' O ' HD13 ' A' ' 174' ' ' LEU . 1.8 mp -75.29 -43.04 43.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 174.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.579 ' HA ' HD23 ' A' ' 174' ' ' LEU . 10.7 mmm180 -54.85 -25.74 30.67 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.994 0.426 . . . . 0.0 110.883 175.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.465 ' HB3' ' O ' ' A' ' 169' ' ' LYS . 6.7 t70 -63.13 -55.66 23.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.415 -0.812 . . . . 0.0 111.11 178.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.525 ' O ' HG22 ' A' ' 177' ' ' VAL . 37.8 pt -67.31 -21.95 28.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.882 -176.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.799 ' HG ' ' HD2' ' A' ' 112' ' ' PRO . 6.7 mp -57.18 -41.69 79.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.825 176.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.469 ' O ' ' HG2' ' A' ' 179' ' ' GLN . . . -68.16 -35.59 78.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.321 178.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -67.56 -32.58 73.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.457 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.56 HG21 ' HD3' ' A' ' 118' ' ' ARG . 60.0 t -72.86 -38.21 56.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.881 0.372 . . . . 0.0 110.535 178.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -69.17 -11.14 60.54 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.298 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.469 ' HG2' ' O ' ' A' ' 175' ' ' ALA . 33.1 mm-40 -68.29 -11.84 60.07 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.143 178.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -57.07 -22.64 40.84 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.829 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -84.71 -24.52 28.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.923 0.392 . . . . 0.0 110.709 -178.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -85.94 -49.93 7.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.927 177.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 52.6 tttm -147.55 131.73 17.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.884 178.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -153.97 164.9 31.5 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.624 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -85.52 60.78 6.45 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.183 0.516 . . . . 0.0 109.788 178.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 4.5 m -66.07 -65.43 0.68 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.065 -175.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -153.98 129.57 2.68 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.213 -177.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -119.14 39.14 3.63 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.449 0.643 . . . . 0.0 110.353 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 86.8 mt -80.99 6.53 13.13 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.588 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -82.76 60.76 5.48 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.178 -178.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.522 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.59 -178.611 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' ' G' . . . . . 1.026 " O2'" ' H6 ' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.425 -0.915 0 C4'-C3'-C2' 105.995 3.295 OUTLIER-EPSILON 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . 1.026 ' H6 ' " O2'" ' B' ' 1' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.426 -0.848 0 P-O3'-C3' 122.393 2.244 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . 0.732 " H1'" ' C5 ' ' B' ' 4' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.422 -1.136 0 O4'-C1'-C2' 103.065 -2.382 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' ' C' . . . . . 1.036 ' H42' ' HA2' ' A' ' 35' ' ' GLY . . . . . . . . 0 O5'--C5' 1.43 -0.643 0 C4'-C3'-C2' 105.753 3.053 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.84 " O5'" " H4'" ' B' ' 4' ' ' ' C' . . . . . . . . 0 P--O3' 1.614 0.608 0 P-O3'-C3' 122.158 2.049 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' ' C' . . . . . 0.564 ' H6 ' " O5'" ' B' ' 6' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.431 -0.568 0 C4'-C3'-C2' 105.232 2.532 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.849 0 C4'-C3'-C2' 105.27 2.57 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.878 0 C3'-C2'-C1' 100.127 -1.526 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.768 0 N-CA-C 111.78 -0.528 . . . . 0.0 111.78 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.72 -36.53 0.43 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.972 0.415 . . . . 0.0 110.776 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 49.0 tpp -93.27 117.85 30.57 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.253 -177.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 85.74 -133.71 12.01 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.621 172.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.56 73.84 5.02 Favored 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 123.137 2.558 . . . . 0.0 113.36 -174.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.2 t -112.35 -51.96 2.81 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.005 174.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 35.4 m -111.51 42.17 1.75 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.167 0.508 . . . . 0.0 110.906 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.4 m -95.24 -3.92 10.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.198 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.5 m -94.76 -2.83 50.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.847 -177.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.57 127.7 9.3 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.942 -0.647 . . . . 0.0 111.589 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -84.83 65.2 9.03 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.173 0.511 . . . . 0.0 110.563 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.711 ' HB1' ' HD3' ' A' ' 13' ' ' PRO . . . -131.98 -56.4 0.03 OUTLIER Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.199 178.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.711 ' HD3' ' HB1' ' A' ' 12' ' ' ALA . 9.2 Cg_exo -72.83 -38.57 2.95 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 122.077 1.851 . . . . 0.0 112.287 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -114.57 167.49 10.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.939 -176.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 48.8 m -148.38 117.16 6.68 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.151 0.5 . . . . 0.0 110.712 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.2 m -93.88 64.16 3.38 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -103.77 -14.62 16.0 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.255 -169.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 48.6 ttm -127.6 76.56 76.88 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -173.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.627 ' HD2' ' HD3' ' A' ' 20' ' ' PRO . 23.0 Cg_exo -65.78 -55.26 0.44 Allowed 'Trans proline' 0 CA--C 1.549 1.257 0 C-N-CA 122.781 2.321 . . . . 0.0 114.632 174.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.627 ' HD3' ' HD2' ' A' ' 19' ' ' PRO . 1.5 Cg_endo -82.47 61.1 7.54 Favored 'Trans proline' 0 C--N 1.361 1.22 0 C-N-CA 122.513 2.142 . . . . 0.0 113.633 -170.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -105.68 -18.98 13.9 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.534 0.683 . . . . 0.0 109.449 172.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -101.99 143.5 31.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.027 -176.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.666 ' OE1' ' HG3' ' A' ' 171' ' ' ARG . 58.4 mt-10 -102.44 132.14 48.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.585 176.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.8 m -100.82 106.73 18.14 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 172.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.669 HG11 HG23 ' A' ' 109' ' ' ILE . 4.6 t -136.08 146.61 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.07 -174.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.445 ' HB2' ' O ' ' A' ' 108' ' ' HIS . 11.5 m170 -104.19 128.58 51.91 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-O 120.932 0.396 . . . . 0.0 110.483 -176.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.486 ' HB ' ' CG1' ' A' ' 71' ' ' VAL . 2.3 t -108.7 142.4 21.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -99.13 112.77 24.83 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -174.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.569 HG22 HD23 ' A' ' 91' ' ' LEU . 6.5 pt -126.81 120.11 22.78 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.846 176.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.536 ' HA ' ' HA ' ' A' ' 68' ' ' VAL . 68.6 Cg_exo -51.46 144.56 31.6 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.395 2.73 . . . . 0.0 112.58 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.584 ' HA ' HG12 ' A' ' 34' ' ' VAL . . . -59.85 -22.94 62.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.974 -1.012 . . . . 0.0 112.218 -173.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -84.2 0.3 49.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.38 -178.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.902 ' HB1' ' HE2' ' A' ' 96' ' ' PHE . . . -125.07 -32.75 2.97 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.594 174.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.584 HG12 ' HA ' ' A' ' 31' ' ' ALA . 11.2 p -57.01 -26.99 25.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-O 121.206 0.527 . . . . 0.0 110.075 -178.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 1.053 ' HA2' ' H42' ' B' ' 4' ' ' ' C' . . . -57.58 -56.95 22.32 Favored Glycine 0 N--CA 1.431 -1.649 0 CA-C-N 115.344 -0.843 . . . . 0.0 111.566 176.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.452 ' HA ' " H5'" ' B' ' 3' ' ' ' A' . . . -78.34 -13.53 59.8 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.826 0.346 . . . . 0.0 111.227 -174.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.638 HD13 ' HG2' ' A' ' 90' ' ' LYS . 3.3 mm -66.35 -39.47 84.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 176.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.77 HD12 ' C5 ' ' B' ' 4' ' ' ' C' . 32.5 mt -64.37 -44.78 97.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 172.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 70.6 104.45 0.04 OUTLIER Glycine 0 CA--C 1.519 0.309 0 N-CA-C 115.706 1.042 . . . . 0.0 115.706 163.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.434 ' C ' ' H ' ' A' ' 42' ' ' GLY . 66.7 mttm 40.54 98.39 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.598 1.159 . . . . 0.0 113.707 167.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.678 ' HE2' ' HB3' ' A' ' 43' ' ' GLN . 24.6 ttpt 76.13 -23.21 0.25 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.209 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.712 ' HA2' HG23 ' A' ' 38' ' ' ILE . . . 92.31 23.06 27.82 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.977 -178.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.678 ' HB3' ' HE2' ' A' ' 41' ' ' LYS . 19.2 pt20 -87.95 -24.71 23.5 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.15 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 81.3 m-70 -66.11 -44.53 84.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.783 0.325 . . . . 0.0 110.775 -178.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.559 ' CD1' HG12 ' A' ' 58' ' ' ILE . 3.0 tt -61.75 -49.06 85.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.242 -177.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -77.55 -21.36 52.67 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.849 0.356 . . . . 0.0 111.033 -175.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -68.43 -36.67 79.4 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 172.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.932 HD22 HG12 ' A' ' 56' ' ' ILE . 1.2 tp -56.73 -40.69 76.15 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.209 177.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.67 ' HA ' HD11 ' A' ' 56' ' ' ILE . 2.1 m -56.85 -38.46 72.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.984 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -70.7 -51.27 28.67 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -175.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.648 ' CZ ' ' HA ' ' A' ' 48' ' ' LEU . 10.6 p90 -79.14 -6.88 57.55 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 120.274 -0.57 . . . . 0.0 111.553 -176.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -97.55 -13.12 21.83 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.863 0.363 . . . . 0.0 110.703 173.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.7 m 56.62 39.61 29.72 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.054 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' A' ' 74' ' ' THR . . . -141.28 174.62 10.36 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.469 -174.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.595 ' HB3' ' HB ' ' A' ' 74' ' ' THR . 32.3 t -92.78 104.34 16.61 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.932 HG12 HD22 ' A' ' 48' ' ' LEU . 1.9 mp -110.97 115.52 50.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.778 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -143.49 151.36 40.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.938 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.633 ' HB ' ' C6 ' ' B' ' 5' ' ' ' A' . 25.1 mm -86.88 134.64 27.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.719 0.295 . . . . 0.0 110.347 178.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.723 ' HB2' HG21 ' A' ' 72' ' ' VAL . . . -95.27 116.77 66.62 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.397 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -62.37 128.61 24.22 Favored 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 122.698 2.265 . . . . 0.0 112.053 178.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.733 ' HD3' ' HG3' ' A' ' 69' ' ' ARG . 57.2 Cg_endo -70.71 157.41 58.6 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 122.449 2.099 . . . . 0.0 111.635 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -64.77 -32.86 74.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.857 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.414 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 11.7 p -131.31 135.68 27.48 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.232 177.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 63' ' ' THR . 20.4 Cg_exo -66.55 -10.16 26.86 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.18 2.587 . . . . 0.0 112.816 -178.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -91.98 -1.64 57.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.056 0.455 . . . . 0.0 110.917 178.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.2 t -56.31 132.75 51.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.257 0.551 . . . . 0.0 110.908 -178.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -71.42 -21.52 61.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.747 -178.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.536 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 2.0 p -134.16 147.15 30.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.192 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.733 ' HG3' ' HD3' ' A' ' 61' ' ' PRO . 27.2 ttm180 -119.18 145.87 45.64 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.62 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 55.3 mtt -87.6 149.07 24.55 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.817 0.342 . . . . 0.0 110.321 -178.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.486 ' CG1' ' HB ' ' A' ' 27' ' ' VAL . 2.8 p -118.5 131.97 69.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 169.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.723 HG21 ' HB2' ' A' ' 59' ' ' ALA . 58.3 t -86.81 102.62 12.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.096 0.474 . . . . 0.0 109.977 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.446 HD12 HG13 ' A' ' 56' ' ' ILE . 1.9 mm -94.97 117.63 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.987 175.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.646 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 25.0 m -130.02 106.26 8.52 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.656 175.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.13 162.0 35.31 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.748 -176.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -69.51 155.41 66.83 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.356 2.038 . . . . 0.0 111.144 171.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -38.92 -42.92 2.11 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 124.041 3.161 . . . . 0.0 114.231 -177.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.453 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 30.4 tt0 -55.99 -50.3 71.24 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.149 0.5 . . . . 0.0 110.561 176.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.429 ' HA ' ' CE ' ' A' ' 82' ' ' LYS . . . -63.54 -36.68 84.57 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.689 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -55.96 -35.58 66.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.942 177.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -69.7 -55.66 9.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.767 -174.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.453 ' HD3' ' O ' ' A' ' 78' ' ' GLU . 0.4 OUTLIER -74.62 -34.16 62.74 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 120.119 -0.632 . . . . 0.0 111.879 -176.36 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.31 -52.59 64.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.93 0.395 . . . . 0.0 110.617 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.428 ' HA ' HG23 ' A' ' 87' ' ' ILE . 47.6 mt-30 -76.38 -31.25 57.9 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.216 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -53.95 -43.65 71.84 Favored Glycine 0 CA--C 1.512 -0.153 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.02 177.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.446 ' HG2' ' O ' ' A' ' 82' ' ' LYS . 12.6 mmt180 -74.84 -43.04 56.73 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.989 0.423 . . . . 0.0 110.076 176.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.874 ' HA ' ' HD3' ' A' ' 90' ' ' LYS . 0.4 OUTLIER -63.8 -35.79 74.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.994 -171.189 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -64.48 -30.51 71.55 Favored 'General case' 0 C--N 1.333 -0.114 0 O-C-N 121.866 -0.522 . . . . 0.0 109.688 176.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -65.0 -29.03 74.31 Favored Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.666 173.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.874 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 4.3 mptp? -68.84 -33.36 73.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.148 0.499 . . . . 0.0 110.103 175.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.758 ' HG ' ' HG ' ' A' ' 105' ' ' LEU . 4.1 mm? -64.55 -40.24 95.21 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.523 172.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.843 ' HE3' ' HB ' ' A' ' 103' ' ' VAL . 0.1 OUTLIER -71.71 -22.0 61.7 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.564 176.659 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -53.52 -47.27 70.06 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.302 178.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -112.81 3.79 16.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.902 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 43.09 59.99 2.7 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 172.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.902 ' HE2' ' HB1' ' A' ' 33' ' ' ALA . 82.8 m-85 -72.55 -46.93 52.09 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.955 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.682 ' CZ ' ' HE2' ' A' ' 92' ' ' LYS . 19.1 p90 -64.5 -26.46 68.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.495 -178.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 150.8 154.29 6.45 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 121.164 -0.541 . . . . 0.0 111.918 -178.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -65.07 -64.96 0.05 OUTLIER 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 122.983 2.456 . . . . 0.0 112.896 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -90.85 -10.0 44.29 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.967 0.413 . . . . 0.0 110.737 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -58.77 135.67 57.53 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.906 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.464 ' O ' ' HG2' ' A' ' 104' ' ' LYS . 6.7 mm-40 -61.13 137.56 58.23 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.296 173.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.843 ' HB ' ' HE3' ' A' ' 92' ' ' LYS . 14.9 p -52.39 125.37 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 CA-C-O 121.576 0.703 . . . . 0.0 111.258 -173.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 47.1 mmtm -120.13 91.16 3.47 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.563 -1.198 . . . . 0.0 108.755 178.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.758 ' HG ' ' HG ' ' A' ' 91' ' ' LEU . 1.5 tt -108.27 124.9 51.01 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.658 -173.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -74.5 120.93 20.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.627 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.4 m -107.33 108.47 19.86 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 173.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.445 ' O ' ' HB2' ' A' ' 26' ' ' HIS . 12.1 m-70 -104.01 121.07 42.39 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.159 0.504 . . . . 0.0 109.921 -177.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.669 HG23 HG11 ' A' ' 25' ' ' VAL . 23.0 pt -122.88 152.22 27.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 C-N-CA 120.534 -0.466 . . . . 0.0 112.138 -173.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.682 ' HD3' HG12 ' A' ' 153' ' ' ILE . 1.7 mmt180 -100.05 116.83 32.99 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.435 174.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 151' ' ' GLN . 31.2 m -104.93 162.31 20.15 Favored Pre-proline 0 C--N 1.316 -0.858 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 173.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -51.83 139.69 49.25 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 121.442 1.428 . . . . 0.0 109.856 170.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -55.18 -30.5 60.03 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.492 -170.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.5 m -93.02 -15.64 25.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.75 0.31 . . . . 0.0 111.439 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.62 -24.72 61.93 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.913 -172.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.564 ' O ' HG11 ' A' ' 119' ' ' VAL . . . -57.99 -28.84 64.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.145 0.498 . . . . 0.0 110.787 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.92 -27.76 73.52 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.997 -0.62 . . . . 0.0 113.014 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.598 ' HD2' ' OE1' ' A' ' 180' ' ' GLN . 69.3 mtp180 -92.12 -22.79 19.69 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 122.385 -0.479 . . . . 0.0 111.488 -178.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.564 HG11 ' O ' ' A' ' 116' ' ' ALA . 9.8 p -73.31 -27.98 24.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 174.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.922 ' HA ' ' HB ' ' A' ' 127' ' ' VAL . 67.7 mt -78.56 -39.44 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 CA-C-O 121.708 0.766 . . . . 0.0 109.339 171.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.588 ' HA3' ' HB ' ' A' ' 126' ' ' THR . . . 96.44 38.77 4.4 Favored Glycine 0 N--CA 1.442 -0.933 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.312 175.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 66.6 -79.08 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 122.948 0.499 . . . . 0.0 111.296 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -83.92 -24.36 30.77 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.043 0.449 . . . . 0.0 110.238 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 121.56 -1.2 11.25 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.499 -0.857 . . . . 0.0 112.47 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 41.3 tptt -57.87 -45.02 86.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.103 0.477 . . . . 0.0 110.621 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.588 ' HB ' ' HA3' ' A' ' 121' ' ' GLY . 84.2 m -65.2 -46.93 78.72 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.306 -176.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.922 ' HB ' ' HA ' ' A' ' 120' ' ' ILE . 11.6 p -67.83 -35.84 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 121.029 -0.268 . . . . 0.0 111.219 -176.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -65.26 -43.57 90.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.2 0.524 . . . . 0.0 109.989 178.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -68.49 -35.68 77.87 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.102 177.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.668 HD23 HD13 ' A' ' 170' ' ' ILE . 39.4 tp -60.74 -49.53 77.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.817 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.496 ' NE2' ' HA ' ' A' ' 137' ' ' GLU . 39.3 mt-30 -66.65 -32.37 73.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.777 0.322 . . . . 0.0 111.129 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -64.05 -43.6 95.04 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.996 0.427 . . . . 0.0 110.703 175.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 6.7 tt -73.88 -48.11 33.3 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.805 -177.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.631 ' HB ' ' HB2' ' A' ' 166' ' ' ALA . 70.5 p -77.65 -29.98 51.9 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -172.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 65.03 28.17 12.48 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.601 -175.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -121.02 169.37 10.56 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.441 177.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.496 ' HA ' ' NE2' ' A' ' 131' ' ' GLN . 9.0 tp10 -96.18 111.86 23.78 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.835 -178.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.451 ' H ' ' NE2' ' A' ' 131' ' ' GLN . 45.3 t -113.63 107.33 22.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 O-C-N 123.82 0.7 . . . . 0.0 109.391 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.641 HG12 ' HD3' ' A' ' 155' ' ' LYS . 14.9 p -125.87 126.9 70.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.231 0.539 . . . . 0.0 111.63 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.416 HG22 ' HB ' ' A' ' 154' ' ' VAL . 59.9 t -104.94 112.95 65.26 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.906 176.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.603 ' HG3' ' HE3' ' A' ' 155' ' ' LYS . 34.6 Cg_exo -62.01 156.98 46.32 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 123.1 2.533 . . . . 0.0 112.325 177.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -87.4 -26.1 23.48 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.076 -178.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -120.2 115.97 24.68 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.133 178.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.512 ' OE1' ' HB ' ' A' ' 153' ' ' ILE . 22.4 mm-40 -127.77 -86.9 0.57 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.012 0.434 . . . . 0.0 112.034 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -152.77 154.65 31.65 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.299 -175.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.76 165.17 26.59 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.731 2.288 . . . . 0.0 111.2 175.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -69.98 -3.96 18.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.96 -177.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -53.84 -42.57 68.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.277 0.56 . . . . 0.0 110.239 169.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -84.21 -14.12 50.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.832 -179.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 47.27 23.46 0.33 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.024 1.33 . . . . 0.0 112.058 -175.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.457 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 57.8 mt-30 -143.27 142.26 31.3 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 120.994 0.426 . . . . 0.0 111.16 -175.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 19.7 m -131.93 163.46 37.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 174.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.682 HG12 ' HD3' ' A' ' 110' ' ' ARG . 12.8 mt -107.39 141.71 21.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.365 0.602 . . . . 0.0 112.393 -176.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.416 ' HB ' HG22 ' A' ' 140' ' ' VAL . 2.5 p -128.49 139.44 51.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.379 163.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.641 ' HD3' HG12 ' A' ' 139' ' ' VAL . 0.0 OUTLIER -99.44 137.76 37.48 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -176.27 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 65.1 mt -113.5 111.18 34.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 169.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 4.7 mp -113.69 140.84 31.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 156.28 -168.52 33.62 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.113 -1.041 . . . . 0.0 112.636 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.413 ' CD2' HG13 ' A' ' 103' ' ' VAL . 12.1 t-80 -75.55 160.85 29.7 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.602 -0.299 . . . . 0.0 110.374 -178.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.531 ' O ' ' HG2' ' A' ' 164' ' ' GLN . 30.4 t80 -49.39 -50.0 42.28 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -172.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -71.47 -47.44 55.63 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.194 -177.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -59.27 -44.62 92.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.911 0.386 . . . . 0.0 110.845 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.652 ' O ' ' HG3' ' A' ' 167' ' ' GLN . 31.9 t -63.79 -52.1 61.79 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.173 -177.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.531 ' HG2' ' O ' ' A' ' 160' ' ' PHE . 4.0 pt20 -66.96 -35.21 79.46 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.406 -177.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' MET . . . . . 0.526 ' HE2' ' HA ' ' A' ' 134' ' ' THR . 47.1 ttp -64.85 -36.72 85.27 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.068 0.461 . . . . 0.0 109.912 177.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.631 ' HB2' ' HB ' ' A' ' 134' ' ' THR . . . -69.47 -43.11 73.88 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.241 174.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.669 ' O ' ' HG2' ' A' ' 171' ' ' ARG . 80.7 mt-30 -51.47 -56.71 11.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.341 -176.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.4 -29.78 66.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.036 -179.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.804 ' HA ' ' HE2' ' A' ' 169' ' ' LYS . 0.6 OUTLIER -75.17 -36.39 61.5 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 120.862 0.363 . . . . 0.0 110.399 -172.903 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.668 HD13 HD23 ' A' ' 130' ' ' LEU . 1.8 mp -74.61 -42.46 48.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.469 178.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.669 ' HG2' ' O ' ' A' ' 167' ' ' GLN . 0.8 OUTLIER -64.25 -25.62 68.14 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.391 0.615 . . . . 0.0 109.419 179.284 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -73.06 -44.24 60.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.583 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.548 HG13 ' O ' ' A' ' 170' ' ' ILE . 2.8 pp -70.95 -19.22 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.904 -178.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 170' ' ' ILE . 39.3 mt -58.82 -34.82 71.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.035 0.445 . . . . 0.0 110.365 174.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.17 -34.53 78.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.767 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -66.44 -39.06 88.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.22 0.533 . . . . 0.0 109.973 176.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.569 HG21 ' HD3' ' A' ' 118' ' ' ARG . 39.6 t -63.53 -38.96 83.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.229 176.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -63.58 -44.49 93.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.271 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -70.42 -29.17 65.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.197 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.598 ' OE1' ' HD2' ' A' ' 118' ' ' ARG . 49.6 tt0 -73.42 -37.22 65.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.087 0.47 . . . . 0.0 110.18 173.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -63.11 -20.84 65.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.143 -178.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -50.87 -41.12 57.86 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.183 173.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt 49.96 77.29 0.12 Allowed 'General case' 0 N--CA 1.465 0.284 0 O-C-N 124.003 0.814 . . . . 0.0 112.145 169.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 142.09 88.02 0.11 Allowed Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.656 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 56.05 55.12 7.15 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -176.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 19.3 m -56.11 106.4 0.27 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.044 -176.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 137.02 -36.52 1.96 Allowed Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.348 -177.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . 0.44 ' HB3' ' H ' ' A' ' 189' ' ' LEU . 34.1 mm-40 56.88 -150.72 0.43 Allowed 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 122.59 0.356 . . . . 0.0 111.472 177.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.44 ' H ' ' HB3' ' A' ' 188' ' ' GLN . 31.7 tp 62.47 69.5 0.61 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.394 0.616 . . . . 0.0 110.86 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -83.56 67.32 9.36 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.685 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.467 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.754 179.03 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' ' G' . . . . . 0.923 " O2'" ' H6 ' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.427 -0.834 0 C4'-C3'-C2' 106.304 3.604 OUTLIER-EPSILON 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . 0.923 ' H6 ' " O2'" ' B' ' 1' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.422 -1.113 0 P-O3'-C3' 122.133 2.028 OUTLIER-EPSILON 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . 0.799 " H1'" ' C5 ' ' B' ' 4' ' ' ' C' . . . . . . . . 0 C2'--C1' 1.518 -0.999 0 P-O3'-C3' 124.269 3.807 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' ' C' . . . . . 1.053 ' H42' ' HA2' ' A' ' 35' ' ' GLY . . . . . . . . 0 O5'--C5' 1.426 -0.875 0 C4'-C3'-C2' 105.728 3.028 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.826 " O4'" " H4'" ' B' ' 4' ' ' ' C' . . . . . . . . 0 P--O3' 1.616 0.711 0 P-O3'-C3' 121.924 1.853 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' ' C' . . . . . 0.479 ' C5 ' ' C4 ' ' B' ' 7' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.429 -0.674 0 C4'-C3'-C2' 104.859 2.159 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . 0.479 ' C4 ' ' C5 ' ' B' ' 6' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.426 -0.853 0 C3'-C2'-C1' 103.212 1.903 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.847 0 C3'-C2'-C1' 100.7 -0.889 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.73 0 N-CA-C 112.191 -0.364 . . . . 0.0 112.191 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.56 86.89 5.17 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.948 0.404 . . . . 0.0 110.212 178.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 61.5 mtm -115.79 92.17 3.82 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.568 -176.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.403 ' HA2' ' HD3' ' A' ' 5' ' ' PRO . . . 161.19 146.61 4.69 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.093 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.403 ' HD3' ' HA2' ' A' ' 4' ' ' GLY . 40.4 Cg_exo -57.59 115.42 2.5 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.972 2.448 . . . . 0.0 112.041 179.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 53.6 m 60.04 21.21 10.36 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.592 -179.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 43.7 m -96.87 61.39 1.82 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.959 0.409 . . . . 0.0 110.685 -177.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.8 m -70.56 123.66 25.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.368 0.604 . . . . 0.0 111.073 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.5 p -89.31 43.63 1.16 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.506 -176.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 171.69 80.36 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.532 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -91.59 55.88 2.86 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.246 0.546 . . . . 0.0 110.167 177.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.571 ' HB2' ' HD2' ' A' ' 14' ' ' PHE . . . -104.59 114.53 63.95 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.166 -176.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -89.81 31.25 0.38 Allowed 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.974 2.449 . . . . 0.0 112.367 178.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.623 ' HB3' ' HG2' ' A' ' 18' ' ' MET . 88.3 m-85 -92.03 92.93 8.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.811 -177.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 58.0 m -101.98 114.65 28.95 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.342 177.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.1 t 73.11 -56.35 0.66 Allowed 'General case' 0 N--CA 1.465 0.324 0 O-C-N 123.959 0.787 . . . . 0.0 110.991 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -95.39 119.89 34.69 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 177.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.873 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 55.5 mtt -117.79 -60.23 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.114 178.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.873 ' HD3' ' HB2' ' A' ' 18' ' ' MET . 42.4 Cg_exo -57.93 -51.73 7.34 Favored 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 122.203 1.935 . . . . 0.0 114.037 176.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.443 ' HD3' ' HB2' ' A' ' 19' ' ' PRO . 6.3 Cg_exo -73.87 75.23 3.21 Favored 'Trans proline' 0 C--N 1.36 1.141 0 C-N-CA 122.162 1.908 . . . . 0.0 112.723 -177.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.44 ' HG2' ' HE1' ' A' ' 14' ' ' PHE . 47.1 mt-10 -75.09 85.23 2.34 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.472 176.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 -72.16 152.33 42.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.223 177.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -98.1 117.74 33.14 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.183 -178.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 48.3 m -110.57 107.72 17.43 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.82 176.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.528 ' HB ' HD12 ' A' ' 73' ' ' ILE . 34.8 t -117.9 147.87 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.424 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 13.8 m-70 -110.04 123.36 49.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.862 0.363 . . . . 0.0 110.71 -173.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.564 ' HB ' ' HB ' ' A' ' 71' ' ' VAL . 44.4 t -90.36 142.03 13.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.59 -176.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.24 105.16 14.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.469 -177.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.549 ' C ' ' HB ' ' A' ' 68' ' ' VAL . 13.9 pt -127.9 123.47 22.81 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 120.938 0.399 . . . . 0.0 110.929 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.43 ' HA ' HG11 ' A' ' 68' ' ' VAL . 81.4 Cg_exo -48.53 143.53 15.75 Favored 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 123.531 2.821 . . . . 0.0 112.638 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.421 ' HA ' HG12 ' A' ' 34' ' ' VAL . . . -58.08 -18.79 27.14 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.101 -176.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.5 mp0 -65.25 -44.28 88.64 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.401 177.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.733 ' HB2' ' HE2' ' A' ' 96' ' ' PHE . . . -93.71 -29.64 15.3 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.196 -171.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.582 ' HA ' HG12 ' A' ' 37' ' ' ILE . 12.2 p -56.92 -27.64 26.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 O-C-N 123.253 0.346 . . . . 0.0 111.201 -174.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.89 ' HA2' ' H42' ' B' ' 4' ' ' ' C' . . . -56.83 -56.82 22.84 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.235 -0.983 . . . . 0.0 111.076 177.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.417 ' HB1' " C1'" ' B' ' 2' ' ' ' C' . . . -75.95 -15.71 60.13 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.607 -176.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.643 HD11 ' HB3' ' A' ' 90' ' ' LYS . 4.8 mm -61.66 -47.16 94.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.242 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.852 HG23 ' HA2' ' A' ' 42' ' ' GLY . 28.9 mt -63.64 -38.61 82.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.203 177.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 81.83 105.34 0.39 Allowed Glycine 0 CA--C 1.52 0.397 0 N-CA-C 115.554 0.982 . . . . 0.0 115.554 164.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.672 ' HA ' ' OP2' ' B' ' 3' ' ' ' A' . 30.0 mmtp 63.64 -81.29 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 168.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.8 ptmt -123.02 10.12 9.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.931 0.396 . . . . 0.0 110.932 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.852 ' HA2' HG23 ' A' ' 38' ' ' ILE . . . 83.34 16.19 69.67 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.408 -0.901 . . . . 0.0 111.786 -177.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -76.4 -28.6 56.77 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.096 0.474 . . . . 0.0 110.048 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.461 ' HB2' ' O ' ' A' ' 38' ' ' ILE . 38.7 m170 -67.04 -30.67 70.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.699 -173.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.783 HD11 HG12 ' A' ' 58' ' ' ILE . 8.9 tt -76.12 -40.33 36.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -175.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.409 ' HD2' " H5'" ' B' ' 6' ' ' ' C' . 0.0 OUTLIER -79.64 -30.98 41.48 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.124 179.857 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.453 ' OE1' ' HD2' ' A' ' 50' ' ' ARG . 6.3 tp60 -64.48 -33.84 76.83 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 173.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.825 HD12 HG12 ' A' ' 56' ' ' ILE . 0.5 OUTLIER -58.73 -47.14 85.65 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.987 176.407 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.616 ' HA ' HD11 ' A' ' 56' ' ' ILE . 57.1 m -58.26 -31.89 67.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.046 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.453 ' HD2' ' OE1' ' A' ' 47' ' ' GLN . 99.6 mtt180 -73.64 -33.66 64.62 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.584 -178.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.722 ' CD2' ' HA ' ' A' ' 48' ' ' LEU . 24.2 m-85 -62.21 -48.12 81.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.108 0.48 . . . . 0.0 110.761 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -94.42 -10.58 32.05 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.362 -172.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 75.6 m 60.39 40.22 17.66 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.479 0.657 . . . . 0.0 110.259 -173.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -130.7 174.3 10.07 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.533 -178.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.2 t -95.44 107.01 19.14 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.777 0.322 . . . . 0.0 110.262 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.825 HG12 HD12 ' A' ' 48' ' ' LEU . 2.0 mp -110.12 113.1 43.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.032 179.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.41 ' HA ' HD13 ' A' ' 45' ' ' ILE . 53.2 mtmt -138.14 153.31 49.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.291 -179.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.783 HG12 HD11 ' A' ' 45' ' ' ILE . 44.9 mm -90.44 127.32 43.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.924 0.392 . . . . 0.0 110.25 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.906 ' HB1' HG21 ' A' ' 72' ' ' VAL . . . -92.41 115.8 65.39 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.759 -178.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -67.87 131.18 23.41 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.538 2.159 . . . . 0.0 111.371 176.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.405 ' HD3' ' HD3' ' A' ' 69' ' ' ARG . 18.6 Cg_endo -60.09 138.0 79.04 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.54 2.16 . . . . 0.0 110.814 176.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -62.9 -37.73 88.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.084 -176.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.458 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 4.1 p -119.25 136.76 24.66 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.149 175.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 63' ' ' THR . 13.7 Cg_exo -70.18 1.59 4.57 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.722 2.948 . . . . 0.0 113.649 -174.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -99.71 13.24 34.3 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.184 0.516 . . . . 0.0 110.685 -178.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.7 m -78.48 147.18 34.02 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.283 0.563 . . . . 0.0 110.756 178.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -79.48 -32.08 42.48 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.505 -175.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.549 ' HB ' ' C ' ' A' ' 29' ' ' ILE . 1.3 m -123.35 174.79 7.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 121.191 0.52 . . . . 0.0 110.947 -174.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.568 ' HB3' HG21 ' A' ' 34' ' ' VAL . 2.0 tpp85 -118.19 132.54 56.32 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 174.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.48 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 56.1 mtm -91.14 149.5 21.77 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.891 -175.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.564 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 94.3 t -113.17 132.2 62.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 175.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.906 HG21 ' HB1' ' A' ' 59' ' ' ALA . 77.6 t -99.92 111.83 30.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 177.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.8 HG22 HG13 ' A' ' 56' ' ' ILE . 2.5 pp -110.93 128.51 67.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.746 173.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 83.3 m -128.18 106.0 8.75 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.968 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -166.78 164.39 37.74 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.041 -178.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -56.81 136.84 78.71 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 121.859 1.706 . . . . 0.0 109.987 170.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -49.67 -19.58 3.6 Favored 'Trans proline' 0 N--CA 1.48 0.68 0 C-N-CA 123.897 3.065 . . . . 0.0 114.515 -172.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -70.72 -33.07 70.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.0 0.428 . . . . 0.0 110.563 177.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.4 -21.82 48.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.809 -177.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.51 -36.22 64.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.47 176.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.608 ' HA ' ' NE2' ' A' ' 164' ' ' GLN . 69.1 t80 -59.3 -47.09 86.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.469 177.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 36.0 tptt -63.89 -52.56 59.36 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.048 -176.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.69 -53.64 14.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.474 -174.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -71.38 -29.36 64.85 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -172.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -53.59 -36.81 55.13 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 120.365 -0.922 . . . . 0.0 111.739 175.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.44 ' HD2' ' N ' ' A' ' 86' ' ' ARG . 4.5 mpt_? -80.11 -32.02 39.11 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.532 0.197 . . . . 0.0 111.532 177.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -68.5 -44.43 83.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 121.119 -0.232 . . . . 0.0 110.422 -176.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.684 ' HA ' HD23 ' A' ' 91' ' ' LEU . 6.9 m-85 -66.38 -32.97 74.68 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.189 0.519 . . . . 0.0 110.274 177.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -66.02 -28.66 73.85 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.051 177.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.643 ' HB3' HD11 ' A' ' 37' ' ' ILE . 30.7 mmtp -78.43 -17.62 56.09 Favored 'General case' 0 N--CA 1.443 -0.787 0 O-C-N 122.388 -0.478 . . . . 0.0 111.332 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.684 HD23 ' HA ' ' A' ' 88' ' ' TYR . 2.6 mm? -65.34 -34.04 77.38 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 120.223 -0.591 . . . . 0.0 109.876 166.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.882 ' HE3' HG21 ' A' ' 103' ' ' VAL . 10.4 mmtp -72.79 -26.07 61.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.37 177.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.401 ' HB2' ' HA ' ' A' ' 90' ' ' LYS . 8.3 tp10 -63.47 -31.29 72.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.394 178.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.481 ' HG3' ' HA ' ' A' ' 33' ' ' ALA . 20.9 mm-40 -97.65 9.22 43.09 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.039 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 65.3 t30 56.8 41.88 27.42 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.654 176.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.733 ' HE2' ' HB2' ' A' ' 33' ' ' ALA . 41.9 m-85 -83.79 -33.08 25.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.04 0.448 . . . . 0.0 110.237 174.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.684 ' HB2' ' HE2' ' A' ' 92' ' ' LYS . 24.2 m-85 -124.58 24.42 7.85 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.272 -176.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 60.19 175.13 1.07 Allowed Glycine 0 CA--C 1.521 0.429 0 CA-C-N 115.659 -0.7 . . . . 0.0 113.717 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -75.32 -52.13 0.11 Allowed 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.667 2.245 . . . . 0.0 112.083 174.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -100.15 -14.35 18.57 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.871 0.322 . . . . 0.0 111.871 -174.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.57 ' HB3' ' O ' ' A' ' 97' ' ' PHE . 10.8 tp10 -67.41 154.99 40.08 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 177.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -65.13 137.59 57.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.402 -176.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.882 HG21 ' HE3' ' A' ' 92' ' ' LYS . 1.0 OUTLIER -73.96 129.08 36.59 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 172.608 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.6 mmmm -129.4 87.01 2.49 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 172.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.659 ' HB3' ' CE2' ' A' ' 88' ' ' TYR . 2.1 tm? -125.04 141.45 52.12 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -176.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.57 ' H ' HD23 ' A' ' 105' ' ' LEU . 39.8 tt0 -95.47 127.51 41.56 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.578 -170.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.515 HG22 ' NE2' ' A' ' 167' ' ' GLN . 0.1 OUTLIER -108.39 147.66 31.24 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 171.519 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -114.05 119.53 37.48 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.887 0.375 . . . . 0.0 110.088 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.414 ' CG1' ' HB ' ' A' ' 154' ' ' VAL . 23.1 pt -107.43 128.09 62.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.121 177.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.665 ' HD3' HG12 ' A' ' 153' ' ' ILE . 8.8 mmt180 -74.34 123.78 25.25 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.19 177.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.684 HG23 ' HB1' ' A' ' 115' ' ' ALA . 6.4 p -134.07 142.35 42.94 Favored Pre-proline 0 N--CA 1.444 -0.773 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.566 -175.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.459 ' HD2' HG23 ' A' ' 111' ' ' VAL . 31.7 Cg_exo -56.16 149.3 54.78 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 123.114 2.543 . . . . 0.0 111.978 179.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.62 -47.88 69.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.2 0.524 . . . . 0.0 111.066 -178.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.4 m -67.43 -28.9 68.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.661 -177.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.712 ' HB2' HD22 ' A' ' 174' ' ' LEU . . . -67.01 -28.83 68.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.933 -175.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.501 ' HB1' HG21 ' A' ' 152' ' ' VAL . . . -64.66 -27.0 68.63 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.099 0.476 . . . . 0.0 111.225 177.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -79.25 -31.09 43.41 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.664 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.495 ' HD3' HG23 ' A' ' 177' ' ' VAL . 23.1 ttt85 -91.63 -28.63 17.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.081 0.441 . . . . 0.0 111.711 -176.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.2 p -61.14 -24.38 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 121.13 0.491 . . . . 0.0 110.826 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.709 ' HA ' ' HB ' ' A' ' 127' ' ' VAL . 47.1 mm -77.85 -51.43 17.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.158 176.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 71.94 77.66 0.53 Allowed Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.18 -175.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -56.03 -34.51 65.94 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.807 0.336 . . . . 0.0 111.785 -175.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -99.65 22.83 10.35 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.529 -177.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -152.63 -154.95 6.88 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.226 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.526 ' HD2' ' HB2' ' A' ' 129' ' ' GLU . 3.7 pptp? -137.06 25.75 2.99 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.03 0.443 . . . . 0.0 110.048 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.507 ' O ' ' HG ' ' A' ' 130' ' ' LEU . 9.3 t -63.27 -34.58 77.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.022 -173.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.709 ' HB ' ' HA ' ' A' ' 120' ' ' ILE . 9.5 p -67.47 -37.69 79.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-O 121.044 0.449 . . . . 0.0 110.549 177.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.477 ' HA ' ' OE1' ' A' ' 131' ' ' GLN . 3.6 t-20 -74.09 -34.55 64.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.515 0.674 . . . . 0.0 109.579 178.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.526 ' HB2' ' HD2' ' A' ' 125' ' ' LYS . 69.4 tt0 -65.33 -37.46 87.15 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.059 177.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 126' ' ' THR . 87.0 mt -56.78 -48.83 77.0 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.406 173.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.477 ' OE1' ' HA ' ' A' ' 128' ' ' ASN . 80.8 mt-30 -57.35 -45.95 83.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.34 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -71.59 -36.15 70.75 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.834 0.349 . . . . 0.0 111.146 -177.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -73.03 -46.4 52.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.791 -177.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.584 HG21 ' HA ' ' A' ' 166' ' ' ALA . 77.0 p -88.07 -18.07 29.71 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.033 0.382 . . . . 0.0 112.033 -174.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 65.98 22.26 11.26 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 123.847 0.717 . . . . 0.0 110.491 -175.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.523 ' HB2' ' HB2' ' A' ' 162' ' ' ALA . . . -122.3 160.8 24.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.63 -177.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.638 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 10.9 tp10 -88.95 111.73 22.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.487 178.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 54.2 t -104.22 106.04 19.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.582 178.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.446 ' O ' ' HD2' ' A' ' 155' ' ' LYS . 5.0 p -128.7 124.45 61.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.322 0.582 . . . . 0.0 111.156 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.503 ' HB ' HG21 ' A' ' 154' ' ' VAL . 11.2 p -122.14 128.85 25.35 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.71 178.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.618 ' HG3' ' HE3' ' A' ' 155' ' ' LYS . 13.1 Cg_exo -68.24 154.92 71.14 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.552 2.168 . . . . 0.0 111.565 -178.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 -93.8 15.8 15.65 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 176.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.594 ' CG ' ' H ' ' A' ' 144' ' ' GLN . 6.6 p-10 -136.24 -91.06 0.28 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.8 177.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.875 ' HG2' ' H ' ' A' ' 153' ' ' ILE . 6.0 tp-100 58.13 88.88 0.06 Allowed 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.613 0.765 . . . . 0.0 112.351 174.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.602 ' HB ' ' HD2' ' A' ' 146' ' ' PRO . 59.5 p 61.35 161.18 0.11 Allowed Pre-proline 0 N--CA 1.473 0.689 0 C-N-CA 124.225 1.01 . . . . 0.0 112.51 176.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.602 ' HD2' ' HB ' ' A' ' 145' ' ' THR . 57.7 Cg_endo -72.21 157.86 53.03 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.261 1.974 . . . . 0.0 112.285 178.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -73.06 8.87 1.39 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.566 -176.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -57.0 -47.48 80.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.232 0.539 . . . . 0.0 110.143 174.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . 0.485 ' O ' ' HG2' ' A' ' 150' ' ' GLU . 56.1 t30 -90.85 -8.75 48.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.149 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.485 ' HG2' ' O ' ' A' ' 149' ' ' ASN . 9.9 pt-20 45.03 36.82 2.14 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 114.44 -1.254 . . . . 0.0 111.642 178.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -148.2 138.97 23.02 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.573 -176.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.501 HG21 ' HB1' ' A' ' 116' ' ' ALA . 21.3 m -120.22 -176.15 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.92 -174.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.875 ' H ' ' HG2' ' A' ' 144' ' ' GLN . 49.9 mt -134.45 128.89 52.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.306 -176.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.503 HG21 ' HB ' ' A' ' 140' ' ' VAL . 53.9 t -95.82 140.28 17.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 173.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.618 ' HE3' ' HG3' ' A' ' 141' ' ' PRO . 0.0 OUTLIER -104.13 134.92 46.56 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 177.657 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.638 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 70.6 mt -118.95 112.06 36.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.914 177.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.422 HD11 ' N ' ' A' ' 157' ' ' ILE . 4.4 mp -110.47 138.62 37.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.793 -178.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 149.72 -157.13 27.1 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.372 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -81.45 159.8 24.16 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 -177.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.496 ' HB3' ' CB ' ' A' ' 88' ' ' TYR . 7.6 p90 -57.89 -47.86 81.56 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.719 -175.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . 0.414 ' O ' ' HG3' ' A' ' 165' ' ' MET . 19.0 m-85 -54.37 -49.89 68.78 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.626 0.251 . . . . 0.0 110.721 177.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.523 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -58.25 -53.47 57.88 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.578 -178.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.467 ' O ' ' HG3' ' A' ' 167' ' ' GLN . 30.0 m -59.84 -49.69 76.73 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.979 -179.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.608 ' NE2' ' HA ' ' A' ' 81' ' ' PHE . 21.6 mt-30 -56.51 -30.84 63.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.764 178.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' MET . . . . . 0.414 ' HG3' ' O ' ' A' ' 161' ' ' TYR . 91.0 mtp -77.96 -42.67 32.09 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.743 0.306 . . . . 0.0 110.798 175.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.584 ' HA ' HG21 ' A' ' 134' ' ' THR . . . -69.4 -41.56 76.27 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -174.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.515 ' NE2' HG22 ' A' ' 107' ' ' THR . 71.9 mt-30 -51.93 -57.77 8.44 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.961 0.41 . . . . 0.0 111.215 -176.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 21.5 ptt180 -68.21 -28.15 67.0 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.533 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.754 ' HA ' ' HE3' ' A' ' 169' ' ' LYS . 0.1 OUTLIER -69.56 -44.9 69.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.851 0.358 . . . . 0.0 110.393 -177.832 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.576 ' O ' ' HG ' ' A' ' 174' ' ' LEU . 1.8 mp -71.54 -40.46 71.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 177.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 27.2 mmm-85 -58.88 -26.23 64.07 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.147 0.499 . . . . 0.0 110.974 174.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -77.87 -46.55 21.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.966 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.543 HG13 ' O ' ' A' ' 170' ' ' ILE . 2.7 pp -66.28 -18.88 24.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-O 121.0 0.429 . . . . 0.0 110.823 -177.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.712 HD22 ' HB2' ' A' ' 115' ' ' ALA . 17.7 mt -57.37 -27.55 62.39 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.247 175.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.684 ' HA ' ' HD3' ' A' ' 178' ' ' LYS . . . -54.87 -33.46 61.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.515 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -70.22 -33.19 71.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.927 0.394 . . . . 0.0 110.568 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.495 HG23 ' HD3' ' A' ' 118' ' ' ARG . 40.3 t -69.32 -40.39 80.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.389 0.614 . . . . 0.0 109.736 178.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.684 ' HD3' ' HA ' ' A' ' 175' ' ' ALA . 50.9 mtpt -59.95 -50.52 73.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.073 176.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -64.09 -34.67 78.57 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.312 -177.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 23.5 tp60 -60.5 -35.83 76.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.721 -177.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 24.2 m-70 -83.69 -21.13 32.46 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.649 -178.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -85.01 -56.97 3.29 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.003 0.43 . . . . 0.0 110.488 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -93.5 61.48 3.22 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.729 0.776 . . . . 0.0 110.666 -177.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -73.94 127.9 10.6 Favored Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 169.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -61.18 112.29 2.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.141 0.496 . . . . 0.0 111.268 -175.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 2.0 m -81.81 70.43 8.71 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.154 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -65.48 -62.29 4.96 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.554 -178.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -145.83 101.92 3.6 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 62.7 tp -154.44 -51.62 0.09 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.0 -177.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -111.86 115.55 29.2 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.108 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.584 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.695 177.74 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' ' G' . . . . . 0.54 ' C2 ' ' N4 ' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.427 -0.825 0 C3'-C2'-C1' 104.445 3.272 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . 0.807 " O2'" " H5'" ' B' ' 3' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.422 -1.119 0 O4'-C4'-C3' 100.87 -3.307 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . 0.807 " H5'" " O2'" ' B' ' 2' ' ' ' C' . . . . . . . . 0 C2'--C1' 1.517 -1.11 1 P-O3'-C3' 125.846 5.122 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' ' C' . . . . . 0.89 ' H42' ' HA2' ' A' ' 35' ' ' GLY . . . . . . . . 0 O5'--C5' 1.426 -0.879 0 C4'-C3'-C2' 105.708 3.008 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.789 " O5'" " H4'" ' B' ' 4' ' ' ' C' . . . . . . . . 0 P--O3' 1.615 0.667 0 P-O3'-C3' 122.518 2.348 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' ' C' . . . . . 0.562 ' H6 ' " O5'" ' B' ' 6' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.429 -0.715 1 C4'-C3'-C2' 106.72 4.02 OUTLIER-DELTA 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.871 0 O4'-C1'-N19 109.134 0.934 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.427 -0.799 0 O4'-C4'-C3' 103.945 -1.111 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.65 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.08 74.58 1.51 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.855 0.359 . . . . 0.0 111.525 -177.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.44 -56.8 4.24 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 171.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -118.68 153.68 16.86 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 174.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.76 122.22 11.1 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 122.5 2.133 . . . . 0.0 111.667 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.3 p -59.99 118.23 6.02 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.627 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 17.2 m -77.67 79.27 4.16 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.763 -177.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.4 m -93.37 152.99 3.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.555 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.4 m -132.03 78.77 1.83 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.604 177.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -128.46 -62.55 0.12 Allowed Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.479 -177.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -146.67 96.08 2.7 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.005 0.431 . . . . 0.0 110.398 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -117.57 107.77 44.24 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.743 -178.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -74.48 159.36 43.16 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.828 2.352 . . . . 0.0 111.759 178.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -88.63 33.42 0.77 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.735 0.779 . . . . 0.0 109.969 -179.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.5 p -84.13 105.55 15.08 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.82 177.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.3 m -70.73 -17.57 62.81 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.326 -0.397 . . . . 0.0 112.022 -173.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -101.12 63.72 1.01 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.55 0.69 . . . . 0.0 110.363 177.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.684 ' H ' ' HD2' ' A' ' 19' ' ' PRO . 27.1 ttt -163.56 -45.49 0.0 OUTLIER Pre-proline 0 CA--C 1.542 0.654 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.852 -178.146 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.684 ' HD2' ' H ' ' A' ' 18' ' ' MET . 44.5 Cg_exo -37.25 -50.66 1.62 Allowed 'Trans proline' 0 C--N 1.366 1.491 0 C-N-CA 123.432 2.755 . . . . 0.0 116.289 -174.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.473 ' HD3' ' HB2' ' A' ' 19' ' ' PRO . 59.2 Cg_endo -72.56 -28.74 14.05 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 121.323 1.349 . . . . 0.0 113.143 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 66.94 -57.79 0.41 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.911 0.884 . . . . 0.0 112.003 -175.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.499 ' HB2' HG21 ' A' ' 74' ' ' THR . 64.2 mt-30 -132.93 136.49 46.15 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -178.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.424 ' OE1' ' HD3' ' A' ' 77' ' ' PRO . 1.5 mp0 -73.57 113.26 10.48 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.354 0.597 . . . . 0.0 111.619 -174.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.604 ' HG1' HG23 ' A' ' 74' ' ' THR . 4.9 m -92.66 109.56 20.98 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.134 177.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.8 m -124.14 152.9 30.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 10.2 m170 -113.81 132.03 56.02 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -174.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.708 ' HB ' ' CG1' ' A' ' 71' ' ' VAL . 20.8 t -108.2 141.02 24.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.559 -177.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.669 ' CE2' HG12 ' A' ' 68' ' ' VAL . 47.2 t80 -97.6 104.87 16.94 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 123.531 0.732 . . . . 0.0 110.198 -174.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.544 ' C ' HG21 ' A' ' 68' ' ' VAL . 11.1 pt -124.5 116.58 26.68 Favored Pre-proline 0 C--N 1.326 -0.435 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.264 176.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.442 ' HA ' ' HA ' ' A' ' 68' ' ' VAL . 18.7 Cg_endo -58.9 147.98 86.61 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.57 2.847 . . . . 0.0 112.572 -177.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.509 ' HA ' HG12 ' A' ' 34' ' ' VAL . . . -54.08 -25.71 23.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.579 -1.191 . . . . 0.0 112.854 -175.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -70.3 -23.65 62.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.909 0.385 . . . . 0.0 111.182 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.574 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -114.12 -30.8 6.54 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.577 -177.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.516 HG22 ' HB3' ' A' ' 69' ' ' ARG . 13.0 p -51.95 -33.8 16.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 O-C-N 123.24 0.337 . . . . 0.0 111.661 -173.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 1.018 ' HA2' ' H42' ' B' ' 4' ' ' ' C' . . . -57.65 -56.94 22.43 Favored Glycine 0 N--CA 1.439 -1.129 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.974 -179.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.522 ' HA ' " H5'" ' B' ' 3' ' ' ' A' . . . -78.74 -14.19 59.41 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.79 -0.205 . . . . 0.0 111.318 -175.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.574 HG12 ' O ' ' A' ' 33' ' ' ALA . 8.3 mm -61.71 -43.01 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 175.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.795 HD12 ' C5 ' ' B' ' 4' ' ' ' C' . 26.3 mt -55.88 -53.48 37.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.532 176.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.32 113.63 0.45 Allowed Glycine 0 CA--C 1.521 0.462 0 C-N-CA 120.515 -0.85 . . . . 0.0 114.942 168.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 46.4 tptt 48.82 77.64 0.1 Allowed 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.191 0.996 . . . . 0.0 113.009 170.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.645 ' HA ' ' OP2' ' B' ' 4' ' ' ' C' . 0.0 OUTLIER 62.68 7.81 2.68 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.945 173.893 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.557 ' O ' HG23 ' A' ' 45' ' ' ILE . . . 76.58 8.67 86.15 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.122 -1.037 . . . . 0.0 111.759 -177.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.484 ' HA ' ' HE3' ' A' ' 46' ' ' LYS . 50.8 mt-30 -62.87 -43.55 98.5 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.061 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 40.7 m-70 -78.74 -26.62 44.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.695 -177.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.557 HG23 ' O ' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -72.1 -42.52 67.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 120.995 -0.282 . . . . 0.0 110.721 -176.629 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.484 ' HE3' ' HA ' ' A' ' 43' ' ' GLN . 18.9 pttp -81.43 -24.54 36.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.151 0.5 . . . . 0.0 110.425 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -69.26 -30.86 69.07 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.261 174.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.772 ' HA ' ' CE2' ' A' ' 51' ' ' PHE . 6.4 tt -60.77 -38.14 84.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.719 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.619 ' HA ' HD13 ' A' ' 56' ' ' ILE . 22.7 m -62.4 -36.15 81.43 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.035 177.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -69.41 -47.98 62.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.139 -173.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.772 ' CE2' ' HA ' ' A' ' 48' ' ' LEU . 14.2 p90 -71.32 -24.6 62.15 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.235 -174.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -90.78 -9.35 46.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.008 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.2 t 60.58 32.81 20.46 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.724 -178.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -128.17 174.41 9.28 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.305 -176.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.419 ' HB2' ' HB ' ' A' ' 74' ' ' THR . 20.2 m -104.51 101.73 11.38 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.629 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.619 HD13 ' HA ' ' A' ' 49' ' ' SER . 3.2 mp -111.38 122.49 65.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.844 178.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -147.09 142.41 27.36 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.209 178.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.645 ' HB ' ' N1 ' ' B' ' 5' ' ' ' A' . 35.2 mm -75.07 124.45 32.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 177.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.908 ' HB1' HG22 ' A' ' 72' ' ' VAL . . . -77.72 133.64 66.2 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.127 -174.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 59' ' ' ALA . 22.8 Cg_exo -65.33 127.01 17.32 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.817 2.345 . . . . 0.0 112.242 178.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -74.04 168.25 25.24 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.605 2.203 . . . . 0.0 111.6 177.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -79.32 -37.01 38.64 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.875 0.369 . . . . 0.0 110.503 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 68.8 p -127.39 149.38 69.75 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 173.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -69.41 -0.02 6.03 Favored 'Trans proline' 0 CA--C 1.529 0.252 0 C-N-CA 123.001 2.467 . . . . 0.0 113.284 -176.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -116.58 13.89 15.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.687 -0.233 . . . . 0.0 111.235 -178.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 74.8 m -52.96 134.25 37.81 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.247 0.546 . . . . 0.0 111.435 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -70.92 -19.57 62.57 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.697 -177.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.669 HG12 ' CE2' ' A' ' 28' ' ' PHE . 7.4 p -139.01 147.74 24.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 175.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.516 ' HB3' HG22 ' A' ' 34' ' ' VAL . 12.6 ttm180 -123.1 126.62 47.39 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 175.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.847 ' HG3' ' HB2' ' A' ' 59' ' ' ALA . 18.7 ptt? -83.18 146.67 28.49 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.316 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.708 ' CG1' ' HB ' ' A' ' 27' ' ' VAL . 3.5 p -110.08 135.68 48.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 173.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.908 HG22 ' HB1' ' A' ' 59' ' ' ALA . 51.4 t -100.47 110.17 26.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.4 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 10.0 pt -113.23 142.45 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.802 174.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.604 HG23 ' HG1' ' A' ' 24' ' ' THR . 20.5 m -137.34 105.95 5.85 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.987 -176.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -166.96 162.51 36.3 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.93 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -59.71 137.26 75.91 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.398 2.065 . . . . 0.0 110.411 172.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.424 ' HD3' ' OE1' ' A' ' 23' ' ' GLU . 63.8 Cg_exo -40.04 -37.99 1.9 Allowed 'Trans proline' 0 N--CA 1.478 0.584 0 C-N-CA 124.352 3.368 . . . . 0.0 115.517 -171.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -72.29 -43.02 64.85 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 121.798 -0.564 . . . . 0.0 111.275 -178.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.38 -27.72 61.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.449 0.643 . . . . 0.0 109.693 175.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -61.43 -48.51 80.86 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.012 173.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.762 ' HD1' ' HG3' ' A' ' 164' ' ' GLN . 80.6 t80 -59.16 -39.67 83.17 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.833 176.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.6 tptp -53.42 -53.04 57.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.398 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.566 ' HB2' HD22 ' A' ' 48' ' ' LEU . . . -72.0 -47.36 52.59 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.107 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.574 ' O ' HG22 ' A' ' 87' ' ' ILE . 24.5 tt0 -66.93 -31.95 72.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.552 -172.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -57.38 -36.78 78.19 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.285 175.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.447 ' HA ' ' HD3' ' A' ' 86' ' ' ARG . 27.8 mmt180 -80.4 -27.21 38.16 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.668 -0.266 . . . . 0.0 111.239 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.574 HG22 ' O ' ' A' ' 84' ' ' GLN . 0.3 OUTLIER -67.82 -41.78 85.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 178.941 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.603 ' HA ' HD22 ' A' ' 91' ' ' LEU . 7.0 m-85 -68.51 -31.13 70.16 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-O 121.164 0.507 . . . . 0.0 109.889 173.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -61.71 -29.28 71.66 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.474 -0.784 . . . . 0.0 112.119 177.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.483 ' HB3' HD13 ' A' ' 37' ' ' ILE . 73.9 mmtt -66.69 -37.71 85.3 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 177.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.661 ' HB3' ' CE1' ' A' ' 97' ' ' PHE . 3.4 mm? -59.55 -36.75 76.77 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.41 0.624 . . . . 0.0 110.597 174.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.743 ' HE3' ' HB ' ' A' ' 103' ' ' VAL . 0.1 OUTLIER -75.35 -37.82 60.45 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.277 -177.565 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -67.93 -27.48 66.65 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.182 -178.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.428 ' HB3' ' CE2' ' A' ' 96' ' ' PHE . 17.3 mm-40 -89.27 5.27 45.65 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.189 0.519 . . . . 0.0 110.859 178.338 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 58.69 41.14 22.45 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.986 172.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.428 ' CE2' ' HB3' ' A' ' 94' ' ' GLU . 70.2 m-85 -89.98 -9.51 48.43 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.2 0.524 . . . . 0.0 109.921 172.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.661 ' CE1' ' HB3' ' A' ' 91' ' ' LEU . 60.6 m-85 -133.78 -44.45 0.81 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.423 -178.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 125.98 165.08 11.94 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -178.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.88 -66.66 0.04 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.237 0 C-N-CA 122.688 2.259 . . . . 0.0 112.476 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -94.36 -9.45 35.79 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.133 0.419 . . . . 0.0 112.133 -175.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -62.49 144.63 55.76 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 173.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -65.17 137.64 57.76 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.014 -177.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.743 ' HB ' ' HE3' ' A' ' 92' ' ' LYS . 14.8 p -80.46 138.58 19.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.644 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -128.2 90.81 3.14 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 175.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.603 ' HB3' ' CE2' ' A' ' 88' ' ' TYR . 2.3 tm? -133.38 126.3 30.99 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.261 0.553 . . . . 0.0 110.408 -173.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.766 ' HG3' HG13 ' A' ' 157' ' ' ILE . 41.1 mp0 -66.81 133.52 50.27 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.963 -1.017 . . . . 0.0 113.612 -175.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.535 HG22 ' NE2' ' A' ' 167' ' ' GLN . 0.2 OUTLIER -111.97 140.43 46.64 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.142 165.852 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -121.69 119.8 32.84 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 32.8 pt -125.9 153.64 34.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.112 0.482 . . . . 0.0 111.292 -178.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.453 ' HD3' HG12 ' A' ' 153' ' ' ILE . 59.2 mmt-85 -87.31 132.24 34.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.872 -175.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.487 ' O ' ' HG3' ' A' ' 151' ' ' GLN . 5.2 m -129.77 147.09 63.96 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 171.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.676 ' HD2' HD22 ' A' ' 174' ' ' LEU . 31.4 Cg_exo -57.43 145.23 89.2 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.28 1.986 . . . . 0.0 110.911 175.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -51.09 -49.61 60.35 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.787 0.327 . . . . 0.0 111.552 -173.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 36.3 t -65.52 -33.25 75.49 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.137 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.18 -26.69 67.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.007 -178.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.402 ' O ' HG13 ' A' ' 120' ' ' ILE . . . -63.19 -29.18 70.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.268 0.556 . . . . 0.0 110.392 177.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -75.12 -38.21 40.68 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.666 177.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.504 ' HD2' HG21 ' A' ' 177' ' ' VAL . 25.3 ttm180 -74.66 -34.23 62.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.371 0.129 . . . . 0.0 110.997 -178.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.475 HG13 HG22 ' A' ' 140' ' ' VAL . 10.2 p -66.8 -32.17 56.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-O 120.834 0.35 . . . . 0.0 110.579 179.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.402 HG13 ' O ' ' A' ' 116' ' ' ALA . 76.3 mt -72.43 -43.73 63.37 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 CA-C-O 121.277 0.561 . . . . 0.0 109.656 173.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.897 ' HA3' ' HB ' ' A' ' 126' ' ' THR . . . 69.77 53.07 17.07 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 119.918 -1.134 . . . . 0.0 110.639 -174.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -63.2 -16.62 60.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.35 0.595 . . . . 0.0 110.585 -175.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -76.18 -21.56 56.36 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.698 178.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -164.06 -98.97 0.13 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 119.854 -1.165 . . . . 0.0 114.023 -176.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -142.25 28.72 1.67 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -168.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.897 ' HB ' ' HA3' ' A' ' 121' ' ' GLY . 26.1 m -62.91 -46.51 87.48 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -175.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.0 p -67.85 -29.91 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-O 121.017 0.437 . . . . 0.0 110.663 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -63.72 -40.61 97.19 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 177.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -64.45 -41.56 96.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.003 177.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 73.6 mt -60.13 -49.31 78.13 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.621 178.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -64.2 -30.13 71.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.631 -177.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -72.55 -42.59 64.53 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.886 0.375 . . . . 0.0 110.298 177.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 94.4 mt -68.61 -49.67 57.47 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.27 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.4 HG21 ' HA ' ' A' ' 166' ' ' ALA . 74.1 p -82.26 -35.37 28.16 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.317 -171.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 66.97 27.49 8.82 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 123.894 0.746 . . . . 0.0 109.9 -170.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.66 ' HB1' ' HB3' ' A' ' 162' ' ' ALA . . . -122.92 163.95 19.38 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.707 -178.024 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.482 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 9.7 mm-40 -88.25 111.58 21.83 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.421 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 42.8 t -97.75 105.83 17.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.411 ' O ' ' HD2' ' A' ' 155' ' ' LYS . 54.0 t -112.81 111.6 36.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.232 -175.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.475 HG22 HG13 ' A' ' 119' ' ' VAL . 34.8 t -106.03 126.5 30.46 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 177.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.413 ' HG2' ' HB3' ' A' ' 144' ' ' GLN . 88.1 Cg_endo -83.81 143.23 10.51 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.766 2.311 . . . . 0.0 113.358 -174.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 39.7 mmt180 -94.1 -26.88 16.55 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.467 173.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -69.78 -35.44 74.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.036 -0.983 . . . . 0.0 110.567 178.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.413 ' HB3' ' HG2' ' A' ' 141' ' ' PRO . 60.2 tt0 -92.86 90.83 7.16 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 175.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.418 ' N ' ' HD3' ' A' ' 146' ' ' PRO . 16.0 p -145.98 58.01 4.43 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.75 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.471 ' HB2' ' HB3' ' A' ' 148' ' ' GLU . 49.5 Cg_endo -92.8 133.07 1.03 Allowed 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.548 2.165 . . . . 0.0 112.986 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -71.07 -12.88 61.75 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 172.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.471 ' HB3' ' HB2' ' A' ' 146' ' ' PRO . 30.9 tt0 -44.78 -48.55 10.91 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 114.315 -1.312 . . . . 0.0 112.599 178.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -114.75 -0.07 13.67 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.174 -175.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 44.41 32.45 0.72 Allowed 'General case' 0 N--CA 1.474 0.748 0 O-C-N 124.469 1.105 . . . . 0.0 111.045 -172.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.487 ' HG3' ' O ' ' A' ' 111' ' ' VAL . 28.4 tt0 -157.86 142.74 16.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.402 -174.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 31.0 m -133.88 -177.01 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.792 -178.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.453 HG12 ' HD3' ' A' ' 110' ' ' ARG . 55.8 mt -120.48 137.99 52.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.922 0.391 . . . . 0.0 111.726 -178.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.5 p -104.49 138.41 29.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.565 169.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.42 ' HD2' ' H ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -101.23 126.31 47.95 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.664 -177.109 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.509 HD12 ' HB2' ' A' ' 166' ' ' ALA . 58.9 mt -109.24 118.71 57.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.107 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.766 HG13 ' HG3' ' A' ' 106' ' ' GLU . 4.0 mp -114.36 138.33 44.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 143.92 -163.01 27.75 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.525 178.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.523 ' HA ' HG13 ' A' ' 103' ' ' VAL . 10.6 p-80 -83.73 145.1 28.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.73 0.3 . . . . 0.0 110.41 178.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.493 ' HD1' HG11 ' A' ' 103' ' ' VAL . 46.0 p90 -57.72 -24.44 56.91 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -168.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . 0.401 ' HB2' ' HD2' ' A' ' 159' ' ' HIS . 94.2 m-85 -61.43 -44.5 97.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.408 0.623 . . . . 0.0 109.625 174.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.66 ' HB3' ' HB1' ' A' ' 136' ' ' ALA . . . -74.6 -40.27 61.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.073 178.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.457 ' O ' ' HG3' ' A' ' 167' ' ' GLN . 19.3 m -55.21 -51.33 66.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.511 178.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.762 ' HG3' ' HD1' ' A' ' 81' ' ' PHE . 7.8 mm100 -57.79 -45.02 86.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.604 177.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 68.8 mtp -61.45 -40.7 95.44 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.8 0.333 . . . . 0.0 110.893 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.509 ' HB2' HD12 ' A' ' 156' ' ' ILE . . . -69.31 -46.2 67.7 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.163 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.535 ' NE2' HG22 ' A' ' 107' ' ' THR . 62.7 mt-30 -55.31 -52.18 64.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.241 -178.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' A' ' 164' ' ' GLN . 6.7 ptp85 -66.42 -32.32 73.63 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.18 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.975 ' HA ' ' HE3' ' A' ' 169' ' ' LYS . 0.6 OUTLIER -77.24 -42.82 35.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.91 0.386 . . . . 0.0 110.965 -173.58 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.508 ' O ' ' HG ' ' A' ' 174' ' ' LEU . 1.8 mp -70.4 -44.71 77.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.923 177.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -59.26 -25.9 64.47 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.819 0.343 . . . . 0.0 110.566 175.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -73.82 -48.29 32.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.175 -179.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 36.1 pt -66.92 -20.53 27.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.112 -177.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.676 HD22 ' HD2' ' A' ' 112' ' ' PRO . 15.5 mt -59.23 -40.5 86.07 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.911 0.386 . . . . 0.0 110.252 176.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.487 ' O ' ' HG2' ' A' ' 179' ' ' GLN . . . -65.91 -37.39 85.95 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.216 178.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -65.99 -32.19 73.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.887 177.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.504 HG21 ' HD2' ' A' ' 118' ' ' ARG . 75.2 t -73.34 -35.57 46.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.056 0.455 . . . . 0.0 110.207 175.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -64.58 -31.03 72.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.158 0.504 . . . . 0.0 109.904 175.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.487 ' HG2' ' O ' ' A' ' 175' ' ' ALA . 73.3 mm-40 -70.45 -24.35 62.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.622 175.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -68.28 -29.59 68.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.129 0.49 . . . . 0.0 109.843 178.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 -71.26 -31.0 66.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.138 176.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -70.91 -56.65 5.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.645 174.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -159.18 -62.0 0.07 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.763 179.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 87.79 74.71 1.28 Allowed Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.779 -178.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -82.07 147.72 28.96 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 19.8 m 71.14 9.47 6.67 Favored 'General case' 0 N--CA 1.466 0.375 0 O-C-N 123.818 0.698 . . . . 0.0 111.218 -176.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -92.06 157.92 24.5 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.84 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -92.96 103.97 16.24 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 94.5 mt -96.17 137.57 35.05 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.809 -178.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -121.14 62.98 0.88 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.484 0.659 . . . . 0.0 109.536 177.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.514 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.563 179.384 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' ' G' . . . . . 1.038 " O2'" ' H6 ' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.424 -0.981 0 C4'-C3'-C2' 106.576 3.876 OUTLIER-EPSILON 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . 1.038 ' H6 ' " O2'" ' B' ' 1' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.425 -0.945 0 P-O3'-C3' 122.216 2.097 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . 0.753 " H1'" ' C5 ' ' B' ' 4' ' ' ' C' . . . . . . . . 0 C2'--C1' 1.517 -1.081 0 C5'-C4'-O4' 112.522 2.373 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' ' C' . . . . . 1.018 ' H42' ' HA2' ' A' ' 35' ' ' GLY . . . . . . . . 0 O5'--C5' 1.429 -0.712 0 C3'-C2'-C1' 104.362 3.179 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.825 " O5'" " H4'" ' B' ' 4' ' ' ' C' . . . . . . . . 0 P--O3' 1.615 0.689 0 P-O3'-C3' 122.818 2.598 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' ' C' . . . . . 0.619 ' H6 ' " O5'" ' B' ' 6' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.427 -0.828 0 C4'-C3'-C2' 105.04 2.34 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.903 0 C4'-C3'-C2' 105.263 2.563 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.879 0 C3'-C2'-C1' 100.88 -0.688 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.797 0 N-CA-C 112.227 -0.349 . . . . 0.0 112.227 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.57 64.14 4.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.085 0.469 . . . . 0.0 110.784 178.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 82.5 mtp -125.76 123.93 39.9 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.23 -179.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -86.84 159.38 31.52 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.801 -178.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -62.13 156.9 47.4 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.214 2.609 . . . . 0.0 112.118 178.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.1 m 61.04 51.68 4.38 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -174.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 24.8 p -58.7 102.77 0.13 Allowed 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.226 -176.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.446 ' O ' ' HB3' ' A' ' 9' ' ' SER . 27.3 t 58.31 78.41 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.626 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.446 ' HB3' ' O ' ' A' ' 8' ' ' VAL . 42.9 t 76.1 -41.85 0.43 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.853 177.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.92 -19.47 40.96 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.443 -177.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 56.06 51.16 12.37 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 122.946 0.498 . . . . 0.0 111.605 177.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -130.71 80.59 69.55 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.596 -178.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -91.27 116.04 0.45 Allowed 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 123.093 2.529 . . . . 0.0 111.747 174.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -123.36 136.6 54.73 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.153 -177.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 29.1 p -130.72 -76.14 0.53 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.145 178.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.475 ' HB3' ' HG2' ' A' ' 19' ' ' PRO . 70.3 m 58.01 64.39 1.53 Allowed 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 121.095 0.474 . . . . 0.0 110.926 -177.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -85.93 -31.96 21.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.124 -178.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.556 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 70.6 mtm -85.5 -52.69 0.47 Allowed Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -176.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 18' ' ' MET . 4.2 Cg_exo -41.42 -50.3 4.65 Favored 'Trans proline' 0 C--N 1.361 1.202 0 C-N-CA 123.696 2.931 . . . . 0.0 115.777 -178.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -63.06 -27.36 73.74 Favored 'Trans proline' 0 C--N 1.36 1.142 0 C-N-CA 121.918 1.745 . . . . 0.0 113.621 -175.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -106.46 70.54 0.83 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.289 0.566 . . . . 0.0 111.564 -177.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 81.9 mm-40 -110.57 148.3 32.44 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.128 171.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -78.98 141.88 37.12 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.076 -171.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.463 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 29.2 m -131.69 112.45 12.56 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.496 -177.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 28.4 m -125.14 161.68 28.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.839 -178.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -117.44 128.1 54.67 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.618 -175.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.548 ' HB ' ' HB ' ' A' ' 71' ' ' VAL . 8.9 t -97.45 143.14 13.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.198 -179.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.468 ' HE1' ' HE1' ' A' ' 70' ' ' MET . 0.3 OUTLIER -103.86 106.06 16.45 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 122.623 0.369 . . . . 0.0 111.723 -172.573 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.608 ' C ' ' HB ' ' A' ' 68' ' ' VAL . 8.7 pt -130.4 121.41 19.39 Favored Pre-proline 0 C--N 1.326 -0.433 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.856 176.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.651 ' HB2' ' HG2' ' A' ' 32' ' ' GLN . 10.6 Cg_endo -53.27 147.67 35.14 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.699 2.933 . . . . 0.0 112.485 -176.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.46 -21.98 40.57 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.509 -0.768 . . . . 0.0 112.096 -175.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.651 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 11.4 pt20 -71.38 -26.2 62.69 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.589 178.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.569 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -111.8 -30.37 7.33 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 121.167 -0.213 . . . . 0.0 111.545 -172.099 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.663 HG23 ' HB3' ' A' ' 69' ' ' ARG . 9.3 p -52.25 -32.86 16.36 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 O-C-N 123.605 0.566 . . . . 0.0 111.392 -174.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.894 ' HA2' ' N4 ' ' B' ' 4' ' ' ' C' . . . -55.7 -57.93 16.45 Favored Glycine 0 N--CA 1.438 -1.193 0 C-N-CA 120.318 -0.944 . . . . 0.0 111.858 -179.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.809 ' HB1' HO2' ' B' ' 2' ' ' ' C' . . . -77.32 -14.11 59.8 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 120.744 0.307 . . . . 0.0 111.074 -174.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.569 HG12 ' O ' ' A' ' 33' ' ' ALA . 7.9 mm -64.71 -38.87 83.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.116 176.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.87 HD13 ' C5 ' ' B' ' 4' ' ' ' C' . 5.0 mt -54.5 -59.42 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -178.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 131.04 77.82 0.17 Allowed Glycine 0 CA--C 1.52 0.357 0 C-N-CA 119.616 -1.278 . . . . 0.0 114.43 175.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.487 ' HA ' ' OP2' ' B' ' 3' ' ' ' A' . 45.9 tttp 54.13 -80.77 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 170.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -101.1 -6.22 24.64 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.821 0.344 . . . . 0.0 111.048 -173.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.541 ' O ' HG21 ' A' ' 45' ' ' ILE . . . 84.86 -1.88 88.57 Favored Glycine 0 C--O 1.229 -0.215 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.152 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -78.78 -32.26 46.39 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 176.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.412 ' HA ' ' HB3' ' A' ' 47' ' ' GLN . 2.2 m-70 -73.62 -22.12 60.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.066 -176.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.541 HG21 ' O ' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -73.65 -42.89 55.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.728 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.401 ' HD2' " C5'" ' B' ' 6' ' ' ' C' . 7.9 pttp -81.68 -22.5 37.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.286 0.565 . . . . 0.0 109.744 177.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.412 ' HB3' ' HA ' ' A' ' 44' ' ' HIS . 49.2 tt0 -66.44 -33.44 75.72 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 171.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.418 ' HA ' ' HB3' ' A' ' 51' ' ' PHE . 7.0 tt -66.09 -38.5 88.39 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.371 175.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.628 ' HA ' HD11 ' A' ' 56' ' ' ILE . 8.1 t -60.04 -39.17 85.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.628 176.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -68.87 -47.47 65.85 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.062 174.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.418 ' HB3' ' HA ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -58.41 -39.03 78.62 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.984 -1.007 . . . . 0.0 112.007 -178.163 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -91.16 0.89 57.44 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 121.185 -0.206 . . . . 0.0 111.325 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 72.5 p 50.89 31.39 6.1 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.667 0.787 . . . . 0.0 111.964 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -140.14 174.25 10.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.886 -175.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 35.5 m -86.25 101.29 12.92 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.675 0.274 . . . . 0.0 110.596 -178.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.628 HD11 ' HA ' ' A' ' 49' ' ' SER . 2.2 mp -108.6 117.1 53.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.892 178.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.419 ' HG2' " O2'" ' B' ' 6' ' ' ' C' . 42.2 mtmt -134.28 146.81 50.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.562 -177.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.646 ' HB ' ' N1 ' ' B' ' 5' ' ' ' A' . 40.0 mm -90.17 107.47 18.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 173.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.455 ' HB3' ' CG1' ' A' ' 72' ' ' VAL . . . -86.33 126.4 64.78 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.854 -173.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.65 141.04 53.49 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.879 2.386 . . . . 0.0 110.805 172.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.38 131.24 39.67 Favored 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 122.906 2.404 . . . . 0.0 111.994 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -57.4 -32.42 66.82 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.684 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.6 p -124.06 132.51 24.3 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.55 174.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -64.01 -9.02 17.67 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 123.279 2.652 . . . . 0.0 112.765 -177.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -82.62 -12.27 57.79 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.974 -178.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.7 t -67.97 141.35 56.31 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.81 -9.7 57.9 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.505 -173.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.608 ' HB ' ' C ' ' A' ' 29' ' ' ILE . 1.4 m -127.41 176.08 8.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-O 121.225 0.536 . . . . 0.0 111.316 -172.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.663 ' HB3' HG23 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -120.01 139.79 51.96 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 106.471 -1.678 . . . . 0.0 106.471 172.837 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.53 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 61.4 mtt -97.43 149.15 22.46 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.282 -0.567 . . . . 0.0 111.397 -169.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.548 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 70.1 t -104.35 116.22 47.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 171.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.455 ' CG1' ' HB3' ' A' ' 59' ' ' ALA . 11.1 p -108.73 121.6 62.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.357 0.598 . . . . 0.0 110.472 -177.033 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 24' ' ' THR . 0.1 OUTLIER -130.63 142.42 43.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.768 0.794 . . . . 0.0 111.135 179.675 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 47.3 m -122.47 111.57 17.0 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.191 -1.368 . . . . 0.0 109.034 176.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.67 162.36 35.78 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 119.845 -1.169 . . . . 0.0 113.158 -175.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.24 148.54 84.91 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.379 2.052 . . . . 0.0 110.824 170.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -38.35 -46.85 2.4 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 124.152 3.235 . . . . 0.0 114.441 -176.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.507 ' HG3' ' N ' ' A' ' 79' ' ' ALA . 7.6 pt-20 -56.8 -43.97 81.48 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.156 0.503 . . . . 0.0 111.203 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.596 ' HA ' ' HD3' ' A' ' 82' ' ' LYS . . . -71.73 -37.64 70.57 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.006 -175.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -68.93 -26.03 64.88 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.946 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.779 ' HA ' HE22 ' A' ' 164' ' ' GLN . 89.8 t80 -64.4 -54.94 24.86 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.709 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.644 ' H ' ' HD2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -70.02 -32.6 70.84 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.459 -0.497 . . . . 0.0 110.726 -177.681 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.3 -51.54 69.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.753 0.311 . . . . 0.0 110.985 177.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.63 ' HA ' HG22 ' A' ' 87' ' ' ILE . 54.1 mt-30 -66.46 -31.89 72.91 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.269 179.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -59.57 -40.04 95.84 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.332 178.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -80.21 -37.83 32.36 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 122.742 -0.269 . . . . 0.0 111.637 -177.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.63 HG22 ' HA ' ' A' ' 84' ' ' GLN . 0.0 OUTLIER -65.21 -43.83 95.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.662 -176.632 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.579 ' CE2' ' HB3' ' A' ' 105' ' ' LEU . 15.2 m-85 -67.13 -30.15 70.07 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.142 0.496 . . . . 0.0 110.148 176.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -60.04 -32.84 76.88 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.213 176.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.504 ' HB3' HD13 ' A' ' 37' ' ' ILE . 31.7 mmtp -72.63 -26.76 61.78 Favored 'General case' 0 N--CA 1.455 -0.213 0 O-C-N 122.541 -0.388 . . . . 0.0 110.624 177.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.58 ' HG ' ' HG ' ' A' ' 105' ' ' LEU . 4.3 mm? -66.35 -38.55 87.85 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.853 0.359 . . . . 0.0 110.156 171.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.854 ' HE3' ' HB ' ' A' ' 103' ' ' VAL . 0.5 OUTLIER -68.78 -26.52 65.25 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.373 176.124 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -64.32 -40.66 96.34 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.995 -176.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.571 ' HB2' ' CE2' ' A' ' 96' ' ' PHE . 10.4 mm-40 -105.94 0.24 25.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.964 0.411 . . . . 0.0 112.079 -178.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.463 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . 37.2 m-80 57.34 47.83 15.96 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.307 -0.86 . . . . 0.0 112.695 171.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.571 ' CE2' ' HB2' ' A' ' 94' ' ' GLU . 80.1 m-85 -69.98 -43.81 70.71 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -176.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.476 ' HE2' ' HB3' ' A' ' 91' ' ' LEU . 23.1 p90 -81.94 -17.86 45.58 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.009 0.433 . . . . 0.0 111.208 -177.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 127.04 122.73 2.57 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.718 -178.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.463 ' HD3' ' HB3' ' A' ' 95' ' ' ASN . 12.2 Cg_endo -57.12 -38.19 96.2 Favored 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 122.981 2.454 . . . . 0.0 113.422 -177.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 39.5 mmtm -87.8 -3.02 58.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.857 0.36 . . . . 0.0 111.419 -178.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.451 ' HG3' ' O ' ' A' ' 102' ' ' GLU . 9.6 tp10 -95.82 141.15 29.61 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.995 -178.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.479 ' HB3' ' CD2' ' A' ' 159' ' ' HIS . 5.2 tt0 -65.06 145.77 55.88 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 171.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.854 ' HB ' ' HE3' ' A' ' 92' ' ' LYS . 11.5 p -54.52 122.84 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.404 0 CA-C-O 121.733 0.778 . . . . 0.0 112.037 -168.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp -117.68 91.29 3.53 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.568 -1.196 . . . . 0.0 108.865 176.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.58 ' HG ' ' HG ' ' A' ' 91' ' ' LEU . 2.0 tm? -128.58 123.81 34.33 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.208 0.527 . . . . 0.0 109.959 -176.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -58.92 129.46 42.26 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.821 -1.081 . . . . 0.0 112.016 -174.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.44 142.51 46.27 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.16 175.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -122.22 120.11 33.2 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.306 0.574 . . . . 0.0 111.546 -179.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.48 HD13 HD11 ' A' ' 156' ' ' ILE . 22.9 pt -114.61 134.16 58.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.872 176.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.556 ' HD3' HG12 ' A' ' 153' ' ' ILE . 6.9 tpp180 -78.48 138.25 38.35 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.249 -176.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.827 HG21 HD21 ' A' ' 174' ' ' LEU . 6.4 p -141.93 143.0 26.75 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 177.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.421 ' HD2' HG23 ' A' ' 111' ' ' VAL . 24.6 Cg_exo -59.84 150.1 79.57 Favored 'Trans proline' 0 N--CA 1.465 -0.18 0 C-N-CA 122.399 2.066 . . . . 0.0 111.296 176.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -56.3 -51.06 69.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.022 0.439 . . . . 0.0 111.007 -175.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.7 m -68.54 -12.3 61.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.544 -178.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.653 ' HB2' HG23 ' A' ' 111' ' ' VAL . . . -84.68 -14.87 47.2 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.347 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.441 ' O ' HG13 ' A' ' 120' ' ' ILE . . . -65.42 -40.96 93.98 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.039 176.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.32 -32.9 83.37 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.615 -0.802 . . . . 0.0 111.55 176.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.444 ' HD2' HG22 ' A' ' 177' ' ' VAL . 15.2 ttm180 -74.2 -42.42 59.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.673 0.273 . . . . 0.0 110.788 -179.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.487 HG13 HG13 ' A' ' 140' ' ' VAL . 7.4 p -68.93 -30.56 47.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.025 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.668 ' HA ' HG22 ' A' ' 127' ' ' VAL . 72.6 mt -69.62 -39.26 78.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.818 0.818 . . . . 0.0 109.558 171.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 97.06 36.71 4.87 Favored Glycine 0 N--CA 1.438 -1.184 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.551 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 67.33 -73.48 0.08 Allowed 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 123.175 0.59 . . . . 0.0 111.541 -176.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -95.26 -27.03 15.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.672 0.272 . . . . 0.0 110.984 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 135.34 5.49 2.32 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.455 -0.878 . . . . 0.0 113.26 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 23.4 pttp -63.72 -26.27 68.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.967 0.413 . . . . 0.0 111.614 -179.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.565 ' O ' ' HG ' ' A' ' 130' ' ' LEU . 50.0 m -88.3 -32.7 18.33 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.268 -174.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.668 HG22 ' HA ' ' A' ' 120' ' ' ILE . 82.0 t -59.81 -37.9 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-O 121.38 0.61 . . . . 0.0 109.809 173.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -56.09 -42.98 77.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.944 177.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.14 -42.83 72.05 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.145 -179.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.565 ' HG ' ' O ' ' A' ' 126' ' ' THR . 77.6 mt -58.29 -52.05 67.23 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.702 -178.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -66.01 -37.97 87.25 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.928 -175.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -65.27 -36.7 84.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.276 -177.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 60.6 tp -88.11 -48.89 7.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.722 0.296 . . . . 0.0 111.525 -176.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.404 HG23 ' HA ' ' A' ' 166' ' ' ALA . 64.2 p -74.67 -25.19 59.01 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.985 -172.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 60.74 20.94 10.98 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.159 -174.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -113.61 173.12 6.57 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.309 -174.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.621 ' HB3' ' HB ' ' A' ' 157' ' ' ILE . 8.6 tp10 -96.95 114.07 25.66 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.04 175.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 57.3 t -114.84 106.98 21.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.758 -176.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.602 HG11 ' HB2' ' A' ' 155' ' ' LYS . 1.5 p -121.22 121.25 64.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.408 0.623 . . . . 0.0 110.991 177.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.635 ' HB ' HG23 ' A' ' 154' ' ' VAL . 7.7 p -127.12 113.01 21.68 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.631 176.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 1.074 ' HG2' ' HB2' ' A' ' 144' ' ' GLN . 96.1 Cg_endo -90.2 138.0 2.71 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.238 2.625 . . . . 0.0 113.526 -174.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -75.41 -23.31 57.02 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 113.636 -1.62 . . . . 0.0 109.418 175.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -97.67 17.29 18.2 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.951 -178.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 1.074 ' HB2' ' HG2' ' A' ' 141' ' ' PRO . 8.9 tp60 -63.83 -63.28 1.21 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.22 0.533 . . . . 0.0 111.54 -177.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.1 p -146.45 150.6 41.15 Favored Pre-proline 0 C--N 1.316 -0.85 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.124 -174.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.57 165.25 32.49 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.189 2.593 . . . . 0.0 112.309 178.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -78.43 23.83 0.29 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.948 -175.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -70.87 -47.6 58.41 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.487 0.661 . . . . 0.0 109.465 176.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -101.82 0.46 35.72 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.744 177.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 44.88 37.86 2.6 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.441 1.096 . . . . 0.0 112.034 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -147.9 141.0 24.98 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.027 0.441 . . . . 0.0 111.779 -174.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.403 HG23 ' CG1' ' A' ' 111' ' ' VAL . 23.3 m -126.95 -176.02 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.186 -178.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.556 HG12 ' HD3' ' A' ' 110' ' ' ARG . 58.2 mt -132.81 134.94 57.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 O-C-N 122.247 -0.283 . . . . 0.0 110.69 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.635 HG23 ' HB ' ' A' ' 140' ' ' VAL . 89.7 t -92.4 139.09 18.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 174.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.702 ' HE3' ' HG3' ' A' ' 141' ' ' PRO . 0.0 OUTLIER -105.57 117.18 33.37 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.997 0.427 . . . . 0.0 109.964 179.258 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.554 HD13 ' HB1' ' A' ' 166' ' ' ALA . 53.4 mt -100.49 116.66 44.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.072 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.621 ' HB ' ' HB3' ' A' ' 137' ' ' GLU . 3.2 mp -107.32 131.8 56.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 175.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 153.36 -152.68 24.27 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.446 -178.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.479 ' CD2' ' HB3' ' A' ' 102' ' ' GLU . 4.1 m80 -102.7 155.12 18.52 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -175.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.437 ' O ' ' HG3' ' A' ' 164' ' ' GLN . 25.0 p90 -56.0 -36.36 67.83 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.037 0.835 . . . . 0.0 111.797 -172.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . 0.448 ' O ' ' HG2' ' A' ' 165' ' ' MET . 35.8 m-85 -60.2 -48.02 83.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.82 0.343 . . . . 0.0 110.746 175.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -70.39 -36.94 74.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.611 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.425 ' HA ' HG23 ' A' ' 156' ' ' ILE . 68.7 m -57.54 -45.78 84.69 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.413 176.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.779 HE22 ' HA ' ' A' ' 81' ' ' PHE . 96.8 mt-30 -64.39 -33.66 76.37 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.777 0.322 . . . . 0.0 111.152 179.082 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' MET . . . . . 0.448 ' HG2' ' O ' ' A' ' 161' ' ' TYR . 95.9 mmm -63.02 -40.57 98.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.173 176.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.554 ' HB1' HD13 ' A' ' 156' ' ' ILE . . . -74.83 -37.99 62.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.826 178.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -53.33 -56.2 18.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.751 177.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -65.88 -31.45 72.4 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.035 -178.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.708 ' HA ' ' HE3' ' A' ' 169' ' ' LYS . 0.2 OUTLIER -72.95 -54.94 7.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.152 -172.886 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 2.4 mp -72.0 -46.77 58.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.8 0.333 . . . . 0.0 110.424 -177.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.582 ' HA ' ' HG ' ' A' ' 174' ' ' LEU . 24.6 mmm180 -60.99 -24.93 66.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.175 -178.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -71.44 -47.36 56.35 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 111.547 0.203 . . . . 0.0 111.547 177.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.459 HG13 HD23 ' A' ' 174' ' ' LEU . 18.3 pt -66.62 -19.26 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.671 -177.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.827 HD21 HG21 ' A' ' 111' ' ' VAL . 6.7 mt -60.92 -28.78 69.18 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.817 177.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.443 ' O ' ' HG3' ' A' ' 179' ' ' GLN . . . -59.0 -43.12 91.45 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.037 176.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 71.3 mm-40 -60.81 -45.43 94.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.656 176.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.636 HG11 ' HB1' ' A' ' 115' ' ' ALA . 46.7 t -61.38 -41.26 89.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.576 179.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -63.0 -44.44 96.0 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.557 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.443 ' HG3' ' O ' ' A' ' 175' ' ' ALA . 96.9 mt-30 -64.2 -43.58 94.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.755 179.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -75.72 -20.82 58.08 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.424 -178.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 -67.59 -32.72 73.65 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.616 0.246 . . . . 0.0 110.954 -178.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -58.8 -28.65 66.19 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.453 0.644 . . . . 0.0 110.373 177.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 42.4 mtmt -122.37 30.33 6.58 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.659 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -82.5 58.13 5.0 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.896 -173.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 54.77 45.66 26.22 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.514 0.673 . . . . 0.0 110.379 177.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 22.8 t -117.34 90.34 3.31 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.804 -178.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -97.67 163.69 21.68 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.953 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -95.09 92.77 6.99 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.788 0.328 . . . . 0.0 110.15 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -143.65 142.71 31.13 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.55 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 52.75 72.91 0.38 Allowed 'General case' 0 N--CA 1.466 0.36 0 O-C-N 123.904 0.752 . . . . 0.0 111.164 177.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.641 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.638 179.048 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' ' G' . . . . . 0.785 " O2'" ' H6 ' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.428 -0.732 0 C4'-C3'-C2' 106.67 3.97 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . 0.809 HO2' ' HB1' ' A' ' 36' ' ' ALA . . . . . . . . 0 O5'--C5' 1.424 -0.982 0 O4'-C4'-C3' 102.061 -2.457 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . 0.705 " H1'" ' C5 ' ' B' ' 4' ' ' ' C' . . . . . . . . 0 C2'--C1' 1.517 -1.096 0 C5'-C4'-O4' 112.728 2.52 OUTLIER-DELTA 0.0 OUTLIER '7D dist 1z' 0.0 . . . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' ' C' . . . . . 0.894 ' N4 ' ' HA2' ' A' ' 35' ' ' GLY . . . . . . . . 0 O5'--C5' 1.427 -0.793 0 C4'-C3'-C2' 105.703 3.003 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.862 " O5'" " H4'" ' B' ' 4' ' ' ' C' . . . . . . . . 0 P--O3' 1.615 0.675 0 P-O3'-C3' 122.439 2.282 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' ' C' . . . . . 0.65 ' H6 ' " O5'" ' B' ' 6' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.429 -0.717 0 C4'-C3'-C2' 104.67 1.97 . 0.0 OUTLIER '7D dist 1m' 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.428 -0.756 0 C4'-C3'-C2' 104.559 1.859 . 0.104 1[ . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.425 -0.925 0 C3'-C2'-C1' 100.151 -1.499 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 83.2 mm-40 . . . . . 0 N--CA 1.45 -0.471 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -73.74 120.37 19.24 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.081 0.467 . . . . 0.0 110.879 -177.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.633 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 53.1 m -122.87 114.77 20.93 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.61 -176.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.589 HG21 HE21 ' A' ' 167' ' ' GLN . 27.2 m -132.8 161.72 41.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.636 -179.206 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.556 ' HB3' ' HB3' ' A' ' 70' ' ' MET . 13.1 m170 -107.74 113.61 27.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.747 -173.211 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.63 ' O ' ' HA ' ' A' ' 70' ' ' MET . 40.2 t -90.83 123.36 42.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.909 0.385 . . . . 0.0 110.557 -176.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.736 ' CZ ' HG11 ' A' ' 68' ' ' VAL . 2.3 t80 -85.13 104.67 15.23 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.527 -168.343 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.569 ' C ' HG23 ' A' ' 68' ' ' VAL . 18.9 pt -130.3 117.09 17.75 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.424 0.63 . . . . 0.0 110.892 174.161 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.639 ' HB2' ' HG2' ' A' ' 32' ' ' GLN . 51.0 Cg_exo -54.42 153.87 21.33 Favored 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 123.315 2.677 . . . . 0.0 112.505 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.616 ' HA ' HG12 ' A' ' 34' ' ' VAL . . . -56.89 -18.22 12.41 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 114.848 -1.069 . . . . 0.0 112.423 -176.017 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.639 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 30.1 pt20 -72.05 -18.62 61.93 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.94 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.489 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -123.09 -31.82 3.55 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 120.52 -0.472 . . . . 0.0 111.869 -176.418 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.616 HG12 ' HA ' ' A' ' 31' ' ' ALA . 9.1 p -52.56 -34.28 19.07 Favored 'Isoleucine or valine' 0 C--O 1.242 0.675 0 CA-C-O 120.922 0.391 . . . . 0.0 111.715 -172.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.19 -57.11 21.5 Favored Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.355 -178.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.52 -13.46 60.09 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.928 -174.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.657 HD12 ' HB3' ' A' ' 90' ' ' LYS . 3.3 mm -64.28 -39.98 87.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 116.313 -0.403 . . . . 0.0 109.97 176.414 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.645 HG23 HG21 ' A' ' 45' ' ' ILE . 9.1 mt -61.16 -60.05 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.929 176.088 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.574 ' HA3' ' NE2' ' A' ' 44' ' ' HIS . . . 86.48 119.12 1.12 Allowed Glycine 0 CA--C 1.525 0.713 0 C-N-CA 120.288 -0.958 . . . . 0.0 115.393 169.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm 40.43 89.52 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.278 1.431 . . . . 0.0 114.259 169.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.4 ttpt 61.54 5.25 1.18 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.958 175.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.3 29.83 69.88 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.749 -0.738 . . . . 0.0 111.859 -176.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 54.9 tp60 -86.51 -54.71 4.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.532 0.206 . . . . 0.0 111.214 -176.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.574 ' NE2' ' HA3' ' A' ' 39' ' ' GLY . 17.4 p80 -71.64 -21.76 61.78 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.483 -176.227 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.645 HG21 HG23 ' A' ' 38' ' ' ILE . 10.6 tt -68.07 -33.52 61.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 121.131 0.491 . . . . 0.0 110.006 175.133 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.449 ' HE2' ' HA ' ' A' ' 46' ' ' LYS . 0.8 OUTLIER -81.32 -31.62 33.43 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 174.808 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.5 ' HB3' ' HA ' ' A' ' 44' ' ' HIS . 34.1 tt0 -58.58 -36.57 74.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.349 171.309 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.791 HD22 HG12 ' A' ' 56' ' ' ILE . 6.7 tt -61.43 -39.17 89.82 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.271 177.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.693 ' HA ' HD13 ' A' ' 56' ' ' ILE . 17.1 m -61.55 -29.28 69.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.301 177.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 43.8 mtp180 -79.57 -50.89 10.03 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.617 -177.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.742 ' CZ ' ' HA ' ' A' ' 48' ' ' LEU . 1.7 p90 -75.18 -18.99 60.06 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.853 -177.403 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -92.05 -22.47 19.92 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.829 175.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.2 t 65.85 37.2 5.67 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.616 -177.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -132.36 173.41 11.31 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.17 -178.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.805 ' HB3' ' HB ' ' A' ' 74' ' ' THR . 18.6 t -100.5 101.8 12.82 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.791 HG12 HD22 ' A' ' 48' ' ' LEU . 2.1 mp -98.23 111.9 29.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.814 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.503 ' HB2' ' HB ' ' A' ' 72' ' ' VAL . 41.7 mtpt -128.75 154.31 46.5 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.849 -178.097 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.493 HG13 HD11 ' A' ' 38' ' ' ILE . 42.4 mm -110.1 113.31 43.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 174.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.727 ' HB2' HG23 ' A' ' 72' ' ' VAL . . . -71.69 126.16 91.58 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.396 -175.368 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -65.03 143.81 80.05 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.404 2.069 . . . . 0.0 110.341 171.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo . . . . . 0 C--N 1.351 0.694 0 C-N-CA 124.098 3.199 . . . . 0.0 113.497 -176.556 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.4 tmtp? . . . . . 0 C--O 1.232 0.133 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.736 HG11 ' CZ ' ' A' ' 28' ' ' PHE . 2.7 p -154.02 150.91 11.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.327 -167.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.522 ' HD3' HG11 ' A' ' 34' ' ' VAL . 61.2 mtp180 -125.83 129.9 50.31 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 175.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.63 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 3.6 mpp? -94.27 136.88 34.08 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.824 -172.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.599 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 84.6 t -83.61 120.48 34.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 175.334 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.727 HG23 ' HB2' ' A' ' 59' ' ' ALA . 74.4 t -86.88 96.43 5.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.052 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.633 ' O ' ' HA ' ' A' ' 24' ' ' THR . 10.2 tp -93.48 114.57 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 CA-C-O 121.422 0.63 . . . . 0.0 110.162 178.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.805 ' HB ' ' HB3' ' A' ' 55' ' ' SER . 75.3 m -113.27 103.25 11.14 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 173.273 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -168.75 162.91 36.7 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.046 -1.073 . . . . 0.0 112.934 -176.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.457 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 37.9 Cg_endo -67.81 147.66 75.5 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.285 1.99 . . . . 0.0 110.361 169.111 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 76' ' ' PRO . 81.0 Cg_exo -49.85 -27.27 15.44 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 124.092 3.194 . . . . 0.0 113.722 -177.221 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -61.38 -43.06 99.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.425 0.631 . . . . 0.0 110.23 175.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.36 -38.77 41.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.798 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -59.04 -30.58 68.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.14 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.422 ' HA ' ' OE1' ' A' ' 164' ' ' GLN . 55.5 t80 -59.72 -48.92 79.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.53 178.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 17.3 mttt -68.39 -50.78 50.46 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.242 0.544 . . . . 0.0 109.682 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.91 -54.06 49.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.968 -1.014 . . . . 0.0 111.93 -174.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.518 ' O ' HG22 ' A' ' 87' ' ' ILE . 23.8 mt-30 -76.27 -31.07 58.07 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.95 -0.3 . . . . 0.0 111.135 -178.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -59.2 -42.06 97.02 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.295 -0.955 . . . . 0.0 111.589 175.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.457 ' HA ' ' HD3' ' A' ' 86' ' ' ARG . 21.6 mmt180 -79.79 -27.92 40.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.861 -0.169 . . . . 0.0 111.156 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.518 HG22 ' O ' ' A' ' 84' ' ' GLN . 0.3 OUTLIER -68.57 -39.49 80.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.069 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.582 ' HB3' HG21 ' A' ' 103' ' ' VAL . 9.1 m-85 -68.11 -30.17 69.27 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.148 0.499 . . . . 0.0 109.886 173.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -65.69 -28.88 74.05 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.773 175.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.657 ' HB3' HD12 ' A' ' 37' ' ' ILE . 10.9 mptt -70.31 -29.96 66.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.822 0.344 . . . . 0.0 110.372 176.176 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' A' ' 88' ' ' TYR . 4.6 mm? -61.99 -44.97 95.61 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 169.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 1.097 ' HE3' ' HB ' ' A' ' 103' ' ' VAL . 1.8 mptm? -63.44 -30.23 71.39 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.637 176.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -55.31 -46.02 76.27 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.522 -178.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -109.63 -5.78 15.56 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -178.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 61.87 40.53 12.53 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.223 174.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.42 ' CE2' ' HB2' ' A' ' 33' ' ' ALA . 53.2 m-85 . . . . . 0 N--CA 1.467 0.397 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -178.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.436 -1.172 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 1.097 ' HB ' ' HE3' ' A' ' 92' ' ' LYS . 7.6 p -57.28 124.29 10.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 122.136 0.969 . . . . 0.0 111.734 -170.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 35.6 mmtm -126.03 90.44 3.19 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 113.976 -1.466 . . . . 0.0 108.43 176.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.551 ' HB3' ' CE2' ' A' ' 88' ' ' TYR . 2.0 tm? -128.12 125.64 39.58 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.508 0.67 . . . . 0.0 110.525 -175.418 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.52 ' HG3' HG13 ' A' ' 157' ' ' ILE . 2.5 mp0 -71.35 132.11 44.38 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.58 -1.191 . . . . 0.0 112.064 -177.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 20.3 m -119.56 135.16 54.9 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 169.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 10.2 m170 -108.75 120.86 43.71 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.731 0.301 . . . . 0.0 110.329 -177.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.483 HD13 ' HA ' ' A' ' 167' ' ' GLN . 37.4 pt -114.1 136.06 51.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.135 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.608 HH11 HG13 ' A' ' 153' ' ' ILE . 19.5 mmm180 -87.17 119.16 27.12 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.862 -176.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.626 HG12 HD11 ' A' ' 174' ' ' LEU . 19.2 m -123.04 153.33 64.26 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.827 176.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.535 ' HD2' HD22 ' A' ' 174' ' ' LEU . 51.8 Cg_exo -54.33 142.89 67.64 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.221 1.948 . . . . 0.0 111.098 176.169 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.58 ' HA ' HG22 ' A' ' 152' ' ' VAL . . . -50.17 -47.41 54.42 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -170.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 43.8 t -75.1 -28.95 60.47 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.523 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.39 -32.26 73.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.14 -178.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.664 ' O ' HG12 ' A' ' 119' ' ' VAL . . . -64.56 -32.76 74.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.368 0.604 . . . . 0.0 110.231 175.203 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -74.74 -25.32 70.0 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.548 177.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.411 ' HD3' HG22 ' A' ' 177' ' ' VAL . 56.3 ttt180 -92.95 -15.09 26.68 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.722 0.267 . . . . 0.0 111.722 -178.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.664 HG12 ' O ' ' A' ' 116' ' ' ALA . 9.5 p -71.31 -20.88 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 173.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 1.072 ' HA ' ' HB ' ' A' ' 127' ' ' VAL . 71.9 mt -66.35 -25.98 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.953 170.027 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.03 0 CA-C-N 114.993 -1.003 . . . . 0.0 112.219 178.185 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 31.0 mtmm . . . . . 0 N--CA 1.462 0.157 0 CA-C-O 120.979 0.419 . . . . 0.0 110.948 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 23.5 m -65.09 -39.19 92.83 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.642 -170.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 1.072 ' HB ' ' HA ' ' A' ' 120' ' ' ILE . 14.4 p -63.71 -32.73 58.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.028 0.442 . . . . 0.0 111.082 -177.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -71.9 -40.56 68.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.241 0.544 . . . . 0.0 110.237 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -78.67 -25.4 44.87 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.394 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.487 HD23 HG11 ' A' ' 138' ' ' VAL . 25.8 tp -58.59 -45.53 88.89 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 174.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -60.55 -36.03 77.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.068 0.461 . . . . 0.0 110.693 176.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -67.51 -33.03 74.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.407 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -88.16 -43.95 11.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.852 0.358 . . . . 0.0 110.755 -178.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.633 ' HB ' ' HB2' ' A' ' 166' ' ' ALA . 62.0 p -73.65 -22.57 59.93 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.956 -174.195 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 65.08 15.74 10.17 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.044 -178.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.545 ' HB2' ' HB1' ' A' ' 162' ' ' ALA . . . -120.84 168.75 11.12 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.124 -178.288 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.464 ' HB3' ' HB ' ' A' ' 157' ' ' ILE . 23.5 tt0 -93.84 109.71 21.39 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 177.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.487 HG11 HD23 ' A' ' 130' ' ' LEU . 55.0 t -106.29 105.89 19.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.879 -177.164 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.659 HG13 ' HD3' ' A' ' 155' ' ' LYS . 4.8 p -108.76 115.1 48.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.464 0.649 . . . . 0.0 110.605 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 47.0 t -101.68 115.33 65.04 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.125 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.519 ' HG3' ' HE3' ' A' ' 155' ' ' LYS . 84.0 Cg_endo -82.87 155.25 15.28 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.724 2.283 . . . . 0.0 112.608 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 39.8 mmt180 -86.52 -12.65 48.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.071 176.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -116.93 -89.17 0.58 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.795 -178.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.988 ' HG2' ' H ' ' A' ' 153' ' ' ILE . 23.8 tp60 67.43 -77.39 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.04 0.536 . . . . 0.0 111.624 -178.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.1 p -145.31 139.51 15.06 Favored Pre-proline 0 C--N 1.316 -0.851 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -57.19 148.77 67.88 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 122.641 2.227 . . . . 0.0 111.97 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -72.95 8.64 1.46 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.025 -178.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -61.55 -29.22 69.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.574 0.702 . . . . 0.0 109.571 169.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ASN . . . . . 0.413 ' O ' ' HG2' ' A' ' 150' ' ' GLU . 8.6 t-20 -95.94 0.46 51.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.515 177.533 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' A' ' 149' ' ' ASN . 8.8 pt-20 46.46 23.82 0.25 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.91 1.284 . . . . 0.0 112.323 -175.187 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.408 ' HG3' ' O ' ' A' ' 111' ' ' VAL . 34.4 tt0 -152.97 139.49 18.71 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 120.871 0.367 . . . . 0.0 110.706 -171.37 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.58 HG22 ' HA ' ' A' ' 113' ' ' ALA . 17.5 m -132.19 -177.04 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.951 -178.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.988 ' H ' ' HG2' ' A' ' 144' ' ' GLN . 20.5 mt -126.27 141.0 47.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.889 0.376 . . . . 0.0 111.462 -178.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 5.6 p -109.88 138.93 35.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 165.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.659 ' HD3' HG13 ' A' ' 139' ' ' VAL . 0.0 OUTLIER -99.6 129.09 45.72 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.915 -173.668 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.5 HG21 ' HA ' ' A' ' 163' ' ' SER . 59.9 mt -110.86 117.69 55.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.221 179.003 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.52 HG13 ' HG3' ' A' ' 106' ' ' GLU . 3.9 mp -112.27 139.62 36.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.658 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 142.38 -153.2 24.3 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.351 -0.928 . . . . 0.0 112.897 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 17.9 m80 -85.69 158.22 20.11 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -177.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.471 ' HB3' ' CG ' ' A' ' 88' ' ' TYR . 51.4 p90 -63.64 -36.73 84.8 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.459 -175.278 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -54.58 -46.82 73.82 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.384 0.611 . . . . 0.0 110.371 175.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.545 ' HB1' ' HB2' ' A' ' 136' ' ' ALA . . . -68.76 -48.31 64.04 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.854 -178.332 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.5 ' HA ' HG21 ' A' ' 156' ' ' ILE . 41.9 m -56.63 -49.95 73.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.173 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' GLN . . . . . 0.422 ' OE1' ' HA ' ' A' ' 81' ' ' PHE . 18.4 mt-30 -59.64 -39.43 84.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.93 0.395 . . . . 0.0 111.289 -178.094 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 35.9 ttp -72.8 -37.23 67.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.774 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.633 ' HB2' ' HB ' ' A' ' 134' ' ' THR . . . -66.56 -48.68 68.87 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.805 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.589 HE21 HG21 ' A' ' 25' ' ' VAL . 42.2 mt-30 -51.82 -55.79 17.8 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.953 -178.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -64.32 -30.44 71.49 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.635 -174.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.969 ' HA ' ' HE2' ' A' ' 169' ' ' LYS . 3.5 mmpt? -76.82 -40.99 46.02 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.367 -177.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.425 ' O ' ' HG ' ' A' ' 174' ' ' LEU . 17.0 mt -70.89 -42.21 77.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.006 0.431 . . . . 0.0 110.132 176.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -61.46 -27.0 68.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.891 175.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -77.02 -40.43 46.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.4 -177.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.431 ' O ' HG23 ' A' ' 177' ' ' VAL . 18.2 pt -69.46 -26.75 31.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.602 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.626 HD11 HG12 ' A' ' 111' ' ' VAL . 19.3 mt -50.46 -47.74 56.79 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.831 0.348 . . . . 0.0 111.138 177.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.73 -40.52 97.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.787 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -73.68 -30.08 62.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.102 -178.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 173' ' ' ILE . 53.3 t -67.38 -45.82 84.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.27 175.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -63.3 -19.54 64.68 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.678 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 . . . . . 0 CA--C 1.535 0.391 0 CA-C-O 120.895 0.379 . . . . 0.0 111.229 179.888 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 . . . . . 0 C--O 1.235 0.324 0 CA-C-O 121.299 0.571 . . . . 0.0 111.22 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -85.08 103.53 14.17 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.145 -178.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.67 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 8.0 t -120.05 123.12 42.65 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 121.556 0.693 . . . . 0.0 109.572 173.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.543 ' HB ' HG22 ' A' ' 109' ' ' ILE . 27.2 m -126.44 160.94 33.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -106.07 121.41 44.07 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 121.009 -0.277 . . . . 0.0 110.785 -171.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.617 ' O ' ' HA ' ' A' ' 70' ' ' MET . 21.6 t -96.93 128.43 48.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.614 -174.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.43 ' CZ ' HG11 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -90.65 104.84 17.38 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 122.326 0.25 . . . . 0.0 111.232 -171.622 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.474 ' C ' HG23 ' A' ' 68' ' ' VAL . 20.4 pt -126.97 120.06 22.53 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.179 0.514 . . . . 0.0 110.682 175.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.447 ' HA ' ' HA ' ' A' ' 68' ' ' VAL . 38.2 Cg_exo -58.92 152.38 58.41 Favored 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 122.955 2.437 . . . . 0.0 112.8 -177.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.668 ' HA ' HG12 ' A' ' 34' ' ' VAL . . . -60.01 -19.98 55.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.89 -1.05 . . . . 0.0 112.889 -173.026 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -68.54 -24.81 64.68 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.657 ' HB2' ' HE2' ' A' ' 96' ' ' PHE . . . -116.28 -31.03 5.76 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.939 -176.084 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.668 HG12 ' HA ' ' A' ' 31' ' ' ALA . 10.2 p -51.44 -34.96 15.92 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 CA-C-O 120.93 0.395 . . . . 0.0 111.432 -174.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -55.84 -55.91 26.62 Favored Glycine 0 N--CA 1.438 -1.231 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.268 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.25 -14.89 60.55 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 120.987 0.422 . . . . 0.0 111.099 -175.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.952 HD12 ' HB3' ' A' ' 90' ' ' LYS . 3.7 mm -65.98 -39.96 86.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.16 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.566 HG23 HG21 ' A' ' 45' ' ' ILE . 17.7 mt -61.94 -37.8 79.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-O 121.074 0.464 . . . . 0.0 111.392 177.308 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.66 141.21 9.07 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.063 178.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -46.52 -34.18 4.65 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.342 0.657 . . . . 0.0 112.132 -172.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.502 ' HE2' ' HB3' ' A' ' 43' ' ' GLN . 15.4 ptmt -123.09 93.2 3.88 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 166.064 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.46 ' HA2' HG22 ' A' ' 38' ' ' ILE . . . -33.23 88.8 0.01 OUTLIER Glycine 0 C--N 1.338 0.671 0 O-C-N 124.355 1.034 . . . . 0.0 113.673 172.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.502 ' HB3' ' HE2' ' A' ' 41' ' ' LYS . 5.4 tp-100 -176.19 -34.91 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -175.513 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -56.89 -41.8 78.72 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.023 169.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.566 HG21 HG23 ' A' ' 38' ' ' ILE . 8.5 tt -56.99 -34.16 44.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.036 173.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 23.5 mmmt -82.35 -29.96 30.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.594 -178.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.414 ' OE1' ' HD3' ' A' ' 50' ' ' ARG . 46.9 tp60 -62.85 -35.46 80.05 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 170.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.817 ' HG ' ' HE1' ' A' ' 51' ' ' PHE . 7.3 tt -60.98 -42.38 98.24 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.513 173.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 14.9 m -56.74 -34.95 68.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.609 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.414 ' HD3' ' OE1' ' A' ' 47' ' ' GLN . 76.1 mtp180 -72.31 -51.87 18.77 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.693 -176.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.817 ' HE1' ' HG ' ' A' ' 48' ' ' LEU . 3.2 p90 -77.0 -29.98 55.71 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.728 -173.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.606 ' HB1' ' HB2' ' A' ' 83' ' ' ALA . . . -81.73 -12.56 58.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.244 -178.101 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.7 t 61.27 30.07 18.98 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.541 178.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -131.91 159.66 38.0 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.345 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.699 ' HB2' ' HB ' ' A' ' 74' ' ' THR . 19.6 m -91.12 100.46 13.29 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -178.29 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.405 HG13 HD22 ' A' ' 48' ' ' LEU . 33.4 mm -88.4 111.53 22.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.319 -177.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -130.6 137.76 49.8 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.39 176.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.8 mm -94.27 112.35 26.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 172.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.667 ' HB2' HG23 ' A' ' 72' ' ' VAL . . . -67.73 117.73 50.76 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.452 -174.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.53 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 7.5 Cg_exo -73.07 132.02 17.56 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.798 2.332 . . . . 0.0 111.406 176.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.53 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 6.3 Cg_exo . . . . . 0 N--CA 1.456 -0.703 0 C-N-CA 122.706 2.271 . . . . 0.0 111.531 177.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.6 tmtp? . . . . . 0 C--O 1.234 0.251 0 CA-C-O 121.566 0.698 . . . . 0.0 110.475 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.474 HG23 ' C ' ' A' ' 29' ' ' ILE . 2.4 p -144.78 151.91 15.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.724 -171.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.497 ' HD3' HG11 ' A' ' 34' ' ' VAL . 59.3 mtp180 -126.18 132.23 51.83 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 177.539 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.617 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 76.7 mtm -92.26 147.47 22.9 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.873 -175.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.548 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 86.4 t -96.09 124.42 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 172.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.667 HG23 ' HB2' ' A' ' 59' ' ' ALA . 97.5 t -86.8 102.13 11.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 174.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.67 ' O ' ' HA ' ' A' ' 24' ' ' THR . 8.8 tp -101.34 100.18 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 CA-C-O 121.882 0.849 . . . . 0.0 110.252 -177.135 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.699 ' HB ' ' HB2' ' A' ' 55' ' ' SER . 9.4 m -102.61 105.83 16.4 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.688 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -160.35 163.62 34.03 Favored Glycine 0 CA--C 1.497 -1.088 0 C-N-CA 119.674 -1.25 . . . . 0.0 113.254 -174.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.48 ' HD2' ' HB3' ' A' ' 79' ' ' ALA . 7.1 Cg_exo -67.23 136.77 41.55 Favored 'Trans proline' 0 N--CA 1.446 -1.273 0 C-N-CA 121.944 1.763 . . . . 0.0 109.859 170.276 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.573 ' HA ' ' NH2' ' A' ' 168' ' ' ARG . 3.7 Cg_exo -36.78 -50.93 1.4 Allowed 'Trans proline' 0 C--O 1.24 0.614 0 C-N-CA 124.59 3.527 . . . . 0.0 113.684 -176.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -63.81 -49.82 71.39 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.942 0.401 . . . . 0.0 111.174 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.56 ' HB1' ' O ' ' A' ' 52' ' ' ALA . . . -66.87 -34.4 77.72 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.407 -177.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -61.91 -31.22 71.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.73 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -65.77 -42.17 91.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.603 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.3 mtmt -63.02 -37.98 89.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.548 0.689 . . . . 0.0 109.952 -178.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.606 ' HB2' ' HB1' ' A' ' 52' ' ' ALA . . . -69.76 -49.05 56.74 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.534 179.247 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.435 ' O ' HG22 ' A' ' 87' ' ' ILE . 42.9 mt-30 -67.14 -30.81 70.91 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -177.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -56.99 -35.19 67.7 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.848 175.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.4 mmt180 -79.44 -36.76 38.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.576 0.227 . . . . 0.0 111.154 177.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.543 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 0.3 OUTLIER -67.75 -40.87 84.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.738 -174.93 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.745 ' HA ' HD23 ' A' ' 91' ' ' LEU . 6.7 m-85 -68.33 -32.04 71.88 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.056 0.455 . . . . 0.0 110.292 175.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -61.44 -28.91 70.29 Favored Glycine 0 C--O 1.224 -0.526 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.709 174.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.952 ' HB3' HD12 ' A' ' 37' ' ' ILE . 69.3 mmtt -66.99 -38.87 86.82 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 122.827 0.451 . . . . 0.0 111.002 174.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.745 HD23 ' HA ' ' A' ' 88' ' ' TYR . 3.2 mm? -60.49 -38.36 84.04 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.157 0.504 . . . . 0.0 110.555 173.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.984 ' HE3' ' HB ' ' A' ' 103' ' ' VAL . 3.6 mmtp -76.44 -26.54 55.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.502 178.369 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -68.43 -30.92 69.91 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.472 -175.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.583 ' OE1' ' HA ' ' A' ' 94' ' ' GLU . 4.4 mm-40 -96.42 10.7 37.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.307 0.575 . . . . 0.0 110.799 177.265 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 63.2 t30 57.2 45.52 20.37 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 114.757 -1.11 . . . . 0.0 112.143 172.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.657 ' HE2' ' HB2' ' A' ' 33' ' ' ALA . 61.2 m-85 . . . . . 0 C--N 1.324 -0.54 0 CA-C-O 121.148 0.499 . . . . 0.0 110.243 174.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 . . . . . 0 N--CA 1.454 -0.268 0 CA-C-O 120.726 0.298 . . . . 0.0 110.726 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.984 ' HB ' ' HE3' ' A' ' 92' ' ' LYS . 7.1 p -76.45 122.83 31.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 172.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -124.53 90.31 3.23 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 176.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.594 ' HB3' ' CE2' ' A' ' 88' ' ' TYR . 1.8 tm? -118.86 130.81 55.95 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.869 -173.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.865 ' HG2' HG13 ' A' ' 157' ' ' ILE . 32.0 mt-10 -73.5 126.89 31.25 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.188 -0.915 . . . . 0.0 112.743 -176.155 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.81 125.5 54.16 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 167.012 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 21.5 m170 -107.81 121.49 44.83 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -177.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.543 HG22 ' HB ' ' A' ' 25' ' ' VAL . 10.4 pt -113.83 147.24 17.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 177.102 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.896 ' HG3' ' HG2' ' A' ' 151' ' ' GLN . 4.2 tpt180 -97.88 118.65 34.92 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -176.148 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.708 HG12 HD22 ' A' ' 174' ' ' LEU . 11.1 m -116.82 150.1 45.2 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 178.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.641 ' CD ' HD13 ' A' ' 174' ' ' LEU . 44.8 Cg_exo -49.77 149.66 10.42 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 123.217 2.612 . . . . 0.0 112.341 177.472 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -48.6 -49.15 38.11 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -171.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 23.1 t -85.93 -19.74 30.04 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.839 0.352 . . . . 0.0 110.921 -176.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.443 ' O ' HG23 ' A' ' 119' ' ' VAL . . . -65.66 -26.08 67.63 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.521 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.517 ' O ' ' HB ' ' A' ' 119' ' ' VAL . . . -63.51 -34.44 77.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.59 177.309 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -67.66 -32.91 79.34 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.852 -0.689 . . . . 0.0 111.473 177.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.471 ' HD3' HG22 ' A' ' 177' ' ' VAL . 26.1 mtp180 -83.77 -6.8 59.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.488 -0.356 . . . . 0.0 110.609 176.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.713 HG22 HD11 ' A' ' 173' ' ' ILE . 12.0 t -75.11 -51.19 22.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.331 0.586 . . . . 0.0 109.788 172.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 1.015 ' HA ' ' HB ' ' A' ' 127' ' ' VAL . 20.2 pt -81.12 -34.22 13.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.946 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.479 ' HA3' HG22 ' A' ' 126' ' ' THR . . . . . . . . 0 N--CA 1.444 -0.825 0 C-N-CA 120.98 -0.628 . . . . 0.0 111.891 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? . . . . . 0 N--CA 1.456 -0.165 0 CA-C-O 120.669 0.271 . . . . 0.0 111.25 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.631 ' O ' ' HG ' ' A' ' 130' ' ' LEU . 8.1 t -76.79 -20.22 56.68 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.756 -174.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 1.015 ' HB ' ' HA ' ' A' ' 120' ' ' ILE . 8.8 p -69.25 -29.21 41.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 176.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -65.95 -41.04 91.77 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.494 174.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.33 -48.76 80.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.761 173.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.631 ' HG ' ' O ' ' A' ' 126' ' ' THR . 87.7 mt -58.02 -50.47 73.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.457 -177.274 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -62.0 -49.69 75.04 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -176.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -77.81 -11.3 59.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.794 -173.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 59.5 tp -97.46 -49.34 4.94 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.749 0.309 . . . . 0.0 110.96 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 82.1 p -79.62 -20.2 47.39 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.85 -173.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 66.2 27.47 10.31 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.875 0.735 . . . . 0.0 110.168 -174.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -127.33 176.21 7.6 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.528 -177.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.546 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 7.3 tp10 -108.74 111.4 23.14 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.845 177.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.49 HG21 HD11 ' A' ' 170' ' ' ILE . 46.2 t -108.41 106.24 20.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 177.069 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.698 HG13 ' HD3' ' A' ' 155' ' ' LYS . 5.1 p -123.16 125.33 71.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.351 0.596 . . . . 0.0 111.819 -175.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.415 ' HA ' ' HD2' ' A' ' 141' ' ' PRO . 89.3 t -92.8 118.1 67.8 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 173.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 140' ' ' VAL . 9.6 Cg_endo -50.72 137.71 41.78 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 123.811 3.007 . . . . 0.0 113.25 -171.472 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.539 ' HA ' ' NE ' ' A' ' 142' ' ' ARG . 4.6 mmp_? -81.64 -28.99 33.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.309 178.169 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -93.56 62.89 3.37 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 163.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -57.93 139.31 54.6 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.607 -1.179 . . . . 0.0 111.438 -171.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 30.2 p -59.13 130.47 86.83 Favored Pre-proline 0 N--CA 1.448 -0.542 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.292 173.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.448 ' C ' ' H ' ' A' ' 148' ' ' GLU . 17.8 Cg_endo -58.27 150.98 63.2 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.684 2.256 . . . . 0.0 112.226 -175.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -78.24 35.32 0.22 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.321 0.582 . . . . 0.0 110.751 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.448 ' H ' ' C ' ' A' ' 146' ' ' PRO . 24.0 tt0 -52.26 -47.15 65.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.019 177.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -109.15 25.01 12.3 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.314 178.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 49.48 31.34 3.95 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.854 1.262 . . . . 0.0 112.544 178.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.896 ' HG2' ' HG3' ' A' ' 110' ' ' ARG . 44.5 tt0 -156.68 136.12 12.22 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.141 -177.361 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 32.6 m -122.41 169.32 13.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.007 0.432 . . . . 0.0 111.716 -172.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 10.7 mm -102.27 142.76 15.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.098 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 4.1 p -127.97 140.04 50.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.939 171.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.698 ' HD3' HG13 ' A' ' 139' ' ' VAL . 0.0 OUTLIER -96.77 130.4 44.03 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.738 -174.685 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.546 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 76.0 mt -114.43 111.53 36.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 172.255 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.865 HG13 ' HG2' ' A' ' 106' ' ' GLU . 4.2 mp -110.05 131.69 60.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.12 -177.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 163.82 -164.0 36.14 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.313 -0.946 . . . . 0.0 112.53 177.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.585 ' HA ' HG13 ' A' ' 103' ' ' VAL . 5.1 m80 -79.07 160.07 27.25 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.544 ' HB3' ' CG ' ' A' ' 88' ' ' TYR . 13.5 p90 -57.43 -33.3 67.75 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 118.561 0.619 . . . . 0.0 112.028 -175.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -61.86 -52.95 62.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.522 0.677 . . . . 0.0 110.112 175.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -65.59 -41.65 92.59 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.808 -175.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.48 ' O ' ' HG3' ' A' ' 167' ' ' GLN . 26.2 p -68.08 -49.13 63.16 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.318 -176.057 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -61.62 -31.63 71.72 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.708 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 25.6 ttt -66.83 -45.66 77.56 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.036 0.446 . . . . 0.0 110.301 176.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.533 ' HB3' HG21 ' A' ' 156' ' ' ILE . . . -71.16 -35.31 71.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.833 -177.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.48 ' HG3' ' O ' ' A' ' 163' ' ' SER . 24.7 mt-30 -51.54 -56.58 12.64 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.005 0.431 . . . . 0.0 110.807 -179.077 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.662 ' HA ' ' HB2' ' A' ' 171' ' ' ARG . 0.4 OUTLIER -74.09 -27.18 60.77 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.498 178.812 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.616 ' HA ' ' HE3' ' A' ' 169' ' ' LYS . 0.2 OUTLIER -64.52 -49.76 70.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.064 0.459 . . . . 0.0 109.992 -179.245 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.562 HG23 HG22 ' A' ' 119' ' ' VAL . 2.0 mp -71.87 -35.24 53.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.755 177.075 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.729 ' HA ' HD23 ' A' ' 174' ' ' LEU . 1.0 OUTLIER -56.58 -33.82 66.55 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.38 172.894 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.49 -44.13 45.53 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.73 0.271 . . . . 0.0 111.73 -178.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.713 HD11 HG22 ' A' ' 119' ' ' VAL . 2.7 pp -68.58 -30.86 48.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.61 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.729 HD23 ' HA ' ' A' ' 171' ' ' ARG . 0.3 OUTLIER -71.89 -37.59 70.11 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.624 0.726 . . . . 0.0 109.278 174.191 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -58.01 -32.21 67.7 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.981 -1.008 . . . . 0.0 111.067 176.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -61.36 -33.74 74.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.082 0.468 . . . . 0.0 110.113 174.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.471 HG22 ' HD3' ' A' ' 118' ' ' ARG . 22.0 t -73.8 -29.41 26.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.358 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -63.83 -34.85 78.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.005 0.431 . . . . 0.0 110.44 175.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 . . . . . 0 C--N 1.326 -0.436 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.238 -174.672 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.505 ' HB3' HG22 ' A' ' 74' ' ' THR . 97.1 mt-30 . . . . . 0 N--CA 1.452 -0.326 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -73.27 143.67 46.96 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.679 -174.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 44.8 m -115.16 107.45 15.32 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.509 0.671 . . . . 0.0 110.774 -176.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.0 t -106.96 148.41 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.429 ' HB3' ' SD ' ' A' ' 70' ' ' MET . 15.9 m-70 -113.74 146.51 39.77 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -174.483 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.695 ' HB ' HG22 ' A' ' 71' ' ' VAL . 7.4 t -124.26 142.79 39.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 120.912 0.387 . . . . 0.0 111.173 -174.645 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.754 ' CE2' HG11 ' A' ' 68' ' ' VAL . 45.4 t80 -97.58 105.27 17.39 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.088 0.955 . . . . 0.0 110.269 -176.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.53 ' C ' HG23 ' A' ' 68' ' ' VAL . 17.6 pt -124.07 120.22 26.43 Favored Pre-proline 0 C--N 1.324 -0.53 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.766 174.338 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.612 ' HA ' ' HA ' ' A' ' 68' ' ' VAL . 18.0 Cg_endo -57.96 150.73 62.19 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 122.966 2.444 . . . . 0.0 112.05 -176.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.62 ' HA ' HG12 ' A' ' 34' ' ' VAL . . . -60.17 -19.64 54.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.082 -174.085 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -69.96 -22.99 63.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.214 177.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.457 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -113.59 -31.79 6.39 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 120.889 -0.325 . . . . 0.0 111.625 -175.158 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.62 HG12 ' HA ' ' A' ' 31' ' ' ALA . 11.7 p -55.58 -31.23 28.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 O-C-N 123.431 0.457 . . . . 0.0 111.714 -171.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.71 -57.58 18.84 Favored Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.019 -178.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.43 -13.73 59.7 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 120.673 0.273 . . . . 0.0 111.368 -175.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.594 HD12 ' HB3' ' A' ' 90' ' ' LYS . 2.1 mm -65.49 -36.43 77.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 177.405 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.497 HG22 ' HA2' ' A' ' 42' ' ' GLY . 37.8 mt -63.99 -52.64 53.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.012 173.315 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 81.7 106.37 0.37 Allowed Glycine 0 CA--C 1.523 0.549 0 N-CA-C 115.131 0.812 . . . . 0.0 115.131 168.077 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.0 tptt 42.16 89.51 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.841 1.256 . . . . 0.0 113.757 169.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.427 ' HG2' ' O ' ' A' ' 41' ' ' LYS . 21.0 ttpt 66.85 -0.35 1.68 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.702 0.801 . . . . 0.0 111.947 176.113 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.497 ' HA2' HG22 ' A' ' 38' ' ' ILE . . . 84.96 18.92 60.27 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.274 -0.965 . . . . 0.0 111.398 -175.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -67.84 -47.21 69.61 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.989 0.423 . . . . 0.0 110.076 178.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 64.0 m-70 -68.29 -39.59 82.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.753 -172.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.0 tt -62.51 -47.31 93.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.719 0.295 . . . . 0.0 111.775 -178.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.2 ptmm? -81.43 -22.87 37.89 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.924 -177.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -64.81 -39.21 93.22 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 169.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.637 ' HA ' ' CZ ' ' A' ' 51' ' ' PHE . 7.8 tt -61.95 -42.12 98.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.931 177.102 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.642 ' HA ' HD13 ' A' ' 56' ' ' ILE . 44.0 t -53.98 -34.85 60.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.687 177.122 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -76.85 -50.96 12.17 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.661 -177.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.637 ' CZ ' ' HA ' ' A' ' 48' ' ' LEU . 2.4 p90 -76.77 -11.42 59.83 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 119.995 -0.682 . . . . 0.0 111.85 -175.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -96.36 -18.53 19.88 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.73 0.3 . . . . 0.0 110.975 176.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.7 t 65.32 34.36 8.35 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.698 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -141.18 168.93 18.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.291 -176.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.665 ' HB2' ' HB ' ' A' ' 74' ' ' THR . 29.9 m -90.71 103.26 15.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.743 0.306 . . . . 0.0 110.679 -178.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.642 HD13 ' HA ' ' A' ' 49' ' ' SER . 2.4 mp -107.21 113.13 42.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.035 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -134.64 157.76 45.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.794 -177.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 40.8 mm -97.6 135.7 31.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 174.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.864 ' HB2' HG23 ' A' ' 72' ' ' VAL . . . -92.5 140.58 24.08 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-O 120.642 0.258 . . . . 0.0 110.772 -178.122 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 59' ' ' ALA . 21.9 Cg_exo -65.63 120.8 8.04 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.794 2.33 . . . . 0.0 111.495 175.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo . . . . . 0 N--CA 1.461 -0.436 0 C-N-CA 122.325 2.017 . . . . 0.0 111.733 -179.058 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.738 0.304 . . . . 0.0 111.74 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.754 HG11 ' CE2' ' A' ' 28' ' ' PHE . 7.7 p -137.23 150.99 26.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-O 120.925 0.393 . . . . 0.0 110.602 -175.087 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.616 ' HB3' HG21 ' A' ' 34' ' ' VAL . 18.6 ttm180 -122.21 121.88 37.86 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 174.343 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.454 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 44.5 ttp -79.83 148.11 31.51 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.134 -178.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.695 HG22 ' HB ' ' A' ' 27' ' ' VAL . 21.8 m -115.19 145.64 20.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.716 0.293 . . . . 0.0 110.555 175.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.864 HG23 ' HB2' ' A' ' 59' ' ' ALA . 58.3 t -107.8 111.11 34.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.15 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.578 ' O ' HD12 ' A' ' 73' ' ' ILE . 2.7 pp -118.77 125.32 74.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.817 0.818 . . . . 0.0 111.133 176.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.665 ' HB ' ' HB2' ' A' ' 55' ' ' SER . 59.4 m -107.04 106.03 16.35 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.786 176.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.03 134.58 7.4 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 119.995 -1.098 . . . . 0.0 113.464 -172.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -69.42 151.03 70.95 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.057 1.838 . . . . 0.0 110.247 167.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -38.13 -49.07 2.28 Favored 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 124.862 3.708 . . . . 0.0 115.407 -173.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -71.3 -49.97 37.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.875 0.369 . . . . 0.0 110.132 -178.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.59 -27.19 68.78 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.806 -177.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -53.9 -42.56 68.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.307 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -72.5 -34.65 67.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.844 -177.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 15.4 tppt? -64.99 -47.83 76.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.714 -178.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.0 -53.13 19.06 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.868 -177.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.547 ' O ' HG22 ' A' ' 87' ' ' ILE . 6.5 tt0 -72.18 -30.23 64.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.386 -173.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -56.29 -34.76 63.48 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.508 177.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -76.7 -36.85 56.95 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 1.005 ' HA ' ' HD3' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -70.41 -30.31 42.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.804 -174.492 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.419 ' HA ' HD12 ' A' ' 105' ' ' LEU . 7.4 m-85 -66.94 -30.67 70.87 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.166 0.508 . . . . 0.0 109.752 171.32 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -61.87 -29.22 71.76 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.867 175.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 1.005 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 5.2 mptp? -60.0 -45.79 91.58 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.909 0.385 . . . . 0.0 109.999 173.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.404 ' HB2' ' O ' ' A' ' 88' ' ' TYR . 3.6 mm? -57.23 -37.67 72.62 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.591 176.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.985 ' HE3' ' HB ' ' A' ' 103' ' ' VAL . 11.4 mmtp -75.26 -24.43 57.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.028 -176.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -69.47 -44.39 71.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.705 0.288 . . . . 0.0 111.407 -176.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.681 ' HB2' ' CE2' ' A' ' 96' ' ' PHE . 22.7 mm-40 -108.2 1.81 22.37 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 52.27 47.9 23.77 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.269 177.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.681 ' CE2' ' HB2' ' A' ' 94' ' ' GLU . 71.8 m-85 . . . . . 0 N--CA 1.467 0.405 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.442 -177.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 . . . . . 0 CA--C 1.519 -0.243 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.985 ' HB ' ' HE3' ' A' ' 92' ' ' LYS . 9.8 p -68.12 123.37 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 C-N-CA 118.392 -1.323 . . . . 0.0 109.328 174.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 158' ' ' GLY . 30.3 mmtp -130.75 89.68 2.79 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.43 177.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.419 HD12 ' HA ' ' A' ' 88' ' ' TYR . 0.9 OUTLIER -109.02 115.94 31.04 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -177.473 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.488 ' O ' ' HB3' ' A' ' 28' ' ' PHE . 33.5 tt0 -71.26 116.52 11.67 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.021 -176.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -101.66 144.25 30.61 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.053 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 -124.84 120.98 33.25 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.083 0.468 . . . . 0.0 110.785 -177.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 16.2 pt -121.17 138.15 52.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.144 0.497 . . . . 0.0 111.062 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.618 ' HD3' HG12 ' A' ' 153' ' ' ILE . 9.6 mmt85 -82.66 119.02 23.76 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.442 177.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.956 HG23 HD11 ' A' ' 174' ' ' LEU . 6.0 p -121.69 143.11 37.39 Favored Pre-proline 0 C--N 1.318 -0.783 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.481 ' HD2' ' HG ' ' A' ' 174' ' ' LEU . 50.7 Cg_exo -53.42 140.03 64.16 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.259 1.972 . . . . 0.0 110.111 177.217 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.68 -28.51 68.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.179 0.514 . . . . 0.0 110.761 -174.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.2 p -75.89 -34.5 59.97 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.461 176.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.525 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -71.89 -20.35 61.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.973 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.421 ' HB2' HG21 ' A' ' 152' ' ' VAL . . . -59.48 -32.65 70.45 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.236 0.541 . . . . 0.0 110.446 176.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -73.43 -39.63 50.17 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.576 175.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.544 ' HD3' HG22 ' A' ' 177' ' ' VAL . 45.5 mtp180 -73.41 -34.64 65.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.486 0.184 . . . . 0.0 111.459 -177.24 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.546 HG11 HG21 ' A' ' 140' ' ' VAL . 14.0 p -69.73 -36.43 70.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.923 0.392 . . . . 0.0 110.376 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.972 ' HA ' ' HB ' ' A' ' 127' ' ' VAL . 75.5 mt -75.11 -31.4 24.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.651 0.739 . . . . 0.0 109.449 174.345 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.096 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 179.637 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt . . . . . 0 C--O 1.234 0.283 0 CA-C-O 120.884 0.373 . . . . 0.0 110.422 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 11.0 m -60.09 -46.15 90.55 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.246 -175.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.972 ' HB ' ' HA ' ' A' ' 120' ' ' ILE . 9.9 p -68.82 -33.89 61.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.266 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -60.71 -42.56 97.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.346 0.593 . . . . 0.0 109.533 176.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -61.08 -48.89 79.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.844 175.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 91.4 mt -58.6 -49.37 77.73 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.09 -177.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -58.52 -43.88 89.31 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 123.14 0.275 . . . . 0.0 111.575 -174.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -81.13 -33.26 33.33 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 121.061 -0.256 . . . . 0.0 111.344 -178.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.34 -48.74 74.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.098 0.475 . . . . 0.0 110.009 178.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.621 HG21 ' HA ' ' A' ' 166' ' ' ALA . 66.7 p -85.6 -18.06 34.41 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.762 -174.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 63.6 29.32 15.19 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.523 -175.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -127.44 170.17 12.84 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.4 -177.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.448 ' HB3' ' HB ' ' A' ' 157' ' ' ILE . 10.1 tp10 -95.77 113.61 25.26 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 177.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 59.1 t -110.8 105.97 19.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.939 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.637 HG22 ' HD3' ' A' ' 141' ' ' PRO . 6.3 p -125.25 128.34 72.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.348 177.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.894 HG22 HG13 ' A' ' 154' ' ' VAL . 2.3 t -130.75 81.55 67.08 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 121.02 0.438 . . . . 0.0 110.723 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.809 ' HD2' ' HE3' ' A' ' 155' ' ' LYS . 51.6 Cg_exo -57.1 142.18 94.28 Favored 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 123.083 2.522 . . . . 0.0 112.113 176.047 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -78.17 -19.34 54.15 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.545 -176.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -97.3 16.56 19.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.035 -172.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.686 ' HG3' ' H ' ' A' ' 153' ' ' ILE . 28.1 mm-40 -50.79 -70.26 0.09 Allowed 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -177.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -137.98 159.94 66.49 Favored Pre-proline 0 C--N 1.311 -1.079 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.587 -174.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -56.44 144.31 84.08 Favored 'Trans proline' 0 C--O 1.238 0.503 0 C-N-CA 123.084 2.523 . . . . 0.0 112.902 -176.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -67.23 -7.45 24.03 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.407 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -49.96 -47.73 52.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.483 169.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ASN . . . . . 0.49 ' O ' ' HG2' ' A' ' 150' ' ' GLU . 10.8 t-20 -87.52 -7.16 57.92 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.792 -178.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 149' ' ' ASN . 11.1 pt-20 48.13 33.26 3.46 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.712 1.205 . . . . 0.0 111.457 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -149.55 144.0 25.96 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.436 -173.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.421 HG21 ' HB2' ' A' ' 116' ' ' ALA . 25.2 m -128.47 -176.54 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.965 -178.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.686 ' H ' ' HG3' ' A' ' 144' ' ' GLN . 39.3 mt -122.41 131.24 73.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.588 0.233 . . . . 0.0 111.6 -177.198 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.894 HG13 HG22 ' A' ' 140' ' ' VAL . 32.4 t -92.77 140.2 16.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 172.011 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.809 ' HE3' ' HD2' ' A' ' 141' ' ' PRO . 0.0 OUTLIER -107.39 126.19 52.16 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 177.397 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 60.2 mt -110.04 111.21 35.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.089 178.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.448 ' HB ' ' HB3' ' A' ' 137' ' ' GLU . 3.8 mp -109.1 119.75 59.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 176.135 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 104' ' ' LYS . . . 177.53 -157.4 21.95 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 119.62 -1.276 . . . . 0.0 113.1 -174.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.462 ' H ' ' HB3' ' A' ' 162' ' ' ALA . 1.1 m-70 -102.63 173.25 6.42 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 -173.034 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -59.96 -46.24 90.08 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 121.172 -0.211 . . . . 0.0 111.22 -177.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -60.89 -51.76 67.92 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.931 0.396 . . . . 0.0 110.516 175.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.462 ' HB3' ' H ' ' A' ' 159' ' ' HIS . . . -59.22 -49.04 79.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.259 -174.122 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.445 ' O ' ' HG3' ' A' ' 167' ' ' GLN . 32.4 t -62.16 -47.44 84.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.058 -175.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -56.41 -37.82 70.7 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.923 0.392 . . . . 0.0 111.001 178.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 89.9 mtp -71.92 -38.72 69.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.653 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.621 ' HA ' HG21 ' A' ' 134' ' ' THR . . . -66.83 -49.53 65.47 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.33 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.445 ' HG3' ' O ' ' A' ' 163' ' ' SER . 75.7 mt-30 -51.87 -52.46 49.44 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.233 -177.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 18.4 ptt180 -66.85 -38.15 85.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.146 -177.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.621 ' HA ' ' HE2' ' A' ' 169' ' ' LYS . 0.1 OUTLIER -68.09 -39.17 82.93 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.706 0.289 . . . . 0.0 111.299 -172.798 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.462 ' O ' HG12 ' A' ' 173' ' ' ILE . 1.9 mp -74.98 -44.19 44.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 177.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 -55.83 -25.59 42.57 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.2 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -60.77 -55.55 31.84 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.463 175.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.497 ' O ' HG23 ' A' ' 177' ' ' VAL . 42.5 pt -67.57 -23.94 30.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.446 -172.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.956 HD11 HG23 ' A' ' 111' ' ' VAL . 10.9 mp -58.33 -37.69 75.65 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.843 176.431 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -65.74 -34.97 79.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.058 0.456 . . . . 0.0 110.378 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -71.37 -38.1 71.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.508 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.544 HG22 ' HD3' ' A' ' 118' ' ' ARG . 58.0 t -66.7 -37.28 79.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.5 177.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 174' ' ' LEU . 98.2 mttt -66.06 -41.38 90.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.185 176.335 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.395 177.807 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 . . . . . 0 CA--C 1.516 -0.329 0 CA-C-O 121.1 0.476 . . . . 0.0 111.36 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -94.83 102.4 14.25 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.054 174.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 56.1 m -104.59 114.25 28.35 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.214 -177.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.426 HG22 ' HE ' ' A' ' 171' ' ' ARG . 42.1 t -126.42 149.94 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 176.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -108.52 146.45 33.2 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 122.086 -0.384 . . . . 0.0 110.138 -174.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.673 ' HB ' ' CG1' ' A' ' 71' ' ' VAL . 21.1 t -120.76 133.16 68.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.232 -174.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.782 ' CE1' HG11 ' A' ' 68' ' ' VAL . 32.5 t80 -93.56 104.15 16.29 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.483 0.713 . . . . 0.0 110.048 -176.36 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.496 ' CD1' HG23 ' A' ' 34' ' ' VAL . 8.8 pt -126.74 124.69 24.19 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.283 0.563 . . . . 0.0 111.13 178.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.457 ' HG2' ' HB3' ' A' ' 33' ' ' ALA . 3.0 Cg_endo -45.82 140.65 9.5 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 124.474 3.449 . . . . 0.0 114.064 -174.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.74 -18.71 22.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.958 -176.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -89.71 -29.47 18.72 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.11 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.566 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -96.47 -30.84 13.12 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -175.076 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.825 HG21 ' HB3' ' A' ' 69' ' ' ARG . 10.6 p -54.09 -29.91 19.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.707 179.198 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.76 -57.0 22.17 Favored Glycine 0 N--CA 1.432 -1.633 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.242 176.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.36 -14.16 59.78 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.552 -0.324 . . . . 0.0 111.201 -174.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.873 HD12 ' HB3' ' A' ' 90' ' ' LYS . 9.5 mm -63.16 -39.29 84.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 172.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.461 ' CG2' ' HA2' ' A' ' 42' ' ' GLY . 38.4 mt -61.83 -52.34 61.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.566 177.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.7 111.87 2.82 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 120.27 -0.967 . . . . 0.0 114.855 170.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.459 ' HD2' ' HA ' ' A' ' 40' ' ' LYS . 27.8 mmmt 59.23 -89.43 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.286 1.034 . . . . 0.0 113.561 173.413 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.495 ' CD ' ' HB2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -129.28 23.94 5.55 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.18 0.514 . . . . 0.0 111.156 -177.478 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.461 ' HA2' ' CG2' ' A' ' 38' ' ' ILE . . . 82.37 28.79 38.78 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.441 -0.885 . . . . 0.0 110.992 -175.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.495 ' HB2' ' CD ' ' A' ' 41' ' ' LYS . 25.4 tm0? -91.02 -47.61 7.46 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.024 0.44 . . . . 0.0 109.855 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -70.52 -32.78 70.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.492 -174.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.616 HG23 ' HG3' ' A' ' 46' ' ' LYS . 6.2 tt -61.04 -44.59 98.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.176 0.512 . . . . 0.0 111.145 177.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.616 ' HG3' HG23 ' A' ' 45' ' ' ILE . 55.0 mtpt -81.41 -30.92 33.41 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.428 -177.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -63.11 -33.46 75.51 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 172.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.815 ' HA ' ' HD1' ' A' ' 51' ' ' PHE . 6.1 tt -62.95 -49.26 75.44 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.422 174.399 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.639 ' HA ' HD13 ' A' ' 56' ' ' ILE . 14.4 t -55.52 -40.84 72.31 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.704 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.834 ' HE ' ' HA ' ' A' ' 50' ' ' ARG . 0.9 OUTLIER -78.84 -40.54 32.47 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -177.68 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.815 ' HD1' ' HA ' ' A' ' 48' ' ' LEU . 0.4 OUTLIER -74.51 -30.84 61.96 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 121.829 -0.545 . . . . 0.0 110.484 -178.03 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -84.59 -12.96 53.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.529 -177.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.9 m 66.9 30.13 7.88 Favored 'General case' 0 N--CA 1.463 0.223 0 O-C-N 123.644 0.59 . . . . 0.0 110.854 -179.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -134.54 166.95 21.7 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.539 -176.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.45 ' HB2' ' HB ' ' A' ' 74' ' ' THR . 18.4 m -92.53 108.1 19.72 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.567 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.733 HG13 HG22 ' A' ' 73' ' ' ILE . 1.9 mp -110.47 115.03 48.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.224 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -137.66 135.75 36.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.234 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 37.6 mm -80.38 124.42 38.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 177.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.743 ' HB2' HG23 ' A' ' 72' ' ' VAL . . . -90.05 129.75 44.87 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.606 -177.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.34 140.61 95.29 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 122.942 2.428 . . . . 0.0 111.897 176.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.455 ' HD3' ' HG3' ' A' ' 69' ' ' ARG . 40.2 Cg_endo . . . . . 0 C--O 1.233 0.26 0 C-N-CA 122.796 2.33 . . . . 0.0 112.054 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.497 ' O ' ' HD2' ' A' ' 67' ' ' LYS . 1.0 OUTLIER . . . . . 0 CA--C 1.536 0.417 0 CA-C-O 121.786 0.803 . . . . 0.0 110.578 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.782 HG11 ' CE1' ' A' ' 28' ' ' PHE . 11.2 p -146.54 154.64 12.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.798 -175.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.825 ' HB3' HG21 ' A' ' 34' ' ' VAL . 11.7 ttm180 -129.94 129.38 43.75 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 170.46 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.515 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 42.2 mtt -96.48 134.63 39.42 Favored 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.236 -173.116 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.673 ' CG1' ' HB ' ' A' ' 27' ' ' VAL . 3.9 p -99.98 140.21 19.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 177.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.743 HG23 ' HB2' ' A' ' 59' ' ' ALA . 63.9 t -101.56 120.5 51.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.112 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.733 HG22 HG13 ' A' ' 56' ' ' ILE . 2.6 pp -114.76 127.31 72.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.499 0.666 . . . . 0.0 110.522 176.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.45 ' HB ' ' HB2' ' A' ' 55' ' ' SER . 91.3 m -125.55 113.21 17.12 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.674 178.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.62 161.14 34.65 Favored Glycine 0 CA--C 1.498 -1.03 0 C-N-CA 119.811 -1.185 . . . . 0.0 113.115 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.31 153.07 71.54 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 122.5 2.133 . . . . 0.0 110.964 169.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.425 ' HA ' ' NH2' ' A' ' 168' ' ' ARG . 35.8 Cg_exo -38.18 -51.59 2.0 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 124.804 3.669 . . . . 0.0 114.85 -176.068 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -66.61 -36.02 81.61 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.264 0.554 . . . . 0.0 110.994 -177.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.88 -49.82 27.53 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.724 -178.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.563 ' HG3' HD13 ' A' ' 73' ' ' ILE . 19.9 tt0 -63.47 -31.9 73.19 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.955 -178.36 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -54.21 -54.62 37.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.513 -177.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.6 pttm -72.93 -33.09 65.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.378 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.05 -53.03 62.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.224 177.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.403 ' O ' HG22 ' A' ' 87' ' ' ILE . 35.0 mt-30 -72.76 -31.16 64.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.38 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -54.12 -42.33 71.72 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.957 176.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -81.19 -28.81 34.79 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 178.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.403 HG22 ' O ' ' A' ' 84' ' ' GLN . 0.4 OUTLIER -65.24 -41.25 91.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 120.981 -0.287 . . . . 0.0 110.49 -176.202 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.596 ' HA ' HD23 ' A' ' 91' ' ' LEU . 26.5 m-85 -67.39 -31.67 72.05 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.249 0.547 . . . . 0.0 110.239 176.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.08 -29.38 74.22 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.913 176.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.873 ' HB3' HD12 ' A' ' 37' ' ' ILE . 67.0 mmtt -77.3 -21.06 54.11 Favored 'General case' 0 N--CA 1.442 -0.87 0 O-C-N 122.62 -0.341 . . . . 0.0 110.491 178.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.596 HD23 ' HA ' ' A' ' 88' ' ' TYR . 3.8 mm? -66.05 -33.27 75.43 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.239 0.542 . . . . 0.0 109.847 167.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.804 ' HE3' ' HB ' ' A' ' 103' ' ' VAL . 13.8 mmtp -75.94 -21.8 56.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.117 176.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.523 ' HB2' ' HA ' ' A' ' 90' ' ' LYS . 5.2 tp10 -62.78 -33.05 74.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.772 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.606 ' HG2' ' CE2' ' A' ' 96' ' ' PHE . 6.5 tp10 -88.96 -1.38 58.08 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.957 0.884 . . . . 0.0 109.605 178.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 65.87 29.09 10.57 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.423 177.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.606 ' CE2' ' HG2' ' A' ' 94' ' ' GLU . 14.2 m-85 . . . . . 0 C--N 1.331 -0.216 0 CA-C-O 121.072 0.463 . . . . 0.0 111.149 178.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 . . . . . 0 CA--C 1.52 -0.197 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.804 ' HB ' ' HE3' ' A' ' 92' ' ' LYS . 7.1 p -65.95 122.23 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 175.091 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -116.79 88.23 2.86 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 174.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.595 ' HG ' ' HG ' ' A' ' 91' ' ' LEU . 1.6 tm? -112.02 124.66 52.87 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.973 -173.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -65.23 118.32 9.09 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.642 -178.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.501 HG21 ' NE2' ' A' ' 167' ' ' GLN . 1.2 m -109.92 136.9 48.47 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.252 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -108.0 118.76 37.6 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.286 0.565 . . . . 0.0 111.102 -174.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.523 HG13 ' HB ' ' A' ' 154' ' ' VAL . 12.4 pt -110.76 112.66 41.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.689 175.543 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.924 ' HG3' ' HG2' ' A' ' 151' ' ' GLN . 5.6 tpt180 -77.96 117.51 19.36 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.673 HG12 HD21 ' A' ' 174' ' ' LEU . 13.0 m -116.2 150.85 45.96 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -177.261 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -49.44 155.82 3.16 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.864 2.376 . . . . 0.0 111.461 175.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -52.83 -49.92 64.73 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.111 0.482 . . . . 0.0 111.513 -172.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 13.7 m -78.65 -8.26 58.48 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.913 -177.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.24 -29.99 61.95 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 122.215 -0.303 . . . . 0.0 111.453 -175.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.663 ' HB1' HG21 ' A' ' 140' ' ' VAL . . . -65.26 -37.84 88.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.2 0.524 . . . . 0.0 110.684 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -69.41 -28.29 72.65 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.912 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 37.1 mtp85 -92.02 -18.12 24.1 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 111.555 0.206 . . . . 0.0 111.555 -178.07 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.593 HG12 ' O ' ' A' ' 116' ' ' ALA . 8.4 p -76.64 -29.2 18.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 175.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.55 ' HA ' ' HB ' ' A' ' 127' ' ' VAL . 69.3 mt -65.79 -40.62 88.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 170.193 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.969 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.931 174.207 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? . . . . . 0 C--O 1.233 0.207 0 CA-C-O 120.989 0.423 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 15.1 m -64.69 -37.76 88.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.691 -175.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.55 ' HB ' ' HA ' ' A' ' 120' ' ' ILE . 14.0 p -63.24 -33.48 61.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-O 120.872 0.368 . . . . 0.0 110.731 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -65.95 -42.59 89.78 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 177.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -63.93 -40.96 97.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.233 177.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 79.3 mt -57.85 -50.77 72.17 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.202 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -68.4 -35.35 77.54 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.941 0.401 . . . . 0.0 110.881 -177.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -67.36 -36.99 82.51 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.385 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -84.9 -47.72 10.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.099 -175.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.548 ' HB ' ' HB2' ' A' ' 166' ' ' ALA . 76.9 p -79.88 -21.08 44.45 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -172.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 66.17 21.39 11.12 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.53 -174.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -120.13 164.15 16.62 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.002 177.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.501 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 49.0 mt-10 -101.07 113.02 25.65 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.188 0.518 . . . . 0.0 111.033 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 60.0 t -104.85 106.45 20.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.912 -178.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.474 ' O ' ' HD2' ' A' ' 155' ' ' LYS . 7.2 p -128.46 130.88 69.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.065 0.46 . . . . 0.0 111.136 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.688 ' HB ' HG22 ' A' ' 154' ' ' VAL . 8.5 p -125.94 131.04 23.86 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 116.136 -0.483 . . . . 0.0 109.855 178.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.46 ' HB2' ' HB2' ' A' ' 144' ' ' GLN . 36.7 Cg_exo -60.89 121.01 9.03 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.7 2.267 . . . . 0.0 111.631 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.663 ' H ' ' HD2' ' A' ' 142' ' ' ARG . 0.3 OUTLIER -83.19 14.78 3.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.586 0.708 . . . . 0.0 110.102 -175.043 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -117.84 -1.74 11.47 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.346 176.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.46 ' HB2' ' HB2' ' A' ' 141' ' ' PRO . 6.4 tp-100 -98.11 115.11 27.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.07 -172.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.1 t -175.29 70.53 0.27 Allowed Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.381 176.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -91.55 143.96 3.06 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.384 2.056 . . . . 0.0 112.568 -178.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -70.0 -16.62 63.2 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.981 178.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -52.3 -48.67 65.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.974 -1.012 . . . . 0.0 112.204 -178.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ASN . . . . . 0.441 ' O ' ' HG2' ' A' ' 150' ' ' GLU . 4.4 t-20 -119.62 -10.4 9.61 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.014 -175.003 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 149' ' ' ASN . 12.2 pt-20 47.33 29.68 1.33 Allowed 'General case' 0 N--CA 1.475 0.799 0 O-C-N 124.31 1.007 . . . . 0.0 111.097 -173.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.924 ' HG2' ' HG3' ' A' ' 110' ' ' ARG . 30.5 tt0 -155.71 128.31 7.86 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.15 -174.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.401 HG21 ' HB2' ' A' ' 116' ' ' ALA . 33.1 m -114.41 -177.1 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.338 -171.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.411 HG12 ' HD2' ' A' ' 110' ' ' ARG . 53.9 mt -122.16 131.39 73.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -173.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.688 HG22 ' HB ' ' A' ' 140' ' ' VAL . 46.2 t -107.29 140.77 24.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 168.35 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.474 ' HD2' ' O ' ' A' ' 139' ' ' VAL . 0.0 OUTLIER -104.12 122.39 45.22 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.07 178.898 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.501 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 51.6 mt -102.71 112.67 36.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 173.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.401 ' N ' HD12 ' A' ' 157' ' ' ILE . 4.4 mp -103.6 129.86 54.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.82 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 161.3 -172.07 37.45 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.436 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.512 ' HA ' HG13 ' A' ' 103' ' ' VAL . 18.3 p-80 -88.68 153.68 20.91 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.437 ' HB3' ' CG ' ' A' ' 88' ' ' TYR . 10.2 p90 -50.82 -46.59 59.99 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -165.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.411 ' O ' ' HG3' ' A' ' 164' ' ' GLN . 16.8 m-85 -59.67 -48.94 79.7 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 118.85 0.75 . . . . 0.0 111.174 -178.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.59 -42.91 86.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.603 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.475 ' O ' ' HG3' ' A' ' 167' ' ' GLN . 35.7 t -63.59 -50.37 69.68 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.418 -177.136 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' GLN . . . . . 0.411 ' HG3' ' O ' ' A' ' 161' ' ' TYR . 5.1 pp0? -59.37 -35.48 73.97 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.478 0.18 . . . . 0.0 111.034 -177.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 49.0 ttp -73.76 -33.45 64.28 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 120.621 -0.431 . . . . 0.0 110.806 177.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.548 ' HB2' ' HB ' ' A' ' 134' ' ' THR . . . -69.96 -43.61 71.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.103 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.501 ' NE2' HG21 ' A' ' 107' ' ' THR . 71.9 mt-30 -51.94 -52.81 47.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.953 -178.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.825 ' HA ' ' HB2' ' A' ' 171' ' ' ARG . 1.3 ptp180 -70.85 -27.36 63.78 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.455 178.15 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.648 ' HA ' ' HE2' ' A' ' 169' ' ' LYS . 0.1 OUTLIER -67.55 -37.85 83.29 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.753 -178.688 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.486 ' O ' HG13 ' A' ' 173' ' ' ILE . 1.9 mp -75.24 -39.88 42.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 173.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.825 ' HB2' ' HA ' ' A' ' 168' ' ' ARG . 1.1 mpt_? -51.74 -28.0 13.74 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.072 171.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.484 ' HB2' ' O ' ' A' ' 169' ' ' LYS . 1.3 m-20 -68.66 -56.14 9.16 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 122.679 0.392 . . . . 0.0 111.499 178.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.486 HG13 ' O ' ' A' ' 170' ' ' ILE . 2.7 pp -66.59 -18.64 24.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.525 -174.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.673 HD21 HG12 ' A' ' 111' ' ' VAL . 6.7 mp -66.41 -33.86 76.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.093 174.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.99 -31.82 73.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.107 0.48 . . . . 0.0 110.28 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -69.6 -33.45 72.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.923 176.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 173' ' ' ILE . 48.7 t -66.06 -46.4 88.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.796 176.084 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -61.18 -40.89 95.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.845 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.016 -179.515 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.464 ' HB3' HG22 ' A' ' 74' ' ' THR . 48.5 mt-30 . . . . . 0 CA--C 1.514 -0.407 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.532 ' O ' ' HA ' ' A' ' 74' ' ' THR . 7.1 tp10 -81.05 147.67 30.04 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.399 -0.818 . . . . 0.0 111.101 -174.177 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.636 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 39.8 m -116.15 107.16 14.54 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.492 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.412 HG13 HG22 ' A' ' 109' ' ' ILE . 37.0 t -119.14 150.02 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.723 -177.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -111.69 125.15 53.66 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-O 120.773 0.32 . . . . 0.0 110.776 -175.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.497 ' HB ' ' HB ' ' A' ' 71' ' ' VAL . 13.6 t -94.09 139.69 17.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.473 ' CZ ' HG11 ' A' ' 68' ' ' VAL . 1.0 OUTLIER -103.54 104.89 15.01 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.406 -175.704 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.443 ' C ' HG23 ' A' ' 68' ' ' VAL . 21.7 pt -129.68 123.36 21.15 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 121.169 0.509 . . . . 0.0 111.291 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.452 ' HA ' ' HA ' ' A' ' 68' ' ' VAL . 50.5 Cg_exo -53.5 149.12 31.86 Favored 'Trans proline' 0 C--O 1.238 0.501 0 C-N-CA 123.439 2.76 . . . . 0.0 112.643 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.671 ' HA ' HG12 ' A' ' 34' ' ' VAL . . . -57.7 -23.57 52.33 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 114.9 -1.046 . . . . 0.0 112.529 -173.172 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -66.12 -30.01 70.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.235 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.518 ' HB2' ' CE2' ' A' ' 96' ' ' PHE . . . -108.25 -31.07 8.03 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.663 -175.252 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.753 HG21 ' HB3' ' A' ' 69' ' ' ARG . 13.3 p -53.98 -32.48 22.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-O 120.945 0.402 . . . . 0.0 110.968 -175.315 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.81 -56.36 25.71 Favored Glycine 0 N--CA 1.434 -1.448 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.959 178.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.44 -14.54 59.67 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.621 0.248 . . . . 0.0 111.298 -175.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.998 HD12 ' HB3' ' A' ' 90' ' ' LYS . 2.4 mm -67.44 -36.96 77.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.369 -0.378 . . . . 0.0 109.99 177.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.42 HG23 HG21 ' A' ' 45' ' ' ILE . 24.6 mt -61.45 -32.72 54.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-O 121.528 0.68 . . . . 0.0 110.337 174.096 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.18 153.72 30.18 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.627 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.562 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 34.1 mtpt -66.02 131.38 46.08 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -175.035 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.562 ' HG2' ' O ' ' A' ' 40' ' ' LYS . 19.8 pttt 73.63 4.21 4.69 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.051 1.34 . . . . 0.0 112.198 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 61.05 38.64 95.88 Favored Glycine 0 CA--C 1.523 0.545 0 CA-C-N 116.253 -0.431 . . . . 0.0 113.607 176.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.447 ' HB3' ' HE2' ' A' ' 41' ' ' LYS . 19.4 tt0 -109.1 -36.65 6.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 117.322 0.561 . . . . 0.0 110.985 175.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 77.7 m-70 -55.87 -41.62 74.67 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.393 0.616 . . . . 0.0 109.778 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.469 ' O ' HG21 ' A' ' 56' ' ' ILE . 4.5 tt -56.52 -44.13 79.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 114.515 -1.221 . . . . 0.0 112.231 176.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.433 ' HG2' HG23 ' A' ' 45' ' ' ILE . 28.4 mmmt -81.45 -29.09 33.91 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 121.984 -0.447 . . . . 0.0 110.779 -173.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -60.47 -40.55 91.65 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 172.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.704 HD22 ' HZ ' ' A' ' 51' ' ' PHE . 0.2 OUTLIER -49.72 -47.8 50.35 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.048 175.898 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.838 ' HB2' ' HB ' ' A' ' 56' ' ' ILE . 14.5 t -61.77 -35.88 79.43 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.629 -176.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -78.81 -41.35 30.53 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -169.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.704 ' HZ ' HD22 ' A' ' 48' ' ' LEU . 10.2 p90 -79.56 -17.02 54.89 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 120.167 -0.613 . . . . 0.0 111.609 -177.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -94.09 -16.89 23.38 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.199 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.2 t 67.3 13.97 9.55 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.544 -177.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -108.73 153.57 23.27 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.838 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.495 ' HB2' ' HB ' ' A' ' 74' ' ' THR . 60.4 m -80.27 102.41 9.48 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.018 0.437 . . . . 0.0 110.185 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.838 ' HB ' ' HB2' ' A' ' 49' ' ' SER . 1.5 mp -92.98 117.64 36.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.147 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -144.77 151.13 38.37 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.891 -175.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 38.8 mm -102.43 129.1 54.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.599 ' HB3' ' HB2' ' A' ' 70' ' ' MET . . . -95.86 108.55 41.23 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.841 -178.328 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 59' ' ' ALA . 14.6 Cg_exo -69.59 146.0 59.89 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 123.061 2.507 . . . . 0.0 112.338 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.864 ' HD3' ' HG3' ' A' ' 69' ' ' ARG . 98.6 Cg_endo . . . . . 0 N--CA 1.459 -0.527 0 C-N-CA 122.874 2.383 . . . . 0.0 112.396 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? . . . . . 0 CA--C 1.528 0.113 0 CA-C-O 121.353 0.597 . . . . 0.0 110.417 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.473 HG11 ' CZ ' ' A' ' 28' ' ' PHE . 1.5 p -145.83 150.53 15.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.457 -172.303 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.864 ' HG3' ' HD3' ' A' ' 61' ' ' PRO . 22.9 ttm180 -127.05 151.3 48.79 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 177.08 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.599 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 63.6 mtt -100.13 149.41 23.55 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.269 0.557 . . . . 0.0 112.127 -173.512 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.497 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 86.8 t -105.44 120.34 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 168.108 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.6 p -109.23 115.54 49.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-O 121.563 0.697 . . . . 0.0 110.451 -176.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.636 ' O ' ' HA ' ' A' ' 24' ' ' THR . 2.1 pp -120.34 140.84 43.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.598 -176.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 58.9 m -123.76 108.77 12.88 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.934 177.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -163.95 162.03 34.8 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.098 -1.049 . . . . 0.0 113.326 -176.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.408 ' HD3' ' HG2' ' A' ' 22' ' ' GLN . 30.7 Cg_endo -64.39 142.61 79.58 Favored 'Trans proline' 0 CA--C 1.533 0.427 0 C-N-CA 123.079 2.519 . . . . 0.0 111.908 175.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.481 ' O ' ' HB2' ' A' ' 80' ' ' GLN . 97.4 Cg_exo -46.14 -35.39 14.89 Favored 'Trans proline' 0 N--CA 1.478 0.565 0 C-N-CA 125.013 3.808 . . . . 0.0 115.298 -174.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.3 -46.87 69.14 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.115 0.483 . . . . 0.0 109.849 177.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.56 -22.44 63.54 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.894 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.481 ' HB2' ' O ' ' A' ' 77' ' ' PRO . 71.3 mm-40 -52.76 -52.0 58.31 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.787 176.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -66.74 -33.15 74.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.832 -179.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 47.1 tttp -61.5 -52.95 62.38 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.189 0.519 . . . . 0.0 110.334 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.4 -53.74 13.07 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.854 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.507 ' O ' HG22 ' A' ' 87' ' ' ILE . 9.5 tt0 -69.15 -31.03 69.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.68 -173.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -58.13 -32.54 67.4 Favored Glycine 0 CA--C 1.518 0.219 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.884 177.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.521 ' HA ' ' NE ' ' A' ' 86' ' ' ARG . 3.5 mmp_? -79.69 -26.83 40.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.654 0.264 . . . . 0.0 111.054 178.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.507 HG22 ' O ' ' A' ' 84' ' ' GLN . 0.4 OUTLIER -66.33 -35.16 74.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.646 -177.307 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.668 ' CE2' ' HB3' ' A' ' 105' ' ' LEU . 10.0 m-85 -68.66 -34.57 75.93 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.361 176.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -62.26 -30.43 75.96 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.524 176.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.998 ' HB3' HD12 ' A' ' 37' ' ' ILE . 75.0 mmtt -59.96 -52.96 63.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.7 0.286 . . . . 0.0 110.612 175.421 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.57 HD23 HD11 ' A' ' 105' ' ' LEU . 3.8 mm? -61.35 -39.66 91.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.606 178.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.83 ' HE3' ' HB ' ' A' ' 103' ' ' VAL . 0.3 OUTLIER -61.65 -41.17 97.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.821 0.343 . . . . 0.0 110.92 174.711 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -71.18 -23.45 62.05 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.028 -176.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.509 ' HB3' ' CE2' ' A' ' 96' ' ' PHE . 58.7 mm-40 -88.26 4.23 46.65 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.927 -179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 63.56 21.04 12.56 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.742 172.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.518 ' CE2' ' HB2' ' A' ' 33' ' ' ALA . 78.2 m-85 . . . . . 0 C--N 1.326 -0.453 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 168.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 . . . . . 0 CA--C 1.514 -0.409 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.83 ' HB ' ' HE3' ' A' ' 92' ' ' LYS . 15.0 p -54.6 123.94 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 CA-C-O 121.819 0.819 . . . . 0.0 111.995 -172.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -123.02 90.81 3.36 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 170.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.668 ' HB3' ' CE2' ' A' ' 88' ' ' TYR . 2.5 tt -117.17 114.89 24.32 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -177.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.877 ' HG3' HG13 ' A' ' 157' ' ' ILE . 1.7 mp0 -71.86 128.73 36.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.694 -175.126 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.1 m -114.69 128.06 56.1 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 170.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 16.2 m170 -102.26 119.62 39.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.14 0.495 . . . . 0.0 110.064 -178.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.468 HG13 ' HB ' ' A' ' 154' ' ' VAL . 34.8 pt -112.33 157.52 13.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.231 -178.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 110' ' ' ARG . 22.6 mmt180 -102.26 133.64 46.83 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.879 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.777 HG12 HD21 ' A' ' 174' ' ' LEU . 10.4 m -133.15 148.24 68.43 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 173.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.766 ' HD2' ' HG ' ' A' ' 174' ' ' LEU . 51.6 Cg_exo -53.96 146.27 48.01 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.139 1.893 . . . . 0.0 110.596 175.029 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.15 -27.77 65.95 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.616 -175.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 44.0 t -81.5 -33.11 32.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.3 0.571 . . . . 0.0 110.281 175.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.56 -21.05 61.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.011 -178.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.556 ' O ' HG12 ' A' ' 119' ' ' VAL . . . -61.45 -50.82 71.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.071 0.462 . . . . 0.0 110.59 177.001 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.93 -29.39 67.14 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.562 177.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.6 ' HD3' HG22 ' A' ' 177' ' ' VAL . 13.7 ttt85 -73.04 -36.1 66.86 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.832 -0.184 . . . . 0.0 111.316 -178.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.556 HG12 ' O ' ' A' ' 116' ' ' ALA . 7.0 p -69.89 -26.21 29.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-O 121.014 0.435 . . . . 0.0 109.905 178.088 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.921 ' HA ' ' HB ' ' A' ' 127' ' ' VAL . 73.7 mt -68.12 -33.36 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 CA-C-O 121.495 0.664 . . . . 0.0 109.347 171.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.617 ' HA3' ' H ' ' A' ' 126' ' ' THR . . . . . . . . 0 N--CA 1.446 -0.672 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.182 176.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 53.2 tptt . . . . . 0 C--O 1.231 0.089 0 CA-C-O 121.069 0.461 . . . . 0.0 110.623 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.617 ' H ' ' HA3' ' A' ' 121' ' ' GLY . 21.7 m -60.16 -34.62 73.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.905 -177.016 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.921 ' HB ' ' HA ' ' A' ' 120' ' ' ILE . 10.2 p -63.11 -29.24 46.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.7 0.286 . . . . 0.0 110.856 -178.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -63.77 -45.49 89.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.149 0.5 . . . . 0.0 109.835 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -72.35 -37.36 68.84 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.946 178.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.635 HD21 HD11 ' A' ' 170' ' ' ILE . 23.1 tp -58.98 -49.43 77.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.937 178.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.504 ' HG3' HG12 ' A' ' 138' ' ' VAL . 16.4 tt0 -63.12 -36.24 82.94 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.195 -178.384 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -75.11 -37.0 61.63 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.783 -178.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 133' ' ' LEU . 21.8 mt -79.98 -22.08 42.97 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -178.227 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 38.5 p -96.7 -22.03 17.23 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.747 -177.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 65.25 18.53 11.43 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.623 -178.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -118.95 168.93 10.33 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.585 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.505 ' HB3' ' HB ' ' A' ' 157' ' ' ILE . 21.8 tt0 -105.1 122.05 45.08 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.987 0.423 . . . . 0.0 110.225 -178.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.504 HG12 ' HG3' ' A' ' 131' ' ' GLN . 2.4 p -121.09 122.01 66.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.067 -172.248 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 13.5 p -130.66 133.23 63.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.54 176.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.818 ' HB ' HG22 ' A' ' 154' ' ' VAL . 6.7 p -137.49 97.68 10.32 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-O 121.824 0.821 . . . . 0.0 111.14 177.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -60.57 166.45 9.75 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 123.427 2.751 . . . . 0.0 112.656 175.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -79.05 -50.31 11.26 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.399 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -94.27 102.19 14.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.438 178.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.762 ' HB2' ' HB ' ' A' ' 152' ' ' VAL . 23.7 mm-40 -127.78 93.23 3.64 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.551 176.229 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.925 ' HB ' ' HD2' ' A' ' 146' ' ' PRO . 60.8 p 58.67 172.91 0.05 OUTLIER Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 123.615 0.766 . . . . 0.0 111.519 -176.203 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.925 ' HD2' ' HB ' ' A' ' 145' ' ' THR . 35.1 Cg_endo -65.8 154.71 72.75 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.07 1.847 . . . . 0.0 111.965 178.059 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -78.88 36.3 0.27 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.527 0.68 . . . . 0.0 110.544 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.422 ' H ' ' C ' ' A' ' 146' ' ' PRO . 37.8 tt0 -63.21 -33.34 75.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.598 -177.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -118.61 22.63 11.94 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 175.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 48.17 31.62 2.66 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 114.104 -1.407 . . . . 0.0 112.716 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -136.35 158.4 44.51 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.503 0.668 . . . . 0.0 112.434 -177.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.762 ' HB ' ' HB2' ' A' ' 144' ' ' GLN . 27.0 m -123.69 -175.78 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.787 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.442 ' HB ' ' OE1' ' A' ' 144' ' ' GLN . 25.2 mt -115.47 136.93 50.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.098 0.475 . . . . 0.0 112.27 -172.083 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.818 HG22 ' HB ' ' A' ' 140' ' ' VAL . 59.6 t -114.35 141.09 31.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.259 172.361 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 6.5 mttt -113.22 121.27 43.97 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.333 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.5 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 64.4 mt -104.85 116.34 48.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.177 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.877 HG13 ' HG3' ' A' ' 106' ' ' GLU . 3.9 mp -110.57 133.19 56.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.523 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 153.8 -156.17 26.63 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.114 -1.041 . . . . 0.0 112.757 176.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.642 ' HA ' HG13 ' A' ' 103' ' ' VAL . 74.3 m80 -86.95 160.08 18.8 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -178.17 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.519 ' HB3' ' CG ' ' A' ' 88' ' ' TYR . 19.7 p90 -68.67 -24.47 64.52 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -170.007 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -73.26 -41.28 63.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.219 0.533 . . . . 0.0 109.981 172.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -73.27 -39.73 65.15 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.452 -176.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.438 ' O ' ' HG3' ' A' ' 167' ' ' GLN . 29.0 p -65.07 -50.08 67.54 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.223 -177.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -62.23 -34.55 76.71 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.723 0.297 . . . . 0.0 110.627 178.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 26.6 ttt -63.79 -43.46 96.27 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.09 0.472 . . . . 0.0 110.266 177.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.43 ' HB3' HD13 ' A' ' 156' ' ' ILE . . . -68.65 -46.46 69.1 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.02 178.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.438 ' HG3' ' O ' ' A' ' 163' ' ' SER . 72.4 mt-30 -51.52 -51.36 55.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.26 -178.298 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -70.07 -30.82 68.16 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.151 -178.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -71.49 -40.64 70.07 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.945 0.402 . . . . 0.0 110.92 -178.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.646 ' O ' HD13 ' A' ' 174' ' ' LEU . 1.9 mp -73.01 -51.0 28.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.434 178.182 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.648 ' HA ' HD22 ' A' ' 174' ' ' LEU . 25.8 mmm180 -56.98 -24.82 56.1 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.727 0.298 . . . . 0.0 110.909 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -69.4 -51.35 37.4 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.638 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.416 ' O ' HG23 ' A' ' 177' ' ' VAL . 34.4 pt -68.5 -19.82 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 121.017 0.437 . . . . 0.0 110.722 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.777 HD21 HG12 ' A' ' 111' ' ' VAL . 3.5 mp -64.08 -29.15 70.3 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.133 178.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.78 -31.89 72.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.26 0.553 . . . . 0.0 110.146 175.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -73.44 -47.09 44.44 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.161 177.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.6 HG22 ' HD3' ' A' ' 118' ' ' ARG . 29.6 t -67.33 -32.51 57.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.657 -178.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -57.25 -49.01 77.4 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 174.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 . . . . . 0 C--N 1.327 -0.385 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.821 178.189 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 . . . . . 0 N--CA 1.453 -0.297 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.61 ' O ' ' HA ' ' A' ' 74' ' ' THR . 22.1 mm-40 -72.64 130.53 40.77 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.255 -174.363 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.61 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 29.6 m -131.7 109.94 10.54 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.61 -178.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.749 HG22 HD11 ' A' ' 73' ' ' ILE . 14.3 m -127.73 161.24 35.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.237 178.525 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 10.0 m170 -111.47 127.95 55.85 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 -174.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.621 ' O ' ' HA ' ' A' ' 70' ' ' MET . 10.4 t -105.87 123.87 60.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.821 -174.46 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.787 ' CZ ' HG11 ' A' ' 68' ' ' VAL . 3.7 t80 -82.33 103.2 11.73 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.313 -174.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.537 ' C ' HG23 ' A' ' 68' ' ' VAL . 39.6 pt -126.52 113.14 23.03 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.701 0.762 . . . . 0.0 110.724 174.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.97 ' HB2' ' HG2' ' A' ' 32' ' ' GLN . 88.8 Cg_exo -50.45 150.95 10.66 Favored 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 123.513 2.808 . . . . 0.0 113.325 -179.287 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.689 ' HA ' HG12 ' A' ' 34' ' ' VAL . . . -58.73 -18.73 33.98 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.909 -175.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.97 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 3.5 pt20 -51.65 -36.53 46.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.021 176.33 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.587 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -126.4 -25.35 3.48 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -169.423 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.689 HG12 ' HA ' ' A' ' 31' ' ' ALA . 14.4 p -49.94 -34.53 9.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 O-C-N 123.355 0.409 . . . . 0.0 111.622 -173.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.22 -55.8 28.42 Favored Glycine 0 N--CA 1.44 -1.084 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.155 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.87 -15.05 62.11 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 120.906 0.384 . . . . 0.0 111.057 -175.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.587 HG12 ' O ' ' A' ' 33' ' ' ALA . 6.5 mm -71.74 -36.0 57.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.683 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.538 HG22 ' HA2' ' A' ' 42' ' ' GLY . 8.2 mt -63.51 -32.12 55.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-O 121.41 0.624 . . . . 0.0 110.265 173.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.532 ' HA3' ' HB2' ' A' ' 44' ' ' HIS . . . 86.72 163.48 38.66 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.443 176.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -61.36 128.15 34.94 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 120.927 0.394 . . . . 0.0 110.039 -178.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.419 ' O ' ' HE3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER 72.62 1.84 4.13 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.178 179.149 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.538 ' HA2' HG22 ' A' ' 38' ' ' ILE . . . 69.94 19.86 75.68 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.395 -0.907 . . . . 0.0 110.889 -173.234 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -73.86 -41.85 61.62 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.427 -0.386 . . . . 0.0 110.227 -178.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.532 ' HB2' ' HA3' ' A' ' 39' ' ' GLY . 18.8 m-70 -64.6 -40.52 95.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.539 -173.43 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.459 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 13.8 tt -64.46 -45.45 95.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.887 0.375 . . . . 0.0 111.442 -179.026 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.418 ' O ' ' HB3' ' A' ' 49' ' ' SER . 13.9 ptmm? -82.26 -22.32 35.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.671 0.272 . . . . 0.0 111.324 -178.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -69.34 -34.78 75.14 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 172.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.865 ' HG ' ' HE1' ' A' ' 51' ' ' PHE . 6.4 tt -60.1 -41.97 93.68 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.052 -0.976 . . . . 0.0 108.983 173.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.638 ' HA ' HD13 ' A' ' 56' ' ' ILE . 34.0 t -54.99 -35.31 64.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.931 178.454 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -73.53 -51.28 17.55 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.865 ' HE1' ' HG ' ' A' ' 48' ' ' LEU . 1.5 p90 -72.49 -32.18 65.99 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.823 -174.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.53 -19.02 36.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.858 0.361 . . . . 0.0 110.804 179.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.5 m 63.95 31.05 14.03 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.078 178.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -132.4 171.16 14.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.992 -177.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.504 ' HB3' ' HB ' ' A' ' 74' ' ' THR . 33.2 t -93.19 115.85 28.45 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.904 HG13 HG22 ' A' ' 73' ' ' ILE . 3.2 mp -115.58 119.15 61.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.238 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -148.43 136.69 21.19 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.012 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.597 HG12 HG22 ' A' ' 71' ' ' VAL . 10.4 mt -88.8 128.48 40.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.189 0.518 . . . . 0.0 111.224 -177.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.53 ' HB2' HG23 ' A' ' 72' ' ' VAL . . . -71.19 141.79 86.57 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.239 -176.187 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 59' ' ' ALA . 2.4 Cg_endo -80.36 137.46 11.84 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.933 2.422 . . . . 0.0 111.956 177.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo . . . . . 0 N--CA 1.461 -0.405 0 C-N-CA 122.853 2.369 . . . . 0.0 111.782 176.913 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? . . . . . 0 N--CA 1.457 -0.105 0 CA-C-O 121.135 0.493 . . . . 0.0 109.734 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.787 HG11 ' CZ ' ' A' ' 28' ' ' PHE . 3.7 p -154.65 153.64 7.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.788 -167.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.578 ' HB2' HG21 ' A' ' 34' ' ' VAL . 30.4 mtp180 -128.59 130.2 47.02 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 171.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.621 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 4.1 mpp? -92.35 125.88 37.19 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.803 0.335 . . . . 0.0 110.846 -175.08 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.597 HG22 HG12 ' A' ' 58' ' ' ILE . 93.1 t -84.47 127.11 40.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 120.924 0.393 . . . . 0.0 110.244 178.219 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.53 HG23 ' HB2' ' A' ' 59' ' ' ALA . 81.9 t -99.29 118.05 45.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.929 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.904 HG22 HG13 ' A' ' 56' ' ' ILE . 2.4 pp -118.58 133.45 65.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.271 0.557 . . . . 0.0 110.938 178.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.61 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 30.0 m -126.08 106.26 9.46 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.068 -179.044 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.63 164.38 37.29 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.859 -173.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -61.33 138.9 79.83 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 122.488 2.126 . . . . 0.0 111.665 173.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -40.05 -48.36 3.86 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 124.449 3.433 . . . . 0.0 115.316 -173.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -72.9 -32.22 65.2 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 121.031 -0.268 . . . . 0.0 111.617 -175.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.42 -32.21 69.72 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.231 0.539 . . . . 0.0 109.966 177.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -57.85 -41.57 82.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.774 177.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -64.99 -35.03 79.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.409 -175.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.7 mtmt -66.09 -44.02 85.63 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.405 0.621 . . . . 0.0 109.699 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.77 -41.55 75.02 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.058 178.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.494 ' O ' HG22 ' A' ' 87' ' ' ILE . 49.0 tt0 -64.48 -34.44 78.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.242 -177.277 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -56.79 -42.07 91.37 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.197 177.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 32.7 mmt180 -76.78 -33.38 58.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.788 0.328 . . . . 0.0 111.497 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.494 HG22 ' O ' ' A' ' 84' ' ' GLN . 0.4 OUTLIER -65.53 -37.29 79.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -177.909 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.696 ' HA ' HD23 ' A' ' 91' ' ' LEU . 10.7 m-85 -69.39 -30.66 68.69 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.201 0.524 . . . . 0.0 110.795 174.037 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -58.02 -33.81 70.38 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.759 175.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.711 ' HG3' HD22 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -61.33 -36.51 80.34 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 117.435 0.617 . . . . 0.0 109.646 177.774 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.711 HD22 ' HG3' ' A' ' 90' ' ' LYS . 2.8 mm? -61.79 -44.87 96.02 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.772 175.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 1.075 ' HE3' ' HB ' ' A' ' 103' ' ' VAL . 3.6 mmtp -76.67 -34.96 58.21 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -176.182 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -63.1 -33.05 74.62 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.768 -171.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.418 ' HB2' ' CE2' ' A' ' 96' ' ' PHE . 8.8 mm-40 -97.68 18.79 14.8 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.169 -0.613 . . . . 0.0 110.763 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 65.8 t30 58.07 40.5 25.24 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.186 174.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.418 ' CE2' ' HB2' ' A' ' 94' ' ' GLU . 27.7 m-85 . . . . . 0 C--N 1.324 -0.542 0 C-N-CA 120.591 -0.443 . . . . 0.0 109.986 176.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 . . . . . 0 N--CA 1.454 -0.236 0 CA-C-O 120.569 0.223 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 1.075 ' HB ' ' HE3' ' A' ' 92' ' ' LYS . 13.3 p -60.45 123.3 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 173.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -126.27 89.89 3.09 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.773 0.797 . . . . 0.0 109.335 176.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 tt -101.22 126.92 47.99 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.467 -1.242 . . . . 0.0 108.191 -176.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -81.56 103.32 11.19 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.247 0.546 . . . . 0.0 110.383 -177.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.3 m -95.07 130.77 41.63 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.865 0.364 . . . . 0.0 110.036 177.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' HIS . . . . . 0.405 ' HB3' HG21 ' A' ' 153' ' ' ILE . 11.1 m-70 -103.65 120.18 40.39 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.813 0.34 . . . . 0.0 110.643 -177.335 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 32.9 pt -115.63 134.41 58.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.174 0.512 . . . . 0.0 110.191 178.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.567 HH11 HD11 ' A' ' 153' ' ' ILE . 12.7 tpt180 -86.84 118.98 26.58 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.254 -174.219 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.693 HG23 ' CD2' ' A' ' 174' ' ' LEU . 7.1 p -121.51 145.04 41.73 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -177.25 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.81 ' HA ' ' HG2' ' A' ' 151' ' ' GLN . 32.7 Cg_exo -55.67 144.54 75.08 Favored 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 122.586 2.191 . . . . 0.0 110.871 173.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.21 -32.15 70.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.692 -175.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.5 p -79.75 -26.04 40.86 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.778 178.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.654 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -75.51 -20.41 58.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.315 -177.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.42 -35.1 79.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.11 0.481 . . . . 0.0 110.098 175.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -81.52 -11.3 83.33 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.909 176.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.426 ' HD2' HG22 ' A' ' 177' ' ' VAL . 18.3 ttm180 -93.09 -38.36 11.65 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.723 0.296 . . . . 0.0 111.037 179.465 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.6 p -65.66 -29.83 48.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.353 -177.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 1.004 ' HA ' ' HB ' ' A' ' 127' ' ' VAL . 34.9 pt -77.28 -19.48 14.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.005 0.431 . . . . 0.0 110.485 178.353 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.686 ' HA3' HG22 ' A' ' 126' ' ' THR . . . . . . . . 0 N--CA 1.445 -0.706 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.213 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 64.2 mttp . . . . . 0 CA--C 1.523 -0.067 0 CA-C-O 120.568 0.223 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.686 HG22 ' HA3' ' A' ' 121' ' ' GLY . 14.4 t -69.24 -14.98 63.26 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.961 -0.295 . . . . 0.0 111.129 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 1.004 ' HB ' ' HA ' ' A' ' 120' ' ' ILE . 12.7 p -66.76 -32.44 58.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.015 0.435 . . . . 0.0 109.964 174.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -66.29 -45.98 78.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.337 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -63.85 -39.06 93.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.242 175.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.715 HD21 HD11 ' A' ' 170' ' ' ILE . 33.4 tp -56.68 -49.44 75.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.147 -176.425 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.646 ' HG2' ' H ' ' A' ' 138' ' ' VAL . 48.2 mt-30 -61.42 -47.4 85.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.599 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -66.99 -40.09 87.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.855 0.36 . . . . 0.0 111.349 -178.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 34.3 tp -73.13 -42.0 63.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.318 -176.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.427 ' HB ' ' HB2' ' A' ' 166' ' ' ALA . 68.2 p -76.52 -16.26 59.67 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.86 0.362 . . . . 0.0 110.888 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 64.96 26.34 12.74 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.837 -178.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -137.96 162.96 32.71 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.106 -177.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.56 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 8.6 mm-40 -90.23 110.01 21.07 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-O 120.957 0.408 . . . . 0.0 110.395 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.646 ' H ' ' HG2' ' A' ' 131' ' ' GLN . 43.2 t -101.52 104.9 17.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.92 176.353 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.552 HG13 ' HE3' ' A' ' 155' ' ' LYS . 4.9 p -113.81 111.85 37.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.466 0.65 . . . . 0.0 111.059 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.608 HG12 HG22 ' A' ' 154' ' ' VAL . 9.2 m -90.59 139.14 26.43 Favored Pre-proline 0 N--CA 1.446 -0.631 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 172.166 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.473 ' HB2' ' H ' ' A' ' 144' ' ' GLN . 67.8 Cg_endo -76.43 122.12 6.37 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 121.845 1.697 . . . . 0.0 112.525 -174.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 11.2 mpt_? -81.53 -13.79 57.67 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 174.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -80.2 -52.13 8.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.933 -1.031 . . . . 0.0 109.44 175.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.515 ' HG2' HG11 ' A' ' 152' ' ' VAL . 40.6 mt-30 73.36 151.1 0.11 Allowed 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 172.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.551 ' HB ' ' HD2' ' A' ' 146' ' ' PRO . 2.2 p -90.95 165.37 22.15 Favored Pre-proline 0 N--CA 1.448 -0.529 0 CA-C-N 114.427 -1.26 . . . . 0.0 110.358 177.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.551 ' HD2' ' HB ' ' A' ' 145' ' ' THR . 20.0 Cg_endo -59.97 159.92 23.88 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.105 2.537 . . . . 0.0 113.601 -177.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -70.83 1.51 5.4 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.096 -0.957 . . . . 0.0 111.207 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -50.13 -35.88 27.58 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.721 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -119.73 7.45 11.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.453 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 44.69 29.86 0.47 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.149 0.98 . . . . 0.0 111.808 -173.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.81 ' HG2' ' HA ' ' A' ' 112' ' ' PRO . 73.9 mt-30 -143.97 153.15 41.96 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 121.069 0.462 . . . . 0.0 111.249 -174.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.515 HG11 ' HG2' ' A' ' 144' ' ' GLN . 33.7 m -126.16 177.91 4.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 176.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.567 HD11 HH11 ' A' ' 110' ' ' ARG . 15.1 mt -121.89 129.62 75.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 O-C-N 121.718 -0.614 . . . . 0.0 111.747 -178.198 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.608 HG22 HG12 ' A' ' 140' ' ' VAL . 59.4 t -93.1 138.67 19.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 173.145 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.552 ' HE3' HG13 ' A' ' 139' ' ' VAL . 4.9 mtmt -107.21 123.6 48.53 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.764 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.56 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 52.7 mt -108.0 111.69 36.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 176.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 4.7 mp -107.66 118.45 55.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.904 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 171.7 -165.78 38.69 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.127 -1.035 . . . . 0.0 113.102 178.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.744 ' HA ' HG13 ' A' ' 103' ' ' VAL . 0.3 OUTLIER -77.81 157.24 30.03 Favored 'General case' 0 C--O 1.223 -0.334 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.185 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.507 ' HB3' ' CG ' ' A' ' 88' ' ' TYR . 44.8 p90 -64.24 -23.35 67.27 Favored 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -175.133 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.569 ' O ' ' HG3' ' A' ' 164' ' ' GLN . 91.1 m-85 -68.73 -51.61 39.55 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.737 0.78 . . . . 0.0 109.543 173.215 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.15 -41.42 67.11 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.563 -174.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 62.0 p -64.59 -44.28 91.16 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.941 -176.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' GLN . . . . . 0.613 ' O ' ' HG2' ' A' ' 168' ' ' ARG . 1.2 pp0? -61.09 -38.04 84.84 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.605 177.229 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.426 ' HG3' ' O ' ' A' ' 161' ' ' TYR . 81.9 mtp -61.24 -42.4 98.56 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.864 0.364 . . . . 0.0 110.818 177.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.427 ' HB2' ' HB ' ' A' ' 134' ' ' THR . . . -70.67 -43.52 68.92 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.748 178.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -51.99 -55.76 18.44 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.728 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.613 ' HG2' ' O ' ' A' ' 164' ' ' GLN . 9.3 ptt180 -65.38 -29.88 70.64 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.824 -179.324 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -70.96 -51.12 27.65 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.949 -178.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.715 HD11 HD21 ' A' ' 130' ' ' LEU . 2.3 mp -68.09 -44.83 84.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.591 ' HA ' ' HG ' ' A' ' 174' ' ' LEU . 20.3 mmm180 -58.62 -26.27 63.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.811 0.339 . . . . 0.0 111.352 177.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -69.49 -46.4 66.69 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.655 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.519 HG13 HD23 ' A' ' 174' ' ' LEU . 32.7 pt -72.16 -19.74 19.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.691 -179.109 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.693 ' CD2' HG23 ' A' ' 111' ' ' VAL . 5.6 mt -66.99 -34.5 77.88 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 177.336 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.4 -31.72 72.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.18 176.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -71.6 -42.27 67.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.988 177.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.426 HG22 ' HD2' ' A' ' 118' ' ' ARG . 88.9 t -67.5 -35.01 71.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.507 176.277 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -57.48 -46.59 83.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.165 0.507 . . . . 0.0 110.328 175.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 . . . . . 0 C--N 1.327 -0.387 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.393 177.802 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.235 0.298 0 CA-C-O 121.016 0.436 . . . . 0.0 110.301 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.524 ' O ' ' HA ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -107.65 161.58 14.74 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.663 178.7 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.8 m -139.84 108.63 5.96 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.765 0.317 . . . . 0.0 110.99 -178.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.413 HG22 HD11 ' A' ' 73' ' ' ILE . 35.5 m -127.77 161.02 36.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.128 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -114.97 130.2 56.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.274 -174.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.548 ' O ' ' HA ' ' A' ' 70' ' ' MET . 21.4 t -105.06 132.81 50.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.823 -174.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.694 ' CZ ' HG11 ' A' ' 68' ' ' VAL . 5.0 t80 -94.12 104.58 16.6 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.012 0.525 . . . . 0.0 110.846 -174.082 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.472 ' C ' HG23 ' A' ' 68' ' ' VAL . 26.7 pt -124.66 120.57 25.77 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.391 0.615 . . . . 0.0 110.404 174.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.586 ' HA ' ' HA ' ' A' ' 68' ' ' VAL . 36.5 Cg_endo -64.82 153.1 79.61 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 123.045 2.497 . . . . 0.0 112.541 -174.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.639 ' HA ' HG12 ' A' ' 34' ' ' VAL . . . -60.48 -18.95 54.88 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.052 -176.185 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -74.09 -13.98 60.92 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.828 177.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.541 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -123.47 -30.75 3.6 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.914 -177.026 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.639 HG12 ' HA ' ' A' ' 31' ' ' ALA . 11.1 p -54.47 -31.54 23.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -172.06 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.59 -59.26 11.1 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.174 -1.012 . . . . 0.0 111.642 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.4 -13.48 59.92 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 120.788 0.327 . . . . 0.0 111.007 -174.323 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.816 HD12 ' HB3' ' A' ' 90' ' ' LYS . 2.0 mm -67.79 -34.4 67.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.75 178.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.491 ' HA ' HD12 ' A' ' 45' ' ' ILE . 19.2 mt -63.23 -59.45 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.962 177.319 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.443 ' HA3' ' NE2' ' A' ' 44' ' ' HIS . . . 118.8 90.55 1.34 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 119.761 -1.209 . . . . 0.0 115.311 168.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 43.9 tptt 57.38 -79.13 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.655 1.182 . . . . 0.0 113.805 171.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.534 ' HE2' ' HB3' ' A' ' 43' ' ' GLN . 19.2 pttm -117.36 7.68 12.89 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.749 0.309 . . . . 0.0 111.389 -175.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 62.9 39.25 97.8 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.995 -0.622 . . . . 0.0 112.942 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.534 ' HB3' ' HE2' ' A' ' 41' ' ' LYS . 23.0 tt0 -114.82 -48.79 2.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 117.158 0.479 . . . . 0.0 111.384 178.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.443 ' NE2' ' HA3' ' A' ' 39' ' ' GLY . 4.6 p80 -63.56 -19.19 64.6 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.075 0.464 . . . . 0.0 110.703 178.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.491 HD12 ' HA ' ' A' ' 38' ' ' ILE . 10.2 tt -67.26 -32.2 56.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.385 174.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -81.54 -22.25 37.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.287 0.565 . . . . 0.0 110.159 178.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -66.79 -30.57 70.8 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 173.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.645 HD22 ' HE1' ' A' ' 51' ' ' PHE . 0.3 OUTLIER -55.58 -49.31 73.06 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.173 173.822 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.67 ' HA ' HD13 ' A' ' 56' ' ' ILE . 8.6 m -57.87 -37.03 73.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.186 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.8 mtp180 -73.48 -50.92 19.09 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -176.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.645 ' HE1' HD22 ' A' ' 48' ' ' LEU . 0.6 OUTLIER -68.63 -27.46 66.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.938 0.399 . . . . 0.0 110.223 -176.43 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.566 ' O ' ' HB1' ' A' ' 79' ' ' ALA . . . -86.82 -10.64 53.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.892 0.377 . . . . 0.0 110.864 177.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 31.5 m 57.62 38.22 27.7 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.148 178.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -138.65 173.46 11.56 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.623 -174.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.402 ' HB2' ' HB ' ' A' ' 74' ' ' THR . 26.4 m -94.7 101.6 13.45 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.179 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.821 HG13 HG22 ' A' ' 73' ' ' ILE . 1.9 mp -106.14 123.12 60.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.129 178.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -138.65 150.97 46.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.23 176.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.2 mm -89.97 120.83 39.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 169.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.818 ' HB2' HG23 ' A' ' 72' ' ' VAL . . . -65.24 122.45 80.0 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.552 -175.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.41 127.29 19.91 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.987 2.458 . . . . 0.0 111.746 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo . . . . . 0 C--O 1.235 0.358 0 C-N-CA 123.204 2.603 . . . . 0.0 112.56 -177.893 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.47 ' O ' ' HD2' ' A' ' 67' ' ' LYS . 24.4 tptp . . . . . 0 C--O 1.232 0.143 0 CA-C-O 121.219 0.533 . . . . 0.0 110.282 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.694 HG11 ' CZ ' ' A' ' 28' ' ' PHE . 10.8 p -139.29 148.8 23.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.857 175.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.588 ' HB3' HG21 ' A' ' 34' ' ' VAL . 17.6 ttm180 -127.09 133.8 50.36 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 175.183 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.548 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 41.0 mtp -100.42 149.33 23.77 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 119.863 -0.735 . . . . 0.0 111.14 -171.421 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.548 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 89.9 t -99.05 127.95 51.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.953 175.437 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.818 HG23 ' HB2' ' A' ' 59' ' ' ALA . 92.3 t -103.28 110.0 28.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 177.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.821 HG22 HG13 ' A' ' 56' ' ' ILE . 2.6 pp -117.0 129.23 73.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.307 0.575 . . . . 0.0 111.072 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 35.4 m -125.14 109.44 12.89 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.922 -1.036 . . . . 0.0 109.889 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.45 162.04 35.43 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.363 -0.922 . . . . 0.0 112.601 -177.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.486 ' HG2' ' HB3' ' A' ' 79' ' ' ALA . 19.3 Cg_endo -59.67 137.01 74.53 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.754 2.303 . . . . 0.0 111.339 174.41 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_exo -40.03 -49.85 3.56 Favored 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 124.314 3.342 . . . . 0.0 114.683 -174.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -68.16 -36.32 79.46 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.888 0.375 . . . . 0.0 111.373 -176.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.566 ' HB1' ' O ' ' A' ' 52' ' ' ALA . . . -74.83 -31.7 61.75 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.425 0.631 . . . . 0.0 110.206 177.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -62.87 -33.45 75.3 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.239 175.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.408 ' HE1' HE22 ' A' ' 164' ' ' GLN . 74.5 t80 -53.75 -54.73 34.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.673 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.564 ' HE2' ' HA ' ' A' ' 79' ' ' ALA . 37.0 pttt -70.9 -33.77 70.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.677 0.275 . . . . 0.0 111.444 -177.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.35 -45.65 86.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.997 0.427 . . . . 0.0 111.011 177.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.654 ' HB3' ' HE1' ' A' ' 160' ' ' PHE . 23.6 tt0 -71.41 -31.69 67.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.318 -177.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -58.0 -32.7 67.11 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.829 176.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -76.65 -27.63 55.72 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.56 0.219 . . . . 0.0 111.197 178.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.524 HG22 ' O ' ' A' ' 84' ' ' GLN . 0.4 OUTLIER -70.26 -39.73 77.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -177.739 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.482 ' HA ' HD12 ' A' ' 105' ' ' LEU . 18.3 m-85 -69.68 -30.81 68.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.095 0.474 . . . . 0.0 109.999 174.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -58.48 -28.6 62.49 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.91 173.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.816 ' HB3' HD12 ' A' ' 37' ' ' ILE . 34.8 mmtp -67.97 -44.39 76.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.082 0.468 . . . . 0.0 109.893 175.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -60.46 -41.71 94.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.851 174.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 1.025 ' HE3' ' HB ' ' A' ' 103' ' ' VAL . 0.6 OUTLIER -65.73 -31.78 72.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.379 178.46 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -52.72 -47.52 67.26 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.575 -176.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.751 ' HB2' ' CE2' ' A' ' 96' ' ' PHE . 10.4 mm-40 -110.14 0.3 18.22 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.665 -177.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 55.72 43.58 27.7 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.751 178.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.751 ' CE2' ' HB2' ' A' ' 94' ' ' GLU . 92.9 m-85 . . . . . 0 N--CA 1.467 0.387 0 CA-C-O 121.101 0.477 . . . . 0.0 111.342 -178.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.437 ' HB3' ' NE2' ' A' ' 159' ' ' HIS . 38.5 mt-10 . . . . . 0 N--CA 1.453 -0.308 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 1.025 ' HB ' ' HE3' ' A' ' 92' ' ' LYS . 12.6 p -59.03 129.84 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.149 175.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 74.3 mmtt -136.86 91.25 2.62 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.423 -177.112 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.482 HD12 ' HA ' ' A' ' 88' ' ' TYR . 2.4 tt -115.88 117.01 29.0 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -76.95 113.93 15.19 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.311 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.5 m -104.99 143.73 32.78 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' HIS . . . . . 0.463 ' NE2' ' HG2' ' A' ' 155' ' ' LYS . 22.1 m170 -114.41 120.28 39.78 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 120.962 0.411 . . . . 0.0 110.346 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.415 ' CD1' ' HB ' ' A' ' 170' ' ' ILE . 16.6 pt -107.97 138.37 34.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 176.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -90.82 118.68 30.42 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.363 -174.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.653 HG12 HD11 ' A' ' 174' ' ' LEU . 11.1 m -116.95 154.34 49.64 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.769 178.376 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.658 ' HD2' HD22 ' A' ' 174' ' ' LEU . 38.4 Cg_exo -58.62 146.06 92.98 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.05 1.833 . . . . 0.0 110.891 173.064 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.455 ' HA ' HG22 ' A' ' 152' ' ' VAL . . . -48.65 -52.21 24.37 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -172.49 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.5 m -76.34 -17.82 59.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.676 -176.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.19 -24.66 62.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.652 0.263 . . . . 0.0 111.24 -177.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.64 ' HB1' HG11 ' A' ' 140' ' ' VAL . . . -64.17 -29.86 70.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.23 0.538 . . . . 0.0 110.357 177.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -77.01 -23.88 67.95 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.827 177.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.482 ' HD2' HG22 ' A' ' 177' ' ' VAL . 78.8 mtt-85 -83.72 -27.79 28.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.568 0.223 . . . . 0.0 110.592 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.728 HG22 HD11 ' A' ' 130' ' ' LEU . 9.9 p -77.47 -32.34 18.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.086 -178.152 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.428 ' O ' HG13 ' A' ' 127' ' ' VAL . 47.1 mm -74.34 -38.64 47.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.427 0.632 . . . . 0.0 109.944 177.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.065 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.384 -178.77 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 23.5 tptm . . . . . 0 N--CA 1.468 0.458 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 26.4 m -68.75 -37.34 79.31 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.891 0.377 . . . . 0.0 110.784 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.428 HG13 ' O ' ' A' ' 120' ' ' ILE . 6.4 m -65.21 -20.95 28.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.669 175.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -63.81 -33.43 75.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.969 0.414 . . . . 0.0 109.954 178.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -79.15 -40.31 31.3 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.642 -0.423 . . . . 0.0 109.957 175.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.728 HD11 HG22 ' A' ' 119' ' ' VAL . 66.4 mt -55.57 -52.01 65.17 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -174.434 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -84.34 -31.92 24.55 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.361 -0.535 . . . . 0.0 112.233 -173.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -72.26 -38.3 68.89 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.785 0.326 . . . . 0.0 111.083 -178.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.413 HD23 ' HE3' ' A' ' 169' ' ' LYS . 42.7 tp -83.03 -46.59 12.67 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.514 -176.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.577 HG21 ' HA ' ' A' ' 166' ' ' ALA . 39.6 p -75.88 -28.01 57.96 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.526 -174.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 67.36 15.48 9.92 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.546 -175.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -112.59 172.1 7.12 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.75 -178.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.468 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 35.2 tt0 -99.99 110.74 23.06 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 177.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 59.8 t -108.42 106.65 21.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.822 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 6.2 p -119.71 115.82 48.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.288 0.566 . . . . 0.0 111.428 -177.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.64 HG11 ' HB1' ' A' ' 116' ' ' ALA . 86.3 t -93.56 110.82 49.43 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.388 173.31 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.65 ' HG3' ' HE2' ' A' ' 155' ' ' LYS . 21.1 Cg_exo -67.5 149.9 80.16 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 123.104 2.536 . . . . 0.0 112.639 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.35 118.71 22.23 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.581 177.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 65.93 97.34 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.422 0.629 . . . . 0.0 112.004 -178.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.614 ' OE1' ' HB ' ' A' ' 153' ' ' ILE . 20.8 mm-40 -102.96 -66.94 0.9 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.545 176.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -145.61 144.61 23.11 Favored Pre-proline 0 C--N 1.314 -0.978 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.957 -179.158 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -67.43 168.33 18.26 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 123.23 2.62 . . . . 0.0 113.531 -174.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -58.84 -15.77 14.07 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.904 -177.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -55.41 -43.17 75.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.9 0.381 . . . . 0.0 110.497 172.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ASN . . . . . 0.414 ' O ' ' HG2' ' A' ' 150' ' ' GLU . 0.2 OUTLIER -87.48 -16.75 33.87 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.102 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 149' ' ' ASN . 10.7 pt-20 46.35 28.91 0.77 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.948 1.299 . . . . 0.0 111.731 -178.127 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -145.29 149.11 34.26 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.381 -174.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.455 HG22 ' HA ' ' A' ' 113' ' ' ALA . 11.2 m -137.59 177.65 5.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 O-C-N 123.362 0.414 . . . . 0.0 110.203 178.084 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.614 ' HB ' ' OE1' ' A' ' 144' ' ' GLN . 96.7 mt -119.92 144.81 27.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.188 -173.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.625 ' HB ' HG22 ' A' ' 140' ' ' VAL . 1.5 p -135.46 139.43 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-O 121.251 0.548 . . . . 0.0 110.342 168.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.65 ' HE2' ' HG3' ' A' ' 141' ' ' PRO . 19.6 mttm -101.88 133.55 46.46 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.342 -172.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.468 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 68.2 mt -115.3 112.12 38.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.901 177.433 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.42 ' N ' HD12 ' A' ' 157' ' ' ILE . 4.5 mp -109.63 132.51 57.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.816 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 156.33 -158.43 28.67 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.222 -0.99 . . . . 0.0 112.866 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.844 ' HA ' HG13 ' A' ' 103' ' ' VAL . 13.6 m-70 -76.7 166.08 23.86 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 123.729 0.311 . . . . 0.0 110.64 -177.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.654 ' HE1' ' HB3' ' A' ' 84' ' ' GLN . 10.4 t80 -61.99 -49.04 77.67 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.59 0.233 . . . . 0.0 110.534 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.402 ' HA ' ' HG2' ' A' ' 164' ' ' GLN . 96.5 m-85 -69.46 -33.61 73.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.894 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.06 -49.85 53.79 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.028 0.442 . . . . 0.0 110.672 178.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.538 ' O ' ' HG3' ' A' ' 167' ' ' GLN . 49.7 m -66.49 -38.43 87.24 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.704 -177.319 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' GLN . . . . . 0.408 HE22 ' HE1' ' A' ' 81' ' ' PHE . 12.8 pt20 -64.16 -36.67 84.79 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.708 178.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 90.1 mtp -66.01 -34.08 77.27 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.951 0.405 . . . . 0.0 110.357 176.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.577 ' HA ' HG21 ' A' ' 134' ' ' THR . . . -71.68 -44.16 64.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.493 177.166 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.538 ' HG3' ' O ' ' A' ' 163' ' ' SER . 75.0 mt-30 -52.46 -51.6 58.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.624 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.753 ' O ' ' HB2' ' A' ' 172' ' ' ASP . 5.9 ptm180 -67.05 -31.74 72.46 Favored 'General case' 0 C--O 1.217 -0.651 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.376 -178.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.441 ' N ' ' HG3' ' A' ' 168' ' ' ARG . 16.2 tppt? -65.25 -53.14 48.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.828 0.347 . . . . 0.0 111.208 -176.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.478 ' O ' ' HG ' ' A' ' 174' ' ' LEU . 3.0 mp -72.29 -44.23 63.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.321 -177.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -61.46 -25.5 67.28 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.916 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.753 ' HB2' ' O ' ' A' ' 168' ' ' ARG . 2.1 t0 -71.16 -47.98 54.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.914 -177.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 18.1 pt -70.12 -19.73 22.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.925 -176.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.658 HD22 ' HD2' ' A' ' 112' ' ' PRO . 19.1 mt -57.73 -32.34 67.33 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.883 0.373 . . . . 0.0 110.733 175.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.71 -31.8 73.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.743 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -67.57 -35.69 79.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.998 177.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.482 HG22 ' HD2' ' A' ' 118' ' ' ARG . 42.1 t -74.82 -27.37 20.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.902 177.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 52.1 tptt -65.66 -45.01 84.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.508 172.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.64 175.159 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 . . . . . 0 N--CA 1.454 -0.227 0 CA-C-O 121.101 0.477 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.43 110.14 15.6 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.126 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 66.0 m -106.62 107.62 18.72 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 173.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.656 ' HB ' HG22 ' A' ' 109' ' ' ILE . 22.2 m -132.14 160.96 42.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.166 -177.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.511 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 12.8 m-70 -116.96 132.0 56.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.615 0.245 . . . . 0.0 110.777 -173.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.552 ' O ' ' HA ' ' A' ' 70' ' ' MET . 9.6 t -101.52 137.39 29.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.571 -176.492 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.511 ' CE2' HG11 ' A' ' 68' ' ' VAL . 1.7 t80 -102.05 105.0 15.67 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.253 -177.594 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.629 HD13 HD11 ' A' ' 87' ' ' ILE . 18.9 pt -132.4 125.83 19.93 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-O 121.288 0.566 . . . . 0.0 111.676 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.538 ' HA ' ' HA ' ' A' ' 68' ' ' VAL . 52.0 Cg_exo -55.85 148.27 57.41 Favored 'Trans proline' 0 C--O 1.239 0.553 0 C-N-CA 123.31 2.674 . . . . 0.0 112.504 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.745 ' HA ' HG12 ' A' ' 34' ' ' VAL . . . -57.83 -23.8 54.41 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.762 -1.108 . . . . 0.0 112.916 -171.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.673 ' HB2' ' HZ ' ' A' ' 96' ' ' PHE . 62.6 mm-40 -64.67 -21.74 66.81 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -175.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.622 ' HB2' ' HE2' ' A' ' 96' ' ' PHE . . . -121.86 -28.97 4.38 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.521 -175.448 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.745 HG12 ' HA ' ' A' ' 31' ' ' ALA . 14.3 p -57.28 -29.21 32.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-O 121.24 0.543 . . . . 0.0 110.166 -178.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.6 -55.32 31.42 Favored Glycine 0 N--CA 1.438 -1.216 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.627 176.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.45 -13.88 61.15 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 120.891 0.377 . . . . 0.0 110.585 -177.051 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.613 HG12 ' O ' ' A' ' 33' ' ' ALA . 7.8 mm -66.29 -37.38 79.56 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.149 175.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.429 HG12 HD12 ' A' ' 45' ' ' ILE . 19.6 mt -66.94 -43.9 88.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.628 174.492 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 83.78 -173.86 51.14 Favored Glycine 0 C--O 1.224 -0.525 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.957 174.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -47.83 91.07 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.509 0.723 . . . . 0.0 112.486 -177.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.6 ttpt 49.28 37.41 11.34 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.984 0.913 . . . . 0.0 111.544 -175.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.437 ' HA2' HG22 ' A' ' 45' ' ' ILE . . . 83.01 26.85 43.09 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.233 -0.984 . . . . 0.0 112.557 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -56.1 -71.57 0.09 Allowed 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -76.78 -20.6 56.25 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.208 0.448 . . . . 0.0 112.208 -173.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.437 HG22 ' HA2' ' A' ' 42' ' ' GLY . 10.3 tt -68.8 -37.07 76.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.904 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.419 ' HG2' ' O ' ' A' ' 42' ' ' GLY . 1.9 mmmp? -82.23 -22.42 35.89 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 121.939 -0.476 . . . . 0.0 110.679 177.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -69.96 -30.38 67.73 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 172.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.705 ' HA ' ' HE1' ' A' ' 51' ' ' PHE . 0.2 OUTLIER -51.38 -50.46 59.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.996 175.733 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.492 ' HA ' HD13 ' A' ' 56' ' ' ILE . 1.6 p -63.91 -23.26 67.28 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.231 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -74.38 -51.75 14.11 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.705 ' HE1' ' HA ' ' A' ' 48' ' ' LEU . 13.1 p90 -83.97 -22.71 31.35 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.512 -173.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -95.7 -16.53 21.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.85 0.357 . . . . 0.0 111.095 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 73.2 m 56.29 26.46 10.54 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.482 -178.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -106.64 171.55 7.3 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.824 -179.102 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.5 m -95.7 107.38 19.59 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 178.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.814 HG13 HG22 ' A' ' 73' ' ' ILE . 2.9 mp -108.02 121.31 60.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.782 -176.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -139.51 155.75 47.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.828 175.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 48.5 mm -99.92 129.56 50.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 173.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.745 ' HB2' HG23 ' A' ' 72' ' ' VAL . . . -81.74 119.08 74.51 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.137 -175.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 59' ' ' ALA . 7.4 Cg_exo -73.25 125.65 10.43 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 123.037 2.491 . . . . 0.0 112.055 176.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.443 ' HD3' ' HG3' ' A' ' 69' ' ' ARG . 72.3 Cg_endo . . . . . 0 N--CA 1.458 -0.56 0 C-N-CA 122.242 1.961 . . . . 0.0 111.658 176.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? . . . . . 0 N--CA 1.456 -0.146 0 CA-C-O 121.542 0.687 . . . . 0.0 110.171 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.538 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 1.4 p -137.46 148.66 25.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.723 -174.251 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.443 ' HG3' ' HD3' ' A' ' 61' ' ' PRO . 19.8 ttm180 -126.1 144.35 50.77 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 177.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.552 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 42.0 mtp -98.58 149.45 22.74 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.429 -173.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 26' ' ' HIS . 90.9 t -105.98 137.92 33.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.828 174.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.745 HG23 ' HB2' ' A' ' 59' ' ' ALA . 58.6 t -111.57 109.36 28.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 178.434 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.814 HG22 HG13 ' A' ' 56' ' ' ILE . 2.0 pp -124.6 140.32 48.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.143 0.497 . . . . 0.0 111.31 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 90.1 m -131.28 113.92 14.39 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.132 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.65 162.75 36.14 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.37 -177.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.47 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 45.3 Cg_endo -68.42 140.44 48.13 Favored 'Trans proline' 0 CA--C 1.531 0.346 0 C-N-CA 122.698 2.265 . . . . 0.0 111.371 175.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 76' ' ' PRO . 80.4 Cg_exo -45.98 -36.37 15.73 Favored 'Trans proline' 0 N--CA 1.477 0.543 0 C-N-CA 124.746 3.631 . . . . 0.0 114.897 -172.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -72.37 -39.37 68.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.84 0.352 . . . . 0.0 110.813 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.56 ' HA ' ' HE2' ' A' ' 82' ' ' LYS . . . -75.44 -29.31 59.65 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.235 0.54 . . . . 0.0 110.186 176.447 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -64.72 -35.38 80.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.3 178.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -53.34 -51.0 63.84 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.14 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.56 ' HE2' ' HA ' ' A' ' 79' ' ' ALA . 47.2 pttt -72.71 -33.85 66.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.465 -177.449 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.466 ' HB1' HD11 ' A' ' 48' ' ' LEU . . . -67.14 -53.8 27.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.866 0.365 . . . . 0.0 111.097 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.453 ' O ' HG22 ' A' ' 87' ' ' ILE . 45.1 tt0 -65.82 -29.72 70.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.107 -178.12 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -53.85 -35.73 53.81 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.737 177.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -75.81 -40.06 55.7 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 120.855 0.36 . . . . 0.0 110.852 178.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.629 HD11 HD13 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -65.33 -38.5 82.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.052 -177.343 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.848 ' HA ' HD22 ' A' ' 91' ' ' LEU . 2.2 m-30 -69.62 -27.34 64.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.763 0.316 . . . . 0.0 111.166 173.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -57.81 -41.14 93.86 Favored Glycine 0 CA--C 1.52 0.402 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.567 177.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.595 ' HG3' ' O ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -65.29 -24.64 67.35 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.68 0.276 . . . . 0.0 111.038 179.171 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.848 HD22 ' HA ' ' A' ' 88' ' ' TYR . 1.6 mp -58.37 -50.57 73.2 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.443 0.639 . . . . 0.0 110.392 177.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.86 ' HE3' ' HB ' ' A' ' 103' ' ' VAL . 0.6 OUTLIER -73.67 -37.89 65.11 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.434 177.711 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.512 ' HB3' ' HA ' ' A' ' 90' ' ' LYS . 3.7 tp10 -58.74 -38.46 78.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.525 -177.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.406 ' HG3' ' HB2' ' A' ' 33' ' ' ALA . 5.1 mm-40 -96.74 8.81 43.43 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -176.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 54.98 34.61 22.77 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.911 175.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.673 ' HZ ' ' HB2' ' A' ' 32' ' ' GLN . 44.4 m-85 . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 121.404 0.621 . . . . 0.0 109.555 174.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 . . . . . 0 N--CA 1.454 -0.236 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.86 ' HB ' ' HE3' ' A' ' 92' ' ' LYS . 7.2 p -79.68 129.65 37.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.177 0.513 . . . . 0.0 110.227 174.418 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.565 ' HD2' ' HA2' ' A' ' 158' ' ' GLY . 21.1 mmmt -139.14 89.48 2.35 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 174.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.809 ' HG ' HD21 ' A' ' 91' ' ' LEU . 3.4 tm? -110.94 130.48 55.57 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.489 -169.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.446 ' HA ' HG13 ' A' ' 157' ' ' ILE . 6.8 tp10 -64.88 118.91 9.73 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.394 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.0 m -126.39 114.93 18.86 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 177.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 49.9 m170 -99.66 120.42 39.67 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.942 0.401 . . . . 0.0 110.792 -177.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.656 HG22 ' HB ' ' A' ' 25' ' ' VAL . 39.8 pt -110.22 149.38 13.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.063 176.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 13.7 mmt180 -96.76 119.48 35.32 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.336 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.66 HG12 HD21 ' A' ' 174' ' ' LEU . 16.8 m -111.79 152.23 44.01 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 177.298 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.848 ' HD2' ' HG ' ' A' ' 174' ' ' LEU . 32.4 Cg_exo -56.22 147.73 64.38 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.435 2.09 . . . . 0.0 111.043 176.261 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -50.11 -52.1 37.63 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -171.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 18.6 m -72.25 -25.4 61.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.795 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.5 -26.52 65.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.798 0.333 . . . . 0.0 110.881 -178.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.798 ' HB1' HG21 ' A' ' 140' ' ' VAL . . . -64.96 -28.84 69.79 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.967 178.443 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -81.43 -18.97 67.44 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.613 -0.804 . . . . 0.0 111.838 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.59 ' HD3' HG22 ' A' ' 177' ' ' VAL . 17.8 mtp85 -92.38 -19.53 21.99 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 122.733 -0.275 . . . . 0.0 111.23 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.63 HG12 ' O ' ' A' ' 116' ' ' ALA . 7.6 p -69.52 -29.16 40.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.066 0.46 . . . . 0.0 110.236 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.958 ' HA ' ' HB ' ' A' ' 127' ' ' VAL . 7.7 pt -86.5 -33.62 7.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.59 175.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.562 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.913 179.264 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.403 ' HD3' ' N ' ' A' ' 126' ' ' THR . 1.2 tmtp? . . . . . 0 CA--C 1.538 0.509 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.403 ' N ' ' HD3' ' A' ' 125' ' ' LYS . 95.1 m -60.16 -46.07 90.95 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -175.229 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.958 ' HB ' ' HA ' ' A' ' 120' ' ' ILE . 7.1 p -64.62 -40.4 88.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.813 0.34 . . . . 0.0 111.322 -178.194 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -68.61 -33.96 74.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.258 0.551 . . . . 0.0 109.94 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -64.24 -41.71 96.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.864 175.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 127' ' ' VAL . 80.9 mt -59.45 -50.04 75.49 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.567 175.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -62.76 -40.55 97.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.292 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -68.03 -27.69 66.76 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.401 -177.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' A' ' 133' ' ' LEU . 1.9 tm? -93.18 -43.19 8.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.886 0.375 . . . . 0.0 110.961 -176.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 76.1 p -84.66 -20.47 31.22 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -175.006 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 67.04 20.64 10.37 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 123.724 0.64 . . . . 0.0 110.998 -178.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -118.43 157.46 27.15 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.167 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.57 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 36.4 tt0 -88.35 110.55 20.88 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 59.2 t -108.74 106.8 21.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.321 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.421 ' C ' HG23 ' A' ' 154' ' ' VAL . 6.7 p -132.28 120.74 44.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.38 0.61 . . . . 0.0 111.482 -178.045 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.798 HG21 ' HB1' ' A' ' 116' ' ' ALA . 2.6 p -99.82 113.16 64.95 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.01 177.112 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.54 ' HD2' ' O ' ' A' ' 153' ' ' ILE . 36.1 Cg_exo -60.78 125.64 17.74 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.439 2.092 . . . . 0.0 111.55 175.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -83.75 -15.22 49.34 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.26 0.553 . . . . 0.0 109.814 178.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -106.66 59.28 0.64 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.03 172.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.685 ' HG2' ' HB ' ' A' ' 152' ' ' VAL . 57.5 tp60 -100.52 171.75 7.54 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.147 -174.037 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.432 ' N ' ' HG3' ' A' ' 144' ' ' GLN . 31.7 p -45.21 153.82 0.52 Allowed Pre-proline 0 C--N 1.325 -0.499 0 C-N-CA 123.564 0.746 . . . . 0.0 112.346 174.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -54.61 153.85 22.3 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 123.398 2.732 . . . . 0.0 112.914 -176.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -78.33 9.34 3.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.544 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -53.05 -43.61 66.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.627 175.037 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ASN . . . . . 0.421 ' O ' ' HG2' ' A' ' 150' ' ' GLU . 0.2 OUTLIER -79.74 1.02 28.19 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.668 -175.149 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 149' ' ' ASN . 9.2 pt-20 46.42 29.06 0.81 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.074 0.95 . . . . 0.0 110.484 -171.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -164.5 130.39 2.88 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.17 -169.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.685 ' HB ' ' HG2' ' A' ' 144' ' ' GLN . 23.7 m -128.26 -176.55 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.899 -175.218 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.54 ' O ' ' HD2' ' A' ' 141' ' ' PRO . 49.2 mt -104.85 142.52 17.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.03 -174.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.421 HG23 ' C ' ' A' ' 139' ' ' VAL . 2.1 p -135.0 140.0 46.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.074 164.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.9 mttt -95.24 145.6 24.94 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.424 -172.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.57 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 70.6 mt -131.42 110.79 18.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.476 174.198 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.446 HG13 ' HA ' ' A' ' 106' ' ' GLU . 3.8 mp -120.32 118.44 56.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 178.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.565 ' HA2' ' HD2' ' A' ' 104' ' ' LYS . . . -170.87 -170.17 34.77 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.489 -0.863 . . . . 0.0 112.164 -174.412 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.551 ' HA ' ' O ' ' A' ' 103' ' ' VAL . 24.6 m170 -80.35 169.99 17.0 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.336 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -53.26 -45.89 69.01 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -174.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.465 ' O ' ' HG3' ' A' ' 165' ' ' MET . 36.3 p90 -73.88 -33.85 64.21 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.92 0.391 . . . . 0.0 110.762 178.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.79 -50.97 37.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.133 -174.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 26.5 m -58.1 -48.57 79.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.64 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' GLN . . . . . 0.501 ' O ' ' HG2' ' A' ' 168' ' ' ARG . 65.7 mt-30 -61.74 -32.03 72.24 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.665 -178.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.465 ' HG3' ' O ' ' A' ' 161' ' ' TYR . 77.0 mtp -70.04 -48.54 57.54 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.382 175.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.43 -42.07 98.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.534 -177.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.55 HE21 HG21 ' A' ' 25' ' ' VAL . 39.0 mt-30 -51.4 -54.65 24.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.279 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.501 ' HG2' ' O ' ' A' ' 164' ' ' GLN . 19.4 ptt180 -75.7 -30.81 59.43 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.278 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.895 ' HA ' ' HE3' ' A' ' 169' ' ' LYS . 0.1 OUTLIER -70.85 -36.79 73.03 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 122.195 -0.316 . . . . 0.0 111.292 -177.342 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.649 ' O ' HD13 ' A' ' 174' ' ' LEU . 1.8 mp -75.29 -43.04 43.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 174.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.616 ' HA ' HD22 ' A' ' 174' ' ' LEU . 10.7 mmm180 -54.85 -25.74 30.67 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.994 0.426 . . . . 0.0 110.883 175.111 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.481 ' HB3' ' O ' ' A' ' 169' ' ' LYS . 6.7 t70 -63.13 -55.66 23.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.415 -0.812 . . . . 0.0 111.11 178.242 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.529 ' O ' HG23 ' A' ' 177' ' ' VAL . 37.8 pt -67.31 -21.95 28.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.882 -176.105 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.848 ' HG ' ' HD2' ' A' ' 112' ' ' PRO . 6.7 mp -57.18 -41.69 79.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.825 176.035 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.471 ' O ' ' HG2' ' A' ' 179' ' ' GLN . . . -68.16 -35.59 78.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.321 178.205 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -67.56 -32.58 73.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.457 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.59 HG22 ' HD3' ' A' ' 118' ' ' ARG . 60.0 t -72.86 -38.21 56.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.881 0.372 . . . . 0.0 110.535 178.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -69.17 -11.14 60.54 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.298 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 175' ' ' ALA . 33.1 mm-40 . . . . . 0 N--CA 1.464 0.261 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.143 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 . . . . . 0 N--CA 1.454 -0.265 0 CA-C-O 120.911 0.386 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.68 ' OE1' ' HG3' ' A' ' 171' ' ' ARG . 58.4 mt-10 -102.44 132.14 48.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.585 176.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.8 m -100.82 106.73 18.14 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 172.035 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.717 HG13 HG22 ' A' ' 109' ' ' ILE . 4.6 t -136.08 146.61 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.07 -174.535 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.456 ' HB2' ' O ' ' A' ' 108' ' ' HIS . 11.5 m170 -104.19 128.58 51.91 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-O 120.932 0.396 . . . . 0.0 110.483 -176.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.5 ' HB ' ' CG1' ' A' ' 71' ' ' VAL . 2.3 t -108.7 142.4 21.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -99.13 112.77 24.83 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -174.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.595 HG22 HD21 ' A' ' 91' ' ' LEU . 6.5 pt -126.81 120.11 22.78 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.846 176.533 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.619 ' HA ' ' HA ' ' A' ' 68' ' ' VAL . 68.6 Cg_exo -51.46 144.56 31.6 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.395 2.73 . . . . 0.0 112.58 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.711 ' HA ' HG12 ' A' ' 34' ' ' VAL . . . -59.85 -22.94 62.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.974 -1.012 . . . . 0.0 112.218 -173.11 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -84.2 0.3 49.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.38 -178.052 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.892 ' HB2' ' HE2' ' A' ' 96' ' ' PHE . . . -125.07 -32.75 2.97 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.594 174.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.711 HG12 ' HA ' ' A' ' 31' ' ' ALA . 11.2 p -57.01 -26.99 25.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-O 121.206 0.527 . . . . 0.0 110.075 -178.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.58 -56.95 22.32 Favored Glycine 0 N--CA 1.431 -1.649 0 CA-C-N 115.344 -0.843 . . . . 0.0 111.566 176.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.34 -13.53 59.8 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.826 0.346 . . . . 0.0 111.227 -174.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.661 HD12 ' HG2' ' A' ' 90' ' ' LYS . 3.3 mm -66.35 -39.47 84.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 176.165 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.711 HG22 ' HA2' ' A' ' 42' ' ' GLY . 32.5 mt -64.37 -44.78 97.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 172.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 70.6 104.45 0.04 OUTLIER Glycine 0 CA--C 1.519 0.309 0 N-CA-C 115.706 1.042 . . . . 0.0 115.706 163.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 66.7 mttm 40.54 98.39 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.598 1.159 . . . . 0.0 113.707 167.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.686 ' HE2' ' HB3' ' A' ' 43' ' ' GLN . 24.6 ttpt 76.13 -23.21 0.25 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.209 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.711 ' HA2' HG22 ' A' ' 38' ' ' ILE . . . 92.31 23.06 27.82 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.977 -178.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.686 ' HB3' ' HE2' ' A' ' 41' ' ' LYS . 19.2 pt20 -87.95 -24.71 23.5 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.15 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -66.11 -44.53 84.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.783 0.325 . . . . 0.0 110.775 -178.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.574 ' CD1' HG12 ' A' ' 58' ' ' ILE . 3.0 tt -61.75 -49.06 85.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.242 -177.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -77.55 -21.36 52.67 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.849 0.356 . . . . 0.0 111.033 -175.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -68.43 -36.67 79.4 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 172.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.958 HD23 HG12 ' A' ' 56' ' ' ILE . 1.2 tp -56.73 -40.69 76.15 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.209 177.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.69 ' HA ' HD13 ' A' ' 56' ' ' ILE . 2.1 m -56.85 -38.46 72.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.984 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -70.7 -51.27 28.67 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -175.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.658 ' CZ ' ' HA ' ' A' ' 48' ' ' LEU . 10.6 p90 -79.14 -6.88 57.55 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 120.274 -0.57 . . . . 0.0 111.553 -176.024 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -97.55 -13.12 21.83 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.863 0.363 . . . . 0.0 110.703 173.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.7 m 56.62 39.61 29.72 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.054 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.441 ' HB1' ' O ' ' A' ' 74' ' ' THR . . . -141.28 174.62 10.36 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.469 -174.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.616 ' HB3' ' HB ' ' A' ' 74' ' ' THR . 32.3 t -92.78 104.34 16.61 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.958 HG12 HD23 ' A' ' 48' ' ' LEU . 1.9 mp -110.97 115.52 50.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.778 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -143.49 151.36 40.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.938 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.574 HG12 ' CD1' ' A' ' 45' ' ' ILE . 25.1 mm -86.88 134.64 27.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.719 0.295 . . . . 0.0 110.347 178.087 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.73 ' HB2' HG23 ' A' ' 72' ' ' VAL . . . -95.27 116.77 66.62 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.397 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -62.37 128.61 24.22 Favored 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 122.698 2.265 . . . . 0.0 112.053 178.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.73 ' HD3' ' HG3' ' A' ' 69' ' ' ARG . 57.2 Cg_endo . . . . . 0 C--O 1.237 0.437 0 C-N-CA 122.449 2.099 . . . . 0.0 111.635 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? . . . . . 0 C--O 1.23 0.076 0 CA-C-O 121.047 0.451 . . . . 0.0 110.747 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.619 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 2.0 p -134.16 147.15 30.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.192 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.73 ' HG3' ' HD3' ' A' ' 61' ' ' PRO . 27.2 ttm180 -119.18 145.87 45.64 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.617 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 55.3 mtt -87.6 149.07 24.55 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.817 0.342 . . . . 0.0 110.321 -178.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.5 ' CG1' ' HB ' ' A' ' 27' ' ' VAL . 2.8 p -118.5 131.97 69.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 169.013 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.73 HG23 ' HB2' ' A' ' 59' ' ' ALA . 58.3 t -86.81 102.62 12.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.096 0.474 . . . . 0.0 109.977 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.457 ' HA ' HD13 ' A' ' 73' ' ' ILE . 1.9 mm -94.97 117.63 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.987 175.449 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.661 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 25.0 m -130.02 106.26 8.52 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.656 175.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.13 162.0 35.31 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.748 -176.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -69.51 155.41 66.83 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.356 2.038 . . . . 0.0 111.144 171.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -38.92 -42.92 2.11 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 124.041 3.161 . . . . 0.0 114.231 -177.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.47 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 30.4 tt0 -55.99 -50.3 71.24 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.149 0.5 . . . . 0.0 110.561 176.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.434 ' HA ' ' CE ' ' A' ' 82' ' ' LYS . . . -63.54 -36.68 84.57 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.689 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -55.96 -35.58 66.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.942 177.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -69.7 -55.66 9.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.767 -174.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.47 ' HD3' ' O ' ' A' ' 78' ' ' GLU . 0.4 OUTLIER -74.62 -34.16 62.74 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 120.119 -0.632 . . . . 0.0 111.879 -176.36 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.31 -52.59 64.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.93 0.395 . . . . 0.0 110.617 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.474 ' HA ' HG22 ' A' ' 87' ' ' ILE . 47.6 mt-30 -76.38 -31.25 57.9 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.216 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.401 ' HA2' ' CE1' ' A' ' 160' ' ' PHE . . . -53.95 -43.65 71.84 Favored Glycine 0 CA--C 1.512 -0.153 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.02 177.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' A' ' 82' ' ' LYS . 12.6 mmt180 -74.84 -43.04 56.73 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.989 0.423 . . . . 0.0 110.076 176.267 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.903 ' HA ' ' HD3' ' A' ' 90' ' ' LYS . 0.4 OUTLIER -63.8 -35.79 74.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.994 -171.189 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -64.48 -30.51 71.55 Favored 'General case' 0 C--N 1.333 -0.114 0 O-C-N 121.866 -0.522 . . . . 0.0 109.688 176.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -65.0 -29.03 74.31 Favored Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.666 173.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.903 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 4.3 mptp? -68.84 -33.36 73.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.148 0.499 . . . . 0.0 110.103 175.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.735 ' HG ' ' HG ' ' A' ' 105' ' ' LEU . 4.1 mm? -64.55 -40.24 95.21 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.523 172.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.878 ' HE3' ' HB ' ' A' ' 103' ' ' VAL . 0.1 OUTLIER -71.71 -22.0 61.7 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.564 176.659 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -53.52 -47.27 70.06 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.302 178.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -112.81 3.79 16.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.902 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 43.09 59.99 2.7 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 172.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.892 ' HE2' ' HB2' ' A' ' 33' ' ' ALA . 82.8 m-85 . . . . . 0 C--N 1.327 -0.41 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.955 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.467 ' O ' ' HG2' ' A' ' 104' ' ' LYS . 6.7 mm-40 . . . . . 0 CA--C 1.515 -0.4 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.878 ' HB ' ' HE3' ' A' ' 92' ' ' LYS . 14.9 p -52.39 125.37 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 CA-C-O 121.576 0.703 . . . . 0.0 111.258 -173.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 47.1 mmtm -120.13 91.16 3.47 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.563 -1.198 . . . . 0.0 108.755 178.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.735 ' HG ' ' HG ' ' A' ' 91' ' ' LEU . 1.5 tt -108.27 124.9 51.01 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.658 -173.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -74.5 120.93 20.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.627 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.4 m -107.33 108.47 19.86 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 173.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' HIS . . . . . 0.456 ' O ' ' HB2' ' A' ' 26' ' ' HIS . 12.1 m-70 -104.01 121.07 42.39 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.159 0.504 . . . . 0.0 109.921 -177.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.717 HG22 HG13 ' A' ' 25' ' ' VAL . 23.0 pt -122.88 152.22 27.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 C-N-CA 120.534 -0.466 . . . . 0.0 112.138 -173.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.713 ' HD3' HG12 ' A' ' 153' ' ' ILE . 1.7 mmt180 -100.05 116.83 32.99 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.435 174.315 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 151' ' ' GLN . 31.2 m -104.93 162.31 20.15 Favored Pre-proline 0 C--N 1.316 -0.858 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 173.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.421 ' HD2' HD22 ' A' ' 174' ' ' LEU . 51.7 Cg_exo -51.83 139.69 49.25 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 121.442 1.428 . . . . 0.0 109.856 170.244 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -55.18 -30.5 60.03 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.492 -170.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.5 m -93.02 -15.64 25.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.75 0.31 . . . . 0.0 111.439 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.62 -24.72 61.93 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.913 -172.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.546 ' O ' HG12 ' A' ' 119' ' ' VAL . . . -57.99 -28.84 64.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.145 0.498 . . . . 0.0 110.787 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.92 -27.76 73.52 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.997 -0.62 . . . . 0.0 113.014 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.609 ' HD3' HG22 ' A' ' 177' ' ' VAL . 69.3 mtp180 -92.12 -22.79 19.69 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 122.385 -0.479 . . . . 0.0 111.488 -178.015 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.546 HG12 ' O ' ' A' ' 116' ' ' ALA . 9.8 p -73.31 -27.98 24.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 174.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.943 ' HA ' ' HB ' ' A' ' 127' ' ' VAL . 67.7 mt -78.56 -39.44 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 CA-C-O 121.708 0.766 . . . . 0.0 109.339 171.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.589 ' HA3' ' HB ' ' A' ' 126' ' ' THR . . . . . . . . 0 N--CA 1.442 -0.933 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.312 175.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 41.3 tptt . . . . . 0 C--O 1.232 0.177 0 CA-C-O 121.103 0.477 . . . . 0.0 110.621 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.589 ' HB ' ' HA3' ' A' ' 121' ' ' GLY . 84.2 m -65.2 -46.93 78.72 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.306 -176.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.943 ' HB ' ' HA ' ' A' ' 120' ' ' ILE . 11.6 p -67.83 -35.84 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 121.029 -0.268 . . . . 0.0 111.219 -176.54 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -65.26 -43.57 90.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.2 0.524 . . . . 0.0 109.989 178.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -68.49 -35.68 77.87 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.102 177.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.69 HD21 HD11 ' A' ' 170' ' ' ILE . 39.4 tp -60.74 -49.53 77.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.817 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -66.65 -32.37 73.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.777 0.322 . . . . 0.0 111.129 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -64.05 -43.6 95.04 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.996 0.427 . . . . 0.0 110.703 175.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 6.7 tt -73.88 -48.11 33.3 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.805 -177.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.671 ' HB ' ' HB2' ' A' ' 166' ' ' ALA . 70.5 p -77.65 -29.98 51.9 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -172.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 65.03 28.17 12.48 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.601 -175.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -121.02 169.37 10.56 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.441 177.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 9.0 tp10 -96.18 111.86 23.78 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.835 -178.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 45.3 t -113.63 107.33 22.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 O-C-N 123.82 0.7 . . . . 0.0 109.391 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.693 HG13 ' HD3' ' A' ' 155' ' ' LYS . 14.9 p -125.87 126.9 70.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.231 0.539 . . . . 0.0 111.63 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.443 HG22 ' HB ' ' A' ' 154' ' ' VAL . 59.9 t -104.94 112.95 65.26 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.906 176.214 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.638 ' HG3' ' HE3' ' A' ' 155' ' ' LYS . 34.6 Cg_exo -62.01 156.98 46.32 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 123.1 2.533 . . . . 0.0 112.325 177.338 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -87.4 -26.1 23.48 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.076 -178.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -120.2 115.97 24.68 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.133 178.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.53 ' OE1' ' HB ' ' A' ' 153' ' ' ILE . 22.4 mm-40 -127.77 -86.9 0.57 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.012 0.434 . . . . 0.0 112.034 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -152.77 154.65 31.65 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.299 -175.185 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.76 165.17 26.59 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.731 2.288 . . . . 0.0 111.2 175.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -69.98 -3.96 18.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.96 -177.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -53.84 -42.57 68.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.277 0.56 . . . . 0.0 110.239 169.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -84.21 -14.12 50.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.832 -179.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 47.27 23.46 0.33 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.024 1.33 . . . . 0.0 112.058 -175.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.467 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 57.8 mt-30 -143.27 142.26 31.3 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 120.994 0.426 . . . . 0.0 111.16 -175.153 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 19.7 m -131.93 163.46 37.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 174.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.713 HG12 ' HD3' ' A' ' 110' ' ' ARG . 12.8 mt -107.39 141.71 21.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.365 0.602 . . . . 0.0 112.393 -176.419 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.443 ' HB ' HG22 ' A' ' 140' ' ' VAL . 2.5 p -128.49 139.44 51.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.379 163.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.693 ' HD3' HG13 ' A' ' 139' ' ' VAL . 0.0 OUTLIER -99.44 137.76 37.48 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -176.27 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.447 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 65.1 mt -113.5 111.18 34.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 169.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 4.7 mp -113.69 140.84 31.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 156.28 -168.52 33.62 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.113 -1.041 . . . . 0.0 112.636 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.402 ' HA ' ' O ' ' A' ' 103' ' ' VAL . 44.6 t60 -75.55 160.85 29.7 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.602 -0.299 . . . . 0.0 110.374 -178.111 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.535 ' O ' ' HG2' ' A' ' 164' ' ' GLN . 30.4 t80 -49.39 -50.0 42.28 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -172.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -71.47 -47.44 55.63 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.194 -177.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -59.27 -44.62 92.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.911 0.386 . . . . 0.0 110.845 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.659 ' O ' ' HG3' ' A' ' 167' ' ' GLN . 31.9 t -63.79 -52.1 61.79 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.173 -177.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' GLN . . . . . 0.535 ' HG2' ' O ' ' A' ' 160' ' ' PHE . 10.5 pt20 -66.96 -35.21 79.46 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.406 -177.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 47.1 ttp -64.85 -36.72 85.27 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.068 0.461 . . . . 0.0 109.912 177.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.671 ' HB2' ' HB ' ' A' ' 134' ' ' THR . . . -69.47 -43.11 73.88 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.241 174.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.68 ' O ' ' HG2' ' A' ' 171' ' ' ARG . 80.7 mt-30 -51.47 -56.71 11.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.341 -176.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.401 ' HG3' ' N ' ' A' ' 169' ' ' LYS . 0.1 OUTLIER -58.4 -29.78 66.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.036 -179.102 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.803 ' HA ' ' HE2' ' A' ' 169' ' ' LYS . 0.6 OUTLIER -75.17 -36.39 61.5 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 120.862 0.363 . . . . 0.0 110.399 -172.903 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.69 HD11 HD21 ' A' ' 130' ' ' LEU . 1.8 mp -74.61 -42.46 48.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.469 178.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.68 ' HG3' ' OE1' ' A' ' 23' ' ' GLU . 0.8 OUTLIER -64.25 -25.62 68.14 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.391 0.615 . . . . 0.0 109.419 179.284 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -73.06 -44.24 60.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.583 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.551 HG13 ' O ' ' A' ' 170' ' ' ILE . 2.8 pp -70.95 -19.22 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.904 -178.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 170' ' ' ILE . 39.3 mt -58.82 -34.82 71.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.035 0.445 . . . . 0.0 110.365 174.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.17 -34.53 78.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.767 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -66.44 -39.06 88.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.22 0.533 . . . . 0.0 109.973 176.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.609 HG22 ' HD3' ' A' ' 118' ' ' ARG . 39.6 t -63.53 -38.96 83.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.229 176.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -63.58 -44.49 93.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.271 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.197 -179.308 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.409 ' OE1' ' HA ' ' A' ' 22' ' ' GLN . 14.5 mm-40 . . . . . 0 C--O 1.236 0.362 0 CA-C-O 120.972 0.415 . . . . 0.0 110.223 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -98.1 117.74 33.14 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.183 -178.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 48.3 m -110.57 107.72 17.43 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.82 176.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.528 ' HB ' HD11 ' A' ' 73' ' ' ILE . 34.8 t -117.9 147.87 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.438 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 7.3 m80 -110.04 123.36 49.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.862 0.363 . . . . 0.0 110.71 -173.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.585 ' HB ' ' HB ' ' A' ' 71' ' ' VAL . 44.4 t -90.36 142.03 13.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.59 -176.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.24 105.16 14.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.469 -177.342 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.555 ' C ' ' HB ' ' A' ' 68' ' ' VAL . 13.9 pt -127.9 123.47 22.81 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 120.938 0.399 . . . . 0.0 110.929 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -48.53 143.53 15.75 Favored 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 123.531 2.821 . . . . 0.0 112.638 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.466 ' HA ' HG12 ' A' ' 34' ' ' VAL . . . -58.08 -18.79 27.14 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.101 -176.38 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.5 mp0 -65.25 -44.28 88.64 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.401 177.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.746 ' HB2' ' HE2' ' A' ' 96' ' ' PHE . . . -93.71 -29.64 15.3 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.196 -171.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.611 ' HA ' HG12 ' A' ' 37' ' ' ILE . 12.2 p -56.92 -27.64 26.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 O-C-N 123.253 0.346 . . . . 0.0 111.201 -174.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.83 -56.82 22.84 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.235 -0.983 . . . . 0.0 111.076 177.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.95 -15.71 60.13 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.607 -176.178 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.703 HD12 ' HB3' ' A' ' 90' ' ' LYS . 4.8 mm -61.66 -47.16 94.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.242 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.871 HG22 ' HA2' ' A' ' 42' ' ' GLY . 28.9 mt -63.64 -38.61 82.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.203 177.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.416 ' HA3' ' CD2' ' A' ' 44' ' ' HIS . . . 81.83 105.34 0.39 Allowed Glycine 0 CA--C 1.52 0.397 0 N-CA-C 115.554 0.982 . . . . 0.0 115.554 164.465 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.486 ' HA ' ' HD3' ' A' ' 40' ' ' LYS . 30.0 mmtp 63.64 -81.29 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 168.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.8 ptmt -123.02 10.12 9.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.931 0.396 . . . . 0.0 110.932 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.871 ' HA2' HG22 ' A' ' 38' ' ' ILE . . . 83.34 16.19 69.67 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.408 -0.901 . . . . 0.0 111.786 -177.28 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -76.4 -28.6 56.77 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.096 0.474 . . . . 0.0 110.048 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.463 ' HB2' ' O ' ' A' ' 38' ' ' ILE . 1.7 m-70 -67.04 -30.67 70.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.699 -173.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.793 HD12 HG12 ' A' ' 58' ' ' ILE . 8.9 tt -76.12 -40.33 36.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -175.166 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.64 -30.98 41.48 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.124 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.469 ' OE1' ' HD2' ' A' ' 50' ' ' ARG . 6.3 tp60 -64.48 -33.84 76.83 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 173.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.835 HD12 HG12 ' A' ' 56' ' ' ILE . 0.5 OUTLIER -58.73 -47.14 85.65 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.987 176.407 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.636 ' HA ' HD13 ' A' ' 56' ' ' ILE . 57.1 m -58.26 -31.89 67.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.046 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.469 ' HD2' ' OE1' ' A' ' 47' ' ' GLN . 99.6 mtt180 -73.64 -33.66 64.62 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.584 -178.249 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.735 ' CD2' ' HA ' ' A' ' 48' ' ' LEU . 24.2 m-85 -62.21 -48.12 81.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.108 0.48 . . . . 0.0 110.761 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.419 ' HB1' ' HB1' ' A' ' 79' ' ' ALA . . . -94.42 -10.58 32.05 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.362 -172.108 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 75.6 m 60.39 40.22 17.66 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.479 0.657 . . . . 0.0 110.259 -173.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -130.7 174.3 10.07 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.533 -178.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.2 t -95.44 107.01 19.14 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.777 0.322 . . . . 0.0 110.262 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.835 HG12 HD12 ' A' ' 48' ' ' LEU . 2.0 mp -110.12 113.1 43.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.032 179.05 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.445 ' HA ' HD11 ' A' ' 45' ' ' ILE . 53.2 mtmt -138.14 153.31 49.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.291 -179.358 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.793 HG12 HD12 ' A' ' 45' ' ' ILE . 44.9 mm -90.44 127.32 43.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.924 0.392 . . . . 0.0 110.25 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.925 ' HB2' HG23 ' A' ' 72' ' ' VAL . . . -92.41 115.8 65.39 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.759 -178.267 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -67.87 131.18 23.41 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.538 2.159 . . . . 0.0 111.371 176.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.446 ' HD3' ' HD3' ' A' ' 69' ' ' ARG . 18.6 Cg_endo . . . . . 0 N--CA 1.462 -0.361 0 C-N-CA 122.54 2.16 . . . . 0.0 110.814 176.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? . . . . . 0 C--O 1.233 0.225 0 CA-C-O 120.943 0.401 . . . . 0.0 111.505 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.555 ' HB ' ' C ' ' A' ' 29' ' ' ILE . 1.3 m -123.35 174.79 7.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 121.191 0.52 . . . . 0.0 110.947 -174.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.574 ' HB3' HG21 ' A' ' 34' ' ' VAL . 2.0 tpp85 -118.19 132.54 56.32 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 174.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.499 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 56.1 mtm -91.14 149.5 21.77 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.891 -175.5 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.585 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 94.3 t -113.17 132.2 62.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 175.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.925 HG23 ' HB2' ' A' ' 59' ' ' ALA . 77.6 t -99.92 111.83 30.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 177.377 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.816 HG22 HG13 ' A' ' 56' ' ' ILE . 2.5 pp -110.93 128.51 67.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.746 173.348 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 83.3 m -128.18 106.0 8.75 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.968 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -166.78 164.39 37.74 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.041 -178.11 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -56.81 136.84 78.71 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 121.859 1.706 . . . . 0.0 109.987 170.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -49.67 -19.58 3.6 Favored 'Trans proline' 0 N--CA 1.48 0.68 0 C-N-CA 123.897 3.065 . . . . 0.0 114.515 -172.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -70.72 -33.07 70.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.0 0.428 . . . . 0.0 110.563 177.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.419 ' HB1' ' HB1' ' A' ' 52' ' ' ALA . . . -78.4 -21.82 48.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.809 -177.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.51 -36.22 64.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.47 176.419 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.624 ' HA ' ' NE2' ' A' ' 164' ' ' GLN . 69.1 t80 -59.3 -47.09 86.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.469 177.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 36.0 tptt -63.89 -52.56 59.36 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.048 -176.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.69 -53.64 14.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.474 -174.047 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -71.38 -29.36 64.85 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -172.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -53.59 -36.81 55.13 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 120.365 -0.922 . . . . 0.0 111.739 175.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.448 ' HD2' ' N ' ' A' ' 86' ' ' ARG . 4.5 mpt_? -80.11 -32.02 39.11 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.532 0.197 . . . . 0.0 111.532 177.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -68.5 -44.43 83.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 121.119 -0.232 . . . . 0.0 110.422 -176.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.699 ' HA ' HD23 ' A' ' 91' ' ' LEU . 6.9 m-85 -66.38 -32.97 74.68 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.189 0.519 . . . . 0.0 110.274 177.356 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -66.02 -28.66 73.85 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.051 177.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.703 ' HB3' HD12 ' A' ' 37' ' ' ILE . 30.7 mmtp -78.43 -17.62 56.09 Favored 'General case' 0 N--CA 1.443 -0.787 0 O-C-N 122.388 -0.478 . . . . 0.0 111.332 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.699 HD23 ' HA ' ' A' ' 88' ' ' TYR . 2.6 mm? -65.34 -34.04 77.38 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 120.223 -0.591 . . . . 0.0 109.876 166.304 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.922 ' HE3' HG22 ' A' ' 103' ' ' VAL . 10.4 mmtp -72.79 -26.07 61.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.37 177.244 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.441 ' HB2' ' HA ' ' A' ' 90' ' ' LYS . 8.3 tp10 -63.47 -31.29 72.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.394 178.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.49 ' HG3' ' HA ' ' A' ' 33' ' ' ALA . 20.9 mm-40 -97.65 9.22 43.09 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.039 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 65.3 t30 56.8 41.88 27.42 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.654 176.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.746 ' HE2' ' HB2' ' A' ' 33' ' ' ALA . 41.9 m-85 . . . . . 0 C--N 1.327 -0.396 0 CA-C-O 121.04 0.448 . . . . 0.0 110.237 174.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 . . . . . 0 CA--C 1.523 -0.094 0 CA-C-O 120.772 0.32 . . . . 0.0 111.402 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.922 HG22 ' HE3' ' A' ' 92' ' ' LYS . 1.0 OUTLIER -73.96 129.08 36.59 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 172.608 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.6 mmmm -129.4 87.01 2.49 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 172.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.67 ' HB3' ' CE2' ' A' ' 88' ' ' TYR . 2.1 tm? -125.04 141.45 52.12 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -176.043 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.571 ' H ' HD22 ' A' ' 105' ' ' LEU . 39.8 tt0 -95.47 127.51 41.56 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.578 -170.303 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.519 HG21 ' NE2' ' A' ' 167' ' ' GLN . 0.1 OUTLIER -108.39 147.66 31.24 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 171.519 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -114.05 119.53 37.48 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.887 0.375 . . . . 0.0 110.088 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.428 ' CG1' ' HB ' ' A' ' 154' ' ' VAL . 23.1 pt -107.43 128.09 62.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.121 177.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.684 ' HD3' HG12 ' A' ' 153' ' ' ILE . 8.8 mmt180 -74.34 123.78 25.25 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.19 177.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.658 HG22 ' HB3' ' A' ' 115' ' ' ALA . 6.4 p -134.07 142.35 42.94 Favored Pre-proline 0 N--CA 1.444 -0.773 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.566 -175.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.442 ' HD2' HG22 ' A' ' 111' ' ' VAL . 31.7 Cg_exo -56.16 149.3 54.78 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 123.114 2.543 . . . . 0.0 111.978 179.038 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.62 -47.88 69.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.2 0.524 . . . . 0.0 111.066 -178.023 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.4 m -67.43 -28.9 68.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.661 -177.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.73 ' HB1' HD22 ' A' ' 174' ' ' LEU . . . -67.01 -28.83 68.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.933 -175.421 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.479 ' HB2' HG21 ' A' ' 152' ' ' VAL . . . -64.66 -27.0 68.63 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.099 0.476 . . . . 0.0 111.225 177.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -79.25 -31.09 43.41 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.664 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.584 ' HD3' HG22 ' A' ' 177' ' ' VAL . 23.1 ttt85 -91.63 -28.63 17.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.081 0.441 . . . . 0.0 111.711 -176.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.2 p -61.14 -24.38 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 121.13 0.491 . . . . 0.0 110.826 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.72 ' HA ' ' HB ' ' A' ' 127' ' ' VAL . 47.1 mm -77.85 -51.43 17.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.158 176.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.592 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.18 -175.986 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.546 ' HD2' ' HB2' ' A' ' 129' ' ' GLU . 3.7 pptp? . . . . . 0 CA--C 1.521 -0.142 0 CA-C-O 121.03 0.443 . . . . 0.0 110.048 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.517 ' O ' ' HG ' ' A' ' 130' ' ' LEU . 9.3 t -63.27 -34.58 77.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.022 -173.119 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.72 ' HB ' ' HA ' ' A' ' 120' ' ' ILE . 9.5 p -67.47 -37.69 79.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-O 121.044 0.449 . . . . 0.0 110.549 177.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.491 ' HA ' ' OE1' ' A' ' 131' ' ' GLN . 3.6 t-20 -74.09 -34.55 64.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.515 0.674 . . . . 0.0 109.579 178.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.546 ' HB2' ' HD2' ' A' ' 125' ' ' LYS . 69.4 tt0 -65.33 -37.46 87.15 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.059 177.107 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 126' ' ' THR . 87.0 mt -56.78 -48.83 77.0 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.406 173.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.491 ' OE1' ' HA ' ' A' ' 128' ' ' ASN . 80.8 mt-30 -57.35 -45.95 83.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.34 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -71.59 -36.15 70.75 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.834 0.349 . . . . 0.0 111.146 -177.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -73.03 -46.4 52.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.791 -177.049 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.582 HG21 ' HA ' ' A' ' 166' ' ' ALA . 77.0 p -88.07 -18.07 29.71 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.033 0.382 . . . . 0.0 112.033 -174.396 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 65.98 22.26 11.26 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 123.847 0.717 . . . . 0.0 110.491 -175.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.576 ' HB2' ' HB1' ' A' ' 162' ' ' ALA . . . -122.3 160.8 24.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.63 -177.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.645 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 10.9 tp10 -88.95 111.73 22.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.487 178.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 54.2 t -104.22 106.04 19.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.582 178.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.464 ' O ' ' HD2' ' A' ' 155' ' ' LYS . 5.0 p -128.7 124.45 61.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.322 0.582 . . . . 0.0 111.156 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.5 ' HB ' HG22 ' A' ' 154' ' ' VAL . 11.2 p -122.14 128.85 25.35 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.71 178.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.648 ' HG3' ' HE3' ' A' ' 155' ' ' LYS . 13.1 Cg_exo -68.24 154.92 71.14 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.552 2.168 . . . . 0.0 111.565 -178.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 -93.8 15.8 15.65 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 176.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.564 ' CG ' ' H ' ' A' ' 144' ' ' GLN . 6.6 p-10 -136.24 -91.06 0.28 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.8 177.323 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.921 ' HG2' ' H ' ' A' ' 153' ' ' ILE . 6.0 tp-100 58.13 88.88 0.06 Allowed 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.613 0.765 . . . . 0.0 112.351 174.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.636 ' HB ' ' HD2' ' A' ' 146' ' ' PRO . 59.5 p 61.35 161.18 0.11 Allowed Pre-proline 0 N--CA 1.473 0.689 0 C-N-CA 124.225 1.01 . . . . 0.0 112.51 176.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.636 ' HD2' ' HB ' ' A' ' 145' ' ' THR . 57.7 Cg_endo -72.21 157.86 53.03 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.261 1.974 . . . . 0.0 112.285 178.325 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -73.06 8.87 1.39 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.566 -176.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -57.0 -47.48 80.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.232 0.539 . . . . 0.0 110.143 174.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ASN . . . . . 0.499 ' O ' ' HG2' ' A' ' 150' ' ' GLU . 56.1 t30 -90.85 -8.75 48.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.149 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 149' ' ' ASN . 9.9 pt-20 45.03 36.82 2.14 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 114.44 -1.254 . . . . 0.0 111.642 178.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -148.2 138.97 23.02 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.573 -176.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.493 HG23 ' CG1' ' A' ' 111' ' ' VAL . 21.3 m -120.22 -176.15 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.92 -174.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.921 ' H ' ' HG2' ' A' ' 144' ' ' GLN . 49.9 mt -134.45 128.89 52.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.306 -176.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.5 HG22 ' HB ' ' A' ' 140' ' ' VAL . 53.9 t -95.82 140.28 17.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 173.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.648 ' HE3' ' HG3' ' A' ' 141' ' ' PRO . 0.0 OUTLIER -104.13 134.92 46.56 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 177.657 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.645 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 70.6 mt -118.95 112.06 36.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.914 177.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.421 ' N ' HD12 ' A' ' 157' ' ' ILE . 4.4 mp -110.47 138.62 37.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.793 -178.218 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 149.72 -157.13 27.1 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.372 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -81.45 159.8 24.16 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 -177.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.504 ' HB3' ' CB ' ' A' ' 88' ' ' TYR . 7.6 p90 -57.89 -47.86 81.56 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.719 -175.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.408 ' O ' ' HG3' ' A' ' 165' ' ' MET . 19.0 m-85 -54.37 -49.89 68.78 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.626 0.251 . . . . 0.0 110.721 177.512 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.576 ' HB1' ' HB2' ' A' ' 136' ' ' ALA . . . -58.25 -53.47 57.88 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.578 -178.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.466 ' O ' ' HG3' ' A' ' 167' ' ' GLN . 30.0 m -59.84 -49.69 76.73 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.979 -179.067 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' GLN . . . . . 0.624 ' NE2' ' HA ' ' A' ' 81' ' ' PHE . 21.6 mt-30 -56.51 -30.84 63.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.764 178.539 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.408 ' HG3' ' O ' ' A' ' 161' ' ' TYR . 91.0 mtp -77.96 -42.67 32.09 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.743 0.306 . . . . 0.0 110.798 175.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.582 ' HA ' HG21 ' A' ' 134' ' ' THR . . . -69.4 -41.56 76.27 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -174.558 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.519 ' NE2' HG21 ' A' ' 107' ' ' THR . 71.9 mt-30 -51.93 -57.77 8.44 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.961 0.41 . . . . 0.0 111.215 -176.255 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 21.5 ptt180 -68.21 -28.15 67.0 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.533 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.769 ' HA ' ' HE3' ' A' ' 169' ' ' LYS . 0.1 OUTLIER -69.56 -44.9 69.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.851 0.358 . . . . 0.0 110.393 -177.832 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.588 ' O ' ' HG ' ' A' ' 174' ' ' LEU . 1.8 mp -71.54 -40.46 71.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 177.18 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 27.2 mmm-85 -58.88 -26.23 64.07 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.147 0.499 . . . . 0.0 110.974 174.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -77.87 -46.55 21.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.966 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.547 HG13 ' O ' ' A' ' 170' ' ' ILE . 2.7 pp -66.28 -18.88 24.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-O 121.0 0.429 . . . . 0.0 110.823 -177.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.73 HD22 ' HB1' ' A' ' 115' ' ' ALA . 17.7 mt -57.37 -27.55 62.39 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.247 175.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.7 ' HA ' ' HD3' ' A' ' 178' ' ' LYS . . . -54.87 -33.46 61.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.515 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -70.22 -33.19 71.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.927 0.394 . . . . 0.0 110.568 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.584 HG22 ' HD3' ' A' ' 118' ' ' ARG . 40.3 t -69.32 -40.39 80.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.389 0.614 . . . . 0.0 109.736 178.36 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.7 ' HD3' ' HA ' ' A' ' 175' ' ' ALA . 50.9 mtpt -59.95 -50.52 73.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.073 176.573 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.312 -177.73 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.524 ' HB2' HG22 ' A' ' 74' ' ' THR . 64.2 mt-30 . . . . . 0 N--CA 1.45 -0.441 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.442 ' OE1' ' HD3' ' A' ' 77' ' ' PRO . 1.5 mp0 -73.57 113.26 10.48 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.354 0.597 . . . . 0.0 111.619 -174.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 4.9 m -92.66 109.56 20.98 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.134 177.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.8 m -124.14 152.9 30.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.252 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 10.2 m170 -113.81 132.03 56.02 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -174.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.713 ' HB ' ' CG1' ' A' ' 71' ' ' VAL . 20.8 t -108.2 141.02 24.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.559 -177.15 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.674 ' CE2' HG11 ' A' ' 68' ' ' VAL . 47.2 t80 -97.6 104.87 16.94 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 123.531 0.732 . . . . 0.0 110.198 -174.071 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.544 ' C ' HG23 ' A' ' 68' ' ' VAL . 11.1 pt -124.5 116.58 26.68 Favored Pre-proline 0 C--N 1.326 -0.435 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.264 176.405 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.515 ' HA ' ' HA ' ' A' ' 68' ' ' VAL . 18.7 Cg_endo -58.9 147.98 86.61 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.57 2.847 . . . . 0.0 112.572 -177.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.636 ' HA ' HG12 ' A' ' 34' ' ' VAL . . . -54.08 -25.71 23.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.579 -1.191 . . . . 0.0 112.854 -175.364 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -70.3 -23.65 62.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.909 0.385 . . . . 0.0 111.182 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.578 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -114.12 -30.8 6.54 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.577 -177.056 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.636 HG12 ' HA ' ' A' ' 31' ' ' ALA . 13.0 p -51.95 -33.8 16.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 O-C-N 123.24 0.337 . . . . 0.0 111.661 -173.288 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.65 -56.94 22.43 Favored Glycine 0 N--CA 1.439 -1.129 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.974 -179.07 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.74 -14.19 59.41 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.79 -0.205 . . . . 0.0 111.318 -175.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.662 HD12 ' HB3' ' A' ' 90' ' ' LYS . 8.3 mm -61.71 -43.01 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 175.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.479 HG23 HG21 ' A' ' 45' ' ' ILE . 26.3 mt -55.88 -53.48 37.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.532 176.208 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.32 113.63 0.45 Allowed Glycine 0 CA--C 1.521 0.462 0 C-N-CA 120.515 -0.85 . . . . 0.0 114.942 168.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.413 ' HA ' ' HD2' ' A' ' 40' ' ' LYS . 46.4 tptt 48.82 77.64 0.1 Allowed 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.191 0.996 . . . . 0.0 113.009 170.142 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.459 ' HB3' ' HG3' ' A' ' 43' ' ' GLN . 0.0 OUTLIER 62.68 7.81 2.68 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.945 173.893 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.573 ' O ' HG22 ' A' ' 45' ' ' ILE . . . 76.58 8.67 86.15 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.122 -1.037 . . . . 0.0 111.759 -177.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.494 ' HA ' ' HE3' ' A' ' 46' ' ' LYS . 50.8 mt-30 -62.87 -43.55 98.5 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.061 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 40.7 m-70 -78.74 -26.62 44.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.695 -177.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.573 HG22 ' O ' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -72.1 -42.52 67.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 120.995 -0.282 . . . . 0.0 110.721 -176.629 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.494 ' HE3' ' HA ' ' A' ' 43' ' ' GLN . 18.9 pttp -81.43 -24.54 36.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.151 0.5 . . . . 0.0 110.425 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -69.26 -30.86 69.07 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.261 174.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.796 ' HA ' ' CE2' ' A' ' 51' ' ' PHE . 6.4 tt -60.77 -38.14 84.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.719 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.635 ' HA ' HD13 ' A' ' 56' ' ' ILE . 22.7 m -62.4 -36.15 81.43 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.035 177.597 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -69.41 -47.98 62.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.139 -173.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.796 ' CE2' ' HA ' ' A' ' 48' ' ' LEU . 14.2 p90 -71.32 -24.6 62.15 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.235 -174.178 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -90.78 -9.35 46.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.008 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.2 t 60.58 32.81 20.46 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.724 -178.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -128.17 174.41 9.28 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.305 -176.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.424 ' HB2' ' HB ' ' A' ' 74' ' ' THR . 20.2 m -104.51 101.73 11.38 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.629 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.635 HD13 ' HA ' ' A' ' 49' ' ' SER . 3.2 mp -111.38 122.49 65.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.844 178.514 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -147.09 142.41 27.36 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.209 178.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 35.2 mm -75.07 124.45 32.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 177.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.942 ' HB2' HG23 ' A' ' 72' ' ' VAL . . . -77.72 133.64 66.2 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.127 -174.59 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 59' ' ' ALA . 22.8 Cg_exo -65.33 127.01 17.32 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.817 2.345 . . . . 0.0 112.242 178.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo . . . . . 0 N--CA 1.462 -0.334 0 C-N-CA 122.605 2.203 . . . . 0.0 111.6 177.849 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? . . . . . 0 C--O 1.23 0.077 0 CA-C-O 121.147 0.499 . . . . 0.0 110.697 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.674 HG11 ' CE2' ' A' ' 28' ' ' PHE . 7.4 p -139.01 147.74 24.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 175.123 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.541 ' HB3' HG21 ' A' ' 34' ' ' VAL . 12.6 ttm180 -123.1 126.62 47.39 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 175.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.848 ' HG3' ' HB3' ' A' ' 59' ' ' ALA . 18.7 ptt? -83.18 146.67 28.49 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.316 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.713 ' CG1' ' HB ' ' A' ' 27' ' ' VAL . 3.5 p -110.08 135.68 48.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 173.31 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.942 HG23 ' HB2' ' A' ' 59' ' ' ALA . 51.4 t -100.47 110.17 26.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.4 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.417 HG22 HG13 ' A' ' 56' ' ' ILE . 10.0 pt -113.23 142.45 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.802 174.044 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.524 HG22 ' HB2' ' A' ' 22' ' ' GLN . 20.5 m -137.34 105.95 5.85 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.987 -176.017 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -166.96 162.51 36.3 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.93 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -59.71 137.26 75.91 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.398 2.065 . . . . 0.0 110.411 172.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.448 ' HA ' ' HB3' ' A' ' 80' ' ' GLN . 63.8 Cg_exo -40.04 -37.99 1.9 Allowed 'Trans proline' 0 N--CA 1.478 0.584 0 C-N-CA 124.352 3.368 . . . . 0.0 115.517 -171.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -72.29 -43.02 64.85 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 121.798 -0.564 . . . . 0.0 111.275 -178.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.38 -27.72 61.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.449 0.643 . . . . 0.0 109.693 175.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.448 ' HB3' ' HA ' ' A' ' 77' ' ' PRO . 35.1 tt0 -61.43 -48.51 80.86 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.012 173.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.772 ' HD1' ' HG3' ' A' ' 164' ' ' GLN . 80.6 t80 -59.16 -39.67 83.17 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.833 176.004 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.6 tptp -53.42 -53.04 57.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.398 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.524 ' HB1' HD21 ' A' ' 48' ' ' LEU . . . -72.0 -47.36 52.59 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.107 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.584 ' O ' HG22 ' A' ' 87' ' ' ILE . 14.2 tt0 -66.93 -31.95 72.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.552 -172.56 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -57.38 -36.78 78.19 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.285 175.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.459 ' HD3' ' HA ' ' A' ' 86' ' ' ARG . 27.8 mmt180 -80.4 -27.21 38.16 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.668 -0.266 . . . . 0.0 111.239 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.584 HG22 ' O ' ' A' ' 84' ' ' GLN . 0.3 OUTLIER -67.82 -41.78 85.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 178.941 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.615 ' CE2' ' HB3' ' A' ' 105' ' ' LEU . 7.0 m-85 -68.51 -31.13 70.16 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-O 121.164 0.507 . . . . 0.0 109.889 173.691 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -61.71 -29.28 71.66 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.474 -0.784 . . . . 0.0 112.119 177.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.662 ' HB3' HD12 ' A' ' 37' ' ' ILE . 73.9 mmtt -66.69 -37.71 85.3 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 177.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.612 HD23 ' HA ' ' A' ' 88' ' ' TYR . 3.4 mm? -59.55 -36.75 76.77 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.41 0.624 . . . . 0.0 110.597 174.655 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.77 ' HE3' ' HB ' ' A' ' 103' ' ' VAL . 0.1 OUTLIER -75.35 -37.82 60.45 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.277 -177.565 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -67.93 -27.48 66.65 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.182 -178.162 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.449 ' HB3' ' CE2' ' A' ' 96' ' ' PHE . 17.3 mm-40 -89.27 5.27 45.65 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.189 0.519 . . . . 0.0 110.859 178.338 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 58.69 41.14 22.45 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.986 172.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.449 ' CE2' ' HB3' ' A' ' 94' ' ' GLU . 70.2 m-85 . . . . . 0 C--N 1.326 -0.448 0 CA-C-O 121.2 0.524 . . . . 0.0 109.921 172.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 . . . . . 0 N--CA 1.437 -1.119 0 CA-C-O 120.867 0.365 . . . . 0.0 111.014 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.77 ' HB ' ' HE3' ' A' ' 92' ' ' LYS . 14.8 p -80.46 138.58 19.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.644 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -128.2 90.81 3.14 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 175.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.615 ' HB3' ' CE2' ' A' ' 88' ' ' TYR . 2.3 tm? -133.38 126.3 30.99 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.261 0.553 . . . . 0.0 110.408 -173.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.782 ' HG3' HG13 ' A' ' 157' ' ' ILE . 41.1 mp0 -66.81 133.52 50.27 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.963 -1.017 . . . . 0.0 113.612 -175.157 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.97 140.43 46.64 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.142 165.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -121.69 119.8 32.84 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 32.8 pt -125.9 153.64 34.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.112 0.482 . . . . 0.0 111.292 -178.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.48 ' HD3' HG12 ' A' ' 153' ' ' ILE . 59.2 mmt-85 -87.31 132.24 34.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.872 -175.46 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.502 ' O ' ' HG3' ' A' ' 151' ' ' GLN . 5.2 m -129.77 147.09 63.96 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 171.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.72 ' HD2' HD22 ' A' ' 174' ' ' LEU . 31.4 Cg_exo -57.43 145.23 89.2 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.28 1.986 . . . . 0.0 110.911 175.125 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -51.09 -49.61 60.35 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.787 0.327 . . . . 0.0 111.552 -173.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 36.3 t -65.52 -33.25 75.49 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.137 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.18 -26.69 67.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.007 -178.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.19 -29.18 70.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.268 0.556 . . . . 0.0 110.392 177.019 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -75.12 -38.21 40.68 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.666 177.058 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.522 ' HD2' HG22 ' A' ' 177' ' ' VAL . 25.3 ttm180 -74.66 -34.23 62.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.371 0.129 . . . . 0.0 110.997 -178.493 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.477 HG13 HG21 ' A' ' 140' ' ' VAL . 10.2 p -66.8 -32.17 56.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-O 120.834 0.35 . . . . 0.0 110.579 179.059 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 76.3 mt -72.43 -43.73 63.37 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 CA-C-O 121.277 0.561 . . . . 0.0 109.656 173.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.904 ' HA3' ' HB ' ' A' ' 126' ' ' THR . . . . . . . . 0 N--CA 1.44 -1.047 0 C-N-CA 119.918 -1.134 . . . . 0.0 110.639 -174.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 22.8 pttp . . . . . 0 N--CA 1.463 0.198 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.904 ' HB ' ' HA3' ' A' ' 121' ' ' GLY . 26.1 m -62.91 -46.51 87.48 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -175.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.0 p -67.85 -29.91 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-O 121.017 0.437 . . . . 0.0 110.663 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -63.72 -40.61 97.19 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 177.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -64.45 -41.56 96.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.003 177.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 73.6 mt -60.13 -49.31 78.13 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.621 178.362 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -64.2 -30.13 71.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.631 -177.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -72.55 -42.59 64.53 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.886 0.375 . . . . 0.0 110.298 177.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 94.4 mt -68.61 -49.67 57.47 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.27 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 74.1 p -82.26 -35.37 28.16 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.317 -171.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 66.97 27.49 8.82 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 123.894 0.746 . . . . 0.0 109.9 -170.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.695 ' HB2' ' HB1' ' A' ' 162' ' ' ALA . . . -122.92 163.95 19.38 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.707 -178.024 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.486 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 9.7 mm-40 -88.25 111.58 21.83 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.421 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 42.8 t -97.75 105.83 17.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.072 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.434 ' O ' ' HD2' ' A' ' 155' ' ' LYS . 54.0 t -112.81 111.6 36.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.232 -175.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.477 HG21 HG13 ' A' ' 119' ' ' VAL . 34.8 t -106.03 126.5 30.46 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 177.352 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.439 ' HG2' ' HB3' ' A' ' 144' ' ' GLN . 88.1 Cg_endo -83.81 143.23 10.51 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.766 2.311 . . . . 0.0 113.358 -174.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 39.7 mmt180 -94.1 -26.88 16.55 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.467 173.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -69.78 -35.44 74.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.036 -0.983 . . . . 0.0 110.567 178.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.439 ' HB3' ' HG2' ' A' ' 141' ' ' PRO . 60.2 tt0 -92.86 90.83 7.16 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 175.582 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.429 ' N ' ' HD3' ' A' ' 146' ' ' PRO . 16.0 p -145.98 58.01 4.43 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.75 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.495 ' HB2' ' HB3' ' A' ' 148' ' ' GLU . 49.5 Cg_endo -92.8 133.07 1.03 Allowed 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.548 2.165 . . . . 0.0 112.986 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -71.07 -12.88 61.75 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 172.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.495 ' HB3' ' HB2' ' A' ' 146' ' ' PRO . 30.9 tt0 -44.78 -48.55 10.91 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 114.315 -1.312 . . . . 0.0 112.599 178.487 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -114.75 -0.07 13.67 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.174 -175.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 44.41 32.45 0.72 Allowed 'General case' 0 N--CA 1.474 0.748 0 O-C-N 124.469 1.105 . . . . 0.0 111.045 -172.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.502 ' HG3' ' O ' ' A' ' 111' ' ' VAL . 28.4 tt0 -157.86 142.74 16.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.402 -174.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.401 HG12 ' HD2' ' A' ' 146' ' ' PRO . 31.0 m -133.88 -177.01 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.792 -178.584 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.48 HG12 ' HD3' ' A' ' 110' ' ' ARG . 55.8 mt -120.48 137.99 52.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.922 0.391 . . . . 0.0 111.726 -178.646 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.5 p -104.49 138.41 29.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.565 169.316 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.468 ' HD2' ' H ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -101.23 126.31 47.95 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.664 -177.109 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.486 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 58.9 mt -109.24 118.71 57.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.107 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.782 HG13 ' HG3' ' A' ' 106' ' ' GLU . 4.0 mp -114.36 138.33 44.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 143.92 -163.01 27.75 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.525 178.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.543 ' HA ' HG13 ' A' ' 103' ' ' VAL . 10.6 p-80 -83.73 145.1 28.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.73 0.3 . . . . 0.0 110.41 178.527 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.503 ' HD1' HG11 ' A' ' 103' ' ' VAL . 46.0 p90 -57.72 -24.44 56.91 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -168.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.407 ' HB2' ' HD2' ' A' ' 159' ' ' HIS . 94.2 m-85 -61.43 -44.5 97.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.408 0.623 . . . . 0.0 109.625 174.564 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.695 ' HB1' ' HB2' ' A' ' 136' ' ' ALA . . . -74.6 -40.27 61.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.073 178.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.448 ' O ' ' HG3' ' A' ' 167' ' ' GLN . 19.3 m -55.21 -51.33 66.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.511 178.011 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' GLN . . . . . 0.772 ' HG3' ' HD1' ' A' ' 81' ' ' PHE . 7.8 mm100 -57.79 -45.02 86.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.604 177.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 68.8 mtp -61.45 -40.7 95.44 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.8 0.333 . . . . 0.0 110.893 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.464 ' HB3' HD13 ' A' ' 156' ' ' ILE . . . -69.31 -46.2 67.7 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.163 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.448 ' HG3' ' O ' ' A' ' 163' ' ' SER . 24.7 mt-30 -55.31 -52.18 64.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.241 -178.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' A' ' 164' ' ' GLN . 6.7 ptp85 -66.42 -32.32 73.63 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.18 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.997 ' HA ' ' HE3' ' A' ' 169' ' ' LYS . 0.6 OUTLIER -77.24 -42.82 35.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.91 0.386 . . . . 0.0 110.965 -173.58 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.518 ' O ' ' HG ' ' A' ' 174' ' ' LEU . 1.8 mp -70.4 -44.71 77.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.923 177.562 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -59.26 -25.9 64.47 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.819 0.343 . . . . 0.0 110.566 175.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -73.82 -48.29 32.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.175 -179.174 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 36.1 pt -66.92 -20.53 27.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.112 -177.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.72 HD22 ' HD2' ' A' ' 112' ' ' PRO . 15.5 mt -59.23 -40.5 86.07 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.911 0.386 . . . . 0.0 110.252 176.153 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.493 ' O ' ' HG2' ' A' ' 179' ' ' GLN . . . -65.91 -37.39 85.95 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.216 178.441 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -65.99 -32.19 73.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.887 177.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.522 HG22 ' HD2' ' A' ' 118' ' ' ARG . 75.2 t -73.34 -35.57 46.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.056 0.455 . . . . 0.0 110.207 175.53 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -64.58 -31.03 72.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.158 0.504 . . . . 0.0 109.904 175.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' GLN . . . . . 0.493 ' HG2' ' O ' ' A' ' 175' ' ' ALA . 73.3 mm-40 . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.622 175.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 81.9 mm-40 . . . . . 0 C--O 1.235 0.339 0 N-CA-C 109.128 -0.694 . . . . 0.0 109.128 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -78.98 141.88 37.12 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.076 -171.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 29.2 m -131.69 112.45 12.56 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.496 -177.564 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.401 HG21 ' NE2' ' A' ' 167' ' ' GLN . 28.4 m -125.14 161.68 28.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.839 -178.054 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -117.44 128.1 54.67 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.618 -175.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.562 ' HB ' ' HB ' ' A' ' 71' ' ' VAL . 8.9 t -97.45 143.14 13.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.198 -179.23 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.429 ' CG ' HG21 ' A' ' 68' ' ' VAL . 0.3 OUTLIER -103.86 106.06 16.45 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 122.623 0.369 . . . . 0.0 111.723 -172.573 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.618 ' C ' ' HB ' ' A' ' 68' ' ' VAL . 8.7 pt -130.4 121.41 19.39 Favored Pre-proline 0 C--N 1.326 -0.433 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.856 176.318 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.666 ' HB2' ' HG2' ' A' ' 32' ' ' GLN . 10.6 Cg_endo -53.27 147.67 35.14 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.699 2.933 . . . . 0.0 112.485 -176.267 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.444 ' HA ' HG12 ' A' ' 34' ' ' VAL . . . -57.46 -21.98 40.57 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.509 -0.768 . . . . 0.0 112.096 -175.685 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.666 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 11.4 pt20 -71.38 -26.2 62.69 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.589 178.588 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.572 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -111.8 -30.37 7.33 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 121.167 -0.213 . . . . 0.0 111.545 -172.099 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.663 HG21 ' HB3' ' A' ' 69' ' ' ARG . 9.3 p -52.25 -32.86 16.36 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 O-C-N 123.605 0.566 . . . . 0.0 111.392 -174.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -55.7 -57.93 16.45 Favored Glycine 0 N--CA 1.438 -1.193 0 C-N-CA 120.318 -0.944 . . . . 0.0 111.858 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.32 -14.11 59.8 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 120.744 0.307 . . . . 0.0 111.074 -174.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.637 HD12 ' HB3' ' A' ' 90' ' ' LYS . 7.9 mm -64.71 -38.87 83.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.116 176.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.556 HG23 ' HB ' ' A' ' 45' ' ' ILE . 5.0 mt -54.5 -59.42 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -178.581 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 131.04 77.82 0.17 Allowed Glycine 0 CA--C 1.52 0.357 0 C-N-CA 119.616 -1.278 . . . . 0.0 114.43 175.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 45.9 tttp 54.13 -80.77 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 170.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -101.1 -6.22 24.64 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.821 0.344 . . . . 0.0 111.048 -173.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.55 ' O ' HG22 ' A' ' 45' ' ' ILE . . . 84.86 -1.88 88.57 Favored Glycine 0 C--O 1.229 -0.215 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.152 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -78.78 -32.26 46.39 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 176.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.444 ' HA ' ' HB3' ' A' ' 47' ' ' GLN . 2.2 m-70 -73.62 -22.12 60.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.066 -176.549 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.556 ' HB ' HG23 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -73.65 -42.89 55.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.728 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.9 pttp -81.68 -22.5 37.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.286 0.565 . . . . 0.0 109.744 177.431 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.444 ' HB3' ' HA ' ' A' ' 44' ' ' HIS . 49.2 tt0 -66.44 -33.44 75.72 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 171.381 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.411 ' HA ' ' HB3' ' A' ' 51' ' ' PHE . 7.0 tt -66.09 -38.5 88.39 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.371 175.065 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.666 ' HA ' HD13 ' A' ' 56' ' ' ILE . 8.1 t -60.04 -39.17 85.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.628 176.512 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -68.87 -47.47 65.85 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.062 174.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.411 ' HB3' ' HA ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -58.41 -39.03 78.62 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.984 -1.007 . . . . 0.0 112.007 -178.163 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -91.16 0.89 57.44 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 121.185 -0.206 . . . . 0.0 111.325 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 72.5 p 50.89 31.39 6.1 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.667 0.787 . . . . 0.0 111.964 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -140.14 174.25 10.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.886 -175.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.5 m -86.25 101.29 12.92 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.675 0.274 . . . . 0.0 110.596 -178.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.666 HD13 ' HA ' ' A' ' 49' ' ' SER . 2.2 mp -108.6 117.1 53.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.892 178.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -134.28 146.81 50.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.562 -177.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 40.0 mm -90.17 107.47 18.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 173.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.464 ' HB2' ' CG1' ' A' ' 72' ' ' VAL . . . -86.33 126.4 64.78 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.854 -173.043 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 59' ' ' ALA . 17.1 Cg_exo -67.65 141.04 53.49 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.879 2.386 . . . . 0.0 110.805 172.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo . . . . . 0 C--O 1.233 0.248 0 C-N-CA 122.906 2.404 . . . . 0.0 111.994 -179.745 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.233 0.219 0 CA-C-O 121.113 0.482 . . . . 0.0 111.505 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.618 ' HB ' ' C ' ' A' ' 29' ' ' ILE . 1.4 m -127.41 176.08 8.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-O 121.225 0.536 . . . . 0.0 111.316 -172.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.663 ' HB3' HG21 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -120.01 139.79 51.96 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 106.471 -1.678 . . . . 0.0 106.471 172.837 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.542 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 61.4 mtt -97.43 149.15 22.46 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.282 -0.567 . . . . 0.0 111.397 -169.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.562 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 70.1 t -104.35 116.22 47.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 171.069 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.464 ' CG1' ' HB2' ' A' ' 59' ' ' ALA . 11.1 p -108.73 121.6 62.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.357 0.598 . . . . 0.0 110.472 -177.033 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 24' ' ' THR . 0.1 OUTLIER -130.63 142.42 43.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.768 0.794 . . . . 0.0 111.135 179.675 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 47.3 m -122.47 111.57 17.0 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.191 -1.368 . . . . 0.0 109.034 176.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.67 162.36 35.78 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 119.845 -1.169 . . . . 0.0 113.158 -175.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.24 148.54 84.91 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.379 2.052 . . . . 0.0 110.824 170.258 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -38.35 -46.85 2.4 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 124.152 3.235 . . . . 0.0 114.441 -176.081 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.516 ' HG3' ' N ' ' A' ' 79' ' ' ALA . 7.6 pt-20 -56.8 -43.97 81.48 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.156 0.503 . . . . 0.0 111.203 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.642 ' HA ' ' HD3' ' A' ' 82' ' ' LYS . . . -71.73 -37.64 70.57 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.006 -175.205 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -68.93 -26.03 64.88 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.946 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.594 ' HD1' HE22 ' A' ' 164' ' ' GLN . 89.8 t80 -64.4 -54.94 24.86 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.709 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.713 ' H ' ' HD2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -70.02 -32.6 70.84 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.459 -0.497 . . . . 0.0 110.726 -177.681 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.3 -51.54 69.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.753 0.311 . . . . 0.0 110.985 177.178 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.638 ' HA ' HG22 ' A' ' 87' ' ' ILE . 54.1 mt-30 -66.46 -31.89 72.91 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.269 179.297 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -59.57 -40.04 95.84 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.332 178.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -80.21 -37.83 32.36 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 122.742 -0.269 . . . . 0.0 111.637 -177.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.638 HG22 ' HA ' ' A' ' 84' ' ' GLN . 0.0 OUTLIER -65.21 -43.83 95.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.662 -176.632 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.592 ' CE2' ' HB3' ' A' ' 105' ' ' LEU . 15.2 m-85 -67.13 -30.15 70.07 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.142 0.496 . . . . 0.0 110.148 176.039 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -60.04 -32.84 76.88 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.213 176.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.637 ' HB3' HD12 ' A' ' 37' ' ' ILE . 31.7 mmtp -72.63 -26.76 61.78 Favored 'General case' 0 N--CA 1.455 -0.213 0 O-C-N 122.541 -0.388 . . . . 0.0 110.624 177.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.601 ' HG ' ' HG ' ' A' ' 105' ' ' LEU . 4.3 mm? -66.35 -38.55 87.85 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.853 0.359 . . . . 0.0 110.156 171.579 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.89 ' HE3' ' HB ' ' A' ' 103' ' ' VAL . 0.5 OUTLIER -68.78 -26.52 65.25 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.373 176.124 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -64.32 -40.66 96.34 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.995 -176.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.588 ' HB2' ' CE2' ' A' ' 96' ' ' PHE . 10.4 mm-40 -105.94 0.24 25.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.964 0.411 . . . . 0.0 112.079 -178.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 57.34 47.83 15.96 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.307 -0.86 . . . . 0.0 112.695 171.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.588 ' CE2' ' HB2' ' A' ' 94' ' ' GLU . 80.1 m-85 . . . . . 0 N--CA 1.467 0.418 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -176.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.51 ' HB3' ' CE1' ' A' ' 159' ' ' HIS . 5.2 tt0 . . . . . 0 N--CA 1.439 -1.0 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.89 ' HB ' ' HE3' ' A' ' 92' ' ' LYS . 11.5 p -54.52 122.84 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.404 0 CA-C-O 121.733 0.778 . . . . 0.0 112.037 -168.357 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp -117.68 91.29 3.53 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.568 -1.196 . . . . 0.0 108.865 176.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.601 ' HG ' ' HG ' ' A' ' 91' ' ' LEU . 2.0 tm? -128.58 123.81 34.33 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.208 0.527 . . . . 0.0 109.959 -176.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -58.92 129.46 42.26 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.821 -1.081 . . . . 0.0 112.016 -174.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.44 142.51 46.27 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.16 175.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -122.22 120.11 33.2 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.306 0.574 . . . . 0.0 111.546 -179.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.482 HD13 HD11 ' A' ' 156' ' ' ILE . 22.9 pt -114.61 134.16 58.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.872 176.145 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.594 ' HD3' HG12 ' A' ' 153' ' ' ILE . 6.9 tpp180 -78.48 138.25 38.35 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.249 -176.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.694 HG23 ' CD2' ' A' ' 174' ' ' LEU . 6.4 p -141.93 143.0 26.75 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 177.523 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.42 ' HD2' HG22 ' A' ' 111' ' ' VAL . 24.6 Cg_exo -59.84 150.1 79.57 Favored 'Trans proline' 0 N--CA 1.465 -0.18 0 C-N-CA 122.399 2.066 . . . . 0.0 111.296 176.492 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -56.3 -51.06 69.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.022 0.439 . . . . 0.0 111.007 -175.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.7 m -68.54 -12.3 61.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.544 -178.299 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.642 ' HB2' HG11 ' A' ' 177' ' ' VAL . . . -84.68 -14.87 47.2 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.347 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.458 ' HA ' HG12 ' A' ' 119' ' ' VAL . . . -65.42 -40.96 93.98 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.039 176.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.32 -32.9 83.37 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.615 -0.802 . . . . 0.0 111.55 176.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.447 ' HD2' HG22 ' A' ' 177' ' ' VAL . 15.2 ttm180 -74.2 -42.42 59.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.673 0.273 . . . . 0.0 110.788 -179.182 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.498 HG22 HD11 ' A' ' 130' ' ' LEU . 7.4 p -68.93 -30.56 47.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.025 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.65 ' HA ' HG23 ' A' ' 127' ' ' VAL . 72.6 mt -69.62 -39.26 78.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.818 0.818 . . . . 0.0 109.558 171.187 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.184 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.551 179.889 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 23.4 pttp . . . . . 0 N--CA 1.463 0.177 0 CA-C-O 120.967 0.413 . . . . 0.0 111.614 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.572 ' O ' ' HG ' ' A' ' 130' ' ' LEU . 50.0 m -88.3 -32.7 18.33 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.268 -174.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.65 HG23 ' HA ' ' A' ' 120' ' ' ILE . 82.0 t -59.81 -37.9 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-O 121.38 0.61 . . . . 0.0 109.809 173.205 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -56.09 -42.98 77.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.944 177.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.14 -42.83 72.05 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.145 -179.295 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.572 ' HG ' ' O ' ' A' ' 126' ' ' THR . 77.6 mt -58.29 -52.05 67.23 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.702 -178.468 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -66.01 -37.97 87.25 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.928 -175.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -65.27 -36.7 84.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.276 -177.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 60.6 tp -88.11 -48.89 7.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.722 0.296 . . . . 0.0 111.525 -176.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.429 HG21 ' HA ' ' A' ' 166' ' ' ALA . 64.2 p -74.67 -25.19 59.01 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.985 -172.417 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 60.74 20.94 10.98 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.159 -174.367 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -113.61 173.12 6.57 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.309 -174.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.648 ' HB3' ' HB ' ' A' ' 157' ' ' ILE . 8.6 tp10 -96.95 114.07 25.66 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.04 175.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 57.3 t -114.84 106.98 21.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.758 -176.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.598 HG13 ' HB2' ' A' ' 155' ' ' LYS . 1.5 p -121.22 121.25 64.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.408 0.623 . . . . 0.0 110.991 177.611 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.642 ' HB ' HG22 ' A' ' 154' ' ' VAL . 7.7 p -127.12 113.01 21.68 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.631 176.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 1.054 ' HG2' ' HB2' ' A' ' 144' ' ' GLN . 96.1 Cg_endo -90.2 138.0 2.71 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.238 2.625 . . . . 0.0 113.526 -174.116 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -75.41 -23.31 57.02 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 113.636 -1.62 . . . . 0.0 109.418 175.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -97.67 17.29 18.2 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.951 -178.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 1.054 ' HB2' ' HG2' ' A' ' 141' ' ' PRO . 8.9 tp60 -63.83 -63.28 1.21 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.22 0.533 . . . . 0.0 111.54 -177.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.1 p -146.45 150.6 41.15 Favored Pre-proline 0 C--N 1.316 -0.85 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.124 -174.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.57 165.25 32.49 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.189 2.593 . . . . 0.0 112.309 178.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -78.43 23.83 0.29 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.948 -175.057 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -70.87 -47.6 58.41 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.487 0.661 . . . . 0.0 109.465 176.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -101.82 0.46 35.72 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.744 177.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 44.88 37.86 2.6 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.441 1.096 . . . . 0.0 112.034 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -147.9 141.0 24.98 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.027 0.441 . . . . 0.0 111.779 -174.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.414 HG23 ' CG1' ' A' ' 111' ' ' VAL . 23.3 m -126.95 -176.02 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.186 -178.505 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.594 HG12 ' HD3' ' A' ' 110' ' ' ARG . 58.2 mt -132.81 134.94 57.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 O-C-N 122.247 -0.283 . . . . 0.0 110.69 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.642 HG22 ' HB ' ' A' ' 140' ' ' VAL . 89.7 t -92.4 139.09 18.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 174.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.719 ' HE3' ' HG3' ' A' ' 141' ' ' PRO . 0.0 OUTLIER -105.57 117.18 33.37 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.997 0.427 . . . . 0.0 109.964 179.258 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.533 HD13 ' HB3' ' A' ' 166' ' ' ALA . 53.4 mt -100.49 116.66 44.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.072 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.648 ' HB ' ' HB3' ' A' ' 137' ' ' GLU . 3.2 mp -107.32 131.8 56.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 175.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 153.36 -152.68 24.27 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.446 -178.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.51 ' CE1' ' HB3' ' A' ' 102' ' ' GLU . 7.8 m-70 -102.7 155.12 18.52 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -175.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.435 ' O ' ' HG3' ' A' ' 164' ' ' GLN . 25.0 p90 -56.0 -36.36 67.83 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.037 0.835 . . . . 0.0 111.797 -172.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.461 ' O ' ' HG2' ' A' ' 165' ' ' MET . 35.8 m-85 -60.2 -48.02 83.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.82 0.343 . . . . 0.0 110.746 175.744 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -70.39 -36.94 74.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.611 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.451 ' HA ' HG21 ' A' ' 156' ' ' ILE . 68.7 m -57.54 -45.78 84.69 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.413 176.306 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' GLN . . . . . 0.594 HE22 ' HD1' ' A' ' 81' ' ' PHE . 27.5 mt-30 -64.39 -33.66 76.37 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.777 0.322 . . . . 0.0 111.152 179.082 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.461 ' HG2' ' O ' ' A' ' 161' ' ' TYR . 95.9 mmm -63.02 -40.57 98.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.173 176.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.533 ' HB3' HD13 ' A' ' 156' ' ' ILE . . . -74.83 -37.99 62.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.826 178.134 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.401 ' NE2' HG21 ' A' ' 25' ' ' VAL . 32.4 mt-30 -53.33 -56.2 18.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.751 177.543 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -65.88 -31.45 72.4 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.035 -178.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.726 ' HA ' ' HE3' ' A' ' 169' ' ' LYS . 0.2 OUTLIER -72.95 -54.94 7.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.152 -172.886 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 2.4 mp -72.0 -46.77 58.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.8 0.333 . . . . 0.0 110.424 -177.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.586 ' HA ' ' HG ' ' A' ' 174' ' ' LEU . 24.6 mmm180 -60.99 -24.93 66.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.175 -178.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -71.44 -47.36 56.35 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 111.547 0.203 . . . . 0.0 111.547 177.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.471 HG13 HD23 ' A' ' 174' ' ' LEU . 18.3 pt -66.62 -19.26 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.671 -177.587 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.694 ' CD2' HG23 ' A' ' 111' ' ' VAL . 6.7 mt -60.92 -28.78 69.18 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.817 177.402 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.438 ' O ' ' HG3' ' A' ' 179' ' ' GLN . . . -59.0 -43.12 91.45 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.037 176.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 71.3 mm-40 -60.81 -45.43 94.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.656 176.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.642 HG11 ' HB2' ' A' ' 115' ' ' ALA . 46.7 t -61.38 -41.26 89.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.576 179.499 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -63.0 -44.44 96.0 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.557 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' GLN . . . . . 0.438 ' HG3' ' O ' ' A' ' 175' ' ' ALA . 96.9 mt-30 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.755 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.777 0 N-CA-C 112.201 -0.359 . . . . 0.0 112.201 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.22 123.21 6.36 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 60.8 mtt -77.13 96.11 4.4 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.953 0.406 . . . . 0.0 111.291 -178.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.406 ' HA2' ' HD3' ' A' ' 5' ' ' PRO . . . -89.86 128.88 9.43 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.857 -0.687 . . . . 0.0 111.417 175.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.406 ' HD3' ' HA2' ' A' ' 4' ' ' GLY . 52.3 Cg_exo -55.2 107.19 0.22 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.223 2.615 . . . . 0.0 112.617 -177.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.8 m 61.12 20.07 10.58 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.108 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.9 t -103.07 35.47 2.53 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.563 0.697 . . . . 0.0 110.093 -177.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 18.8 m -102.83 130.79 52.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.134 178.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.8 m -143.35 -176.92 5.13 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.083 0.468 . . . . 0.0 111.263 -176.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 169.12 -88.28 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -177.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 55.95 83.14 0.1 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.158 0.504 . . . . 0.0 111.819 177.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -119.79 82.29 27.17 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.727 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -99.29 35.54 0.09 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 123.547 2.831 . . . . 0.0 112.781 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -104.99 77.35 1.32 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.247 0.546 . . . . 0.0 110.709 -178.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.1 p -112.98 -173.63 2.29 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.614 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.2 m 72.0 138.94 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 O-C-N 123.863 0.727 . . . . 0.0 111.392 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -106.12 87.14 2.5 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.291 177.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 17.1 tpt -92.43 110.07 42.42 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.197 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.96 109.6 1.96 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.794 2.329 . . . . 0.0 112.017 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -90.44 43.58 0.53 Allowed 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 123.048 2.499 . . . . 0.0 112.454 -176.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -94.44 21.05 7.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.228 0.537 . . . . 0.0 110.889 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 83.2 mm-40 -90.27 151.09 21.66 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 174.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -73.74 120.37 19.24 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.081 0.467 . . . . 0.0 110.879 -177.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.633 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 53.1 m -122.87 114.77 20.93 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.61 -176.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.589 HG21 HE21 ' A' ' 167' ' ' GLN . 27.2 m -132.8 161.72 41.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.636 -179.206 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.556 ' HB3' ' HB3' ' A' ' 70' ' ' MET . 13.1 m170 -107.74 113.61 27.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.747 -173.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.63 ' O ' ' HA ' ' A' ' 70' ' ' MET . 40.2 t -90.83 123.36 42.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.909 0.385 . . . . 0.0 110.557 -176.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.736 ' CZ ' HG11 ' A' ' 68' ' ' VAL . 2.3 t80 -85.13 104.67 15.23 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.527 -168.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.569 ' C ' HG23 ' A' ' 68' ' ' VAL . 18.9 pt -130.3 117.09 17.75 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.424 0.63 . . . . 0.0 110.892 174.161 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.639 ' HB2' ' HG2' ' A' ' 32' ' ' GLN . 51.0 Cg_exo -54.42 153.87 21.33 Favored 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 123.315 2.677 . . . . 0.0 112.505 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.616 ' HA ' HG12 ' A' ' 34' ' ' VAL . . . -56.89 -18.22 12.41 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 114.848 -1.069 . . . . 0.0 112.423 -176.017 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.639 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 30.1 pt20 -72.05 -18.62 61.93 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.94 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.489 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -123.09 -31.82 3.55 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 120.52 -0.472 . . . . 0.0 111.869 -176.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.616 HG12 ' HA ' ' A' ' 31' ' ' ALA . 9.1 p -52.56 -34.28 19.07 Favored 'Isoleucine or valine' 0 C--O 1.242 0.675 0 CA-C-O 120.922 0.391 . . . . 0.0 111.715 -172.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.913 ' HA2' ' N4 ' ' B' ' 4' ' ' ' C' . . . -57.19 -57.11 21.5 Favored Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.355 -178.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.45 ' HB2' " O2'" ' B' ' 2' ' ' ' C' . . . -76.52 -13.46 60.09 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.928 -174.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.657 HD12 ' HB3' ' A' ' 90' ' ' LYS . 3.3 mm -64.28 -39.98 87.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 116.313 -0.403 . . . . 0.0 109.97 176.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.816 HD12 ' C5 ' ' B' ' 4' ' ' ' C' . 9.1 mt -61.16 -60.05 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.929 176.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.593 ' HA2' ' OP1' ' B' ' 3' ' ' ' A' . . . 86.48 119.12 1.12 Allowed Glycine 0 CA--C 1.525 0.713 0 C-N-CA 120.288 -0.958 . . . . 0.0 115.393 169.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm 40.43 89.52 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.278 1.431 . . . . 0.0 114.259 169.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.53 ' HA ' ' OP2' ' B' ' 4' ' ' ' C' . 10.4 ttpt 61.54 5.25 1.18 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.958 175.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.3 29.83 69.88 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.749 -0.738 . . . . 0.0 111.859 -176.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 54.9 tp60 -86.51 -54.71 4.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.532 0.206 . . . . 0.0 111.214 -176.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.574 ' NE2' ' HA3' ' A' ' 39' ' ' GLY . 17.4 p80 -71.64 -21.76 61.78 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.483 -176.227 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.645 HG21 HG23 ' A' ' 38' ' ' ILE . 10.6 tt -68.07 -33.52 61.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 121.131 0.491 . . . . 0.0 110.006 175.133 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.449 ' HE2' ' HA ' ' A' ' 46' ' ' LYS . 0.8 OUTLIER -81.32 -31.62 33.43 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 174.808 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.5 ' HB3' ' HA ' ' A' ' 44' ' ' HIS . 34.1 tt0 -58.58 -36.57 74.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.349 171.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.791 HD22 HG12 ' A' ' 56' ' ' ILE . 6.7 tt -61.43 -39.17 89.82 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.271 177.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.693 ' HA ' HD13 ' A' ' 56' ' ' ILE . 17.1 m -61.55 -29.28 69.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.301 177.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 43.8 mtp180 -79.57 -50.89 10.03 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.617 -177.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.742 ' CZ ' ' HA ' ' A' ' 48' ' ' LEU . 1.7 p90 -75.18 -18.99 60.06 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.853 -177.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -92.05 -22.47 19.92 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.829 175.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.2 t 65.85 37.2 5.67 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.616 -177.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -132.36 173.41 11.31 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.17 -178.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.805 ' HB3' ' HB ' ' A' ' 74' ' ' THR . 18.6 t -100.5 101.8 12.82 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.791 HG12 HD22 ' A' ' 48' ' ' LEU . 2.1 mp -98.23 111.9 29.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.814 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.503 ' HB2' ' HB ' ' A' ' 72' ' ' VAL . 41.7 mtpt -128.75 154.31 46.5 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.849 -178.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.666 ' HB ' ' N1 ' ' B' ' 5' ' ' ' A' . 42.4 mm -110.1 113.31 43.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 174.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.727 ' HB2' HG23 ' A' ' 72' ' ' VAL . . . -71.69 126.16 91.58 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.396 -175.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -65.03 143.81 80.05 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.404 2.069 . . . . 0.0 110.341 171.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -37.89 107.33 0.06 OUTLIER 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 124.098 3.199 . . . . 0.0 113.497 -176.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -66.93 -27.8 67.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.57 -178.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.462 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 19.0 p -126.91 139.2 34.36 Favored Pre-proline 0 C--N 1.324 -0.539 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 172.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 63' ' ' THR . 21.4 Cg_exo -65.89 -7.84 17.98 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.933 2.422 . . . . 0.0 112.652 -177.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -104.01 12.29 34.33 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.218 -179.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 53.4 p -82.47 139.18 34.09 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.317 0.58 . . . . 0.0 111.32 -177.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.4 tmtp? -106.37 26.84 9.36 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 175.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.736 HG11 ' CZ ' ' A' ' 28' ' ' PHE . 2.7 p -154.02 150.91 11.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.327 -167.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.522 ' HD3' HG11 ' A' ' 34' ' ' VAL . 61.2 mtp180 -125.83 129.9 50.31 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 175.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.63 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 3.6 mpp? -94.27 136.88 34.08 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.824 -172.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.599 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 84.6 t -83.61 120.48 34.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 175.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.727 HG23 ' HB2' ' A' ' 59' ' ' ALA . 74.4 t -86.88 96.43 5.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.052 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.633 ' O ' ' HA ' ' A' ' 24' ' ' THR . 10.2 tp -93.48 114.57 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 CA-C-O 121.422 0.63 . . . . 0.0 110.162 178.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.805 ' HB ' ' HB3' ' A' ' 55' ' ' SER . 75.3 m -113.27 103.25 11.14 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 173.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -168.75 162.91 36.7 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.046 -1.073 . . . . 0.0 112.934 -176.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.457 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 37.9 Cg_endo -67.81 147.66 75.5 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.285 1.99 . . . . 0.0 110.361 169.111 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 76' ' ' PRO . 81.0 Cg_exo -49.85 -27.27 15.44 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 124.092 3.194 . . . . 0.0 113.722 -177.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -61.38 -43.06 99.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.425 0.631 . . . . 0.0 110.23 175.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.36 -38.77 41.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.798 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -59.04 -30.58 68.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.14 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.422 ' HA ' ' OE1' ' A' ' 164' ' ' GLN . 55.5 t80 -59.72 -48.92 79.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.53 178.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 17.3 mttt -68.39 -50.78 50.46 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.242 0.544 . . . . 0.0 109.682 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.91 -54.06 49.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.968 -1.014 . . . . 0.0 111.93 -174.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.518 ' O ' HG22 ' A' ' 87' ' ' ILE . 23.8 mt-30 -76.27 -31.07 58.07 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.95 -0.3 . . . . 0.0 111.135 -178.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -59.2 -42.06 97.02 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.295 -0.955 . . . . 0.0 111.589 175.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.457 ' HA ' ' HD3' ' A' ' 86' ' ' ARG . 21.6 mmt180 -79.79 -27.92 40.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.861 -0.169 . . . . 0.0 111.156 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.518 HG22 ' O ' ' A' ' 84' ' ' GLN . 0.3 OUTLIER -68.57 -39.49 80.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.069 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.582 ' HB3' HG21 ' A' ' 103' ' ' VAL . 9.1 m-85 -68.11 -30.17 69.27 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.148 0.499 . . . . 0.0 109.886 173.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -65.69 -28.88 74.05 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.773 175.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.657 ' HB3' HD12 ' A' ' 37' ' ' ILE . 10.9 mptt -70.31 -29.96 66.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.822 0.344 . . . . 0.0 110.372 176.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' A' ' 88' ' ' TYR . 4.6 mm? -61.99 -44.97 95.61 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 169.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 1.097 ' HE3' ' HB ' ' A' ' 103' ' ' VAL . 1.8 mptm? -63.44 -30.23 71.39 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.637 176.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -55.31 -46.02 76.27 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.522 -178.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -109.63 -5.78 15.56 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -178.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 61.87 40.53 12.53 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.223 174.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.42 ' CE2' ' HB2' ' A' ' 33' ' ' ALA . 53.2 m-85 -66.84 -46.58 74.63 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -178.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.523 ' CZ ' ' HE2' ' A' ' 92' ' ' LYS . 26.0 p90 -64.71 -29.84 70.83 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.172 -177.023 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.437 ' HA3' ' HB2' ' A' ' 101' ' ' GLU . . . 157.58 130.91 1.25 Allowed Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -178.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.45 -51.48 5.19 Favored 'Trans proline' 0 CA--C 1.529 0.239 0 C-N-CA 122.824 2.349 . . . . 0.0 113.078 -178.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -92.18 -18.85 22.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.895 0.379 . . . . 0.0 111.166 -178.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.437 ' HB2' ' HA3' ' A' ' 98' ' ' GLY . 5.3 mm-40 -61.98 144.93 54.39 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.06 -179.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.47 156.76 37.89 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 168.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 1.097 ' HB ' ' HE3' ' A' ' 92' ' ' LYS . 7.6 p -57.28 124.29 10.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 122.136 0.969 . . . . 0.0 111.734 -170.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 35.6 mmtm -126.03 90.44 3.19 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 113.976 -1.466 . . . . 0.0 108.43 176.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.551 ' HB3' ' CE2' ' A' ' 88' ' ' TYR . 2.0 tm? -128.12 125.64 39.58 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.508 0.67 . . . . 0.0 110.525 -175.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.52 ' HG3' HG13 ' A' ' 157' ' ' ILE . 2.5 mp0 -71.35 132.11 44.38 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.58 -1.191 . . . . 0.0 112.064 -177.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 20.3 m -119.56 135.16 54.9 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 169.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 10.2 m170 -108.75 120.86 43.71 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.731 0.301 . . . . 0.0 110.329 -177.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.483 HD13 ' HA ' ' A' ' 167' ' ' GLN . 37.4 pt -114.1 136.06 51.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.135 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.608 HH11 HG13 ' A' ' 153' ' ' ILE . 19.5 mmm180 -87.17 119.16 27.12 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.862 -176.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.626 HG12 HD11 ' A' ' 174' ' ' LEU . 19.2 m -123.04 153.33 64.26 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.827 176.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.535 ' HD2' HD22 ' A' ' 174' ' ' LEU . 51.8 Cg_exo -54.33 142.89 67.64 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.221 1.948 . . . . 0.0 111.098 176.169 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.58 ' HA ' HG22 ' A' ' 152' ' ' VAL . . . -50.17 -47.41 54.42 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -170.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 43.8 t -75.1 -28.95 60.47 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.523 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.39 -32.26 73.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.14 -178.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.664 ' O ' HG12 ' A' ' 119' ' ' VAL . . . -64.56 -32.76 74.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.368 0.604 . . . . 0.0 110.231 175.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -74.74 -25.32 70.0 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.548 177.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.411 ' HD3' HG22 ' A' ' 177' ' ' VAL . 56.3 ttt180 -92.95 -15.09 26.68 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.722 0.267 . . . . 0.0 111.722 -178.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.664 HG12 ' O ' ' A' ' 116' ' ' ALA . 9.5 p -71.31 -20.88 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 173.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 1.072 ' HA ' ' HB ' ' A' ' 127' ' ' VAL . 71.9 mt -66.35 -25.98 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.953 170.027 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 111.67 151.86 11.96 Favored Glycine 0 N--CA 1.441 -1.03 0 CA-C-N 114.993 -1.003 . . . . 0.0 112.219 178.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -64.67 -26.37 68.35 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 175.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -103.36 -14.81 16.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.902 176.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.584 ' HA2' HG22 ' A' ' 120' ' ' ILE . . . 91.34 -1.64 76.89 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.447 -176.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 31.0 mtmm -85.51 -23.63 27.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.979 0.419 . . . . 0.0 110.948 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 23.5 m -65.09 -39.19 92.83 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.642 -170.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 1.072 ' HB ' ' HA ' ' A' ' 120' ' ' ILE . 14.4 p -63.71 -32.73 58.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.028 0.442 . . . . 0.0 111.082 -177.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -71.9 -40.56 68.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.241 0.544 . . . . 0.0 110.237 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -78.67 -25.4 44.87 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.394 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.487 HD23 HG11 ' A' ' 138' ' ' VAL . 25.8 tp -58.59 -45.53 88.89 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 174.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -60.55 -36.03 77.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.068 0.461 . . . . 0.0 110.693 176.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -67.51 -33.03 74.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.407 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -88.16 -43.95 11.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.852 0.358 . . . . 0.0 110.755 -178.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.633 ' HB ' ' HB2' ' A' ' 166' ' ' ALA . 62.0 p -73.65 -22.57 59.93 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.956 -174.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 65.08 15.74 10.17 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.044 -178.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.545 ' HB2' ' HB1' ' A' ' 162' ' ' ALA . . . -120.84 168.75 11.12 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.124 -178.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.464 ' HB3' ' HB ' ' A' ' 157' ' ' ILE . 23.5 tt0 -93.84 109.71 21.39 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 177.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.487 HG11 HD23 ' A' ' 130' ' ' LEU . 55.0 t -106.29 105.89 19.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.879 -177.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.659 HG13 ' HD3' ' A' ' 155' ' ' LYS . 4.8 p -108.76 115.1 48.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.464 0.649 . . . . 0.0 110.605 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 47.0 t -101.68 115.33 65.04 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.125 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.519 ' HG3' ' HE3' ' A' ' 155' ' ' LYS . 84.0 Cg_endo -82.87 155.25 15.28 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.724 2.283 . . . . 0.0 112.608 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 39.8 mmt180 -86.52 -12.65 48.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.071 176.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -116.93 -89.17 0.58 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.795 -178.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.988 ' HG2' ' H ' ' A' ' 153' ' ' ILE . 23.8 tp60 67.43 -77.39 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.04 0.536 . . . . 0.0 111.624 -178.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.1 p -145.31 139.51 15.06 Favored Pre-proline 0 C--N 1.316 -0.851 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -57.19 148.77 67.88 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 122.641 2.227 . . . . 0.0 111.97 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -72.95 8.64 1.46 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.025 -178.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -61.55 -29.22 69.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.574 0.702 . . . . 0.0 109.571 169.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ASN . . . . . 0.413 ' O ' ' HG2' ' A' ' 150' ' ' GLU . 8.6 t-20 -95.94 0.46 51.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.515 177.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' A' ' 149' ' ' ASN . 8.8 pt-20 46.46 23.82 0.25 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.91 1.284 . . . . 0.0 112.323 -175.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.408 ' HG3' ' O ' ' A' ' 111' ' ' VAL . 34.4 tt0 -152.97 139.49 18.71 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 120.871 0.367 . . . . 0.0 110.706 -171.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.58 HG22 ' HA ' ' A' ' 113' ' ' ALA . 17.5 m -132.19 -177.04 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.951 -178.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.988 ' H ' ' HG2' ' A' ' 144' ' ' GLN . 20.5 mt -126.27 141.0 47.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.889 0.376 . . . . 0.0 111.462 -178.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 5.6 p -109.88 138.93 35.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 165.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.659 ' HD3' HG13 ' A' ' 139' ' ' VAL . 0.0 OUTLIER -99.6 129.09 45.72 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.915 -173.668 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.5 HG21 ' HA ' ' A' ' 163' ' ' SER . 59.9 mt -110.86 117.69 55.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.221 179.003 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.52 HG13 ' HG3' ' A' ' 106' ' ' GLU . 3.9 mp -112.27 139.62 36.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.658 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 142.38 -153.2 24.3 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.351 -0.928 . . . . 0.0 112.897 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 17.9 m80 -85.69 158.22 20.11 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -177.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.471 ' HB3' ' CG ' ' A' ' 88' ' ' TYR . 51.4 p90 -63.64 -36.73 84.8 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.459 -175.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -54.58 -46.82 73.82 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.384 0.611 . . . . 0.0 110.371 175.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.545 ' HB1' ' HB2' ' A' ' 136' ' ' ALA . . . -68.76 -48.31 64.04 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.854 -178.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.5 ' HA ' HG21 ' A' ' 156' ' ' ILE . 41.9 m -56.63 -49.95 73.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.173 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.422 ' OE1' ' HA ' ' A' ' 81' ' ' PHE . 18.4 mt-30 -59.64 -39.43 84.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.93 0.395 . . . . 0.0 111.289 -178.094 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 35.9 ttp -72.8 -37.23 67.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.774 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.633 ' HB2' ' HB ' ' A' ' 134' ' ' THR . . . -66.56 -48.68 68.87 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.805 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.589 HE21 HG21 ' A' ' 25' ' ' VAL . 42.2 mt-30 -51.82 -55.79 17.8 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.953 -178.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -64.32 -30.44 71.49 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.635 -174.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.969 ' HA ' ' HE2' ' A' ' 169' ' ' LYS . 3.5 mmpt? -76.82 -40.99 46.02 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.367 -177.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.425 ' O ' ' HG ' ' A' ' 174' ' ' LEU . 17.0 mt -70.89 -42.21 77.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.006 0.431 . . . . 0.0 110.132 176.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -61.46 -27.0 68.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.891 175.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -77.02 -40.43 46.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.4 -177.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.431 ' O ' HG23 ' A' ' 177' ' ' VAL . 18.2 pt -69.46 -26.75 31.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.602 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.626 HD11 HG12 ' A' ' 111' ' ' VAL . 19.3 mt -50.46 -47.74 56.79 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.831 0.348 . . . . 0.0 111.138 177.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.73 -40.52 97.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.787 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -73.68 -30.08 62.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.102 -178.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 173' ' ' ILE . 53.3 t -67.38 -45.82 84.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.27 175.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -63.3 -19.54 64.68 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.678 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -60.57 -12.12 9.09 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 120.895 0.379 . . . . 0.0 111.229 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -55.3 -20.9 12.68 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.389 176.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 51.2 p-80 -59.28 -25.58 64.22 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.385 178.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 52.1 tp60 -67.91 -49.12 63.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt 53.86 87.8 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 O-C-N 123.937 0.773 . . . . 0.0 111.547 177.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 159.75 98.08 0.13 Allowed Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -77.94 78.0 4.44 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.05 0.452 . . . . 0.0 110.735 -178.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 15.3 m -83.14 45.18 1.0 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.74 174.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 170.41 164.31 25.92 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.442 -176.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -94.92 172.88 7.88 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.241 0.543 . . . . 0.0 111.645 -177.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 55.6 tp -152.78 138.56 17.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.315 -0.857 . . . . 0.0 108.949 177.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -78.95 71.25 5.4 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.059 0.457 . . . . 0.0 110.72 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.441 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.376 179.086 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' ' G' . . . . . 0.975 " O2'" ' H6 ' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.424 -0.99 0 C4'-C3'-C2' 106.293 3.593 OUTLIER-EPSILON 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . 0.975 ' H6 ' " O2'" ' B' ' 1' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.423 -1.031 0 C3'-C2'-C1' 99.136 -2.627 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . 0.646 " H1'" ' C5 ' ' B' ' 4' ' ' ' C' . . . . . . . . 0 C2'--C1' 1.516 -1.229 0 C5'-C4'-O4' 112.519 2.37 . 0.0 OUTLIER '7D dist 1[' 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 4' ' ' ' C' . . . . . 0.913 ' N4 ' ' HA2' ' A' ' 35' ' ' GLY . . . . . . . . 0 O3'--C3' 1.432 0.653 0 C4'-C3'-C2' 105.887 3.187 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.795 " O4'" " H4'" ' B' ' 4' ' ' ' C' . . . . . . . . 0 P--O3' 1.614 0.597 0 P-O3'-C3' 122.623 2.436 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 6' ' ' ' C' . . . . . 0.728 ' H6 ' " O5'" ' B' ' 6' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.427 -0.84 0 C3'-C2'-C1' 103.484 2.205 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.425 -0.919 0 O4'-C1'-C2' 107.77 0.979 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.867 0 C3'-C2'-C1' 100.233 -1.408 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.695 0 N-CA-C 111.907 -0.477 . . . . 0.0 111.907 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -131.48 149.64 52.45 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.702 0.287 . . . . 0.0 110.473 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.4 mmt -101.9 76.6 1.64 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.267 0.556 . . . . 0.0 110.236 178.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.4 ' HA2' ' HD3' ' A' ' 5' ' ' PRO . . . -152.9 117.98 0.85 Allowed Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.81 -178.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.4 ' HD3' ' HA2' ' A' ' 4' ' ' GLY . 31.2 Cg_exo -60.03 149.08 86.49 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 123.039 2.493 . . . . 0.0 112.686 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 24.9 m -88.49 79.27 7.69 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.231 -176.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.7 t -154.39 30.47 0.43 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.061 0.458 . . . . 0.0 110.265 177.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.8 p -157.15 77.31 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 122.271 1.034 . . . . 0.0 110.485 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.2 p -147.36 21.63 1.19 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.237 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.94 88.82 0.9 Allowed Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.937 -177.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -100.75 -30.07 11.92 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.812 0.339 . . . . 0.0 111.047 -176.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -127.72 83.93 64.73 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 120.921 0.391 . . . . 0.0 110.7 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -81.03 -61.46 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 123.044 2.496 . . . . 0.0 113.157 -177.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -108.82 126.41 53.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.654 -173.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.4 p -155.47 174.67 14.93 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.146 -178.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 31.1 m 70.21 -69.67 0.17 Allowed 'General case' 0 N--CA 1.468 0.428 0 O-C-N 123.914 0.759 . . . . 0.0 112.038 176.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -81.73 148.73 28.8 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.477 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -155.23 142.79 13.98 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.06 175.983 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.524 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 1.6 Cg_endo -86.84 113.84 1.08 Allowed 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 123.149 2.566 . . . . 0.0 111.372 174.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.524 ' HD3' ' HA ' ' A' ' 19' ' ' PRO . 2.7 Cg_exo -76.34 56.82 5.16 Favored 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 123.142 2.561 . . . . 0.0 113.388 -174.206 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -85.24 63.38 8.06 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 172.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -65.51 134.52 53.56 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.22 -175.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -85.08 103.53 14.17 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.145 -178.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.67 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 8.0 t -120.05 123.12 42.65 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 121.556 0.693 . . . . 0.0 109.572 173.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.543 ' HB ' HG22 ' A' ' 109' ' ' ILE . 27.2 m -126.44 160.94 33.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -106.07 121.41 44.07 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 121.009 -0.277 . . . . 0.0 110.785 -171.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.617 ' O ' ' HA ' ' A' ' 70' ' ' MET . 21.6 t -96.93 128.43 48.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.614 -174.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.43 ' CZ ' HG11 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -90.65 104.84 17.38 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 122.326 0.25 . . . . 0.0 111.232 -171.622 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.474 ' C ' HG23 ' A' ' 68' ' ' VAL . 20.4 pt -126.97 120.06 22.53 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.179 0.514 . . . . 0.0 110.682 175.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.447 ' HA ' ' HA ' ' A' ' 68' ' ' VAL . 38.2 Cg_exo -58.92 152.38 58.41 Favored 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 122.955 2.437 . . . . 0.0 112.8 -177.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.668 ' HA ' HG12 ' A' ' 34' ' ' VAL . . . -60.01 -19.98 55.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.89 -1.05 . . . . 0.0 112.889 -173.026 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -68.54 -24.81 64.68 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.657 ' HB2' ' HE2' ' A' ' 96' ' ' PHE . . . -116.28 -31.03 5.76 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.939 -176.084 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.668 HG12 ' HA ' ' A' ' 31' ' ' ALA . 10.2 p -51.44 -34.96 15.92 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 CA-C-O 120.93 0.395 . . . . 0.0 111.432 -174.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.951 ' HA2' ' N4 ' ' B' ' 4' ' ' ' C' . . . -55.84 -55.91 26.62 Favored Glycine 0 N--CA 1.438 -1.231 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.268 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.25 -14.89 60.55 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 120.987 0.422 . . . . 0.0 111.099 -175.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.952 HD12 ' HB3' ' A' ' 90' ' ' LYS . 3.7 mm -65.98 -39.96 86.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.16 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.726 HD12 ' C5 ' ' B' ' 4' ' ' ' C' . 17.7 mt -61.94 -37.8 79.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-O 121.074 0.464 . . . . 0.0 111.392 177.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.66 141.21 9.07 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.063 178.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -46.52 -34.18 4.65 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.342 0.657 . . . . 0.0 112.132 -172.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.502 ' HE2' ' HB3' ' A' ' 43' ' ' GLN . 15.4 ptmt -123.09 93.2 3.88 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 166.064 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.574 ' HA3' " H5'" ' B' ' 4' ' ' ' C' . . . -33.23 88.8 0.01 OUTLIER Glycine 0 C--N 1.338 0.671 0 O-C-N 124.355 1.034 . . . . 0.0 113.673 172.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.502 ' HB3' ' HE2' ' A' ' 41' ' ' LYS . 5.4 tp-100 -176.19 -34.91 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -175.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -56.89 -41.8 78.72 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.023 169.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.566 HG21 HG23 ' A' ' 38' ' ' ILE . 8.5 tt -56.99 -34.16 44.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.036 173.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.54 ' HE2' " H4'" ' B' ' 6' ' ' ' C' . 23.5 mmmt -82.35 -29.96 30.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.594 -178.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.414 ' OE1' ' HD3' ' A' ' 50' ' ' ARG . 46.9 tp60 -62.85 -35.46 80.05 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 170.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.817 ' HG ' ' HE1' ' A' ' 51' ' ' PHE . 7.3 tt -60.98 -42.38 98.24 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.513 173.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 14.9 m -56.74 -34.95 68.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.609 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.414 ' HD3' ' OE1' ' A' ' 47' ' ' GLN . 76.1 mtp180 -72.31 -51.87 18.77 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.693 -176.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.817 ' HE1' ' HG ' ' A' ' 48' ' ' LEU . 3.2 p90 -77.0 -29.98 55.71 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.728 -173.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.606 ' HB1' ' HB2' ' A' ' 83' ' ' ALA . . . -81.73 -12.56 58.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.244 -178.101 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.7 t 61.27 30.07 18.98 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.541 178.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -131.91 159.66 38.0 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.345 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.699 ' HB2' ' HB ' ' A' ' 74' ' ' THR . 19.6 m -91.12 100.46 13.29 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -178.29 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.405 HG13 HD22 ' A' ' 48' ' ' LEU . 33.4 mm -88.4 111.53 22.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.319 -177.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -130.6 137.76 49.8 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.39 176.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.631 ' HB ' ' N1 ' ' B' ' 5' ' ' ' A' . 46.8 mm -94.27 112.35 26.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 172.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.667 ' HB2' HG23 ' A' ' 72' ' ' VAL . . . -67.73 117.73 50.76 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.452 -174.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.53 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 7.5 Cg_exo -73.07 132.02 17.56 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.798 2.332 . . . . 0.0 111.406 176.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.53 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 6.3 Cg_exo -78.24 146.28 22.27 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.706 2.271 . . . . 0.0 111.531 177.149 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -70.48 -44.55 67.47 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 176.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.426 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 32.5 p -96.32 129.74 32.72 Favored Pre-proline 0 N--CA 1.446 -0.669 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.738 177.183 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 63' ' ' THR . 11.9 Cg_exo -70.41 -6.06 18.05 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 123.284 2.656 . . . . 0.0 111.987 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -82.07 -10.92 59.05 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.634 -179.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.2 t -57.43 126.03 25.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.501 0.667 . . . . 0.0 111.505 -177.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.6 tmtp? -79.21 -11.01 59.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.475 -176.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.474 HG23 ' C ' ' A' ' 29' ' ' ILE . 2.4 p -144.78 151.91 15.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.724 -171.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.497 ' HD3' HG11 ' A' ' 34' ' ' VAL . 59.3 mtp180 -126.18 132.23 51.83 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 177.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.617 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 76.7 mtm -92.26 147.47 22.9 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.873 -175.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.548 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 86.4 t -96.09 124.42 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 172.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.667 HG23 ' HB2' ' A' ' 59' ' ' ALA . 97.5 t -86.8 102.13 11.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 174.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.67 ' O ' ' HA ' ' A' ' 24' ' ' THR . 8.8 tp -101.34 100.18 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 CA-C-O 121.882 0.849 . . . . 0.0 110.252 -177.135 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.699 ' HB ' ' HB2' ' A' ' 55' ' ' SER . 9.4 m -102.61 105.83 16.4 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.688 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -160.35 163.62 34.03 Favored Glycine 0 CA--C 1.497 -1.088 0 C-N-CA 119.674 -1.25 . . . . 0.0 113.254 -174.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.48 ' HD2' ' HB3' ' A' ' 79' ' ' ALA . 7.1 Cg_exo -67.23 136.77 41.55 Favored 'Trans proline' 0 N--CA 1.446 -1.273 0 C-N-CA 121.944 1.763 . . . . 0.0 109.859 170.276 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.573 ' HA ' ' NH2' ' A' ' 168' ' ' ARG . 3.7 Cg_exo -36.78 -50.93 1.4 Allowed 'Trans proline' 0 C--O 1.24 0.614 0 C-N-CA 124.59 3.527 . . . . 0.0 113.684 -176.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -63.81 -49.82 71.39 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.942 0.401 . . . . 0.0 111.174 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.56 ' HB1' ' O ' ' A' ' 52' ' ' ALA . . . -66.87 -34.4 77.72 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.407 -177.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -61.91 -31.22 71.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.73 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -65.77 -42.17 91.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.603 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.3 mtmt -63.02 -37.98 89.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.548 0.689 . . . . 0.0 109.952 -178.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.606 ' HB2' ' HB1' ' A' ' 52' ' ' ALA . . . -69.76 -49.05 56.74 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.534 179.247 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.435 ' O ' HG22 ' A' ' 87' ' ' ILE . 42.9 mt-30 -67.14 -30.81 70.91 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -177.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -56.99 -35.19 67.7 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.848 175.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.4 mmt180 -79.44 -36.76 38.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.576 0.227 . . . . 0.0 111.154 177.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.543 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 0.3 OUTLIER -67.75 -40.87 84.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.738 -174.93 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.745 ' HA ' HD23 ' A' ' 91' ' ' LEU . 6.7 m-85 -68.33 -32.04 71.88 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.056 0.455 . . . . 0.0 110.292 175.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -61.44 -28.91 70.29 Favored Glycine 0 C--O 1.224 -0.526 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.709 174.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.952 ' HB3' HD12 ' A' ' 37' ' ' ILE . 69.3 mmtt -66.99 -38.87 86.82 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 122.827 0.451 . . . . 0.0 111.002 174.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.745 HD23 ' HA ' ' A' ' 88' ' ' TYR . 3.2 mm? -60.49 -38.36 84.04 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.157 0.504 . . . . 0.0 110.555 173.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.984 ' HE3' ' HB ' ' A' ' 103' ' ' VAL . 3.6 mmtp -76.44 -26.54 55.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.502 178.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -68.43 -30.92 69.91 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.472 -175.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.583 ' OE1' ' HA ' ' A' ' 94' ' ' GLU . 4.4 mm-40 -96.42 10.7 37.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.307 0.575 . . . . 0.0 110.799 177.265 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 63.2 t30 57.2 45.52 20.37 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 114.757 -1.11 . . . . 0.0 112.143 172.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.657 ' HE2' ' HB2' ' A' ' 33' ' ' ALA . 61.2 m-85 -90.16 -21.94 21.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.148 0.499 . . . . 0.0 110.243 174.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.743 ' O ' ' HB3' ' A' ' 101' ' ' GLU . 12.0 m-85 -131.0 26.38 4.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.037 -179.265 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 59.72 175.52 0.97 Allowed Glycine 0 CA--C 1.525 0.693 0 C-N-CA 121.277 -0.487 . . . . 0.0 113.219 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -82.19 -35.23 0.37 Allowed 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.856 2.371 . . . . 0.0 112.534 174.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -106.98 -23.18 12.42 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.654 0.264 . . . . 0.0 111.429 -175.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.743 ' HB3' ' O ' ' A' ' 97' ' ' PHE . 10.6 tp10 -61.4 151.65 31.81 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.463 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -62.6 126.58 27.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.726 -177.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.984 ' HB ' ' HE3' ' A' ' 92' ' ' LYS . 7.1 p -76.45 122.83 31.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 172.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -124.53 90.31 3.23 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 176.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.594 ' HB3' ' CE2' ' A' ' 88' ' ' TYR . 1.8 tm? -118.86 130.81 55.95 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.869 -173.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.865 ' HG2' HG13 ' A' ' 157' ' ' ILE . 32.0 mt-10 -73.5 126.89 31.25 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.188 -0.915 . . . . 0.0 112.743 -176.155 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.81 125.5 54.16 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 167.012 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 21.5 m170 -107.81 121.49 44.83 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -177.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.543 HG22 ' HB ' ' A' ' 25' ' ' VAL . 10.4 pt -113.83 147.24 17.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 177.102 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.896 ' HG3' ' HG2' ' A' ' 151' ' ' GLN . 4.2 tpt180 -97.88 118.65 34.92 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -176.148 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.708 HG12 HD22 ' A' ' 174' ' ' LEU . 11.1 m -116.82 150.1 45.2 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 178.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.641 ' CD ' HD13 ' A' ' 174' ' ' LEU . 44.8 Cg_exo -49.77 149.66 10.42 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 123.217 2.612 . . . . 0.0 112.341 177.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -48.6 -49.15 38.11 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -171.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 23.1 t -85.93 -19.74 30.04 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.839 0.352 . . . . 0.0 110.921 -176.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.443 ' O ' HG23 ' A' ' 119' ' ' VAL . . . -65.66 -26.08 67.63 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.521 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.517 ' O ' ' HB ' ' A' ' 119' ' ' VAL . . . -63.51 -34.44 77.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.59 177.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -67.66 -32.91 79.34 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.852 -0.689 . . . . 0.0 111.473 177.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.471 ' HD3' HG22 ' A' ' 177' ' ' VAL . 26.1 mtp180 -83.77 -6.8 59.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.488 -0.356 . . . . 0.0 110.609 176.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.713 HG22 HD11 ' A' ' 173' ' ' ILE . 12.0 t -75.11 -51.19 22.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.331 0.586 . . . . 0.0 109.788 172.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 1.015 ' HA ' ' HB ' ' A' ' 127' ' ' VAL . 20.2 pt -81.12 -34.22 13.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.946 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.479 ' HA3' HG22 ' A' ' 126' ' ' THR . . . 89.39 58.49 1.64 Allowed Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.98 -0.628 . . . . 0.0 111.891 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 59.9 -88.25 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.16 0.584 . . . . 0.0 111.797 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -86.87 -25.63 24.38 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.734 -178.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 135.26 39.63 0.17 Allowed Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.306 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -79.31 -63.18 1.47 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.669 0.271 . . . . 0.0 111.25 -177.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.631 ' O ' ' HG ' ' A' ' 130' ' ' LEU . 8.1 t -76.79 -20.22 56.68 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.756 -174.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 1.015 ' HB ' ' HA ' ' A' ' 120' ' ' ILE . 8.8 p -69.25 -29.21 41.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 176.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -65.95 -41.04 91.77 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.494 174.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.33 -48.76 80.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.761 173.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.631 ' HG ' ' O ' ' A' ' 126' ' ' THR . 87.7 mt -58.02 -50.47 73.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.457 -177.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -62.0 -49.69 75.04 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -176.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -77.81 -11.3 59.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.794 -173.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 59.5 tp -97.46 -49.34 4.94 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.749 0.309 . . . . 0.0 110.96 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 82.1 p -79.62 -20.2 47.39 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.85 -173.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 66.2 27.47 10.31 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.875 0.735 . . . . 0.0 110.168 -174.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -127.33 176.21 7.6 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.528 -177.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.546 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 7.3 tp10 -108.74 111.4 23.14 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.845 177.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.49 HG21 HD11 ' A' ' 170' ' ' ILE . 46.2 t -108.41 106.24 20.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 177.069 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.698 HG13 ' HD3' ' A' ' 155' ' ' LYS . 5.1 p -123.16 125.33 71.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.351 0.596 . . . . 0.0 111.819 -175.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.415 ' HA ' ' HD2' ' A' ' 141' ' ' PRO . 89.3 t -92.8 118.1 67.8 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 173.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 140' ' ' VAL . 9.6 Cg_endo -50.72 137.71 41.78 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 123.811 3.007 . . . . 0.0 113.25 -171.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.539 ' HA ' ' NE ' ' A' ' 142' ' ' ARG . 4.6 mmp_? -81.64 -28.99 33.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.309 178.169 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -93.56 62.89 3.37 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 163.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -57.93 139.31 54.6 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.607 -1.179 . . . . 0.0 111.438 -171.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 30.2 p -59.13 130.47 86.83 Favored Pre-proline 0 N--CA 1.448 -0.542 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.292 173.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.448 ' C ' ' H ' ' A' ' 148' ' ' GLU . 17.8 Cg_endo -58.27 150.98 63.2 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.684 2.256 . . . . 0.0 112.226 -175.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -78.24 35.32 0.22 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.321 0.582 . . . . 0.0 110.751 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.448 ' H ' ' C ' ' A' ' 146' ' ' PRO . 24.0 tt0 -52.26 -47.15 65.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.019 177.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -109.15 25.01 12.3 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.314 178.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 49.48 31.34 3.95 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.854 1.262 . . . . 0.0 112.544 178.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.896 ' HG2' ' HG3' ' A' ' 110' ' ' ARG . 44.5 tt0 -156.68 136.12 12.22 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.141 -177.361 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 32.6 m -122.41 169.32 13.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.007 0.432 . . . . 0.0 111.716 -172.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 10.7 mm -102.27 142.76 15.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.098 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 4.1 p -127.97 140.04 50.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.939 171.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.698 ' HD3' HG13 ' A' ' 139' ' ' VAL . 0.0 OUTLIER -96.77 130.4 44.03 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.738 -174.685 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.546 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 76.0 mt -114.43 111.53 36.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 172.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.865 HG13 ' HG2' ' A' ' 106' ' ' GLU . 4.2 mp -110.05 131.69 60.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.12 -177.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 163.82 -164.0 36.14 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.313 -0.946 . . . . 0.0 112.53 177.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.585 ' HA ' HG13 ' A' ' 103' ' ' VAL . 5.1 m80 -79.07 160.07 27.25 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.544 ' HB3' ' CG ' ' A' ' 88' ' ' TYR . 13.5 p90 -57.43 -33.3 67.75 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 118.561 0.619 . . . . 0.0 112.028 -175.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -61.86 -52.95 62.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.522 0.677 . . . . 0.0 110.112 175.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -65.59 -41.65 92.59 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.808 -175.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.48 ' O ' ' HG3' ' A' ' 167' ' ' GLN . 26.2 p -68.08 -49.13 63.16 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.318 -176.057 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -61.62 -31.63 71.72 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.708 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 25.6 ttt -66.83 -45.66 77.56 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.036 0.446 . . . . 0.0 110.301 176.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.533 ' HB3' HG21 ' A' ' 156' ' ' ILE . . . -71.16 -35.31 71.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.833 -177.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.48 ' HG3' ' O ' ' A' ' 163' ' ' SER . 24.7 mt-30 -51.54 -56.58 12.64 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.005 0.431 . . . . 0.0 110.807 -179.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.662 ' HA ' ' HB2' ' A' ' 171' ' ' ARG . 0.4 OUTLIER -74.09 -27.18 60.77 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.498 178.812 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.616 ' HA ' ' HE3' ' A' ' 169' ' ' LYS . 0.2 OUTLIER -64.52 -49.76 70.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.064 0.459 . . . . 0.0 109.992 -179.245 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.562 HG23 HG22 ' A' ' 119' ' ' VAL . 2.0 mp -71.87 -35.24 53.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.755 177.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.729 ' HA ' HD23 ' A' ' 174' ' ' LEU . 1.0 OUTLIER -56.58 -33.82 66.55 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.38 172.894 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.49 -44.13 45.53 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.73 0.271 . . . . 0.0 111.73 -178.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.713 HD11 HG22 ' A' ' 119' ' ' VAL . 2.7 pp -68.58 -30.86 48.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.61 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.729 HD23 ' HA ' ' A' ' 171' ' ' ARG . 0.3 OUTLIER -71.89 -37.59 70.11 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.624 0.726 . . . . 0.0 109.278 174.191 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -58.01 -32.21 67.7 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.981 -1.008 . . . . 0.0 111.067 176.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -61.36 -33.74 74.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.082 0.468 . . . . 0.0 110.113 174.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.715 ' O ' ' HG2' ' A' ' 180' ' ' GLN . 22.0 t -73.8 -29.41 26.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.358 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -63.83 -34.85 78.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.005 0.431 . . . . 0.0 110.44 175.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -67.93 -21.24 65.12 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.238 -174.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 0.715 ' HG2' ' O ' ' A' ' 177' ' ' VAL . 24.5 pt20 -74.43 -20.88 59.88 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.064 178.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -79.05 -44.29 22.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.94 176.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -70.1 -36.02 74.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.753 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.479 ' HE3' ' O ' ' A' ' 180' ' ' GLN . 32.3 mmtp 60.73 83.94 0.14 Allowed 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.266 0.555 . . . . 0.0 110.644 -178.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -80.4 107.17 2.6 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.905 -178.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -69.97 96.48 1.04 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.761 0.315 . . . . 0.0 110.2 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 8.1 t 61.38 34.84 18.15 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.328 -178.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 114.06 -89.9 0.52 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.335 178.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 21.4 mm-40 64.09 33.46 12.01 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.083 0.468 . . . . 0.0 110.928 -178.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 1.5 pp -91.25 164.3 13.93 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.619 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 79.4 mm-40 -99.36 -12.64 20.12 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.124 -175.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.334 0 O-C-N 123.811 0.694 . . . . 0.0 111.663 177.855 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' ' G' . . . . . 0.962 " O2'" ' H6 ' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.424 -0.977 0 C4'-C3'-C2' 106.455 3.755 OUTLIER-EPSILON 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . 0.962 ' H6 ' " O2'" ' B' ' 1' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.425 -0.915 0 C3'-C2'-C1' 99.567 -2.148 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . 0.64 ' C8 ' ' HA3' ' A' ' 35' ' ' GLY . . . . . . . . 0 C2'--C1' 1.516 -1.166 0 O4'-C1'-C2' 103.257 -2.245 . 0.0 OUTLIER '7D dist 1z' 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 4' ' ' ' C' . . . . . 0.951 ' N4 ' ' HA2' ' A' ' 35' ' ' GLY . . . . . . . . 0 O5'--C5' 1.428 -0.73 0 C4'-C3'-C2' 105.997 3.297 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.776 " O5'" " H4'" ' B' ' 4' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.43 -0.623 0 P-O3'-C3' 122.222 2.101 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 6' ' ' ' C' . . . . . 0.54 " H4'" ' HE2' ' A' ' 46' ' ' LYS . . . . . . . . 0 O5'--C5' 1.429 -0.703 0 C4'-C3'-C2' 104.961 2.261 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . 0.442 " O4'" " H2'" ' B' ' 6' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.426 -0.852 0 O4'-C4'-C3' 104.628 -0.623 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.425 -0.953 0 C3'-C2'-C1' 100.49 -1.122 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.445 0 N-CA-C 112.113 -0.395 . . . . 0.0 112.113 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -119.77 156.4 30.68 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 51.6 ttp -88.51 123.77 33.35 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.543 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 104.53 173.28 24.88 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.171 176.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.19 62.05 7.43 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.887 2.391 . . . . 0.0 111.839 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.0 m -62.91 107.27 0.96 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.292 178.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.1 m -69.48 136.48 51.54 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.068 -177.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.3 t -78.67 82.06 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 176.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.2 m -56.84 130.43 45.7 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.696 -176.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.43 4.95 29.74 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 177.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.25 79.66 7.85 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.163 0.506 . . . . 0.0 110.726 177.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.473 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . . . -72.39 133.24 83.24 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.63 175.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 12' ' ' ALA . 13.3 Cg_exo -69.84 70.66 1.61 Allowed 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 123.099 2.533 . . . . 0.0 112.855 -177.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -89.58 -42.22 11.54 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 174.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 37.1 m -130.13 -57.18 1.09 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.766 174.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.411 ' OG ' ' HA ' ' A' ' 13' ' ' PRO . 42.6 m 51.41 65.15 1.57 Allowed 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.297 0.57 . . . . 0.0 111.949 177.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -97.03 117.95 32.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.356 178.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.728 ' HB3' ' HD3' ' A' ' 19' ' ' PRO . 51.1 ttp -96.41 -58.82 0.18 Allowed Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.852 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.728 ' HD3' ' HB3' ' A' ' 18' ' ' MET . 25.4 Cg_exo -62.62 108.87 0.78 Allowed 'Trans proline' 0 C--N 1.36 1.155 0 C-N-CA 122.233 1.955 . . . . 0.0 112.199 -177.175 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 19' ' ' PRO . 5.2 Cg_exo -79.35 78.51 3.69 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 123.36 2.707 . . . . 0.0 113.066 -173.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 54.32 66.2 1.3 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.687 171.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.505 ' HB3' HG22 ' A' ' 74' ' ' THR . 97.1 mt-30 -92.35 104.42 16.76 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 171.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -73.27 143.67 46.96 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.679 -174.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 44.8 m -115.16 107.45 15.32 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.509 0.671 . . . . 0.0 110.774 -176.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.0 t -106.96 148.41 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.429 ' HB3' ' SD ' ' A' ' 70' ' ' MET . 15.9 m-70 -113.74 146.51 39.77 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -174.483 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.695 ' HB ' HG22 ' A' ' 71' ' ' VAL . 7.4 t -124.26 142.79 39.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 120.912 0.387 . . . . 0.0 111.173 -174.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.754 ' CE2' HG11 ' A' ' 68' ' ' VAL . 45.4 t80 -97.58 105.27 17.39 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.088 0.955 . . . . 0.0 110.269 -176.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.53 ' C ' HG23 ' A' ' 68' ' ' VAL . 17.6 pt -124.07 120.22 26.43 Favored Pre-proline 0 C--N 1.324 -0.53 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.766 174.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.612 ' HA ' ' HA ' ' A' ' 68' ' ' VAL . 18.0 Cg_endo -57.96 150.73 62.19 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 122.966 2.444 . . . . 0.0 112.05 -176.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.62 ' HA ' HG12 ' A' ' 34' ' ' VAL . . . -60.17 -19.64 54.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.082 -174.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -69.96 -22.99 63.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.214 177.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.457 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -113.59 -31.79 6.39 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 120.889 -0.325 . . . . 0.0 111.625 -175.158 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.62 HG12 ' HA ' ' A' ' 31' ' ' ALA . 11.7 p -55.58 -31.23 28.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 O-C-N 123.431 0.457 . . . . 0.0 111.714 -171.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 1.117 ' HA2' ' H41' ' B' ' 4' ' ' ' C' . . . -56.71 -57.58 18.84 Favored Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.019 -178.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.43 -13.73 59.7 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 120.673 0.273 . . . . 0.0 111.368 -175.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.594 HD12 ' HB3' ' A' ' 90' ' ' LYS . 2.1 mm -65.49 -36.43 77.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 177.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.81 HD12 ' C5 ' ' B' ' 4' ' ' ' C' . 37.8 mt -63.99 -52.64 53.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.012 173.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 81.7 106.37 0.37 Allowed Glycine 0 CA--C 1.523 0.549 0 N-CA-C 115.131 0.812 . . . . 0.0 115.131 168.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.0 tptt 42.16 89.51 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.841 1.256 . . . . 0.0 113.757 169.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.46 ' HA ' ' OP2' ' B' ' 4' ' ' ' C' . 21.0 ttpt 66.85 -0.35 1.68 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.702 0.801 . . . . 0.0 111.947 176.113 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.497 ' HA2' HG22 ' A' ' 38' ' ' ILE . . . 84.96 18.92 60.27 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.274 -0.965 . . . . 0.0 111.398 -175.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -67.84 -47.21 69.61 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.989 0.423 . . . . 0.0 110.076 178.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 64.0 m-70 -68.29 -39.59 82.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.753 -172.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.0 tt -62.51 -47.31 93.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.719 0.295 . . . . 0.0 111.775 -178.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.2 ptmm? -81.43 -22.87 37.89 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.924 -177.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -64.81 -39.21 93.22 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 169.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.637 ' HA ' ' CZ ' ' A' ' 51' ' ' PHE . 7.8 tt -61.95 -42.12 98.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.931 177.102 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.642 ' HA ' HD13 ' A' ' 56' ' ' ILE . 44.0 t -53.98 -34.85 60.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.687 177.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -76.85 -50.96 12.17 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.661 -177.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.637 ' CZ ' ' HA ' ' A' ' 48' ' ' LEU . 2.4 p90 -76.77 -11.42 59.83 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 119.995 -0.682 . . . . 0.0 111.85 -175.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -96.36 -18.53 19.88 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.73 0.3 . . . . 0.0 110.975 176.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.7 t 65.32 34.36 8.35 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.698 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -141.18 168.93 18.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.291 -176.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.665 ' HB2' ' HB ' ' A' ' 74' ' ' THR . 29.9 m -90.71 103.26 15.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.743 0.306 . . . . 0.0 110.679 -178.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.642 HD13 ' HA ' ' A' ' 49' ' ' SER . 2.4 mp -107.21 113.13 42.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.035 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -134.64 157.76 45.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.794 -177.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.693 ' HB ' ' N1 ' ' B' ' 5' ' ' ' A' . 40.8 mm -97.6 135.7 31.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 174.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.864 ' HB2' HG23 ' A' ' 72' ' ' VAL . . . -92.5 140.58 24.08 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-O 120.642 0.258 . . . . 0.0 110.772 -178.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 59' ' ' ALA . 21.9 Cg_exo -65.63 120.8 8.04 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.794 2.33 . . . . 0.0 111.495 175.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -73.5 -176.38 2.48 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.325 2.017 . . . . 0.0 111.733 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -59.61 -61.61 2.5 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.477 0.656 . . . . 0.0 109.715 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.468 ' HB ' ' HD2' ' A' ' 64' ' ' PRO . 32.0 p -143.44 173.86 4.12 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.934 178.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.468 ' HD2' ' HB ' ' A' ' 63' ' ' THR . 39.7 Cg_exo -62.39 -21.5 72.79 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 121.901 1.734 . . . . 0.0 111.421 173.203 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -92.97 17.08 11.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.095 -177.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.8 t -85.02 143.91 28.61 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -72.65 -24.92 61.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.74 -174.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.754 HG11 ' CE2' ' A' ' 28' ' ' PHE . 7.7 p -137.23 150.99 26.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-O 120.925 0.393 . . . . 0.0 110.602 -175.087 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.616 ' HB3' HG21 ' A' ' 34' ' ' VAL . 18.6 ttm180 -122.21 121.88 37.86 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 174.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.454 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 44.5 ttp -79.83 148.11 31.51 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.134 -178.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.695 HG22 ' HB ' ' A' ' 27' ' ' VAL . 21.8 m -115.19 145.64 20.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.716 0.293 . . . . 0.0 110.555 175.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.864 HG23 ' HB2' ' A' ' 59' ' ' ALA . 58.3 t -107.8 111.11 34.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.15 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.578 ' O ' HD12 ' A' ' 73' ' ' ILE . 2.7 pp -118.77 125.32 74.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.817 0.818 . . . . 0.0 111.133 176.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.665 ' HB ' ' HB2' ' A' ' 55' ' ' SER . 59.4 m -107.04 106.03 16.35 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.786 176.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.03 134.58 7.4 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 119.995 -1.098 . . . . 0.0 113.464 -172.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -69.42 151.03 70.95 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.057 1.838 . . . . 0.0 110.247 167.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -38.13 -49.07 2.28 Favored 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 124.862 3.708 . . . . 0.0 115.407 -173.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -71.3 -49.97 37.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.875 0.369 . . . . 0.0 110.132 -178.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.59 -27.19 68.78 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.806 -177.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -53.9 -42.56 68.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.307 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -72.5 -34.65 67.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.844 -177.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 15.4 tppt? -64.99 -47.83 76.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.714 -178.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.0 -53.13 19.06 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.868 -177.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.547 ' O ' HG22 ' A' ' 87' ' ' ILE . 6.5 tt0 -72.18 -30.23 64.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.386 -173.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -56.29 -34.76 63.48 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.508 177.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -76.7 -36.85 56.95 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 1.005 ' HA ' ' HD3' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -70.41 -30.31 42.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.804 -174.492 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.419 ' HA ' HD12 ' A' ' 105' ' ' LEU . 7.4 m-85 -66.94 -30.67 70.87 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.166 0.508 . . . . 0.0 109.752 171.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -61.87 -29.22 71.76 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.867 175.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 1.005 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 5.2 mptp? -60.0 -45.79 91.58 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.909 0.385 . . . . 0.0 109.999 173.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.404 ' HB2' ' O ' ' A' ' 88' ' ' TYR . 3.6 mm? -57.23 -37.67 72.62 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.591 176.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.985 ' HE3' ' HB ' ' A' ' 103' ' ' VAL . 11.4 mmtp -75.26 -24.43 57.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.028 -176.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -69.47 -44.39 71.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.705 0.288 . . . . 0.0 111.407 -176.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.681 ' HB2' ' CE2' ' A' ' 96' ' ' PHE . 22.7 mm-40 -108.2 1.81 22.37 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 52.27 47.9 23.77 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.269 177.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.681 ' CE2' ' HB2' ' A' ' 94' ' ' GLU . 71.8 m-85 -63.52 -27.41 69.24 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.442 -177.18 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.462 ' HD2' ' HB3' ' A' ' 101' ' ' GLU . 10.9 p90 -72.39 -28.09 62.78 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.217 -177.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 131.95 158.17 8.93 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.11 -178.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -73.78 -30.62 9.24 Favored 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 122.447 2.098 . . . . 0.0 113.149 -178.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -106.13 23.89 13.32 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.953 0.406 . . . . 0.0 111.157 -174.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.462 ' HB3' ' HD2' ' A' ' 97' ' ' PHE . 12.2 tp10 -123.86 157.41 34.24 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.265 -176.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.428 ' O ' ' HG3' ' A' ' 101' ' ' GLU . 46.7 mt-10 -83.29 -174.86 5.53 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 170.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.985 ' HB ' ' HE3' ' A' ' 92' ' ' LYS . 9.8 p -68.12 123.37 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 C-N-CA 118.392 -1.323 . . . . 0.0 109.328 174.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 158' ' ' GLY . 30.3 mmtp -130.75 89.68 2.79 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.43 177.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.419 HD12 ' HA ' ' A' ' 88' ' ' TYR . 0.9 OUTLIER -109.02 115.94 31.04 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -177.473 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.488 ' O ' ' HB3' ' A' ' 28' ' ' PHE . 33.5 tt0 -71.26 116.52 11.67 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.021 -176.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -101.66 144.25 30.61 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.053 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 -124.84 120.98 33.25 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.083 0.468 . . . . 0.0 110.785 -177.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 16.2 pt -121.17 138.15 52.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.144 0.497 . . . . 0.0 111.062 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.618 ' HD3' HG12 ' A' ' 153' ' ' ILE . 9.6 mmt85 -82.66 119.02 23.76 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.442 177.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.956 HG23 HD11 ' A' ' 174' ' ' LEU . 6.0 p -121.69 143.11 37.39 Favored Pre-proline 0 C--N 1.318 -0.783 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.481 ' HD2' ' HG ' ' A' ' 174' ' ' LEU . 50.7 Cg_exo -53.42 140.03 64.16 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.259 1.972 . . . . 0.0 110.111 177.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.68 -28.51 68.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.179 0.514 . . . . 0.0 110.761 -174.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.2 p -75.89 -34.5 59.97 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.461 176.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.525 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -71.89 -20.35 61.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.973 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.421 ' HB2' HG21 ' A' ' 152' ' ' VAL . . . -59.48 -32.65 70.45 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.236 0.541 . . . . 0.0 110.446 176.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -73.43 -39.63 50.17 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.576 175.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.544 ' HD3' HG22 ' A' ' 177' ' ' VAL . 45.5 mtp180 -73.41 -34.64 65.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.486 0.184 . . . . 0.0 111.459 -177.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.546 HG11 HG21 ' A' ' 140' ' ' VAL . 14.0 p -69.73 -36.43 70.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.923 0.392 . . . . 0.0 110.376 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.972 ' HA ' ' HB ' ' A' ' 127' ' ' VAL . 75.5 mt -75.11 -31.4 24.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.651 0.739 . . . . 0.0 109.449 174.345 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 118.58 -33.75 4.67 Favored Glycine 0 N--CA 1.44 -1.096 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.9 t70 65.48 -72.61 0.07 Allowed 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.548 0.739 . . . . 0.0 110.96 178.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -107.13 -11.32 15.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.957 0.408 . . . . 0.0 110.237 176.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -113.75 -168.96 16.75 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.082 -176.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -109.11 35.94 3.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.884 0.373 . . . . 0.0 110.422 -176.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 11.0 m -60.09 -46.15 90.55 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.246 -175.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.972 ' HB ' ' HA ' ' A' ' 120' ' ' ILE . 9.9 p -68.82 -33.89 61.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.266 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -60.71 -42.56 97.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.346 0.593 . . . . 0.0 109.533 176.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -61.08 -48.89 79.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.844 175.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 91.4 mt -58.6 -49.37 77.73 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.09 -177.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -58.52 -43.88 89.31 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 123.14 0.275 . . . . 0.0 111.575 -174.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -81.13 -33.26 33.33 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 121.061 -0.256 . . . . 0.0 111.344 -178.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.34 -48.74 74.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.098 0.475 . . . . 0.0 110.009 178.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.621 HG21 ' HA ' ' A' ' 166' ' ' ALA . 66.7 p -85.6 -18.06 34.41 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.762 -174.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 63.6 29.32 15.19 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.523 -175.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -127.44 170.17 12.84 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.4 -177.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.448 ' HB3' ' HB ' ' A' ' 157' ' ' ILE . 10.1 tp10 -95.77 113.61 25.26 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 177.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 59.1 t -110.8 105.97 19.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.939 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.637 HG22 ' HD3' ' A' ' 141' ' ' PRO . 6.3 p -125.25 128.34 72.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.348 177.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.894 HG22 HG13 ' A' ' 154' ' ' VAL . 2.3 t -130.75 81.55 67.08 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 121.02 0.438 . . . . 0.0 110.723 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.809 ' HD2' ' HE3' ' A' ' 155' ' ' LYS . 51.6 Cg_exo -57.1 142.18 94.28 Favored 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 123.083 2.522 . . . . 0.0 112.113 176.047 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -78.17 -19.34 54.15 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.545 -176.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -97.3 16.56 19.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.035 -172.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.686 ' HG3' ' H ' ' A' ' 153' ' ' ILE . 28.1 mm-40 -50.79 -70.26 0.09 Allowed 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -177.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -137.98 159.94 66.49 Favored Pre-proline 0 C--N 1.311 -1.079 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.587 -174.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -56.44 144.31 84.08 Favored 'Trans proline' 0 C--O 1.238 0.503 0 C-N-CA 123.084 2.523 . . . . 0.0 112.902 -176.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -67.23 -7.45 24.03 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.407 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -49.96 -47.73 52.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.483 169.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ASN . . . . . 0.49 ' O ' ' HG2' ' A' ' 150' ' ' GLU . 10.8 t-20 -87.52 -7.16 57.92 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.792 -178.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 149' ' ' ASN . 11.1 pt-20 48.13 33.26 3.46 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.712 1.205 . . . . 0.0 111.457 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -149.55 144.0 25.96 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.436 -173.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.421 HG21 ' HB2' ' A' ' 116' ' ' ALA . 25.2 m -128.47 -176.54 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.965 -178.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.686 ' H ' ' HG3' ' A' ' 144' ' ' GLN . 39.3 mt -122.41 131.24 73.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.588 0.233 . . . . 0.0 111.6 -177.198 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.894 HG13 HG22 ' A' ' 140' ' ' VAL . 32.4 t -92.77 140.2 16.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 172.011 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.809 ' HE3' ' HD2' ' A' ' 141' ' ' PRO . 0.0 OUTLIER -107.39 126.19 52.16 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 177.397 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 60.2 mt -110.04 111.21 35.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.089 178.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.448 ' HB ' ' HB3' ' A' ' 137' ' ' GLU . 3.8 mp -109.1 119.75 59.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 176.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 104' ' ' LYS . . . 177.53 -157.4 21.95 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 119.62 -1.276 . . . . 0.0 113.1 -174.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.462 ' H ' ' HB3' ' A' ' 162' ' ' ALA . 1.1 m-70 -102.63 173.25 6.42 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 -173.034 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -59.96 -46.24 90.08 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 121.172 -0.211 . . . . 0.0 111.22 -177.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -60.89 -51.76 67.92 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.931 0.396 . . . . 0.0 110.516 175.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.462 ' HB3' ' H ' ' A' ' 159' ' ' HIS . . . -59.22 -49.04 79.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.259 -174.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.445 ' O ' ' HG3' ' A' ' 167' ' ' GLN . 32.4 t -62.16 -47.44 84.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.058 -175.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -56.41 -37.82 70.7 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.923 0.392 . . . . 0.0 111.001 178.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 89.9 mtp -71.92 -38.72 69.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.653 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.621 ' HA ' HG21 ' A' ' 134' ' ' THR . . . -66.83 -49.53 65.47 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.33 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.445 ' HG3' ' O ' ' A' ' 163' ' ' SER . 75.7 mt-30 -51.87 -52.46 49.44 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.233 -177.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 18.4 ptt180 -66.85 -38.15 85.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.146 -177.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.621 ' HA ' ' HE2' ' A' ' 169' ' ' LYS . 0.1 OUTLIER -68.09 -39.17 82.93 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.706 0.289 . . . . 0.0 111.299 -172.798 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.462 ' O ' HG12 ' A' ' 173' ' ' ILE . 1.9 mp -74.98 -44.19 44.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 177.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 -55.83 -25.59 42.57 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.2 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -60.77 -55.55 31.84 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.463 175.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.497 ' O ' HG23 ' A' ' 177' ' ' VAL . 42.5 pt -67.57 -23.94 30.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.446 -172.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.956 HD11 HG23 ' A' ' 111' ' ' VAL . 10.9 mp -58.33 -37.69 75.65 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.843 176.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -65.74 -34.97 79.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.058 0.456 . . . . 0.0 110.378 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -71.37 -38.1 71.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.508 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.544 HG22 ' HD3' ' A' ' 118' ' ' ARG . 58.0 t -66.7 -37.28 79.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.5 177.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 174' ' ' LEU . 98.2 mttt -66.06 -41.38 90.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.185 176.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -63.3 -37.68 88.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.395 177.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -60.15 -32.09 70.71 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.672 177.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 52.6 m170 -85.21 -25.92 27.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.096 0.474 . . . . 0.0 110.568 178.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -74.94 -41.96 58.62 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.709 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -87.35 73.72 9.57 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.744 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -122.5 137.7 11.49 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.068 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -142.8 143.64 32.25 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.769 0.319 . . . . 0.0 110.352 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 14.9 p -91.28 -10.07 42.79 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.464 -176.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 82.82 -152.3 29.96 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.52 177.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -142.05 140.58 32.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.771 0.319 . . . . 0.0 110.951 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 60.3 tp -104.78 88.37 2.89 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.827 178.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -123.58 152.83 41.46 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.297 -178.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.57 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.593 178.059 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' ' G' . . . . . 0.877 " O2'" ' H6 ' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.426 -0.9 0 C3'-C2'-C1' 105.08 3.978 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . 0.877 ' H6 ' " O2'" ' B' ' 1' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.424 -0.981 0 C3'-C2'-C1' 99.674 -2.029 . 0.0 OUTLIER '7D dist 2a' 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . 0.751 " H1'" ' C5 ' ' B' ' 4' ' ' ' C' . . . . . . . . 0 C2'--C1' 1.517 -1.144 0 C5'-C4'-O4' 112.289 2.207 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 4' ' ' ' C' . . . . . 1.117 ' H41' ' HA2' ' A' ' 35' ' ' GLY . . . . . . . . 0 O5'--C5' 1.429 -0.687 0 C4'-C3'-C2' 105.631 2.931 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.903 " O4'" " H4'" ' B' ' 4' ' ' ' C' . . . . . . . . 0 P--O3' 1.616 0.79 0 O4'-C1'-N19 110.251 2.051 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 6' ' ' ' C' . . . . . 0.616 ' H6 ' " O5'" ' B' ' 6' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.428 -0.723 0 C4'-C3'-C2' 106.409 3.709 OUTLIER-DELTA 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . 0.449 ' H41' ' N4 ' ' B' ' 6' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.425 -0.939 0 C4'-C3'-C2' 103.456 0.756 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.424 -0.981 0 O4'-C1'-N19 108.776 0.576 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.72 0 N-CA-C 111.748 -0.541 . . . . 0.0 111.748 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.78 66.7 9.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.787 0.327 . . . . 0.0 110.716 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 17.1 tpt 62.58 -89.14 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.295 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.463 ' HA2' ' HD3' ' A' ' 5' ' ' PRO . . . 82.25 115.5 0.47 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.012 -177.144 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.463 ' HD3' ' HA2' ' A' ' 4' ' ' GLY . 2.8 Cg_exo -75.78 51.36 3.02 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.269 2.646 . . . . 0.0 112.506 -179.136 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.2 m -128.81 140.42 51.71 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 177.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.4 t 59.89 42.52 16.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.612 0.72 . . . . 0.0 109.407 -176.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.4 p -68.64 141.15 17.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.747 -177.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.5 p -74.99 75.53 2.2 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.274 0.559 . . . . 0.0 111.092 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -117.79 -145.92 8.07 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.86 178.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.679 ' HB1' ' HA ' ' A' ' 15' ' ' SER . . . 56.02 37.92 29.38 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.121 0.486 . . . . 0.0 110.595 -177.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.65 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . . . -71.38 -54.4 6.93 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.343 -174.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.65 ' HD3' ' HB3' ' A' ' 12' ' ' ALA . 17.0 Cg_exo -67.98 -32.7 27.88 Favored 'Trans proline' 0 C--N 1.356 0.921 0 C-N-CA 121.982 1.788 . . . . 0.0 111.778 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.403 ' CD1' ' HB2' ' A' ' 13' ' ' PRO . 19.9 p90 -155.72 122.19 5.21 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.495 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.679 ' HA ' ' HB1' ' A' ' 11' ' ' ALA . 16.6 m -95.39 -24.04 16.89 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.414 0.626 . . . . 0.0 109.656 175.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.4 m -112.56 135.71 52.95 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.62 177.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -98.42 113.95 26.14 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.437 -175.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 87.8 mtp 61.0 85.31 0.18 Allowed Pre-proline 0 N--CA 1.466 0.344 0 O-C-N 123.538 0.524 . . . . 0.0 111.097 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.476 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 83.8 Cg_endo -78.75 139.4 15.71 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.364 2.043 . . . . 0.0 112.424 -178.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 19' ' ' PRO . 3.7 Cg_exo -75.49 60.19 5.72 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.935 2.423 . . . . 0.0 110.884 174.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.589 ' HG2' ' HG3' ' A' ' 22' ' ' GLN . 40.0 tt0 -62.02 -75.32 0.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.893 -174.276 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.589 ' HG3' ' HG2' ' A' ' 21' ' ' GLU . 79.3 mt-30 -133.95 109.73 9.21 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.1 0.476 . . . . 0.0 111.36 -176.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -94.83 102.4 14.25 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.054 174.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 56.1 m -104.59 114.25 28.35 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.214 -177.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.426 HG22 ' HE ' ' A' ' 171' ' ' ARG . 42.1 t -126.42 149.94 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 176.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -108.52 146.45 33.2 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 122.086 -0.384 . . . . 0.0 110.138 -174.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.673 ' HB ' ' CG1' ' A' ' 71' ' ' VAL . 21.1 t -120.76 133.16 68.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.232 -174.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.782 ' CE1' HG11 ' A' ' 68' ' ' VAL . 32.5 t80 -93.56 104.15 16.29 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.483 0.713 . . . . 0.0 110.048 -176.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.496 ' CD1' HG23 ' A' ' 34' ' ' VAL . 8.8 pt -126.74 124.69 24.19 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.283 0.563 . . . . 0.0 111.13 178.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.457 ' HG2' ' HB3' ' A' ' 33' ' ' ALA . 3.0 Cg_endo -45.82 140.65 9.5 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 124.474 3.449 . . . . 0.0 114.064 -174.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.74 -18.71 22.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.958 -176.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -89.71 -29.47 18.72 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.11 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.566 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -96.47 -30.84 13.12 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -175.076 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.825 HG21 ' HB3' ' A' ' 69' ' ' ARG . 10.6 p -54.09 -29.91 19.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.707 179.198 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 1.121 ' HA2' ' H41' ' B' ' 4' ' ' ' C' . . . -58.76 -57.0 22.17 Favored Glycine 0 N--CA 1.432 -1.633 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.242 176.287 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.674 ' HB2' " O2'" ' B' ' 2' ' ' ' C' . . . -77.36 -14.16 59.78 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.552 -0.324 . . . . 0.0 111.201 -174.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.873 HD12 ' HB3' ' A' ' 90' ' ' LYS . 9.5 mm -63.16 -39.29 84.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 172.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.844 HD12 ' C5 ' ' B' ' 4' ' ' ' C' . 38.4 mt -61.83 -52.34 61.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.566 177.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.7 111.87 2.82 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 120.27 -0.967 . . . . 0.0 114.855 170.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.459 ' HD2' ' HA ' ' A' ' 40' ' ' LYS . 27.8 mmmt 59.23 -89.43 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.286 1.034 . . . . 0.0 113.561 173.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.757 ' HA ' ' OP2' ' B' ' 4' ' ' ' C' . 0.0 OUTLIER -129.28 23.94 5.55 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.18 0.514 . . . . 0.0 111.156 -177.478 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.461 ' HA2' ' CG2' ' A' ' 38' ' ' ILE . . . 82.37 28.79 38.78 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.441 -0.885 . . . . 0.0 110.992 -175.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.495 ' HB2' ' CD ' ' A' ' 41' ' ' LYS . 25.4 tm0? -91.02 -47.61 7.46 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.024 0.44 . . . . 0.0 109.855 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -70.52 -32.78 70.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.492 -174.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.616 HG23 ' HG3' ' A' ' 46' ' ' LYS . 6.2 tt -61.04 -44.59 98.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.176 0.512 . . . . 0.0 111.145 177.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.616 ' HG3' HG23 ' A' ' 45' ' ' ILE . 55.0 mtpt -81.41 -30.92 33.41 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.428 -177.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -63.11 -33.46 75.51 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 172.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.815 ' HA ' ' HD1' ' A' ' 51' ' ' PHE . 6.1 tt -62.95 -49.26 75.44 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.422 174.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.639 ' HA ' HD13 ' A' ' 56' ' ' ILE . 14.4 t -55.52 -40.84 72.31 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.704 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.834 ' HE ' ' HA ' ' A' ' 50' ' ' ARG . 0.9 OUTLIER -78.84 -40.54 32.47 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -177.68 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.815 ' HD1' ' HA ' ' A' ' 48' ' ' LEU . 0.4 OUTLIER -74.51 -30.84 61.96 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 121.829 -0.545 . . . . 0.0 110.484 -178.03 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -84.59 -12.96 53.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.529 -177.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.9 m 66.9 30.13 7.88 Favored 'General case' 0 N--CA 1.463 0.223 0 O-C-N 123.644 0.59 . . . . 0.0 110.854 -179.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -134.54 166.95 21.7 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.539 -176.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.45 ' HB2' ' HB ' ' A' ' 74' ' ' THR . 18.4 m -92.53 108.1 19.72 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.567 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.733 HG13 HG22 ' A' ' 73' ' ' ILE . 1.9 mp -110.47 115.03 48.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.224 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -137.66 135.75 36.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.234 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.671 ' HB ' ' N1 ' ' B' ' 5' ' ' ' A' . 37.6 mm -80.38 124.42 38.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 177.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.743 ' HB2' HG23 ' A' ' 72' ' ' VAL . . . -90.05 129.75 44.87 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.606 -177.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.34 140.61 95.29 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 122.942 2.428 . . . . 0.0 111.897 176.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.455 ' HD3' ' HG3' ' A' ' 69' ' ' ARG . 40.2 Cg_endo -67.58 159.71 51.32 Favored 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 122.796 2.33 . . . . 0.0 112.054 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -84.75 -47.16 10.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.384 0.611 . . . . 0.0 109.936 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.2 p -129.5 139.06 34.55 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.782 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.66 -8.31 21.96 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 123.541 2.827 . . . . 0.0 112.9 -178.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -87.46 -4.76 59.0 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.405 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.4 t -87.93 115.56 25.48 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.497 ' O ' ' HD2' ' A' ' 67' ' ' LYS . 1.0 OUTLIER -78.39 33.34 0.2 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.786 0.803 . . . . 0.0 110.578 -176.294 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.782 HG11 ' CE1' ' A' ' 28' ' ' PHE . 11.2 p -146.54 154.64 12.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.798 -175.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.825 ' HB3' HG21 ' A' ' 34' ' ' VAL . 11.7 ttm180 -129.94 129.38 43.75 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 170.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.515 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 42.2 mtt -96.48 134.63 39.42 Favored 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.236 -173.116 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.673 ' CG1' ' HB ' ' A' ' 27' ' ' VAL . 3.9 p -99.98 140.21 19.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 177.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.743 HG23 ' HB2' ' A' ' 59' ' ' ALA . 63.9 t -101.56 120.5 51.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.112 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.733 HG22 HG13 ' A' ' 56' ' ' ILE . 2.6 pp -114.76 127.31 72.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.499 0.666 . . . . 0.0 110.522 176.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.45 ' HB ' ' HB2' ' A' ' 55' ' ' SER . 91.3 m -125.55 113.21 17.12 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.674 178.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.62 161.14 34.65 Favored Glycine 0 CA--C 1.498 -1.03 0 C-N-CA 119.811 -1.185 . . . . 0.0 113.115 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.31 153.07 71.54 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 122.5 2.133 . . . . 0.0 110.964 169.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.425 ' HA ' ' NH2' ' A' ' 168' ' ' ARG . 35.8 Cg_exo -38.18 -51.59 2.0 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 124.804 3.669 . . . . 0.0 114.85 -176.068 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -66.61 -36.02 81.61 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.264 0.554 . . . . 0.0 110.994 -177.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.88 -49.82 27.53 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.724 -178.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.563 ' HG3' HD13 ' A' ' 73' ' ' ILE . 19.9 tt0 -63.47 -31.9 73.19 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.955 -178.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -54.21 -54.62 37.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.513 -177.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.6 pttm -72.93 -33.09 65.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.378 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.05 -53.03 62.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.224 177.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.403 ' O ' HG22 ' A' ' 87' ' ' ILE . 35.0 mt-30 -72.76 -31.16 64.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.38 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -54.12 -42.33 71.72 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.957 176.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -81.19 -28.81 34.79 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 178.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.403 HG22 ' O ' ' A' ' 84' ' ' GLN . 0.4 OUTLIER -65.24 -41.25 91.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 120.981 -0.287 . . . . 0.0 110.49 -176.202 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.596 ' HA ' HD23 ' A' ' 91' ' ' LEU . 26.5 m-85 -67.39 -31.67 72.05 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.249 0.547 . . . . 0.0 110.239 176.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.08 -29.38 74.22 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.913 176.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.873 ' HB3' HD12 ' A' ' 37' ' ' ILE . 67.0 mmtt -77.3 -21.06 54.11 Favored 'General case' 0 N--CA 1.442 -0.87 0 O-C-N 122.62 -0.341 . . . . 0.0 110.491 178.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.596 HD23 ' HA ' ' A' ' 88' ' ' TYR . 3.8 mm? -66.05 -33.27 75.43 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.239 0.542 . . . . 0.0 109.847 167.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.823 ' HE2' ' HB2' ' A' ' 97' ' ' PHE . 13.8 mmtp -75.94 -21.8 56.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.117 176.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.523 ' HB2' ' HA ' ' A' ' 90' ' ' LYS . 5.2 tp10 -62.78 -33.05 74.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.772 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.606 ' HG2' ' CE2' ' A' ' 96' ' ' PHE . 6.5 tp10 -88.96 -1.38 58.08 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.957 0.884 . . . . 0.0 109.605 178.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 65.87 29.09 10.57 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.423 177.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.606 ' CE2' ' HG2' ' A' ' 94' ' ' GLU . 14.2 m-85 -65.01 -51.36 62.08 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.072 0.463 . . . . 0.0 111.149 178.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.823 ' HB2' ' HE2' ' A' ' 92' ' ' LYS . 17.8 m-85 -105.87 34.76 3.16 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.889 -172.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 56.58 -173.42 1.76 Allowed Glycine 0 CA--C 1.525 0.671 0 CA-C-N 115.976 -0.556 . . . . 0.0 113.708 178.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -85.2 -66.51 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.072 2.515 . . . . 0.0 111.975 175.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 53.2 tptt -76.65 -26.71 55.16 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.027 -177.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.657 ' HB3' ' O ' ' A' ' 97' ' ' PHE . 10.4 tp10 -58.15 134.2 56.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.109 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -61.65 130.1 44.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.303 -177.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.804 ' HB ' ' HE3' ' A' ' 92' ' ' LYS . 7.1 p -65.95 122.23 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 175.091 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -116.79 88.23 2.86 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 174.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.595 ' HG ' ' HG ' ' A' ' 91' ' ' LEU . 1.6 tm? -112.02 124.66 52.87 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.973 -173.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -65.23 118.32 9.09 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.642 -178.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.501 HG21 ' NE2' ' A' ' 167' ' ' GLN . 1.2 m -109.92 136.9 48.47 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.252 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -108.0 118.76 37.6 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.286 0.565 . . . . 0.0 111.102 -174.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.523 HG13 ' HB ' ' A' ' 154' ' ' VAL . 12.4 pt -110.76 112.66 41.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.689 175.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.924 ' HG3' ' HG2' ' A' ' 151' ' ' GLN . 5.6 tpt180 -77.96 117.51 19.36 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.673 HG12 HD21 ' A' ' 174' ' ' LEU . 13.0 m -116.2 150.85 45.96 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -177.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -49.44 155.82 3.16 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.864 2.376 . . . . 0.0 111.461 175.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -52.83 -49.92 64.73 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.111 0.482 . . . . 0.0 111.513 -172.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 13.7 m -78.65 -8.26 58.48 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.913 -177.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.24 -29.99 61.95 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 122.215 -0.303 . . . . 0.0 111.453 -175.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.663 ' HB1' HG21 ' A' ' 140' ' ' VAL . . . -65.26 -37.84 88.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.2 0.524 . . . . 0.0 110.684 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -69.41 -28.29 72.65 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.912 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 37.1 mtp85 -92.02 -18.12 24.1 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 111.555 0.206 . . . . 0.0 111.555 -178.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.593 HG12 ' O ' ' A' ' 116' ' ' ALA . 8.4 p -76.64 -29.2 18.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 175.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.853 HG22 ' HA2' ' A' ' 124' ' ' GLY . 69.3 mt -65.79 -40.62 88.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 170.193 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 117.55 -179.26 17.26 Favored Glycine 0 N--CA 1.441 -0.969 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.931 174.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -42.65 -73.77 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.522 0.729 . . . . 0.0 111.641 178.208 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -112.12 26.66 10.37 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 122.121 0.963 . . . . 0.0 108.522 171.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.853 ' HA2' HG22 ' A' ' 120' ' ' ILE . . . 88.77 21.39 43.35 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.512 -177.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -83.84 -32.91 25.01 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.989 0.423 . . . . 0.0 110.761 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 15.1 m -64.69 -37.76 88.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.691 -175.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.55 ' HB ' ' HA ' ' A' ' 120' ' ' ILE . 14.0 p -63.24 -33.48 61.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-O 120.872 0.368 . . . . 0.0 110.731 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -65.95 -42.59 89.78 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 177.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -63.93 -40.96 97.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.233 177.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 79.3 mt -57.85 -50.77 72.17 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.202 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -68.4 -35.35 77.54 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.941 0.401 . . . . 0.0 110.881 -177.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -67.36 -36.99 82.51 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.385 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -84.9 -47.72 10.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.099 -175.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.548 ' HB ' ' HB2' ' A' ' 166' ' ' ALA . 76.9 p -79.88 -21.08 44.45 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -172.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 66.17 21.39 11.12 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.53 -174.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -120.13 164.15 16.62 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.002 177.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.501 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 49.0 mt-10 -101.07 113.02 25.65 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.188 0.518 . . . . 0.0 111.033 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 60.0 t -104.85 106.45 20.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.912 -178.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.474 ' O ' ' HD2' ' A' ' 155' ' ' LYS . 7.2 p -128.46 130.88 69.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.065 0.46 . . . . 0.0 111.136 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.688 ' HB ' HG22 ' A' ' 154' ' ' VAL . 8.5 p -125.94 131.04 23.86 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 116.136 -0.483 . . . . 0.0 109.855 178.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.46 ' HB2' ' HB2' ' A' ' 144' ' ' GLN . 36.7 Cg_exo -60.89 121.01 9.03 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.7 2.267 . . . . 0.0 111.631 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.663 ' H ' ' HD2' ' A' ' 142' ' ' ARG . 0.3 OUTLIER -83.19 14.78 3.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.586 0.708 . . . . 0.0 110.102 -175.043 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -117.84 -1.74 11.47 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.346 176.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.46 ' HB2' ' HB2' ' A' ' 141' ' ' PRO . 6.4 tp-100 -98.11 115.11 27.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.07 -172.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.1 t -175.29 70.53 0.27 Allowed Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.381 176.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -91.55 143.96 3.06 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.384 2.056 . . . . 0.0 112.568 -178.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -70.0 -16.62 63.2 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.981 178.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -52.3 -48.67 65.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.974 -1.012 . . . . 0.0 112.204 -178.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ASN . . . . . 0.441 ' O ' ' HG2' ' A' ' 150' ' ' GLU . 4.4 t-20 -119.62 -10.4 9.61 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.014 -175.003 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 149' ' ' ASN . 12.2 pt-20 47.33 29.68 1.33 Allowed 'General case' 0 N--CA 1.475 0.799 0 O-C-N 124.31 1.007 . . . . 0.0 111.097 -173.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.924 ' HG2' ' HG3' ' A' ' 110' ' ' ARG . 30.5 tt0 -155.71 128.31 7.86 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.15 -174.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.401 HG21 ' HB2' ' A' ' 116' ' ' ALA . 33.1 m -114.41 -177.1 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.338 -171.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.411 HG12 ' HD2' ' A' ' 110' ' ' ARG . 53.9 mt -122.16 131.39 73.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -173.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.688 HG22 ' HB ' ' A' ' 140' ' ' VAL . 46.2 t -107.29 140.77 24.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 168.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.474 ' HD2' ' O ' ' A' ' 139' ' ' VAL . 0.0 OUTLIER -104.12 122.39 45.22 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.07 178.898 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.501 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 51.6 mt -102.71 112.67 36.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 173.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.401 ' N ' HD12 ' A' ' 157' ' ' ILE . 4.4 mp -103.6 129.86 54.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.82 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 161.3 -172.07 37.45 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.436 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.512 ' HA ' HG13 ' A' ' 103' ' ' VAL . 18.3 p-80 -88.68 153.68 20.91 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.437 ' HB3' ' CG ' ' A' ' 88' ' ' TYR . 10.2 p90 -50.82 -46.59 59.99 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -165.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.411 ' O ' ' HG3' ' A' ' 164' ' ' GLN . 16.8 m-85 -59.67 -48.94 79.7 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 118.85 0.75 . . . . 0.0 111.174 -178.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.59 -42.91 86.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.603 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.475 ' O ' ' HG3' ' A' ' 167' ' ' GLN . 35.7 t -63.59 -50.37 69.68 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.418 -177.136 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.411 ' HG3' ' O ' ' A' ' 161' ' ' TYR . 5.1 pp0? -59.37 -35.48 73.97 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.478 0.18 . . . . 0.0 111.034 -177.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 49.0 ttp -73.76 -33.45 64.28 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 120.621 -0.431 . . . . 0.0 110.806 177.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.548 ' HB2' ' HB ' ' A' ' 134' ' ' THR . . . -69.96 -43.61 71.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.103 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.501 ' NE2' HG21 ' A' ' 107' ' ' THR . 71.9 mt-30 -51.94 -52.81 47.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.953 -178.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.825 ' HA ' ' HB2' ' A' ' 171' ' ' ARG . 1.3 ptp180 -70.85 -27.36 63.78 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.455 178.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.648 ' HA ' ' HE2' ' A' ' 169' ' ' LYS . 0.1 OUTLIER -67.55 -37.85 83.29 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.753 -178.688 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.486 ' O ' HG13 ' A' ' 173' ' ' ILE . 1.9 mp -75.24 -39.88 42.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 173.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.825 ' HB2' ' HA ' ' A' ' 168' ' ' ARG . 1.1 mpt_? -51.74 -28.0 13.74 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.072 171.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.484 ' HB2' ' O ' ' A' ' 169' ' ' LYS . 1.3 m-20 -68.66 -56.14 9.16 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 122.679 0.392 . . . . 0.0 111.499 178.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.486 HG13 ' O ' ' A' ' 170' ' ' ILE . 2.7 pp -66.59 -18.64 24.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.525 -174.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.673 HD21 HG12 ' A' ' 111' ' ' VAL . 6.7 mp -66.41 -33.86 76.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.093 174.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.99 -31.82 73.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.107 0.48 . . . . 0.0 110.28 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -69.6 -33.45 72.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.923 176.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 173' ' ' ILE . 48.7 t -66.06 -46.4 88.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.796 176.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -61.18 -40.89 95.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.845 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -59.04 -47.04 86.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.016 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -72.67 -35.45 67.69 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.154 0.502 . . . . 0.0 110.431 -178.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 19.8 t60 -73.86 -53.57 9.9 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.406 -175.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -73.04 -51.17 19.17 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 111.59 0.218 . . . . 0.0 111.59 -175.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm 69.72 -61.87 0.43 Allowed 'General case' 0 N--CA 1.468 0.431 0 O-C-N 123.744 0.652 . . . . 0.0 111.429 -177.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 156.38 -100.81 0.2 Allowed Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.033 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -132.42 79.78 1.87 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.259 0.552 . . . . 0.0 110.031 -178.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 40.7 m -101.99 113.08 25.99 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.265 -178.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 120.53 124.34 3.14 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.693 -0.765 . . . . 0.0 113.444 175.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 50.96 71.75 0.41 Allowed 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.326 0.65 . . . . 0.0 112.373 174.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 7.7 mp -83.58 99.02 9.9 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 177.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -121.8 -53.5 1.97 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.761 -175.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.365 -178.355 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' ' G' . . . . . 0.767 HO2' ' H6 ' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.429 -0.698 1 C3'-C2'-C1' 105.218 4.131 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . 0.767 ' H6 ' HO2' ' B' ' 1' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.428 -0.738 0 C3'-C2'-C1' 100.373 -1.252 . 0.0 OUTLIER '7D dist 2a' 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . 0.788 " H1'" ' C5 ' ' B' ' 4' ' ' ' C' . . . . . . . . 0 C2'--C1' 1.516 -1.218 0 C5'-C4'-O4' 113.199 2.857 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 4' ' ' ' C' . . . . . 1.121 ' H41' ' HA2' ' A' ' 35' ' ' GLY . . . . . . . . 0 C4'--C3' 1.516 -0.704 0 C3'-C2'-C1' 104.169 2.965 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.9 " O4'" " H4'" ' B' ' 4' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.431 -0.564 0 O4'-C1'-N19 110.124 1.924 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 6' ' ' ' C' . . . . . 0.53 " O5'" " H2'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.43 -0.645 0 C4'-C3'-C2' 105.114 2.414 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.427 -0.83 0 O4'-C1'-C2' 107.417 0.726 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.427 -0.788 0 C3'-C2'-C1' 99.775 -1.916 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.663 0 N-CA-C 111.688 -0.565 . . . . 0.0 111.688 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.1 84.94 7.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.966 0.412 . . . . 0.0 111.096 -176.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 22.9 ptp -92.88 -16.14 25.58 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.805 176.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -90.62 177.99 42.41 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.117 177.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.0 159.8 47.17 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.692 2.262 . . . . 0.0 112.929 -177.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.4 m -137.19 86.13 2.18 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.825 178.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.436 ' HB2' ' HB3' ' A' ' 11' ' ' ALA . 16.4 p -76.53 -18.79 58.52 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.756 -174.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.8 p -75.48 18.12 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 121.647 0.737 . . . . 0.0 111.405 -177.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.404 ' H ' ' C ' ' A' ' 7' ' ' SER . 46.1 m -131.35 31.06 4.41 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.123 176.438 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 176.28 -50.31 0.11 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.583 -0.817 . . . . 0.0 112.481 179.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.436 ' HB3' ' HB2' ' A' ' 7' ' ' SER . . . -82.37 83.7 7.39 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.108 0.48 . . . . 0.0 110.96 -178.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -102.02 107.06 51.01 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.388 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -57.9 140.02 92.38 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 123.171 2.581 . . . . 0.0 112.91 -177.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -135.02 46.18 2.46 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.767 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.0 m -78.4 46.51 0.63 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.177 -172.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.1 m -80.89 61.75 4.63 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.209 0.528 . . . . 0.0 109.872 176.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -123.71 -70.72 0.75 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.244 -176.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.546 ' HB3' ' HD3' ' A' ' 19' ' ' PRO . 46.9 ttm -89.14 -48.89 0.41 Allowed Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.615 178.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.546 ' HD3' ' HB3' ' A' ' 18' ' ' MET . 85.0 Cg_exo -50.13 143.0 26.47 Favored 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 122.328 2.019 . . . . 0.0 112.34 176.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 19' ' ' PRO . 6.7 Cg_exo -73.87 59.1 4.22 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.277 2.651 . . . . 0.0 112.864 -176.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -88.74 37.86 0.85 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.507 0.67 . . . . 0.0 109.911 175.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.464 ' HB3' HG22 ' A' ' 74' ' ' THR . 48.5 mt-30 -87.36 98.84 11.58 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.393 177.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.532 ' O ' ' HA ' ' A' ' 74' ' ' THR . 7.1 tp10 -81.05 147.67 30.04 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.399 -0.818 . . . . 0.0 111.101 -174.177 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.636 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 39.8 m -116.15 107.16 14.54 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.492 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.412 HG13 HG22 ' A' ' 109' ' ' ILE . 37.0 t -119.14 150.02 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.723 -177.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -111.69 125.15 53.66 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-O 120.773 0.32 . . . . 0.0 110.776 -175.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.497 ' HB ' ' HB ' ' A' ' 71' ' ' VAL . 13.6 t -94.09 139.69 17.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.473 ' CZ ' HG11 ' A' ' 68' ' ' VAL . 1.0 OUTLIER -103.54 104.89 15.01 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.406 -175.704 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.443 ' C ' HG23 ' A' ' 68' ' ' VAL . 21.7 pt -129.68 123.36 21.15 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 121.169 0.509 . . . . 0.0 111.291 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.452 ' HA ' ' HA ' ' A' ' 68' ' ' VAL . 50.5 Cg_exo -53.5 149.12 31.86 Favored 'Trans proline' 0 C--O 1.238 0.501 0 C-N-CA 123.439 2.76 . . . . 0.0 112.643 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.671 ' HA ' HG12 ' A' ' 34' ' ' VAL . . . -57.7 -23.57 52.33 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 114.9 -1.046 . . . . 0.0 112.529 -173.172 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -66.12 -30.01 70.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.235 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.518 ' HB2' ' CE2' ' A' ' 96' ' ' PHE . . . -108.25 -31.07 8.03 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.663 -175.252 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.753 HG21 ' HB3' ' A' ' 69' ' ' ARG . 13.3 p -53.98 -32.48 22.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-O 120.945 0.402 . . . . 0.0 110.968 -175.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 1.062 ' HA2' ' H41' ' B' ' 4' ' ' ' C' . . . -58.81 -56.36 25.71 Favored Glycine 0 N--CA 1.434 -1.448 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.959 178.232 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.454 ' HB2' " O2'" ' B' ' 2' ' ' ' C' . . . -77.44 -14.54 59.67 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.621 0.248 . . . . 0.0 111.298 -175.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.998 HD12 ' HB3' ' A' ' 90' ' ' LYS . 2.4 mm -67.44 -36.96 77.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.369 -0.378 . . . . 0.0 109.99 177.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.815 HD12 ' C5 ' ' B' ' 4' ' ' ' C' . 24.6 mt -61.45 -32.72 54.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-O 121.528 0.68 . . . . 0.0 110.337 174.096 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.18 153.72 30.18 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.627 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.562 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 34.1 mtpt -66.02 131.38 46.08 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -175.035 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.562 ' HG2' ' O ' ' A' ' 40' ' ' LYS . 19.8 pttt 73.63 4.21 4.69 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.051 1.34 . . . . 0.0 112.198 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.437 ' HA3' " H5'" ' B' ' 4' ' ' ' C' . . . 61.05 38.64 95.88 Favored Glycine 0 CA--C 1.523 0.545 0 CA-C-N 116.253 -0.431 . . . . 0.0 113.607 176.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.447 ' HB3' ' HE2' ' A' ' 41' ' ' LYS . 19.4 tt0 -109.1 -36.65 6.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 117.322 0.561 . . . . 0.0 110.985 175.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 77.7 m-70 -55.87 -41.62 74.67 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.393 0.616 . . . . 0.0 109.778 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.469 ' O ' HG21 ' A' ' 56' ' ' ILE . 4.5 tt -56.52 -44.13 79.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 114.515 -1.221 . . . . 0.0 112.231 176.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.782 ' HE2' " H4'" ' B' ' 6' ' ' ' C' . 28.4 mmmt -81.45 -29.09 33.91 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 121.984 -0.447 . . . . 0.0 110.779 -173.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -60.47 -40.55 91.65 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 172.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.704 HD22 ' HZ ' ' A' ' 51' ' ' PHE . 0.2 OUTLIER -49.72 -47.8 50.35 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.048 175.898 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.838 ' HB2' ' HB ' ' A' ' 56' ' ' ILE . 14.5 t -61.77 -35.88 79.43 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.629 -176.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -78.81 -41.35 30.53 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -169.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.704 ' HZ ' HD22 ' A' ' 48' ' ' LEU . 10.2 p90 -79.56 -17.02 54.89 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 120.167 -0.613 . . . . 0.0 111.609 -177.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -94.09 -16.89 23.38 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.199 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.2 t 67.3 13.97 9.55 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.544 -177.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -108.73 153.57 23.27 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.838 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.495 ' HB2' ' HB ' ' A' ' 74' ' ' THR . 60.4 m -80.27 102.41 9.48 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.018 0.437 . . . . 0.0 110.185 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.838 ' HB ' ' HB2' ' A' ' 49' ' ' SER . 1.5 mp -92.98 117.64 36.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.147 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -144.77 151.13 38.37 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.891 -175.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.648 ' HB ' ' C6 ' ' B' ' 5' ' ' ' A' . 38.8 mm -102.43 129.1 54.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 178.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.599 ' HB3' ' HB2' ' A' ' 70' ' ' MET . . . -95.86 108.55 41.23 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.841 -178.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 59' ' ' ALA . 14.6 Cg_exo -69.59 146.0 59.89 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 123.061 2.507 . . . . 0.0 112.338 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.864 ' HD3' ' HG3' ' A' ' 69' ' ' ARG . 98.6 Cg_endo -84.09 141.53 9.37 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.874 2.383 . . . . 0.0 112.396 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -68.37 -25.97 65.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.989 -177.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.431 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 22.6 p -101.99 132.01 22.07 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.938 -179.093 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 63' ' ' THR . 15.1 Cg_exo -68.84 -21.19 38.36 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 123.249 2.633 . . . . 0.0 112.335 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.87 17.0 21.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.077 -178.111 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.5 t -65.74 134.6 53.5 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.196 0.522 . . . . 0.0 110.501 -179.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -81.42 -10.22 59.56 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.417 -178.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.473 HG11 ' CZ ' ' A' ' 28' ' ' PHE . 1.5 p -145.83 150.53 15.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.457 -172.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.864 ' HG3' ' HD3' ' A' ' 61' ' ' PRO . 22.9 ttm180 -127.05 151.3 48.79 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 177.08 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.599 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 63.6 mtt -100.13 149.41 23.55 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.269 0.557 . . . . 0.0 112.127 -173.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.497 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 86.8 t -105.44 120.34 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 168.108 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.6 p -109.23 115.54 49.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-O 121.563 0.697 . . . . 0.0 110.451 -176.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.636 ' O ' ' HA ' ' A' ' 24' ' ' THR . 2.1 pp -120.34 140.84 43.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.598 -176.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 58.9 m -123.76 108.77 12.88 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.934 177.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -163.95 162.03 34.8 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.098 -1.049 . . . . 0.0 113.326 -176.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.408 ' HD3' ' HG2' ' A' ' 22' ' ' GLN . 30.7 Cg_endo -64.39 142.61 79.58 Favored 'Trans proline' 0 CA--C 1.533 0.427 0 C-N-CA 123.079 2.519 . . . . 0.0 111.908 175.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.481 ' O ' ' HB2' ' A' ' 80' ' ' GLN . 97.4 Cg_exo -46.14 -35.39 14.89 Favored 'Trans proline' 0 N--CA 1.478 0.565 0 C-N-CA 125.013 3.808 . . . . 0.0 115.298 -174.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.3 -46.87 69.14 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.115 0.483 . . . . 0.0 109.849 177.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.56 -22.44 63.54 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.894 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.481 ' HB2' ' O ' ' A' ' 77' ' ' PRO . 71.3 mm-40 -52.76 -52.0 58.31 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.787 176.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -66.74 -33.15 74.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.832 -179.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 47.1 tttp -61.5 -52.95 62.38 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.189 0.519 . . . . 0.0 110.334 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.4 -53.74 13.07 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.854 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.507 ' O ' HG22 ' A' ' 87' ' ' ILE . 9.5 tt0 -69.15 -31.03 69.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.68 -173.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -58.13 -32.54 67.4 Favored Glycine 0 CA--C 1.518 0.219 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.884 177.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.521 ' HA ' ' NE ' ' A' ' 86' ' ' ARG . 3.5 mmp_? -79.69 -26.83 40.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.654 0.264 . . . . 0.0 111.054 178.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.507 HG22 ' O ' ' A' ' 84' ' ' GLN . 0.4 OUTLIER -66.33 -35.16 74.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.646 -177.307 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.668 ' CE2' ' HB3' ' A' ' 105' ' ' LEU . 10.0 m-85 -68.66 -34.57 75.93 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.361 176.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -62.26 -30.43 75.96 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.524 176.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.998 ' HB3' HD12 ' A' ' 37' ' ' ILE . 75.0 mmtt -59.96 -52.96 63.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.7 0.286 . . . . 0.0 110.612 175.421 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.895 ' HB3' ' CD1' ' A' ' 97' ' ' PHE . 3.8 mm? -61.35 -39.66 91.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.606 178.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.83 ' HE3' ' HB ' ' A' ' 103' ' ' VAL . 0.3 OUTLIER -61.65 -41.17 97.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.821 0.343 . . . . 0.0 110.92 174.711 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -71.18 -23.45 62.05 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.028 -176.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.509 ' HB3' ' CE2' ' A' ' 96' ' ' PHE . 58.7 mm-40 -88.26 4.23 46.65 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.927 -179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 63.56 21.04 12.56 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.742 172.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.518 ' CE2' ' HB2' ' A' ' 33' ' ' ALA . 78.2 m-85 -85.84 -16.75 37.67 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 168.209 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.895 ' CD1' ' HB3' ' A' ' 91' ' ' LEU . 67.2 m-85 -135.53 48.82 2.2 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 113.939 -1.482 . . . . 0.0 109.113 -177.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -41.24 157.46 0.04 OUTLIER Glycine 0 CA--C 1.521 0.459 0 O-C-N 124.061 0.851 . . . . 0.0 114.437 -174.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -59.04 -4.57 2.19 Favored 'Trans proline' 0 N--CA 1.478 0.605 0 C-N-CA 123.878 3.052 . . . . 0.0 114.419 -172.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.569 ' HD2' ' N ' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -97.49 -14.5 21.08 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.18 0.514 . . . . 0.0 110.118 -179.862 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -100.33 135.52 41.63 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.491 -172.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -70.28 114.99 8.96 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.362 175.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.83 ' HB ' ' HE3' ' A' ' 92' ' ' LYS . 15.0 p -54.6 123.94 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 CA-C-O 121.819 0.819 . . . . 0.0 111.995 -172.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -123.02 90.81 3.36 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 170.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.668 ' HB3' ' CE2' ' A' ' 88' ' ' TYR . 2.5 tt -117.17 114.89 24.32 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -177.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.877 ' HG3' HG13 ' A' ' 157' ' ' ILE . 1.7 mp0 -71.86 128.73 36.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.694 -175.126 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.1 m -114.69 128.06 56.1 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 170.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 16.2 m170 -102.26 119.62 39.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.14 0.495 . . . . 0.0 110.064 -178.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.468 HG13 ' HB ' ' A' ' 154' ' ' VAL . 34.8 pt -112.33 157.52 13.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.231 -178.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 110' ' ' ARG . 22.6 mmt180 -102.26 133.64 46.83 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.879 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.777 HG12 HD21 ' A' ' 174' ' ' LEU . 10.4 m -133.15 148.24 68.43 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 173.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.766 ' HD2' ' HG ' ' A' ' 174' ' ' LEU . 51.6 Cg_exo -53.96 146.27 48.01 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.139 1.893 . . . . 0.0 110.596 175.029 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.15 -27.77 65.95 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.616 -175.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 44.0 t -81.5 -33.11 32.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.3 0.571 . . . . 0.0 110.281 175.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.56 -21.05 61.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.011 -178.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.556 ' O ' HG12 ' A' ' 119' ' ' VAL . . . -61.45 -50.82 71.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.071 0.462 . . . . 0.0 110.59 177.001 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.93 -29.39 67.14 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.562 177.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.6 ' HD3' HG22 ' A' ' 177' ' ' VAL . 13.7 ttt85 -73.04 -36.1 66.86 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.832 -0.184 . . . . 0.0 111.316 -178.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.556 HG12 ' O ' ' A' ' 116' ' ' ALA . 7.0 p -69.89 -26.21 29.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-O 121.014 0.435 . . . . 0.0 109.905 178.088 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.921 ' HA ' ' HB ' ' A' ' 127' ' ' VAL . 73.7 mt -68.12 -33.36 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 CA-C-O 121.495 0.664 . . . . 0.0 109.347 171.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.617 ' HA3' ' H ' ' A' ' 126' ' ' THR . . . 127.57 42.57 0.26 Allowed Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.182 176.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.2 t70 65.21 -75.16 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.296 0.638 . . . . 0.0 109.714 -176.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -87.59 -49.69 7.0 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 170.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.774 ' HA2' HG22 ' A' ' 120' ' ' ILE . . . 153.16 101.08 0.2 Allowed Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.78 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 53.2 tptt -173.07 -48.25 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.069 0.461 . . . . 0.0 110.623 -175.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.617 ' H ' ' HA3' ' A' ' 121' ' ' GLY . 21.7 m -60.16 -34.62 73.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.905 -177.016 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.921 ' HB ' ' HA ' ' A' ' 120' ' ' ILE . 10.2 p -63.11 -29.24 46.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.7 0.286 . . . . 0.0 110.856 -178.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -63.77 -45.49 89.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.149 0.5 . . . . 0.0 109.835 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -72.35 -37.36 68.84 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.946 178.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.635 HD21 HD11 ' A' ' 170' ' ' ILE . 23.1 tp -58.98 -49.43 77.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.937 178.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.504 ' HG3' HG12 ' A' ' 138' ' ' VAL . 16.4 tt0 -63.12 -36.24 82.94 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.195 -178.384 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -75.11 -37.0 61.63 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.783 -178.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 133' ' ' LEU . 21.8 mt -79.98 -22.08 42.97 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -178.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 38.5 p -96.7 -22.03 17.23 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.747 -177.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 65.25 18.53 11.43 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.623 -178.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -118.95 168.93 10.33 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.585 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.505 ' HB3' ' HB ' ' A' ' 157' ' ' ILE . 21.8 tt0 -105.1 122.05 45.08 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.987 0.423 . . . . 0.0 110.225 -178.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.504 HG12 ' HG3' ' A' ' 131' ' ' GLN . 2.4 p -121.09 122.01 66.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.067 -172.248 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 13.5 p -130.66 133.23 63.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.54 176.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.818 ' HB ' HG22 ' A' ' 154' ' ' VAL . 6.7 p -137.49 97.68 10.32 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-O 121.824 0.821 . . . . 0.0 111.14 177.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -60.57 166.45 9.75 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 123.427 2.751 . . . . 0.0 112.656 175.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -79.05 -50.31 11.26 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.399 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -94.27 102.19 14.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.438 178.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.762 ' HB2' ' HB ' ' A' ' 152' ' ' VAL . 23.7 mm-40 -127.78 93.23 3.64 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.551 176.229 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.925 ' HB ' ' HD2' ' A' ' 146' ' ' PRO . 60.8 p 58.67 172.91 0.05 OUTLIER Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 123.615 0.766 . . . . 0.0 111.519 -176.203 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.925 ' HD2' ' HB ' ' A' ' 145' ' ' THR . 35.1 Cg_endo -65.8 154.71 72.75 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.07 1.847 . . . . 0.0 111.965 178.059 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -78.88 36.3 0.27 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.527 0.68 . . . . 0.0 110.544 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.422 ' H ' ' C ' ' A' ' 146' ' ' PRO . 37.8 tt0 -63.21 -33.34 75.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.598 -177.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -118.61 22.63 11.94 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 175.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 48.17 31.62 2.66 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 114.104 -1.407 . . . . 0.0 112.716 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -136.35 158.4 44.51 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.503 0.668 . . . . 0.0 112.434 -177.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.762 ' HB ' ' HB2' ' A' ' 144' ' ' GLN . 27.0 m -123.69 -175.78 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.787 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.442 ' HB ' ' OE1' ' A' ' 144' ' ' GLN . 25.2 mt -115.47 136.93 50.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.098 0.475 . . . . 0.0 112.27 -172.083 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.818 HG22 ' HB ' ' A' ' 140' ' ' VAL . 59.6 t -114.35 141.09 31.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.259 172.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 6.5 mttt -113.22 121.27 43.97 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.333 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.5 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 64.4 mt -104.85 116.34 48.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.177 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.877 HG13 ' HG3' ' A' ' 106' ' ' GLU . 3.9 mp -110.57 133.19 56.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.523 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 153.8 -156.17 26.63 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.114 -1.041 . . . . 0.0 112.757 176.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.642 ' HA ' HG13 ' A' ' 103' ' ' VAL . 74.3 m80 -86.95 160.08 18.8 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -178.17 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.519 ' HB3' ' CG ' ' A' ' 88' ' ' TYR . 19.7 p90 -68.67 -24.47 64.52 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -170.007 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -73.26 -41.28 63.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.219 0.533 . . . . 0.0 109.981 172.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -73.27 -39.73 65.15 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.452 -176.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.438 ' O ' ' HG3' ' A' ' 167' ' ' GLN . 29.0 p -65.07 -50.08 67.54 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.223 -177.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -62.23 -34.55 76.71 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.723 0.297 . . . . 0.0 110.627 178.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 26.6 ttt -63.79 -43.46 96.27 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.09 0.472 . . . . 0.0 110.266 177.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.43 ' HB3' HD13 ' A' ' 156' ' ' ILE . . . -68.65 -46.46 69.1 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.02 178.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.438 ' HG3' ' O ' ' A' ' 163' ' ' SER . 72.4 mt-30 -51.52 -51.36 55.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.26 -178.298 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -70.07 -30.82 68.16 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.151 -178.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -71.49 -40.64 70.07 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.945 0.402 . . . . 0.0 110.92 -178.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.646 ' O ' HD13 ' A' ' 174' ' ' LEU . 1.9 mp -73.01 -51.0 28.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.434 178.182 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.648 ' HA ' HD22 ' A' ' 174' ' ' LEU . 25.8 mmm180 -56.98 -24.82 56.1 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.727 0.298 . . . . 0.0 110.909 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -69.4 -51.35 37.4 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.638 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.416 ' O ' HG23 ' A' ' 177' ' ' VAL . 34.4 pt -68.5 -19.82 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 121.017 0.437 . . . . 0.0 110.722 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.777 HD21 HG12 ' A' ' 111' ' ' VAL . 3.5 mp -64.08 -29.15 70.3 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.133 178.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.78 -31.89 72.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.26 0.553 . . . . 0.0 110.146 175.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -73.44 -47.09 44.44 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.161 177.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.6 HG22 ' HD3' ' A' ' 118' ' ' ARG . 29.6 t -67.33 -32.51 57.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.657 -178.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -57.25 -49.01 77.4 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 174.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -63.99 -38.37 90.82 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.821 178.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -64.47 -50.81 66.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.107 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 12.4 t-160 -66.78 -25.72 66.61 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.025 0.44 . . . . 0.0 110.423 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -73.56 -36.62 65.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.844 177.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -72.89 -58.05 3.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.212 176.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -136.03 145.07 17.02 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.384 -178.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -126.69 158.82 35.43 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 49.6 m -64.2 109.52 1.89 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.106 0.479 . . . . 0.0 111.207 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -130.52 -126.29 2.78 Favored Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.391 176.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 69.39 152.69 0.1 Allowed 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.31 0.644 . . . . 0.0 111.396 -178.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 8.1 mp 57.78 -161.44 0.23 Allowed 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.783 -178.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -86.3 -48.27 8.66 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 175.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.449 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.502 177.702 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' ' G' . . . . . 0.9 " O2'" ' H6 ' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.426 -0.891 0 C3'-C2'-C1' 105.092 3.991 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . 0.9 ' H6 ' " O2'" ' B' ' 1' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.426 -0.858 0 C3'-C2'-C1' 100.171 -1.476 . 0.0 OUTLIER '7D dist 2a' 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . 0.714 " H1'" ' C5 ' ' B' ' 4' ' ' ' C' . . . . . . . . 0 C2'--C1' 1.517 -1.074 0 C5'-C4'-O4' 112.581 2.415 . 0.0 OUTLIER '7D dist 1z' 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 4' ' ' ' C' . . . . . 1.062 ' H41' ' HA2' ' A' ' 35' ' ' GLY . . . . . . . . 0 O5'--C5' 1.429 -0.697 0 C4'-C3'-C2' 105.929 3.229 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.777 " O4'" " H4'" ' B' ' 4' ' ' ' C' . . . . . . . . 0 O3'--C3' 1.434 0.801 0 P-O3'-C3' 122.273 2.144 OUTLIER-EPSILON 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 6' ' ' ' C' . . . . . 0.782 " H4'" ' HE2' ' A' ' 46' ' ' LYS . . . . . . . . 0 O5'--C5' 1.427 -0.799 0 P-O3'-C3' 123.395 3.079 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . 0.44 HO2' ' H6 ' ' B' ' 8' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.427 -0.789 0 C4'-C3'-C2' 105.241 2.541 . 0.0 OUTLIER '7D dist 1b' 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 8' ' ' ' C' . . . . . 0.44 ' H6 ' HO2' ' B' ' 7' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.428 -0.741 0 O4'-C1'-N19 108.981 0.781 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.958 0 N-CA-C 112.674 -0.171 . . . . 0.0 112.674 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -127.62 151.47 48.88 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 177.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.82 -8.08 56.66 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.358 -175.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -150.13 -160.05 9.06 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.232 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.74 71.69 5.98 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 123.004 2.469 . . . . 0.0 112.833 -178.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.4 t -146.46 99.59 3.24 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.12 178.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 62.2 m -85.7 104.59 15.55 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.428 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.7 p -164.56 148.37 2.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.561 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.9 t -81.99 69.97 8.8 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.564 0.697 . . . . 0.0 109.488 177.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -136.36 36.38 2.01 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.361 178.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.09 165.88 24.29 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.918 0.39 . . . . 0.0 110.981 -177.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -111.83 97.06 36.18 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.401 178.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -81.23 52.3 4.26 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 123.274 2.65 . . . . 0.0 112.0 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -77.93 2.63 16.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.994 0.426 . . . . 0.0 111.221 -177.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 36.9 m -130.34 68.72 1.45 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.233 0.539 . . . . 0.0 110.267 177.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.7 t -80.41 104.95 11.31 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.383 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -93.32 8.36 40.72 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.716 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.4 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 22.5 ptp -100.67 120.17 56.57 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.558 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.483 ' HB2' ' HB2' ' A' ' 22' ' ' GLN . 21.8 Cg_exo -65.84 146.63 83.78 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 123.016 2.477 . . . . 0.0 112.023 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.89 84.78 0.31 Allowed 'Trans proline' 0 C--O 1.237 0.428 0 C-N-CA 122.806 2.337 . . . . 0.0 112.812 -178.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 62.2 56.61 2.17 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.249 176.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.483 ' HB2' ' HB2' ' A' ' 19' ' ' PRO . 94.5 mt-30 -118.67 117.57 29.3 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.759 173.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.61 ' O ' ' HA ' ' A' ' 74' ' ' THR . 22.1 mm-40 -72.64 130.53 40.77 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.255 -174.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.61 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 29.6 m -131.7 109.94 10.54 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.61 -178.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.749 HG22 HD11 ' A' ' 73' ' ' ILE . 14.3 m -127.73 161.24 35.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.237 178.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 10.0 m170 -111.47 127.95 55.85 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 -174.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.621 ' O ' ' HA ' ' A' ' 70' ' ' MET . 10.4 t -105.87 123.87 60.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.821 -174.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.787 ' CZ ' HG11 ' A' ' 68' ' ' VAL . 3.7 t80 -82.33 103.2 11.73 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.313 -174.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.537 ' C ' HG23 ' A' ' 68' ' ' VAL . 39.6 pt -126.52 113.14 23.03 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.701 0.762 . . . . 0.0 110.724 174.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.97 ' HB2' ' HG2' ' A' ' 32' ' ' GLN . 88.8 Cg_exo -50.45 150.95 10.66 Favored 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 123.513 2.808 . . . . 0.0 113.325 -179.287 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.689 ' HA ' HG12 ' A' ' 34' ' ' VAL . . . -58.73 -18.73 33.98 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.909 -175.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.97 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 3.5 pt20 -51.65 -36.53 46.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.021 176.33 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.587 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -126.4 -25.35 3.48 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -169.423 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.689 HG12 ' HA ' ' A' ' 31' ' ' ALA . 14.4 p -49.94 -34.53 9.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 O-C-N 123.355 0.409 . . . . 0.0 111.622 -173.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.962 ' HA2' ' N4 ' ' B' ' 4' ' ' ' C' . . . -57.22 -55.8 28.42 Favored Glycine 0 N--CA 1.44 -1.084 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.155 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.444 ' HA ' " H5'" ' B' ' 3' ' ' ' A' . . . -71.87 -15.05 62.11 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 120.906 0.384 . . . . 0.0 111.057 -175.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.587 HG12 ' O ' ' A' ' 33' ' ' ALA . 6.5 mm -71.74 -36.0 57.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.683 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.767 HD12 ' C4 ' ' B' ' 4' ' ' ' C' . 8.2 mt -63.51 -32.12 55.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-O 121.41 0.624 . . . . 0.0 110.265 173.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.532 ' HA3' ' HB2' ' A' ' 44' ' ' HIS . . . 86.72 163.48 38.66 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.443 176.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -61.36 128.15 34.94 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 120.927 0.394 . . . . 0.0 110.039 -178.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.419 ' O ' ' HE3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER 72.62 1.84 4.13 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.178 179.149 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.538 ' HA2' HG22 ' A' ' 38' ' ' ILE . . . 69.94 19.86 75.68 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.395 -0.907 . . . . 0.0 110.889 -173.234 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -73.86 -41.85 61.62 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.427 -0.386 . . . . 0.0 110.227 -178.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.532 ' HB2' ' HA3' ' A' ' 39' ' ' GLY . 18.8 m-70 -64.6 -40.52 95.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.539 -173.43 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.459 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 13.8 tt -64.46 -45.45 95.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.887 0.375 . . . . 0.0 111.442 -179.026 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.418 ' O ' ' HB3' ' A' ' 49' ' ' SER . 13.9 ptmm? -82.26 -22.32 35.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.671 0.272 . . . . 0.0 111.324 -178.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -69.34 -34.78 75.14 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 172.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.865 ' HG ' ' HE1' ' A' ' 51' ' ' PHE . 6.4 tt -60.1 -41.97 93.68 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.052 -0.976 . . . . 0.0 108.983 173.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.638 ' HA ' HD13 ' A' ' 56' ' ' ILE . 34.0 t -54.99 -35.31 64.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.931 178.454 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -73.53 -51.28 17.55 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.865 ' HE1' ' HG ' ' A' ' 48' ' ' LEU . 1.5 p90 -72.49 -32.18 65.99 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.823 -174.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.53 -19.02 36.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.858 0.361 . . . . 0.0 110.804 179.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.5 m 63.95 31.05 14.03 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.078 178.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -132.4 171.16 14.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.992 -177.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.504 ' HB3' ' HB ' ' A' ' 74' ' ' THR . 33.2 t -93.19 115.85 28.45 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.904 HG13 HG22 ' A' ' 73' ' ' ILE . 3.2 mp -115.58 119.15 61.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.238 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.544 ' HD2' ' O2 ' ' B' ' 6' ' ' ' C' . 37.8 ttpt -148.43 136.69 21.19 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.012 179.005 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.597 HG12 HG22 ' A' ' 71' ' ' VAL . 10.4 mt -88.8 128.48 40.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.189 0.518 . . . . 0.0 111.224 -177.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.53 ' HB2' HG23 ' A' ' 72' ' ' VAL . . . -71.19 141.79 86.57 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.239 -176.187 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 59' ' ' ALA . 2.4 Cg_endo -80.36 137.46 11.84 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.933 2.422 . . . . 0.0 111.956 177.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.44 148.54 18.53 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.853 2.369 . . . . 0.0 111.782 176.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -78.39 -32.29 48.77 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.869 -178.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.457 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 9.9 p -122.42 133.4 24.38 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.504 -177.158 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 63' ' ' THR . 23.8 Cg_exo -65.4 -8.77 19.9 Favored 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 123.441 2.761 . . . . 0.0 112.825 177.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -92.38 17.35 10.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.798 0.332 . . . . 0.0 111.096 176.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 24.9 t -74.73 142.82 44.34 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.164 0.506 . . . . 0.0 110.159 177.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -96.43 2.46 52.6 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.734 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.787 HG11 ' CZ ' ' A' ' 28' ' ' PHE . 3.7 p -154.65 153.64 7.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.788 -167.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.578 ' HB2' HG21 ' A' ' 34' ' ' VAL . 30.4 mtp180 -128.59 130.2 47.02 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 171.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.621 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 4.1 mpp? -92.35 125.88 37.19 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.803 0.335 . . . . 0.0 110.846 -175.08 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.597 HG22 HG12 ' A' ' 58' ' ' ILE . 93.1 t -84.47 127.11 40.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 120.924 0.393 . . . . 0.0 110.244 178.219 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.53 HG23 ' HB2' ' A' ' 59' ' ' ALA . 81.9 t -99.29 118.05 45.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.929 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.904 HG22 HG13 ' A' ' 56' ' ' ILE . 2.4 pp -118.58 133.45 65.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.271 0.557 . . . . 0.0 110.938 178.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.61 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 30.0 m -126.08 106.26 9.46 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.068 -179.044 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.63 164.38 37.29 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.859 -173.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -61.33 138.9 79.83 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 122.488 2.126 . . . . 0.0 111.665 173.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -40.05 -48.36 3.86 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 124.449 3.433 . . . . 0.0 115.316 -173.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -72.9 -32.22 65.2 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 121.031 -0.268 . . . . 0.0 111.617 -175.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.42 -32.21 69.72 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.231 0.539 . . . . 0.0 109.966 177.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -57.85 -41.57 82.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.774 177.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -64.99 -35.03 79.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.409 -175.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.7 mtmt -66.09 -44.02 85.63 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.405 0.621 . . . . 0.0 109.699 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.77 -41.55 75.02 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.058 178.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.494 ' O ' HG22 ' A' ' 87' ' ' ILE . 49.0 tt0 -64.48 -34.44 78.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.242 -177.277 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -56.79 -42.07 91.37 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.197 177.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 32.7 mmt180 -76.78 -33.38 58.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.788 0.328 . . . . 0.0 111.497 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.494 HG22 ' O ' ' A' ' 84' ' ' GLN . 0.4 OUTLIER -65.53 -37.29 79.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -177.909 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.696 ' HA ' HD23 ' A' ' 91' ' ' LEU . 10.7 m-85 -69.39 -30.66 68.69 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.201 0.524 . . . . 0.0 110.795 174.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -58.02 -33.81 70.38 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.759 175.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.711 ' HG3' HD22 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -61.33 -36.51 80.34 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 117.435 0.617 . . . . 0.0 109.646 177.774 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.752 ' HB3' ' CE1' ' A' ' 97' ' ' PHE . 2.8 mm? -61.79 -44.87 96.02 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.772 175.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 1.075 ' HE3' ' HB ' ' A' ' 103' ' ' VAL . 3.6 mmtp -76.67 -34.96 58.21 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -176.182 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -63.1 -33.05 74.62 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.768 -171.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.418 ' HB2' ' CE2' ' A' ' 96' ' ' PHE . 8.8 mm-40 -97.68 18.79 14.8 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.169 -0.613 . . . . 0.0 110.763 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 65.8 t30 58.07 40.5 25.24 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.186 174.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.418 ' CE2' ' HB2' ' A' ' 94' ' ' GLU . 27.7 m-85 -80.88 -27.66 36.26 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.591 -0.443 . . . . 0.0 109.986 176.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.752 ' CE1' ' HB3' ' A' ' 91' ' ' LEU . 6.7 m-85 -134.99 28.23 3.5 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.915 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 50.43 -164.67 0.69 Allowed Glycine 0 CA--C 1.523 0.552 0 CA-C-N 115.874 -0.603 . . . . 0.0 113.742 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -87.36 -57.63 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.159 2.572 . . . . 0.0 112.142 173.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.42 ' HB3' ' HE3' ' A' ' 100' ' ' LYS . 21.8 mmmt -80.37 -28.14 38.06 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -175.08 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.703 ' HB3' ' O ' ' A' ' 97' ' ' PHE . 33.9 tt0 -60.89 128.6 37.29 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 178.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -56.37 119.86 6.7 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.126 -175.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 1.075 ' HB ' ' HE3' ' A' ' 92' ' ' LYS . 13.3 p -60.45 123.3 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 173.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -126.27 89.89 3.09 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.773 0.797 . . . . 0.0 109.335 176.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 tt -101.22 126.92 47.99 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.467 -1.242 . . . . 0.0 108.191 -176.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -81.56 103.32 11.19 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.247 0.546 . . . . 0.0 110.383 -177.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.3 m -95.07 130.77 41.63 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.865 0.364 . . . . 0.0 110.036 177.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.405 ' HB3' HG21 ' A' ' 153' ' ' ILE . 11.1 m-70 -103.65 120.18 40.39 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.813 0.34 . . . . 0.0 110.643 -177.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 32.9 pt -115.63 134.41 58.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.174 0.512 . . . . 0.0 110.191 178.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.567 HH11 HD11 ' A' ' 153' ' ' ILE . 12.7 tpt180 -86.84 118.98 26.58 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.254 -174.219 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.693 HG23 ' CD2' ' A' ' 174' ' ' LEU . 7.1 p -121.51 145.04 41.73 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -177.25 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.81 ' HA ' ' HG2' ' A' ' 151' ' ' GLN . 32.7 Cg_exo -55.67 144.54 75.08 Favored 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 122.586 2.191 . . . . 0.0 110.871 173.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.21 -32.15 70.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.692 -175.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.5 p -79.75 -26.04 40.86 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.778 178.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.654 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -75.51 -20.41 58.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.315 -177.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.42 -35.1 79.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.11 0.481 . . . . 0.0 110.098 175.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -81.52 -11.3 83.33 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.909 176.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.426 ' HD2' HG22 ' A' ' 177' ' ' VAL . 18.3 ttm180 -93.09 -38.36 11.65 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.723 0.296 . . . . 0.0 111.037 179.465 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.6 p -65.66 -29.83 48.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.353 -177.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 1.004 ' HA ' ' HB ' ' A' ' 127' ' ' VAL . 34.9 pt -77.28 -19.48 14.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.005 0.431 . . . . 0.0 110.485 178.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.686 ' HA3' HG22 ' A' ' 126' ' ' THR . . . 84.15 -153.96 29.83 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.213 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.409 ' HB3' ' HD2' ' A' ' 125' ' ' LYS . 16.7 t70 -66.38 92.14 0.19 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.696 0.284 . . . . 0.0 111.104 -176.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 30.3 t70 56.3 33.88 23.06 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.826 0.822 . . . . 0.0 110.582 -179.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.695 ' HA2' ' HB ' ' A' ' 120' ' ' ILE . . . 80.26 72.6 1.2 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.545 -0.836 . . . . 0.0 113.008 177.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.409 ' HD2' ' HB3' ' A' ' 122' ' ' ASP . 64.2 mttp -126.05 -56.24 1.45 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.568 0.223 . . . . 0.0 110.538 176.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.686 HG22 ' HA3' ' A' ' 121' ' ' GLY . 14.4 t -69.24 -14.98 63.26 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.961 -0.295 . . . . 0.0 111.129 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 1.004 ' HB ' ' HA ' ' A' ' 120' ' ' ILE . 12.7 p -66.76 -32.44 58.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.015 0.435 . . . . 0.0 109.964 174.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -66.29 -45.98 78.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.337 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -63.85 -39.06 93.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.242 175.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.715 HD21 HD11 ' A' ' 170' ' ' ILE . 33.4 tp -56.68 -49.44 75.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.147 -176.425 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.646 ' HG2' ' H ' ' A' ' 138' ' ' VAL . 48.2 mt-30 -61.42 -47.4 85.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.599 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -66.99 -40.09 87.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.855 0.36 . . . . 0.0 111.349 -178.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 34.3 tp -73.13 -42.0 63.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.318 -176.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.427 ' HB ' ' HB2' ' A' ' 166' ' ' ALA . 68.2 p -76.52 -16.26 59.67 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.86 0.362 . . . . 0.0 110.888 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 64.96 26.34 12.74 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.837 -178.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -137.96 162.96 32.71 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.106 -177.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.56 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 8.6 mm-40 -90.23 110.01 21.07 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-O 120.957 0.408 . . . . 0.0 110.395 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.646 ' H ' ' HG2' ' A' ' 131' ' ' GLN . 43.2 t -101.52 104.9 17.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.92 176.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.552 HG13 ' HE3' ' A' ' 155' ' ' LYS . 4.9 p -113.81 111.85 37.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.466 0.65 . . . . 0.0 111.059 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.608 HG12 HG22 ' A' ' 154' ' ' VAL . 9.2 m -90.59 139.14 26.43 Favored Pre-proline 0 N--CA 1.446 -0.631 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 172.166 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.473 ' HB2' ' H ' ' A' ' 144' ' ' GLN . 67.8 Cg_endo -76.43 122.12 6.37 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 121.845 1.697 . . . . 0.0 112.525 -174.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 11.2 mpt_? -81.53 -13.79 57.67 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 174.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -80.2 -52.13 8.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.933 -1.031 . . . . 0.0 109.44 175.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.515 ' HG2' HG11 ' A' ' 152' ' ' VAL . 40.6 mt-30 73.36 151.1 0.11 Allowed 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 172.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.551 ' HB ' ' HD2' ' A' ' 146' ' ' PRO . 2.2 p -90.95 165.37 22.15 Favored Pre-proline 0 N--CA 1.448 -0.529 0 CA-C-N 114.427 -1.26 . . . . 0.0 110.358 177.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.551 ' HD2' ' HB ' ' A' ' 145' ' ' THR . 20.0 Cg_endo -59.97 159.92 23.88 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.105 2.537 . . . . 0.0 113.601 -177.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -70.83 1.51 5.4 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.096 -0.957 . . . . 0.0 111.207 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -50.13 -35.88 27.58 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.721 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -119.73 7.45 11.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.453 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 44.69 29.86 0.47 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.149 0.98 . . . . 0.0 111.808 -173.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.81 ' HG2' ' HA ' ' A' ' 112' ' ' PRO . 73.9 mt-30 -143.97 153.15 41.96 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 121.069 0.462 . . . . 0.0 111.249 -174.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.515 HG11 ' HG2' ' A' ' 144' ' ' GLN . 33.7 m -126.16 177.91 4.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 176.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.567 HD11 HH11 ' A' ' 110' ' ' ARG . 15.1 mt -121.89 129.62 75.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 O-C-N 121.718 -0.614 . . . . 0.0 111.747 -178.198 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.608 HG22 HG12 ' A' ' 140' ' ' VAL . 59.4 t -93.1 138.67 19.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 173.145 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.552 ' HE3' HG13 ' A' ' 139' ' ' VAL . 4.9 mtmt -107.21 123.6 48.53 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.764 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.56 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 52.7 mt -108.0 111.69 36.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 176.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 4.7 mp -107.66 118.45 55.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.904 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 171.7 -165.78 38.69 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.127 -1.035 . . . . 0.0 113.102 178.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.744 ' HA ' HG13 ' A' ' 103' ' ' VAL . 0.3 OUTLIER -77.81 157.24 30.03 Favored 'General case' 0 C--O 1.223 -0.334 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.185 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.507 ' HB3' ' CG ' ' A' ' 88' ' ' TYR . 44.8 p90 -64.24 -23.35 67.27 Favored 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -175.133 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.569 ' O ' ' HG3' ' A' ' 164' ' ' GLN . 91.1 m-85 -68.73 -51.61 39.55 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.737 0.78 . . . . 0.0 109.543 173.215 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.15 -41.42 67.11 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.563 -174.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 62.0 p -64.59 -44.28 91.16 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.941 -176.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.613 ' O ' ' HG2' ' A' ' 168' ' ' ARG . 1.2 pp0? -61.09 -38.04 84.84 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.605 177.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.426 ' HG3' ' O ' ' A' ' 161' ' ' TYR . 81.9 mtp -61.24 -42.4 98.56 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.864 0.364 . . . . 0.0 110.818 177.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.427 ' HB2' ' HB ' ' A' ' 134' ' ' THR . . . -70.67 -43.52 68.92 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.748 178.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -51.99 -55.76 18.44 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.728 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.613 ' HG2' ' O ' ' A' ' 164' ' ' GLN . 9.3 ptt180 -65.38 -29.88 70.64 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.824 -179.324 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -70.96 -51.12 27.65 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.949 -178.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.715 HD11 HD21 ' A' ' 130' ' ' LEU . 2.3 mp -68.09 -44.83 84.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.591 ' HA ' ' HG ' ' A' ' 174' ' ' LEU . 20.3 mmm180 -58.62 -26.27 63.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.811 0.339 . . . . 0.0 111.352 177.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -69.49 -46.4 66.69 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.655 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.519 HG13 HD23 ' A' ' 174' ' ' LEU . 32.7 pt -72.16 -19.74 19.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.691 -179.109 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.693 ' CD2' HG23 ' A' ' 111' ' ' VAL . 5.6 mt -66.99 -34.5 77.88 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 177.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.4 -31.72 72.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.18 176.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -71.6 -42.27 67.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.988 177.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.426 HG22 ' HD2' ' A' ' 118' ' ' ARG . 88.9 t -67.5 -35.01 71.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.507 176.277 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -57.48 -46.59 83.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.165 0.507 . . . . 0.0 110.328 175.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 0.412 ' O ' ' HB3' ' A' ' 183' ' ' LYS . 43.5 mt-30 -64.3 -39.85 94.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.393 177.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 0.418 ' O ' ' HA3' ' A' ' 184' ' ' GLY . 7.2 tp60 -66.9 -21.48 65.99 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.073 0.463 . . . . 0.0 110.786 178.181 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -83.68 -42.5 16.56 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.51 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -84.94 -29.19 25.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.097 0.475 . . . . 0.0 111.036 -179.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.463 ' O ' ' HG2' ' A' ' 183' ' ' LYS . 46.2 tttm -114.69 34.76 4.59 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 122.063 0.935 . . . . 0.0 109.254 -177.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.418 ' HA3' ' O ' ' A' ' 180' ' ' GLN . . . -146.61 132.31 4.37 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.567 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -121.45 -39.85 2.63 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.096 0.474 . . . . 0.0 109.73 177.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 11.5 t -100.89 -174.58 2.66 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.759 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 99.34 26.89 8.43 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 -177.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -95.46 49.5 1.19 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.251 0.548 . . . . 0.0 110.894 -176.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 97.8 mt -88.73 57.62 4.25 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.027 178.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -90.25 125.25 35.43 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.07 -177.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.632 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.1 179.75 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' ' G' . . . . . 0.767 HO2' ' H6 ' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.427 -0.789 1 C3'-C2'-C1' 105.289 4.21 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . 0.767 ' H6 ' HO2' ' B' ' 1' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.425 -0.937 0 O4'-C4'-C3' 103.362 -1.527 . 0.0 OUTLIER '7D dist 2a' 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . 0.645 ' C8 ' ' HA3' ' A' ' 35' ' ' GLY . . . . . . . . 0 O5'--C5' 1.424 -1.026 0 O4'-C1'-N19 110.785 2.585 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 4' ' ' ' C' . . . . . 0.962 ' N4 ' ' HA2' ' A' ' 35' ' ' GLY . . . . . . . . 0 O5'--C5' 1.426 -0.866 0 C4'-C3'-C2' 105.774 3.074 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.749 " O5'" " H4'" ' B' ' 4' ' ' ' C' . . . . . . . . 0 P--O3' 1.616 0.782 0 P-O3'-C3' 122.357 2.214 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 6' ' ' ' C' . . . . . 0.544 ' O2 ' ' HD2' ' A' ' 57' ' ' LYS . . . . . . . . 0 P--O3' 1.613 0.505 0 C4'-C3'-C2' 106.555 3.855 OUTLIER-DELTA 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.901 0 O4'-C1'-N19 109.051 0.851 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.425 -0.937 0 C3'-C2'-C1' 100.468 -1.146 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.791 0 N-CA-C 111.967 -0.453 . . . . 0.0 111.967 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.16 86.8 1.86 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.999 0.428 . . . . 0.0 111.114 -177.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 65.4 mtt -99.07 172.3 7.48 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.74 176.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 127.16 -85.59 0.33 Allowed Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 110.991 -0.843 . . . . 0.0 110.991 -176.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -59.76 98.44 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.594 2.196 . . . . 0.0 110.451 172.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.3 m -94.1 118.97 32.3 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.421 0.629 . . . . 0.0 111.847 -169.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.1 m -131.62 -68.31 0.65 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.005 171.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.3 t 50.4 54.12 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-O 121.677 0.751 . . . . 0.0 110.752 177.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.5 m -85.95 -28.68 24.12 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.089 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.11 140.31 6.38 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.043 178.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -127.39 -59.5 1.23 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.027 0.441 . . . . 0.0 110.234 178.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -147.22 89.81 5.46 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.705 178.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -63.94 -49.6 3.82 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.906 2.404 . . . . 0.0 112.645 -177.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -107.77 99.38 8.86 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.8 t 70.1 136.87 0.04 OUTLIER 'General case' 0 C--O 1.235 0.296 0 O-C-N 123.944 0.778 . . . . 0.0 111.064 -177.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.6 t -79.71 65.06 4.75 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.187 -178.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -152.38 -55.98 0.13 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.177 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 27.6 ttt 60.69 91.86 0.07 OUTLIER Pre-proline 0 N--CA 1.465 0.313 0 O-C-N 123.8 0.688 . . . . 0.0 111.071 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -74.68 108.91 2.81 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 123.196 2.598 . . . . 0.0 111.868 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -95.17 14.13 1.25 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.286 2.658 . . . . 0.0 112.905 -176.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 76' ' ' PRO . 37.9 tt0 -144.47 95.51 2.72 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.356 -177.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -122.21 142.46 50.41 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.301 177.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.524 ' O ' ' HA ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -107.65 161.58 14.74 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.663 178.7 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.8 m -139.84 108.63 5.96 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.765 0.317 . . . . 0.0 110.99 -178.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.413 HG22 HD11 ' A' ' 73' ' ' ILE . 35.5 m -127.77 161.02 36.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.128 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -114.97 130.2 56.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.274 -174.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.548 ' O ' ' HA ' ' A' ' 70' ' ' MET . 21.4 t -105.06 132.81 50.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.823 -174.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.694 ' CZ ' HG11 ' A' ' 68' ' ' VAL . 5.0 t80 -94.12 104.58 16.6 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.012 0.525 . . . . 0.0 110.846 -174.082 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.472 ' C ' HG23 ' A' ' 68' ' ' VAL . 26.7 pt -124.66 120.57 25.77 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.391 0.615 . . . . 0.0 110.404 174.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.586 ' HA ' ' HA ' ' A' ' 68' ' ' VAL . 36.5 Cg_endo -64.82 153.1 79.61 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 123.045 2.497 . . . . 0.0 112.541 -174.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.639 ' HA ' HG12 ' A' ' 34' ' ' VAL . . . -60.48 -18.95 54.88 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.052 -176.185 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -74.09 -13.98 60.92 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.828 177.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.541 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -123.47 -30.75 3.6 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.914 -177.026 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.639 HG12 ' HA ' ' A' ' 31' ' ' ALA . 11.1 p -54.47 -31.54 23.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -172.06 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 1.031 ' HA2' ' H41' ' B' ' 4' ' ' ' C' . . . -56.59 -59.26 11.1 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.174 -1.012 . . . . 0.0 111.642 -178.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.609 ' HA ' " H5'" ' B' ' 3' ' ' ' A' . . . -77.4 -13.48 59.92 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 120.788 0.327 . . . . 0.0 111.007 -174.323 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.816 HD12 ' HB3' ' A' ' 90' ' ' LYS . 2.0 mm -67.79 -34.4 67.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.75 178.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.774 HD12 ' C5 ' ' B' ' 4' ' ' ' C' . 19.2 mt -63.23 -59.45 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.962 177.319 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.443 ' HA3' ' NE2' ' A' ' 44' ' ' HIS . . . 118.8 90.55 1.34 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 119.761 -1.209 . . . . 0.0 115.311 168.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 43.9 tptt 57.38 -79.13 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.655 1.182 . . . . 0.0 113.805 171.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.534 ' HE2' ' HB3' ' A' ' 43' ' ' GLN . 19.2 pttm -117.36 7.68 12.89 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.749 0.309 . . . . 0.0 111.389 -175.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 62.9 39.25 97.8 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.995 -0.622 . . . . 0.0 112.942 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.534 ' HB3' ' HE2' ' A' ' 41' ' ' LYS . 23.0 tt0 -114.82 -48.79 2.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 117.158 0.479 . . . . 0.0 111.384 178.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.443 ' NE2' ' HA3' ' A' ' 39' ' ' GLY . 4.6 p80 -63.56 -19.19 64.6 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.075 0.464 . . . . 0.0 110.703 178.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.491 HD12 ' HA ' ' A' ' 38' ' ' ILE . 10.2 tt -67.26 -32.2 56.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.385 174.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.448 ' HD3' " C5'" ' B' ' 6' ' ' ' C' . 56.7 mtmt -81.54 -22.25 37.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.287 0.565 . . . . 0.0 110.159 178.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -66.79 -30.57 70.8 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 173.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.645 HD22 ' HE1' ' A' ' 51' ' ' PHE . 0.3 OUTLIER -55.58 -49.31 73.06 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.173 173.822 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.67 ' HA ' HD13 ' A' ' 56' ' ' ILE . 8.6 m -57.87 -37.03 73.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.186 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.8 mtp180 -73.48 -50.92 19.09 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -176.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.645 ' HE1' HD22 ' A' ' 48' ' ' LEU . 0.6 OUTLIER -68.63 -27.46 66.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.938 0.399 . . . . 0.0 110.223 -176.43 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.566 ' O ' ' HB1' ' A' ' 79' ' ' ALA . . . -86.82 -10.64 53.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.892 0.377 . . . . 0.0 110.864 177.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 31.5 m 57.62 38.22 27.7 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.148 178.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -138.65 173.46 11.56 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.623 -174.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.402 ' HB2' ' HB ' ' A' ' 74' ' ' THR . 26.4 m -94.7 101.6 13.45 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.179 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.821 HG13 HG22 ' A' ' 73' ' ' ILE . 1.9 mp -106.14 123.12 60.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.129 178.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -138.65 150.97 46.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.23 176.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.679 ' HB ' ' C6 ' ' B' ' 5' ' ' ' A' . 31.2 mm -89.97 120.83 39.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 169.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.818 ' HB2' HG23 ' A' ' 72' ' ' VAL . . . -65.24 122.45 80.0 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.552 -175.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.41 127.29 19.91 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.987 2.458 . . . . 0.0 111.746 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -49.4 124.62 12.25 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 123.204 2.603 . . . . 0.0 112.56 -177.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -56.66 -39.29 73.46 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.358 177.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.443 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 16.6 p -131.55 144.17 52.25 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 114.812 -1.085 . . . . 0.0 108.81 174.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 63' ' ' THR . 39.0 Cg_exo -61.21 -14.67 35.24 Favored 'Trans proline' 0 N--CA 1.475 0.385 0 C-N-CA 123.137 2.558 . . . . 0.0 113.202 -174.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -116.28 17.66 15.55 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.004 -179.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 27.4 p -49.52 131.47 20.98 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.207 0.527 . . . . 0.0 112.338 -174.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.47 ' O ' ' HD2' ' A' ' 67' ' ' LYS . 24.4 tptp -72.15 -18.96 61.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.282 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.694 HG11 ' CZ ' ' A' ' 28' ' ' PHE . 10.8 p -139.29 148.8 23.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.857 175.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.588 ' HB3' HG21 ' A' ' 34' ' ' VAL . 17.6 ttm180 -127.09 133.8 50.36 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 175.183 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.548 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 41.0 mtp -100.42 149.33 23.77 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 119.863 -0.735 . . . . 0.0 111.14 -171.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.548 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 89.9 t -99.05 127.95 51.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.953 175.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.818 HG23 ' HB2' ' A' ' 59' ' ' ALA . 92.3 t -103.28 110.0 28.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 177.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.821 HG22 HG13 ' A' ' 56' ' ' ILE . 2.6 pp -117.0 129.23 73.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.307 0.575 . . . . 0.0 111.072 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 35.4 m -125.14 109.44 12.89 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.922 -1.036 . . . . 0.0 109.889 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.45 162.04 35.43 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.363 -0.922 . . . . 0.0 112.601 -177.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.486 ' HG2' ' HB3' ' A' ' 79' ' ' ALA . 19.3 Cg_endo -59.67 137.01 74.53 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.754 2.303 . . . . 0.0 111.339 174.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_exo -40.03 -49.85 3.56 Favored 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 124.314 3.342 . . . . 0.0 114.683 -174.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -68.16 -36.32 79.46 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.888 0.375 . . . . 0.0 111.373 -176.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.566 ' HB1' ' O ' ' A' ' 52' ' ' ALA . . . -74.83 -31.7 61.75 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.425 0.631 . . . . 0.0 110.206 177.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -62.87 -33.45 75.3 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.239 175.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.408 ' HE1' HE22 ' A' ' 164' ' ' GLN . 74.5 t80 -53.75 -54.73 34.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.673 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.564 ' HE2' ' HA ' ' A' ' 79' ' ' ALA . 37.0 pttt -70.9 -33.77 70.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.677 0.275 . . . . 0.0 111.444 -177.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.35 -45.65 86.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.997 0.427 . . . . 0.0 111.011 177.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.654 ' HB3' ' HE1' ' A' ' 160' ' ' PHE . 23.6 tt0 -71.41 -31.69 67.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.318 -177.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -58.0 -32.7 67.11 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.829 176.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -76.65 -27.63 55.72 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.56 0.219 . . . . 0.0 111.197 178.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.524 HG22 ' O ' ' A' ' 84' ' ' GLN . 0.4 OUTLIER -70.26 -39.73 77.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -177.739 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.482 ' HA ' HD12 ' A' ' 105' ' ' LEU . 18.3 m-85 -69.68 -30.81 68.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.095 0.474 . . . . 0.0 109.999 174.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -58.48 -28.6 62.49 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.91 173.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.816 ' HB3' HD12 ' A' ' 37' ' ' ILE . 34.8 mmtp -67.97 -44.39 76.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.082 0.468 . . . . 0.0 109.893 175.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -60.46 -41.71 94.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.851 174.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 1.025 ' HE3' ' HB ' ' A' ' 103' ' ' VAL . 0.6 OUTLIER -65.73 -31.78 72.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.379 178.46 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -52.72 -47.52 67.26 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.575 -176.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.751 ' HB2' ' CE2' ' A' ' 96' ' ' PHE . 10.4 mm-40 -110.14 0.3 18.22 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.665 -177.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 55.72 43.58 27.7 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.751 178.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.751 ' CE2' ' HB2' ' A' ' 94' ' ' GLU . 92.9 m-85 -58.71 -38.92 79.36 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.101 0.477 . . . . 0.0 111.342 -178.168 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.68 ' CZ ' ' HE2' ' A' ' 92' ' ' LYS . 20.5 p90 -66.24 -33.54 75.98 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.679 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.421 ' HA3' ' HB2' ' A' ' 101' ' ' GLU . . . 150.83 147.22 4.5 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.627 -177.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -58.32 -54.22 3.28 Favored 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 122.743 2.296 . . . . 0.0 113.016 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -105.24 -6.52 19.68 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.708 0.289 . . . . 0.0 111.141 -178.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.421 ' HB2' ' HA3' ' A' ' 98' ' ' GLY . 5.9 mp0 -61.41 152.49 29.55 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.338 -177.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.437 ' HB3' ' NE2' ' A' ' 159' ' ' HIS . 38.5 mt-10 -61.57 146.55 48.43 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.01 172.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 1.025 ' HB ' ' HE3' ' A' ' 92' ' ' LYS . 12.6 p -59.03 129.84 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.149 175.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 74.3 mmtt -136.86 91.25 2.62 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.423 -177.112 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.482 HD12 ' HA ' ' A' ' 88' ' ' TYR . 2.4 tt -115.88 117.01 29.0 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -76.95 113.93 15.19 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.311 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.5 m -104.99 143.73 32.78 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.463 ' NE2' ' HG2' ' A' ' 155' ' ' LYS . 22.1 m170 -114.41 120.28 39.78 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 120.962 0.411 . . . . 0.0 110.346 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.415 ' CD1' ' HB ' ' A' ' 170' ' ' ILE . 16.6 pt -107.97 138.37 34.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 176.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -90.82 118.68 30.42 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.363 -174.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.653 HG12 HD11 ' A' ' 174' ' ' LEU . 11.1 m -116.95 154.34 49.64 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.769 178.376 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.658 ' HD2' HD22 ' A' ' 174' ' ' LEU . 38.4 Cg_exo -58.62 146.06 92.98 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.05 1.833 . . . . 0.0 110.891 173.064 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.455 ' HA ' HG22 ' A' ' 152' ' ' VAL . . . -48.65 -52.21 24.37 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -172.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.5 m -76.34 -17.82 59.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.676 -176.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.19 -24.66 62.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.652 0.263 . . . . 0.0 111.24 -177.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.64 ' HB1' HG11 ' A' ' 140' ' ' VAL . . . -64.17 -29.86 70.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.23 0.538 . . . . 0.0 110.357 177.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -77.01 -23.88 67.95 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.827 177.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.482 ' HD2' HG22 ' A' ' 177' ' ' VAL . 78.8 mtt-85 -83.72 -27.79 28.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.568 0.223 . . . . 0.0 110.592 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.728 HG22 HD11 ' A' ' 130' ' ' LEU . 9.9 p -77.47 -32.34 18.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.086 -178.152 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.428 ' O ' HG13 ' A' ' 127' ' ' VAL . 47.1 mm -74.34 -38.64 47.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.427 0.632 . . . . 0.0 109.944 177.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 95.54 153.46 30.06 Favored Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.384 -178.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -78.19 115.47 17.93 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 64.77 21.93 12.46 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 123.705 0.628 . . . . 0.0 110.911 -176.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 98.09 -137.45 13.3 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.915 -0.66 . . . . 0.0 111.847 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 23.5 tptm 72.55 -54.39 0.69 Allowed 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.393 0.677 . . . . 0.0 111.834 177.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 26.4 m -68.75 -37.34 79.31 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.891 0.377 . . . . 0.0 110.784 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.428 HG13 ' O ' ' A' ' 120' ' ' ILE . 6.4 m -65.21 -20.95 28.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.669 175.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -63.81 -33.43 75.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.969 0.414 . . . . 0.0 109.954 178.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -79.15 -40.31 31.3 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.642 -0.423 . . . . 0.0 109.957 175.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.728 HD11 HG22 ' A' ' 119' ' ' VAL . 66.4 mt -55.57 -52.01 65.17 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -174.434 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -84.34 -31.92 24.55 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.361 -0.535 . . . . 0.0 112.233 -173.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -72.26 -38.3 68.89 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.785 0.326 . . . . 0.0 111.083 -178.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.413 HD23 ' HE3' ' A' ' 169' ' ' LYS . 42.7 tp -83.03 -46.59 12.67 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.514 -176.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.577 HG21 ' HA ' ' A' ' 166' ' ' ALA . 39.6 p -75.88 -28.01 57.96 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.526 -174.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 67.36 15.48 9.92 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.546 -175.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -112.59 172.1 7.12 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.75 -178.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.468 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 35.2 tt0 -99.99 110.74 23.06 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 177.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 59.8 t -108.42 106.65 21.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.822 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 6.2 p -119.71 115.82 48.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.288 0.566 . . . . 0.0 111.428 -177.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.64 HG11 ' HB1' ' A' ' 116' ' ' ALA . 86.3 t -93.56 110.82 49.43 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.388 173.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.65 ' HG3' ' HE2' ' A' ' 155' ' ' LYS . 21.1 Cg_exo -67.5 149.9 80.16 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 123.104 2.536 . . . . 0.0 112.639 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.35 118.71 22.23 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.581 177.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 65.93 97.34 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.422 0.629 . . . . 0.0 112.004 -178.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.614 ' OE1' ' HB ' ' A' ' 153' ' ' ILE . 20.8 mm-40 -102.96 -66.94 0.9 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.545 176.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -145.61 144.61 23.11 Favored Pre-proline 0 C--N 1.314 -0.978 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.957 -179.158 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -67.43 168.33 18.26 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 123.23 2.62 . . . . 0.0 113.531 -174.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -58.84 -15.77 14.07 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.904 -177.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -55.41 -43.17 75.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.9 0.381 . . . . 0.0 110.497 172.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ASN . . . . . 0.414 ' O ' ' HG2' ' A' ' 150' ' ' GLU . 0.2 OUTLIER -87.48 -16.75 33.87 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.102 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 149' ' ' ASN . 10.7 pt-20 46.35 28.91 0.77 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.948 1.299 . . . . 0.0 111.731 -178.127 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -145.29 149.11 34.26 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.381 -174.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.455 HG22 ' HA ' ' A' ' 113' ' ' ALA . 11.2 m -137.59 177.65 5.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 O-C-N 123.362 0.414 . . . . 0.0 110.203 178.084 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.614 ' HB ' ' OE1' ' A' ' 144' ' ' GLN . 96.7 mt -119.92 144.81 27.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.188 -173.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.625 ' HB ' HG22 ' A' ' 140' ' ' VAL . 1.5 p -135.46 139.43 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-O 121.251 0.548 . . . . 0.0 110.342 168.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.65 ' HE2' ' HG3' ' A' ' 141' ' ' PRO . 19.6 mttm -101.88 133.55 46.46 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.342 -172.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.468 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 68.2 mt -115.3 112.12 38.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.901 177.433 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.42 ' N ' HD12 ' A' ' 157' ' ' ILE . 4.5 mp -109.63 132.51 57.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.816 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 156.33 -158.43 28.67 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.222 -0.99 . . . . 0.0 112.866 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.844 ' HA ' HG13 ' A' ' 103' ' ' VAL . 13.6 m-70 -76.7 166.08 23.86 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 123.729 0.311 . . . . 0.0 110.64 -177.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.654 ' HE1' ' HB3' ' A' ' 84' ' ' GLN . 10.4 t80 -61.99 -49.04 77.67 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.59 0.233 . . . . 0.0 110.534 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.402 ' HA ' ' HG2' ' A' ' 164' ' ' GLN . 96.5 m-85 -69.46 -33.61 73.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.894 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.06 -49.85 53.79 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.028 0.442 . . . . 0.0 110.672 178.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.538 ' O ' ' HG3' ' A' ' 167' ' ' GLN . 49.7 m -66.49 -38.43 87.24 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.704 -177.319 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.408 HE22 ' HE1' ' A' ' 81' ' ' PHE . 12.8 pt20 -64.16 -36.67 84.79 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.708 178.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 90.1 mtp -66.01 -34.08 77.27 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.951 0.405 . . . . 0.0 110.357 176.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.577 ' HA ' HG21 ' A' ' 134' ' ' THR . . . -71.68 -44.16 64.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.493 177.166 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.538 ' HG3' ' O ' ' A' ' 163' ' ' SER . 75.0 mt-30 -52.46 -51.6 58.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.624 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.753 ' O ' ' HB2' ' A' ' 172' ' ' ASP . 5.9 ptm180 -67.05 -31.74 72.46 Favored 'General case' 0 C--O 1.217 -0.651 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.376 -178.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.441 ' N ' ' HG3' ' A' ' 168' ' ' ARG . 16.2 tppt? -65.25 -53.14 48.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.828 0.347 . . . . 0.0 111.208 -176.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.478 ' O ' ' HG ' ' A' ' 174' ' ' LEU . 3.0 mp -72.29 -44.23 63.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.321 -177.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -61.46 -25.5 67.28 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.916 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.753 ' HB2' ' O ' ' A' ' 168' ' ' ARG . 2.1 t0 -71.16 -47.98 54.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.914 -177.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 18.1 pt -70.12 -19.73 22.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.925 -176.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.658 HD22 ' HD2' ' A' ' 112' ' ' PRO . 19.1 mt -57.73 -32.34 67.33 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.883 0.373 . . . . 0.0 110.733 175.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.71 -31.8 73.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.743 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -67.57 -35.69 79.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.998 177.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.482 HG22 ' HD2' ' A' ' 118' ' ' ARG . 42.1 t -74.82 -27.37 20.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.902 177.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 52.1 tptt -65.66 -45.01 84.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.508 172.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -63.54 -33.68 76.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.64 175.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 0.608 ' HA ' ' HA2' ' A' ' 184' ' ' GLY . 25.5 tp60 -62.72 -33.91 76.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.344 175.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 39.9 m-70 -71.81 -35.82 70.07 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.936 0.398 . . . . 0.0 110.814 174.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -65.09 -48.55 73.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.81 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -161.55 -55.89 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.814 176.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.608 ' HA2' ' HA ' ' A' ' 180' ' ' GLN . . . 142.68 100.92 0.38 Allowed Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.263 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 5.4 tp60 -146.6 110.09 4.84 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.906 0.384 . . . . 0.0 110.369 178.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 16.0 p -105.46 -2.61 23.51 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.686 178.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 109.02 -61.05 0.31 Allowed Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.541 -178.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -103.33 75.47 1.35 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.75 0.309 . . . . 0.0 110.615 178.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 5.1 tt -87.78 99.03 11.8 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 178.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 57.41 35.79 26.35 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.618 -176.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.222 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.236 -177.251 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' ' G' . . . . . 0.933 " O2'" ' H6 ' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.426 -0.849 0 C4'-C3'-C2' 106.626 3.926 OUTLIER-EPSILON 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . 0.933 ' H6 ' " O2'" ' B' ' 1' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.424 -0.996 0 C3'-C2'-C1' 99.605 -2.106 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . 0.703 " H1'" ' C5 ' ' B' ' 4' ' ' ' C' . . . . . . . . 0 C2'--C1' 1.517 -1.084 0 C5'-C4'-O4' 112.524 2.374 . 0.01 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 4' ' ' ' C' . . . . . 1.031 ' H41' ' HA2' ' A' ' 35' ' ' GLY . . . . . . . . 0 O5'--C5' 1.427 -0.787 0 C3'-C2'-C1' 104.196 2.995 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.892 " O4'" " H4'" ' B' ' 4' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.431 -0.579 0 P-O3'-C3' 121.867 1.806 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 6' ' ' ' C' . . . . . 0.511 " O5'" " H2'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.43 -0.656 0 C4'-C3'-C2' 105.523 2.823 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.424 -0.969 0 C4'-C3'-C2' 105.43 2.73 OUTLIER-EPSILON 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.424 -0.989 0 P-O3'-C3' 122.765 2.554 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.649 0 N-CA-C 111.86 -0.496 . . . . 0.0 111.86 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -100.99 -43.26 6.1 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.955 0.407 . . . . 0.0 110.091 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.01 141.91 51.38 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.815 177.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -164.99 77.52 0.14 Allowed Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.164 -177.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.2 72.42 5.38 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 123.26 2.64 . . . . 0.0 111.693 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.9 t 73.47 -46.56 0.64 Allowed 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.608 0.763 . . . . 0.0 110.923 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 35.5 t -122.29 155.55 35.71 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.8 m -120.66 137.06 55.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 176.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.6 m -112.65 13.43 19.92 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.134 0.492 . . . . 0.0 110.677 -177.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -77.11 146.81 32.47 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.156 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.94 117.83 22.48 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.892 0.377 . . . . 0.0 111.326 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.489 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . . . -85.51 133.72 41.56 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.584 175.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 12' ' ' ALA . 13.6 Cg_exo -69.3 111.94 2.86 Favored 'Trans proline' 0 N--CA 1.464 -0.257 0 C-N-CA 122.815 2.343 . . . . 0.0 112.326 -178.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -106.83 18.53 21.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.458 177.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.1 m -74.92 100.64 4.17 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.741 -177.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.5 m -92.97 141.25 28.61 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.372 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 57.71 51.77 8.98 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 123.599 0.562 . . . . 0.0 111.231 178.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.856 ' HB3' ' HD3' ' A' ' 19' ' ' PRO . 22.8 ttt -78.8 -56.04 0.93 Allowed Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.496 176.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.856 ' HD3' ' HB3' ' A' ' 18' ' ' MET . 42.3 Cg_endo -97.96 112.01 0.09 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.877 2.385 . . . . 0.0 112.32 176.093 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 19' ' ' PRO . 4.7 Cg_exo -78.23 175.48 11.06 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.752 2.301 . . . . 0.0 111.662 176.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -65.83 114.7 5.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.495 177.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -86.4 151.34 23.63 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.872 -177.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.43 110.14 15.6 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.126 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 66.0 m -106.62 107.62 18.72 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 173.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.656 ' HB ' HG22 ' A' ' 109' ' ' ILE . 22.2 m -132.14 160.96 42.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.166 -177.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.511 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 12.8 m-70 -116.96 132.0 56.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.615 0.245 . . . . 0.0 110.777 -173.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.552 ' O ' ' HA ' ' A' ' 70' ' ' MET . 9.6 t -101.52 137.39 29.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.571 -176.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.511 ' CE2' HG11 ' A' ' 68' ' ' VAL . 1.7 t80 -102.05 105.0 15.67 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.253 -177.594 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.629 HD13 HD11 ' A' ' 87' ' ' ILE . 18.9 pt -132.4 125.83 19.93 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-O 121.288 0.566 . . . . 0.0 111.676 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.538 ' HA ' ' HA ' ' A' ' 68' ' ' VAL . 52.0 Cg_exo -55.85 148.27 57.41 Favored 'Trans proline' 0 C--O 1.239 0.553 0 C-N-CA 123.31 2.674 . . . . 0.0 112.504 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.745 ' HA ' HG12 ' A' ' 34' ' ' VAL . . . -57.83 -23.8 54.41 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.762 -1.108 . . . . 0.0 112.916 -171.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.673 ' HB2' ' HZ ' ' A' ' 96' ' ' PHE . 62.6 mm-40 -64.67 -21.74 66.81 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -175.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.622 ' HB2' ' HE2' ' A' ' 96' ' ' PHE . . . -121.86 -28.97 4.38 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.521 -175.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.745 HG12 ' HA ' ' A' ' 31' ' ' ALA . 14.3 p -57.28 -29.21 32.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-O 121.24 0.543 . . . . 0.0 110.166 -178.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 1.131 ' HA2' ' H41' ' B' ' 4' ' ' ' C' . . . -58.6 -55.32 31.42 Favored Glycine 0 N--CA 1.438 -1.216 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.627 176.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.44 ' HA ' " H5'" ' B' ' 3' ' ' ' A' . . . -73.45 -13.88 61.15 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 120.891 0.377 . . . . 0.0 110.585 -177.051 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.613 HG12 ' O ' ' A' ' 33' ' ' ALA . 7.8 mm -66.29 -37.38 79.56 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.149 175.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.722 HD12 ' C5 ' ' B' ' 4' ' ' ' C' . 19.6 mt -66.94 -43.9 88.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.628 174.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 83.78 -173.86 51.14 Favored Glycine 0 C--O 1.224 -0.525 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.957 174.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -47.83 91.07 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.509 0.723 . . . . 0.0 112.486 -177.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.602 ' HA ' " C5'" ' B' ' 4' ' ' ' C' . 12.6 ttpt 49.28 37.41 11.34 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.984 0.913 . . . . 0.0 111.544 -175.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.437 ' HA2' HG22 ' A' ' 45' ' ' ILE . . . 83.01 26.85 43.09 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.233 -0.984 . . . . 0.0 112.557 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -56.1 -71.57 0.09 Allowed 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -76.78 -20.6 56.25 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.208 0.448 . . . . 0.0 112.208 -173.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.437 HG22 ' HA2' ' A' ' 42' ' ' GLY . 10.3 tt -68.8 -37.07 76.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.904 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.419 ' HG2' ' O ' ' A' ' 42' ' ' GLY . 1.9 mmmp? -82.23 -22.42 35.89 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 121.939 -0.476 . . . . 0.0 110.679 177.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -69.96 -30.38 67.73 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 172.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.705 ' HA ' ' HE1' ' A' ' 51' ' ' PHE . 0.2 OUTLIER -51.38 -50.46 59.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.996 175.733 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.492 ' HA ' HD13 ' A' ' 56' ' ' ILE . 1.6 p -63.91 -23.26 67.28 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.231 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -74.38 -51.75 14.11 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.705 ' HE1' ' HA ' ' A' ' 48' ' ' LEU . 13.1 p90 -83.97 -22.71 31.35 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.512 -173.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -95.7 -16.53 21.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.85 0.357 . . . . 0.0 111.095 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 73.2 m 56.29 26.46 10.54 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.482 -178.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -106.64 171.55 7.3 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.824 -179.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.5 m -95.7 107.38 19.59 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 178.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.814 HG13 HG22 ' A' ' 73' ' ' ILE . 2.9 mp -108.02 121.31 60.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.782 -176.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -139.51 155.75 47.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.828 175.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.724 ' HB ' ' N6 ' ' B' ' 5' ' ' ' A' . 48.5 mm -99.92 129.56 50.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 173.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.745 ' HB2' HG23 ' A' ' 72' ' ' VAL . . . -81.74 119.08 74.51 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.137 -175.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 59' ' ' ALA . 7.4 Cg_exo -73.25 125.65 10.43 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 123.037 2.491 . . . . 0.0 112.055 176.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.443 ' HD3' ' HG3' ' A' ' 69' ' ' ARG . 72.3 Cg_endo -80.06 163.22 22.99 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.242 1.961 . . . . 0.0 111.658 176.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.418 ' H ' ' CD ' ' A' ' 62' ' ' GLU . 1.7 mp0 -59.48 -57.56 12.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.017 0.437 . . . . 0.0 110.247 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 34.5 p -118.38 146.77 40.33 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.97 -179.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -69.09 0.64 4.86 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.308 2.672 . . . . 0.0 112.663 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -89.01 13.92 11.79 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 121.111 0.482 . . . . 0.0 111.119 178.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 22.9 t -82.17 132.96 35.24 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 174.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -74.0 -16.37 61.07 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.542 0.687 . . . . 0.0 110.171 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.538 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 1.4 p -137.46 148.66 25.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.723 -174.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.443 ' HG3' ' HD3' ' A' ' 61' ' ' PRO . 19.8 ttm180 -126.1 144.35 50.77 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 177.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.552 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 42.0 mtp -98.58 149.45 22.74 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.429 -173.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 26' ' ' HIS . 90.9 t -105.98 137.92 33.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.828 174.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.745 HG23 ' HB2' ' A' ' 59' ' ' ALA . 58.6 t -111.57 109.36 28.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 178.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.814 HG22 HG13 ' A' ' 56' ' ' ILE . 2.0 pp -124.6 140.32 48.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.143 0.497 . . . . 0.0 111.31 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 90.1 m -131.28 113.92 14.39 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.132 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.65 162.75 36.14 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.37 -177.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.47 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 45.3 Cg_endo -68.42 140.44 48.13 Favored 'Trans proline' 0 CA--C 1.531 0.346 0 C-N-CA 122.698 2.265 . . . . 0.0 111.371 175.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 76' ' ' PRO . 80.4 Cg_exo -45.98 -36.37 15.73 Favored 'Trans proline' 0 N--CA 1.477 0.543 0 C-N-CA 124.746 3.631 . . . . 0.0 114.897 -172.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -72.37 -39.37 68.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.84 0.352 . . . . 0.0 110.813 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.56 ' HA ' ' HE2' ' A' ' 82' ' ' LYS . . . -75.44 -29.31 59.65 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.235 0.54 . . . . 0.0 110.186 176.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -64.72 -35.38 80.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.3 178.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -53.34 -51.0 63.84 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.14 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.56 ' HE2' ' HA ' ' A' ' 79' ' ' ALA . 47.2 pttt -72.71 -33.85 66.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.465 -177.449 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.466 ' HB1' HD11 ' A' ' 48' ' ' LEU . . . -67.14 -53.8 27.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.866 0.365 . . . . 0.0 111.097 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.453 ' O ' HG22 ' A' ' 87' ' ' ILE . 45.1 tt0 -65.82 -29.72 70.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.107 -178.12 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -53.85 -35.73 53.81 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.737 177.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -75.81 -40.06 55.7 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 120.855 0.36 . . . . 0.0 110.852 178.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.629 HD11 HD13 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -65.33 -38.5 82.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.052 -177.343 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.848 ' HA ' HD22 ' A' ' 91' ' ' LEU . 2.2 m-30 -69.62 -27.34 64.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.763 0.316 . . . . 0.0 111.166 173.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -57.81 -41.14 93.86 Favored Glycine 0 CA--C 1.52 0.402 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.567 177.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.595 ' HG3' ' O ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -65.29 -24.64 67.35 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.68 0.276 . . . . 0.0 111.038 179.171 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.848 HD22 ' HA ' ' A' ' 88' ' ' TYR . 1.6 mp -58.37 -50.57 73.2 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.443 0.639 . . . . 0.0 110.392 177.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.86 ' HE3' ' HB ' ' A' ' 103' ' ' VAL . 0.6 OUTLIER -73.67 -37.89 65.11 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.434 177.711 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.512 ' HB3' ' HA ' ' A' ' 90' ' ' LYS . 3.7 tp10 -58.74 -38.46 78.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.525 -177.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.491 ' CD ' ' H22' ' B' ' 1' ' ' ' G' . 5.1 mm-40 -96.74 8.81 43.43 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -176.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.457 ' OD1' ' HD3' ' A' ' 99' ' ' PRO . 52.0 m-80 54.98 34.61 22.77 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.911 175.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.673 ' HZ ' ' HB2' ' A' ' 32' ' ' GLN . 44.4 m-85 -70.61 -25.08 62.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.404 0.621 . . . . 0.0 109.555 174.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.586 ' HE1' ' HG ' ' A' ' 91' ' ' LEU . 24.1 m-85 -122.31 -44.72 2.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.668 179.228 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 135.47 146.37 5.29 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 114.902 -1.044 . . . . 0.0 111.057 -178.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.457 ' HD3' ' OD1' ' A' ' 95' ' ' ASN . 30.6 Cg_endo -65.08 -34.9 44.89 Favored 'Trans proline' 0 N--CA 1.464 -0.232 0 C-N-CA 122.682 2.254 . . . . 0.0 112.366 -178.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -108.12 1.99 22.66 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.207 0.527 . . . . 0.0 111.057 -178.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -88.01 156.53 19.26 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.964 -175.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -63.66 132.56 51.47 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.143 177.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.86 ' HB ' ' HE3' ' A' ' 92' ' ' LYS . 7.2 p -79.68 129.65 37.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.177 0.513 . . . . 0.0 110.227 174.418 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.565 ' HD2' ' HA2' ' A' ' 158' ' ' GLY . 21.1 mmmt -139.14 89.48 2.35 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 174.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.809 ' HG ' HD21 ' A' ' 91' ' ' LEU . 3.4 tm? -110.94 130.48 55.57 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.489 -169.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.446 ' HA ' HG13 ' A' ' 157' ' ' ILE . 6.8 tp10 -64.88 118.91 9.73 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.394 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.0 m -126.39 114.93 18.86 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 177.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 49.9 m170 -99.66 120.42 39.67 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.942 0.401 . . . . 0.0 110.792 -177.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.656 HG22 ' HB ' ' A' ' 25' ' ' VAL . 39.8 pt -110.22 149.38 13.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.063 176.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 13.7 mmt180 -96.76 119.48 35.32 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.336 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.66 HG12 HD21 ' A' ' 174' ' ' LEU . 16.8 m -111.79 152.23 44.01 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 177.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.848 ' HD2' ' HG ' ' A' ' 174' ' ' LEU . 32.4 Cg_exo -56.22 147.73 64.38 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.435 2.09 . . . . 0.0 111.043 176.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -50.11 -52.1 37.63 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -171.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 18.6 m -72.25 -25.4 61.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.795 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.5 -26.52 65.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.798 0.333 . . . . 0.0 110.881 -178.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.798 ' HB1' HG21 ' A' ' 140' ' ' VAL . . . -64.96 -28.84 69.79 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.967 178.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -81.43 -18.97 67.44 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.613 -0.804 . . . . 0.0 111.838 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.59 ' HD3' HG22 ' A' ' 177' ' ' VAL . 17.8 mtp85 -92.38 -19.53 21.99 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 122.733 -0.275 . . . . 0.0 111.23 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.63 HG12 ' O ' ' A' ' 116' ' ' ALA . 7.6 p -69.52 -29.16 40.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.066 0.46 . . . . 0.0 110.236 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.958 ' HA ' ' HB ' ' A' ' 127' ' ' VAL . 7.7 pt -86.5 -33.62 7.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.59 175.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 117.16 155.45 10.22 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.913 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -57.22 -34.49 68.61 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.009 0.433 . . . . 0.0 110.489 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -141.99 47.0 1.64 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.563 0.697 . . . . 0.0 109.485 174.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.454 ' O ' ' HB3' ' A' ' 125' ' ' LYS . . . 79.09 -155.01 39.87 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.019 -179.069 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.454 ' HB3' ' O ' ' A' ' 124' ' ' GLY . 1.2 tmtp? 73.68 -49.76 0.69 Allowed 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 176.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.403 ' N ' ' HD3' ' A' ' 125' ' ' LYS . 95.1 m -60.16 -46.07 90.95 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -175.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.958 ' HB ' ' HA ' ' A' ' 120' ' ' ILE . 7.1 p -64.62 -40.4 88.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.813 0.34 . . . . 0.0 111.322 -178.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -68.61 -33.96 74.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.258 0.551 . . . . 0.0 109.94 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -64.24 -41.71 96.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.864 175.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 127' ' ' VAL . 80.9 mt -59.45 -50.04 75.49 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.567 175.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -62.76 -40.55 97.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.292 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -68.03 -27.69 66.76 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.401 -177.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' A' ' 133' ' ' LEU . 1.9 tm? -93.18 -43.19 8.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.886 0.375 . . . . 0.0 110.961 -176.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 76.1 p -84.66 -20.47 31.22 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -175.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 67.04 20.64 10.37 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 123.724 0.64 . . . . 0.0 110.998 -178.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -118.43 157.46 27.15 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.167 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.57 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 36.4 tt0 -88.35 110.55 20.88 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 59.2 t -108.74 106.8 21.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.321 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.421 ' C ' HG23 ' A' ' 154' ' ' VAL . 6.7 p -132.28 120.74 44.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.38 0.61 . . . . 0.0 111.482 -178.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.798 HG21 ' HB1' ' A' ' 116' ' ' ALA . 2.6 p -99.82 113.16 64.95 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.01 177.112 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.54 ' HD2' ' O ' ' A' ' 153' ' ' ILE . 36.1 Cg_exo -60.78 125.64 17.74 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.439 2.092 . . . . 0.0 111.55 175.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -83.75 -15.22 49.34 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.26 0.553 . . . . 0.0 109.814 178.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -106.66 59.28 0.64 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.03 172.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.685 ' HG2' ' HB ' ' A' ' 152' ' ' VAL . 57.5 tp60 -100.52 171.75 7.54 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.147 -174.037 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.432 ' N ' ' HG3' ' A' ' 144' ' ' GLN . 31.7 p -45.21 153.82 0.52 Allowed Pre-proline 0 C--N 1.325 -0.499 0 C-N-CA 123.564 0.746 . . . . 0.0 112.346 174.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -54.61 153.85 22.3 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 123.398 2.732 . . . . 0.0 112.914 -176.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -78.33 9.34 3.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.544 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -53.05 -43.61 66.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.627 175.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ASN . . . . . 0.421 ' O ' ' HG2' ' A' ' 150' ' ' GLU . 0.2 OUTLIER -79.74 1.02 28.19 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.668 -175.149 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 149' ' ' ASN . 9.2 pt-20 46.42 29.06 0.81 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.074 0.95 . . . . 0.0 110.484 -171.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -164.5 130.39 2.88 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.17 -169.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.685 ' HB ' ' HG2' ' A' ' 144' ' ' GLN . 23.7 m -128.26 -176.55 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.899 -175.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.54 ' O ' ' HD2' ' A' ' 141' ' ' PRO . 49.2 mt -104.85 142.52 17.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.03 -174.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.421 HG23 ' C ' ' A' ' 139' ' ' VAL . 2.1 p -135.0 140.0 46.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.074 164.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.9 mttt -95.24 145.6 24.94 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.424 -172.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.57 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 70.6 mt -131.42 110.79 18.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.476 174.198 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.446 HG13 ' HA ' ' A' ' 106' ' ' GLU . 3.8 mp -120.32 118.44 56.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 178.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.565 ' HA2' ' HD2' ' A' ' 104' ' ' LYS . . . -170.87 -170.17 34.77 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.489 -0.863 . . . . 0.0 112.164 -174.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.551 ' HA ' ' O ' ' A' ' 103' ' ' VAL . 24.6 m170 -80.35 169.99 17.0 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.336 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -53.26 -45.89 69.01 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -174.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.465 ' O ' ' HG3' ' A' ' 165' ' ' MET . 36.3 p90 -73.88 -33.85 64.21 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.92 0.391 . . . . 0.0 110.762 178.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.79 -50.97 37.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.133 -174.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 26.5 m -58.1 -48.57 79.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.64 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.501 ' O ' ' HG2' ' A' ' 168' ' ' ARG . 65.7 mt-30 -61.74 -32.03 72.24 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.665 -178.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.465 ' HG3' ' O ' ' A' ' 161' ' ' TYR . 77.0 mtp -70.04 -48.54 57.54 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.382 175.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.43 -42.07 98.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.534 -177.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.55 HE21 HG21 ' A' ' 25' ' ' VAL . 39.0 mt-30 -51.4 -54.65 24.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.279 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.501 ' HG2' ' O ' ' A' ' 164' ' ' GLN . 19.4 ptt180 -75.7 -30.81 59.43 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.278 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.895 ' HA ' ' HE3' ' A' ' 169' ' ' LYS . 0.1 OUTLIER -70.85 -36.79 73.03 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 122.195 -0.316 . . . . 0.0 111.292 -177.342 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.649 ' O ' HD13 ' A' ' 174' ' ' LEU . 1.8 mp -75.29 -43.04 43.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 174.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.616 ' HA ' HD22 ' A' ' 174' ' ' LEU . 10.7 mmm180 -54.85 -25.74 30.67 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.994 0.426 . . . . 0.0 110.883 175.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.481 ' HB3' ' O ' ' A' ' 169' ' ' LYS . 6.7 t70 -63.13 -55.66 23.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.415 -0.812 . . . . 0.0 111.11 178.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.529 ' O ' HG23 ' A' ' 177' ' ' VAL . 37.8 pt -67.31 -21.95 28.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.882 -176.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.848 ' HG ' ' HD2' ' A' ' 112' ' ' PRO . 6.7 mp -57.18 -41.69 79.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.825 176.035 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.471 ' O ' ' HG2' ' A' ' 179' ' ' GLN . . . -68.16 -35.59 78.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.321 178.205 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -67.56 -32.58 73.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.457 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.59 HG22 ' HD3' ' A' ' 118' ' ' ARG . 60.0 t -72.86 -38.21 56.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.881 0.372 . . . . 0.0 110.535 178.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -69.17 -11.14 60.54 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.298 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 175' ' ' ALA . 33.1 mm-40 -68.29 -11.84 60.07 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.143 178.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -57.07 -22.64 40.84 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.829 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -84.71 -24.52 28.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.923 0.392 . . . . 0.0 110.709 -178.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -85.94 -49.93 7.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.927 177.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 52.6 tttm -147.55 131.73 17.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.884 178.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -153.97 164.9 31.5 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.624 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -85.52 60.78 6.45 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.183 0.516 . . . . 0.0 109.788 178.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 4.5 m -66.07 -65.43 0.68 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.065 -175.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -153.98 129.57 2.68 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.213 -177.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -119.14 39.14 3.63 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.449 0.643 . . . . 0.0 110.353 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 86.8 mt -80.99 6.53 13.13 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.588 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -82.76 60.76 5.48 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.178 -178.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.522 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.59 -178.611 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' ' G' . . . . . 1.011 " O2'" ' H6 ' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.425 -0.915 0 C4'-C3'-C2' 105.995 3.295 OUTLIER-EPSILON 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . 1.011 ' H6 ' " O2'" ' B' ' 1' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.426 -0.848 0 P-O3'-C3' 122.393 2.244 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . 0.684 " H1'" ' C5 ' ' B' ' 4' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.422 -1.136 0 O4'-C1'-C2' 103.065 -2.382 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 4' ' ' ' C' . . . . . 1.131 ' H41' ' HA2' ' A' ' 35' ' ' GLY . . . . . . . . 0 O5'--C5' 1.43 -0.643 0 C4'-C3'-C2' 105.753 3.053 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.815 " O5'" " H4'" ' B' ' 4' ' ' ' C' . . . . . . . . 0 P--O3' 1.614 0.608 0 P-O3'-C3' 122.158 2.049 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 6' ' ' ' C' . . . . . 0.554 ' H6 ' " O5'" ' B' ' 6' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.431 -0.568 0 C4'-C3'-C2' 105.232 2.532 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.849 0 C4'-C3'-C2' 105.27 2.57 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.878 0 C3'-C2'-C1' 100.127 -1.526 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.768 0 N-CA-C 111.78 -0.528 . . . . 0.0 111.78 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.72 -36.53 0.43 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.972 0.415 . . . . 0.0 110.776 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 49.0 tpp -93.27 117.85 30.57 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.253 -177.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 85.74 -133.71 12.01 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.621 172.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.56 73.84 5.02 Favored 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 123.137 2.558 . . . . 0.0 113.36 -174.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.2 t -112.35 -51.96 2.81 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.005 174.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 35.4 m -111.51 42.17 1.75 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.167 0.508 . . . . 0.0 110.906 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.4 m -95.24 -3.92 10.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.198 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.5 m -94.76 -2.83 50.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.847 -177.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.57 127.7 9.3 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.942 -0.647 . . . . 0.0 111.589 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -84.83 65.2 9.03 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.173 0.511 . . . . 0.0 110.563 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.72 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . . . -131.98 -56.4 0.03 OUTLIER Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.199 178.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.72 ' HD3' ' HB3' ' A' ' 12' ' ' ALA . 9.2 Cg_exo -72.83 -38.57 2.95 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 122.077 1.851 . . . . 0.0 112.287 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -114.57 167.49 10.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.939 -176.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 48.8 m -148.38 117.16 6.68 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.151 0.5 . . . . 0.0 110.712 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.2 m -93.88 64.16 3.38 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -103.77 -14.62 16.0 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.255 -169.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 48.6 ttm -127.6 76.56 76.88 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -173.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.631 ' HD2' ' HD3' ' A' ' 20' ' ' PRO . 23.0 Cg_exo -65.78 -55.26 0.44 Allowed 'Trans proline' 0 CA--C 1.549 1.257 0 C-N-CA 122.781 2.321 . . . . 0.0 114.632 174.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.631 ' HD3' ' HD2' ' A' ' 19' ' ' PRO . 1.5 Cg_endo -82.47 61.1 7.54 Favored 'Trans proline' 0 C--N 1.361 1.22 0 C-N-CA 122.513 2.142 . . . . 0.0 113.633 -170.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -105.68 -18.98 13.9 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.534 0.683 . . . . 0.0 109.449 172.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -101.99 143.5 31.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.027 -176.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.68 ' OE1' ' HG3' ' A' ' 171' ' ' ARG . 58.4 mt-10 -102.44 132.14 48.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.585 176.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.8 m -100.82 106.73 18.14 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 172.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.717 HG13 HG22 ' A' ' 109' ' ' ILE . 4.6 t -136.08 146.61 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.07 -174.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.456 ' HB2' ' O ' ' A' ' 108' ' ' HIS . 11.5 m170 -104.19 128.58 51.91 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-O 120.932 0.396 . . . . 0.0 110.483 -176.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.5 ' HB ' ' CG1' ' A' ' 71' ' ' VAL . 2.3 t -108.7 142.4 21.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -99.13 112.77 24.83 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -174.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.595 HG22 HD21 ' A' ' 91' ' ' LEU . 6.5 pt -126.81 120.11 22.78 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.846 176.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.619 ' HA ' ' HA ' ' A' ' 68' ' ' VAL . 68.6 Cg_exo -51.46 144.56 31.6 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.395 2.73 . . . . 0.0 112.58 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.711 ' HA ' HG12 ' A' ' 34' ' ' VAL . . . -59.85 -22.94 62.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.974 -1.012 . . . . 0.0 112.218 -173.11 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -84.2 0.3 49.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.38 -178.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.892 ' HB2' ' HE2' ' A' ' 96' ' ' PHE . . . -125.07 -32.75 2.97 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.594 174.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.711 HG12 ' HA ' ' A' ' 31' ' ' ALA . 11.2 p -57.01 -26.99 25.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-O 121.206 0.527 . . . . 0.0 110.075 -178.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 1.11 ' HA2' ' H41' ' B' ' 4' ' ' ' C' . . . -57.58 -56.95 22.32 Favored Glycine 0 N--CA 1.431 -1.649 0 CA-C-N 115.344 -0.843 . . . . 0.0 111.566 176.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.468 ' HB2' " C1'" ' B' ' 2' ' ' ' C' . . . -78.34 -13.53 59.8 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.826 0.346 . . . . 0.0 111.227 -174.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.661 HD12 ' HG2' ' A' ' 90' ' ' LYS . 3.3 mm -66.35 -39.47 84.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 176.165 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.782 HD12 ' C5 ' ' B' ' 4' ' ' ' C' . 32.5 mt -64.37 -44.78 97.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 172.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 70.6 104.45 0.04 OUTLIER Glycine 0 CA--C 1.519 0.309 0 N-CA-C 115.706 1.042 . . . . 0.0 115.706 163.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 66.7 mttm 40.54 98.39 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.598 1.159 . . . . 0.0 113.707 167.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.686 ' HE2' ' HB3' ' A' ' 43' ' ' GLN . 24.6 ttpt 76.13 -23.21 0.25 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.209 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.711 ' HA2' HG22 ' A' ' 38' ' ' ILE . . . 92.31 23.06 27.82 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.977 -178.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.686 ' HB3' ' HE2' ' A' ' 41' ' ' LYS . 19.2 pt20 -87.95 -24.71 23.5 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.15 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -66.11 -44.53 84.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.783 0.325 . . . . 0.0 110.775 -178.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.574 ' CD1' HG12 ' A' ' 58' ' ' ILE . 3.0 tt -61.75 -49.06 85.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.242 -177.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -77.55 -21.36 52.67 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.849 0.356 . . . . 0.0 111.033 -175.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -68.43 -36.67 79.4 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 172.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.958 HD23 HG12 ' A' ' 56' ' ' ILE . 1.2 tp -56.73 -40.69 76.15 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.209 177.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.69 ' HA ' HD13 ' A' ' 56' ' ' ILE . 2.1 m -56.85 -38.46 72.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.984 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -70.7 -51.27 28.67 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -175.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.658 ' CZ ' ' HA ' ' A' ' 48' ' ' LEU . 10.6 p90 -79.14 -6.88 57.55 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 120.274 -0.57 . . . . 0.0 111.553 -176.024 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -97.55 -13.12 21.83 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.863 0.363 . . . . 0.0 110.703 173.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.7 m 56.62 39.61 29.72 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.054 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.441 ' HB1' ' O ' ' A' ' 74' ' ' THR . . . -141.28 174.62 10.36 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.469 -174.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.616 ' HB3' ' HB ' ' A' ' 74' ' ' THR . 32.3 t -92.78 104.34 16.61 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.958 HG12 HD23 ' A' ' 48' ' ' LEU . 1.9 mp -110.97 115.52 50.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.778 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -143.49 151.36 40.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.938 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.644 ' HB ' ' C6 ' ' B' ' 5' ' ' ' A' . 25.1 mm -86.88 134.64 27.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.719 0.295 . . . . 0.0 110.347 178.087 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.73 ' HB2' HG23 ' A' ' 72' ' ' VAL . . . -95.27 116.77 66.62 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.397 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -62.37 128.61 24.22 Favored 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 122.698 2.265 . . . . 0.0 112.053 178.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.73 ' HD3' ' HG3' ' A' ' 69' ' ' ARG . 57.2 Cg_endo -70.71 157.41 58.6 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 122.449 2.099 . . . . 0.0 111.635 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -64.77 -32.86 74.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.857 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.435 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 11.7 p -131.31 135.68 27.48 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.232 177.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 63' ' ' THR . 20.4 Cg_exo -66.55 -10.16 26.86 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.18 2.587 . . . . 0.0 112.816 -178.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -91.98 -1.64 57.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.056 0.455 . . . . 0.0 110.917 178.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.2 t -56.31 132.75 51.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.257 0.551 . . . . 0.0 110.908 -178.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -71.42 -21.52 61.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.747 -178.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.619 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 2.0 p -134.16 147.15 30.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.192 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.73 ' HG3' ' HD3' ' A' ' 61' ' ' PRO . 27.2 ttm180 -119.18 145.87 45.64 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.617 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 55.3 mtt -87.6 149.07 24.55 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.817 0.342 . . . . 0.0 110.321 -178.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.5 ' CG1' ' HB ' ' A' ' 27' ' ' VAL . 2.8 p -118.5 131.97 69.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 169.013 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.73 HG23 ' HB2' ' A' ' 59' ' ' ALA . 58.3 t -86.81 102.62 12.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.096 0.474 . . . . 0.0 109.977 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.457 ' HA ' HD13 ' A' ' 73' ' ' ILE . 1.9 mm -94.97 117.63 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.987 175.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.661 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 25.0 m -130.02 106.26 8.52 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.656 175.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.13 162.0 35.31 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.748 -176.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -69.51 155.41 66.83 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.356 2.038 . . . . 0.0 111.144 171.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -38.92 -42.92 2.11 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 124.041 3.161 . . . . 0.0 114.231 -177.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.47 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 30.4 tt0 -55.99 -50.3 71.24 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.149 0.5 . . . . 0.0 110.561 176.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.434 ' HA ' ' CE ' ' A' ' 82' ' ' LYS . . . -63.54 -36.68 84.57 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.689 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -55.96 -35.58 66.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.942 177.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -69.7 -55.66 9.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.767 -174.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.47 ' HD3' ' O ' ' A' ' 78' ' ' GLU . 0.4 OUTLIER -74.62 -34.16 62.74 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 120.119 -0.632 . . . . 0.0 111.879 -176.36 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.31 -52.59 64.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.93 0.395 . . . . 0.0 110.617 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.474 ' HA ' HG22 ' A' ' 87' ' ' ILE . 47.6 mt-30 -76.38 -31.25 57.9 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.216 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.401 ' HA2' ' CE1' ' A' ' 160' ' ' PHE . . . -53.95 -43.65 71.84 Favored Glycine 0 CA--C 1.512 -0.153 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.02 177.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' A' ' 82' ' ' LYS . 12.6 mmt180 -74.84 -43.04 56.73 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.989 0.423 . . . . 0.0 110.076 176.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.903 ' HA ' ' HD3' ' A' ' 90' ' ' LYS . 0.4 OUTLIER -63.8 -35.79 74.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.994 -171.189 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -64.48 -30.51 71.55 Favored 'General case' 0 C--N 1.333 -0.114 0 O-C-N 121.866 -0.522 . . . . 0.0 109.688 176.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -65.0 -29.03 74.31 Favored Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.666 173.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.903 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 4.3 mptp? -68.84 -33.36 73.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.148 0.499 . . . . 0.0 110.103 175.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.735 ' HG ' ' HG ' ' A' ' 105' ' ' LEU . 4.1 mm? -64.55 -40.24 95.21 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.523 172.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.878 ' HE3' ' HB ' ' A' ' 103' ' ' VAL . 0.1 OUTLIER -71.71 -22.0 61.7 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.564 176.659 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -53.52 -47.27 70.06 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.302 178.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -112.81 3.79 16.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.902 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 43.09 59.99 2.7 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 172.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.892 ' HE2' ' HB2' ' A' ' 33' ' ' ALA . 82.8 m-85 -72.55 -46.93 52.09 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.955 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.678 ' CZ ' ' HE2' ' A' ' 92' ' ' LYS . 19.1 p90 -64.5 -26.46 68.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.495 -178.287 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 150.8 154.29 6.45 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 121.164 -0.541 . . . . 0.0 111.918 -178.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -65.07 -64.96 0.05 OUTLIER 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 122.983 2.456 . . . . 0.0 112.896 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -90.85 -10.0 44.29 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.967 0.413 . . . . 0.0 110.737 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -58.77 135.67 57.53 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.906 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.467 ' O ' ' HG2' ' A' ' 104' ' ' LYS . 6.7 mm-40 -61.13 137.56 58.23 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.296 173.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.878 ' HB ' ' HE3' ' A' ' 92' ' ' LYS . 14.9 p -52.39 125.37 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 CA-C-O 121.576 0.703 . . . . 0.0 111.258 -173.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 47.1 mmtm -120.13 91.16 3.47 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.563 -1.198 . . . . 0.0 108.755 178.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.735 ' HG ' ' HG ' ' A' ' 91' ' ' LEU . 1.5 tt -108.27 124.9 51.01 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.658 -173.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -74.5 120.93 20.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.627 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.4 m -107.33 108.47 19.86 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 173.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.456 ' O ' ' HB2' ' A' ' 26' ' ' HIS . 12.1 m-70 -104.01 121.07 42.39 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.159 0.504 . . . . 0.0 109.921 -177.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.717 HG22 HG13 ' A' ' 25' ' ' VAL . 23.0 pt -122.88 152.22 27.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 C-N-CA 120.534 -0.466 . . . . 0.0 112.138 -173.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.713 ' HD3' HG12 ' A' ' 153' ' ' ILE . 1.7 mmt180 -100.05 116.83 32.99 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.435 174.315 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 151' ' ' GLN . 31.2 m -104.93 162.31 20.15 Favored Pre-proline 0 C--N 1.316 -0.858 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 173.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.421 ' HD2' HD22 ' A' ' 174' ' ' LEU . 51.7 Cg_exo -51.83 139.69 49.25 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 121.442 1.428 . . . . 0.0 109.856 170.244 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -55.18 -30.5 60.03 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.492 -170.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.5 m -93.02 -15.64 25.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.75 0.31 . . . . 0.0 111.439 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.62 -24.72 61.93 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.913 -172.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.546 ' O ' HG12 ' A' ' 119' ' ' VAL . . . -57.99 -28.84 64.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.145 0.498 . . . . 0.0 110.787 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.92 -27.76 73.52 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.997 -0.62 . . . . 0.0 113.014 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.616 ' HD2' ' OE1' ' A' ' 180' ' ' GLN . 69.3 mtp180 -92.12 -22.79 19.69 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 122.385 -0.479 . . . . 0.0 111.488 -178.015 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.546 HG12 ' O ' ' A' ' 116' ' ' ALA . 9.8 p -73.31 -27.98 24.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 174.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.943 ' HA ' ' HB ' ' A' ' 127' ' ' VAL . 67.7 mt -78.56 -39.44 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 CA-C-O 121.708 0.766 . . . . 0.0 109.339 171.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.589 ' HA3' ' HB ' ' A' ' 126' ' ' THR . . . 96.44 38.77 4.4 Favored Glycine 0 N--CA 1.442 -0.933 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.312 175.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 66.6 -79.08 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 122.948 0.499 . . . . 0.0 111.296 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -83.92 -24.36 30.77 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.043 0.449 . . . . 0.0 110.238 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.401 ' HA2' HG22 ' A' ' 120' ' ' ILE . . . 121.56 -1.2 11.25 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.499 -0.857 . . . . 0.0 112.47 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 41.3 tptt -57.87 -45.02 86.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.103 0.477 . . . . 0.0 110.621 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.589 ' HB ' ' HA3' ' A' ' 121' ' ' GLY . 84.2 m -65.2 -46.93 78.72 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.306 -176.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.943 ' HB ' ' HA ' ' A' ' 120' ' ' ILE . 11.6 p -67.83 -35.84 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 121.029 -0.268 . . . . 0.0 111.219 -176.54 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -65.26 -43.57 90.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.2 0.524 . . . . 0.0 109.989 178.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -68.49 -35.68 77.87 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.102 177.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.69 HD21 HD11 ' A' ' 170' ' ' ILE . 39.4 tp -60.74 -49.53 77.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.817 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -66.65 -32.37 73.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.777 0.322 . . . . 0.0 111.129 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -64.05 -43.6 95.04 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.996 0.427 . . . . 0.0 110.703 175.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 6.7 tt -73.88 -48.11 33.3 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.805 -177.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.671 ' HB ' ' HB2' ' A' ' 166' ' ' ALA . 70.5 p -77.65 -29.98 51.9 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -172.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 65.03 28.17 12.48 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.601 -175.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -121.02 169.37 10.56 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.441 177.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 9.0 tp10 -96.18 111.86 23.78 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.835 -178.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 45.3 t -113.63 107.33 22.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 O-C-N 123.82 0.7 . . . . 0.0 109.391 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.693 HG13 ' HD3' ' A' ' 155' ' ' LYS . 14.9 p -125.87 126.9 70.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.231 0.539 . . . . 0.0 111.63 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.443 HG22 ' HB ' ' A' ' 154' ' ' VAL . 59.9 t -104.94 112.95 65.26 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.906 176.214 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.638 ' HG3' ' HE3' ' A' ' 155' ' ' LYS . 34.6 Cg_exo -62.01 156.98 46.32 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 123.1 2.533 . . . . 0.0 112.325 177.338 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -87.4 -26.1 23.48 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.076 -178.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -120.2 115.97 24.68 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.133 178.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.53 ' OE1' ' HB ' ' A' ' 153' ' ' ILE . 22.4 mm-40 -127.77 -86.9 0.57 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.012 0.434 . . . . 0.0 112.034 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -152.77 154.65 31.65 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.299 -175.185 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.76 165.17 26.59 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.731 2.288 . . . . 0.0 111.2 175.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -69.98 -3.96 18.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.96 -177.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -53.84 -42.57 68.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.277 0.56 . . . . 0.0 110.239 169.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -84.21 -14.12 50.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.832 -179.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 47.27 23.46 0.33 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.024 1.33 . . . . 0.0 112.058 -175.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.467 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 57.8 mt-30 -143.27 142.26 31.3 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 120.994 0.426 . . . . 0.0 111.16 -175.153 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 19.7 m -131.93 163.46 37.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 174.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.713 HG12 ' HD3' ' A' ' 110' ' ' ARG . 12.8 mt -107.39 141.71 21.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.365 0.602 . . . . 0.0 112.393 -176.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.443 ' HB ' HG22 ' A' ' 140' ' ' VAL . 2.5 p -128.49 139.44 51.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.379 163.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.693 ' HD3' HG13 ' A' ' 139' ' ' VAL . 0.0 OUTLIER -99.44 137.76 37.48 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -176.27 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.447 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 65.1 mt -113.5 111.18 34.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 169.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 4.7 mp -113.69 140.84 31.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 156.28 -168.52 33.62 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.113 -1.041 . . . . 0.0 112.636 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.402 ' HA ' ' O ' ' A' ' 103' ' ' VAL . 44.6 t60 -75.55 160.85 29.7 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.602 -0.299 . . . . 0.0 110.374 -178.111 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.535 ' O ' ' HG2' ' A' ' 164' ' ' GLN . 30.4 t80 -49.39 -50.0 42.28 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -172.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -71.47 -47.44 55.63 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.194 -177.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -59.27 -44.62 92.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.911 0.386 . . . . 0.0 110.845 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.659 ' O ' ' HG3' ' A' ' 167' ' ' GLN . 31.9 t -63.79 -52.1 61.79 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.173 -177.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.535 ' HG2' ' O ' ' A' ' 160' ' ' PHE . 10.5 pt20 -66.96 -35.21 79.46 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.406 -177.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 47.1 ttp -64.85 -36.72 85.27 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.068 0.461 . . . . 0.0 109.912 177.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.671 ' HB2' ' HB ' ' A' ' 134' ' ' THR . . . -69.47 -43.11 73.88 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.241 174.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.68 ' O ' ' HG2' ' A' ' 171' ' ' ARG . 80.7 mt-30 -51.47 -56.71 11.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.341 -176.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.401 ' HG3' ' N ' ' A' ' 169' ' ' LYS . 0.1 OUTLIER -58.4 -29.78 66.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.036 -179.102 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.803 ' HA ' ' HE2' ' A' ' 169' ' ' LYS . 0.6 OUTLIER -75.17 -36.39 61.5 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 120.862 0.363 . . . . 0.0 110.399 -172.903 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.69 HD11 HD21 ' A' ' 130' ' ' LEU . 1.8 mp -74.61 -42.46 48.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.469 178.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.68 ' HG3' ' OE1' ' A' ' 23' ' ' GLU . 0.8 OUTLIER -64.25 -25.62 68.14 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.391 0.615 . . . . 0.0 109.419 179.284 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -73.06 -44.24 60.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.583 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.551 HG13 ' O ' ' A' ' 170' ' ' ILE . 2.8 pp -70.95 -19.22 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.904 -178.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 170' ' ' ILE . 39.3 mt -58.82 -34.82 71.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.035 0.445 . . . . 0.0 110.365 174.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.17 -34.53 78.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.767 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -66.44 -39.06 88.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.22 0.533 . . . . 0.0 109.973 176.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.609 HG22 ' HD3' ' A' ' 118' ' ' ARG . 39.6 t -63.53 -38.96 83.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.229 176.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -63.58 -44.49 93.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.271 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -70.42 -29.17 65.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.197 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 0.616 ' OE1' ' HD2' ' A' ' 118' ' ' ARG . 49.6 tt0 -73.42 -37.22 65.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.087 0.47 . . . . 0.0 110.18 173.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -63.11 -20.84 65.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.143 -178.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -50.87 -41.12 57.86 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.183 173.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt 49.96 77.29 0.12 Allowed 'General case' 0 N--CA 1.465 0.284 0 O-C-N 124.003 0.814 . . . . 0.0 112.145 169.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 142.09 88.02 0.11 Allowed Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.656 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 56.05 55.12 7.15 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -176.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 19.3 m -56.11 106.4 0.27 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.044 -176.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 137.02 -36.52 1.96 Allowed Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.348 -177.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 56.88 -150.72 0.43 Allowed 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 122.59 0.356 . . . . 0.0 111.472 177.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 31.7 tp 62.47 69.5 0.61 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.394 0.616 . . . . 0.0 110.86 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -83.56 67.32 9.36 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.685 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.467 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.754 179.03 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' ' G' . . . . . 0.904 " O2'" ' H6 ' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.427 -0.834 0 C4'-C3'-C2' 106.304 3.604 OUTLIER-EPSILON 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . 0.904 ' H6 ' " O2'" ' B' ' 1' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.422 -1.113 0 P-O3'-C3' 122.133 2.028 OUTLIER-EPSILON 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . 0.741 " H1'" ' C5 ' ' B' ' 4' ' ' ' C' . . . . . . . . 0 C2'--C1' 1.518 -0.999 0 P-O3'-C3' 124.269 3.807 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 4' ' ' ' C' . . . . . 1.11 ' H41' ' HA2' ' A' ' 35' ' ' GLY . . . . . . . . 0 O5'--C5' 1.426 -0.875 0 C4'-C3'-C2' 105.728 3.028 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.875 " O4'" " H4'" ' B' ' 4' ' ' ' C' . . . . . . . . 0 P--O3' 1.616 0.711 0 P-O3'-C3' 121.924 1.853 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 6' ' ' ' C' . . . . . 0.479 ' C5 ' ' C4 ' ' B' ' 7' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.429 -0.674 0 C4'-C3'-C2' 104.859 2.159 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . 0.479 ' C4 ' ' C5 ' ' B' ' 6' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.426 -0.853 0 C3'-C2'-C1' 103.212 1.903 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.847 0 C3'-C2'-C1' 100.7 -0.889 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.73 0 N-CA-C 112.191 -0.364 . . . . 0.0 112.191 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.56 86.89 5.17 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.948 0.404 . . . . 0.0 110.212 178.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 61.5 mtm -115.79 92.17 3.82 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.568 -176.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.42 ' HA2' ' HD3' ' A' ' 5' ' ' PRO . . . 161.19 146.61 4.69 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.093 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.42 ' HD3' ' HA2' ' A' ' 4' ' ' GLY . 40.4 Cg_exo -57.59 115.42 2.5 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.972 2.448 . . . . 0.0 112.041 179.204 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 53.6 m 60.04 21.21 10.36 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.592 -179.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 43.7 m -96.87 61.39 1.82 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.959 0.409 . . . . 0.0 110.685 -177.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.8 m -70.56 123.66 25.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.368 0.604 . . . . 0.0 111.073 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.5 p -89.31 43.63 1.16 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.506 -176.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 171.69 80.36 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.532 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -91.59 55.88 2.86 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.246 0.546 . . . . 0.0 110.167 177.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.571 ' HB1' ' HD2' ' A' ' 14' ' ' PHE . . . -104.59 114.53 63.95 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.166 -176.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -89.81 31.25 0.38 Allowed 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.974 2.449 . . . . 0.0 112.367 178.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.646 ' HB3' ' HG2' ' A' ' 18' ' ' MET . 88.3 m-85 -92.03 92.93 8.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.811 -177.016 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 58.0 m -101.98 114.65 28.95 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.342 177.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.1 t 73.11 -56.35 0.66 Allowed 'General case' 0 N--CA 1.465 0.324 0 O-C-N 123.959 0.787 . . . . 0.0 110.991 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -95.39 119.89 34.69 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 177.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.906 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 55.5 mtt -117.79 -60.23 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.114 178.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.906 ' HD3' ' HB2' ' A' ' 18' ' ' MET . 42.4 Cg_exo -57.93 -51.73 7.34 Favored 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 122.203 1.935 . . . . 0.0 114.037 176.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.406 ' HD3' ' HB2' ' A' ' 19' ' ' PRO . 6.3 Cg_exo -73.87 75.23 3.21 Favored 'Trans proline' 0 C--N 1.36 1.141 0 C-N-CA 122.162 1.908 . . . . 0.0 112.723 -177.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.45 ' HG2' ' HE1' ' A' ' 14' ' ' PHE . 47.1 mt-10 -75.09 85.23 2.34 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.472 176.08 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.409 ' OE1' ' HA ' ' A' ' 22' ' ' GLN . 14.5 mm-40 -72.16 152.33 42.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.223 177.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -98.1 117.74 33.14 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.183 -178.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 48.3 m -110.57 107.72 17.43 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.82 176.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.528 ' HB ' HD11 ' A' ' 73' ' ' ILE . 34.8 t -117.9 147.87 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.438 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 7.3 m80 -110.04 123.36 49.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.862 0.363 . . . . 0.0 110.71 -173.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.585 ' HB ' ' HB ' ' A' ' 71' ' ' VAL . 44.4 t -90.36 142.03 13.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.59 -176.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.24 105.16 14.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.469 -177.342 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.555 ' C ' ' HB ' ' A' ' 68' ' ' VAL . 13.9 pt -127.9 123.47 22.81 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 120.938 0.399 . . . . 0.0 110.929 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -48.53 143.53 15.75 Favored 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 123.531 2.821 . . . . 0.0 112.638 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.466 ' HA ' HG12 ' A' ' 34' ' ' VAL . . . -58.08 -18.79 27.14 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.101 -176.38 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.5 mp0 -65.25 -44.28 88.64 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.401 177.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.746 ' HB2' ' HE2' ' A' ' 96' ' ' PHE . . . -93.71 -29.64 15.3 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.196 -171.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.611 ' HA ' HG12 ' A' ' 37' ' ' ILE . 12.2 p -56.92 -27.64 26.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 O-C-N 123.253 0.346 . . . . 0.0 111.201 -174.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.934 ' HA2' ' H41' ' B' ' 4' ' ' ' C' . . . -56.83 -56.82 22.84 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.235 -0.983 . . . . 0.0 111.076 177.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.431 ' HB2' " C1'" ' B' ' 2' ' ' ' C' . . . -75.95 -15.71 60.13 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.607 -176.178 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.703 HD12 ' HB3' ' A' ' 90' ' ' LYS . 4.8 mm -61.66 -47.16 94.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.242 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.871 HG22 ' HA2' ' A' ' 42' ' ' GLY . 28.9 mt -63.64 -38.61 82.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.203 177.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.416 ' HA3' ' CD2' ' A' ' 44' ' ' HIS . . . 81.83 105.34 0.39 Allowed Glycine 0 CA--C 1.52 0.397 0 N-CA-C 115.554 0.982 . . . . 0.0 115.554 164.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.682 ' HA ' ' OP2' ' B' ' 3' ' ' ' A' . 30.0 mmtp 63.64 -81.29 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 168.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.8 ptmt -123.02 10.12 9.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.931 0.396 . . . . 0.0 110.932 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.871 ' HA2' HG22 ' A' ' 38' ' ' ILE . . . 83.34 16.19 69.67 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.408 -0.901 . . . . 0.0 111.786 -177.28 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -76.4 -28.6 56.77 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.096 0.474 . . . . 0.0 110.048 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.463 ' HB2' ' O ' ' A' ' 38' ' ' ILE . 1.7 m-70 -67.04 -30.67 70.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.699 -173.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.793 HD12 HG12 ' A' ' 58' ' ' ILE . 8.9 tt -76.12 -40.33 36.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -175.166 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.41 ' HD2' " H5'" ' B' ' 6' ' ' ' C' . 0.0 OUTLIER -79.64 -30.98 41.48 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.124 179.857 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.469 ' OE1' ' HD2' ' A' ' 50' ' ' ARG . 6.3 tp60 -64.48 -33.84 76.83 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 173.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.835 HD12 HG12 ' A' ' 56' ' ' ILE . 0.5 OUTLIER -58.73 -47.14 85.65 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.987 176.407 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.636 ' HA ' HD13 ' A' ' 56' ' ' ILE . 57.1 m -58.26 -31.89 67.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.046 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.469 ' HD2' ' OE1' ' A' ' 47' ' ' GLN . 99.6 mtt180 -73.64 -33.66 64.62 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.584 -178.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.735 ' CD2' ' HA ' ' A' ' 48' ' ' LEU . 24.2 m-85 -62.21 -48.12 81.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.108 0.48 . . . . 0.0 110.761 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.419 ' HB1' ' HB1' ' A' ' 79' ' ' ALA . . . -94.42 -10.58 32.05 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.362 -172.108 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 75.6 m 60.39 40.22 17.66 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.479 0.657 . . . . 0.0 110.259 -173.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -130.7 174.3 10.07 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.533 -178.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.2 t -95.44 107.01 19.14 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.777 0.322 . . . . 0.0 110.262 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.835 HG12 HD12 ' A' ' 48' ' ' LEU . 2.0 mp -110.12 113.1 43.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.032 179.05 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.445 ' HA ' HD11 ' A' ' 45' ' ' ILE . 53.2 mtmt -138.14 153.31 49.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.291 -179.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.793 HG12 HD12 ' A' ' 45' ' ' ILE . 44.9 mm -90.44 127.32 43.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.924 0.392 . . . . 0.0 110.25 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.925 ' HB2' HG23 ' A' ' 72' ' ' VAL . . . -92.41 115.8 65.39 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.759 -178.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -67.87 131.18 23.41 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.538 2.159 . . . . 0.0 111.371 176.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.446 ' HD3' ' HD3' ' A' ' 69' ' ' ARG . 18.6 Cg_endo -60.09 138.0 79.04 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.54 2.16 . . . . 0.0 110.814 176.202 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -62.9 -37.73 88.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.084 -176.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.464 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 4.1 p -119.25 136.76 24.66 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.149 175.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 63' ' ' THR . 13.7 Cg_exo -70.18 1.59 4.57 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.722 2.948 . . . . 0.0 113.649 -174.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -99.71 13.24 34.3 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.184 0.516 . . . . 0.0 110.685 -178.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.7 m -78.48 147.18 34.02 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.283 0.563 . . . . 0.0 110.756 178.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -79.48 -32.08 42.48 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.505 -175.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.555 ' HB ' ' C ' ' A' ' 29' ' ' ILE . 1.3 m -123.35 174.79 7.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 121.191 0.52 . . . . 0.0 110.947 -174.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.574 ' HB3' HG21 ' A' ' 34' ' ' VAL . 2.0 tpp85 -118.19 132.54 56.32 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 174.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.499 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 56.1 mtm -91.14 149.5 21.77 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.891 -175.5 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.585 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 94.3 t -113.17 132.2 62.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 175.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.925 HG23 ' HB2' ' A' ' 59' ' ' ALA . 77.6 t -99.92 111.83 30.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 177.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.816 HG22 HG13 ' A' ' 56' ' ' ILE . 2.5 pp -110.93 128.51 67.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.746 173.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 83.3 m -128.18 106.0 8.75 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.968 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -166.78 164.39 37.74 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.041 -178.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -56.81 136.84 78.71 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 121.859 1.706 . . . . 0.0 109.987 170.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -49.67 -19.58 3.6 Favored 'Trans proline' 0 N--CA 1.48 0.68 0 C-N-CA 123.897 3.065 . . . . 0.0 114.515 -172.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -70.72 -33.07 70.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.0 0.428 . . . . 0.0 110.563 177.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.419 ' HB1' ' HB1' ' A' ' 52' ' ' ALA . . . -78.4 -21.82 48.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.809 -177.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.51 -36.22 64.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.47 176.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.624 ' HA ' ' NE2' ' A' ' 164' ' ' GLN . 69.1 t80 -59.3 -47.09 86.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.469 177.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 36.0 tptt -63.89 -52.56 59.36 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.048 -176.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.69 -53.64 14.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.474 -174.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -71.38 -29.36 64.85 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -172.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -53.59 -36.81 55.13 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 120.365 -0.922 . . . . 0.0 111.739 175.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.448 ' HD2' ' N ' ' A' ' 86' ' ' ARG . 4.5 mpt_? -80.11 -32.02 39.11 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.532 0.197 . . . . 0.0 111.532 177.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -68.5 -44.43 83.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 121.119 -0.232 . . . . 0.0 110.422 -176.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.699 ' HA ' HD23 ' A' ' 91' ' ' LEU . 6.9 m-85 -66.38 -32.97 74.68 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.189 0.519 . . . . 0.0 110.274 177.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -66.02 -28.66 73.85 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.051 177.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.703 ' HB3' HD12 ' A' ' 37' ' ' ILE . 30.7 mmtp -78.43 -17.62 56.09 Favored 'General case' 0 N--CA 1.443 -0.787 0 O-C-N 122.388 -0.478 . . . . 0.0 111.332 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.699 HD23 ' HA ' ' A' ' 88' ' ' TYR . 2.6 mm? -65.34 -34.04 77.38 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 120.223 -0.591 . . . . 0.0 109.876 166.304 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.922 ' HE3' HG22 ' A' ' 103' ' ' VAL . 10.4 mmtp -72.79 -26.07 61.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.37 177.244 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.441 ' HB2' ' HA ' ' A' ' 90' ' ' LYS . 8.3 tp10 -63.47 -31.29 72.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.394 178.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.49 ' HG3' ' HA ' ' A' ' 33' ' ' ALA . 20.9 mm-40 -97.65 9.22 43.09 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.039 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 65.3 t30 56.8 41.88 27.42 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.654 176.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.746 ' HE2' ' HB2' ' A' ' 33' ' ' ALA . 41.9 m-85 -83.79 -33.08 25.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.04 0.448 . . . . 0.0 110.237 174.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.693 ' HB2' ' HE2' ' A' ' 92' ' ' LYS . 24.2 m-85 -124.58 24.42 7.85 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.272 -176.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 60.19 175.13 1.07 Allowed Glycine 0 CA--C 1.521 0.429 0 CA-C-N 115.659 -0.7 . . . . 0.0 113.717 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -75.32 -52.13 0.11 Allowed 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.667 2.245 . . . . 0.0 112.083 174.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -100.15 -14.35 18.57 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.871 0.322 . . . . 0.0 111.871 -174.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.572 ' HB3' ' O ' ' A' ' 97' ' ' PHE . 10.8 tp10 -67.41 154.99 40.08 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 177.103 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -65.13 137.59 57.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.402 -176.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.922 HG22 ' HE3' ' A' ' 92' ' ' LYS . 1.0 OUTLIER -73.96 129.08 36.59 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 172.608 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.6 mmmm -129.4 87.01 2.49 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 172.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.67 ' HB3' ' CE2' ' A' ' 88' ' ' TYR . 2.1 tm? -125.04 141.45 52.12 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -176.043 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.571 ' H ' HD22 ' A' ' 105' ' ' LEU . 39.8 tt0 -95.47 127.51 41.56 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.578 -170.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.519 HG21 ' NE2' ' A' ' 167' ' ' GLN . 0.1 OUTLIER -108.39 147.66 31.24 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 171.519 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -114.05 119.53 37.48 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.887 0.375 . . . . 0.0 110.088 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.428 ' CG1' ' HB ' ' A' ' 154' ' ' VAL . 23.1 pt -107.43 128.09 62.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.121 177.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.684 ' HD3' HG12 ' A' ' 153' ' ' ILE . 8.8 mmt180 -74.34 123.78 25.25 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.19 177.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.658 HG22 ' HB3' ' A' ' 115' ' ' ALA . 6.4 p -134.07 142.35 42.94 Favored Pre-proline 0 N--CA 1.444 -0.773 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.566 -175.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.442 ' HD2' HG22 ' A' ' 111' ' ' VAL . 31.7 Cg_exo -56.16 149.3 54.78 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 123.114 2.543 . . . . 0.0 111.978 179.038 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.62 -47.88 69.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.2 0.524 . . . . 0.0 111.066 -178.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.4 m -67.43 -28.9 68.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.661 -177.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.73 ' HB1' HD22 ' A' ' 174' ' ' LEU . . . -67.01 -28.83 68.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.933 -175.421 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.479 ' HB2' HG21 ' A' ' 152' ' ' VAL . . . -64.66 -27.0 68.63 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.099 0.476 . . . . 0.0 111.225 177.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -79.25 -31.09 43.41 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.664 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.584 ' HD3' HG22 ' A' ' 177' ' ' VAL . 23.1 ttt85 -91.63 -28.63 17.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.081 0.441 . . . . 0.0 111.711 -176.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.2 p -61.14 -24.38 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 121.13 0.491 . . . . 0.0 110.826 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.72 ' HA ' ' HB ' ' A' ' 127' ' ' VAL . 47.1 mm -77.85 -51.43 17.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.158 176.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 71.94 77.66 0.53 Allowed Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.18 -175.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -56.03 -34.51 65.94 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.807 0.336 . . . . 0.0 111.785 -175.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -99.65 22.83 10.35 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.529 -177.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -152.63 -154.95 6.88 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.226 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.546 ' HD2' ' HB2' ' A' ' 129' ' ' GLU . 3.7 pptp? -137.06 25.75 2.99 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.03 0.443 . . . . 0.0 110.048 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.517 ' O ' ' HG ' ' A' ' 130' ' ' LEU . 9.3 t -63.27 -34.58 77.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.022 -173.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.72 ' HB ' ' HA ' ' A' ' 120' ' ' ILE . 9.5 p -67.47 -37.69 79.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-O 121.044 0.449 . . . . 0.0 110.549 177.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.491 ' HA ' ' OE1' ' A' ' 131' ' ' GLN . 3.6 t-20 -74.09 -34.55 64.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.515 0.674 . . . . 0.0 109.579 178.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.546 ' HB2' ' HD2' ' A' ' 125' ' ' LYS . 69.4 tt0 -65.33 -37.46 87.15 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.059 177.107 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 126' ' ' THR . 87.0 mt -56.78 -48.83 77.0 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.406 173.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.491 ' OE1' ' HA ' ' A' ' 128' ' ' ASN . 80.8 mt-30 -57.35 -45.95 83.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.34 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -71.59 -36.15 70.75 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.834 0.349 . . . . 0.0 111.146 -177.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -73.03 -46.4 52.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.791 -177.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.582 HG21 ' HA ' ' A' ' 166' ' ' ALA . 77.0 p -88.07 -18.07 29.71 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.033 0.382 . . . . 0.0 112.033 -174.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 65.98 22.26 11.26 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 123.847 0.717 . . . . 0.0 110.491 -175.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.576 ' HB2' ' HB1' ' A' ' 162' ' ' ALA . . . -122.3 160.8 24.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.63 -177.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.645 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 10.9 tp10 -88.95 111.73 22.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.487 178.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 54.2 t -104.22 106.04 19.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.582 178.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.464 ' O ' ' HD2' ' A' ' 155' ' ' LYS . 5.0 p -128.7 124.45 61.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.322 0.582 . . . . 0.0 111.156 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.5 ' HB ' HG22 ' A' ' 154' ' ' VAL . 11.2 p -122.14 128.85 25.35 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.71 178.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.648 ' HG3' ' HE3' ' A' ' 155' ' ' LYS . 13.1 Cg_exo -68.24 154.92 71.14 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.552 2.168 . . . . 0.0 111.565 -178.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 -93.8 15.8 15.65 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 176.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.564 ' CG ' ' H ' ' A' ' 144' ' ' GLN . 6.6 p-10 -136.24 -91.06 0.28 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.8 177.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.921 ' HG2' ' H ' ' A' ' 153' ' ' ILE . 6.0 tp-100 58.13 88.88 0.06 Allowed 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.613 0.765 . . . . 0.0 112.351 174.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.636 ' HB ' ' HD2' ' A' ' 146' ' ' PRO . 59.5 p 61.35 161.18 0.11 Allowed Pre-proline 0 N--CA 1.473 0.689 0 C-N-CA 124.225 1.01 . . . . 0.0 112.51 176.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.636 ' HD2' ' HB ' ' A' ' 145' ' ' THR . 57.7 Cg_endo -72.21 157.86 53.03 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.261 1.974 . . . . 0.0 112.285 178.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -73.06 8.87 1.39 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.566 -176.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -57.0 -47.48 80.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.232 0.539 . . . . 0.0 110.143 174.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ASN . . . . . 0.499 ' O ' ' HG2' ' A' ' 150' ' ' GLU . 56.1 t30 -90.85 -8.75 48.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.149 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 149' ' ' ASN . 9.9 pt-20 45.03 36.82 2.14 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 114.44 -1.254 . . . . 0.0 111.642 178.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -148.2 138.97 23.02 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.573 -176.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.493 HG23 ' CG1' ' A' ' 111' ' ' VAL . 21.3 m -120.22 -176.15 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.92 -174.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.921 ' H ' ' HG2' ' A' ' 144' ' ' GLN . 49.9 mt -134.45 128.89 52.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.306 -176.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.5 HG22 ' HB ' ' A' ' 140' ' ' VAL . 53.9 t -95.82 140.28 17.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 173.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.648 ' HE3' ' HG3' ' A' ' 141' ' ' PRO . 0.0 OUTLIER -104.13 134.92 46.56 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 177.657 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.645 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 70.6 mt -118.95 112.06 36.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.914 177.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.421 ' N ' HD12 ' A' ' 157' ' ' ILE . 4.4 mp -110.47 138.62 37.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.793 -178.218 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 149.72 -157.13 27.1 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.372 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -81.45 159.8 24.16 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 -177.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.504 ' HB3' ' CB ' ' A' ' 88' ' ' TYR . 7.6 p90 -57.89 -47.86 81.56 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.719 -175.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.408 ' O ' ' HG3' ' A' ' 165' ' ' MET . 19.0 m-85 -54.37 -49.89 68.78 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.626 0.251 . . . . 0.0 110.721 177.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.576 ' HB1' ' HB2' ' A' ' 136' ' ' ALA . . . -58.25 -53.47 57.88 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.578 -178.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.466 ' O ' ' HG3' ' A' ' 167' ' ' GLN . 30.0 m -59.84 -49.69 76.73 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.979 -179.067 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.624 ' NE2' ' HA ' ' A' ' 81' ' ' PHE . 21.6 mt-30 -56.51 -30.84 63.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.764 178.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.408 ' HG3' ' O ' ' A' ' 161' ' ' TYR . 91.0 mtp -77.96 -42.67 32.09 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.743 0.306 . . . . 0.0 110.798 175.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.582 ' HA ' HG21 ' A' ' 134' ' ' THR . . . -69.4 -41.56 76.27 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -174.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.519 ' NE2' HG21 ' A' ' 107' ' ' THR . 71.9 mt-30 -51.93 -57.77 8.44 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.961 0.41 . . . . 0.0 111.215 -176.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 21.5 ptt180 -68.21 -28.15 67.0 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.533 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.769 ' HA ' ' HE3' ' A' ' 169' ' ' LYS . 0.1 OUTLIER -69.56 -44.9 69.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.851 0.358 . . . . 0.0 110.393 -177.832 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.588 ' O ' ' HG ' ' A' ' 174' ' ' LEU . 1.8 mp -71.54 -40.46 71.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 177.18 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 27.2 mmm-85 -58.88 -26.23 64.07 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.147 0.499 . . . . 0.0 110.974 174.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -77.87 -46.55 21.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.966 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.547 HG13 ' O ' ' A' ' 170' ' ' ILE . 2.7 pp -66.28 -18.88 24.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-O 121.0 0.429 . . . . 0.0 110.823 -177.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.73 HD22 ' HB1' ' A' ' 115' ' ' ALA . 17.7 mt -57.37 -27.55 62.39 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.247 175.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.7 ' HA ' ' HD3' ' A' ' 178' ' ' LYS . . . -54.87 -33.46 61.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.515 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -70.22 -33.19 71.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.927 0.394 . . . . 0.0 110.568 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.584 HG22 ' HD3' ' A' ' 118' ' ' ARG . 40.3 t -69.32 -40.39 80.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.389 0.614 . . . . 0.0 109.736 178.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.7 ' HD3' ' HA ' ' A' ' 175' ' ' ALA . 50.9 mtpt -59.95 -50.52 73.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.073 176.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -64.09 -34.67 78.57 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.312 -177.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 23.5 tp60 -60.5 -35.83 76.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.721 -177.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 24.2 m-70 -83.69 -21.13 32.46 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.649 -178.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -85.01 -56.97 3.29 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.003 0.43 . . . . 0.0 110.488 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.41 ' HD2' ' HA ' ' A' ' 183' ' ' LYS . 19.8 tptm -93.5 61.48 3.22 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.729 0.776 . . . . 0.0 110.666 -177.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -73.94 127.9 10.6 Favored Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 169.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -61.18 112.29 2.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.141 0.496 . . . . 0.0 111.268 -175.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 2.0 m -81.81 70.43 8.71 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.154 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -65.48 -62.29 4.96 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.554 -178.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -145.83 101.92 3.6 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 62.7 tp -154.44 -51.62 0.09 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.0 -177.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -111.86 115.55 29.2 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.108 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.584 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.695 177.74 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' ' G' . . . . . 0.541 " H2'" ' C6 ' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.427 -0.825 0 C3'-C2'-C1' 104.445 3.272 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . 0.794 " O2'" " H5'" ' B' ' 3' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.422 -1.119 0 O4'-C4'-C3' 100.87 -3.307 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . 0.794 " H5'" " O2'" ' B' ' 2' ' ' ' C' . . . . . . . . 0 C2'--C1' 1.517 -1.11 1 P-O3'-C3' 125.846 5.122 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 4' ' ' ' C' . . . . . 0.934 ' H41' ' HA2' ' A' ' 35' ' ' GLY . . . . . . . . 0 O5'--C5' 1.426 -0.879 0 C4'-C3'-C2' 105.708 3.008 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.816 " O4'" " H4'" ' B' ' 4' ' ' ' C' . . . . . . . . 0 P--O3' 1.615 0.667 0 P-O3'-C3' 122.518 2.348 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 6' ' ' ' C' . . . . . 0.574 " O5'" " H2'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.429 -0.715 1 C4'-C3'-C2' 106.72 4.02 OUTLIER-DELTA 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 4 4 . 1 . 010 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.871 0 O4'-C1'-N19 109.134 0.934 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.427 -0.799 0 O4'-C4'-C3' 103.945 -1.111 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.65 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.08 74.58 1.51 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.855 0.359 . . . . 0.0 111.525 -177.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.44 -56.8 4.24 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 171.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -118.68 153.68 16.86 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 174.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.76 122.22 11.1 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 122.5 2.133 . . . . 0.0 111.667 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.3 p -59.99 118.23 6.02 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.627 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 17.2 m -77.67 79.27 4.16 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.763 -177.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.4 m -93.37 152.99 3.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.555 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.4 m -132.03 78.77 1.83 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.604 177.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -128.46 -62.55 0.12 Allowed Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.479 -177.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -146.67 96.08 2.7 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.005 0.431 . . . . 0.0 110.398 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -117.57 107.77 44.24 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.743 -178.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -74.48 159.36 43.16 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.828 2.352 . . . . 0.0 111.759 178.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -88.63 33.42 0.77 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.735 0.779 . . . . 0.0 109.969 -179.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.4 ' O ' ' HD3' ' A' ' 19' ' ' PRO . 4.5 p -84.13 105.55 15.08 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.82 177.347 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.3 m -70.73 -17.57 62.81 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.326 -0.397 . . . . 0.0 112.022 -173.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -101.12 63.72 1.01 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.55 0.69 . . . . 0.0 110.363 177.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.766 ' H ' ' HD2' ' A' ' 19' ' ' PRO . 27.1 ttt -163.56 -45.49 0.0 OUTLIER Pre-proline 0 CA--C 1.542 0.654 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.852 -178.146 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.766 ' HD2' ' H ' ' A' ' 18' ' ' MET . 44.5 Cg_exo -37.25 -50.66 1.62 Allowed 'Trans proline' 0 C--N 1.366 1.491 0 C-N-CA 123.432 2.755 . . . . 0.0 116.289 -174.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.47 ' HD3' ' HB2' ' A' ' 19' ' ' PRO . 59.2 Cg_endo -72.56 -28.74 14.05 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 121.323 1.349 . . . . 0.0 113.143 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 66.94 -57.79 0.41 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.911 0.884 . . . . 0.0 112.003 -175.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.524 ' HB2' HG22 ' A' ' 74' ' ' THR . 64.2 mt-30 -132.93 136.49 46.15 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -178.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.442 ' OE1' ' HD3' ' A' ' 77' ' ' PRO . 1.5 mp0 -73.57 113.26 10.48 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.354 0.597 . . . . 0.0 111.619 -174.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 4.9 m -92.66 109.56 20.98 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.134 177.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.8 m -124.14 152.9 30.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 10.2 m170 -113.81 132.03 56.02 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -174.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.713 ' HB ' ' CG1' ' A' ' 71' ' ' VAL . 20.8 t -108.2 141.02 24.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.559 -177.15 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.674 ' CE2' HG11 ' A' ' 68' ' ' VAL . 47.2 t80 -97.6 104.87 16.94 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 123.531 0.732 . . . . 0.0 110.198 -174.071 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.544 ' C ' HG23 ' A' ' 68' ' ' VAL . 11.1 pt -124.5 116.58 26.68 Favored Pre-proline 0 C--N 1.326 -0.435 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.264 176.405 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.515 ' HA ' ' HA ' ' A' ' 68' ' ' VAL . 18.7 Cg_endo -58.9 147.98 86.61 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.57 2.847 . . . . 0.0 112.572 -177.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.636 ' HA ' HG12 ' A' ' 34' ' ' VAL . . . -54.08 -25.71 23.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.579 -1.191 . . . . 0.0 112.854 -175.364 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -70.3 -23.65 62.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.909 0.385 . . . . 0.0 111.182 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.578 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -114.12 -30.8 6.54 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.577 -177.056 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.636 HG12 ' HA ' ' A' ' 31' ' ' ALA . 13.0 p -51.95 -33.8 16.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 O-C-N 123.24 0.337 . . . . 0.0 111.661 -173.288 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 1.058 ' HA2' ' H41' ' B' ' 4' ' ' ' C' . . . -57.65 -56.94 22.43 Favored Glycine 0 N--CA 1.439 -1.129 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.974 -179.07 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.526 ' HA ' " H5'" ' B' ' 3' ' ' ' A' . . . -78.74 -14.19 59.41 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.79 -0.205 . . . . 0.0 111.318 -175.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.662 HD12 ' HB3' ' A' ' 90' ' ' LYS . 8.3 mm -61.71 -43.01 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 175.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.807 HD12 ' C5 ' ' B' ' 4' ' ' ' C' . 26.3 mt -55.88 -53.48 37.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.532 176.208 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.32 113.63 0.45 Allowed Glycine 0 CA--C 1.521 0.462 0 C-N-CA 120.515 -0.85 . . . . 0.0 114.942 168.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.413 ' HA ' ' HD2' ' A' ' 40' ' ' LYS . 46.4 tptt 48.82 77.64 0.1 Allowed 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.191 0.996 . . . . 0.0 113.009 170.142 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.656 ' HA ' ' OP2' ' B' ' 4' ' ' ' C' . 0.0 OUTLIER 62.68 7.81 2.68 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.945 173.893 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.573 ' O ' HG22 ' A' ' 45' ' ' ILE . . . 76.58 8.67 86.15 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.122 -1.037 . . . . 0.0 111.759 -177.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.494 ' HA ' ' HE3' ' A' ' 46' ' ' LYS . 50.8 mt-30 -62.87 -43.55 98.5 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.061 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 40.7 m-70 -78.74 -26.62 44.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.695 -177.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.573 HG22 ' O ' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -72.1 -42.52 67.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 120.995 -0.282 . . . . 0.0 110.721 -176.629 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.494 ' HE3' ' HA ' ' A' ' 43' ' ' GLN . 18.9 pttp -81.43 -24.54 36.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.151 0.5 . . . . 0.0 110.425 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -69.26 -30.86 69.07 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.261 174.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.796 ' HA ' ' CE2' ' A' ' 51' ' ' PHE . 6.4 tt -60.77 -38.14 84.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.719 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.635 ' HA ' HD13 ' A' ' 56' ' ' ILE . 22.7 m -62.4 -36.15 81.43 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.035 177.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -69.41 -47.98 62.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.139 -173.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.796 ' CE2' ' HA ' ' A' ' 48' ' ' LEU . 14.2 p90 -71.32 -24.6 62.15 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.235 -174.178 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -90.78 -9.35 46.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.008 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.2 t 60.58 32.81 20.46 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.724 -178.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -128.17 174.41 9.28 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.305 -176.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.424 ' HB2' ' HB ' ' A' ' 74' ' ' THR . 20.2 m -104.51 101.73 11.38 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.629 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.635 HD13 ' HA ' ' A' ' 49' ' ' SER . 3.2 mp -111.38 122.49 65.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.844 178.514 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -147.09 142.41 27.36 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.209 178.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.662 ' HB ' ' N1 ' ' B' ' 5' ' ' ' A' . 35.2 mm -75.07 124.45 32.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 177.34 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.942 ' HB2' HG23 ' A' ' 72' ' ' VAL . . . -77.72 133.64 66.2 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.127 -174.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 59' ' ' ALA . 22.8 Cg_exo -65.33 127.01 17.32 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.817 2.345 . . . . 0.0 112.242 178.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -74.04 168.25 25.24 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.605 2.203 . . . . 0.0 111.6 177.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -79.32 -37.01 38.64 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.875 0.369 . . . . 0.0 110.503 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 68.8 p -127.39 149.38 69.75 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 173.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -69.41 -0.02 6.03 Favored 'Trans proline' 0 CA--C 1.529 0.252 0 C-N-CA 123.001 2.467 . . . . 0.0 113.284 -176.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -116.58 13.89 15.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.687 -0.233 . . . . 0.0 111.235 -178.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 74.8 m -52.96 134.25 37.81 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.247 0.546 . . . . 0.0 111.435 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -70.92 -19.57 62.57 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.697 -177.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.674 HG11 ' CE2' ' A' ' 28' ' ' PHE . 7.4 p -139.01 147.74 24.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 175.123 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.541 ' HB3' HG21 ' A' ' 34' ' ' VAL . 12.6 ttm180 -123.1 126.62 47.39 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 175.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.848 ' HG3' ' HB3' ' A' ' 59' ' ' ALA . 18.7 ptt? -83.18 146.67 28.49 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.316 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.713 ' CG1' ' HB ' ' A' ' 27' ' ' VAL . 3.5 p -110.08 135.68 48.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 173.31 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.942 HG23 ' HB2' ' A' ' 59' ' ' ALA . 51.4 t -100.47 110.17 26.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.4 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.417 HG22 HG13 ' A' ' 56' ' ' ILE . 10.0 pt -113.23 142.45 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.802 174.044 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.524 HG22 ' HB2' ' A' ' 22' ' ' GLN . 20.5 m -137.34 105.95 5.85 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.987 -176.017 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -166.96 162.51 36.3 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.93 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -59.71 137.26 75.91 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.398 2.065 . . . . 0.0 110.411 172.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.448 ' HA ' ' HB3' ' A' ' 80' ' ' GLN . 63.8 Cg_exo -40.04 -37.99 1.9 Allowed 'Trans proline' 0 N--CA 1.478 0.584 0 C-N-CA 124.352 3.368 . . . . 0.0 115.517 -171.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -72.29 -43.02 64.85 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 121.798 -0.564 . . . . 0.0 111.275 -178.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.38 -27.72 61.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.449 0.643 . . . . 0.0 109.693 175.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.448 ' HB3' ' HA ' ' A' ' 77' ' ' PRO . 35.1 tt0 -61.43 -48.51 80.86 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.012 173.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.772 ' HD1' ' HG3' ' A' ' 164' ' ' GLN . 80.6 t80 -59.16 -39.67 83.17 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.833 176.004 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.6 tptp -53.42 -53.04 57.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.398 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.524 ' HB1' HD21 ' A' ' 48' ' ' LEU . . . -72.0 -47.36 52.59 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.107 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.584 ' O ' HG22 ' A' ' 87' ' ' ILE . 14.2 tt0 -66.93 -31.95 72.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.552 -172.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -57.38 -36.78 78.19 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.285 175.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.459 ' HD3' ' HA ' ' A' ' 86' ' ' ARG . 27.8 mmt180 -80.4 -27.21 38.16 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.668 -0.266 . . . . 0.0 111.239 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.584 HG22 ' O ' ' A' ' 84' ' ' GLN . 0.3 OUTLIER -67.82 -41.78 85.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 178.941 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.615 ' CE2' ' HB3' ' A' ' 105' ' ' LEU . 7.0 m-85 -68.51 -31.13 70.16 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-O 121.164 0.507 . . . . 0.0 109.889 173.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -61.71 -29.28 71.66 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.474 -0.784 . . . . 0.0 112.119 177.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.662 ' HB3' HD12 ' A' ' 37' ' ' ILE . 73.9 mmtt -66.69 -37.71 85.3 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 177.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.671 ' HB3' ' CE1' ' A' ' 97' ' ' PHE . 3.4 mm? -59.55 -36.75 76.77 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.41 0.624 . . . . 0.0 110.597 174.655 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.77 ' HE3' ' HB ' ' A' ' 103' ' ' VAL . 0.1 OUTLIER -75.35 -37.82 60.45 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.277 -177.565 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -67.93 -27.48 66.65 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.182 -178.162 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.449 ' HB3' ' CE2' ' A' ' 96' ' ' PHE . 17.3 mm-40 -89.27 5.27 45.65 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.189 0.519 . . . . 0.0 110.859 178.338 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 58.69 41.14 22.45 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.986 172.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.449 ' CE2' ' HB3' ' A' ' 94' ' ' GLU . 70.2 m-85 -89.98 -9.51 48.43 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.2 0.524 . . . . 0.0 109.921 172.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.671 ' CE1' ' HB3' ' A' ' 91' ' ' LEU . 60.6 m-85 -133.78 -44.45 0.81 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.423 -178.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 125.98 165.08 11.94 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -178.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.88 -66.66 0.04 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.237 0 C-N-CA 122.688 2.259 . . . . 0.0 112.476 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -94.36 -9.45 35.79 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.133 0.419 . . . . 0.0 112.133 -175.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -62.49 144.63 55.76 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 173.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -65.17 137.64 57.76 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.014 -177.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.77 ' HB ' ' HE3' ' A' ' 92' ' ' LYS . 14.8 p -80.46 138.58 19.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.644 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -128.2 90.81 3.14 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 175.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.615 ' HB3' ' CE2' ' A' ' 88' ' ' TYR . 2.3 tm? -133.38 126.3 30.99 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.261 0.553 . . . . 0.0 110.408 -173.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.782 ' HG3' HG13 ' A' ' 157' ' ' ILE . 41.1 mp0 -66.81 133.52 50.27 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.963 -1.017 . . . . 0.0 113.612 -175.157 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.97 140.43 46.64 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.142 165.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -121.69 119.8 32.84 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 32.8 pt -125.9 153.64 34.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.112 0.482 . . . . 0.0 111.292 -178.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.48 ' HD3' HG12 ' A' ' 153' ' ' ILE . 59.2 mmt-85 -87.31 132.24 34.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.872 -175.46 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.502 ' O ' ' HG3' ' A' ' 151' ' ' GLN . 5.2 m -129.77 147.09 63.96 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 171.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.72 ' HD2' HD22 ' A' ' 174' ' ' LEU . 31.4 Cg_exo -57.43 145.23 89.2 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.28 1.986 . . . . 0.0 110.911 175.125 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -51.09 -49.61 60.35 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.787 0.327 . . . . 0.0 111.552 -173.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 36.3 t -65.52 -33.25 75.49 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.137 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.18 -26.69 67.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.007 -178.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.19 -29.18 70.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.268 0.556 . . . . 0.0 110.392 177.019 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -75.12 -38.21 40.68 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.666 177.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.522 ' HD2' HG22 ' A' ' 177' ' ' VAL . 25.3 ttm180 -74.66 -34.23 62.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.371 0.129 . . . . 0.0 110.997 -178.493 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.477 HG13 HG21 ' A' ' 140' ' ' VAL . 10.2 p -66.8 -32.17 56.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-O 120.834 0.35 . . . . 0.0 110.579 179.059 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 76.3 mt -72.43 -43.73 63.37 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 CA-C-O 121.277 0.561 . . . . 0.0 109.656 173.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.904 ' HA3' ' HB ' ' A' ' 126' ' ' THR . . . 69.77 53.07 17.07 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 119.918 -1.134 . . . . 0.0 110.639 -174.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -63.2 -16.62 60.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.35 0.595 . . . . 0.0 110.585 -175.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -76.18 -21.56 56.36 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.698 178.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -164.06 -98.97 0.13 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 119.854 -1.165 . . . . 0.0 114.023 -176.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -142.25 28.72 1.67 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -168.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.904 ' HB ' ' HA3' ' A' ' 121' ' ' GLY . 26.1 m -62.91 -46.51 87.48 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -175.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.0 p -67.85 -29.91 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-O 121.017 0.437 . . . . 0.0 110.663 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -63.72 -40.61 97.19 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 177.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -64.45 -41.56 96.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.003 177.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 73.6 mt -60.13 -49.31 78.13 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.621 178.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -64.2 -30.13 71.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.631 -177.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -72.55 -42.59 64.53 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.886 0.375 . . . . 0.0 110.298 177.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 94.4 mt -68.61 -49.67 57.47 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.27 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 74.1 p -82.26 -35.37 28.16 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.317 -171.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 66.97 27.49 8.82 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 123.894 0.746 . . . . 0.0 109.9 -170.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.695 ' HB2' ' HB1' ' A' ' 162' ' ' ALA . . . -122.92 163.95 19.38 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.707 -178.024 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.486 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 9.7 mm-40 -88.25 111.58 21.83 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.421 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 42.8 t -97.75 105.83 17.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.434 ' O ' ' HD2' ' A' ' 155' ' ' LYS . 54.0 t -112.81 111.6 36.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.232 -175.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.477 HG21 HG13 ' A' ' 119' ' ' VAL . 34.8 t -106.03 126.5 30.46 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 177.352 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.439 ' HG2' ' HB3' ' A' ' 144' ' ' GLN . 88.1 Cg_endo -83.81 143.23 10.51 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.766 2.311 . . . . 0.0 113.358 -174.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 39.7 mmt180 -94.1 -26.88 16.55 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.467 173.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -69.78 -35.44 74.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.036 -0.983 . . . . 0.0 110.567 178.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.439 ' HB3' ' HG2' ' A' ' 141' ' ' PRO . 60.2 tt0 -92.86 90.83 7.16 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 175.582 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.429 ' N ' ' HD3' ' A' ' 146' ' ' PRO . 16.0 p -145.98 58.01 4.43 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.75 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.495 ' HB2' ' HB3' ' A' ' 148' ' ' GLU . 49.5 Cg_endo -92.8 133.07 1.03 Allowed 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.548 2.165 . . . . 0.0 112.986 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -71.07 -12.88 61.75 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 172.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.495 ' HB3' ' HB2' ' A' ' 146' ' ' PRO . 30.9 tt0 -44.78 -48.55 10.91 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 114.315 -1.312 . . . . 0.0 112.599 178.487 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -114.75 -0.07 13.67 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.174 -175.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 44.41 32.45 0.72 Allowed 'General case' 0 N--CA 1.474 0.748 0 O-C-N 124.469 1.105 . . . . 0.0 111.045 -172.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.502 ' HG3' ' O ' ' A' ' 111' ' ' VAL . 28.4 tt0 -157.86 142.74 16.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.402 -174.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.401 HG12 ' HD2' ' A' ' 146' ' ' PRO . 31.0 m -133.88 -177.01 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.792 -178.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.48 HG12 ' HD3' ' A' ' 110' ' ' ARG . 55.8 mt -120.48 137.99 52.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.922 0.391 . . . . 0.0 111.726 -178.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.5 p -104.49 138.41 29.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.565 169.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.468 ' HD2' ' H ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -101.23 126.31 47.95 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.664 -177.109 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.486 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 58.9 mt -109.24 118.71 57.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.107 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.782 HG13 ' HG3' ' A' ' 106' ' ' GLU . 4.0 mp -114.36 138.33 44.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 143.92 -163.01 27.75 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.525 178.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.543 ' HA ' HG13 ' A' ' 103' ' ' VAL . 10.6 p-80 -83.73 145.1 28.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.73 0.3 . . . . 0.0 110.41 178.527 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.503 ' HD1' HG11 ' A' ' 103' ' ' VAL . 46.0 p90 -57.72 -24.44 56.91 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -168.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.407 ' HB2' ' HD2' ' A' ' 159' ' ' HIS . 94.2 m-85 -61.43 -44.5 97.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.408 0.623 . . . . 0.0 109.625 174.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.695 ' HB1' ' HB2' ' A' ' 136' ' ' ALA . . . -74.6 -40.27 61.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.073 178.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.448 ' O ' ' HG3' ' A' ' 167' ' ' GLN . 19.3 m -55.21 -51.33 66.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.511 178.011 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.772 ' HG3' ' HD1' ' A' ' 81' ' ' PHE . 7.8 mm100 -57.79 -45.02 86.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.604 177.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 68.8 mtp -61.45 -40.7 95.44 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.8 0.333 . . . . 0.0 110.893 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.464 ' HB3' HD13 ' A' ' 156' ' ' ILE . . . -69.31 -46.2 67.7 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.163 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.448 ' HG3' ' O ' ' A' ' 163' ' ' SER . 24.7 mt-30 -55.31 -52.18 64.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.241 -178.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' A' ' 164' ' ' GLN . 6.7 ptp85 -66.42 -32.32 73.63 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.18 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.997 ' HA ' ' HE3' ' A' ' 169' ' ' LYS . 0.6 OUTLIER -77.24 -42.82 35.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.91 0.386 . . . . 0.0 110.965 -173.58 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.518 ' O ' ' HG ' ' A' ' 174' ' ' LEU . 1.8 mp -70.4 -44.71 77.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.923 177.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -59.26 -25.9 64.47 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.819 0.343 . . . . 0.0 110.566 175.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -73.82 -48.29 32.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.175 -179.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 36.1 pt -66.92 -20.53 27.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.112 -177.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.72 HD22 ' HD2' ' A' ' 112' ' ' PRO . 15.5 mt -59.23 -40.5 86.07 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.911 0.386 . . . . 0.0 110.252 176.153 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.493 ' O ' ' HG2' ' A' ' 179' ' ' GLN . . . -65.91 -37.39 85.95 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.216 178.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -65.99 -32.19 73.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.887 177.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.522 HG22 ' HD2' ' A' ' 118' ' ' ARG . 75.2 t -73.34 -35.57 46.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.056 0.455 . . . . 0.0 110.207 175.53 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -64.58 -31.03 72.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.158 0.504 . . . . 0.0 109.904 175.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 0.493 ' HG2' ' O ' ' A' ' 175' ' ' ALA . 73.3 mm-40 -70.45 -24.35 62.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.622 175.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -68.28 -29.59 68.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.129 0.49 . . . . 0.0 109.843 178.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 -71.26 -31.0 66.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.138 176.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 23.5 tp60 -70.91 -56.65 5.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.645 174.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -159.18 -62.0 0.07 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.763 179.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 87.79 74.71 1.28 Allowed Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.779 -178.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -82.07 147.72 28.96 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 19.8 m 71.14 9.47 6.67 Favored 'General case' 0 N--CA 1.466 0.375 0 O-C-N 123.818 0.698 . . . . 0.0 111.218 -176.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -92.06 157.92 24.5 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.84 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -92.96 103.97 16.24 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 94.5 mt -96.17 137.57 35.05 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.809 -178.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -121.14 62.98 0.88 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.484 0.659 . . . . 0.0 109.536 177.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.514 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.563 179.384 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 1' ' ' ' G' . . . . . 1.017 " O2'" ' H6 ' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.424 -0.981 0 C4'-C3'-C2' 106.576 3.876 OUTLIER-EPSILON 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . 1.017 ' H6 ' " O2'" ' B' ' 1' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.425 -0.945 0 P-O3'-C3' 122.216 2.097 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . 0.694 " H1'" ' C5 ' ' B' ' 4' ' ' ' C' . . . . . . . . 0 C2'--C1' 1.517 -1.081 0 C5'-C4'-O4' 112.522 2.373 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 4' ' ' ' C' . . . . . 1.058 ' H41' ' HA2' ' A' ' 35' ' ' GLY . . . . . . . . 0 O5'--C5' 1.429 -0.712 0 C3'-C2'-C1' 104.362 3.179 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.796 " O4'" " H4'" ' B' ' 4' ' ' ' C' . . . . . . . . 0 P--O3' 1.615 0.689 0 P-O3'-C3' 122.818 2.598 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 6' ' ' ' C' . . . . . 0.605 ' H6 ' " O5'" ' B' ' 6' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.427 -0.828 0 C4'-C3'-C2' 105.04 2.34 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.903 0 C4'-C3'-C2' 105.263 2.563 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.879 0 C3'-C2'-C1' 100.88 -0.688 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.797 0 N-CA-C 112.227 -0.349 . . . . 0.0 112.227 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.57 64.14 4.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.085 0.469 . . . . 0.0 110.784 178.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 82.5 mtp -125.76 123.93 39.9 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.23 -179.078 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -86.84 159.38 31.52 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.801 -178.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -62.13 156.9 47.4 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.214 2.609 . . . . 0.0 112.118 178.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.1 m 61.04 51.68 4.38 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -174.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 24.8 p -58.7 102.77 0.13 Allowed 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.226 -176.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.457 ' O ' ' HB3' ' A' ' 9' ' ' SER . 27.3 t 58.31 78.41 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.626 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.457 ' HB3' ' O ' ' A' ' 8' ' ' VAL . 42.9 t 76.1 -41.85 0.43 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.853 177.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.92 -19.47 40.96 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.443 -177.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 56.06 51.16 12.37 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 122.946 0.498 . . . . 0.0 111.605 177.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -130.71 80.59 69.55 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.596 -178.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -91.27 116.04 0.45 Allowed 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 123.093 2.529 . . . . 0.0 111.747 174.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -123.36 136.6 54.73 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.153 -177.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 29.1 p -130.72 -76.14 0.53 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.145 178.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.496 ' HB3' ' HG2' ' A' ' 19' ' ' PRO . 70.3 m 58.01 64.39 1.53 Allowed 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 121.095 0.474 . . . . 0.0 110.926 -177.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -85.93 -31.96 21.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.124 -178.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.555 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 70.6 mtm -85.5 -52.69 0.47 Allowed Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -176.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 18' ' ' MET . 4.2 Cg_exo -41.42 -50.3 4.65 Favored 'Trans proline' 0 C--N 1.361 1.202 0 C-N-CA 123.696 2.931 . . . . 0.0 115.777 -178.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.406 ' HD2' ' N ' ' A' ' 19' ' ' PRO . 33.0 Cg_endo -63.06 -27.36 73.74 Favored 'Trans proline' 0 C--N 1.36 1.142 0 C-N-CA 121.918 1.745 . . . . 0.0 113.621 -175.174 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -106.46 70.54 0.83 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.289 0.566 . . . . 0.0 111.564 -177.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 81.9 mm-40 -110.57 148.3 32.44 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.128 171.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -78.98 141.88 37.12 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.076 -171.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 29.2 m -131.69 112.45 12.56 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.496 -177.564 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.401 HG21 ' NE2' ' A' ' 167' ' ' GLN . 28.4 m -125.14 161.68 28.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.839 -178.054 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -117.44 128.1 54.67 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.618 -175.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.562 ' HB ' ' HB ' ' A' ' 71' ' ' VAL . 8.9 t -97.45 143.14 13.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.198 -179.23 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.429 ' CG ' HG21 ' A' ' 68' ' ' VAL . 0.3 OUTLIER -103.86 106.06 16.45 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 122.623 0.369 . . . . 0.0 111.723 -172.573 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.618 ' C ' ' HB ' ' A' ' 68' ' ' VAL . 8.7 pt -130.4 121.41 19.39 Favored Pre-proline 0 C--N 1.326 -0.433 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.856 176.318 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.666 ' HB2' ' HG2' ' A' ' 32' ' ' GLN . 10.6 Cg_endo -53.27 147.67 35.14 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.699 2.933 . . . . 0.0 112.485 -176.267 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.444 ' HA ' HG12 ' A' ' 34' ' ' VAL . . . -57.46 -21.98 40.57 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.509 -0.768 . . . . 0.0 112.096 -175.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.666 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 11.4 pt20 -71.38 -26.2 62.69 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.589 178.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.572 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -111.8 -30.37 7.33 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 121.167 -0.213 . . . . 0.0 111.545 -172.099 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.663 HG21 ' HB3' ' A' ' 69' ' ' ARG . 9.3 p -52.25 -32.86 16.36 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 O-C-N 123.605 0.566 . . . . 0.0 111.392 -174.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.901 ' HA2' ' N4 ' ' B' ' 4' ' ' ' C' . . . -55.7 -57.93 16.45 Favored Glycine 0 N--CA 1.438 -1.193 0 C-N-CA 120.318 -0.944 . . . . 0.0 111.858 -179.164 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.402 ' HB2' " O2'" ' B' ' 2' ' ' ' C' . . . -77.32 -14.11 59.8 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 120.744 0.307 . . . . 0.0 111.074 -174.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.637 HD12 ' HB3' ' A' ' 90' ' ' LYS . 7.9 mm -64.71 -38.87 83.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.116 176.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.879 HD12 ' C5 ' ' B' ' 4' ' ' ' C' . 5.0 mt -54.5 -59.42 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -178.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 131.04 77.82 0.17 Allowed Glycine 0 CA--C 1.52 0.357 0 C-N-CA 119.616 -1.278 . . . . 0.0 114.43 175.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.497 ' HA ' ' OP2' ' B' ' 3' ' ' ' A' . 45.9 tttp 54.13 -80.77 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 170.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -101.1 -6.22 24.64 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.821 0.344 . . . . 0.0 111.048 -173.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.55 ' O ' HG22 ' A' ' 45' ' ' ILE . . . 84.86 -1.88 88.57 Favored Glycine 0 C--O 1.229 -0.215 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.152 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -78.78 -32.26 46.39 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 176.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.444 ' HA ' ' HB3' ' A' ' 47' ' ' GLN . 2.2 m-70 -73.62 -22.12 60.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.066 -176.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.556 ' HB ' HG23 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -73.65 -42.89 55.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.728 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.423 ' HD2' " C5'" ' B' ' 6' ' ' ' C' . 7.9 pttp -81.68 -22.5 37.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.286 0.565 . . . . 0.0 109.744 177.431 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.444 ' HB3' ' HA ' ' A' ' 44' ' ' HIS . 49.2 tt0 -66.44 -33.44 75.72 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 171.381 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.411 ' HA ' ' HB3' ' A' ' 51' ' ' PHE . 7.0 tt -66.09 -38.5 88.39 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.371 175.065 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.666 ' HA ' HD13 ' A' ' 56' ' ' ILE . 8.1 t -60.04 -39.17 85.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.628 176.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -68.87 -47.47 65.85 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.062 174.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.411 ' HB3' ' HA ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -58.41 -39.03 78.62 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.984 -1.007 . . . . 0.0 112.007 -178.163 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -91.16 0.89 57.44 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 121.185 -0.206 . . . . 0.0 111.325 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 72.5 p 50.89 31.39 6.1 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.667 0.787 . . . . 0.0 111.964 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -140.14 174.25 10.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.886 -175.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.5 m -86.25 101.29 12.92 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.675 0.274 . . . . 0.0 110.596 -178.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.666 HD13 ' HA ' ' A' ' 49' ' ' SER . 2.2 mp -108.6 117.1 53.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.892 178.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.434 ' HG2' " O2'" ' B' ' 6' ' ' ' C' . 42.2 mtmt -134.28 146.81 50.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.562 -177.379 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.66 ' HB ' ' N1 ' ' B' ' 5' ' ' ' A' . 40.0 mm -90.17 107.47 18.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 173.286 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.464 ' HB2' ' CG1' ' A' ' 72' ' ' VAL . . . -86.33 126.4 64.78 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.854 -173.043 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 59' ' ' ALA . 17.1 Cg_exo -67.65 141.04 53.49 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.879 2.386 . . . . 0.0 110.805 172.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.38 131.24 39.67 Favored 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 122.906 2.404 . . . . 0.0 111.994 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -57.4 -32.42 66.82 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.684 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.6 p -124.06 132.51 24.3 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.55 174.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -64.01 -9.02 17.67 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 123.279 2.652 . . . . 0.0 112.765 -177.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -82.62 -12.27 57.79 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.974 -178.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.7 t -67.97 141.35 56.31 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.81 -9.7 57.9 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.505 -173.017 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.618 ' HB ' ' C ' ' A' ' 29' ' ' ILE . 1.4 m -127.41 176.08 8.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-O 121.225 0.536 . . . . 0.0 111.316 -172.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.663 ' HB3' HG21 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -120.01 139.79 51.96 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 106.471 -1.678 . . . . 0.0 106.471 172.837 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.542 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 61.4 mtt -97.43 149.15 22.46 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.282 -0.567 . . . . 0.0 111.397 -169.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.562 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 70.1 t -104.35 116.22 47.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 171.069 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.464 ' CG1' ' HB2' ' A' ' 59' ' ' ALA . 11.1 p -108.73 121.6 62.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.357 0.598 . . . . 0.0 110.472 -177.033 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 24' ' ' THR . 0.1 OUTLIER -130.63 142.42 43.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.768 0.794 . . . . 0.0 111.135 179.675 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 47.3 m -122.47 111.57 17.0 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.191 -1.368 . . . . 0.0 109.034 176.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.67 162.36 35.78 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 119.845 -1.169 . . . . 0.0 113.158 -175.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.24 148.54 84.91 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.379 2.052 . . . . 0.0 110.824 170.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -38.35 -46.85 2.4 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 124.152 3.235 . . . . 0.0 114.441 -176.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.516 ' HG3' ' N ' ' A' ' 79' ' ' ALA . 7.6 pt-20 -56.8 -43.97 81.48 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.156 0.503 . . . . 0.0 111.203 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.642 ' HA ' ' HD3' ' A' ' 82' ' ' LYS . . . -71.73 -37.64 70.57 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.006 -175.205 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -68.93 -26.03 64.88 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.946 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.594 ' HD1' HE22 ' A' ' 164' ' ' GLN . 89.8 t80 -64.4 -54.94 24.86 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.709 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.713 ' H ' ' HD2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -70.02 -32.6 70.84 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.459 -0.497 . . . . 0.0 110.726 -177.681 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.3 -51.54 69.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.753 0.311 . . . . 0.0 110.985 177.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.638 ' HA ' HG22 ' A' ' 87' ' ' ILE . 54.1 mt-30 -66.46 -31.89 72.91 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.269 179.297 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -59.57 -40.04 95.84 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.332 178.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -80.21 -37.83 32.36 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 122.742 -0.269 . . . . 0.0 111.637 -177.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.638 HG22 ' HA ' ' A' ' 84' ' ' GLN . 0.0 OUTLIER -65.21 -43.83 95.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.662 -176.632 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.592 ' CE2' ' HB3' ' A' ' 105' ' ' LEU . 15.2 m-85 -67.13 -30.15 70.07 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.142 0.496 . . . . 0.0 110.148 176.039 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -60.04 -32.84 76.88 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.213 176.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.637 ' HB3' HD12 ' A' ' 37' ' ' ILE . 31.7 mmtp -72.63 -26.76 61.78 Favored 'General case' 0 N--CA 1.455 -0.213 0 O-C-N 122.541 -0.388 . . . . 0.0 110.624 177.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.601 ' HG ' ' HG ' ' A' ' 105' ' ' LEU . 4.3 mm? -66.35 -38.55 87.85 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.853 0.359 . . . . 0.0 110.156 171.579 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.89 ' HE3' ' HB ' ' A' ' 103' ' ' VAL . 0.5 OUTLIER -68.78 -26.52 65.25 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.373 176.124 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -64.32 -40.66 96.34 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.995 -176.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.588 ' HB2' ' CE2' ' A' ' 96' ' ' PHE . 10.4 mm-40 -105.94 0.24 25.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.964 0.411 . . . . 0.0 112.079 -178.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.465 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . 37.2 m-80 57.34 47.83 15.96 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.307 -0.86 . . . . 0.0 112.695 171.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.588 ' CE2' ' HB2' ' A' ' 94' ' ' GLU . 80.1 m-85 -69.98 -43.81 70.71 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -176.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.492 ' HE2' ' HB3' ' A' ' 91' ' ' LEU . 23.1 p90 -81.94 -17.86 45.58 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.009 0.433 . . . . 0.0 111.208 -177.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 127.04 122.73 2.57 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.718 -178.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.465 ' HD3' ' HB3' ' A' ' 95' ' ' ASN . 12.2 Cg_endo -57.12 -38.19 96.2 Favored 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 122.981 2.454 . . . . 0.0 113.422 -177.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 39.5 mmtm -87.8 -3.02 58.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.857 0.36 . . . . 0.0 111.419 -178.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.459 ' HG3' ' O ' ' A' ' 102' ' ' GLU . 9.6 tp10 -95.82 141.15 29.61 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.995 -178.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.51 ' HB3' ' CE1' ' A' ' 159' ' ' HIS . 5.2 tt0 -65.06 145.77 55.88 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 171.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.89 ' HB ' ' HE3' ' A' ' 92' ' ' LYS . 11.5 p -54.52 122.84 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.404 0 CA-C-O 121.733 0.778 . . . . 0.0 112.037 -168.357 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp -117.68 91.29 3.53 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.568 -1.196 . . . . 0.0 108.865 176.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.601 ' HG ' ' HG ' ' A' ' 91' ' ' LEU . 2.0 tm? -128.58 123.81 34.33 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.208 0.527 . . . . 0.0 109.959 -176.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -58.92 129.46 42.26 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.821 -1.081 . . . . 0.0 112.016 -174.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.44 142.51 46.27 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.16 175.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -122.22 120.11 33.2 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.306 0.574 . . . . 0.0 111.546 -179.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.482 HD13 HD11 ' A' ' 156' ' ' ILE . 22.9 pt -114.61 134.16 58.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.872 176.145 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.594 ' HD3' HG12 ' A' ' 153' ' ' ILE . 6.9 tpp180 -78.48 138.25 38.35 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.249 -176.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.694 HG23 ' CD2' ' A' ' 174' ' ' LEU . 6.4 p -141.93 143.0 26.75 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 177.523 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.42 ' HD2' HG22 ' A' ' 111' ' ' VAL . 24.6 Cg_exo -59.84 150.1 79.57 Favored 'Trans proline' 0 N--CA 1.465 -0.18 0 C-N-CA 122.399 2.066 . . . . 0.0 111.296 176.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -56.3 -51.06 69.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.022 0.439 . . . . 0.0 111.007 -175.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.7 m -68.54 -12.3 61.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.544 -178.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.642 ' HB2' HG11 ' A' ' 177' ' ' VAL . . . -84.68 -14.87 47.2 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.347 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.458 ' HA ' HG12 ' A' ' 119' ' ' VAL . . . -65.42 -40.96 93.98 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.039 176.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.32 -32.9 83.37 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.615 -0.802 . . . . 0.0 111.55 176.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.447 ' HD2' HG22 ' A' ' 177' ' ' VAL . 15.2 ttm180 -74.2 -42.42 59.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.673 0.273 . . . . 0.0 110.788 -179.182 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.498 HG22 HD11 ' A' ' 130' ' ' LEU . 7.4 p -68.93 -30.56 47.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.025 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.65 ' HA ' HG23 ' A' ' 127' ' ' VAL . 72.6 mt -69.62 -39.26 78.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.818 0.818 . . . . 0.0 109.558 171.187 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 97.06 36.71 4.87 Favored Glycine 0 N--CA 1.438 -1.184 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.551 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 67.33 -73.48 0.08 Allowed 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 123.175 0.59 . . . . 0.0 111.541 -176.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -95.26 -27.03 15.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.672 0.272 . . . . 0.0 110.984 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 135.34 5.49 2.32 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.455 -0.878 . . . . 0.0 113.26 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 23.4 pttp -63.72 -26.27 68.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.967 0.413 . . . . 0.0 111.614 -179.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.572 ' O ' ' HG ' ' A' ' 130' ' ' LEU . 50.0 m -88.3 -32.7 18.33 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.268 -174.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.65 HG23 ' HA ' ' A' ' 120' ' ' ILE . 82.0 t -59.81 -37.9 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-O 121.38 0.61 . . . . 0.0 109.809 173.205 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -56.09 -42.98 77.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.944 177.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.14 -42.83 72.05 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.145 -179.295 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.572 ' HG ' ' O ' ' A' ' 126' ' ' THR . 77.6 mt -58.29 -52.05 67.23 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.702 -178.468 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -66.01 -37.97 87.25 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.928 -175.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -65.27 -36.7 84.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.276 -177.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 60.6 tp -88.11 -48.89 7.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.722 0.296 . . . . 0.0 111.525 -176.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.429 HG21 ' HA ' ' A' ' 166' ' ' ALA . 64.2 p -74.67 -25.19 59.01 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.985 -172.417 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 60.74 20.94 10.98 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.159 -174.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -113.61 173.12 6.57 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.309 -174.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.648 ' HB3' ' HB ' ' A' ' 157' ' ' ILE . 8.6 tp10 -96.95 114.07 25.66 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.04 175.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 57.3 t -114.84 106.98 21.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.758 -176.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.598 HG13 ' HB2' ' A' ' 155' ' ' LYS . 1.5 p -121.22 121.25 64.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.408 0.623 . . . . 0.0 110.991 177.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.642 ' HB ' HG22 ' A' ' 154' ' ' VAL . 7.7 p -127.12 113.01 21.68 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.631 176.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 1.054 ' HG2' ' HB2' ' A' ' 144' ' ' GLN . 96.1 Cg_endo -90.2 138.0 2.71 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.238 2.625 . . . . 0.0 113.526 -174.116 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -75.41 -23.31 57.02 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 113.636 -1.62 . . . . 0.0 109.418 175.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -97.67 17.29 18.2 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.951 -178.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 1.054 ' HB2' ' HG2' ' A' ' 141' ' ' PRO . 8.9 tp60 -63.83 -63.28 1.21 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.22 0.533 . . . . 0.0 111.54 -177.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.1 p -146.45 150.6 41.15 Favored Pre-proline 0 C--N 1.316 -0.85 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.124 -174.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.57 165.25 32.49 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.189 2.593 . . . . 0.0 112.309 178.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -78.43 23.83 0.29 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.948 -175.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -70.87 -47.6 58.41 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.487 0.661 . . . . 0.0 109.465 176.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -101.82 0.46 35.72 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.744 177.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 44.88 37.86 2.6 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.441 1.096 . . . . 0.0 112.034 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -147.9 141.0 24.98 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.027 0.441 . . . . 0.0 111.779 -174.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.414 HG23 ' CG1' ' A' ' 111' ' ' VAL . 23.3 m -126.95 -176.02 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.186 -178.505 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.594 HG12 ' HD3' ' A' ' 110' ' ' ARG . 58.2 mt -132.81 134.94 57.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 O-C-N 122.247 -0.283 . . . . 0.0 110.69 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.642 HG22 ' HB ' ' A' ' 140' ' ' VAL . 89.7 t -92.4 139.09 18.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 174.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.719 ' HE3' ' HG3' ' A' ' 141' ' ' PRO . 0.0 OUTLIER -105.57 117.18 33.37 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.997 0.427 . . . . 0.0 109.964 179.258 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.533 HD13 ' HB3' ' A' ' 166' ' ' ALA . 53.4 mt -100.49 116.66 44.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.072 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.648 ' HB ' ' HB3' ' A' ' 137' ' ' GLU . 3.2 mp -107.32 131.8 56.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 175.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 153.36 -152.68 24.27 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.446 -178.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.51 ' CE1' ' HB3' ' A' ' 102' ' ' GLU . 7.8 m-70 -102.7 155.12 18.52 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -175.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.435 ' O ' ' HG3' ' A' ' 164' ' ' GLN . 25.0 p90 -56.0 -36.36 67.83 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.037 0.835 . . . . 0.0 111.797 -172.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.461 ' O ' ' HG2' ' A' ' 165' ' ' MET . 35.8 m-85 -60.2 -48.02 83.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.82 0.343 . . . . 0.0 110.746 175.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -70.39 -36.94 74.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.611 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.451 ' HA ' HG21 ' A' ' 156' ' ' ILE . 68.7 m -57.54 -45.78 84.69 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.413 176.306 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.594 HE22 ' HD1' ' A' ' 81' ' ' PHE . 27.5 mt-30 -64.39 -33.66 76.37 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.777 0.322 . . . . 0.0 111.152 179.082 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.461 ' HG2' ' O ' ' A' ' 161' ' ' TYR . 95.9 mmm -63.02 -40.57 98.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.173 176.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.533 ' HB3' HD13 ' A' ' 156' ' ' ILE . . . -74.83 -37.99 62.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.826 178.134 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.401 ' NE2' HG21 ' A' ' 25' ' ' VAL . 32.4 mt-30 -53.33 -56.2 18.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.751 177.543 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -65.88 -31.45 72.4 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.035 -178.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.726 ' HA ' ' HE3' ' A' ' 169' ' ' LYS . 0.2 OUTLIER -72.95 -54.94 7.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.152 -172.886 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 2.4 mp -72.0 -46.77 58.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.8 0.333 . . . . 0.0 110.424 -177.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.586 ' HA ' ' HG ' ' A' ' 174' ' ' LEU . 24.6 mmm180 -60.99 -24.93 66.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.175 -178.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -71.44 -47.36 56.35 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 111.547 0.203 . . . . 0.0 111.547 177.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.471 HG13 HD23 ' A' ' 174' ' ' LEU . 18.3 pt -66.62 -19.26 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.671 -177.587 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.694 ' CD2' HG23 ' A' ' 111' ' ' VAL . 6.7 mt -60.92 -28.78 69.18 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.817 177.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.438 ' O ' ' HG3' ' A' ' 179' ' ' GLN . . . -59.0 -43.12 91.45 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.037 176.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 71.3 mm-40 -60.81 -45.43 94.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.656 176.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.642 HG11 ' HB2' ' A' ' 115' ' ' ALA . 46.7 t -61.38 -41.26 89.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.576 179.499 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -63.0 -44.44 96.0 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.557 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 0.438 ' HG3' ' O ' ' A' ' 175' ' ' ALA . 96.9 mt-30 -64.2 -43.58 94.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.755 179.281 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -75.72 -20.82 58.08 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.424 -178.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 -67.59 -32.72 73.65 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.616 0.246 . . . . 0.0 110.954 -178.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -58.8 -28.65 66.19 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.453 0.644 . . . . 0.0 110.373 177.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 42.4 mtmt -122.37 30.33 6.58 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.659 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -82.5 58.13 5.0 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.896 -173.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 54.77 45.66 26.22 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.514 0.673 . . . . 0.0 110.379 177.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 22.8 t -117.34 90.34 3.31 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.804 -178.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -97.67 163.69 21.68 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.953 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -95.09 92.77 6.99 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.788 0.328 . . . . 0.0 110.15 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -143.65 142.71 31.13 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.55 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 52.75 72.91 0.38 Allowed 'General case' 0 N--CA 1.466 0.36 0 O-C-N 123.904 0.752 . . . . 0.0 111.164 177.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.641 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.638 179.048 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 1' ' ' ' G' . . . . . 0.738 " O2'" ' H6 ' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.428 -0.732 0 C4'-C3'-C2' 106.67 3.97 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . 0.738 ' H6 ' " O2'" ' B' ' 1' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.424 -0.982 0 O4'-C4'-C3' 102.061 -2.457 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . 0.643 " H1'" ' C5 ' ' B' ' 4' ' ' ' C' . . . . . . . . 0 C2'--C1' 1.517 -1.096 0 C5'-C4'-O4' 112.728 2.52 OUTLIER-DELTA 0.0 OUTLIER '7D dist 1z' 0.0 . . . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 4' ' ' ' C' . . . . . 0.901 ' N4 ' ' HA2' ' A' ' 35' ' ' GLY . . . . . . . . 0 O5'--C5' 1.427 -0.793 0 C4'-C3'-C2' 105.703 3.003 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.833 " O5'" " H4'" ' B' ' 4' ' ' ' C' . . . . . . . . 0 P--O3' 1.615 0.675 0 P-O3'-C3' 122.439 2.282 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 6' ' ' ' C' . . . . . 0.637 ' H6 ' " O5'" ' B' ' 6' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.429 -0.717 0 C4'-C3'-C2' 104.67 1.97 . 0.0 OUTLIER '7D dist 1m' 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.428 -0.756 0 C4'-C3'-C2' 104.559 1.859 . 0.104 1[ . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.425 -0.925 0 C3'-C2'-C1' 100.151 -1.499 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 83.2 mm-40 . . . . . 0 N--CA 1.45 -0.471 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -73.74 120.37 19.24 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.081 0.467 . . . . 0.0 110.879 -177.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.633 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 53.1 m -122.87 114.77 20.93 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.61 -176.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.589 HG21 HE21 ' A' ' 167' ' ' GLN . 27.2 m -132.8 161.72 41.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.636 -179.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.556 ' HB3' ' HB3' ' A' ' 70' ' ' MET . 13.1 m170 -107.74 113.61 27.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.747 -173.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.63 ' O ' ' HA ' ' A' ' 70' ' ' MET . 40.2 t -90.83 123.36 42.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.909 0.385 . . . . 0.0 110.557 -176.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.736 ' CZ ' HG11 ' A' ' 68' ' ' VAL . 2.3 t80 -85.13 104.67 15.23 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.527 -168.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.569 ' C ' HG23 ' A' ' 68' ' ' VAL . 18.9 pt -130.3 117.09 17.75 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.424 0.63 . . . . 0.0 110.892 174.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.639 ' HB2' ' HG2' ' A' ' 32' ' ' GLN . 51.0 Cg_exo -54.42 153.87 21.33 Favored 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 123.315 2.677 . . . . 0.0 112.505 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.616 ' HA ' HG12 ' A' ' 34' ' ' VAL . . . -56.89 -18.22 12.41 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 114.848 -1.069 . . . . 0.0 112.423 -176.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.639 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 30.1 pt20 -72.05 -18.62 61.93 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.94 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.489 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -123.09 -31.82 3.55 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 120.52 -0.472 . . . . 0.0 111.869 -176.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.616 HG12 ' HA ' ' A' ' 31' ' ' ALA . 9.1 p -52.56 -34.28 19.07 Favored 'Isoleucine or valine' 0 C--O 1.242 0.675 0 CA-C-O 120.922 0.391 . . . . 0.0 111.715 -172.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.19 -57.11 21.5 Favored Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.355 -178.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.52 -13.46 60.09 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.928 -174.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.657 HD12 ' HB3' ' A' ' 90' ' ' LYS . 3.3 mm -64.28 -39.98 87.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 116.313 -0.403 . . . . 0.0 109.97 176.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.645 HG23 HG21 ' A' ' 45' ' ' ILE . 9.1 mt -61.16 -60.05 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.929 176.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.574 ' HA3' ' NE2' ' A' ' 44' ' ' HIS . . . 86.48 119.12 1.12 Allowed Glycine 0 CA--C 1.525 0.713 0 C-N-CA 120.288 -0.958 . . . . 0.0 115.393 169.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm 40.43 89.52 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.278 1.431 . . . . 0.0 114.259 169.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.4 ttpt 61.54 5.25 1.18 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.958 175.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.3 29.83 69.88 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.749 -0.738 . . . . 0.0 111.859 -176.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 54.9 tp60 -86.51 -54.71 4.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.532 0.206 . . . . 0.0 111.214 -176.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.574 ' NE2' ' HA3' ' A' ' 39' ' ' GLY . 17.4 p80 -71.64 -21.76 61.78 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.483 -176.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.645 HG21 HG23 ' A' ' 38' ' ' ILE . 10.6 tt -68.07 -33.52 61.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 121.131 0.491 . . . . 0.0 110.006 175.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.449 ' HE2' ' HA ' ' A' ' 46' ' ' LYS . 0.8 OUTLIER -81.32 -31.62 33.43 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 174.808 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.5 ' HB3' ' HA ' ' A' ' 44' ' ' HIS . 34.1 tt0 -58.58 -36.57 74.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.349 171.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.791 HD22 HG12 ' A' ' 56' ' ' ILE . 6.7 tt -61.43 -39.17 89.82 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.271 177.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.693 ' HA ' HD13 ' A' ' 56' ' ' ILE . 17.1 m -61.55 -29.28 69.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.301 177.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 43.8 mtp180 -79.57 -50.89 10.03 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.617 -177.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.742 ' CZ ' ' HA ' ' A' ' 48' ' ' LEU . 1.7 p90 -75.18 -18.99 60.06 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.853 -177.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -92.05 -22.47 19.92 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.829 175.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.2 t 65.85 37.2 5.67 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.616 -177.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -132.36 173.41 11.31 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.17 -178.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.805 ' HB3' ' HB ' ' A' ' 74' ' ' THR . 18.6 t -100.5 101.8 12.82 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.791 HG12 HD22 ' A' ' 48' ' ' LEU . 2.1 mp -98.23 111.9 29.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.814 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.503 ' HB2' ' HB ' ' A' ' 72' ' ' VAL . 41.7 mtpt -128.75 154.31 46.5 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.849 -178.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.493 HG13 HD11 ' A' ' 38' ' ' ILE . 42.4 mm -110.1 113.31 43.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 174.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.727 ' HB2' HG23 ' A' ' 72' ' ' VAL . . . -71.69 126.16 91.58 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.396 -175.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -65.03 143.81 80.05 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.404 2.069 . . . . 0.0 110.341 171.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo . . . . . 0 C--N 1.351 0.694 0 C-N-CA 124.098 3.199 . . . . 0.0 113.497 -176.556 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.4 tmtp? . . . . . 0 C--O 1.232 0.133 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.736 HG11 ' CZ ' ' A' ' 28' ' ' PHE . 2.7 p -154.02 150.91 11.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.327 -167.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.522 ' HD3' HG11 ' A' ' 34' ' ' VAL . 61.2 mtp180 -125.83 129.9 50.31 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 175.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.63 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 3.6 mpp? -94.27 136.88 34.08 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.824 -172.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.599 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 84.6 t -83.61 120.48 34.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 175.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.727 HG23 ' HB2' ' A' ' 59' ' ' ALA . 74.4 t -86.88 96.43 5.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.633 ' O ' ' HA ' ' A' ' 24' ' ' THR . 10.2 tp -93.48 114.57 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 CA-C-O 121.422 0.63 . . . . 0.0 110.162 178.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.805 ' HB ' ' HB3' ' A' ' 55' ' ' SER . 75.3 m -113.27 103.25 11.14 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 173.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -168.75 162.91 36.7 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.046 -1.073 . . . . 0.0 112.934 -176.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.457 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 37.9 Cg_endo -67.81 147.66 75.5 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.285 1.99 . . . . 0.0 110.361 169.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 76' ' ' PRO . 81.0 Cg_exo -49.85 -27.27 15.44 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 124.092 3.194 . . . . 0.0 113.722 -177.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -61.38 -43.06 99.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.425 0.631 . . . . 0.0 110.23 175.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.36 -38.77 41.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.798 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -59.04 -30.58 68.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.14 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.572 ' HA ' ' NE2' ' A' ' 164' ' ' GLN . 55.5 t80 -59.72 -48.92 79.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.53 178.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 17.3 mttt -68.39 -50.78 50.46 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.242 0.544 . . . . 0.0 109.682 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.91 -54.06 49.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.968 -1.014 . . . . 0.0 111.93 -174.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.574 ' HB2' HE21 ' A' ' 164' ' ' GLN . 23.8 mt-30 -76.27 -31.07 58.07 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.95 -0.3 . . . . 0.0 111.135 -178.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -59.2 -42.06 97.02 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.295 -0.955 . . . . 0.0 111.589 175.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.457 ' HA ' ' HD3' ' A' ' 86' ' ' ARG . 21.6 mmt180 -79.79 -27.92 40.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.861 -0.169 . . . . 0.0 111.156 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.518 HG22 ' O ' ' A' ' 84' ' ' GLN . 0.3 OUTLIER -68.57 -39.49 80.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.069 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.582 ' HB3' HG21 ' A' ' 103' ' ' VAL . 9.1 m-85 -68.11 -30.17 69.27 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.148 0.499 . . . . 0.0 109.886 173.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -65.69 -28.88 74.05 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.773 175.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.657 ' HB3' HD12 ' A' ' 37' ' ' ILE . 10.9 mptt -70.31 -29.96 66.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.822 0.344 . . . . 0.0 110.372 176.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' A' ' 88' ' ' TYR . 4.6 mm? -61.99 -44.97 95.61 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 169.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 1.097 ' HE3' ' HB ' ' A' ' 103' ' ' VAL . 1.8 mptm? -63.44 -30.23 71.39 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.637 176.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -55.31 -46.02 76.27 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.522 -178.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -109.63 -5.78 15.56 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -178.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 61.87 40.53 12.53 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.223 174.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.42 ' CE2' ' HB2' ' A' ' 33' ' ' ALA . 53.2 m-85 . . . . . 0 N--CA 1.467 0.397 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -178.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.436 -1.172 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 1.097 ' HB ' ' HE3' ' A' ' 92' ' ' LYS . 7.6 p -57.28 124.29 10.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 122.136 0.969 . . . . 0.0 111.734 -170.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 35.6 mmtm -126.03 90.44 3.19 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 113.976 -1.466 . . . . 0.0 108.43 176.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.551 ' HB3' ' CE2' ' A' ' 88' ' ' TYR . 2.0 tm? -128.12 125.64 39.58 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.508 0.67 . . . . 0.0 110.525 -175.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.52 ' HG3' HG13 ' A' ' 157' ' ' ILE . 2.5 mp0 -71.35 132.11 44.38 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.58 -1.191 . . . . 0.0 112.064 -177.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 20.3 m -119.56 135.16 54.9 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 169.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 10.2 m170 -108.75 120.86 43.71 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.731 0.301 . . . . 0.0 110.329 -177.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.483 HD13 ' HA ' ' A' ' 167' ' ' GLN . 37.4 pt -114.1 136.06 51.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.135 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.608 HH11 HG13 ' A' ' 153' ' ' ILE . 19.5 mmm180 -87.17 119.16 27.12 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.862 -176.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.626 HG12 HD11 ' A' ' 174' ' ' LEU . 19.2 m -123.04 153.33 64.26 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.827 176.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.535 ' HD2' HD22 ' A' ' 174' ' ' LEU . 51.8 Cg_exo -54.33 142.89 67.64 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.221 1.948 . . . . 0.0 111.098 176.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.58 ' HA ' HG22 ' A' ' 152' ' ' VAL . . . -50.17 -47.41 54.42 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -170.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 43.8 t -75.1 -28.95 60.47 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.523 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.39 -32.26 73.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.14 -178.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.664 ' O ' HG12 ' A' ' 119' ' ' VAL . . . -64.56 -32.76 74.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.368 0.604 . . . . 0.0 110.231 175.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -74.74 -25.32 70.0 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.548 177.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.411 ' HD3' HG22 ' A' ' 177' ' ' VAL . 56.3 ttt180 -92.95 -15.09 26.68 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.722 0.267 . . . . 0.0 111.722 -178.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.664 HG12 ' O ' ' A' ' 116' ' ' ALA . 9.5 p -71.31 -20.88 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 173.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 1.072 ' HA ' ' HB ' ' A' ' 127' ' ' VAL . 71.9 mt -66.35 -25.98 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.953 170.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.03 0 CA-C-N 114.993 -1.003 . . . . 0.0 112.219 178.185 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 31.0 mtmm . . . . . 0 N--CA 1.462 0.157 0 CA-C-O 120.979 0.419 . . . . 0.0 110.948 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 23.5 m -65.09 -39.19 92.83 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.642 -170.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 1.072 ' HB ' ' HA ' ' A' ' 120' ' ' ILE . 14.4 p -63.71 -32.73 58.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.028 0.442 . . . . 0.0 111.082 -177.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -71.9 -40.56 68.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.241 0.544 . . . . 0.0 110.237 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -78.67 -25.4 44.87 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.394 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.487 HD23 HG11 ' A' ' 138' ' ' VAL . 25.8 tp -58.59 -45.53 88.89 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 174.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -60.55 -36.03 77.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.068 0.461 . . . . 0.0 110.693 176.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -67.51 -33.03 74.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.407 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -88.16 -43.95 11.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.852 0.358 . . . . 0.0 110.755 -178.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.633 ' HB ' ' HB2' ' A' ' 166' ' ' ALA . 62.0 p -73.65 -22.57 59.93 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.956 -174.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 65.08 15.74 10.17 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.044 -178.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.545 ' HB2' ' HB1' ' A' ' 162' ' ' ALA . . . -120.84 168.75 11.12 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.124 -178.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.464 ' HB3' ' HB ' ' A' ' 157' ' ' ILE . 23.5 tt0 -93.84 109.71 21.39 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 177.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.487 HG11 HD23 ' A' ' 130' ' ' LEU . 55.0 t -106.29 105.89 19.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.879 -177.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.659 HG13 ' HD3' ' A' ' 155' ' ' LYS . 4.8 p -108.76 115.1 48.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.464 0.649 . . . . 0.0 110.605 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 47.0 t -101.68 115.33 65.04 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.125 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.519 ' HG3' ' HE3' ' A' ' 155' ' ' LYS . 84.0 Cg_endo -82.87 155.25 15.28 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.724 2.283 . . . . 0.0 112.608 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 39.8 mmt180 -86.52 -12.65 48.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.071 176.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -116.93 -89.17 0.58 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.795 -178.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.988 ' HG2' ' H ' ' A' ' 153' ' ' ILE . 23.8 tp60 67.43 -77.39 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.04 0.536 . . . . 0.0 111.624 -178.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.1 p -145.31 139.51 15.06 Favored Pre-proline 0 C--N 1.316 -0.851 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -57.19 148.77 67.88 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 122.641 2.227 . . . . 0.0 111.97 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -72.95 8.64 1.46 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.025 -178.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -61.55 -29.22 69.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.574 0.702 . . . . 0.0 109.571 169.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . 0.413 ' O ' ' HG2' ' A' ' 150' ' ' GLU . 8.6 t-20 -95.94 0.46 51.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.515 177.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' A' ' 149' ' ' ASN . 8.8 pt-20 46.46 23.82 0.25 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.91 1.284 . . . . 0.0 112.323 -175.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.408 ' HG3' ' O ' ' A' ' 111' ' ' VAL . 34.4 tt0 -152.97 139.49 18.71 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 120.871 0.367 . . . . 0.0 110.706 -171.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.58 HG22 ' HA ' ' A' ' 113' ' ' ALA . 17.5 m -132.19 -177.04 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.951 -178.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.988 ' H ' ' HG2' ' A' ' 144' ' ' GLN . 20.5 mt -126.27 141.0 47.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.889 0.376 . . . . 0.0 111.462 -178.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 5.6 p -109.88 138.93 35.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 165.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.659 ' HD3' HG13 ' A' ' 139' ' ' VAL . 0.0 OUTLIER -99.6 129.09 45.72 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.915 -173.668 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.5 HG21 ' HA ' ' A' ' 163' ' ' SER . 59.9 mt -110.86 117.69 55.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.221 179.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.52 HG13 ' HG3' ' A' ' 106' ' ' GLU . 3.9 mp -112.27 139.62 36.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.658 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 142.38 -153.2 24.3 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.351 -0.928 . . . . 0.0 112.897 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 17.9 m80 -85.69 158.22 20.11 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -177.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.471 ' HB3' ' CG ' ' A' ' 88' ' ' TYR . 51.4 p90 -63.64 -36.73 84.8 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.459 -175.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -54.58 -46.82 73.82 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.384 0.611 . . . . 0.0 110.371 175.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.545 ' HB1' ' HB2' ' A' ' 136' ' ' ALA . . . -68.76 -48.31 64.04 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.854 -178.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.5 ' HA ' HG21 ' A' ' 156' ' ' ILE . 41.9 m -56.63 -49.95 73.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.173 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . 0.574 HE21 ' HB2' ' A' ' 84' ' ' GLN . 93.4 mt-30 -59.64 -39.43 84.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.93 0.395 . . . . 0.0 111.289 -178.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 35.9 ttp -72.8 -37.23 67.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.774 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.633 ' HB2' ' HB ' ' A' ' 134' ' ' THR . . . -66.56 -48.68 68.87 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.805 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.589 HE21 HG21 ' A' ' 25' ' ' VAL . 42.2 mt-30 -51.82 -55.79 17.8 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.953 -178.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -64.32 -30.44 71.49 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.635 -174.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.969 ' HE2' ' HA ' ' A' ' 169' ' ' LYS . 3.5 mmpt? -76.82 -40.99 46.02 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.367 -177.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.425 ' O ' ' HG ' ' A' ' 174' ' ' LEU . 17.0 mt -70.89 -42.21 77.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.006 0.431 . . . . 0.0 110.132 176.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -61.46 -27.0 68.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.891 175.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -77.02 -40.43 46.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.4 -177.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.431 ' O ' HG23 ' A' ' 177' ' ' VAL . 18.2 pt -69.46 -26.75 31.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.602 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.626 HD11 HG12 ' A' ' 111' ' ' VAL . 19.3 mt -50.46 -47.74 56.79 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.831 0.348 . . . . 0.0 111.138 177.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.73 -40.52 97.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.787 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -73.68 -30.08 62.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.102 -178.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 173' ' ' ILE . 53.3 t -67.38 -45.82 84.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.27 175.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -63.3 -19.54 64.68 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.678 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 . . . . . 0 CA--C 1.535 0.391 0 CA-C-O 120.895 0.379 . . . . 0.0 111.229 179.888 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 . . . . . 0 C--O 1.235 0.324 0 CA-C-O 121.299 0.571 . . . . 0.0 111.22 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.492 ' HG2' HE22 ' A' ' 80' ' ' GLN . 30.4 tt0 -85.08 103.53 14.17 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.145 -178.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.67 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 8.0 t -120.05 123.12 42.65 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 121.556 0.693 . . . . 0.0 109.572 173.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.543 ' HB ' HG22 ' A' ' 109' ' ' ILE . 27.2 m -126.44 160.94 33.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -106.07 121.41 44.07 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 121.009 -0.277 . . . . 0.0 110.785 -171.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.617 ' O ' ' HA ' ' A' ' 70' ' ' MET . 21.6 t -96.93 128.43 48.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.614 -174.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.43 ' CZ ' HG11 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -90.65 104.84 17.38 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 122.326 0.25 . . . . 0.0 111.232 -171.622 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.474 ' C ' HG23 ' A' ' 68' ' ' VAL . 20.4 pt -126.97 120.06 22.53 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.179 0.514 . . . . 0.0 110.682 175.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.447 ' HA ' ' HA ' ' A' ' 68' ' ' VAL . 38.2 Cg_exo -58.92 152.38 58.41 Favored 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 122.955 2.437 . . . . 0.0 112.8 -177.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.668 ' HA ' HG12 ' A' ' 34' ' ' VAL . . . -60.01 -19.98 55.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.89 -1.05 . . . . 0.0 112.889 -173.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -68.54 -24.81 64.68 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.657 ' HB2' ' HE2' ' A' ' 96' ' ' PHE . . . -116.28 -31.03 5.76 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.939 -176.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.668 HG12 ' HA ' ' A' ' 31' ' ' ALA . 10.2 p -51.44 -34.96 15.92 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 CA-C-O 120.93 0.395 . . . . 0.0 111.432 -174.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -55.84 -55.91 26.62 Favored Glycine 0 N--CA 1.438 -1.231 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.268 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.25 -14.89 60.55 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 120.987 0.422 . . . . 0.0 111.099 -175.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.952 HD12 ' HB3' ' A' ' 90' ' ' LYS . 3.7 mm -65.98 -39.96 86.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.16 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.566 HG23 HG21 ' A' ' 45' ' ' ILE . 17.7 mt -61.94 -37.8 79.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-O 121.074 0.464 . . . . 0.0 111.392 177.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.66 141.21 9.07 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.063 178.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -46.52 -34.18 4.65 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.342 0.657 . . . . 0.0 112.132 -172.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.502 ' HE2' ' HB3' ' A' ' 43' ' ' GLN . 15.4 ptmt -123.09 93.2 3.88 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 166.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.46 ' HA2' HG22 ' A' ' 38' ' ' ILE . . . -33.23 88.8 0.01 OUTLIER Glycine 0 C--N 1.338 0.671 0 O-C-N 124.355 1.034 . . . . 0.0 113.673 172.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.502 ' HB3' ' HE2' ' A' ' 41' ' ' LYS . 5.4 tp-100 -176.19 -34.91 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -175.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -56.89 -41.8 78.72 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.023 169.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.566 HG21 HG23 ' A' ' 38' ' ' ILE . 8.5 tt -56.99 -34.16 44.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.036 173.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 23.5 mmmt -82.35 -29.96 30.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.594 -178.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.414 ' OE1' ' HD3' ' A' ' 50' ' ' ARG . 46.9 tp60 -62.85 -35.46 80.05 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 170.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.817 ' HG ' ' HE1' ' A' ' 51' ' ' PHE . 7.3 tt -60.98 -42.38 98.24 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.513 173.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 14.9 m -56.74 -34.95 68.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.609 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.414 ' HD3' ' OE1' ' A' ' 47' ' ' GLN . 76.1 mtp180 -72.31 -51.87 18.77 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.693 -176.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.817 ' HE1' ' HG ' ' A' ' 48' ' ' LEU . 3.2 p90 -77.0 -29.98 55.71 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.728 -173.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.606 ' HB1' ' HB2' ' A' ' 83' ' ' ALA . . . -81.73 -12.56 58.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.244 -178.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.7 t 61.27 30.07 18.98 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.541 178.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -131.91 159.66 38.0 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.345 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.699 ' HB2' ' HB ' ' A' ' 74' ' ' THR . 19.6 m -91.12 100.46 13.29 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -178.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.405 HG13 HD22 ' A' ' 48' ' ' LEU . 33.4 mm -88.4 111.53 22.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.319 -177.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -130.6 137.76 49.8 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.39 176.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.8 mm -94.27 112.35 26.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 172.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.667 ' HB2' HG23 ' A' ' 72' ' ' VAL . . . -67.73 117.73 50.76 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.452 -174.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.53 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 7.5 Cg_exo -73.07 132.02 17.56 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.798 2.332 . . . . 0.0 111.406 176.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.53 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 6.3 Cg_exo . . . . . 0 N--CA 1.456 -0.703 0 C-N-CA 122.706 2.271 . . . . 0.0 111.531 177.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.6 tmtp? . . . . . 0 C--O 1.234 0.251 0 CA-C-O 121.566 0.698 . . . . 0.0 110.475 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.474 HG23 ' C ' ' A' ' 29' ' ' ILE . 2.4 p -144.78 151.91 15.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.724 -171.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.497 ' HD3' HG11 ' A' ' 34' ' ' VAL . 59.3 mtp180 -126.18 132.23 51.83 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 177.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.617 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 76.7 mtm -92.26 147.47 22.9 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.873 -175.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.548 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 86.4 t -96.09 124.42 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 172.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.667 HG23 ' HB2' ' A' ' 59' ' ' ALA . 97.5 t -86.8 102.13 11.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 174.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.67 ' O ' ' HA ' ' A' ' 24' ' ' THR . 8.8 tp -101.34 100.18 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 CA-C-O 121.882 0.849 . . . . 0.0 110.252 -177.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.699 ' HB ' ' HB2' ' A' ' 55' ' ' SER . 9.4 m -102.61 105.83 16.4 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.688 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -160.35 163.62 34.03 Favored Glycine 0 CA--C 1.497 -1.088 0 C-N-CA 119.674 -1.25 . . . . 0.0 113.254 -174.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.48 ' HD2' ' HB3' ' A' ' 79' ' ' ALA . 7.1 Cg_exo -67.23 136.77 41.55 Favored 'Trans proline' 0 N--CA 1.446 -1.273 0 C-N-CA 121.944 1.763 . . . . 0.0 109.859 170.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.573 ' HA ' ' NH2' ' A' ' 168' ' ' ARG . 3.7 Cg_exo -36.78 -50.93 1.4 Allowed 'Trans proline' 0 C--O 1.24 0.614 0 C-N-CA 124.59 3.527 . . . . 0.0 113.684 -176.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -63.81 -49.82 71.39 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.942 0.401 . . . . 0.0 111.174 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.56 ' HB1' ' O ' ' A' ' 52' ' ' ALA . . . -66.87 -34.4 77.72 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.407 -177.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.492 HE22 ' HG2' ' A' ' 23' ' ' GLU . 34.2 tt0 -61.91 -31.22 71.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.73 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -65.77 -42.17 91.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.603 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.3 mtmt -63.02 -37.98 89.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.548 0.689 . . . . 0.0 109.952 -178.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.606 ' HB2' ' HB1' ' A' ' 52' ' ' ALA . . . -69.76 -49.05 56.74 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.534 179.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.446 HE21 ' HG2' ' A' ' 80' ' ' GLN . 41.6 mt-30 -67.14 -30.81 70.91 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -177.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -56.99 -35.19 67.7 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.848 175.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.4 mmt180 -79.44 -36.76 38.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.576 0.227 . . . . 0.0 111.154 177.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.543 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 0.3 OUTLIER -67.75 -40.87 84.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.738 -174.93 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.745 ' HA ' HD23 ' A' ' 91' ' ' LEU . 6.7 m-85 -68.33 -32.04 71.88 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.056 0.455 . . . . 0.0 110.292 175.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -61.44 -28.91 70.29 Favored Glycine 0 C--O 1.224 -0.526 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.709 174.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.952 ' HB3' HD12 ' A' ' 37' ' ' ILE . 69.3 mmtt -66.99 -38.87 86.82 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 122.827 0.451 . . . . 0.0 111.002 174.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.745 HD23 ' HA ' ' A' ' 88' ' ' TYR . 3.2 mm? -60.49 -38.36 84.04 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.157 0.504 . . . . 0.0 110.555 173.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.984 ' HE3' ' HB ' ' A' ' 103' ' ' VAL . 3.6 mmtp -76.44 -26.54 55.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.502 178.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -68.43 -30.92 69.91 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.472 -175.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.583 ' HA ' ' OE1' ' A' ' 94' ' ' GLU . 4.4 mm-40 -96.42 10.7 37.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.307 0.575 . . . . 0.0 110.799 177.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 63.2 t30 57.2 45.52 20.37 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 114.757 -1.11 . . . . 0.0 112.143 172.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.657 ' HE2' ' HB2' ' A' ' 33' ' ' ALA . 61.2 m-85 . . . . . 0 C--N 1.324 -0.54 0 CA-C-O 121.148 0.499 . . . . 0.0 110.243 174.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 . . . . . 0 N--CA 1.454 -0.268 0 CA-C-O 120.726 0.298 . . . . 0.0 110.726 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.984 ' HB ' ' HE3' ' A' ' 92' ' ' LYS . 7.1 p -76.45 122.83 31.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 172.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -124.53 90.31 3.23 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 176.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.594 ' HB3' ' CE2' ' A' ' 88' ' ' TYR . 1.8 tm? -118.86 130.81 55.95 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.869 -173.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.865 ' HG2' HG13 ' A' ' 157' ' ' ILE . 32.0 mt-10 -73.5 126.89 31.25 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.188 -0.915 . . . . 0.0 112.743 -176.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.482 HG21 ' NE2' ' A' ' 167' ' ' GLN . 0.2 OUTLIER -113.81 125.5 54.16 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 167.012 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 21.5 m170 -107.81 121.49 44.83 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -177.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.543 HG22 ' HB ' ' A' ' 25' ' ' VAL . 10.4 pt -113.83 147.24 17.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 177.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.896 ' HG3' ' HG2' ' A' ' 151' ' ' GLN . 4.2 tpt180 -97.88 118.65 34.92 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -176.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.708 HG12 HD22 ' A' ' 174' ' ' LEU . 11.1 m -116.82 150.1 45.2 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 178.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.641 ' CD ' HD13 ' A' ' 174' ' ' LEU . 44.8 Cg_exo -49.77 149.66 10.42 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 123.217 2.612 . . . . 0.0 112.341 177.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -48.6 -49.15 38.11 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -171.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 23.1 t -85.93 -19.74 30.04 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.839 0.352 . . . . 0.0 110.921 -176.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.443 ' O ' HG23 ' A' ' 119' ' ' VAL . . . -65.66 -26.08 67.63 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.521 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.517 ' O ' ' HB ' ' A' ' 119' ' ' VAL . . . -63.51 -34.44 77.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.59 177.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -67.66 -32.91 79.34 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.852 -0.689 . . . . 0.0 111.473 177.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.471 ' HD3' HG22 ' A' ' 177' ' ' VAL . 26.1 mtp180 -83.77 -6.8 59.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.488 -0.356 . . . . 0.0 110.609 176.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.713 HG22 HD11 ' A' ' 173' ' ' ILE . 12.0 t -75.11 -51.19 22.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.331 0.586 . . . . 0.0 109.788 172.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 1.015 ' HA ' ' HB ' ' A' ' 127' ' ' VAL . 20.2 pt -81.12 -34.22 13.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.946 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.479 ' HA3' HG22 ' A' ' 126' ' ' THR . . . . . . . . 0 N--CA 1.444 -0.825 0 C-N-CA 120.98 -0.628 . . . . 0.0 111.891 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? . . . . . 0 N--CA 1.456 -0.165 0 CA-C-O 120.669 0.271 . . . . 0.0 111.25 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.631 ' O ' ' HG ' ' A' ' 130' ' ' LEU . 8.1 t -76.79 -20.22 56.68 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.756 -174.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 1.015 ' HB ' ' HA ' ' A' ' 120' ' ' ILE . 8.8 p -69.25 -29.21 41.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 176.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -65.95 -41.04 91.77 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.494 174.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.33 -48.76 80.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.761 173.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.631 ' HG ' ' O ' ' A' ' 126' ' ' THR . 87.7 mt -58.02 -50.47 73.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.457 -177.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -62.0 -49.69 75.04 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -176.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -77.81 -11.3 59.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.794 -173.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 59.5 tp -97.46 -49.34 4.94 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.749 0.309 . . . . 0.0 110.96 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 82.1 p -79.62 -20.2 47.39 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.85 -173.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 66.2 27.47 10.31 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.875 0.735 . . . . 0.0 110.168 -174.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -127.33 176.21 7.6 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.528 -177.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.546 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 7.3 tp10 -108.74 111.4 23.14 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.845 177.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.49 HG21 HD11 ' A' ' 170' ' ' ILE . 46.2 t -108.41 106.24 20.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 177.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.698 HG13 ' HD3' ' A' ' 155' ' ' LYS . 5.1 p -123.16 125.33 71.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.351 0.596 . . . . 0.0 111.819 -175.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.415 ' HA ' ' HD2' ' A' ' 141' ' ' PRO . 89.3 t -92.8 118.1 67.8 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 173.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 140' ' ' VAL . 9.6 Cg_endo -50.72 137.71 41.78 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 123.811 3.007 . . . . 0.0 113.25 -171.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.539 ' NE ' ' HA ' ' A' ' 142' ' ' ARG . 4.6 mmp_? -81.64 -28.99 33.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.309 178.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -93.56 62.89 3.37 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 163.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -57.93 139.31 54.6 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.607 -1.179 . . . . 0.0 111.438 -171.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 30.2 p -59.13 130.47 86.83 Favored Pre-proline 0 N--CA 1.448 -0.542 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.292 173.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.448 ' C ' ' H ' ' A' ' 148' ' ' GLU . 17.8 Cg_endo -58.27 150.98 63.2 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.684 2.256 . . . . 0.0 112.226 -175.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -78.24 35.32 0.22 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.321 0.582 . . . . 0.0 110.751 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.448 ' H ' ' C ' ' A' ' 146' ' ' PRO . 24.0 tt0 -52.26 -47.15 65.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.019 177.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -109.15 25.01 12.3 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.314 178.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 49.48 31.34 3.95 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.854 1.262 . . . . 0.0 112.544 178.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.896 ' HG2' ' HG3' ' A' ' 110' ' ' ARG . 7.8 tt0 -156.68 136.12 12.22 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.141 -177.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 32.6 m -122.41 169.32 13.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.007 0.432 . . . . 0.0 111.716 -172.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 10.7 mm -102.27 142.76 15.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.098 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 4.1 p -127.97 140.04 50.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.939 171.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.698 ' HD3' HG13 ' A' ' 139' ' ' VAL . 0.0 OUTLIER -96.77 130.4 44.03 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.738 -174.685 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.546 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 76.0 mt -114.43 111.53 36.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 172.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.865 HG13 ' HG2' ' A' ' 106' ' ' GLU . 4.2 mp -110.05 131.69 60.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.12 -177.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 163.82 -164.0 36.14 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.313 -0.946 . . . . 0.0 112.53 177.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.585 ' HA ' HG13 ' A' ' 103' ' ' VAL . 5.1 m80 -79.07 160.07 27.25 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.544 ' HB3' ' CG ' ' A' ' 88' ' ' TYR . 13.5 p90 -57.43 -33.3 67.75 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 118.561 0.619 . . . . 0.0 112.028 -175.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -61.86 -52.95 62.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.522 0.677 . . . . 0.0 110.112 175.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -65.59 -41.65 92.59 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.808 -175.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.48 ' O ' ' HG3' ' A' ' 167' ' ' GLN . 26.2 p -68.08 -49.13 63.16 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.318 -176.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.62 -31.63 71.72 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.708 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 25.6 ttt -66.83 -45.66 77.56 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.036 0.446 . . . . 0.0 110.301 176.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.533 ' HB3' HG21 ' A' ' 156' ' ' ILE . . . -71.16 -35.31 71.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.833 -177.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.482 ' NE2' HG21 ' A' ' 107' ' ' THR . 66.4 mt-30 -51.54 -56.58 12.64 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.005 0.431 . . . . 0.0 110.807 -179.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.662 ' HA ' ' HB2' ' A' ' 171' ' ' ARG . 0.4 OUTLIER -74.09 -27.18 60.77 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.498 178.812 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.616 ' HA ' ' HE3' ' A' ' 169' ' ' LYS . 0.2 OUTLIER -64.52 -49.76 70.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.064 0.459 . . . . 0.0 109.992 -179.245 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.562 HG23 HG22 ' A' ' 119' ' ' VAL . 2.0 mp -71.87 -35.24 53.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.755 177.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.729 ' HA ' HD23 ' A' ' 174' ' ' LEU . 1.0 OUTLIER -56.58 -33.82 66.55 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.38 172.894 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.49 -44.13 45.53 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.73 0.271 . . . . 0.0 111.73 -178.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.713 HD11 HG22 ' A' ' 119' ' ' VAL . 2.7 pp -68.58 -30.86 48.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.61 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.729 HD23 ' HA ' ' A' ' 171' ' ' ARG . 0.3 OUTLIER -71.89 -37.59 70.11 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.624 0.726 . . . . 0.0 109.278 174.191 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -58.01 -32.21 67.7 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.981 -1.008 . . . . 0.0 111.067 176.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -61.36 -33.74 74.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.082 0.468 . . . . 0.0 110.113 174.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.471 HG22 ' HD3' ' A' ' 118' ' ' ARG . 22.0 t -73.8 -29.41 26.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.358 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -63.83 -34.85 78.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.005 0.431 . . . . 0.0 110.44 175.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 . . . . . 0 C--N 1.326 -0.436 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.238 -174.672 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.505 ' HB3' HG22 ' A' ' 74' ' ' THR . 97.1 mt-30 . . . . . 0 N--CA 1.452 -0.326 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -73.27 143.67 46.96 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.679 -174.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 44.8 m -115.16 107.45 15.32 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.509 0.671 . . . . 0.0 110.774 -176.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.0 t -106.96 148.41 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.429 ' HB3' ' SD ' ' A' ' 70' ' ' MET . 15.9 m-70 -113.74 146.51 39.77 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -174.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.695 ' HB ' HG22 ' A' ' 71' ' ' VAL . 7.4 t -124.26 142.79 39.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 120.912 0.387 . . . . 0.0 111.173 -174.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.754 ' CE2' HG11 ' A' ' 68' ' ' VAL . 45.4 t80 -97.58 105.27 17.39 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.088 0.955 . . . . 0.0 110.269 -176.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.53 ' C ' HG23 ' A' ' 68' ' ' VAL . 17.6 pt -124.07 120.22 26.43 Favored Pre-proline 0 C--N 1.324 -0.53 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.766 174.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.612 ' HA ' ' HA ' ' A' ' 68' ' ' VAL . 18.0 Cg_endo -57.96 150.73 62.19 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 122.966 2.444 . . . . 0.0 112.05 -176.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.62 ' HA ' HG12 ' A' ' 34' ' ' VAL . . . -60.17 -19.64 54.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.082 -174.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -69.96 -22.99 63.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.214 177.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.457 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -113.59 -31.79 6.39 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 120.889 -0.325 . . . . 0.0 111.625 -175.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.62 HG12 ' HA ' ' A' ' 31' ' ' ALA . 11.7 p -55.58 -31.23 28.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 O-C-N 123.431 0.457 . . . . 0.0 111.714 -171.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.71 -57.58 18.84 Favored Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.019 -178.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.43 -13.73 59.7 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 120.673 0.273 . . . . 0.0 111.368 -175.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.594 HD12 ' HB3' ' A' ' 90' ' ' LYS . 2.1 mm -65.49 -36.43 77.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 177.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.497 HG22 ' HA2' ' A' ' 42' ' ' GLY . 37.8 mt -63.99 -52.64 53.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.012 173.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 81.7 106.37 0.37 Allowed Glycine 0 CA--C 1.523 0.549 0 N-CA-C 115.131 0.812 . . . . 0.0 115.131 168.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.0 tptt 42.16 89.51 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.841 1.256 . . . . 0.0 113.757 169.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.427 ' HG2' ' O ' ' A' ' 41' ' ' LYS . 21.0 ttpt 66.85 -0.35 1.68 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.702 0.801 . . . . 0.0 111.947 176.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.497 ' HA2' HG22 ' A' ' 38' ' ' ILE . . . 84.96 18.92 60.27 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.274 -0.965 . . . . 0.0 111.398 -175.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -67.84 -47.21 69.61 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.989 0.423 . . . . 0.0 110.076 178.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 64.0 m-70 -68.29 -39.59 82.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.753 -172.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.0 tt -62.51 -47.31 93.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.719 0.295 . . . . 0.0 111.775 -178.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.2 ptmm? -81.43 -22.87 37.89 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.924 -177.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -64.81 -39.21 93.22 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 169.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.637 ' HA ' ' CZ ' ' A' ' 51' ' ' PHE . 7.8 tt -61.95 -42.12 98.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.931 177.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.642 ' HA ' HD13 ' A' ' 56' ' ' ILE . 44.0 t -53.98 -34.85 60.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.687 177.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -76.85 -50.96 12.17 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.661 -177.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.637 ' CZ ' ' HA ' ' A' ' 48' ' ' LEU . 2.4 p90 -76.77 -11.42 59.83 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 119.995 -0.682 . . . . 0.0 111.85 -175.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -96.36 -18.53 19.88 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.73 0.3 . . . . 0.0 110.975 176.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.7 t 65.32 34.36 8.35 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.698 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -141.18 168.93 18.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.291 -176.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.665 ' HB2' ' HB ' ' A' ' 74' ' ' THR . 29.9 m -90.71 103.26 15.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.743 0.306 . . . . 0.0 110.679 -178.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.642 HD13 ' HA ' ' A' ' 49' ' ' SER . 2.4 mp -107.21 113.13 42.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.035 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -134.64 157.76 45.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.794 -177.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 40.8 mm -97.6 135.7 31.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 174.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.864 ' HB2' HG23 ' A' ' 72' ' ' VAL . . . -92.5 140.58 24.08 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-O 120.642 0.258 . . . . 0.0 110.772 -178.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 59' ' ' ALA . 21.9 Cg_exo -65.63 120.8 8.04 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.794 2.33 . . . . 0.0 111.495 175.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo . . . . . 0 N--CA 1.461 -0.436 0 C-N-CA 122.325 2.017 . . . . 0.0 111.733 -179.058 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.738 0.304 . . . . 0.0 111.74 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.754 HG11 ' CE2' ' A' ' 28' ' ' PHE . 7.7 p -137.23 150.99 26.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-O 120.925 0.393 . . . . 0.0 110.602 -175.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.616 ' HB3' HG21 ' A' ' 34' ' ' VAL . 18.6 ttm180 -122.21 121.88 37.86 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 174.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.454 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 44.5 ttp -79.83 148.11 31.51 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.134 -178.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.695 HG22 ' HB ' ' A' ' 27' ' ' VAL . 21.8 m -115.19 145.64 20.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.716 0.293 . . . . 0.0 110.555 175.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.864 HG23 ' HB2' ' A' ' 59' ' ' ALA . 58.3 t -107.8 111.11 34.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.15 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.578 ' O ' HD12 ' A' ' 73' ' ' ILE . 2.7 pp -118.77 125.32 74.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.817 0.818 . . . . 0.0 111.133 176.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.665 ' HB ' ' HB2' ' A' ' 55' ' ' SER . 59.4 m -107.04 106.03 16.35 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.786 176.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.03 134.58 7.4 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 119.995 -1.098 . . . . 0.0 113.464 -172.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -69.42 151.03 70.95 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.057 1.838 . . . . 0.0 110.247 167.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -38.13 -49.07 2.28 Favored 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 124.862 3.708 . . . . 0.0 115.407 -173.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -71.3 -49.97 37.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.875 0.369 . . . . 0.0 110.132 -178.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.59 -27.19 68.78 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.806 -177.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -53.9 -42.56 68.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.307 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -72.5 -34.65 67.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.844 -177.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 15.4 tppt? -64.99 -47.83 76.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.714 -178.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.0 -53.13 19.06 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.868 -177.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.547 ' O ' HG22 ' A' ' 87' ' ' ILE . 6.5 tt0 -72.18 -30.23 64.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.386 -173.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -56.29 -34.76 63.48 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.508 177.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -76.7 -36.85 56.95 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 1.005 ' HA ' ' HD3' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -70.41 -30.31 42.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.804 -174.492 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.419 ' HA ' HD12 ' A' ' 105' ' ' LEU . 7.4 m-85 -66.94 -30.67 70.87 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.166 0.508 . . . . 0.0 109.752 171.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -61.87 -29.22 71.76 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.867 175.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 1.005 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 5.2 mptp? -60.0 -45.79 91.58 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.909 0.385 . . . . 0.0 109.999 173.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.404 ' HB2' ' O ' ' A' ' 88' ' ' TYR . 3.6 mm? -57.23 -37.67 72.62 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.591 176.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.985 ' HE3' ' HB ' ' A' ' 103' ' ' VAL . 11.4 mmtp -75.26 -24.43 57.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.028 -176.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -69.47 -44.39 71.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.705 0.288 . . . . 0.0 111.407 -176.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.681 ' HB2' ' CE2' ' A' ' 96' ' ' PHE . 22.7 mm-40 -108.2 1.81 22.37 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 52.27 47.9 23.77 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.269 177.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.681 ' CE2' ' HB2' ' A' ' 94' ' ' GLU . 71.8 m-85 . . . . . 0 N--CA 1.467 0.405 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.442 -177.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 . . . . . 0 CA--C 1.519 -0.243 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.985 ' HB ' ' HE3' ' A' ' 92' ' ' LYS . 9.8 p -68.12 123.37 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 C-N-CA 118.392 -1.323 . . . . 0.0 109.328 174.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 158' ' ' GLY . 30.3 mmtp -130.75 89.68 2.79 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.43 177.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.419 HD12 ' HA ' ' A' ' 88' ' ' TYR . 0.9 OUTLIER -109.02 115.94 31.04 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -177.473 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.488 ' O ' ' HB3' ' A' ' 28' ' ' PHE . 33.5 tt0 -71.26 116.52 11.67 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.021 -176.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -101.66 144.25 30.61 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.053 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 -124.84 120.98 33.25 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.083 0.468 . . . . 0.0 110.785 -177.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 16.2 pt -121.17 138.15 52.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.144 0.497 . . . . 0.0 111.062 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.618 ' HD3' HG12 ' A' ' 153' ' ' ILE . 9.6 mmt85 -82.66 119.02 23.76 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.442 177.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.956 HG23 HD11 ' A' ' 174' ' ' LEU . 6.0 p -121.69 143.11 37.39 Favored Pre-proline 0 C--N 1.318 -0.783 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.481 ' HD2' ' HG ' ' A' ' 174' ' ' LEU . 50.7 Cg_exo -53.42 140.03 64.16 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.259 1.972 . . . . 0.0 110.111 177.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.68 -28.51 68.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.179 0.514 . . . . 0.0 110.761 -174.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.2 p -75.89 -34.5 59.97 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.461 176.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.525 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -71.89 -20.35 61.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.973 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.421 ' HB2' HG21 ' A' ' 152' ' ' VAL . . . -59.48 -32.65 70.45 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.236 0.541 . . . . 0.0 110.446 176.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -73.43 -39.63 50.17 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.576 175.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.544 ' HD3' HG22 ' A' ' 177' ' ' VAL . 45.5 mtp180 -73.41 -34.64 65.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.486 0.184 . . . . 0.0 111.459 -177.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.546 HG11 HG21 ' A' ' 140' ' ' VAL . 14.0 p -69.73 -36.43 70.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.923 0.392 . . . . 0.0 110.376 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.972 ' HA ' ' HB ' ' A' ' 127' ' ' VAL . 75.5 mt -75.11 -31.4 24.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.651 0.739 . . . . 0.0 109.449 174.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.096 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 179.637 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt . . . . . 0 C--O 1.234 0.283 0 CA-C-O 120.884 0.373 . . . . 0.0 110.422 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 11.0 m -60.09 -46.15 90.55 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.246 -175.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.972 ' HB ' ' HA ' ' A' ' 120' ' ' ILE . 9.9 p -68.82 -33.89 61.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.266 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -60.71 -42.56 97.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.346 0.593 . . . . 0.0 109.533 176.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -61.08 -48.89 79.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.844 175.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 91.4 mt -58.6 -49.37 77.73 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.09 -177.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -58.52 -43.88 89.31 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 123.14 0.275 . . . . 0.0 111.575 -174.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -81.13 -33.26 33.33 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 121.061 -0.256 . . . . 0.0 111.344 -178.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.34 -48.74 74.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.098 0.475 . . . . 0.0 110.009 178.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.621 HG21 ' HA ' ' A' ' 166' ' ' ALA . 66.7 p -85.6 -18.06 34.41 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.762 -174.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 63.6 29.32 15.19 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.523 -175.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -127.44 170.17 12.84 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.4 -177.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.448 ' HB3' ' HB ' ' A' ' 157' ' ' ILE . 10.1 tp10 -95.77 113.61 25.26 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 177.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 59.1 t -110.8 105.97 19.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.939 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.637 HG22 ' HD3' ' A' ' 141' ' ' PRO . 6.3 p -125.25 128.34 72.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.348 177.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.894 HG22 HG13 ' A' ' 154' ' ' VAL . 2.3 t -130.75 81.55 67.08 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 121.02 0.438 . . . . 0.0 110.723 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.809 ' HD2' ' HE3' ' A' ' 155' ' ' LYS . 51.6 Cg_exo -57.1 142.18 94.28 Favored 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 123.083 2.522 . . . . 0.0 112.113 176.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -78.17 -19.34 54.15 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.545 -176.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -97.3 16.56 19.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.035 -172.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.966 HE21 ' HB ' ' A' ' 153' ' ' ILE . 14.4 mm100 -50.79 -70.26 0.09 Allowed 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -177.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -137.98 159.94 66.49 Favored Pre-proline 0 C--N 1.311 -1.079 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.587 -174.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -56.44 144.31 84.08 Favored 'Trans proline' 0 C--O 1.238 0.503 0 C-N-CA 123.084 2.523 . . . . 0.0 112.902 -176.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -67.23 -7.45 24.03 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.407 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -49.96 -47.73 52.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.483 169.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . 0.49 ' O ' ' HG2' ' A' ' 150' ' ' GLU . 10.8 t-20 -87.52 -7.16 57.92 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.792 -178.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 149' ' ' ASN . 11.1 pt-20 48.13 33.26 3.46 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.712 1.205 . . . . 0.0 111.457 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -149.55 144.0 25.96 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.436 -173.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.421 HG21 ' HB2' ' A' ' 116' ' ' ALA . 25.2 m -128.47 -176.54 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.965 -178.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.966 ' HB ' HE21 ' A' ' 144' ' ' GLN . 39.3 mt -122.41 131.24 73.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.588 0.233 . . . . 0.0 111.6 -177.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.894 HG13 HG22 ' A' ' 140' ' ' VAL . 32.4 t -92.77 140.2 16.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 172.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.809 ' HE3' ' HD2' ' A' ' 141' ' ' PRO . 0.0 OUTLIER -107.39 126.19 52.16 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 177.397 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 60.2 mt -110.04 111.21 35.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.089 178.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.448 ' HB ' ' HB3' ' A' ' 137' ' ' GLU . 3.8 mp -109.1 119.75 59.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 176.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 104' ' ' LYS . . . 177.53 -157.4 21.95 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 119.62 -1.276 . . . . 0.0 113.1 -174.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.462 ' H ' ' HB3' ' A' ' 162' ' ' ALA . 1.1 m-70 -102.63 173.25 6.42 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 -173.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -59.96 -46.24 90.08 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 121.172 -0.211 . . . . 0.0 111.22 -177.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -60.89 -51.76 67.92 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.931 0.396 . . . . 0.0 110.516 175.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.462 ' HB3' ' H ' ' A' ' 159' ' ' HIS . . . -59.22 -49.04 79.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.259 -174.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.445 ' O ' ' HG3' ' A' ' 167' ' ' GLN . 32.4 t -62.16 -47.44 84.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.058 -175.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -56.41 -37.82 70.7 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.923 0.392 . . . . 0.0 111.001 178.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 89.9 mtp -71.92 -38.72 69.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.653 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.621 ' HA ' HG21 ' A' ' 134' ' ' THR . . . -66.83 -49.53 65.47 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.33 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.445 ' HG3' ' O ' ' A' ' 163' ' ' SER . 75.7 mt-30 -51.87 -52.46 49.44 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.233 -177.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 18.4 ptt180 -66.85 -38.15 85.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.146 -177.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.621 ' HE2' ' HA ' ' A' ' 169' ' ' LYS . 0.1 OUTLIER -68.09 -39.17 82.93 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.706 0.289 . . . . 0.0 111.299 -172.798 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.462 ' O ' HG12 ' A' ' 173' ' ' ILE . 1.9 mp -74.98 -44.19 44.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 177.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 -55.83 -25.59 42.57 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.2 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -60.77 -55.55 31.84 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.463 175.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.497 ' O ' HG23 ' A' ' 177' ' ' VAL . 42.5 pt -67.57 -23.94 30.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.446 -172.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.956 HD11 HG23 ' A' ' 111' ' ' VAL . 10.9 mp -58.33 -37.69 75.65 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.843 176.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -65.74 -34.97 79.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.058 0.456 . . . . 0.0 110.378 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -71.37 -38.1 71.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.508 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.544 HG22 ' HD3' ' A' ' 118' ' ' ARG . 58.0 t -66.7 -37.28 79.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.5 177.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 174' ' ' LEU . 98.2 mttt -66.06 -41.38 90.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.185 176.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.395 177.807 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 . . . . . 0 CA--C 1.516 -0.329 0 CA-C-O 121.1 0.476 . . . . 0.0 111.36 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -94.83 102.4 14.25 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.054 174.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 56.1 m -104.59 114.25 28.35 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.214 -177.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.426 HG22 ' HE ' ' A' ' 171' ' ' ARG . 42.1 t -126.42 149.94 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 176.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -108.52 146.45 33.2 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 122.086 -0.384 . . . . 0.0 110.138 -174.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.673 ' HB ' ' CG1' ' A' ' 71' ' ' VAL . 21.1 t -120.76 133.16 68.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.232 -174.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.782 ' CE1' HG11 ' A' ' 68' ' ' VAL . 32.5 t80 -93.56 104.15 16.29 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.483 0.713 . . . . 0.0 110.048 -176.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.496 ' CD1' HG23 ' A' ' 34' ' ' VAL . 8.8 pt -126.74 124.69 24.19 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.283 0.563 . . . . 0.0 111.13 178.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.457 ' HG2' ' HB3' ' A' ' 33' ' ' ALA . 3.0 Cg_endo -45.82 140.65 9.5 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 124.474 3.449 . . . . 0.0 114.064 -174.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.74 -18.71 22.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.958 -176.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -89.71 -29.47 18.72 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.11 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.566 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -96.47 -30.84 13.12 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -175.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.825 HG21 ' HB3' ' A' ' 69' ' ' ARG . 10.6 p -54.09 -29.91 19.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.707 179.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.76 -57.0 22.17 Favored Glycine 0 N--CA 1.432 -1.633 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.242 176.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.36 -14.16 59.78 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.552 -0.324 . . . . 0.0 111.201 -174.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.873 HD12 ' HB3' ' A' ' 90' ' ' LYS . 9.5 mm -63.16 -39.29 84.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 172.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.461 ' CG2' ' HA2' ' A' ' 42' ' ' GLY . 38.4 mt -61.83 -52.34 61.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.566 177.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.7 111.87 2.82 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 120.27 -0.967 . . . . 0.0 114.855 170.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.459 ' HD2' ' HA ' ' A' ' 40' ' ' LYS . 27.8 mmmt 59.23 -89.43 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.286 1.034 . . . . 0.0 113.561 173.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.495 ' CD ' ' HB2' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -129.28 23.94 5.55 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.18 0.514 . . . . 0.0 111.156 -177.478 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.461 ' HA2' ' CG2' ' A' ' 38' ' ' ILE . . . 82.37 28.79 38.78 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.441 -0.885 . . . . 0.0 110.992 -175.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.495 ' HB2' ' CD ' ' A' ' 41' ' ' LYS . 25.4 tm0? -91.02 -47.61 7.46 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.024 0.44 . . . . 0.0 109.855 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -70.52 -32.78 70.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.492 -174.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.616 HG23 ' HG3' ' A' ' 46' ' ' LYS . 6.2 tt -61.04 -44.59 98.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.176 0.512 . . . . 0.0 111.145 177.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.616 ' HG3' HG23 ' A' ' 45' ' ' ILE . 55.0 mtpt -81.41 -30.92 33.41 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.428 -177.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -63.11 -33.46 75.51 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 172.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.815 ' HA ' ' HD1' ' A' ' 51' ' ' PHE . 6.1 tt -62.95 -49.26 75.44 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.422 174.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.639 ' HA ' HD13 ' A' ' 56' ' ' ILE . 14.4 t -55.52 -40.84 72.31 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.704 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.834 ' HA ' ' HE ' ' A' ' 50' ' ' ARG . 0.9 OUTLIER -78.84 -40.54 32.47 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -177.68 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.815 ' HD1' ' HA ' ' A' ' 48' ' ' LEU . 0.4 OUTLIER -74.51 -30.84 61.96 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 121.829 -0.545 . . . . 0.0 110.484 -178.03 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -84.59 -12.96 53.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.529 -177.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.9 m 66.9 30.13 7.88 Favored 'General case' 0 N--CA 1.463 0.223 0 O-C-N 123.644 0.59 . . . . 0.0 110.854 -179.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -134.54 166.95 21.7 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.539 -176.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.45 ' HB2' ' HB ' ' A' ' 74' ' ' THR . 18.4 m -92.53 108.1 19.72 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.567 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.733 HG13 HG22 ' A' ' 73' ' ' ILE . 1.9 mp -110.47 115.03 48.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.224 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -137.66 135.75 36.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.234 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 37.6 mm -80.38 124.42 38.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 177.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.743 ' HB2' HG23 ' A' ' 72' ' ' VAL . . . -90.05 129.75 44.87 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.606 -177.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.34 140.61 95.29 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 122.942 2.428 . . . . 0.0 111.897 176.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.455 ' HD3' ' HG3' ' A' ' 69' ' ' ARG . 40.2 Cg_endo . . . . . 0 C--O 1.233 0.26 0 C-N-CA 122.796 2.33 . . . . 0.0 112.054 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.497 ' O ' ' HD2' ' A' ' 67' ' ' LYS . 1.0 OUTLIER . . . . . 0 CA--C 1.536 0.417 0 CA-C-O 121.786 0.803 . . . . 0.0 110.578 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.782 HG11 ' CE1' ' A' ' 28' ' ' PHE . 11.2 p -146.54 154.64 12.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.798 -175.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.825 ' HB3' HG21 ' A' ' 34' ' ' VAL . 11.7 ttm180 -129.94 129.38 43.75 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 170.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.515 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 42.2 mtt -96.48 134.63 39.42 Favored 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.236 -173.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.673 ' CG1' ' HB ' ' A' ' 27' ' ' VAL . 3.9 p -99.98 140.21 19.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 177.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.743 HG23 ' HB2' ' A' ' 59' ' ' ALA . 63.9 t -101.56 120.5 51.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.112 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.733 HG22 HG13 ' A' ' 56' ' ' ILE . 2.6 pp -114.76 127.31 72.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.499 0.666 . . . . 0.0 110.522 176.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.45 ' HB ' ' HB2' ' A' ' 55' ' ' SER . 91.3 m -125.55 113.21 17.12 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.674 178.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.62 161.14 34.65 Favored Glycine 0 CA--C 1.498 -1.03 0 C-N-CA 119.811 -1.185 . . . . 0.0 113.115 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.31 153.07 71.54 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 122.5 2.133 . . . . 0.0 110.964 169.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.425 ' HA ' ' NH2' ' A' ' 168' ' ' ARG . 35.8 Cg_exo -38.18 -51.59 2.0 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 124.804 3.669 . . . . 0.0 114.85 -176.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -66.61 -36.02 81.61 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.264 0.554 . . . . 0.0 110.994 -177.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.88 -49.82 27.53 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.724 -178.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.563 ' HG3' HD13 ' A' ' 73' ' ' ILE . 19.9 tt0 -63.47 -31.9 73.19 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.955 -178.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -54.21 -54.62 37.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.513 -177.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.6 pttm -72.93 -33.09 65.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.378 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.05 -53.03 62.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.224 177.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.403 ' O ' HG22 ' A' ' 87' ' ' ILE . 35.0 mt-30 -72.76 -31.16 64.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.38 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -54.12 -42.33 71.72 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.957 176.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -81.19 -28.81 34.79 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 178.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.403 HG22 ' O ' ' A' ' 84' ' ' GLN . 0.4 OUTLIER -65.24 -41.25 91.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 120.981 -0.287 . . . . 0.0 110.49 -176.202 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.596 ' HA ' HD23 ' A' ' 91' ' ' LEU . 26.5 m-85 -67.39 -31.67 72.05 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.249 0.547 . . . . 0.0 110.239 176.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.08 -29.38 74.22 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.913 176.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.873 ' HB3' HD12 ' A' ' 37' ' ' ILE . 67.0 mmtt -77.3 -21.06 54.11 Favored 'General case' 0 N--CA 1.442 -0.87 0 O-C-N 122.62 -0.341 . . . . 0.0 110.491 178.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.596 HD23 ' HA ' ' A' ' 88' ' ' TYR . 3.8 mm? -66.05 -33.27 75.43 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.239 0.542 . . . . 0.0 109.847 167.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.804 ' HE3' ' HB ' ' A' ' 103' ' ' VAL . 13.8 mmtp -75.94 -21.8 56.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.117 176.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.523 ' HB2' ' HA ' ' A' ' 90' ' ' LYS . 5.2 tp10 -62.78 -33.05 74.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.772 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.606 ' HG2' ' CE2' ' A' ' 96' ' ' PHE . 6.5 tp10 -88.96 -1.38 58.08 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.957 0.884 . . . . 0.0 109.605 178.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 12.5 m120 65.87 29.09 10.57 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.423 177.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.606 ' CE2' ' HG2' ' A' ' 94' ' ' GLU . 14.2 m-85 . . . . . 0 C--N 1.331 -0.216 0 CA-C-O 121.072 0.463 . . . . 0.0 111.149 178.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 . . . . . 0 CA--C 1.52 -0.197 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.804 ' HB ' ' HE3' ' A' ' 92' ' ' LYS . 7.1 p -65.95 122.23 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 175.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -116.79 88.23 2.86 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 174.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.595 ' HG ' ' HG ' ' A' ' 91' ' ' LEU . 1.6 tm? -112.02 124.66 52.87 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.973 -173.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -65.23 118.32 9.09 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.642 -178.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.501 HG21 ' NE2' ' A' ' 167' ' ' GLN . 1.2 m -109.92 136.9 48.47 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -108.0 118.76 37.6 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.286 0.565 . . . . 0.0 111.102 -174.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.523 HG13 ' HB ' ' A' ' 154' ' ' VAL . 12.4 pt -110.76 112.66 41.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.689 175.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.924 ' HG3' ' HG2' ' A' ' 151' ' ' GLN . 5.6 tpt180 -77.96 117.51 19.36 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.673 HG12 HD21 ' A' ' 174' ' ' LEU . 13.0 m -116.2 150.85 45.96 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -177.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -49.44 155.82 3.16 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.864 2.376 . . . . 0.0 111.461 175.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -52.83 -49.92 64.73 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.111 0.482 . . . . 0.0 111.513 -172.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 13.7 m -78.65 -8.26 58.48 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.913 -177.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.24 -29.99 61.95 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 122.215 -0.303 . . . . 0.0 111.453 -175.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.663 ' HB1' HG21 ' A' ' 140' ' ' VAL . . . -65.26 -37.84 88.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.2 0.524 . . . . 0.0 110.684 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -69.41 -28.29 72.65 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.912 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 37.1 mtp85 -92.02 -18.12 24.1 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 111.555 0.206 . . . . 0.0 111.555 -178.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.593 HG12 ' O ' ' A' ' 116' ' ' ALA . 8.4 p -76.64 -29.2 18.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 175.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.55 ' HA ' ' HB ' ' A' ' 127' ' ' VAL . 69.3 mt -65.79 -40.62 88.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 170.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.969 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.931 174.207 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? . . . . . 0 C--O 1.233 0.207 0 CA-C-O 120.989 0.423 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 15.1 m -64.69 -37.76 88.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.691 -175.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.55 ' HB ' ' HA ' ' A' ' 120' ' ' ILE . 14.0 p -63.24 -33.48 61.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-O 120.872 0.368 . . . . 0.0 110.731 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -65.95 -42.59 89.78 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 177.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -63.93 -40.96 97.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.233 177.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 79.3 mt -57.85 -50.77 72.17 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.202 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -68.4 -35.35 77.54 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.941 0.401 . . . . 0.0 110.881 -177.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -67.36 -36.99 82.51 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.385 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -84.9 -47.72 10.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.099 -175.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.548 ' HB ' ' HB2' ' A' ' 166' ' ' ALA . 76.9 p -79.88 -21.08 44.45 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -172.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 66.17 21.39 11.12 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.53 -174.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -120.13 164.15 16.62 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.002 177.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.501 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 49.0 mt-10 -101.07 113.02 25.65 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.188 0.518 . . . . 0.0 111.033 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 60.0 t -104.85 106.45 20.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.912 -178.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.474 ' O ' ' HD2' ' A' ' 155' ' ' LYS . 7.2 p -128.46 130.88 69.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.065 0.46 . . . . 0.0 111.136 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.688 ' HB ' HG22 ' A' ' 154' ' ' VAL . 8.5 p -125.94 131.04 23.86 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 116.136 -0.483 . . . . 0.0 109.855 178.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.46 ' HB2' ' HB2' ' A' ' 144' ' ' GLN . 36.7 Cg_exo -60.89 121.01 9.03 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.7 2.267 . . . . 0.0 111.631 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.663 ' H ' ' HD2' ' A' ' 142' ' ' ARG . 0.3 OUTLIER -83.19 14.78 3.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.586 0.708 . . . . 0.0 110.102 -175.043 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -117.84 -1.74 11.47 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.346 176.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.46 ' HB2' ' HB2' ' A' ' 141' ' ' PRO . 6.4 tp-100 -98.11 115.11 27.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.07 -172.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.1 t -175.29 70.53 0.27 Allowed Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.381 176.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -91.55 143.96 3.06 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.384 2.056 . . . . 0.0 112.568 -178.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -70.0 -16.62 63.2 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.981 178.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -52.3 -48.67 65.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.974 -1.012 . . . . 0.0 112.204 -178.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . 0.441 ' O ' ' HG2' ' A' ' 150' ' ' GLU . 4.4 t-20 -119.62 -10.4 9.61 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.014 -175.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 149' ' ' ASN . 12.2 pt-20 47.33 29.68 1.33 Allowed 'General case' 0 N--CA 1.475 0.799 0 O-C-N 124.31 1.007 . . . . 0.0 111.097 -173.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.924 ' HG2' ' HG3' ' A' ' 110' ' ' ARG . 30.5 tt0 -155.71 128.31 7.86 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.15 -174.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.401 HG21 ' HB2' ' A' ' 116' ' ' ALA . 33.1 m -114.41 -177.1 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.338 -171.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.411 HG12 ' HD2' ' A' ' 110' ' ' ARG . 53.9 mt -122.16 131.39 73.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -173.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.688 HG22 ' HB ' ' A' ' 140' ' ' VAL . 46.2 t -107.29 140.77 24.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 168.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.474 ' HD2' ' O ' ' A' ' 139' ' ' VAL . 0.0 OUTLIER -104.12 122.39 45.22 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.07 178.898 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.501 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 51.6 mt -102.71 112.67 36.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 173.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.401 ' N ' HD12 ' A' ' 157' ' ' ILE . 4.4 mp -103.6 129.86 54.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.82 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 161.3 -172.07 37.45 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.436 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.512 ' HA ' HG13 ' A' ' 103' ' ' VAL . 6.3 p80 -88.68 153.68 20.91 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.437 ' HB3' ' CG ' ' A' ' 88' ' ' TYR . 10.2 p90 -50.82 -46.59 59.99 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -165.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.411 ' O ' ' HG3' ' A' ' 164' ' ' GLN . 16.8 m-85 -59.67 -48.94 79.7 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 118.85 0.75 . . . . 0.0 111.174 -178.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.59 -42.91 86.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.603 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.475 ' O ' ' HG3' ' A' ' 167' ' ' GLN . 35.7 t -63.59 -50.37 69.68 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.418 -177.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . 0.411 ' HG3' ' O ' ' A' ' 161' ' ' TYR . 5.1 pp0? -59.37 -35.48 73.97 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.478 0.18 . . . . 0.0 111.034 -177.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 49.0 ttp -73.76 -33.45 64.28 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 120.621 -0.431 . . . . 0.0 110.806 177.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.548 ' HB2' ' HB ' ' A' ' 134' ' ' THR . . . -69.96 -43.61 71.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.103 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.501 ' NE2' HG21 ' A' ' 107' ' ' THR . 71.9 mt-30 -51.94 -52.81 47.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.953 -178.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.825 ' HA ' ' HB2' ' A' ' 171' ' ' ARG . 1.3 ptp180 -70.85 -27.36 63.78 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.455 178.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.648 ' HE2' ' HA ' ' A' ' 169' ' ' LYS . 0.1 OUTLIER -67.55 -37.85 83.29 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.753 -178.688 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.486 ' O ' HG13 ' A' ' 173' ' ' ILE . 1.9 mp -75.24 -39.88 42.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 173.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.825 ' HB2' ' HA ' ' A' ' 168' ' ' ARG . 1.1 mpt_? -51.74 -28.0 13.74 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.072 171.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.484 ' HB2' ' O ' ' A' ' 169' ' ' LYS . 1.3 m-20 -68.66 -56.14 9.16 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 122.679 0.392 . . . . 0.0 111.499 178.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.486 HG13 ' O ' ' A' ' 170' ' ' ILE . 2.7 pp -66.59 -18.64 24.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.525 -174.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.673 HD21 HG12 ' A' ' 111' ' ' VAL . 6.7 mp -66.41 -33.86 76.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.093 174.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.99 -31.82 73.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.107 0.48 . . . . 0.0 110.28 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -69.6 -33.45 72.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.923 176.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 173' ' ' ILE . 48.7 t -66.06 -46.4 88.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.796 176.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -61.18 -40.89 95.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.845 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.016 -179.515 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.464 ' HB3' HG22 ' A' ' 74' ' ' THR . 48.5 mt-30 . . . . . 0 CA--C 1.514 -0.407 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.532 ' O ' ' HA ' ' A' ' 74' ' ' THR . 7.1 tp10 -81.05 147.67 30.04 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.399 -0.818 . . . . 0.0 111.101 -174.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.636 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 39.8 m -116.15 107.16 14.54 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.492 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.412 HG13 HG22 ' A' ' 109' ' ' ILE . 37.0 t -119.14 150.02 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.723 -177.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -111.69 125.15 53.66 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-O 120.773 0.32 . . . . 0.0 110.776 -175.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.497 ' HB ' ' HB ' ' A' ' 71' ' ' VAL . 13.6 t -94.09 139.69 17.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.473 ' CZ ' HG11 ' A' ' 68' ' ' VAL . 1.0 OUTLIER -103.54 104.89 15.01 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.406 -175.704 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.443 ' C ' HG23 ' A' ' 68' ' ' VAL . 21.7 pt -129.68 123.36 21.15 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 121.169 0.509 . . . . 0.0 111.291 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.452 ' HA ' ' HA ' ' A' ' 68' ' ' VAL . 50.5 Cg_exo -53.5 149.12 31.86 Favored 'Trans proline' 0 C--O 1.238 0.501 0 C-N-CA 123.439 2.76 . . . . 0.0 112.643 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.671 ' HA ' HG12 ' A' ' 34' ' ' VAL . . . -57.7 -23.57 52.33 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 114.9 -1.046 . . . . 0.0 112.529 -173.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -66.12 -30.01 70.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.235 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.518 ' HB2' ' CE2' ' A' ' 96' ' ' PHE . . . -108.25 -31.07 8.03 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.663 -175.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.753 HG21 ' HB3' ' A' ' 69' ' ' ARG . 13.3 p -53.98 -32.48 22.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-O 120.945 0.402 . . . . 0.0 110.968 -175.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.81 -56.36 25.71 Favored Glycine 0 N--CA 1.434 -1.448 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.959 178.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.44 -14.54 59.67 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.621 0.248 . . . . 0.0 111.298 -175.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.998 HD12 ' HB3' ' A' ' 90' ' ' LYS . 2.4 mm -67.44 -36.96 77.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.369 -0.378 . . . . 0.0 109.99 177.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.42 HG23 HG21 ' A' ' 45' ' ' ILE . 24.6 mt -61.45 -32.72 54.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-O 121.528 0.68 . . . . 0.0 110.337 174.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.18 153.72 30.18 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.627 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.562 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 34.1 mtpt -66.02 131.38 46.08 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -175.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.562 ' HG2' ' O ' ' A' ' 40' ' ' LYS . 19.8 pttt 73.63 4.21 4.69 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.051 1.34 . . . . 0.0 112.198 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 61.05 38.64 95.88 Favored Glycine 0 CA--C 1.523 0.545 0 CA-C-N 116.253 -0.431 . . . . 0.0 113.607 176.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.447 ' HB3' ' HE2' ' A' ' 41' ' ' LYS . 19.4 tt0 -109.1 -36.65 6.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 117.322 0.561 . . . . 0.0 110.985 175.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 77.7 m-70 -55.87 -41.62 74.67 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.393 0.616 . . . . 0.0 109.778 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.469 ' O ' HG21 ' A' ' 56' ' ' ILE . 4.5 tt -56.52 -44.13 79.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 114.515 -1.221 . . . . 0.0 112.231 176.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.433 ' HG2' HG23 ' A' ' 45' ' ' ILE . 28.4 mmmt -81.45 -29.09 33.91 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 121.984 -0.447 . . . . 0.0 110.779 -173.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -60.47 -40.55 91.65 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 172.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.704 HD22 ' HZ ' ' A' ' 51' ' ' PHE . 0.2 OUTLIER -49.72 -47.8 50.35 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.048 175.898 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.838 ' HB2' ' HB ' ' A' ' 56' ' ' ILE . 14.5 t -61.77 -35.88 79.43 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.629 -176.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -78.81 -41.35 30.53 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -169.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.704 ' HZ ' HD22 ' A' ' 48' ' ' LEU . 10.2 p90 -79.56 -17.02 54.89 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 120.167 -0.613 . . . . 0.0 111.609 -177.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -94.09 -16.89 23.38 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.199 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.2 t 67.3 13.97 9.55 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.544 -177.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -108.73 153.57 23.27 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.838 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.495 ' HB2' ' HB ' ' A' ' 74' ' ' THR . 60.4 m -80.27 102.41 9.48 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.018 0.437 . . . . 0.0 110.185 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.838 ' HB ' ' HB2' ' A' ' 49' ' ' SER . 1.5 mp -92.98 117.64 36.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.147 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -144.77 151.13 38.37 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.891 -175.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 38.8 mm -102.43 129.1 54.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.599 ' HB3' ' HB2' ' A' ' 70' ' ' MET . . . -95.86 108.55 41.23 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.841 -178.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 59' ' ' ALA . 14.6 Cg_exo -69.59 146.0 59.89 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 123.061 2.507 . . . . 0.0 112.338 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.864 ' HD3' ' HG3' ' A' ' 69' ' ' ARG . 98.6 Cg_endo . . . . . 0 N--CA 1.459 -0.527 0 C-N-CA 122.874 2.383 . . . . 0.0 112.396 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? . . . . . 0 CA--C 1.528 0.113 0 CA-C-O 121.353 0.597 . . . . 0.0 110.417 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.473 HG11 ' CZ ' ' A' ' 28' ' ' PHE . 1.5 p -145.83 150.53 15.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.457 -172.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.864 ' HG3' ' HD3' ' A' ' 61' ' ' PRO . 22.9 ttm180 -127.05 151.3 48.79 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 177.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.599 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 63.6 mtt -100.13 149.41 23.55 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.269 0.557 . . . . 0.0 112.127 -173.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.497 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 86.8 t -105.44 120.34 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 168.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.6 p -109.23 115.54 49.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-O 121.563 0.697 . . . . 0.0 110.451 -176.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.636 ' O ' ' HA ' ' A' ' 24' ' ' THR . 2.1 pp -120.34 140.84 43.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.598 -176.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 58.9 m -123.76 108.77 12.88 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.934 177.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -163.95 162.03 34.8 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.098 -1.049 . . . . 0.0 113.326 -176.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.408 ' HD3' ' HG2' ' A' ' 22' ' ' GLN . 30.7 Cg_endo -64.39 142.61 79.58 Favored 'Trans proline' 0 CA--C 1.533 0.427 0 C-N-CA 123.079 2.519 . . . . 0.0 111.908 175.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.481 ' O ' ' HB2' ' A' ' 80' ' ' GLN . 97.4 Cg_exo -46.14 -35.39 14.89 Favored 'Trans proline' 0 N--CA 1.478 0.565 0 C-N-CA 125.013 3.808 . . . . 0.0 115.298 -174.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.3 -46.87 69.14 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.115 0.483 . . . . 0.0 109.849 177.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.56 -22.44 63.54 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.894 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.481 ' HB2' ' O ' ' A' ' 77' ' ' PRO . 71.3 mm-40 -52.76 -52.0 58.31 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.787 176.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -66.74 -33.15 74.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.832 -179.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 47.1 tttp -61.5 -52.95 62.38 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.189 0.519 . . . . 0.0 110.334 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.4 -53.74 13.07 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.854 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.507 ' O ' HG22 ' A' ' 87' ' ' ILE . 9.5 tt0 -69.15 -31.03 69.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.68 -173.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -58.13 -32.54 67.4 Favored Glycine 0 CA--C 1.518 0.219 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.884 177.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.521 ' NE ' ' HA ' ' A' ' 86' ' ' ARG . 3.5 mmp_? -79.69 -26.83 40.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.654 0.264 . . . . 0.0 111.054 178.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.507 HG22 ' O ' ' A' ' 84' ' ' GLN . 0.4 OUTLIER -66.33 -35.16 74.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.646 -177.307 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.668 ' CE2' ' HB3' ' A' ' 105' ' ' LEU . 10.0 m-85 -68.66 -34.57 75.93 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.361 176.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -62.26 -30.43 75.96 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.524 176.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.998 ' HB3' HD12 ' A' ' 37' ' ' ILE . 75.0 mmtt -59.96 -52.96 63.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.7 0.286 . . . . 0.0 110.612 175.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.57 HD23 HD11 ' A' ' 105' ' ' LEU . 3.8 mm? -61.35 -39.66 91.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.606 178.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.83 ' HE3' ' HB ' ' A' ' 103' ' ' VAL . 0.3 OUTLIER -61.65 -41.17 97.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.821 0.343 . . . . 0.0 110.92 174.711 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -71.18 -23.45 62.05 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.028 -176.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.509 ' HB3' ' CE2' ' A' ' 96' ' ' PHE . 58.7 mm-40 -88.26 4.23 46.65 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.927 -179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 63.56 21.04 12.56 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.742 172.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.518 ' CE2' ' HB2' ' A' ' 33' ' ' ALA . 78.2 m-85 . . . . . 0 C--N 1.326 -0.453 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 168.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 . . . . . 0 CA--C 1.514 -0.409 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.83 ' HB ' ' HE3' ' A' ' 92' ' ' LYS . 15.0 p -54.6 123.94 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 CA-C-O 121.819 0.819 . . . . 0.0 111.995 -172.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -123.02 90.81 3.36 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 170.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.668 ' HB3' ' CE2' ' A' ' 88' ' ' TYR . 2.5 tt -117.17 114.89 24.32 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -177.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.877 ' HG3' HG13 ' A' ' 157' ' ' ILE . 1.7 mp0 -71.86 128.73 36.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.694 -175.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.1 m -114.69 128.06 56.1 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 170.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 16.2 m170 -102.26 119.62 39.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.14 0.495 . . . . 0.0 110.064 -178.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.468 HG13 ' HB ' ' A' ' 154' ' ' VAL . 34.8 pt -112.33 157.52 13.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.231 -178.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 110' ' ' ARG . 22.6 mmt180 -102.26 133.64 46.83 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.879 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.777 HG12 HD21 ' A' ' 174' ' ' LEU . 10.4 m -133.15 148.24 68.43 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 173.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.766 ' HD2' ' HG ' ' A' ' 174' ' ' LEU . 51.6 Cg_exo -53.96 146.27 48.01 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.139 1.893 . . . . 0.0 110.596 175.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.15 -27.77 65.95 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.616 -175.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 44.0 t -81.5 -33.11 32.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.3 0.571 . . . . 0.0 110.281 175.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.56 -21.05 61.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.011 -178.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.556 ' O ' HG12 ' A' ' 119' ' ' VAL . . . -61.45 -50.82 71.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.071 0.462 . . . . 0.0 110.59 177.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.93 -29.39 67.14 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.562 177.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.6 ' HD3' HG22 ' A' ' 177' ' ' VAL . 13.7 ttt85 -73.04 -36.1 66.86 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.832 -0.184 . . . . 0.0 111.316 -178.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.556 HG12 ' O ' ' A' ' 116' ' ' ALA . 7.0 p -69.89 -26.21 29.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-O 121.014 0.435 . . . . 0.0 109.905 178.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.921 ' HA ' ' HB ' ' A' ' 127' ' ' VAL . 73.7 mt -68.12 -33.36 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 CA-C-O 121.495 0.664 . . . . 0.0 109.347 171.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.617 ' HA3' ' H ' ' A' ' 126' ' ' THR . . . . . . . . 0 N--CA 1.446 -0.672 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.182 176.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 53.2 tptt . . . . . 0 C--O 1.231 0.089 0 CA-C-O 121.069 0.461 . . . . 0.0 110.623 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.617 ' H ' ' HA3' ' A' ' 121' ' ' GLY . 21.7 m -60.16 -34.62 73.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.905 -177.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.921 ' HB ' ' HA ' ' A' ' 120' ' ' ILE . 10.2 p -63.11 -29.24 46.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.7 0.286 . . . . 0.0 110.856 -178.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -63.77 -45.49 89.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.149 0.5 . . . . 0.0 109.835 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -72.35 -37.36 68.84 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.946 178.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.635 HD21 HD11 ' A' ' 170' ' ' ILE . 23.1 tp -58.98 -49.43 77.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.937 178.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.504 ' HG3' HG12 ' A' ' 138' ' ' VAL . 16.4 tt0 -63.12 -36.24 82.94 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.195 -178.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -75.11 -37.0 61.63 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.783 -178.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 133' ' ' LEU . 21.8 mt -79.98 -22.08 42.97 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -178.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 38.5 p -96.7 -22.03 17.23 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.747 -177.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 65.25 18.53 11.43 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.623 -178.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -118.95 168.93 10.33 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.585 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.505 ' HB3' ' HB ' ' A' ' 157' ' ' ILE . 21.8 tt0 -105.1 122.05 45.08 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.987 0.423 . . . . 0.0 110.225 -178.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.504 HG12 ' HG3' ' A' ' 131' ' ' GLN . 2.4 p -121.09 122.01 66.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.067 -172.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 13.5 p -130.66 133.23 63.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.54 176.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.818 ' HB ' HG22 ' A' ' 154' ' ' VAL . 6.7 p -137.49 97.68 10.32 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-O 121.824 0.821 . . . . 0.0 111.14 177.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -60.57 166.45 9.75 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 123.427 2.751 . . . . 0.0 112.656 175.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -79.05 -50.31 11.26 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.399 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -94.27 102.19 14.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.438 178.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.762 ' HB2' ' HB ' ' A' ' 152' ' ' VAL . 23.7 mm-40 -127.78 93.23 3.64 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.551 176.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.925 ' HB ' ' HD2' ' A' ' 146' ' ' PRO . 60.8 p 58.67 172.91 0.05 OUTLIER Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 123.615 0.766 . . . . 0.0 111.519 -176.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.925 ' HD2' ' HB ' ' A' ' 145' ' ' THR . 35.1 Cg_endo -65.8 154.71 72.75 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.07 1.847 . . . . 0.0 111.965 178.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -78.88 36.3 0.27 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.527 0.68 . . . . 0.0 110.544 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.422 ' H ' ' C ' ' A' ' 146' ' ' PRO . 37.8 tt0 -63.21 -33.34 75.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.598 -177.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -118.61 22.63 11.94 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 175.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 48.17 31.62 2.66 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 114.104 -1.407 . . . . 0.0 112.716 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -136.35 158.4 44.51 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.503 0.668 . . . . 0.0 112.434 -177.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.762 ' HB ' ' HB2' ' A' ' 144' ' ' GLN . 27.0 m -123.69 -175.78 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.787 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.442 ' HB ' ' OE1' ' A' ' 144' ' ' GLN . 25.2 mt -115.47 136.93 50.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.098 0.475 . . . . 0.0 112.27 -172.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.818 HG22 ' HB ' ' A' ' 140' ' ' VAL . 59.6 t -114.35 141.09 31.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.259 172.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 6.5 mttt -113.22 121.27 43.97 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.333 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.5 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 64.4 mt -104.85 116.34 48.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.177 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.877 HG13 ' HG3' ' A' ' 106' ' ' GLU . 3.9 mp -110.57 133.19 56.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.523 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 153.8 -156.17 26.63 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.114 -1.041 . . . . 0.0 112.757 176.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.642 ' HA ' HG13 ' A' ' 103' ' ' VAL . 74.3 m80 -86.95 160.08 18.8 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -178.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.519 ' HB3' ' CG ' ' A' ' 88' ' ' TYR . 19.7 p90 -68.67 -24.47 64.52 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -170.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -73.26 -41.28 63.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.219 0.533 . . . . 0.0 109.981 172.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -73.27 -39.73 65.15 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.452 -176.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.438 ' O ' ' HG3' ' A' ' 167' ' ' GLN . 29.0 p -65.07 -50.08 67.54 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.223 -177.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -62.23 -34.55 76.71 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.723 0.297 . . . . 0.0 110.627 178.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 26.6 ttt -63.79 -43.46 96.27 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.09 0.472 . . . . 0.0 110.266 177.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.43 ' HB3' HD13 ' A' ' 156' ' ' ILE . . . -68.65 -46.46 69.1 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.02 178.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.438 ' HG3' ' O ' ' A' ' 163' ' ' SER . 72.4 mt-30 -51.52 -51.36 55.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.26 -178.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -70.07 -30.82 68.16 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.151 -178.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -71.49 -40.64 70.07 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.945 0.402 . . . . 0.0 110.92 -178.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.646 ' O ' HD13 ' A' ' 174' ' ' LEU . 1.9 mp -73.01 -51.0 28.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.434 178.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.648 ' HA ' HD22 ' A' ' 174' ' ' LEU . 25.8 mmm180 -56.98 -24.82 56.1 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.727 0.298 . . . . 0.0 110.909 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -69.4 -51.35 37.4 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.638 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.416 ' O ' HG23 ' A' ' 177' ' ' VAL . 34.4 pt -68.5 -19.82 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 121.017 0.437 . . . . 0.0 110.722 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.777 HD21 HG12 ' A' ' 111' ' ' VAL . 3.5 mp -64.08 -29.15 70.3 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.133 178.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.78 -31.89 72.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.26 0.553 . . . . 0.0 110.146 175.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -73.44 -47.09 44.44 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.161 177.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.6 HG22 ' HD3' ' A' ' 118' ' ' ARG . 29.6 t -67.33 -32.51 57.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.657 -178.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -57.25 -49.01 77.4 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 174.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 . . . . . 0 C--N 1.327 -0.385 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.821 178.189 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 . . . . . 0 N--CA 1.453 -0.297 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.61 ' O ' ' HA ' ' A' ' 74' ' ' THR . 22.1 mm-40 -72.64 130.53 40.77 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.255 -174.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.61 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 29.6 m -131.7 109.94 10.54 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.61 -178.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.749 HG22 HD11 ' A' ' 73' ' ' ILE . 14.3 m -127.73 161.24 35.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.237 178.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 10.0 m170 -111.47 127.95 55.85 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 -174.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.621 ' O ' ' HA ' ' A' ' 70' ' ' MET . 10.4 t -105.87 123.87 60.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.821 -174.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.787 ' CZ ' HG11 ' A' ' 68' ' ' VAL . 3.7 t80 -82.33 103.2 11.73 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.313 -174.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.537 ' C ' HG23 ' A' ' 68' ' ' VAL . 39.6 pt -126.52 113.14 23.03 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.701 0.762 . . . . 0.0 110.724 174.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.97 ' HB2' ' HG2' ' A' ' 32' ' ' GLN . 88.8 Cg_exo -50.45 150.95 10.66 Favored 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 123.513 2.808 . . . . 0.0 113.325 -179.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.689 ' HA ' HG12 ' A' ' 34' ' ' VAL . . . -58.73 -18.73 33.98 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.909 -175.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.97 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 3.5 pt20 -51.65 -36.53 46.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.021 176.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.587 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -126.4 -25.35 3.48 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -169.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.689 HG12 ' HA ' ' A' ' 31' ' ' ALA . 14.4 p -49.94 -34.53 9.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 O-C-N 123.355 0.409 . . . . 0.0 111.622 -173.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.22 -55.8 28.42 Favored Glycine 0 N--CA 1.44 -1.084 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.155 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.87 -15.05 62.11 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 120.906 0.384 . . . . 0.0 111.057 -175.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.587 HG12 ' O ' ' A' ' 33' ' ' ALA . 6.5 mm -71.74 -36.0 57.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.683 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.538 HG22 ' HA2' ' A' ' 42' ' ' GLY . 8.2 mt -63.51 -32.12 55.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-O 121.41 0.624 . . . . 0.0 110.265 173.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.532 ' HA3' ' HB2' ' A' ' 44' ' ' HIS . . . 86.72 163.48 38.66 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.443 176.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -61.36 128.15 34.94 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 120.927 0.394 . . . . 0.0 110.039 -178.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.419 ' O ' ' HE3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER 72.62 1.84 4.13 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.178 179.149 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.538 ' HA2' HG22 ' A' ' 38' ' ' ILE . . . 69.94 19.86 75.68 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.395 -0.907 . . . . 0.0 110.889 -173.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -73.86 -41.85 61.62 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.427 -0.386 . . . . 0.0 110.227 -178.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.532 ' HB2' ' HA3' ' A' ' 39' ' ' GLY . 18.8 m-70 -64.6 -40.52 95.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.539 -173.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.459 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 13.8 tt -64.46 -45.45 95.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.887 0.375 . . . . 0.0 111.442 -179.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.418 ' O ' ' HB3' ' A' ' 49' ' ' SER . 13.9 ptmm? -82.26 -22.32 35.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.671 0.272 . . . . 0.0 111.324 -178.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -69.34 -34.78 75.14 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 172.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.865 ' HG ' ' HE1' ' A' ' 51' ' ' PHE . 6.4 tt -60.1 -41.97 93.68 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.052 -0.976 . . . . 0.0 108.983 173.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.638 ' HA ' HD13 ' A' ' 56' ' ' ILE . 34.0 t -54.99 -35.31 64.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.931 178.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -73.53 -51.28 17.55 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.865 ' HE1' ' HG ' ' A' ' 48' ' ' LEU . 1.5 p90 -72.49 -32.18 65.99 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.823 -174.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.53 -19.02 36.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.858 0.361 . . . . 0.0 110.804 179.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.5 m 63.95 31.05 14.03 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.078 178.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -132.4 171.16 14.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.992 -177.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.504 ' HB3' ' HB ' ' A' ' 74' ' ' THR . 33.2 t -93.19 115.85 28.45 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.904 HG13 HG22 ' A' ' 73' ' ' ILE . 3.2 mp -115.58 119.15 61.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.238 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -148.43 136.69 21.19 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.012 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.597 HG12 HG22 ' A' ' 71' ' ' VAL . 10.4 mt -88.8 128.48 40.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.189 0.518 . . . . 0.0 111.224 -177.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.53 ' HB2' HG23 ' A' ' 72' ' ' VAL . . . -71.19 141.79 86.57 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.239 -176.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 59' ' ' ALA . 2.4 Cg_endo -80.36 137.46 11.84 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.933 2.422 . . . . 0.0 111.956 177.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo . . . . . 0 N--CA 1.461 -0.405 0 C-N-CA 122.853 2.369 . . . . 0.0 111.782 176.913 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? . . . . . 0 N--CA 1.457 -0.105 0 CA-C-O 121.135 0.493 . . . . 0.0 109.734 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.787 HG11 ' CZ ' ' A' ' 28' ' ' PHE . 3.7 p -154.65 153.64 7.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.788 -167.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.578 ' HB2' HG21 ' A' ' 34' ' ' VAL . 30.4 mtp180 -128.59 130.2 47.02 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 171.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.621 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 4.1 mpp? -92.35 125.88 37.19 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.803 0.335 . . . . 0.0 110.846 -175.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.597 HG22 HG12 ' A' ' 58' ' ' ILE . 93.1 t -84.47 127.11 40.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 120.924 0.393 . . . . 0.0 110.244 178.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.53 HG23 ' HB2' ' A' ' 59' ' ' ALA . 81.9 t -99.29 118.05 45.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.929 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.904 HG22 HG13 ' A' ' 56' ' ' ILE . 2.4 pp -118.58 133.45 65.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.271 0.557 . . . . 0.0 110.938 178.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.61 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 30.0 m -126.08 106.26 9.46 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.068 -179.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.63 164.38 37.29 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.859 -173.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -61.33 138.9 79.83 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 122.488 2.126 . . . . 0.0 111.665 173.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -40.05 -48.36 3.86 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 124.449 3.433 . . . . 0.0 115.316 -173.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -72.9 -32.22 65.2 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 121.031 -0.268 . . . . 0.0 111.617 -175.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.42 -32.21 69.72 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.231 0.539 . . . . 0.0 109.966 177.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -57.85 -41.57 82.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.774 177.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -64.99 -35.03 79.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.409 -175.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.7 mtmt -66.09 -44.02 85.63 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.405 0.621 . . . . 0.0 109.699 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.77 -41.55 75.02 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.058 178.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.494 ' O ' HG22 ' A' ' 87' ' ' ILE . 49.0 tt0 -64.48 -34.44 78.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.242 -177.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -56.79 -42.07 91.37 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.197 177.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 32.7 mmt180 -76.78 -33.38 58.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.788 0.328 . . . . 0.0 111.497 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.494 HG22 ' O ' ' A' ' 84' ' ' GLN . 0.4 OUTLIER -65.53 -37.29 79.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -177.909 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.696 ' HA ' HD23 ' A' ' 91' ' ' LEU . 10.7 m-85 -69.39 -30.66 68.69 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.201 0.524 . . . . 0.0 110.795 174.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -58.02 -33.81 70.38 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.759 175.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.711 ' HG3' HD22 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -61.33 -36.51 80.34 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 117.435 0.617 . . . . 0.0 109.646 177.774 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.711 HD22 ' HG3' ' A' ' 90' ' ' LYS . 2.8 mm? -61.79 -44.87 96.02 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.772 175.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 1.075 ' HE3' ' HB ' ' A' ' 103' ' ' VAL . 3.6 mmtp -76.67 -34.96 58.21 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -176.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -63.1 -33.05 74.62 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.768 -171.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.418 ' HB2' ' CE2' ' A' ' 96' ' ' PHE . 8.8 mm-40 -97.68 18.79 14.8 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.169 -0.613 . . . . 0.0 110.763 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 65.8 t30 58.07 40.5 25.24 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.186 174.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.418 ' CE2' ' HB2' ' A' ' 94' ' ' GLU . 27.7 m-85 . . . . . 0 C--N 1.324 -0.542 0 C-N-CA 120.591 -0.443 . . . . 0.0 109.986 176.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 . . . . . 0 N--CA 1.454 -0.236 0 CA-C-O 120.569 0.223 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 1.075 ' HB ' ' HE3' ' A' ' 92' ' ' LYS . 13.3 p -60.45 123.3 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 173.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -126.27 89.89 3.09 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.773 0.797 . . . . 0.0 109.335 176.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 tt -101.22 126.92 47.99 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.467 -1.242 . . . . 0.0 108.191 -176.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -81.56 103.32 11.19 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.247 0.546 . . . . 0.0 110.383 -177.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.3 m -95.07 130.77 41.63 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.865 0.364 . . . . 0.0 110.036 177.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . 0.405 ' HB3' HG21 ' A' ' 153' ' ' ILE . 11.1 m-70 -103.65 120.18 40.39 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.813 0.34 . . . . 0.0 110.643 -177.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 32.9 pt -115.63 134.41 58.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.174 0.512 . . . . 0.0 110.191 178.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.567 HH11 HD11 ' A' ' 153' ' ' ILE . 12.7 tpt180 -86.84 118.98 26.58 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.254 -174.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.693 HG23 ' CD2' ' A' ' 174' ' ' LEU . 7.1 p -121.51 145.04 41.73 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -177.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.81 ' HA ' ' HG2' ' A' ' 151' ' ' GLN . 32.7 Cg_exo -55.67 144.54 75.08 Favored 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 122.586 2.191 . . . . 0.0 110.871 173.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.21 -32.15 70.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.692 -175.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.5 p -79.75 -26.04 40.86 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.778 178.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.654 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -75.51 -20.41 58.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.315 -177.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.42 -35.1 79.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.11 0.481 . . . . 0.0 110.098 175.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -81.52 -11.3 83.33 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.909 176.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.426 ' HD2' HG22 ' A' ' 177' ' ' VAL . 18.3 ttm180 -93.09 -38.36 11.65 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.723 0.296 . . . . 0.0 111.037 179.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.6 p -65.66 -29.83 48.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.353 -177.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 1.004 ' HA ' ' HB ' ' A' ' 127' ' ' VAL . 34.9 pt -77.28 -19.48 14.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.005 0.431 . . . . 0.0 110.485 178.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.686 ' HA3' HG22 ' A' ' 126' ' ' THR . . . . . . . . 0 N--CA 1.445 -0.706 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.213 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 64.2 mttp . . . . . 0 CA--C 1.523 -0.067 0 CA-C-O 120.568 0.223 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.686 HG22 ' HA3' ' A' ' 121' ' ' GLY . 14.4 t -69.24 -14.98 63.26 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.961 -0.295 . . . . 0.0 111.129 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 1.004 ' HB ' ' HA ' ' A' ' 120' ' ' ILE . 12.7 p -66.76 -32.44 58.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.015 0.435 . . . . 0.0 109.964 174.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -66.29 -45.98 78.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.337 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -63.85 -39.06 93.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.242 175.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.715 HD21 HD11 ' A' ' 170' ' ' ILE . 33.4 tp -56.68 -49.44 75.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.147 -176.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.646 ' HG2' ' H ' ' A' ' 138' ' ' VAL . 48.2 mt-30 -61.42 -47.4 85.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.599 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -66.99 -40.09 87.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.855 0.36 . . . . 0.0 111.349 -178.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 34.3 tp -73.13 -42.0 63.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.318 -176.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.427 ' HB ' ' HB2' ' A' ' 166' ' ' ALA . 68.2 p -76.52 -16.26 59.67 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.86 0.362 . . . . 0.0 110.888 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 64.96 26.34 12.74 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.837 -178.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -137.96 162.96 32.71 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.106 -177.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.56 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 8.6 mm-40 -90.23 110.01 21.07 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-O 120.957 0.408 . . . . 0.0 110.395 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.646 ' H ' ' HG2' ' A' ' 131' ' ' GLN . 43.2 t -101.52 104.9 17.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.92 176.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.552 HG13 ' HE3' ' A' ' 155' ' ' LYS . 4.9 p -113.81 111.85 37.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.466 0.65 . . . . 0.0 111.059 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.608 HG12 HG22 ' A' ' 154' ' ' VAL . 9.2 m -90.59 139.14 26.43 Favored Pre-proline 0 N--CA 1.446 -0.631 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 172.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.473 ' HB2' ' H ' ' A' ' 144' ' ' GLN . 67.8 Cg_endo -76.43 122.12 6.37 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 121.845 1.697 . . . . 0.0 112.525 -174.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 11.2 mpt_? -81.53 -13.79 57.67 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 174.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -80.2 -52.13 8.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.933 -1.031 . . . . 0.0 109.44 175.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.515 ' HG2' HG11 ' A' ' 152' ' ' VAL . 40.6 mt-30 73.36 151.1 0.11 Allowed 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 172.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.551 ' HB ' ' HD2' ' A' ' 146' ' ' PRO . 2.2 p -90.95 165.37 22.15 Favored Pre-proline 0 N--CA 1.448 -0.529 0 CA-C-N 114.427 -1.26 . . . . 0.0 110.358 177.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.551 ' HD2' ' HB ' ' A' ' 145' ' ' THR . 20.0 Cg_endo -59.97 159.92 23.88 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.105 2.537 . . . . 0.0 113.601 -177.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -70.83 1.51 5.4 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.096 -0.957 . . . . 0.0 111.207 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -50.13 -35.88 27.58 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.721 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -119.73 7.45 11.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.453 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 44.69 29.86 0.47 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.149 0.98 . . . . 0.0 111.808 -173.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.81 ' HG2' ' HA ' ' A' ' 112' ' ' PRO . 73.9 mt-30 -143.97 153.15 41.96 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 121.069 0.462 . . . . 0.0 111.249 -174.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.515 HG11 ' HG2' ' A' ' 144' ' ' GLN . 33.7 m -126.16 177.91 4.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 176.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.567 HD11 HH11 ' A' ' 110' ' ' ARG . 15.1 mt -121.89 129.62 75.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 O-C-N 121.718 -0.614 . . . . 0.0 111.747 -178.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.608 HG22 HG12 ' A' ' 140' ' ' VAL . 59.4 t -93.1 138.67 19.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 173.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.552 ' HE3' HG13 ' A' ' 139' ' ' VAL . 4.9 mtmt -107.21 123.6 48.53 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.764 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.56 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 52.7 mt -108.0 111.69 36.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 176.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 4.7 mp -107.66 118.45 55.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.904 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 171.7 -165.78 38.69 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.127 -1.035 . . . . 0.0 113.102 178.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.744 ' HA ' HG13 ' A' ' 103' ' ' VAL . 0.3 OUTLIER -77.81 157.24 30.03 Favored 'General case' 0 C--O 1.223 -0.334 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.185 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.507 ' HB3' ' CG ' ' A' ' 88' ' ' TYR . 44.8 p90 -64.24 -23.35 67.27 Favored 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -175.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.569 ' O ' ' HG3' ' A' ' 164' ' ' GLN . 91.1 m-85 -68.73 -51.61 39.55 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.737 0.78 . . . . 0.0 109.543 173.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.15 -41.42 67.11 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.563 -174.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 62.0 p -64.59 -44.28 91.16 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.941 -176.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . 0.613 ' O ' ' HG2' ' A' ' 168' ' ' ARG . 1.2 pp0? -61.09 -38.04 84.84 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.605 177.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.426 ' HG3' ' O ' ' A' ' 161' ' ' TYR . 81.9 mtp -61.24 -42.4 98.56 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.864 0.364 . . . . 0.0 110.818 177.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.427 ' HB2' ' HB ' ' A' ' 134' ' ' THR . . . -70.67 -43.52 68.92 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.748 178.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -51.99 -55.76 18.44 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.728 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.613 ' HG2' ' O ' ' A' ' 164' ' ' GLN . 9.3 ptt180 -65.38 -29.88 70.64 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.824 -179.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -70.96 -51.12 27.65 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.949 -178.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.715 HD11 HD21 ' A' ' 130' ' ' LEU . 2.3 mp -68.09 -44.83 84.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.591 ' HA ' ' HG ' ' A' ' 174' ' ' LEU . 20.3 mmm180 -58.62 -26.27 63.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.811 0.339 . . . . 0.0 111.352 177.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -69.49 -46.4 66.69 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.655 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.519 HG13 HD23 ' A' ' 174' ' ' LEU . 32.7 pt -72.16 -19.74 19.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.691 -179.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.693 ' CD2' HG23 ' A' ' 111' ' ' VAL . 5.6 mt -66.99 -34.5 77.88 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 177.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.4 -31.72 72.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.18 176.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -71.6 -42.27 67.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.988 177.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.426 HG22 ' HD2' ' A' ' 118' ' ' ARG . 88.9 t -67.5 -35.01 71.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.507 176.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -57.48 -46.59 83.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.165 0.507 . . . . 0.0 110.328 175.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 . . . . . 0 C--N 1.327 -0.387 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.393 177.802 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.235 0.298 0 CA-C-O 121.016 0.436 . . . . 0.0 110.301 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.524 ' O ' ' HA ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -107.65 161.58 14.74 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.663 178.7 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.8 m -139.84 108.63 5.96 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.765 0.317 . . . . 0.0 110.99 -178.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.413 HG22 HD11 ' A' ' 73' ' ' ILE . 35.5 m -127.77 161.02 36.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.128 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -114.97 130.2 56.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.274 -174.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.548 ' HB ' ' HB ' ' A' ' 71' ' ' VAL . 21.4 t -105.06 132.81 50.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.823 -174.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.694 ' CZ ' HG11 ' A' ' 68' ' ' VAL . 5.0 t80 -94.12 104.58 16.6 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.012 0.525 . . . . 0.0 110.846 -174.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.472 ' C ' HG23 ' A' ' 68' ' ' VAL . 26.7 pt -124.66 120.57 25.77 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.391 0.615 . . . . 0.0 110.404 174.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.586 ' HA ' ' HA ' ' A' ' 68' ' ' VAL . 36.5 Cg_endo -64.82 153.1 79.61 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 123.045 2.497 . . . . 0.0 112.541 -174.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.639 ' HA ' HG12 ' A' ' 34' ' ' VAL . . . -60.48 -18.95 54.88 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.052 -176.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -74.09 -13.98 60.92 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.828 177.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.541 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -123.47 -30.75 3.6 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.914 -177.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.639 HG12 ' HA ' ' A' ' 31' ' ' ALA . 11.1 p -54.47 -31.54 23.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -172.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.59 -59.26 11.1 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.174 -1.012 . . . . 0.0 111.642 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.4 -13.48 59.92 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 120.788 0.327 . . . . 0.0 111.007 -174.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.816 HD12 ' HB3' ' A' ' 90' ' ' LYS . 2.0 mm -67.79 -34.4 67.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.75 178.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.491 ' HA ' HD12 ' A' ' 45' ' ' ILE . 19.2 mt -63.23 -59.45 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.962 177.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.443 ' HA3' ' NE2' ' A' ' 44' ' ' HIS . . . 118.8 90.55 1.34 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 119.761 -1.209 . . . . 0.0 115.311 168.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 43.9 tptt 57.38 -79.13 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.655 1.182 . . . . 0.0 113.805 171.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.534 ' HE2' ' HB3' ' A' ' 43' ' ' GLN . 19.2 pttm -117.36 7.68 12.89 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.749 0.309 . . . . 0.0 111.389 -175.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 62.9 39.25 97.8 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.995 -0.622 . . . . 0.0 112.942 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.534 ' HB3' ' HE2' ' A' ' 41' ' ' LYS . 23.0 tt0 -114.82 -48.79 2.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 117.158 0.479 . . . . 0.0 111.384 178.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.443 ' NE2' ' HA3' ' A' ' 39' ' ' GLY . 4.6 p80 -63.56 -19.19 64.6 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.075 0.464 . . . . 0.0 110.703 178.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.491 HD12 ' HA ' ' A' ' 38' ' ' ILE . 10.2 tt -67.26 -32.2 56.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.385 174.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -81.54 -22.25 37.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.287 0.565 . . . . 0.0 110.159 178.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -66.79 -30.57 70.8 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 173.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.645 HD22 ' HE1' ' A' ' 51' ' ' PHE . 0.3 OUTLIER -55.58 -49.31 73.06 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.173 173.822 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.67 ' HA ' HD13 ' A' ' 56' ' ' ILE . 8.6 m -57.87 -37.03 73.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.186 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.8 mtp180 -73.48 -50.92 19.09 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -176.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.645 ' HE1' HD22 ' A' ' 48' ' ' LEU . 0.6 OUTLIER -68.63 -27.46 66.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.938 0.399 . . . . 0.0 110.223 -176.43 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.566 ' O ' ' HB1' ' A' ' 79' ' ' ALA . . . -86.82 -10.64 53.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.892 0.377 . . . . 0.0 110.864 177.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 31.5 m 57.62 38.22 27.7 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.148 178.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -138.65 173.46 11.56 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.623 -174.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.402 ' HB2' ' HB ' ' A' ' 74' ' ' THR . 26.4 m -94.7 101.6 13.45 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.179 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.821 HG13 HG22 ' A' ' 73' ' ' ILE . 1.9 mp -106.14 123.12 60.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.129 178.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -138.65 150.97 46.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.23 176.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.2 mm -89.97 120.83 39.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 169.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.818 ' HB2' HG23 ' A' ' 72' ' ' VAL . . . -65.24 122.45 80.0 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.552 -175.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.41 127.29 19.91 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.987 2.458 . . . . 0.0 111.746 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo . . . . . 0 C--O 1.235 0.358 0 C-N-CA 123.204 2.603 . . . . 0.0 112.56 -177.893 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.47 ' O ' ' HD2' ' A' ' 67' ' ' LYS . 24.4 tptp . . . . . 0 C--O 1.232 0.143 0 CA-C-O 121.219 0.533 . . . . 0.0 110.282 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.694 HG11 ' CZ ' ' A' ' 28' ' ' PHE . 10.8 p -139.29 148.8 23.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.857 175.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.588 ' HB3' HG21 ' A' ' 34' ' ' VAL . 17.6 ttm180 -127.09 133.8 50.36 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 175.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.548 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 41.0 mtp -100.42 149.33 23.77 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 119.863 -0.735 . . . . 0.0 111.14 -171.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.548 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 89.9 t -99.05 127.95 51.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.953 175.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.818 HG23 ' HB2' ' A' ' 59' ' ' ALA . 92.3 t -103.28 110.0 28.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 177.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.821 HG22 HG13 ' A' ' 56' ' ' ILE . 2.6 pp -117.0 129.23 73.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.307 0.575 . . . . 0.0 111.072 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 35.4 m -125.14 109.44 12.89 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.922 -1.036 . . . . 0.0 109.889 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.45 162.04 35.43 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.363 -0.922 . . . . 0.0 112.601 -177.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.486 ' HG2' ' HB3' ' A' ' 79' ' ' ALA . 19.3 Cg_endo -59.67 137.01 74.53 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.754 2.303 . . . . 0.0 111.339 174.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_exo -40.03 -49.85 3.56 Favored 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 124.314 3.342 . . . . 0.0 114.683 -174.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -68.16 -36.32 79.46 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.888 0.375 . . . . 0.0 111.373 -176.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.566 ' HB1' ' O ' ' A' ' 52' ' ' ALA . . . -74.83 -31.7 61.75 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.425 0.631 . . . . 0.0 110.206 177.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -62.87 -33.45 75.3 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.239 175.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.408 ' HE1' HE22 ' A' ' 164' ' ' GLN . 74.5 t80 -53.75 -54.73 34.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.673 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.564 ' HE2' ' HA ' ' A' ' 79' ' ' ALA . 37.0 pttt -70.9 -33.77 70.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.677 0.275 . . . . 0.0 111.444 -177.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.35 -45.65 86.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.997 0.427 . . . . 0.0 111.011 177.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.654 ' HB3' ' HE1' ' A' ' 160' ' ' PHE . 23.6 tt0 -71.41 -31.69 67.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.318 -177.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -58.0 -32.7 67.11 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.829 176.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -76.65 -27.63 55.72 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.56 0.219 . . . . 0.0 111.197 178.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.524 HG22 ' O ' ' A' ' 84' ' ' GLN . 0.4 OUTLIER -70.26 -39.73 77.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -177.739 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.482 ' HA ' HD12 ' A' ' 105' ' ' LEU . 18.3 m-85 -69.68 -30.81 68.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.095 0.474 . . . . 0.0 109.999 174.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -58.48 -28.6 62.49 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.91 173.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.816 ' HB3' HD12 ' A' ' 37' ' ' ILE . 34.8 mmtp -67.97 -44.39 76.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.082 0.468 . . . . 0.0 109.893 175.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -60.46 -41.71 94.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.851 174.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 1.025 ' HE3' ' HB ' ' A' ' 103' ' ' VAL . 0.6 OUTLIER -65.73 -31.78 72.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.379 178.46 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -52.72 -47.52 67.26 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.575 -176.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.751 ' HB2' ' CE2' ' A' ' 96' ' ' PHE . 10.4 mm-40 -110.14 0.3 18.22 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.665 -177.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 55.72 43.58 27.7 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.751 178.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.751 ' CE2' ' HB2' ' A' ' 94' ' ' GLU . 92.9 m-85 . . . . . 0 N--CA 1.467 0.387 0 CA-C-O 121.101 0.477 . . . . 0.0 111.342 -178.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.437 ' HB3' ' NE2' ' A' ' 159' ' ' HIS . 38.5 mt-10 . . . . . 0 N--CA 1.453 -0.308 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 1.025 ' HB ' ' HE3' ' A' ' 92' ' ' LYS . 12.6 p -59.03 129.84 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.149 175.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 74.3 mmtt -136.86 91.25 2.62 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.423 -177.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.482 HD12 ' HA ' ' A' ' 88' ' ' TYR . 2.4 tt -115.88 117.01 29.0 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -76.95 113.93 15.19 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.311 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.5 m -104.99 143.73 32.78 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . 0.463 ' NE2' ' HG2' ' A' ' 155' ' ' LYS . 22.1 m170 -114.41 120.28 39.78 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 120.962 0.411 . . . . 0.0 110.346 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.415 ' CD1' ' HB ' ' A' ' 170' ' ' ILE . 16.6 pt -107.97 138.37 34.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 176.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -90.82 118.68 30.42 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.363 -174.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.653 HG12 HD11 ' A' ' 174' ' ' LEU . 11.1 m -116.95 154.34 49.64 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.769 178.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.658 ' HD2' HD22 ' A' ' 174' ' ' LEU . 38.4 Cg_exo -58.62 146.06 92.98 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.05 1.833 . . . . 0.0 110.891 173.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.455 ' HA ' HG22 ' A' ' 152' ' ' VAL . . . -48.65 -52.21 24.37 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -172.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.5 m -76.34 -17.82 59.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.676 -176.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.19 -24.66 62.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.652 0.263 . . . . 0.0 111.24 -177.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.64 ' HB1' HG11 ' A' ' 140' ' ' VAL . . . -64.17 -29.86 70.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.23 0.538 . . . . 0.0 110.357 177.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -77.01 -23.88 67.95 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.827 177.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.482 ' HD2' HG22 ' A' ' 177' ' ' VAL . 78.8 mtt-85 -83.72 -27.79 28.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.568 0.223 . . . . 0.0 110.592 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.728 HG22 HD11 ' A' ' 130' ' ' LEU . 9.9 p -77.47 -32.34 18.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.086 -178.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.428 ' O ' HG13 ' A' ' 127' ' ' VAL . 47.1 mm -74.34 -38.64 47.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.427 0.632 . . . . 0.0 109.944 177.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.065 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.384 -178.77 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 23.5 tptm . . . . . 0 N--CA 1.468 0.458 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 26.4 m -68.75 -37.34 79.31 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.891 0.377 . . . . 0.0 110.784 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.428 HG13 ' O ' ' A' ' 120' ' ' ILE . 6.4 m -65.21 -20.95 28.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.669 175.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -63.81 -33.43 75.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.969 0.414 . . . . 0.0 109.954 178.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -79.15 -40.31 31.3 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.642 -0.423 . . . . 0.0 109.957 175.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.728 HD11 HG22 ' A' ' 119' ' ' VAL . 66.4 mt -55.57 -52.01 65.17 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -174.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -84.34 -31.92 24.55 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.361 -0.535 . . . . 0.0 112.233 -173.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -72.26 -38.3 68.89 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.785 0.326 . . . . 0.0 111.083 -178.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.413 HD23 ' HE3' ' A' ' 169' ' ' LYS . 42.7 tp -83.03 -46.59 12.67 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.514 -176.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.577 HG21 ' HA ' ' A' ' 166' ' ' ALA . 39.6 p -75.88 -28.01 57.96 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.526 -174.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 67.36 15.48 9.92 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.546 -175.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -112.59 172.1 7.12 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.75 -178.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.468 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 35.2 tt0 -99.99 110.74 23.06 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 177.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 59.8 t -108.42 106.65 21.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.822 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 6.2 p -119.71 115.82 48.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.288 0.566 . . . . 0.0 111.428 -177.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.64 HG11 ' HB1' ' A' ' 116' ' ' ALA . 86.3 t -93.56 110.82 49.43 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.388 173.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.65 ' HG3' ' HE2' ' A' ' 155' ' ' LYS . 21.1 Cg_exo -67.5 149.9 80.16 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 123.104 2.536 . . . . 0.0 112.639 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.35 118.71 22.23 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.581 177.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 65.93 97.34 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.422 0.629 . . . . 0.0 112.004 -178.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.614 ' OE1' ' HB ' ' A' ' 153' ' ' ILE . 20.8 mm-40 -102.96 -66.94 0.9 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.545 176.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -145.61 144.61 23.11 Favored Pre-proline 0 C--N 1.314 -0.978 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.957 -179.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -67.43 168.33 18.26 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 123.23 2.62 . . . . 0.0 113.531 -174.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -58.84 -15.77 14.07 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.904 -177.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -55.41 -43.17 75.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.9 0.381 . . . . 0.0 110.497 172.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . 0.414 ' O ' ' HG2' ' A' ' 150' ' ' GLU . 0.2 OUTLIER -87.48 -16.75 33.87 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.102 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 149' ' ' ASN . 10.7 pt-20 46.35 28.91 0.77 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.948 1.299 . . . . 0.0 111.731 -178.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -145.29 149.11 34.26 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.381 -174.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.455 HG22 ' HA ' ' A' ' 113' ' ' ALA . 11.2 m -137.59 177.65 5.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 O-C-N 123.362 0.414 . . . . 0.0 110.203 178.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.614 ' HB ' ' OE1' ' A' ' 144' ' ' GLN . 96.7 mt -119.92 144.81 27.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.188 -173.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.625 ' HB ' HG22 ' A' ' 140' ' ' VAL . 1.5 p -135.46 139.43 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-O 121.251 0.548 . . . . 0.0 110.342 168.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.65 ' HE2' ' HG3' ' A' ' 141' ' ' PRO . 19.6 mttm -101.88 133.55 46.46 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.342 -172.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.468 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 68.2 mt -115.3 112.12 38.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.901 177.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.42 HD12 ' N ' ' A' ' 157' ' ' ILE . 4.5 mp -109.63 132.51 57.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.816 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 156.33 -158.43 28.67 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.222 -0.99 . . . . 0.0 112.866 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.844 ' HA ' HG13 ' A' ' 103' ' ' VAL . 13.6 m-70 -76.7 166.08 23.86 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 123.729 0.311 . . . . 0.0 110.64 -177.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.654 ' HE1' ' HB3' ' A' ' 84' ' ' GLN . 10.4 t80 -61.99 -49.04 77.67 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.59 0.233 . . . . 0.0 110.534 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.402 ' HA ' ' HG2' ' A' ' 164' ' ' GLN . 96.5 m-85 -69.46 -33.61 73.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.894 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.06 -49.85 53.79 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.028 0.442 . . . . 0.0 110.672 178.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.538 ' O ' ' HG3' ' A' ' 167' ' ' GLN . 49.7 m -66.49 -38.43 87.24 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.704 -177.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . 0.408 HE22 ' HE1' ' A' ' 81' ' ' PHE . 12.8 pt20 -64.16 -36.67 84.79 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.708 178.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 90.1 mtp -66.01 -34.08 77.27 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.951 0.405 . . . . 0.0 110.357 176.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.577 ' HA ' HG21 ' A' ' 134' ' ' THR . . . -71.68 -44.16 64.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.493 177.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.538 ' HG3' ' O ' ' A' ' 163' ' ' SER . 75.0 mt-30 -52.46 -51.6 58.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.624 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.753 ' O ' ' HB2' ' A' ' 172' ' ' ASP . 5.9 ptm180 -67.05 -31.74 72.46 Favored 'General case' 0 C--O 1.217 -0.651 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.376 -178.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.441 ' N ' ' HG3' ' A' ' 168' ' ' ARG . 16.2 tppt? -65.25 -53.14 48.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.828 0.347 . . . . 0.0 111.208 -176.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.478 ' O ' ' HG ' ' A' ' 174' ' ' LEU . 3.0 mp -72.29 -44.23 63.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.321 -177.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -61.46 -25.5 67.28 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.916 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.753 ' HB2' ' O ' ' A' ' 168' ' ' ARG . 2.1 t0 -71.16 -47.98 54.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.914 -177.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 18.1 pt -70.12 -19.73 22.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.925 -176.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.658 HD22 ' HD2' ' A' ' 112' ' ' PRO . 19.1 mt -57.73 -32.34 67.33 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.883 0.373 . . . . 0.0 110.733 175.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.71 -31.8 73.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.743 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -67.57 -35.69 79.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.998 177.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.482 HG22 ' HD2' ' A' ' 118' ' ' ARG . 42.1 t -74.82 -27.37 20.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.902 177.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 52.1 tptt -65.66 -45.01 84.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.508 172.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.64 175.159 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 . . . . . 0 N--CA 1.454 -0.227 0 CA-C-O 121.101 0.477 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.43 110.14 15.6 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.126 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 66.0 m -106.62 107.62 18.72 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 173.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.656 ' HB ' HG22 ' A' ' 109' ' ' ILE . 22.2 m -132.14 160.96 42.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.166 -177.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.511 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 12.8 m-70 -116.96 132.0 56.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.615 0.245 . . . . 0.0 110.777 -173.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.552 ' O ' ' HA ' ' A' ' 70' ' ' MET . 9.6 t -101.52 137.39 29.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.571 -176.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.511 ' CE2' HG11 ' A' ' 68' ' ' VAL . 1.7 t80 -102.05 105.0 15.67 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.253 -177.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.629 HD13 HD11 ' A' ' 87' ' ' ILE . 18.9 pt -132.4 125.83 19.93 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-O 121.288 0.566 . . . . 0.0 111.676 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.538 ' HA ' ' HA ' ' A' ' 68' ' ' VAL . 52.0 Cg_exo -55.85 148.27 57.41 Favored 'Trans proline' 0 C--O 1.239 0.553 0 C-N-CA 123.31 2.674 . . . . 0.0 112.504 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.745 ' HA ' HG12 ' A' ' 34' ' ' VAL . . . -57.83 -23.8 54.41 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.762 -1.108 . . . . 0.0 112.916 -171.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.673 ' HB2' ' HZ ' ' A' ' 96' ' ' PHE . 62.6 mm-40 -64.67 -21.74 66.81 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -175.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.622 ' HB2' ' HE2' ' A' ' 96' ' ' PHE . . . -121.86 -28.97 4.38 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.521 -175.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.745 HG12 ' HA ' ' A' ' 31' ' ' ALA . 14.3 p -57.28 -29.21 32.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-O 121.24 0.543 . . . . 0.0 110.166 -178.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.6 -55.32 31.42 Favored Glycine 0 N--CA 1.438 -1.216 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.627 176.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.45 -13.88 61.15 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 120.891 0.377 . . . . 0.0 110.585 -177.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.613 HG12 ' O ' ' A' ' 33' ' ' ALA . 7.8 mm -66.29 -37.38 79.56 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.149 175.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.429 HG12 HD12 ' A' ' 45' ' ' ILE . 19.6 mt -66.94 -43.9 88.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.628 174.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 83.78 -173.86 51.14 Favored Glycine 0 C--O 1.224 -0.525 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.957 174.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -47.83 91.07 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.509 0.723 . . . . 0.0 112.486 -177.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.6 ttpt 49.28 37.41 11.34 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.984 0.913 . . . . 0.0 111.544 -175.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.437 ' HA2' HG22 ' A' ' 45' ' ' ILE . . . 83.01 26.85 43.09 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.233 -0.984 . . . . 0.0 112.557 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -56.1 -71.57 0.09 Allowed 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -76.78 -20.6 56.25 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.208 0.448 . . . . 0.0 112.208 -173.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.437 HG22 ' HA2' ' A' ' 42' ' ' GLY . 10.3 tt -68.8 -37.07 76.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.904 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.419 ' HG2' ' O ' ' A' ' 42' ' ' GLY . 1.9 mmmp? -82.23 -22.42 35.89 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 121.939 -0.476 . . . . 0.0 110.679 177.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -69.96 -30.38 67.73 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 172.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.705 ' HA ' ' HE1' ' A' ' 51' ' ' PHE . 0.2 OUTLIER -51.38 -50.46 59.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.996 175.733 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.492 ' HA ' HD13 ' A' ' 56' ' ' ILE . 1.6 p -63.91 -23.26 67.28 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.231 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -74.38 -51.75 14.11 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.705 ' HE1' ' HA ' ' A' ' 48' ' ' LEU . 13.1 p90 -83.97 -22.71 31.35 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.512 -173.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -95.7 -16.53 21.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.85 0.357 . . . . 0.0 111.095 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 73.2 m 56.29 26.46 10.54 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.482 -178.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -106.64 171.55 7.3 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.824 -179.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.5 m -95.7 107.38 19.59 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 178.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.814 HG13 HG22 ' A' ' 73' ' ' ILE . 2.9 mp -108.02 121.31 60.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.782 -176.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -139.51 155.75 47.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.828 175.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 48.5 mm -99.92 129.56 50.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 173.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.745 ' HB2' HG23 ' A' ' 72' ' ' VAL . . . -81.74 119.08 74.51 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.137 -175.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 59' ' ' ALA . 7.4 Cg_exo -73.25 125.65 10.43 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 123.037 2.491 . . . . 0.0 112.055 176.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.443 ' HD3' ' HG3' ' A' ' 69' ' ' ARG . 72.3 Cg_endo . . . . . 0 N--CA 1.458 -0.56 0 C-N-CA 122.242 1.961 . . . . 0.0 111.658 176.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? . . . . . 0 N--CA 1.456 -0.146 0 CA-C-O 121.542 0.687 . . . . 0.0 110.171 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.538 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 1.4 p -137.46 148.66 25.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.723 -174.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.443 ' HG3' ' HD3' ' A' ' 61' ' ' PRO . 19.8 ttm180 -126.1 144.35 50.77 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 177.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.552 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 42.0 mtp -98.58 149.45 22.74 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.429 -173.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 26' ' ' HIS . 90.9 t -105.98 137.92 33.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.828 174.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.745 HG23 ' HB2' ' A' ' 59' ' ' ALA . 58.6 t -111.57 109.36 28.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 178.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.814 HG22 HG13 ' A' ' 56' ' ' ILE . 2.0 pp -124.6 140.32 48.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.143 0.497 . . . . 0.0 111.31 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 90.1 m -131.28 113.92 14.39 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.132 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.65 162.75 36.14 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.37 -177.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.47 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 45.3 Cg_endo -68.42 140.44 48.13 Favored 'Trans proline' 0 CA--C 1.531 0.346 0 C-N-CA 122.698 2.265 . . . . 0.0 111.371 175.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 76' ' ' PRO . 80.4 Cg_exo -45.98 -36.37 15.73 Favored 'Trans proline' 0 N--CA 1.477 0.543 0 C-N-CA 124.746 3.631 . . . . 0.0 114.897 -172.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -72.37 -39.37 68.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.84 0.352 . . . . 0.0 110.813 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.56 ' HA ' ' HE2' ' A' ' 82' ' ' LYS . . . -75.44 -29.31 59.65 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.235 0.54 . . . . 0.0 110.186 176.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -64.72 -35.38 80.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.3 178.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -53.34 -51.0 63.84 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.14 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.56 ' HE2' ' HA ' ' A' ' 79' ' ' ALA . 47.2 pttt -72.71 -33.85 66.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.465 -177.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.466 ' HB1' HD11 ' A' ' 48' ' ' LEU . . . -67.14 -53.8 27.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.866 0.365 . . . . 0.0 111.097 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.453 ' O ' HG22 ' A' ' 87' ' ' ILE . 45.1 tt0 -65.82 -29.72 70.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.107 -178.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -53.85 -35.73 53.81 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.737 177.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -75.81 -40.06 55.7 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 120.855 0.36 . . . . 0.0 110.852 178.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.629 HD11 HD13 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -65.33 -38.5 82.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.052 -177.343 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.848 ' HA ' HD22 ' A' ' 91' ' ' LEU . 2.2 m-30 -69.62 -27.34 64.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.763 0.316 . . . . 0.0 111.166 173.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -57.81 -41.14 93.86 Favored Glycine 0 CA--C 1.52 0.402 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.567 177.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.595 ' HG3' ' O ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -65.29 -24.64 67.35 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.68 0.276 . . . . 0.0 111.038 179.171 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.848 HD22 ' HA ' ' A' ' 88' ' ' TYR . 1.6 mp -58.37 -50.57 73.2 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.443 0.639 . . . . 0.0 110.392 177.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.86 ' HE3' ' HB ' ' A' ' 103' ' ' VAL . 0.6 OUTLIER -73.67 -37.89 65.11 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.434 177.711 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.512 ' HB3' ' HA ' ' A' ' 90' ' ' LYS . 3.7 tp10 -58.74 -38.46 78.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.525 -177.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.406 ' HG3' ' HB2' ' A' ' 33' ' ' ALA . 5.1 mm-40 -96.74 8.81 43.43 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -176.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 54.98 34.61 22.77 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.911 175.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.673 ' HZ ' ' HB2' ' A' ' 32' ' ' GLN . 44.4 m-85 . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 121.404 0.621 . . . . 0.0 109.555 174.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 . . . . . 0 N--CA 1.454 -0.236 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.86 ' HB ' ' HE3' ' A' ' 92' ' ' LYS . 7.2 p -79.68 129.65 37.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.177 0.513 . . . . 0.0 110.227 174.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.565 ' HD2' ' HA2' ' A' ' 158' ' ' GLY . 21.1 mmmt -139.14 89.48 2.35 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 174.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.809 ' HG ' HD21 ' A' ' 91' ' ' LEU . 3.4 tm? -110.94 130.48 55.57 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.489 -169.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.446 ' HA ' HG13 ' A' ' 157' ' ' ILE . 6.8 tp10 -64.88 118.91 9.73 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.394 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.0 m -126.39 114.93 18.86 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 177.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 49.9 m170 -99.66 120.42 39.67 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.942 0.401 . . . . 0.0 110.792 -177.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.656 HG22 ' HB ' ' A' ' 25' ' ' VAL . 39.8 pt -110.22 149.38 13.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.063 176.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 13.7 mmt180 -96.76 119.48 35.32 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.336 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.66 HG12 HD21 ' A' ' 174' ' ' LEU . 16.8 m -111.79 152.23 44.01 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 177.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.848 ' HD2' ' HG ' ' A' ' 174' ' ' LEU . 32.4 Cg_exo -56.22 147.73 64.38 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.435 2.09 . . . . 0.0 111.043 176.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -50.11 -52.1 37.63 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -171.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 18.6 m -72.25 -25.4 61.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.795 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.5 -26.52 65.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.798 0.333 . . . . 0.0 110.881 -178.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.798 ' HB1' HG21 ' A' ' 140' ' ' VAL . . . -64.96 -28.84 69.79 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.967 178.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -81.43 -18.97 67.44 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.613 -0.804 . . . . 0.0 111.838 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.59 ' HD3' HG22 ' A' ' 177' ' ' VAL . 17.8 mtp85 -92.38 -19.53 21.99 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 122.733 -0.275 . . . . 0.0 111.23 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.63 HG12 ' O ' ' A' ' 116' ' ' ALA . 7.6 p -69.52 -29.16 40.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.066 0.46 . . . . 0.0 110.236 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.958 ' HA ' ' HB ' ' A' ' 127' ' ' VAL . 7.7 pt -86.5 -33.62 7.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.59 175.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.562 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.913 179.264 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.403 ' HD3' ' N ' ' A' ' 126' ' ' THR . 1.2 tmtp? . . . . . 0 CA--C 1.538 0.509 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.403 ' N ' ' HD3' ' A' ' 125' ' ' LYS . 95.1 m -60.16 -46.07 90.95 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -175.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.958 ' HB ' ' HA ' ' A' ' 120' ' ' ILE . 7.1 p -64.62 -40.4 88.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.813 0.34 . . . . 0.0 111.322 -178.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -68.61 -33.96 74.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.258 0.551 . . . . 0.0 109.94 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -64.24 -41.71 96.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.864 175.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 127' ' ' VAL . 80.9 mt -59.45 -50.04 75.49 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.567 175.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -62.76 -40.55 97.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.292 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -68.03 -27.69 66.76 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.401 -177.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' A' ' 133' ' ' LEU . 1.9 tm? -93.18 -43.19 8.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.886 0.375 . . . . 0.0 110.961 -176.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 76.1 p -84.66 -20.47 31.22 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -175.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 67.04 20.64 10.37 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 123.724 0.64 . . . . 0.0 110.998 -178.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -118.43 157.46 27.15 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.167 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.57 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 36.4 tt0 -88.35 110.55 20.88 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 59.2 t -108.74 106.8 21.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.321 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.421 ' C ' HG23 ' A' ' 154' ' ' VAL . 6.7 p -132.28 120.74 44.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.38 0.61 . . . . 0.0 111.482 -178.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.798 HG21 ' HB1' ' A' ' 116' ' ' ALA . 2.6 p -99.82 113.16 64.95 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.01 177.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.54 ' HD2' ' O ' ' A' ' 153' ' ' ILE . 36.1 Cg_exo -60.78 125.64 17.74 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.439 2.092 . . . . 0.0 111.55 175.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -83.75 -15.22 49.34 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.26 0.553 . . . . 0.0 109.814 178.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -106.66 59.28 0.64 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.03 172.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.685 ' HG2' ' HB ' ' A' ' 152' ' ' VAL . 57.5 tp60 -100.52 171.75 7.54 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.147 -174.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.432 ' N ' ' HG3' ' A' ' 144' ' ' GLN . 31.7 p -45.21 153.82 0.52 Allowed Pre-proline 0 C--N 1.325 -0.499 0 C-N-CA 123.564 0.746 . . . . 0.0 112.346 174.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -54.61 153.85 22.3 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 123.398 2.732 . . . . 0.0 112.914 -176.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -78.33 9.34 3.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.544 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -53.05 -43.61 66.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.627 175.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . 0.421 ' O ' ' HG2' ' A' ' 150' ' ' GLU . 0.2 OUTLIER -79.74 1.02 28.19 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.668 -175.149 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 149' ' ' ASN . 9.2 pt-20 46.42 29.06 0.81 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.074 0.95 . . . . 0.0 110.484 -171.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -164.5 130.39 2.88 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.17 -169.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.685 ' HB ' ' HG2' ' A' ' 144' ' ' GLN . 23.7 m -128.26 -176.55 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.899 -175.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.54 ' O ' ' HD2' ' A' ' 141' ' ' PRO . 49.2 mt -104.85 142.52 17.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.03 -174.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.421 HG23 ' C ' ' A' ' 139' ' ' VAL . 2.1 p -135.0 140.0 46.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.074 164.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.9 mttt -95.24 145.6 24.94 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.424 -172.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.57 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 70.6 mt -131.42 110.79 18.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.476 174.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.446 HG13 ' HA ' ' A' ' 106' ' ' GLU . 3.8 mp -120.32 118.44 56.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 178.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.565 ' HA2' ' HD2' ' A' ' 104' ' ' LYS . . . -170.87 -170.17 34.77 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.489 -0.863 . . . . 0.0 112.164 -174.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.551 ' HA ' ' O ' ' A' ' 103' ' ' VAL . 24.6 m170 -80.35 169.99 17.0 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -53.26 -45.89 69.01 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -174.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.465 ' O ' ' HG3' ' A' ' 165' ' ' MET . 36.3 p90 -73.88 -33.85 64.21 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.92 0.391 . . . . 0.0 110.762 178.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.79 -50.97 37.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.133 -174.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 26.5 m -58.1 -48.57 79.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.64 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . 0.501 ' O ' ' HG2' ' A' ' 168' ' ' ARG . 65.7 mt-30 -61.74 -32.03 72.24 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.665 -178.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.465 ' HG3' ' O ' ' A' ' 161' ' ' TYR . 77.0 mtp -70.04 -48.54 57.54 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.382 175.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.43 -42.07 98.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.534 -177.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.55 HE21 HG21 ' A' ' 25' ' ' VAL . 39.0 mt-30 -51.4 -54.65 24.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.279 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.501 ' HG2' ' O ' ' A' ' 164' ' ' GLN . 19.4 ptt180 -75.7 -30.81 59.43 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.895 ' HA ' ' HE3' ' A' ' 169' ' ' LYS . 0.1 OUTLIER -70.85 -36.79 73.03 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 122.195 -0.316 . . . . 0.0 111.292 -177.342 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.649 ' O ' HD13 ' A' ' 174' ' ' LEU . 1.8 mp -75.29 -43.04 43.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 174.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.616 ' HA ' HD22 ' A' ' 174' ' ' LEU . 10.7 mmm180 -54.85 -25.74 30.67 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.994 0.426 . . . . 0.0 110.883 175.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.481 ' HB3' ' O ' ' A' ' 169' ' ' LYS . 6.7 t70 -63.13 -55.66 23.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.415 -0.812 . . . . 0.0 111.11 178.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.529 ' O ' HG23 ' A' ' 177' ' ' VAL . 37.8 pt -67.31 -21.95 28.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.882 -176.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.848 ' HG ' ' HD2' ' A' ' 112' ' ' PRO . 6.7 mp -57.18 -41.69 79.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.825 176.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.471 ' O ' ' HG2' ' A' ' 179' ' ' GLN . . . -68.16 -35.59 78.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.321 178.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -67.56 -32.58 73.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.457 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.59 HG22 ' HD3' ' A' ' 118' ' ' ARG . 60.0 t -72.86 -38.21 56.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.881 0.372 . . . . 0.0 110.535 178.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -69.17 -11.14 60.54 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.298 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 175' ' ' ALA . 33.1 mm-40 . . . . . 0 N--CA 1.464 0.261 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.143 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 . . . . . 0 N--CA 1.454 -0.265 0 CA-C-O 120.911 0.386 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.68 ' OE1' ' HG3' ' A' ' 171' ' ' ARG . 58.4 mt-10 -102.44 132.14 48.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.585 176.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.8 m -100.82 106.73 18.14 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 172.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.717 HG13 HG22 ' A' ' 109' ' ' ILE . 4.6 t -136.08 146.61 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.07 -174.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.456 ' HB2' ' O ' ' A' ' 108' ' ' HIS . 11.5 m170 -104.19 128.58 51.91 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-O 120.932 0.396 . . . . 0.0 110.483 -176.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.5 ' HB ' ' CG1' ' A' ' 71' ' ' VAL . 2.3 t -108.7 142.4 21.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -99.13 112.77 24.83 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -174.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.595 HG22 HD21 ' A' ' 91' ' ' LEU . 6.5 pt -126.81 120.11 22.78 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.846 176.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.619 ' HA ' ' HA ' ' A' ' 68' ' ' VAL . 68.6 Cg_exo -51.46 144.56 31.6 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.395 2.73 . . . . 0.0 112.58 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.711 ' HA ' HG12 ' A' ' 34' ' ' VAL . . . -59.85 -22.94 62.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.974 -1.012 . . . . 0.0 112.218 -173.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -84.2 0.3 49.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.38 -178.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.892 ' HB2' ' HE2' ' A' ' 96' ' ' PHE . . . -125.07 -32.75 2.97 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.594 174.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.711 HG12 ' HA ' ' A' ' 31' ' ' ALA . 11.2 p -57.01 -26.99 25.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-O 121.206 0.527 . . . . 0.0 110.075 -178.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.58 -56.95 22.32 Favored Glycine 0 N--CA 1.431 -1.649 0 CA-C-N 115.344 -0.843 . . . . 0.0 111.566 176.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.34 -13.53 59.8 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.826 0.346 . . . . 0.0 111.227 -174.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.661 HD12 ' HG2' ' A' ' 90' ' ' LYS . 3.3 mm -66.35 -39.47 84.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 176.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.711 HG22 ' HA2' ' A' ' 42' ' ' GLY . 32.5 mt -64.37 -44.78 97.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 172.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 70.6 104.45 0.04 OUTLIER Glycine 0 CA--C 1.519 0.309 0 N-CA-C 115.706 1.042 . . . . 0.0 115.706 163.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 66.7 mttm 40.54 98.39 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.598 1.159 . . . . 0.0 113.707 167.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.686 ' HE2' ' HB3' ' A' ' 43' ' ' GLN . 24.6 ttpt 76.13 -23.21 0.25 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.209 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.711 ' HA2' HG22 ' A' ' 38' ' ' ILE . . . 92.31 23.06 27.82 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.977 -178.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.686 ' HB3' ' HE2' ' A' ' 41' ' ' LYS . 19.2 pt20 -87.95 -24.71 23.5 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.15 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 81.3 m-70 -66.11 -44.53 84.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.783 0.325 . . . . 0.0 110.775 -178.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.574 ' CD1' HG12 ' A' ' 58' ' ' ILE . 3.0 tt -61.75 -49.06 85.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.242 -177.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -77.55 -21.36 52.67 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.849 0.356 . . . . 0.0 111.033 -175.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -68.43 -36.67 79.4 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 172.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.958 HD23 HG12 ' A' ' 56' ' ' ILE . 1.2 tp -56.73 -40.69 76.15 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.209 177.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.69 ' HA ' HD13 ' A' ' 56' ' ' ILE . 2.1 m -56.85 -38.46 72.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.984 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -70.7 -51.27 28.67 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -175.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.658 ' CZ ' ' HA ' ' A' ' 48' ' ' LEU . 10.6 p90 -79.14 -6.88 57.55 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 120.274 -0.57 . . . . 0.0 111.553 -176.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -97.55 -13.12 21.83 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.863 0.363 . . . . 0.0 110.703 173.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.7 m 56.62 39.61 29.72 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.054 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.441 ' HB1' ' O ' ' A' ' 74' ' ' THR . . . -141.28 174.62 10.36 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.469 -174.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.616 ' HB3' ' HB ' ' A' ' 74' ' ' THR . 32.3 t -92.78 104.34 16.61 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.958 HG12 HD23 ' A' ' 48' ' ' LEU . 1.9 mp -110.97 115.52 50.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.778 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -143.49 151.36 40.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.938 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.574 HG12 ' CD1' ' A' ' 45' ' ' ILE . 25.1 mm -86.88 134.64 27.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.719 0.295 . . . . 0.0 110.347 178.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.73 ' HB2' HG23 ' A' ' 72' ' ' VAL . . . -95.27 116.77 66.62 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.397 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -62.37 128.61 24.22 Favored 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 122.698 2.265 . . . . 0.0 112.053 178.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.73 ' HD3' ' HG3' ' A' ' 69' ' ' ARG . 57.2 Cg_endo . . . . . 0 C--O 1.237 0.437 0 C-N-CA 122.449 2.099 . . . . 0.0 111.635 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? . . . . . 0 C--O 1.23 0.076 0 CA-C-O 121.047 0.451 . . . . 0.0 110.747 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.619 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 2.0 p -134.16 147.15 30.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.192 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.73 ' HG3' ' HD3' ' A' ' 61' ' ' PRO . 27.2 ttm180 -119.18 145.87 45.64 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.617 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 55.3 mtt -87.6 149.07 24.55 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.817 0.342 . . . . 0.0 110.321 -178.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.5 ' CG1' ' HB ' ' A' ' 27' ' ' VAL . 2.8 p -118.5 131.97 69.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 169.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.73 HG23 ' HB2' ' A' ' 59' ' ' ALA . 58.3 t -86.81 102.62 12.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.096 0.474 . . . . 0.0 109.977 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.457 ' HA ' HD13 ' A' ' 73' ' ' ILE . 1.9 mm -94.97 117.63 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.987 175.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.661 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 25.0 m -130.02 106.26 8.52 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.656 175.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.13 162.0 35.31 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.748 -176.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -69.51 155.41 66.83 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.356 2.038 . . . . 0.0 111.144 171.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -38.92 -42.92 2.11 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 124.041 3.161 . . . . 0.0 114.231 -177.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.47 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 30.4 tt0 -55.99 -50.3 71.24 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.149 0.5 . . . . 0.0 110.561 176.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.434 ' HA ' ' CE ' ' A' ' 82' ' ' LYS . . . -63.54 -36.68 84.57 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.689 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -55.96 -35.58 66.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.942 177.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -69.7 -55.66 9.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.767 -174.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.47 ' HD3' ' O ' ' A' ' 78' ' ' GLU . 0.4 OUTLIER -74.62 -34.16 62.74 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 120.119 -0.632 . . . . 0.0 111.879 -176.36 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.31 -52.59 64.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.93 0.395 . . . . 0.0 110.617 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.474 ' HA ' HG22 ' A' ' 87' ' ' ILE . 47.6 mt-30 -76.38 -31.25 57.9 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.216 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.401 ' HA2' ' CE1' ' A' ' 160' ' ' PHE . . . -53.95 -43.65 71.84 Favored Glycine 0 CA--C 1.512 -0.153 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.02 177.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' A' ' 82' ' ' LYS . 12.6 mmt180 -74.84 -43.04 56.73 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.989 0.423 . . . . 0.0 110.076 176.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.903 ' HA ' ' HD3' ' A' ' 90' ' ' LYS . 0.4 OUTLIER -63.8 -35.79 74.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.994 -171.189 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -64.48 -30.51 71.55 Favored 'General case' 0 C--N 1.333 -0.114 0 O-C-N 121.866 -0.522 . . . . 0.0 109.688 176.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -65.0 -29.03 74.31 Favored Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.666 173.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.903 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 4.3 mptp? -68.84 -33.36 73.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.148 0.499 . . . . 0.0 110.103 175.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.735 ' HG ' ' HG ' ' A' ' 105' ' ' LEU . 4.1 mm? -64.55 -40.24 95.21 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.523 172.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.878 ' HE3' ' HB ' ' A' ' 103' ' ' VAL . 0.1 OUTLIER -71.71 -22.0 61.7 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.564 176.659 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -53.52 -47.27 70.06 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.302 178.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -112.81 3.79 16.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.902 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 43.09 59.99 2.7 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 172.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.892 ' HE2' ' HB2' ' A' ' 33' ' ' ALA . 82.8 m-85 . . . . . 0 C--N 1.327 -0.41 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.955 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.467 ' O ' ' HG2' ' A' ' 104' ' ' LYS . 6.7 mm-40 . . . . . 0 CA--C 1.515 -0.4 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.878 ' HB ' ' HE3' ' A' ' 92' ' ' LYS . 14.9 p -52.39 125.37 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 CA-C-O 121.576 0.703 . . . . 0.0 111.258 -173.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 47.1 mmtm -120.13 91.16 3.47 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.563 -1.198 . . . . 0.0 108.755 178.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.735 ' HG ' ' HG ' ' A' ' 91' ' ' LEU . 1.5 tt -108.27 124.9 51.01 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.658 -173.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -74.5 120.93 20.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.627 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.4 m -107.33 108.47 19.86 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 173.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . 0.456 ' O ' ' HB2' ' A' ' 26' ' ' HIS . 12.1 m-70 -104.01 121.07 42.39 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.159 0.504 . . . . 0.0 109.921 -177.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.717 HG22 HG13 ' A' ' 25' ' ' VAL . 23.0 pt -122.88 152.22 27.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 C-N-CA 120.534 -0.466 . . . . 0.0 112.138 -173.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.713 ' HD3' HG12 ' A' ' 153' ' ' ILE . 1.7 mmt180 -100.05 116.83 32.99 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.435 174.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 151' ' ' GLN . 31.2 m -104.93 162.31 20.15 Favored Pre-proline 0 C--N 1.316 -0.858 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 173.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.421 ' HD2' HD22 ' A' ' 174' ' ' LEU . 51.7 Cg_exo -51.83 139.69 49.25 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 121.442 1.428 . . . . 0.0 109.856 170.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -55.18 -30.5 60.03 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.492 -170.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.5 m -93.02 -15.64 25.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.75 0.31 . . . . 0.0 111.439 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.62 -24.72 61.93 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.913 -172.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.546 ' O ' HG12 ' A' ' 119' ' ' VAL . . . -57.99 -28.84 64.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.145 0.498 . . . . 0.0 110.787 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.92 -27.76 73.52 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.997 -0.62 . . . . 0.0 113.014 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.609 ' HD3' HG22 ' A' ' 177' ' ' VAL . 69.3 mtp180 -92.12 -22.79 19.69 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 122.385 -0.479 . . . . 0.0 111.488 -178.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.546 HG12 ' O ' ' A' ' 116' ' ' ALA . 9.8 p -73.31 -27.98 24.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 174.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.943 ' HA ' ' HB ' ' A' ' 127' ' ' VAL . 67.7 mt -78.56 -39.44 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 CA-C-O 121.708 0.766 . . . . 0.0 109.339 171.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.589 ' HA3' ' HB ' ' A' ' 126' ' ' THR . . . . . . . . 0 N--CA 1.442 -0.933 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.312 175.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 41.3 tptt . . . . . 0 C--O 1.232 0.177 0 CA-C-O 121.103 0.477 . . . . 0.0 110.621 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.589 ' HB ' ' HA3' ' A' ' 121' ' ' GLY . 84.2 m -65.2 -46.93 78.72 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.306 -176.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.943 ' HB ' ' HA ' ' A' ' 120' ' ' ILE . 11.6 p -67.83 -35.84 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 121.029 -0.268 . . . . 0.0 111.219 -176.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -65.26 -43.57 90.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.2 0.524 . . . . 0.0 109.989 178.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -68.49 -35.68 77.87 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.102 177.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.69 HD21 HD11 ' A' ' 170' ' ' ILE . 39.4 tp -60.74 -49.53 77.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.817 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.541 HE21 ' HA ' ' A' ' 137' ' ' GLU . 39.3 mt-30 -66.65 -32.37 73.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.777 0.322 . . . . 0.0 111.129 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -64.05 -43.6 95.04 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.996 0.427 . . . . 0.0 110.703 175.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 6.7 tt -73.88 -48.11 33.3 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.805 -177.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.671 ' HB ' ' HB2' ' A' ' 166' ' ' ALA . 70.5 p -77.65 -29.98 51.9 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -172.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 65.03 28.17 12.48 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.601 -175.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -121.02 169.37 10.56 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.441 177.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.541 ' HA ' HE21 ' A' ' 131' ' ' GLN . 9.0 tp10 -96.18 111.86 23.78 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.835 -178.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.451 ' H ' ' NE2' ' A' ' 131' ' ' GLN . 45.3 t -113.63 107.33 22.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 O-C-N 123.82 0.7 . . . . 0.0 109.391 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.693 HG13 ' HD3' ' A' ' 155' ' ' LYS . 14.9 p -125.87 126.9 70.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.231 0.539 . . . . 0.0 111.63 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.443 HG22 ' HB ' ' A' ' 154' ' ' VAL . 59.9 t -104.94 112.95 65.26 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.906 176.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.638 ' HG3' ' HE3' ' A' ' 155' ' ' LYS . 34.6 Cg_exo -62.01 156.98 46.32 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 123.1 2.533 . . . . 0.0 112.325 177.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -87.4 -26.1 23.48 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.076 -178.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -120.2 115.97 24.68 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.133 178.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.53 ' OE1' ' HB ' ' A' ' 153' ' ' ILE . 22.4 mm-40 -127.77 -86.9 0.57 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.012 0.434 . . . . 0.0 112.034 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -152.77 154.65 31.65 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.299 -175.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.76 165.17 26.59 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.731 2.288 . . . . 0.0 111.2 175.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -69.98 -3.96 18.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.96 -177.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -53.84 -42.57 68.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.277 0.56 . . . . 0.0 110.239 169.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -84.21 -14.12 50.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.832 -179.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 47.27 23.46 0.33 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.024 1.33 . . . . 0.0 112.058 -175.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.467 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 57.8 mt-30 -143.27 142.26 31.3 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 120.994 0.426 . . . . 0.0 111.16 -175.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 19.7 m -131.93 163.46 37.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 174.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.713 HG12 ' HD3' ' A' ' 110' ' ' ARG . 12.8 mt -107.39 141.71 21.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.365 0.602 . . . . 0.0 112.393 -176.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.443 ' HB ' HG22 ' A' ' 140' ' ' VAL . 2.5 p -128.49 139.44 51.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.379 163.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.693 ' HD3' HG13 ' A' ' 139' ' ' VAL . 0.0 OUTLIER -99.44 137.76 37.48 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -176.27 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.447 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 65.1 mt -113.5 111.18 34.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 169.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 4.7 mp -113.69 140.84 31.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 156.28 -168.52 33.62 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.113 -1.041 . . . . 0.0 112.636 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.405 ' CD2' HG12 ' A' ' 103' ' ' VAL . 12.1 t-80 -75.55 160.85 29.7 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.602 -0.299 . . . . 0.0 110.374 -178.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.535 ' O ' ' HG2' ' A' ' 164' ' ' GLN . 30.4 t80 -49.39 -50.0 42.28 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -172.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -71.47 -47.44 55.63 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.194 -177.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -59.27 -44.62 92.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.911 0.386 . . . . 0.0 110.845 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.659 ' O ' ' HG3' ' A' ' 167' ' ' GLN . 31.9 t -63.79 -52.1 61.79 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.173 -177.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . 0.535 ' HG2' ' O ' ' A' ' 160' ' ' PHE . 4.0 pt20 -66.96 -35.21 79.46 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.406 -177.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 47.1 ttp -64.85 -36.72 85.27 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.068 0.461 . . . . 0.0 109.912 177.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.671 ' HB2' ' HB ' ' A' ' 134' ' ' THR . . . -69.47 -43.11 73.88 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.241 174.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.68 ' O ' ' HG2' ' A' ' 171' ' ' ARG . 80.7 mt-30 -51.47 -56.71 11.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.341 -176.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.401 ' HG3' ' N ' ' A' ' 169' ' ' LYS . 0.1 OUTLIER -58.4 -29.78 66.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.036 -179.102 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.803 ' HE2' ' HA ' ' A' ' 169' ' ' LYS . 0.6 OUTLIER -75.17 -36.39 61.5 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 120.862 0.363 . . . . 0.0 110.399 -172.903 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.69 HD11 HD21 ' A' ' 130' ' ' LEU . 1.8 mp -74.61 -42.46 48.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.469 178.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.68 ' HG3' ' OE1' ' A' ' 23' ' ' GLU . 0.8 OUTLIER -64.25 -25.62 68.14 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.391 0.615 . . . . 0.0 109.419 179.284 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -73.06 -44.24 60.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.583 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.551 HG13 ' O ' ' A' ' 170' ' ' ILE . 2.8 pp -70.95 -19.22 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.904 -178.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 170' ' ' ILE . 39.3 mt -58.82 -34.82 71.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.035 0.445 . . . . 0.0 110.365 174.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.17 -34.53 78.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.767 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -66.44 -39.06 88.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.22 0.533 . . . . 0.0 109.973 176.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.609 HG22 ' HD3' ' A' ' 118' ' ' ARG . 39.6 t -63.53 -38.96 83.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.229 176.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -63.58 -44.49 93.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.271 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.197 -179.308 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.409 ' OE1' ' HA ' ' A' ' 22' ' ' GLN . 14.5 mm-40 . . . . . 0 C--O 1.236 0.362 0 CA-C-O 120.972 0.415 . . . . 0.0 110.223 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -98.1 117.74 33.14 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.183 -178.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 48.3 m -110.57 107.72 17.43 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.82 176.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.528 ' HB ' HD11 ' A' ' 73' ' ' ILE . 34.8 t -117.9 147.87 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.438 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 13.8 m-70 -110.04 123.36 49.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.862 0.363 . . . . 0.0 110.71 -173.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.585 ' HB ' ' HB ' ' A' ' 71' ' ' VAL . 44.4 t -90.36 142.03 13.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.59 -176.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.24 105.16 14.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.469 -177.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.555 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 13.9 pt -127.9 123.47 22.81 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 120.938 0.399 . . . . 0.0 110.929 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -48.53 143.53 15.75 Favored 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 123.531 2.821 . . . . 0.0 112.638 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.466 ' HA ' HG12 ' A' ' 34' ' ' VAL . . . -58.08 -18.79 27.14 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.101 -176.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.5 mp0 -65.25 -44.28 88.64 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.401 177.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.746 ' HB2' ' HE2' ' A' ' 96' ' ' PHE . . . -93.71 -29.64 15.3 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.196 -171.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.611 ' HA ' HG12 ' A' ' 37' ' ' ILE . 12.2 p -56.92 -27.64 26.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 O-C-N 123.253 0.346 . . . . 0.0 111.201 -174.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.83 -56.82 22.84 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.235 -0.983 . . . . 0.0 111.076 177.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.95 -15.71 60.13 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.607 -176.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.703 HD12 ' HB3' ' A' ' 90' ' ' LYS . 4.8 mm -61.66 -47.16 94.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.242 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.871 HG22 ' HA2' ' A' ' 42' ' ' GLY . 28.9 mt -63.64 -38.61 82.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.203 177.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 81.83 105.34 0.39 Allowed Glycine 0 CA--C 1.52 0.397 0 N-CA-C 115.554 0.982 . . . . 0.0 115.554 164.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.486 ' HA ' ' HD3' ' A' ' 40' ' ' LYS . 30.0 mmtp 63.64 -81.29 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 168.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.8 ptmt -123.02 10.12 9.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.931 0.396 . . . . 0.0 110.932 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.871 ' HA2' HG22 ' A' ' 38' ' ' ILE . . . 83.34 16.19 69.67 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.408 -0.901 . . . . 0.0 111.786 -177.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -76.4 -28.6 56.77 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.096 0.474 . . . . 0.0 110.048 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.463 ' HB2' ' O ' ' A' ' 38' ' ' ILE . 38.7 m170 -67.04 -30.67 70.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.699 -173.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.793 HD12 HG12 ' A' ' 58' ' ' ILE . 8.9 tt -76.12 -40.33 36.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -175.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.64 -30.98 41.48 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.124 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.469 ' OE1' ' HD2' ' A' ' 50' ' ' ARG . 6.3 tp60 -64.48 -33.84 76.83 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 173.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.835 HD12 HG12 ' A' ' 56' ' ' ILE . 0.5 OUTLIER -58.73 -47.14 85.65 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.987 176.407 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.636 ' HA ' HD13 ' A' ' 56' ' ' ILE . 57.1 m -58.26 -31.89 67.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.046 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.469 ' HD2' ' OE1' ' A' ' 47' ' ' GLN . 99.6 mtt180 -73.64 -33.66 64.62 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.584 -178.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.735 ' CD2' ' HA ' ' A' ' 48' ' ' LEU . 24.2 m-85 -62.21 -48.12 81.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.108 0.48 . . . . 0.0 110.761 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.419 ' HB1' ' HB1' ' A' ' 79' ' ' ALA . . . -94.42 -10.58 32.05 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.362 -172.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 75.6 m 60.39 40.22 17.66 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.479 0.657 . . . . 0.0 110.259 -173.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -130.7 174.3 10.07 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.533 -178.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.2 t -95.44 107.01 19.14 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.777 0.322 . . . . 0.0 110.262 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.835 HG12 HD12 ' A' ' 48' ' ' LEU . 2.0 mp -110.12 113.1 43.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.032 179.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.445 ' HA ' HD11 ' A' ' 45' ' ' ILE . 53.2 mtmt -138.14 153.31 49.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.291 -179.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.793 HG12 HD12 ' A' ' 45' ' ' ILE . 44.9 mm -90.44 127.32 43.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.924 0.392 . . . . 0.0 110.25 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.925 ' HB2' HG23 ' A' ' 72' ' ' VAL . . . -92.41 115.8 65.39 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.759 -178.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -67.87 131.18 23.41 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.538 2.159 . . . . 0.0 111.371 176.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.446 ' HD3' ' HD3' ' A' ' 69' ' ' ARG . 18.6 Cg_endo . . . . . 0 N--CA 1.462 -0.361 0 C-N-CA 122.54 2.16 . . . . 0.0 110.814 176.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? . . . . . 0 C--O 1.233 0.225 0 CA-C-O 120.943 0.401 . . . . 0.0 111.505 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.555 ' HB ' ' O ' ' A' ' 29' ' ' ILE . 1.3 m -123.35 174.79 7.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 121.191 0.52 . . . . 0.0 110.947 -174.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.574 ' HB3' HG21 ' A' ' 34' ' ' VAL . 2.0 tpp85 -118.19 132.54 56.32 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 174.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.499 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 56.1 mtm -91.14 149.5 21.77 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.891 -175.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.585 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 94.3 t -113.17 132.2 62.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 175.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.925 HG23 ' HB2' ' A' ' 59' ' ' ALA . 77.6 t -99.92 111.83 30.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 177.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.816 HG22 HG13 ' A' ' 56' ' ' ILE . 2.5 pp -110.93 128.51 67.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.746 173.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 83.3 m -128.18 106.0 8.75 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.968 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -166.78 164.39 37.74 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.041 -178.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -56.81 136.84 78.71 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 121.859 1.706 . . . . 0.0 109.987 170.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -49.67 -19.58 3.6 Favored 'Trans proline' 0 N--CA 1.48 0.68 0 C-N-CA 123.897 3.065 . . . . 0.0 114.515 -172.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -70.72 -33.07 70.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.0 0.428 . . . . 0.0 110.563 177.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.419 ' HB1' ' HB1' ' A' ' 52' ' ' ALA . . . -78.4 -21.82 48.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.809 -177.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.51 -36.22 64.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.47 176.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.624 ' HA ' ' NE2' ' A' ' 164' ' ' GLN . 69.1 t80 -59.3 -47.09 86.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.469 177.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 36.0 tptt -63.89 -52.56 59.36 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.048 -176.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.69 -53.64 14.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.474 -174.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -71.38 -29.36 64.85 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -172.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -53.59 -36.81 55.13 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 120.365 -0.922 . . . . 0.0 111.739 175.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.448 ' HD2' ' N ' ' A' ' 86' ' ' ARG . 4.5 mpt_? -80.11 -32.02 39.11 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.532 0.197 . . . . 0.0 111.532 177.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -68.5 -44.43 83.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 121.119 -0.232 . . . . 0.0 110.422 -176.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.699 ' HA ' HD23 ' A' ' 91' ' ' LEU . 6.9 m-85 -66.38 -32.97 74.68 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.189 0.519 . . . . 0.0 110.274 177.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -66.02 -28.66 73.85 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.051 177.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.703 ' HB3' HD12 ' A' ' 37' ' ' ILE . 30.7 mmtp -78.43 -17.62 56.09 Favored 'General case' 0 N--CA 1.443 -0.787 0 O-C-N 122.388 -0.478 . . . . 0.0 111.332 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.699 HD23 ' HA ' ' A' ' 88' ' ' TYR . 2.6 mm? -65.34 -34.04 77.38 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 120.223 -0.591 . . . . 0.0 109.876 166.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.922 ' HE3' HG22 ' A' ' 103' ' ' VAL . 10.4 mmtp -72.79 -26.07 61.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.37 177.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.441 ' HB2' ' HA ' ' A' ' 90' ' ' LYS . 8.3 tp10 -63.47 -31.29 72.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.394 178.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.49 ' HG3' ' HA ' ' A' ' 33' ' ' ALA . 20.9 mm-40 -97.65 9.22 43.09 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.039 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 65.3 t30 56.8 41.88 27.42 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.654 176.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.746 ' HE2' ' HB2' ' A' ' 33' ' ' ALA . 41.9 m-85 . . . . . 0 C--N 1.327 -0.396 0 CA-C-O 121.04 0.448 . . . . 0.0 110.237 174.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 . . . . . 0 CA--C 1.523 -0.094 0 CA-C-O 120.772 0.32 . . . . 0.0 111.402 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.922 HG22 ' HE3' ' A' ' 92' ' ' LYS . 1.0 OUTLIER -73.96 129.08 36.59 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 172.608 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.6 mmmm -129.4 87.01 2.49 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 172.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.67 ' HB3' ' CE2' ' A' ' 88' ' ' TYR . 2.1 tm? -125.04 141.45 52.12 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -176.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.571 ' H ' HD22 ' A' ' 105' ' ' LEU . 39.8 tt0 -95.47 127.51 41.56 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.578 -170.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.519 HG21 ' NE2' ' A' ' 167' ' ' GLN . 0.1 OUTLIER -108.39 147.66 31.24 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 171.519 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -114.05 119.53 37.48 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.887 0.375 . . . . 0.0 110.088 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.428 ' CG1' ' HB ' ' A' ' 154' ' ' VAL . 23.1 pt -107.43 128.09 62.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.121 177.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.684 ' HD3' HG12 ' A' ' 153' ' ' ILE . 8.8 mmt180 -74.34 123.78 25.25 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.19 177.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.658 HG22 ' HB3' ' A' ' 115' ' ' ALA . 6.4 p -134.07 142.35 42.94 Favored Pre-proline 0 N--CA 1.444 -0.773 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.566 -175.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.442 ' HD2' HG22 ' A' ' 111' ' ' VAL . 31.7 Cg_exo -56.16 149.3 54.78 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 123.114 2.543 . . . . 0.0 111.978 179.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.62 -47.88 69.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.2 0.524 . . . . 0.0 111.066 -178.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.4 m -67.43 -28.9 68.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.661 -177.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.73 ' HB1' HD22 ' A' ' 174' ' ' LEU . . . -67.01 -28.83 68.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.933 -175.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.479 ' HB2' HG21 ' A' ' 152' ' ' VAL . . . -64.66 -27.0 68.63 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.099 0.476 . . . . 0.0 111.225 177.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -79.25 -31.09 43.41 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.664 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.584 ' HD3' HG22 ' A' ' 177' ' ' VAL . 23.1 ttt85 -91.63 -28.63 17.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.081 0.441 . . . . 0.0 111.711 -176.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.2 p -61.14 -24.38 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 121.13 0.491 . . . . 0.0 110.826 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.72 ' HA ' ' HB ' ' A' ' 127' ' ' VAL . 47.1 mm -77.85 -51.43 17.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.158 176.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.592 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.18 -175.986 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.546 ' HD2' ' HB2' ' A' ' 129' ' ' GLU . 3.7 pptp? . . . . . 0 CA--C 1.521 -0.142 0 CA-C-O 121.03 0.443 . . . . 0.0 110.048 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.517 ' O ' ' HG ' ' A' ' 130' ' ' LEU . 9.3 t -63.27 -34.58 77.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.022 -173.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.72 ' HB ' ' HA ' ' A' ' 120' ' ' ILE . 9.5 p -67.47 -37.69 79.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-O 121.044 0.449 . . . . 0.0 110.549 177.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.491 ' HA ' ' OE1' ' A' ' 131' ' ' GLN . 3.6 t-20 -74.09 -34.55 64.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.515 0.674 . . . . 0.0 109.579 178.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.546 ' HB2' ' HD2' ' A' ' 125' ' ' LYS . 69.4 tt0 -65.33 -37.46 87.15 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.059 177.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 126' ' ' THR . 87.0 mt -56.78 -48.83 77.0 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.406 173.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.491 ' OE1' ' HA ' ' A' ' 128' ' ' ASN . 80.8 mt-30 -57.35 -45.95 83.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.34 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -71.59 -36.15 70.75 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.834 0.349 . . . . 0.0 111.146 -177.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -73.03 -46.4 52.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.791 -177.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.582 HG21 ' HA ' ' A' ' 166' ' ' ALA . 77.0 p -88.07 -18.07 29.71 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.033 0.382 . . . . 0.0 112.033 -174.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 65.98 22.26 11.26 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 123.847 0.717 . . . . 0.0 110.491 -175.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.576 ' HB2' ' HB1' ' A' ' 162' ' ' ALA . . . -122.3 160.8 24.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.63 -177.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.645 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 10.9 tp10 -88.95 111.73 22.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.487 178.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 54.2 t -104.22 106.04 19.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.582 178.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.464 ' O ' ' HD2' ' A' ' 155' ' ' LYS . 5.0 p -128.7 124.45 61.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.322 0.582 . . . . 0.0 111.156 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.5 ' HB ' HG22 ' A' ' 154' ' ' VAL . 11.2 p -122.14 128.85 25.35 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.71 178.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.648 ' HG3' ' HE3' ' A' ' 155' ' ' LYS . 13.1 Cg_exo -68.24 154.92 71.14 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.552 2.168 . . . . 0.0 111.565 -178.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 -93.8 15.8 15.65 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 176.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.564 ' CG ' ' H ' ' A' ' 144' ' ' GLN . 6.6 p-10 -136.24 -91.06 0.28 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.8 177.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.921 ' HG2' ' H ' ' A' ' 153' ' ' ILE . 6.0 tp-100 58.13 88.88 0.06 Allowed 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.613 0.765 . . . . 0.0 112.351 174.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.636 ' HB ' ' HD2' ' A' ' 146' ' ' PRO . 59.5 p 61.35 161.18 0.11 Allowed Pre-proline 0 N--CA 1.473 0.689 0 C-N-CA 124.225 1.01 . . . . 0.0 112.51 176.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.636 ' HD2' ' HB ' ' A' ' 145' ' ' THR . 57.7 Cg_endo -72.21 157.86 53.03 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.261 1.974 . . . . 0.0 112.285 178.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -73.06 8.87 1.39 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.566 -176.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -57.0 -47.48 80.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.232 0.539 . . . . 0.0 110.143 174.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . 0.499 ' O ' ' HG2' ' A' ' 150' ' ' GLU . 56.1 t30 -90.85 -8.75 48.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.149 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 149' ' ' ASN . 9.9 pt-20 45.03 36.82 2.14 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 114.44 -1.254 . . . . 0.0 111.642 178.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -148.2 138.97 23.02 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.573 -176.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.493 HG23 ' CG1' ' A' ' 111' ' ' VAL . 21.3 m -120.22 -176.15 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.92 -174.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.921 ' H ' ' HG2' ' A' ' 144' ' ' GLN . 49.9 mt -134.45 128.89 52.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.306 -176.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.5 HG22 ' HB ' ' A' ' 140' ' ' VAL . 53.9 t -95.82 140.28 17.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 173.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.648 ' HE3' ' HG3' ' A' ' 141' ' ' PRO . 0.0 OUTLIER -104.13 134.92 46.56 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 177.657 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.645 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 70.6 mt -118.95 112.06 36.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.914 177.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.421 HD12 ' N ' ' A' ' 157' ' ' ILE . 4.4 mp -110.47 138.62 37.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.793 -178.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 149.72 -157.13 27.1 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.372 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -81.45 159.8 24.16 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 -177.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.504 ' HB3' ' CB ' ' A' ' 88' ' ' TYR . 7.6 p90 -57.89 -47.86 81.56 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.719 -175.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.408 ' O ' ' HG3' ' A' ' 165' ' ' MET . 19.0 m-85 -54.37 -49.89 68.78 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.626 0.251 . . . . 0.0 110.721 177.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.576 ' HB1' ' HB2' ' A' ' 136' ' ' ALA . . . -58.25 -53.47 57.88 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.578 -178.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.466 ' O ' ' HG3' ' A' ' 167' ' ' GLN . 30.0 m -59.84 -49.69 76.73 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.979 -179.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . 0.624 ' NE2' ' HA ' ' A' ' 81' ' ' PHE . 21.6 mt-30 -56.51 -30.84 63.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.764 178.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.408 ' HG3' ' O ' ' A' ' 161' ' ' TYR . 91.0 mtp -77.96 -42.67 32.09 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.743 0.306 . . . . 0.0 110.798 175.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.582 ' HA ' HG21 ' A' ' 134' ' ' THR . . . -69.4 -41.56 76.27 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -174.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.519 ' NE2' HG21 ' A' ' 107' ' ' THR . 71.9 mt-30 -51.93 -57.77 8.44 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.961 0.41 . . . . 0.0 111.215 -176.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 21.5 ptt180 -68.21 -28.15 67.0 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.533 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.769 ' HA ' ' HE3' ' A' ' 169' ' ' LYS . 0.1 OUTLIER -69.56 -44.9 69.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.851 0.358 . . . . 0.0 110.393 -177.832 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.588 ' O ' ' HG ' ' A' ' 174' ' ' LEU . 1.8 mp -71.54 -40.46 71.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 177.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 27.2 mmm-85 -58.88 -26.23 64.07 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.147 0.499 . . . . 0.0 110.974 174.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -77.87 -46.55 21.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.966 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.547 HG13 ' O ' ' A' ' 170' ' ' ILE . 2.7 pp -66.28 -18.88 24.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-O 121.0 0.429 . . . . 0.0 110.823 -177.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.73 HD22 ' HB1' ' A' ' 115' ' ' ALA . 17.7 mt -57.37 -27.55 62.39 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.247 175.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.7 ' HA ' ' HD3' ' A' ' 178' ' ' LYS . . . -54.87 -33.46 61.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.515 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -70.22 -33.19 71.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.927 0.394 . . . . 0.0 110.568 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.584 HG22 ' HD3' ' A' ' 118' ' ' ARG . 40.3 t -69.32 -40.39 80.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.389 0.614 . . . . 0.0 109.736 178.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.7 ' HD3' ' HA ' ' A' ' 175' ' ' ALA . 50.9 mtpt -59.95 -50.52 73.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.073 176.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.312 -177.73 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.524 ' HB2' HG22 ' A' ' 74' ' ' THR . 64.2 mt-30 . . . . . 0 N--CA 1.45 -0.441 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.442 ' OE1' ' HD3' ' A' ' 77' ' ' PRO . 1.5 mp0 -73.57 113.26 10.48 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.354 0.597 . . . . 0.0 111.619 -174.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 4.9 m -92.66 109.56 20.98 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.134 177.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.8 m -124.14 152.9 30.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 10.2 m170 -113.81 132.03 56.02 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -174.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.713 ' HB ' ' CG1' ' A' ' 71' ' ' VAL . 20.8 t -108.2 141.02 24.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.559 -177.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.674 ' CE2' HG11 ' A' ' 68' ' ' VAL . 47.2 t80 -97.6 104.87 16.94 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 123.531 0.732 . . . . 0.0 110.198 -174.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.544 ' C ' HG23 ' A' ' 68' ' ' VAL . 11.1 pt -124.5 116.58 26.68 Favored Pre-proline 0 C--N 1.326 -0.435 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.264 176.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.515 ' HA ' ' HA ' ' A' ' 68' ' ' VAL . 18.7 Cg_endo -58.9 147.98 86.61 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.57 2.847 . . . . 0.0 112.572 -177.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.636 ' HA ' HG12 ' A' ' 34' ' ' VAL . . . -54.08 -25.71 23.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.579 -1.191 . . . . 0.0 112.854 -175.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -70.3 -23.65 62.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.909 0.385 . . . . 0.0 111.182 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.578 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -114.12 -30.8 6.54 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.577 -177.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.636 HG12 ' HA ' ' A' ' 31' ' ' ALA . 13.0 p -51.95 -33.8 16.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 O-C-N 123.24 0.337 . . . . 0.0 111.661 -173.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.65 -56.94 22.43 Favored Glycine 0 N--CA 1.439 -1.129 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.974 -179.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.74 -14.19 59.41 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.79 -0.205 . . . . 0.0 111.318 -175.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.662 HD12 ' HB3' ' A' ' 90' ' ' LYS . 8.3 mm -61.71 -43.01 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 175.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.479 HG23 HG21 ' A' ' 45' ' ' ILE . 26.3 mt -55.88 -53.48 37.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.532 176.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.32 113.63 0.45 Allowed Glycine 0 CA--C 1.521 0.462 0 C-N-CA 120.515 -0.85 . . . . 0.0 114.942 168.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.413 ' HA ' ' HD2' ' A' ' 40' ' ' LYS . 46.4 tptt 48.82 77.64 0.1 Allowed 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.191 0.996 . . . . 0.0 113.009 170.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.459 ' HB3' ' HG3' ' A' ' 43' ' ' GLN . 0.0 OUTLIER 62.68 7.81 2.68 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.945 173.893 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.573 ' O ' HG22 ' A' ' 45' ' ' ILE . . . 76.58 8.67 86.15 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.122 -1.037 . . . . 0.0 111.759 -177.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.494 ' HA ' ' HE3' ' A' ' 46' ' ' LYS . 50.8 mt-30 -62.87 -43.55 98.5 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 40.7 m-70 -78.74 -26.62 44.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.695 -177.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.573 HG22 ' O ' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -72.1 -42.52 67.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 120.995 -0.282 . . . . 0.0 110.721 -176.629 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.494 ' HE3' ' HA ' ' A' ' 43' ' ' GLN . 18.9 pttp -81.43 -24.54 36.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.151 0.5 . . . . 0.0 110.425 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -69.26 -30.86 69.07 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.261 174.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.796 ' HA ' ' CE2' ' A' ' 51' ' ' PHE . 6.4 tt -60.77 -38.14 84.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.719 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.635 ' HA ' HD13 ' A' ' 56' ' ' ILE . 22.7 m -62.4 -36.15 81.43 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.035 177.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -69.41 -47.98 62.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.139 -173.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.796 ' CE2' ' HA ' ' A' ' 48' ' ' LEU . 14.2 p90 -71.32 -24.6 62.15 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.235 -174.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -90.78 -9.35 46.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.008 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.2 t 60.58 32.81 20.46 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.724 -178.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -128.17 174.41 9.28 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.305 -176.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.424 ' HB2' ' HB ' ' A' ' 74' ' ' THR . 20.2 m -104.51 101.73 11.38 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.629 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.635 HD13 ' HA ' ' A' ' 49' ' ' SER . 3.2 mp -111.38 122.49 65.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.844 178.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -147.09 142.41 27.36 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.209 178.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 35.2 mm -75.07 124.45 32.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 177.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.942 ' HB2' HG23 ' A' ' 72' ' ' VAL . . . -77.72 133.64 66.2 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.127 -174.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 59' ' ' ALA . 22.8 Cg_exo -65.33 127.01 17.32 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.817 2.345 . . . . 0.0 112.242 178.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo . . . . . 0 N--CA 1.462 -0.334 0 C-N-CA 122.605 2.203 . . . . 0.0 111.6 177.849 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? . . . . . 0 C--O 1.23 0.077 0 CA-C-O 121.147 0.499 . . . . 0.0 110.697 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.674 HG11 ' CE2' ' A' ' 28' ' ' PHE . 7.4 p -139.01 147.74 24.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 175.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.541 ' HB3' HG21 ' A' ' 34' ' ' VAL . 12.6 ttm180 -123.1 126.62 47.39 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 175.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.848 ' HG3' ' HB3' ' A' ' 59' ' ' ALA . 18.7 ptt? -83.18 146.67 28.49 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.316 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.713 ' CG1' ' HB ' ' A' ' 27' ' ' VAL . 3.5 p -110.08 135.68 48.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 173.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.942 HG23 ' HB2' ' A' ' 59' ' ' ALA . 51.4 t -100.47 110.17 26.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.4 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.417 HG22 HG13 ' A' ' 56' ' ' ILE . 10.0 pt -113.23 142.45 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.802 174.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.524 HG22 ' HB2' ' A' ' 22' ' ' GLN . 20.5 m -137.34 105.95 5.85 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.987 -176.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -166.96 162.51 36.3 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.93 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -59.71 137.26 75.91 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.398 2.065 . . . . 0.0 110.411 172.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.448 ' HA ' ' HB3' ' A' ' 80' ' ' GLN . 63.8 Cg_exo -40.04 -37.99 1.9 Allowed 'Trans proline' 0 N--CA 1.478 0.584 0 C-N-CA 124.352 3.368 . . . . 0.0 115.517 -171.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -72.29 -43.02 64.85 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 121.798 -0.564 . . . . 0.0 111.275 -178.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.38 -27.72 61.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.449 0.643 . . . . 0.0 109.693 175.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.448 ' HB3' ' HA ' ' A' ' 77' ' ' PRO . 35.1 tt0 -61.43 -48.51 80.86 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.012 173.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.772 ' HD1' ' HG3' ' A' ' 164' ' ' GLN . 80.6 t80 -59.16 -39.67 83.17 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.833 176.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.6 tptp -53.42 -53.04 57.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.398 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.524 ' HB1' HD21 ' A' ' 48' ' ' LEU . . . -72.0 -47.36 52.59 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.107 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.584 ' O ' HG22 ' A' ' 87' ' ' ILE . 24.5 tt0 -66.93 -31.95 72.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.552 -172.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -57.38 -36.78 78.19 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.285 175.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.459 ' HD3' ' HA ' ' A' ' 86' ' ' ARG . 27.8 mmt180 -80.4 -27.21 38.16 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.668 -0.266 . . . . 0.0 111.239 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.584 HG22 ' O ' ' A' ' 84' ' ' GLN . 0.3 OUTLIER -67.82 -41.78 85.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 178.941 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.615 ' CE2' ' HB3' ' A' ' 105' ' ' LEU . 7.0 m-85 -68.51 -31.13 70.16 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-O 121.164 0.507 . . . . 0.0 109.889 173.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -61.71 -29.28 71.66 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.474 -0.784 . . . . 0.0 112.119 177.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.662 ' HB3' HD12 ' A' ' 37' ' ' ILE . 73.9 mmtt -66.69 -37.71 85.3 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 177.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.612 HD23 ' HA ' ' A' ' 88' ' ' TYR . 3.4 mm? -59.55 -36.75 76.77 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.41 0.624 . . . . 0.0 110.597 174.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.77 ' HE3' ' HB ' ' A' ' 103' ' ' VAL . 0.1 OUTLIER -75.35 -37.82 60.45 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.277 -177.565 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -67.93 -27.48 66.65 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.182 -178.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.449 ' HB3' ' CE2' ' A' ' 96' ' ' PHE . 17.3 mm-40 -89.27 5.27 45.65 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.189 0.519 . . . . 0.0 110.859 178.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 58.69 41.14 22.45 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.986 172.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.449 ' CE2' ' HB3' ' A' ' 94' ' ' GLU . 70.2 m-85 . . . . . 0 C--N 1.326 -0.448 0 CA-C-O 121.2 0.524 . . . . 0.0 109.921 172.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 . . . . . 0 N--CA 1.437 -1.119 0 CA-C-O 120.867 0.365 . . . . 0.0 111.014 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.77 ' HB ' ' HE3' ' A' ' 92' ' ' LYS . 14.8 p -80.46 138.58 19.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.644 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -128.2 90.81 3.14 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 175.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.615 ' HB3' ' CE2' ' A' ' 88' ' ' TYR . 2.3 tm? -133.38 126.3 30.99 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.261 0.553 . . . . 0.0 110.408 -173.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.782 ' HG3' HG13 ' A' ' 157' ' ' ILE . 41.1 mp0 -66.81 133.52 50.27 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.963 -1.017 . . . . 0.0 113.612 -175.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.534 HG21 ' NE2' ' A' ' 167' ' ' GLN . 0.2 OUTLIER -111.97 140.43 46.64 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.142 165.852 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -121.69 119.8 32.84 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 32.8 pt -125.9 153.64 34.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.112 0.482 . . . . 0.0 111.292 -178.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.48 ' HD3' HG12 ' A' ' 153' ' ' ILE . 59.2 mmt-85 -87.31 132.24 34.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.872 -175.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.502 ' O ' ' HG3' ' A' ' 151' ' ' GLN . 5.2 m -129.77 147.09 63.96 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 171.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.72 ' HD2' HD22 ' A' ' 174' ' ' LEU . 31.4 Cg_exo -57.43 145.23 89.2 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.28 1.986 . . . . 0.0 110.911 175.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -51.09 -49.61 60.35 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.787 0.327 . . . . 0.0 111.552 -173.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 36.3 t -65.52 -33.25 75.49 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.137 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.18 -26.69 67.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.007 -178.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.19 -29.18 70.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.268 0.556 . . . . 0.0 110.392 177.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -75.12 -38.21 40.68 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.666 177.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.522 ' HD2' HG22 ' A' ' 177' ' ' VAL . 25.3 ttm180 -74.66 -34.23 62.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.371 0.129 . . . . 0.0 110.997 -178.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.477 HG13 HG21 ' A' ' 140' ' ' VAL . 10.2 p -66.8 -32.17 56.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-O 120.834 0.35 . . . . 0.0 110.579 179.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 76.3 mt -72.43 -43.73 63.37 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 CA-C-O 121.277 0.561 . . . . 0.0 109.656 173.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.904 ' HA3' ' HB ' ' A' ' 126' ' ' THR . . . . . . . . 0 N--CA 1.44 -1.047 0 C-N-CA 119.918 -1.134 . . . . 0.0 110.639 -174.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 22.8 pttp . . . . . 0 N--CA 1.463 0.198 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.904 ' HB ' ' HA3' ' A' ' 121' ' ' GLY . 26.1 m -62.91 -46.51 87.48 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -175.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.0 p -67.85 -29.91 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-O 121.017 0.437 . . . . 0.0 110.663 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -63.72 -40.61 97.19 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 177.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -64.45 -41.56 96.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.003 177.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 73.6 mt -60.13 -49.31 78.13 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.621 178.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -64.2 -30.13 71.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.631 -177.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -72.55 -42.59 64.53 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.886 0.375 . . . . 0.0 110.298 177.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 94.4 mt -68.61 -49.67 57.47 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.27 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 74.1 p -82.26 -35.37 28.16 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.317 -171.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 66.97 27.49 8.82 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 123.894 0.746 . . . . 0.0 109.9 -170.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.695 ' HB2' ' HB1' ' A' ' 162' ' ' ALA . . . -122.92 163.95 19.38 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.707 -178.024 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.486 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 9.7 mm-40 -88.25 111.58 21.83 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.421 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 42.8 t -97.75 105.83 17.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.434 ' O ' ' HD2' ' A' ' 155' ' ' LYS . 54.0 t -112.81 111.6 36.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.232 -175.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.477 HG21 HG13 ' A' ' 119' ' ' VAL . 34.8 t -106.03 126.5 30.46 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 177.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.439 ' HG2' ' HB3' ' A' ' 144' ' ' GLN . 88.1 Cg_endo -83.81 143.23 10.51 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.766 2.311 . . . . 0.0 113.358 -174.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 39.7 mmt180 -94.1 -26.88 16.55 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.467 173.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -69.78 -35.44 74.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.036 -0.983 . . . . 0.0 110.567 178.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.439 ' HB3' ' HG2' ' A' ' 141' ' ' PRO . 60.2 tt0 -92.86 90.83 7.16 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 175.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.429 ' N ' ' HD3' ' A' ' 146' ' ' PRO . 16.0 p -145.98 58.01 4.43 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.75 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.495 ' HB2' ' HB3' ' A' ' 148' ' ' GLU . 49.5 Cg_endo -92.8 133.07 1.03 Allowed 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.548 2.165 . . . . 0.0 112.986 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -71.07 -12.88 61.75 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 172.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.495 ' HB3' ' HB2' ' A' ' 146' ' ' PRO . 30.9 tt0 -44.78 -48.55 10.91 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 114.315 -1.312 . . . . 0.0 112.599 178.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -114.75 -0.07 13.67 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.174 -175.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 44.41 32.45 0.72 Allowed 'General case' 0 N--CA 1.474 0.748 0 O-C-N 124.469 1.105 . . . . 0.0 111.045 -172.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.502 ' HG3' ' O ' ' A' ' 111' ' ' VAL . 28.4 tt0 -157.86 142.74 16.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.402 -174.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.401 HG12 ' HD2' ' A' ' 146' ' ' PRO . 31.0 m -133.88 -177.01 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.792 -178.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.48 HG12 ' HD3' ' A' ' 110' ' ' ARG . 55.8 mt -120.48 137.99 52.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.922 0.391 . . . . 0.0 111.726 -178.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.5 p -104.49 138.41 29.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.565 169.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.468 ' H ' ' HD2' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -101.23 126.31 47.95 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.664 -177.109 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.486 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 58.9 mt -109.24 118.71 57.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.107 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.782 HG13 ' HG3' ' A' ' 106' ' ' GLU . 4.0 mp -114.36 138.33 44.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 143.92 -163.01 27.75 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.525 178.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.543 ' HA ' HG13 ' A' ' 103' ' ' VAL . 10.6 p-80 -83.73 145.1 28.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.73 0.3 . . . . 0.0 110.41 178.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.503 ' HD1' HG11 ' A' ' 103' ' ' VAL . 46.0 p90 -57.72 -24.44 56.91 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -168.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.407 ' HB2' ' HD2' ' A' ' 159' ' ' HIS . 94.2 m-85 -61.43 -44.5 97.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.408 0.623 . . . . 0.0 109.625 174.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.695 ' HB1' ' HB2' ' A' ' 136' ' ' ALA . . . -74.6 -40.27 61.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.073 178.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.448 ' O ' ' HG3' ' A' ' 167' ' ' GLN . 19.3 m -55.21 -51.33 66.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.511 178.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . 0.772 ' HG3' ' HD1' ' A' ' 81' ' ' PHE . 7.8 mm100 -57.79 -45.02 86.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.604 177.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 68.8 mtp -61.45 -40.7 95.44 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.8 0.333 . . . . 0.0 110.893 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.464 ' HB3' HD13 ' A' ' 156' ' ' ILE . . . -69.31 -46.2 67.7 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.163 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.534 ' NE2' HG21 ' A' ' 107' ' ' THR . 62.7 mt-30 -55.31 -52.18 64.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.241 -178.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' A' ' 164' ' ' GLN . 6.7 ptp85 -66.42 -32.32 73.63 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.18 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.997 ' HA ' ' HE3' ' A' ' 169' ' ' LYS . 0.6 OUTLIER -77.24 -42.82 35.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.91 0.386 . . . . 0.0 110.965 -173.58 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.518 ' O ' ' HG ' ' A' ' 174' ' ' LEU . 1.8 mp -70.4 -44.71 77.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.923 177.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -59.26 -25.9 64.47 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.819 0.343 . . . . 0.0 110.566 175.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -73.82 -48.29 32.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.175 -179.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.404 ' HA ' HE21 ' A' ' 176' ' ' GLN . 36.1 pt -66.92 -20.53 27.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.112 -177.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.72 HD22 ' HD2' ' A' ' 112' ' ' PRO . 15.5 mt -59.23 -40.5 86.07 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.911 0.386 . . . . 0.0 110.252 176.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.493 ' O ' ' HG2' ' A' ' 179' ' ' GLN . . . -65.91 -37.39 85.95 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.216 178.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . 0.404 HE21 ' HA ' ' A' ' 173' ' ' ILE . 48.4 mt-30 -65.99 -32.19 73.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.887 177.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.522 HG22 ' HD2' ' A' ' 118' ' ' ARG . 75.2 t -73.34 -35.57 46.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.056 0.455 . . . . 0.0 110.207 175.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -64.58 -31.03 72.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.158 0.504 . . . . 0.0 109.904 175.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 0.493 ' HG2' ' O ' ' A' ' 175' ' ' ALA . 73.3 mm-40 . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.622 175.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 81.9 mm-40 . . . . . 0 C--O 1.235 0.339 0 N-CA-C 109.128 -0.694 . . . . 0.0 109.128 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -78.98 141.88 37.12 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.076 -171.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 29.2 m -131.69 112.45 12.56 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.496 -177.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.401 HG21 ' NE2' ' A' ' 167' ' ' GLN . 28.4 m -125.14 161.68 28.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.839 -178.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -117.44 128.1 54.67 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.618 -175.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.562 ' HB ' ' HB ' ' A' ' 71' ' ' VAL . 8.9 t -97.45 143.14 13.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.198 -179.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.429 ' CG ' HG21 ' A' ' 68' ' ' VAL . 0.3 OUTLIER -103.86 106.06 16.45 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 122.623 0.369 . . . . 0.0 111.723 -172.573 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.618 ' C ' ' HB ' ' A' ' 68' ' ' VAL . 8.7 pt -130.4 121.41 19.39 Favored Pre-proline 0 C--N 1.326 -0.433 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.856 176.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.666 ' HB2' ' HG2' ' A' ' 32' ' ' GLN . 10.6 Cg_endo -53.27 147.67 35.14 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.699 2.933 . . . . 0.0 112.485 -176.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.444 ' HA ' HG12 ' A' ' 34' ' ' VAL . . . -57.46 -21.98 40.57 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.509 -0.768 . . . . 0.0 112.096 -175.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.666 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 11.4 pt20 -71.38 -26.2 62.69 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.589 178.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.572 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -111.8 -30.37 7.33 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 121.167 -0.213 . . . . 0.0 111.545 -172.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.663 HG21 ' HB3' ' A' ' 69' ' ' ARG . 9.3 p -52.25 -32.86 16.36 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 O-C-N 123.605 0.566 . . . . 0.0 111.392 -174.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -55.7 -57.93 16.45 Favored Glycine 0 N--CA 1.438 -1.193 0 C-N-CA 120.318 -0.944 . . . . 0.0 111.858 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.32 -14.11 59.8 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 120.744 0.307 . . . . 0.0 111.074 -174.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.637 HD12 ' HB3' ' A' ' 90' ' ' LYS . 7.9 mm -64.71 -38.87 83.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.116 176.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.556 HG23 ' HB ' ' A' ' 45' ' ' ILE . 5.0 mt -54.5 -59.42 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -178.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 131.04 77.82 0.17 Allowed Glycine 0 CA--C 1.52 0.357 0 C-N-CA 119.616 -1.278 . . . . 0.0 114.43 175.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 45.9 tttp 54.13 -80.77 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 170.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -101.1 -6.22 24.64 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.821 0.344 . . . . 0.0 111.048 -173.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.55 ' O ' HG22 ' A' ' 45' ' ' ILE . . . 84.86 -1.88 88.57 Favored Glycine 0 C--O 1.229 -0.215 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.152 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -78.78 -32.26 46.39 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 176.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.444 ' HA ' ' HB3' ' A' ' 47' ' ' GLN . 2.2 m-70 -73.62 -22.12 60.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.066 -176.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.556 ' HB ' HG23 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -73.65 -42.89 55.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.728 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.9 pttp -81.68 -22.5 37.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.286 0.565 . . . . 0.0 109.744 177.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.444 ' HB3' ' HA ' ' A' ' 44' ' ' HIS . 49.2 tt0 -66.44 -33.44 75.72 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 171.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.411 ' HA ' ' HB3' ' A' ' 51' ' ' PHE . 7.0 tt -66.09 -38.5 88.39 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.371 175.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.666 ' HA ' HD13 ' A' ' 56' ' ' ILE . 8.1 t -60.04 -39.17 85.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.628 176.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -68.87 -47.47 65.85 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.062 174.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.411 ' HB3' ' HA ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -58.41 -39.03 78.62 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.984 -1.007 . . . . 0.0 112.007 -178.163 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -91.16 0.89 57.44 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 121.185 -0.206 . . . . 0.0 111.325 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 72.5 p 50.89 31.39 6.1 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.667 0.787 . . . . 0.0 111.964 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -140.14 174.25 10.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.886 -175.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.5 m -86.25 101.29 12.92 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.675 0.274 . . . . 0.0 110.596 -178.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.666 HD13 ' HA ' ' A' ' 49' ' ' SER . 2.2 mp -108.6 117.1 53.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.892 178.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -134.28 146.81 50.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.562 -177.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 40.0 mm -90.17 107.47 18.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 173.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.464 ' HB2' ' CG1' ' A' ' 72' ' ' VAL . . . -86.33 126.4 64.78 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.854 -173.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 59' ' ' ALA . 17.1 Cg_exo -67.65 141.04 53.49 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.879 2.386 . . . . 0.0 110.805 172.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo . . . . . 0 C--O 1.233 0.248 0 C-N-CA 122.906 2.404 . . . . 0.0 111.994 -179.745 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.233 0.219 0 CA-C-O 121.113 0.482 . . . . 0.0 111.505 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.618 ' HB ' ' C ' ' A' ' 29' ' ' ILE . 1.4 m -127.41 176.08 8.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-O 121.225 0.536 . . . . 0.0 111.316 -172.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.663 ' HB3' HG21 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -120.01 139.79 51.96 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 106.471 -1.678 . . . . 0.0 106.471 172.837 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.542 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 61.4 mtt -97.43 149.15 22.46 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.282 -0.567 . . . . 0.0 111.397 -169.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.562 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 70.1 t -104.35 116.22 47.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 171.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.464 ' CG1' ' HB2' ' A' ' 59' ' ' ALA . 11.1 p -108.73 121.6 62.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.357 0.598 . . . . 0.0 110.472 -177.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 24' ' ' THR . 0.1 OUTLIER -130.63 142.42 43.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.768 0.794 . . . . 0.0 111.135 179.675 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 47.3 m -122.47 111.57 17.0 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.191 -1.368 . . . . 0.0 109.034 176.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.67 162.36 35.78 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 119.845 -1.169 . . . . 0.0 113.158 -175.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.24 148.54 84.91 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.379 2.052 . . . . 0.0 110.824 170.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -38.35 -46.85 2.4 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 124.152 3.235 . . . . 0.0 114.441 -176.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.516 ' HG3' ' N ' ' A' ' 79' ' ' ALA . 7.6 pt-20 -56.8 -43.97 81.48 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.156 0.503 . . . . 0.0 111.203 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.642 ' HA ' ' HD3' ' A' ' 82' ' ' LYS . . . -71.73 -37.64 70.57 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.006 -175.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -68.93 -26.03 64.88 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.946 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.841 ' HA ' HE22 ' A' ' 164' ' ' GLN . 89.8 t80 -64.4 -54.94 24.86 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.709 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.713 ' H ' ' HD2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -70.02 -32.6 70.84 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.459 -0.497 . . . . 0.0 110.726 -177.681 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.3 -51.54 69.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.753 0.311 . . . . 0.0 110.985 177.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.638 ' HA ' HG22 ' A' ' 87' ' ' ILE . 54.1 mt-30 -66.46 -31.89 72.91 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.269 179.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -59.57 -40.04 95.84 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.332 178.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -80.21 -37.83 32.36 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 122.742 -0.269 . . . . 0.0 111.637 -177.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.638 HG22 ' HA ' ' A' ' 84' ' ' GLN . 0.0 OUTLIER -65.21 -43.83 95.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.662 -176.632 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.592 ' CE2' ' HB3' ' A' ' 105' ' ' LEU . 15.2 m-85 -67.13 -30.15 70.07 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.142 0.496 . . . . 0.0 110.148 176.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -60.04 -32.84 76.88 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.213 176.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.637 ' HB3' HD12 ' A' ' 37' ' ' ILE . 31.7 mmtp -72.63 -26.76 61.78 Favored 'General case' 0 N--CA 1.455 -0.213 0 O-C-N 122.541 -0.388 . . . . 0.0 110.624 177.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.601 ' HG ' ' HG ' ' A' ' 105' ' ' LEU . 4.3 mm? -66.35 -38.55 87.85 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.853 0.359 . . . . 0.0 110.156 171.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.89 ' HE3' ' HB ' ' A' ' 103' ' ' VAL . 0.5 OUTLIER -68.78 -26.52 65.25 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.373 176.124 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -64.32 -40.66 96.34 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.995 -176.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.588 ' HB2' ' CE2' ' A' ' 96' ' ' PHE . 10.4 mm-40 -105.94 0.24 25.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.964 0.411 . . . . 0.0 112.079 -178.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 57.34 47.83 15.96 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.307 -0.86 . . . . 0.0 112.695 171.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.588 ' CE2' ' HB2' ' A' ' 94' ' ' GLU . 80.1 m-85 . . . . . 0 N--CA 1.467 0.418 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -176.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.484 ' HB3' ' CD2' ' A' ' 159' ' ' HIS . 5.2 tt0 . . . . . 0 N--CA 1.439 -1.0 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.89 ' HB ' ' HE3' ' A' ' 92' ' ' LYS . 11.5 p -54.52 122.84 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.404 0 CA-C-O 121.733 0.778 . . . . 0.0 112.037 -168.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp -117.68 91.29 3.53 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.568 -1.196 . . . . 0.0 108.865 176.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.601 ' HG ' ' HG ' ' A' ' 91' ' ' LEU . 2.0 tm? -128.58 123.81 34.33 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.208 0.527 . . . . 0.0 109.959 -176.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -58.92 129.46 42.26 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.821 -1.081 . . . . 0.0 112.016 -174.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.44 142.51 46.27 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.16 175.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -122.22 120.11 33.2 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.306 0.574 . . . . 0.0 111.546 -179.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.482 HD13 HD11 ' A' ' 156' ' ' ILE . 22.9 pt -114.61 134.16 58.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.872 176.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.594 ' HD3' HG12 ' A' ' 153' ' ' ILE . 6.9 tpp180 -78.48 138.25 38.35 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.249 -176.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.694 HG23 ' CD2' ' A' ' 174' ' ' LEU . 6.4 p -141.93 143.0 26.75 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 177.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.42 ' HD2' HG22 ' A' ' 111' ' ' VAL . 24.6 Cg_exo -59.84 150.1 79.57 Favored 'Trans proline' 0 N--CA 1.465 -0.18 0 C-N-CA 122.399 2.066 . . . . 0.0 111.296 176.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -56.3 -51.06 69.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.022 0.439 . . . . 0.0 111.007 -175.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.7 m -68.54 -12.3 61.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.544 -178.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.642 ' HB2' HG11 ' A' ' 177' ' ' VAL . . . -84.68 -14.87 47.2 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.347 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.458 ' HA ' HG12 ' A' ' 119' ' ' VAL . . . -65.42 -40.96 93.98 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.039 176.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.32 -32.9 83.37 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.615 -0.802 . . . . 0.0 111.55 176.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.447 ' HD2' HG22 ' A' ' 177' ' ' VAL . 15.2 ttm180 -74.2 -42.42 59.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.673 0.273 . . . . 0.0 110.788 -179.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.498 HG22 HD11 ' A' ' 130' ' ' LEU . 7.4 p -68.93 -30.56 47.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.025 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.65 ' HA ' HG23 ' A' ' 127' ' ' VAL . 72.6 mt -69.62 -39.26 78.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.818 0.818 . . . . 0.0 109.558 171.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.184 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.551 179.889 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 23.4 pttp . . . . . 0 N--CA 1.463 0.177 0 CA-C-O 120.967 0.413 . . . . 0.0 111.614 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.572 ' O ' ' HG ' ' A' ' 130' ' ' LEU . 50.0 m -88.3 -32.7 18.33 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.268 -174.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.65 HG23 ' HA ' ' A' ' 120' ' ' ILE . 82.0 t -59.81 -37.9 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-O 121.38 0.61 . . . . 0.0 109.809 173.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -56.09 -42.98 77.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.944 177.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.14 -42.83 72.05 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.145 -179.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.572 ' HG ' ' O ' ' A' ' 126' ' ' THR . 77.6 mt -58.29 -52.05 67.23 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.702 -178.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -66.01 -37.97 87.25 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.928 -175.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -65.27 -36.7 84.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.276 -177.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 60.6 tp -88.11 -48.89 7.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.722 0.296 . . . . 0.0 111.525 -176.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.429 HG21 ' HA ' ' A' ' 166' ' ' ALA . 64.2 p -74.67 -25.19 59.01 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.985 -172.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 60.74 20.94 10.98 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.159 -174.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -113.61 173.12 6.57 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.309 -174.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.648 ' HB3' ' HB ' ' A' ' 157' ' ' ILE . 8.6 tp10 -96.95 114.07 25.66 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.04 175.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 57.3 t -114.84 106.98 21.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.758 -176.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.598 HG13 ' HB2' ' A' ' 155' ' ' LYS . 1.5 p -121.22 121.25 64.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.408 0.623 . . . . 0.0 110.991 177.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.642 ' HB ' HG22 ' A' ' 154' ' ' VAL . 7.7 p -127.12 113.01 21.68 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.631 176.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 1.054 ' HG2' ' HB2' ' A' ' 144' ' ' GLN . 96.1 Cg_endo -90.2 138.0 2.71 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.238 2.625 . . . . 0.0 113.526 -174.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -75.41 -23.31 57.02 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 113.636 -1.62 . . . . 0.0 109.418 175.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -97.67 17.29 18.2 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.951 -178.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 1.054 ' HB2' ' HG2' ' A' ' 141' ' ' PRO . 8.9 tp60 -63.83 -63.28 1.21 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.22 0.533 . . . . 0.0 111.54 -177.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.1 p -146.45 150.6 41.15 Favored Pre-proline 0 C--N 1.316 -0.85 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.124 -174.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.57 165.25 32.49 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.189 2.593 . . . . 0.0 112.309 178.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -78.43 23.83 0.29 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.948 -175.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -70.87 -47.6 58.41 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.487 0.661 . . . . 0.0 109.465 176.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -101.82 0.46 35.72 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.744 177.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 44.88 37.86 2.6 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.441 1.096 . . . . 0.0 112.034 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -147.9 141.0 24.98 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.027 0.441 . . . . 0.0 111.779 -174.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.414 HG23 ' CG1' ' A' ' 111' ' ' VAL . 23.3 m -126.95 -176.02 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.186 -178.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.594 HG12 ' HD3' ' A' ' 110' ' ' ARG . 58.2 mt -132.81 134.94 57.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 O-C-N 122.247 -0.283 . . . . 0.0 110.69 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.642 HG22 ' HB ' ' A' ' 140' ' ' VAL . 89.7 t -92.4 139.09 18.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 174.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.719 ' HE3' ' HG3' ' A' ' 141' ' ' PRO . 0.0 OUTLIER -105.57 117.18 33.37 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.997 0.427 . . . . 0.0 109.964 179.258 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.533 HD13 ' HB3' ' A' ' 166' ' ' ALA . 53.4 mt -100.49 116.66 44.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.072 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.648 ' HB ' ' HB3' ' A' ' 137' ' ' GLU . 3.2 mp -107.32 131.8 56.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 175.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 153.36 -152.68 24.27 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.446 -178.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.484 ' CD2' ' HB3' ' A' ' 102' ' ' GLU . 4.1 m80 -102.7 155.12 18.52 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -175.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.435 ' O ' ' HG3' ' A' ' 164' ' ' GLN . 25.0 p90 -56.0 -36.36 67.83 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.037 0.835 . . . . 0.0 111.797 -172.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.461 ' O ' ' HG2' ' A' ' 165' ' ' MET . 35.8 m-85 -60.2 -48.02 83.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.82 0.343 . . . . 0.0 110.746 175.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -70.39 -36.94 74.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.611 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.451 ' HA ' HG21 ' A' ' 156' ' ' ILE . 68.7 m -57.54 -45.78 84.69 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.413 176.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . 0.841 HE22 ' HA ' ' A' ' 81' ' ' PHE . 96.8 mt-30 -64.39 -33.66 76.37 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.777 0.322 . . . . 0.0 111.152 179.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.461 ' HG2' ' O ' ' A' ' 161' ' ' TYR . 95.9 mmm -63.02 -40.57 98.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.173 176.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.533 ' HB3' HD13 ' A' ' 156' ' ' ILE . . . -74.83 -37.99 62.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.826 178.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.401 ' NE2' HG21 ' A' ' 25' ' ' VAL . 32.4 mt-30 -53.33 -56.2 18.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.751 177.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -65.88 -31.45 72.4 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.035 -178.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.726 ' HA ' ' HE3' ' A' ' 169' ' ' LYS . 0.2 OUTLIER -72.95 -54.94 7.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.152 -172.886 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 2.4 mp -72.0 -46.77 58.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.8 0.333 . . . . 0.0 110.424 -177.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.586 ' HA ' ' HG ' ' A' ' 174' ' ' LEU . 24.6 mmm180 -60.99 -24.93 66.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.175 -178.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -71.44 -47.36 56.35 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 111.547 0.203 . . . . 0.0 111.547 177.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.471 HG13 HD23 ' A' ' 174' ' ' LEU . 18.3 pt -66.62 -19.26 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.671 -177.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.694 ' CD2' HG23 ' A' ' 111' ' ' VAL . 6.7 mt -60.92 -28.78 69.18 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.817 177.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.438 ' O ' ' HG3' ' A' ' 179' ' ' GLN . . . -59.0 -43.12 91.45 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.037 176.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 71.3 mm-40 -60.81 -45.43 94.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.656 176.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.642 HG11 ' HB2' ' A' ' 115' ' ' ALA . 46.7 t -61.38 -41.26 89.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.576 179.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -63.0 -44.44 96.0 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.557 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 0.438 ' HG3' ' O ' ' A' ' 175' ' ' ALA . 96.9 mt-30 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.755 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.777 0 N-CA-C 112.201 -0.359 . . . . 0.0 112.201 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.22 123.21 6.36 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 60.8 mtt -77.13 96.11 4.4 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.953 0.406 . . . . 0.0 111.291 -178.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.406 ' HA2' ' HD3' ' A' ' 5' ' ' PRO . . . -89.86 128.88 9.43 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.857 -0.687 . . . . 0.0 111.417 175.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.406 ' HD3' ' HA2' ' A' ' 4' ' ' GLY . 52.3 Cg_exo -55.2 107.19 0.22 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.223 2.615 . . . . 0.0 112.617 -177.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.8 m 61.12 20.07 10.58 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.108 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.9 t -103.07 35.47 2.53 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.563 0.697 . . . . 0.0 110.093 -177.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 18.8 m -102.83 130.79 52.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.134 178.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.8 m -143.35 -176.92 5.13 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.083 0.468 . . . . 0.0 111.263 -176.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 169.12 -88.28 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -177.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 55.95 83.14 0.1 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.158 0.504 . . . . 0.0 111.819 177.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -119.79 82.29 27.17 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.727 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -99.29 35.54 0.09 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 123.547 2.831 . . . . 0.0 112.781 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -104.99 77.35 1.32 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.247 0.546 . . . . 0.0 110.709 -178.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.1 p -112.98 -173.63 2.29 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.614 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.2 m 72.0 138.94 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 O-C-N 123.863 0.727 . . . . 0.0 111.392 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -106.12 87.14 2.5 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.291 177.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 17.1 tpt -92.43 110.07 42.42 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.197 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.96 109.6 1.96 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.794 2.329 . . . . 0.0 112.017 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -90.44 43.58 0.53 Allowed 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 123.048 2.499 . . . . 0.0 112.454 -176.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -94.44 21.05 7.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.228 0.537 . . . . 0.0 110.889 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 83.2 mm-40 -90.27 151.09 21.66 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 174.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -73.74 120.37 19.24 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.081 0.467 . . . . 0.0 110.879 -177.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.633 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 53.1 m -122.87 114.77 20.93 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.61 -176.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.589 HG21 HE21 ' A' ' 167' ' ' GLN . 27.2 m -132.8 161.72 41.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.636 -179.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.556 ' HB3' ' HB3' ' A' ' 70' ' ' MET . 13.1 m170 -107.74 113.61 27.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.747 -173.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.63 ' O ' ' HA ' ' A' ' 70' ' ' MET . 40.2 t -90.83 123.36 42.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.909 0.385 . . . . 0.0 110.557 -176.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.736 ' CZ ' HG11 ' A' ' 68' ' ' VAL . 2.3 t80 -85.13 104.67 15.23 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.527 -168.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.569 ' C ' HG23 ' A' ' 68' ' ' VAL . 18.9 pt -130.3 117.09 17.75 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.424 0.63 . . . . 0.0 110.892 174.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.639 ' HB2' ' HG2' ' A' ' 32' ' ' GLN . 51.0 Cg_exo -54.42 153.87 21.33 Favored 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 123.315 2.677 . . . . 0.0 112.505 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.616 ' HA ' HG12 ' A' ' 34' ' ' VAL . . . -56.89 -18.22 12.41 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 114.848 -1.069 . . . . 0.0 112.423 -176.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.639 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 30.1 pt20 -72.05 -18.62 61.93 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.94 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.489 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -123.09 -31.82 3.55 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 120.52 -0.472 . . . . 0.0 111.869 -176.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.616 HG12 ' HA ' ' A' ' 31' ' ' ALA . 9.1 p -52.56 -34.28 19.07 Favored 'Isoleucine or valine' 0 C--O 1.242 0.675 0 CA-C-O 120.922 0.391 . . . . 0.0 111.715 -172.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.913 ' HA2' ' N4 ' ' B' ' 4' ' ' ' C' . . . -57.19 -57.11 21.5 Favored Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.355 -178.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.45 ' HB2' " O2'" ' B' ' 2' ' ' ' C' . . . -76.52 -13.46 60.09 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.928 -174.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.657 HD12 ' HB3' ' A' ' 90' ' ' LYS . 3.3 mm -64.28 -39.98 87.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 116.313 -0.403 . . . . 0.0 109.97 176.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.816 HD12 ' C5 ' ' B' ' 4' ' ' ' C' . 9.1 mt -61.16 -60.05 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.929 176.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.593 ' HA2' ' OP1' ' B' ' 3' ' ' ' A' . . . 86.48 119.12 1.12 Allowed Glycine 0 CA--C 1.525 0.713 0 C-N-CA 120.288 -0.958 . . . . 0.0 115.393 169.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm 40.43 89.52 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.278 1.431 . . . . 0.0 114.259 169.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.53 ' HA ' ' OP2' ' B' ' 4' ' ' ' C' . 10.4 ttpt 61.54 5.25 1.18 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.958 175.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.3 29.83 69.88 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.749 -0.738 . . . . 0.0 111.859 -176.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 54.9 tp60 -86.51 -54.71 4.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.532 0.206 . . . . 0.0 111.214 -176.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.574 ' NE2' ' HA3' ' A' ' 39' ' ' GLY . 17.4 p80 -71.64 -21.76 61.78 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.483 -176.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.645 HG21 HG23 ' A' ' 38' ' ' ILE . 10.6 tt -68.07 -33.52 61.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 121.131 0.491 . . . . 0.0 110.006 175.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.449 ' HE2' ' HA ' ' A' ' 46' ' ' LYS . 0.8 OUTLIER -81.32 -31.62 33.43 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 174.808 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.5 ' HB3' ' HA ' ' A' ' 44' ' ' HIS . 34.1 tt0 -58.58 -36.57 74.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.349 171.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.791 HD22 HG12 ' A' ' 56' ' ' ILE . 6.7 tt -61.43 -39.17 89.82 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.271 177.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.693 ' HA ' HD13 ' A' ' 56' ' ' ILE . 17.1 m -61.55 -29.28 69.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.301 177.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 43.8 mtp180 -79.57 -50.89 10.03 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.617 -177.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.742 ' CZ ' ' HA ' ' A' ' 48' ' ' LEU . 1.7 p90 -75.18 -18.99 60.06 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.853 -177.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -92.05 -22.47 19.92 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.829 175.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.2 t 65.85 37.2 5.67 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.616 -177.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -132.36 173.41 11.31 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.17 -178.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.805 ' HB3' ' HB ' ' A' ' 74' ' ' THR . 18.6 t -100.5 101.8 12.82 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.791 HG12 HD22 ' A' ' 48' ' ' LEU . 2.1 mp -98.23 111.9 29.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.814 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.503 ' HB2' ' HB ' ' A' ' 72' ' ' VAL . 41.7 mtpt -128.75 154.31 46.5 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.849 -178.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.666 ' HB ' ' N1 ' ' B' ' 5' ' ' ' A' . 42.4 mm -110.1 113.31 43.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 174.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.727 ' HB2' HG23 ' A' ' 72' ' ' VAL . . . -71.69 126.16 91.58 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.396 -175.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -65.03 143.81 80.05 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.404 2.069 . . . . 0.0 110.341 171.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -37.89 107.33 0.06 OUTLIER 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 124.098 3.199 . . . . 0.0 113.497 -176.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -66.93 -27.8 67.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.57 -178.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.462 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 19.0 p -126.91 139.2 34.36 Favored Pre-proline 0 C--N 1.324 -0.539 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 172.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 63' ' ' THR . 21.4 Cg_exo -65.89 -7.84 17.98 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.933 2.422 . . . . 0.0 112.652 -177.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -104.01 12.29 34.33 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.218 -179.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 53.4 p -82.47 139.18 34.09 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.317 0.58 . . . . 0.0 111.32 -177.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.4 tmtp? -106.37 26.84 9.36 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 175.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.736 HG11 ' CZ ' ' A' ' 28' ' ' PHE . 2.7 p -154.02 150.91 11.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.327 -167.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.522 ' HD3' HG11 ' A' ' 34' ' ' VAL . 61.2 mtp180 -125.83 129.9 50.31 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 175.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.63 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 3.6 mpp? -94.27 136.88 34.08 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.824 -172.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.599 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 84.6 t -83.61 120.48 34.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 175.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.727 HG23 ' HB2' ' A' ' 59' ' ' ALA . 74.4 t -86.88 96.43 5.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.633 ' O ' ' HA ' ' A' ' 24' ' ' THR . 10.2 tp -93.48 114.57 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 CA-C-O 121.422 0.63 . . . . 0.0 110.162 178.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.805 ' HB ' ' HB3' ' A' ' 55' ' ' SER . 75.3 m -113.27 103.25 11.14 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 173.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -168.75 162.91 36.7 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.046 -1.073 . . . . 0.0 112.934 -176.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.457 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 37.9 Cg_endo -67.81 147.66 75.5 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.285 1.99 . . . . 0.0 110.361 169.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 76' ' ' PRO . 81.0 Cg_exo -49.85 -27.27 15.44 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 124.092 3.194 . . . . 0.0 113.722 -177.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -61.38 -43.06 99.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.425 0.631 . . . . 0.0 110.23 175.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.36 -38.77 41.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.798 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -59.04 -30.58 68.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.14 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.572 ' HA ' ' NE2' ' A' ' 164' ' ' GLN . 55.5 t80 -59.72 -48.92 79.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.53 178.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 17.3 mttt -68.39 -50.78 50.46 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.242 0.544 . . . . 0.0 109.682 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.91 -54.06 49.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.968 -1.014 . . . . 0.0 111.93 -174.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.574 ' HB2' HE21 ' A' ' 164' ' ' GLN . 23.8 mt-30 -76.27 -31.07 58.07 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.95 -0.3 . . . . 0.0 111.135 -178.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -59.2 -42.06 97.02 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.295 -0.955 . . . . 0.0 111.589 175.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.457 ' HA ' ' HD3' ' A' ' 86' ' ' ARG . 21.6 mmt180 -79.79 -27.92 40.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.861 -0.169 . . . . 0.0 111.156 179.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.518 HG22 ' O ' ' A' ' 84' ' ' GLN . 0.3 OUTLIER -68.57 -39.49 80.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.069 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.582 ' HB3' HG21 ' A' ' 103' ' ' VAL . 9.1 m-85 -68.11 -30.17 69.27 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.148 0.499 . . . . 0.0 109.886 173.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -65.69 -28.88 74.05 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.773 175.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.657 ' HB3' HD12 ' A' ' 37' ' ' ILE . 10.9 mptt -70.31 -29.96 66.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.822 0.344 . . . . 0.0 110.372 176.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' A' ' 88' ' ' TYR . 4.6 mm? -61.99 -44.97 95.61 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 169.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 1.097 ' HE3' ' HB ' ' A' ' 103' ' ' VAL . 1.8 mptm? -63.44 -30.23 71.39 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.637 176.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -55.31 -46.02 76.27 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.522 -178.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -109.63 -5.78 15.56 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -178.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 61.87 40.53 12.53 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.223 174.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.42 ' CE2' ' HB2' ' A' ' 33' ' ' ALA . 53.2 m-85 -66.84 -46.58 74.63 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -178.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.523 ' CZ ' ' HE2' ' A' ' 92' ' ' LYS . 26.0 p90 -64.71 -29.84 70.83 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.172 -177.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.437 ' HA3' ' HB2' ' A' ' 101' ' ' GLU . . . 157.58 130.91 1.25 Allowed Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -178.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.45 -51.48 5.19 Favored 'Trans proline' 0 CA--C 1.529 0.239 0 C-N-CA 122.824 2.349 . . . . 0.0 113.078 -178.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -92.18 -18.85 22.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.895 0.379 . . . . 0.0 111.166 -178.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.437 ' HB2' ' HA3' ' A' ' 98' ' ' GLY . 5.3 mm-40 -61.98 144.93 54.39 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.06 -179.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.47 156.76 37.89 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 168.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 1.097 ' HB ' ' HE3' ' A' ' 92' ' ' LYS . 7.6 p -57.28 124.29 10.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 122.136 0.969 . . . . 0.0 111.734 -170.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 35.6 mmtm -126.03 90.44 3.19 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 113.976 -1.466 . . . . 0.0 108.43 176.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.551 ' HB3' ' CE2' ' A' ' 88' ' ' TYR . 2.0 tm? -128.12 125.64 39.58 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.508 0.67 . . . . 0.0 110.525 -175.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.52 ' HG3' HG13 ' A' ' 157' ' ' ILE . 2.5 mp0 -71.35 132.11 44.38 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.58 -1.191 . . . . 0.0 112.064 -177.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 20.3 m -119.56 135.16 54.9 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 169.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 10.2 m170 -108.75 120.86 43.71 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.731 0.301 . . . . 0.0 110.329 -177.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.483 HD13 ' HA ' ' A' ' 167' ' ' GLN . 37.4 pt -114.1 136.06 51.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.135 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.608 HH11 HG13 ' A' ' 153' ' ' ILE . 19.5 mmm180 -87.17 119.16 27.12 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.862 -176.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.626 HG12 HD11 ' A' ' 174' ' ' LEU . 19.2 m -123.04 153.33 64.26 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.827 176.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.535 ' HD2' HD22 ' A' ' 174' ' ' LEU . 51.8 Cg_exo -54.33 142.89 67.64 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.221 1.948 . . . . 0.0 111.098 176.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.58 ' HA ' HG22 ' A' ' 152' ' ' VAL . . . -50.17 -47.41 54.42 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -170.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 43.8 t -75.1 -28.95 60.47 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.523 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.39 -32.26 73.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.14 -178.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.664 ' O ' HG12 ' A' ' 119' ' ' VAL . . . -64.56 -32.76 74.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.368 0.604 . . . . 0.0 110.231 175.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -74.74 -25.32 70.0 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.548 177.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.411 ' HD3' HG22 ' A' ' 177' ' ' VAL . 56.3 ttt180 -92.95 -15.09 26.68 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.722 0.267 . . . . 0.0 111.722 -178.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.664 HG12 ' O ' ' A' ' 116' ' ' ALA . 9.5 p -71.31 -20.88 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 173.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 1.072 ' HA ' ' HB ' ' A' ' 127' ' ' VAL . 71.9 mt -66.35 -25.98 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.953 170.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 111.67 151.86 11.96 Favored Glycine 0 N--CA 1.441 -1.03 0 CA-C-N 114.993 -1.003 . . . . 0.0 112.219 178.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -64.67 -26.37 68.35 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 175.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -103.36 -14.81 16.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.902 176.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.584 ' HA2' HG22 ' A' ' 120' ' ' ILE . . . 91.34 -1.64 76.89 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.447 -176.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 31.0 mtmm -85.51 -23.63 27.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.979 0.419 . . . . 0.0 110.948 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 23.5 m -65.09 -39.19 92.83 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.642 -170.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 1.072 ' HB ' ' HA ' ' A' ' 120' ' ' ILE . 14.4 p -63.71 -32.73 58.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.028 0.442 . . . . 0.0 111.082 -177.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -71.9 -40.56 68.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.241 0.544 . . . . 0.0 110.237 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -78.67 -25.4 44.87 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.394 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.487 HD23 HG11 ' A' ' 138' ' ' VAL . 25.8 tp -58.59 -45.53 88.89 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 174.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -60.55 -36.03 77.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.068 0.461 . . . . 0.0 110.693 176.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -67.51 -33.03 74.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.407 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -88.16 -43.95 11.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.852 0.358 . . . . 0.0 110.755 -178.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.633 ' HB ' ' HB2' ' A' ' 166' ' ' ALA . 62.0 p -73.65 -22.57 59.93 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.956 -174.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 65.08 15.74 10.17 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.044 -178.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.545 ' HB2' ' HB1' ' A' ' 162' ' ' ALA . . . -120.84 168.75 11.12 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.124 -178.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.464 ' HB3' ' HB ' ' A' ' 157' ' ' ILE . 23.5 tt0 -93.84 109.71 21.39 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 177.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.487 HG11 HD23 ' A' ' 130' ' ' LEU . 55.0 t -106.29 105.89 19.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.879 -177.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.659 HG13 ' HD3' ' A' ' 155' ' ' LYS . 4.8 p -108.76 115.1 48.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.464 0.649 . . . . 0.0 110.605 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 47.0 t -101.68 115.33 65.04 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.125 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.519 ' HG3' ' HE3' ' A' ' 155' ' ' LYS . 84.0 Cg_endo -82.87 155.25 15.28 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.724 2.283 . . . . 0.0 112.608 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 39.8 mmt180 -86.52 -12.65 48.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.071 176.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -116.93 -89.17 0.58 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.795 -178.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.988 ' HG2' ' H ' ' A' ' 153' ' ' ILE . 23.8 tp60 67.43 -77.39 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.04 0.536 . . . . 0.0 111.624 -178.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.1 p -145.31 139.51 15.06 Favored Pre-proline 0 C--N 1.316 -0.851 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -57.19 148.77 67.88 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 122.641 2.227 . . . . 0.0 111.97 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -72.95 8.64 1.46 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.025 -178.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -61.55 -29.22 69.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.574 0.702 . . . . 0.0 109.571 169.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . 0.413 ' O ' ' HG2' ' A' ' 150' ' ' GLU . 8.6 t-20 -95.94 0.46 51.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.515 177.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' A' ' 149' ' ' ASN . 8.8 pt-20 46.46 23.82 0.25 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.91 1.284 . . . . 0.0 112.323 -175.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.408 ' HG3' ' O ' ' A' ' 111' ' ' VAL . 34.4 tt0 -152.97 139.49 18.71 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 120.871 0.367 . . . . 0.0 110.706 -171.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.58 HG22 ' HA ' ' A' ' 113' ' ' ALA . 17.5 m -132.19 -177.04 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.951 -178.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.988 ' H ' ' HG2' ' A' ' 144' ' ' GLN . 20.5 mt -126.27 141.0 47.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.889 0.376 . . . . 0.0 111.462 -178.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 5.6 p -109.88 138.93 35.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 165.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.659 ' HD3' HG13 ' A' ' 139' ' ' VAL . 0.0 OUTLIER -99.6 129.09 45.72 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.915 -173.668 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.5 HG21 ' HA ' ' A' ' 163' ' ' SER . 59.9 mt -110.86 117.69 55.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.221 179.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.52 HG13 ' HG3' ' A' ' 106' ' ' GLU . 3.9 mp -112.27 139.62 36.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.658 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 142.38 -153.2 24.3 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.351 -0.928 . . . . 0.0 112.897 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 17.9 m80 -85.69 158.22 20.11 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -177.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.471 ' HB3' ' CG ' ' A' ' 88' ' ' TYR . 51.4 p90 -63.64 -36.73 84.8 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.459 -175.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -54.58 -46.82 73.82 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.384 0.611 . . . . 0.0 110.371 175.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.545 ' HB1' ' HB2' ' A' ' 136' ' ' ALA . . . -68.76 -48.31 64.04 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.854 -178.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.5 ' HA ' HG21 ' A' ' 156' ' ' ILE . 41.9 m -56.63 -49.95 73.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.173 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.574 HE21 ' HB2' ' A' ' 84' ' ' GLN . 93.4 mt-30 -59.64 -39.43 84.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.93 0.395 . . . . 0.0 111.289 -178.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 35.9 ttp -72.8 -37.23 67.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.774 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.633 ' HB2' ' HB ' ' A' ' 134' ' ' THR . . . -66.56 -48.68 68.87 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.805 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.589 HE21 HG21 ' A' ' 25' ' ' VAL . 42.2 mt-30 -51.82 -55.79 17.8 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.953 -178.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -64.32 -30.44 71.49 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.635 -174.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.969 ' HE2' ' HA ' ' A' ' 169' ' ' LYS . 3.5 mmpt? -76.82 -40.99 46.02 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.367 -177.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.425 ' O ' ' HG ' ' A' ' 174' ' ' LEU . 17.0 mt -70.89 -42.21 77.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.006 0.431 . . . . 0.0 110.132 176.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -61.46 -27.0 68.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.891 175.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -77.02 -40.43 46.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.4 -177.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.431 ' O ' HG23 ' A' ' 177' ' ' VAL . 18.2 pt -69.46 -26.75 31.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.602 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.626 HD11 HG12 ' A' ' 111' ' ' VAL . 19.3 mt -50.46 -47.74 56.79 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.831 0.348 . . . . 0.0 111.138 177.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.73 -40.52 97.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.787 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -73.68 -30.08 62.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.102 -178.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 173' ' ' ILE . 53.3 t -67.38 -45.82 84.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.27 175.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.476 ' O ' ' HD2' ' A' ' 181' ' ' HIS . 54.8 mtpt -63.3 -19.54 64.68 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.678 -178.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -60.57 -12.12 9.09 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 120.895 0.379 . . . . 0.0 111.229 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -55.3 -20.9 12.68 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.389 176.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . 0.476 ' HD2' ' O ' ' A' ' 178' ' ' LYS . 16.9 p80 -59.28 -25.58 64.22 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.385 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 52.1 tp60 -67.91 -49.12 63.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt 53.86 87.8 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 O-C-N 123.937 0.773 . . . . 0.0 111.547 177.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 159.75 98.08 0.13 Allowed Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -77.94 78.0 4.44 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.05 0.452 . . . . 0.0 110.735 -178.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 15.3 m -83.14 45.18 1.0 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.74 174.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 170.41 164.31 25.92 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.442 -176.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -94.92 172.88 7.88 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.241 0.543 . . . . 0.0 111.645 -177.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 55.6 tp -152.78 138.56 17.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.315 -0.857 . . . . 0.0 108.949 177.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -78.95 71.25 5.4 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.059 0.457 . . . . 0.0 110.72 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.441 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.376 179.086 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' ' G' . . . . . 0.975 " O2'" ' H6 ' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.424 -0.99 0 C4'-C3'-C2' 106.293 3.593 OUTLIER-EPSILON 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . 0.975 ' H6 ' " O2'" ' B' ' 1' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.423 -1.031 0 C3'-C2'-C1' 99.136 -2.627 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . 0.646 " H1'" ' C5 ' ' B' ' 4' ' ' ' C' . . . . . . . . 0 C2'--C1' 1.516 -1.229 0 C5'-C4'-O4' 112.519 2.37 . 0.0 OUTLIER '7D dist 1[' 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' ' C' . . . . . 0.913 ' N4 ' ' HA2' ' A' ' 35' ' ' GLY . . . . . . . . 0 O3'--C3' 1.432 0.653 0 C4'-C3'-C2' 105.887 3.187 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.795 " O4'" " H4'" ' B' ' 4' ' ' ' C' . . . . . . . . 0 P--O3' 1.614 0.597 0 P-O3'-C3' 122.623 2.436 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' ' C' . . . . . 0.728 " O5'" ' H6 ' ' B' ' 6' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.427 -0.84 0 C3'-C2'-C1' 103.484 2.205 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.425 -0.919 0 O4'-C1'-C2' 107.77 0.979 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.867 0 C3'-C2'-C1' 100.233 -1.408 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.695 0 N-CA-C 111.907 -0.477 . . . . 0.0 111.907 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -131.48 149.64 52.45 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.702 0.287 . . . . 0.0 110.473 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.4 mmt -101.9 76.6 1.64 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.267 0.556 . . . . 0.0 110.236 178.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.4 ' HA2' ' HD3' ' A' ' 5' ' ' PRO . . . -152.9 117.98 0.85 Allowed Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.81 -178.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.4 ' HD3' ' HA2' ' A' ' 4' ' ' GLY . 31.2 Cg_exo -60.03 149.08 86.49 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 123.039 2.493 . . . . 0.0 112.686 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 24.9 m -88.49 79.27 7.69 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.231 -176.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.7 t -154.39 30.47 0.43 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.061 0.458 . . . . 0.0 110.265 177.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.8 p -157.15 77.31 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 122.271 1.034 . . . . 0.0 110.485 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.2 p -147.36 21.63 1.19 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.237 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.94 88.82 0.9 Allowed Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.937 -177.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -100.75 -30.07 11.92 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.812 0.339 . . . . 0.0 111.047 -176.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -127.72 83.93 64.73 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 120.921 0.391 . . . . 0.0 110.7 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -81.03 -61.46 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 123.044 2.496 . . . . 0.0 113.157 -177.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -108.82 126.41 53.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.654 -173.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.4 p -155.47 174.67 14.93 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.146 -178.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 31.1 m 70.21 -69.67 0.17 Allowed 'General case' 0 N--CA 1.468 0.428 0 O-C-N 123.914 0.759 . . . . 0.0 112.038 176.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -81.73 148.73 28.8 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.477 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -155.23 142.79 13.98 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.06 175.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.524 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 1.6 Cg_endo -86.84 113.84 1.08 Allowed 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 123.149 2.566 . . . . 0.0 111.372 174.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.524 ' HD3' ' HA ' ' A' ' 19' ' ' PRO . 2.7 Cg_exo -76.34 56.82 5.16 Favored 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 123.142 2.561 . . . . 0.0 113.388 -174.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -85.24 63.38 8.06 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 172.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -65.51 134.52 53.56 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.22 -175.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.492 ' HG2' HE22 ' A' ' 80' ' ' GLN . 30.4 tt0 -85.08 103.53 14.17 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.145 -178.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.67 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 8.0 t -120.05 123.12 42.65 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 121.556 0.693 . . . . 0.0 109.572 173.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.543 ' HB ' HG22 ' A' ' 109' ' ' ILE . 27.2 m -126.44 160.94 33.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -106.07 121.41 44.07 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 121.009 -0.277 . . . . 0.0 110.785 -171.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.617 ' O ' ' HA ' ' A' ' 70' ' ' MET . 21.6 t -96.93 128.43 48.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.614 -174.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.43 ' CZ ' HG11 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -90.65 104.84 17.38 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 122.326 0.25 . . . . 0.0 111.232 -171.622 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.474 ' C ' HG23 ' A' ' 68' ' ' VAL . 20.4 pt -126.97 120.06 22.53 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.179 0.514 . . . . 0.0 110.682 175.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.447 ' HA ' ' HA ' ' A' ' 68' ' ' VAL . 38.2 Cg_exo -58.92 152.38 58.41 Favored 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 122.955 2.437 . . . . 0.0 112.8 -177.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.668 ' HA ' HG12 ' A' ' 34' ' ' VAL . . . -60.01 -19.98 55.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.89 -1.05 . . . . 0.0 112.889 -173.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -68.54 -24.81 64.68 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.657 ' HB2' ' HE2' ' A' ' 96' ' ' PHE . . . -116.28 -31.03 5.76 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.939 -176.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.668 HG12 ' HA ' ' A' ' 31' ' ' ALA . 10.2 p -51.44 -34.96 15.92 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 CA-C-O 120.93 0.395 . . . . 0.0 111.432 -174.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.951 ' HA2' ' N4 ' ' B' ' 4' ' ' ' C' . . . -55.84 -55.91 26.62 Favored Glycine 0 N--CA 1.438 -1.231 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.268 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.25 -14.89 60.55 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 120.987 0.422 . . . . 0.0 111.099 -175.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.952 HD12 ' HB3' ' A' ' 90' ' ' LYS . 3.7 mm -65.98 -39.96 86.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.16 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.726 HD12 ' C5 ' ' B' ' 4' ' ' ' C' . 17.7 mt -61.94 -37.8 79.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-O 121.074 0.464 . . . . 0.0 111.392 177.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.66 141.21 9.07 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.063 178.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -46.52 -34.18 4.65 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.342 0.657 . . . . 0.0 112.132 -172.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.502 ' HE2' ' HB3' ' A' ' 43' ' ' GLN . 15.4 ptmt -123.09 93.2 3.88 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 166.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.574 ' HA3' " H5'" ' B' ' 4' ' ' ' C' . . . -33.23 88.8 0.01 OUTLIER Glycine 0 C--N 1.338 0.671 0 O-C-N 124.355 1.034 . . . . 0.0 113.673 172.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.502 ' HB3' ' HE2' ' A' ' 41' ' ' LYS . 5.4 tp-100 -176.19 -34.91 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -175.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -56.89 -41.8 78.72 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.023 169.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.566 HG21 HG23 ' A' ' 38' ' ' ILE . 8.5 tt -56.99 -34.16 44.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.036 173.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.54 ' HE2' " H4'" ' B' ' 6' ' ' ' C' . 23.5 mmmt -82.35 -29.96 30.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.594 -178.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.414 ' OE1' ' HD3' ' A' ' 50' ' ' ARG . 46.9 tp60 -62.85 -35.46 80.05 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 170.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.817 ' HG ' ' HE1' ' A' ' 51' ' ' PHE . 7.3 tt -60.98 -42.38 98.24 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.513 173.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 14.9 m -56.74 -34.95 68.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.609 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.414 ' HD3' ' OE1' ' A' ' 47' ' ' GLN . 76.1 mtp180 -72.31 -51.87 18.77 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.693 -176.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.817 ' HE1' ' HG ' ' A' ' 48' ' ' LEU . 3.2 p90 -77.0 -29.98 55.71 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.728 -173.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.606 ' HB1' ' HB2' ' A' ' 83' ' ' ALA . . . -81.73 -12.56 58.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.244 -178.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.7 t 61.27 30.07 18.98 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.541 178.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -131.91 159.66 38.0 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.345 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.699 ' HB2' ' HB ' ' A' ' 74' ' ' THR . 19.6 m -91.12 100.46 13.29 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -178.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.405 HG13 HD22 ' A' ' 48' ' ' LEU . 33.4 mm -88.4 111.53 22.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.319 -177.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -130.6 137.76 49.8 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.39 176.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.631 ' HB ' ' N1 ' ' B' ' 5' ' ' ' A' . 46.8 mm -94.27 112.35 26.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 172.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.667 ' HB2' HG23 ' A' ' 72' ' ' VAL . . . -67.73 117.73 50.76 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.452 -174.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.53 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 7.5 Cg_exo -73.07 132.02 17.56 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.798 2.332 . . . . 0.0 111.406 176.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.53 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 6.3 Cg_exo -78.24 146.28 22.27 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.706 2.271 . . . . 0.0 111.531 177.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -70.48 -44.55 67.47 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 176.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.426 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 32.5 p -96.32 129.74 32.72 Favored Pre-proline 0 N--CA 1.446 -0.669 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.738 177.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 63' ' ' THR . 11.9 Cg_exo -70.41 -6.06 18.05 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 123.284 2.656 . . . . 0.0 111.987 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -82.07 -10.92 59.05 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.634 -179.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.2 t -57.43 126.03 25.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.501 0.667 . . . . 0.0 111.505 -177.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.6 tmtp? -79.21 -11.01 59.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.475 -176.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.474 HG23 ' C ' ' A' ' 29' ' ' ILE . 2.4 p -144.78 151.91 15.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.724 -171.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.497 ' HD3' HG11 ' A' ' 34' ' ' VAL . 59.3 mtp180 -126.18 132.23 51.83 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 177.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.617 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 76.7 mtm -92.26 147.47 22.9 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.873 -175.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.548 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 86.4 t -96.09 124.42 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 172.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.667 HG23 ' HB2' ' A' ' 59' ' ' ALA . 97.5 t -86.8 102.13 11.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 174.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.67 ' O ' ' HA ' ' A' ' 24' ' ' THR . 8.8 tp -101.34 100.18 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 CA-C-O 121.882 0.849 . . . . 0.0 110.252 -177.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.699 ' HB ' ' HB2' ' A' ' 55' ' ' SER . 9.4 m -102.61 105.83 16.4 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.688 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -160.35 163.62 34.03 Favored Glycine 0 CA--C 1.497 -1.088 0 C-N-CA 119.674 -1.25 . . . . 0.0 113.254 -174.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.48 ' HD2' ' HB3' ' A' ' 79' ' ' ALA . 7.1 Cg_exo -67.23 136.77 41.55 Favored 'Trans proline' 0 N--CA 1.446 -1.273 0 C-N-CA 121.944 1.763 . . . . 0.0 109.859 170.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.573 ' HA ' ' NH2' ' A' ' 168' ' ' ARG . 3.7 Cg_exo -36.78 -50.93 1.4 Allowed 'Trans proline' 0 C--O 1.24 0.614 0 C-N-CA 124.59 3.527 . . . . 0.0 113.684 -176.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -63.81 -49.82 71.39 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.942 0.401 . . . . 0.0 111.174 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.56 ' HB1' ' O ' ' A' ' 52' ' ' ALA . . . -66.87 -34.4 77.72 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.407 -177.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.492 HE22 ' HG2' ' A' ' 23' ' ' GLU . 34.2 tt0 -61.91 -31.22 71.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.73 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -65.77 -42.17 91.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.603 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.3 mtmt -63.02 -37.98 89.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.548 0.689 . . . . 0.0 109.952 -178.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.606 ' HB2' ' HB1' ' A' ' 52' ' ' ALA . . . -69.76 -49.05 56.74 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.534 179.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.446 HE21 ' HG2' ' A' ' 80' ' ' GLN . 41.6 mt-30 -67.14 -30.81 70.91 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -177.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -56.99 -35.19 67.7 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.848 175.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.4 mmt180 -79.44 -36.76 38.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.576 0.227 . . . . 0.0 111.154 177.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.543 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 0.3 OUTLIER -67.75 -40.87 84.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.738 -174.93 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.745 ' HA ' HD23 ' A' ' 91' ' ' LEU . 6.7 m-85 -68.33 -32.04 71.88 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.056 0.455 . . . . 0.0 110.292 175.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -61.44 -28.91 70.29 Favored Glycine 0 C--O 1.224 -0.526 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.709 174.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.952 ' HB3' HD12 ' A' ' 37' ' ' ILE . 69.3 mmtt -66.99 -38.87 86.82 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 122.827 0.451 . . . . 0.0 111.002 174.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.745 HD23 ' HA ' ' A' ' 88' ' ' TYR . 3.2 mm? -60.49 -38.36 84.04 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.157 0.504 . . . . 0.0 110.555 173.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.984 ' HE3' ' HB ' ' A' ' 103' ' ' VAL . 3.6 mmtp -76.44 -26.54 55.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.502 178.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -68.43 -30.92 69.91 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.472 -175.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.583 ' HA ' ' OE1' ' A' ' 94' ' ' GLU . 4.4 mm-40 -96.42 10.7 37.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.307 0.575 . . . . 0.0 110.799 177.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 63.2 t30 57.2 45.52 20.37 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 114.757 -1.11 . . . . 0.0 112.143 172.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.657 ' HE2' ' HB2' ' A' ' 33' ' ' ALA . 61.2 m-85 -90.16 -21.94 21.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.148 0.499 . . . . 0.0 110.243 174.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.743 ' O ' ' HB3' ' A' ' 101' ' ' GLU . 12.0 m-85 -131.0 26.38 4.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.037 -179.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 59.72 175.52 0.97 Allowed Glycine 0 CA--C 1.525 0.693 0 C-N-CA 121.277 -0.487 . . . . 0.0 113.219 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -82.19 -35.23 0.37 Allowed 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.856 2.371 . . . . 0.0 112.534 174.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -106.98 -23.18 12.42 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.654 0.264 . . . . 0.0 111.429 -175.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.743 ' HB3' ' O ' ' A' ' 97' ' ' PHE . 10.6 tp10 -61.4 151.65 31.81 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.463 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -62.6 126.58 27.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.726 -177.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.984 ' HB ' ' HE3' ' A' ' 92' ' ' LYS . 7.1 p -76.45 122.83 31.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 172.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -124.53 90.31 3.23 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 176.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.594 ' HB3' ' CE2' ' A' ' 88' ' ' TYR . 1.8 tm? -118.86 130.81 55.95 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.869 -173.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.865 ' HG2' HG13 ' A' ' 157' ' ' ILE . 32.0 mt-10 -73.5 126.89 31.25 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.188 -0.915 . . . . 0.0 112.743 -176.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.482 HG21 ' NE2' ' A' ' 167' ' ' GLN . 0.2 OUTLIER -113.81 125.5 54.16 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 167.012 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 21.5 m170 -107.81 121.49 44.83 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -177.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.543 HG22 ' HB ' ' A' ' 25' ' ' VAL . 10.4 pt -113.83 147.24 17.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 177.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.896 ' HG3' ' HG2' ' A' ' 151' ' ' GLN . 4.2 tpt180 -97.88 118.65 34.92 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -176.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.708 HG12 HD22 ' A' ' 174' ' ' LEU . 11.1 m -116.82 150.1 45.2 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 178.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.641 ' CD ' HD13 ' A' ' 174' ' ' LEU . 44.8 Cg_exo -49.77 149.66 10.42 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 123.217 2.612 . . . . 0.0 112.341 177.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -48.6 -49.15 38.11 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -171.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 23.1 t -85.93 -19.74 30.04 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.839 0.352 . . . . 0.0 110.921 -176.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.443 ' O ' HG23 ' A' ' 119' ' ' VAL . . . -65.66 -26.08 67.63 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.521 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.517 ' O ' ' HB ' ' A' ' 119' ' ' VAL . . . -63.51 -34.44 77.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.59 177.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -67.66 -32.91 79.34 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.852 -0.689 . . . . 0.0 111.473 177.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.471 ' HD3' HG22 ' A' ' 177' ' ' VAL . 26.1 mtp180 -83.77 -6.8 59.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.488 -0.356 . . . . 0.0 110.609 176.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.713 HG22 HD11 ' A' ' 173' ' ' ILE . 12.0 t -75.11 -51.19 22.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.331 0.586 . . . . 0.0 109.788 172.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 1.015 ' HA ' ' HB ' ' A' ' 127' ' ' VAL . 20.2 pt -81.12 -34.22 13.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.946 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.479 ' HA3' HG22 ' A' ' 126' ' ' THR . . . 89.39 58.49 1.64 Allowed Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.98 -0.628 . . . . 0.0 111.891 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 59.9 -88.25 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.16 0.584 . . . . 0.0 111.797 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -86.87 -25.63 24.38 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.734 -178.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 135.26 39.63 0.17 Allowed Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.306 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -79.31 -63.18 1.47 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.669 0.271 . . . . 0.0 111.25 -177.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.631 ' O ' ' HG ' ' A' ' 130' ' ' LEU . 8.1 t -76.79 -20.22 56.68 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.756 -174.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 1.015 ' HB ' ' HA ' ' A' ' 120' ' ' ILE . 8.8 p -69.25 -29.21 41.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 176.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -65.95 -41.04 91.77 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.494 174.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.33 -48.76 80.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.761 173.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.631 ' HG ' ' O ' ' A' ' 126' ' ' THR . 87.7 mt -58.02 -50.47 73.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.457 -177.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -62.0 -49.69 75.04 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -176.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -77.81 -11.3 59.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.794 -173.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 59.5 tp -97.46 -49.34 4.94 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.749 0.309 . . . . 0.0 110.96 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 82.1 p -79.62 -20.2 47.39 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.85 -173.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 66.2 27.47 10.31 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.875 0.735 . . . . 0.0 110.168 -174.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -127.33 176.21 7.6 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.528 -177.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.546 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 7.3 tp10 -108.74 111.4 23.14 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.845 177.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.49 HG21 HD11 ' A' ' 170' ' ' ILE . 46.2 t -108.41 106.24 20.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 177.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.698 HG13 ' HD3' ' A' ' 155' ' ' LYS . 5.1 p -123.16 125.33 71.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.351 0.596 . . . . 0.0 111.819 -175.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.415 ' HA ' ' HD2' ' A' ' 141' ' ' PRO . 89.3 t -92.8 118.1 67.8 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 173.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 140' ' ' VAL . 9.6 Cg_endo -50.72 137.71 41.78 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 123.811 3.007 . . . . 0.0 113.25 -171.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.539 ' NE ' ' HA ' ' A' ' 142' ' ' ARG . 4.6 mmp_? -81.64 -28.99 33.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.309 178.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -93.56 62.89 3.37 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 163.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -57.93 139.31 54.6 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.607 -1.179 . . . . 0.0 111.438 -171.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 30.2 p -59.13 130.47 86.83 Favored Pre-proline 0 N--CA 1.448 -0.542 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.292 173.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.448 ' C ' ' H ' ' A' ' 148' ' ' GLU . 17.8 Cg_endo -58.27 150.98 63.2 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.684 2.256 . . . . 0.0 112.226 -175.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -78.24 35.32 0.22 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.321 0.582 . . . . 0.0 110.751 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.448 ' H ' ' C ' ' A' ' 146' ' ' PRO . 24.0 tt0 -52.26 -47.15 65.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.019 177.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -109.15 25.01 12.3 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.314 178.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 49.48 31.34 3.95 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.854 1.262 . . . . 0.0 112.544 178.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.896 ' HG2' ' HG3' ' A' ' 110' ' ' ARG . 7.8 tt0 -156.68 136.12 12.22 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.141 -177.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 32.6 m -122.41 169.32 13.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.007 0.432 . . . . 0.0 111.716 -172.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 10.7 mm -102.27 142.76 15.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.098 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 4.1 p -127.97 140.04 50.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.939 171.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.698 ' HD3' HG13 ' A' ' 139' ' ' VAL . 0.0 OUTLIER -96.77 130.4 44.03 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.738 -174.685 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.546 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 76.0 mt -114.43 111.53 36.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 172.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.865 HG13 ' HG2' ' A' ' 106' ' ' GLU . 4.2 mp -110.05 131.69 60.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.12 -177.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 163.82 -164.0 36.14 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.313 -0.946 . . . . 0.0 112.53 177.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.585 ' HA ' HG13 ' A' ' 103' ' ' VAL . 5.1 m80 -79.07 160.07 27.25 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.544 ' HB3' ' CG ' ' A' ' 88' ' ' TYR . 13.5 p90 -57.43 -33.3 67.75 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 118.561 0.619 . . . . 0.0 112.028 -175.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -61.86 -52.95 62.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.522 0.677 . . . . 0.0 110.112 175.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -65.59 -41.65 92.59 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.808 -175.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.48 ' O ' ' HG3' ' A' ' 167' ' ' GLN . 26.2 p -68.08 -49.13 63.16 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.318 -176.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.62 -31.63 71.72 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.708 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 25.6 ttt -66.83 -45.66 77.56 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.036 0.446 . . . . 0.0 110.301 176.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.533 ' HB3' HG21 ' A' ' 156' ' ' ILE . . . -71.16 -35.31 71.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.833 -177.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.482 ' NE2' HG21 ' A' ' 107' ' ' THR . 66.4 mt-30 -51.54 -56.58 12.64 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.005 0.431 . . . . 0.0 110.807 -179.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.662 ' HA ' ' HB2' ' A' ' 171' ' ' ARG . 0.4 OUTLIER -74.09 -27.18 60.77 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.498 178.812 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.616 ' HA ' ' HE3' ' A' ' 169' ' ' LYS . 0.2 OUTLIER -64.52 -49.76 70.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.064 0.459 . . . . 0.0 109.992 -179.245 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.562 HG23 HG22 ' A' ' 119' ' ' VAL . 2.0 mp -71.87 -35.24 53.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.755 177.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.729 ' HA ' HD23 ' A' ' 174' ' ' LEU . 1.0 OUTLIER -56.58 -33.82 66.55 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.38 172.894 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.49 -44.13 45.53 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.73 0.271 . . . . 0.0 111.73 -178.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.713 HD11 HG22 ' A' ' 119' ' ' VAL . 2.7 pp -68.58 -30.86 48.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.61 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.729 HD23 ' HA ' ' A' ' 171' ' ' ARG . 0.3 OUTLIER -71.89 -37.59 70.11 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.624 0.726 . . . . 0.0 109.278 174.191 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -58.01 -32.21 67.7 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.981 -1.008 . . . . 0.0 111.067 176.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -61.36 -33.74 74.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.082 0.468 . . . . 0.0 110.113 174.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.715 ' O ' ' HG2' ' A' ' 180' ' ' GLN . 22.0 t -73.8 -29.41 26.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.358 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -63.83 -34.85 78.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.005 0.431 . . . . 0.0 110.44 175.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -67.93 -21.24 65.12 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.238 -174.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.715 ' HG2' ' O ' ' A' ' 177' ' ' VAL . 24.5 pt20 -74.43 -20.88 59.88 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.064 178.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -79.05 -44.29 22.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.94 176.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -70.1 -36.02 74.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.753 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.479 ' HE3' ' O ' ' A' ' 180' ' ' GLN . 32.3 mmtp 60.73 83.94 0.14 Allowed 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.266 0.555 . . . . 0.0 110.644 -178.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -80.4 107.17 2.6 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.905 -178.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -69.97 96.48 1.04 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.761 0.315 . . . . 0.0 110.2 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 8.1 t 61.38 34.84 18.15 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.328 -178.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 114.06 -89.9 0.52 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.335 178.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . 0.788 ' HA ' HE21 ' A' ' 188' ' ' GLN . 0.0 OUTLIER 64.09 33.46 12.01 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.083 0.468 . . . . 0.0 110.928 -178.476 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 1.5 pp -91.25 164.3 13.93 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.619 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 79.4 mm-40 -99.36 -12.64 20.12 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.124 -175.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.334 0 O-C-N 123.811 0.694 . . . . 0.0 111.663 177.855 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' ' G' . . . . . 0.962 " O2'" ' H6 ' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.424 -0.977 0 C4'-C3'-C2' 106.455 3.755 OUTLIER-EPSILON 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . 0.962 ' H6 ' " O2'" ' B' ' 1' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.425 -0.915 0 C3'-C2'-C1' 99.567 -2.148 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . 0.64 ' C8 ' ' HA3' ' A' ' 35' ' ' GLY . . . . . . . . 0 C2'--C1' 1.516 -1.166 0 O4'-C1'-C2' 103.257 -2.245 . 0.0 OUTLIER '7D dist 1z' 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' ' C' . . . . . 0.951 ' N4 ' ' HA2' ' A' ' 35' ' ' GLY . . . . . . . . 0 O5'--C5' 1.428 -0.73 0 C4'-C3'-C2' 105.997 3.297 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.776 " O5'" " H4'" ' B' ' 4' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.43 -0.623 0 P-O3'-C3' 122.222 2.101 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' ' C' . . . . . 0.54 " H4'" ' HE2' ' A' ' 46' ' ' LYS . . . . . . . . 0 O5'--C5' 1.429 -0.703 0 C4'-C3'-C2' 104.961 2.261 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . 0.442 " O4'" " H2'" ' B' ' 6' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.426 -0.852 0 O4'-C4'-C3' 104.628 -0.623 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.425 -0.953 0 C3'-C2'-C1' 100.49 -1.122 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.445 0 N-CA-C 112.113 -0.395 . . . . 0.0 112.113 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -119.77 156.4 30.68 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 51.6 ttp -88.51 123.77 33.35 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.543 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 104.53 173.28 24.88 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.171 176.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.19 62.05 7.43 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.887 2.391 . . . . 0.0 111.839 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.0 m -62.91 107.27 0.96 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.292 178.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.1 m -69.48 136.48 51.54 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.068 -177.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.3 t -78.67 82.06 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 176.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.2 m -56.84 130.43 45.7 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.696 -176.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.43 4.95 29.74 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 177.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.25 79.66 7.85 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.163 0.506 . . . . 0.0 110.726 177.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.473 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . . . -72.39 133.24 83.24 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.63 175.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 12' ' ' ALA . 13.3 Cg_exo -69.84 70.66 1.61 Allowed 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 123.099 2.533 . . . . 0.0 112.855 -177.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -89.58 -42.22 11.54 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 174.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 37.1 m -130.13 -57.18 1.09 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.766 174.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.411 ' OG ' ' HA ' ' A' ' 13' ' ' PRO . 42.6 m 51.41 65.15 1.57 Allowed 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.297 0.57 . . . . 0.0 111.949 177.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -97.03 117.95 32.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.356 178.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.728 ' HB3' ' HD3' ' A' ' 19' ' ' PRO . 51.1 ttp -96.41 -58.82 0.18 Allowed Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.852 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.728 ' HD3' ' HB3' ' A' ' 18' ' ' MET . 25.4 Cg_exo -62.62 108.87 0.78 Allowed 'Trans proline' 0 C--N 1.36 1.155 0 C-N-CA 122.233 1.955 . . . . 0.0 112.199 -177.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 19' ' ' PRO . 5.2 Cg_exo -79.35 78.51 3.69 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 123.36 2.707 . . . . 0.0 113.066 -173.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 54.32 66.2 1.3 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.687 171.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.505 ' HB3' HG22 ' A' ' 74' ' ' THR . 97.1 mt-30 -92.35 104.42 16.76 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 171.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -73.27 143.67 46.96 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.679 -174.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 44.8 m -115.16 107.45 15.32 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.509 0.671 . . . . 0.0 110.774 -176.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.0 t -106.96 148.41 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.429 ' HB3' ' SD ' ' A' ' 70' ' ' MET . 15.9 m-70 -113.74 146.51 39.77 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -174.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.695 ' HB ' HG22 ' A' ' 71' ' ' VAL . 7.4 t -124.26 142.79 39.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 120.912 0.387 . . . . 0.0 111.173 -174.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.754 ' CE2' HG11 ' A' ' 68' ' ' VAL . 45.4 t80 -97.58 105.27 17.39 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.088 0.955 . . . . 0.0 110.269 -176.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.53 ' C ' HG23 ' A' ' 68' ' ' VAL . 17.6 pt -124.07 120.22 26.43 Favored Pre-proline 0 C--N 1.324 -0.53 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.766 174.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.612 ' HA ' ' HA ' ' A' ' 68' ' ' VAL . 18.0 Cg_endo -57.96 150.73 62.19 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 122.966 2.444 . . . . 0.0 112.05 -176.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.62 ' HA ' HG12 ' A' ' 34' ' ' VAL . . . -60.17 -19.64 54.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.082 -174.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -69.96 -22.99 63.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.214 177.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.457 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -113.59 -31.79 6.39 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 120.889 -0.325 . . . . 0.0 111.625 -175.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.62 HG12 ' HA ' ' A' ' 31' ' ' ALA . 11.7 p -55.58 -31.23 28.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 O-C-N 123.431 0.457 . . . . 0.0 111.714 -171.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 1.117 ' HA2' ' H41' ' B' ' 4' ' ' ' C' . . . -56.71 -57.58 18.84 Favored Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.019 -178.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.43 -13.73 59.7 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 120.673 0.273 . . . . 0.0 111.368 -175.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.594 HD12 ' HB3' ' A' ' 90' ' ' LYS . 2.1 mm -65.49 -36.43 77.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 177.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.81 HD12 ' C5 ' ' B' ' 4' ' ' ' C' . 37.8 mt -63.99 -52.64 53.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.012 173.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 81.7 106.37 0.37 Allowed Glycine 0 CA--C 1.523 0.549 0 N-CA-C 115.131 0.812 . . . . 0.0 115.131 168.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.0 tptt 42.16 89.51 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.841 1.256 . . . . 0.0 113.757 169.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.46 ' HA ' ' OP2' ' B' ' 4' ' ' ' C' . 21.0 ttpt 66.85 -0.35 1.68 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.702 0.801 . . . . 0.0 111.947 176.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.497 ' HA2' HG22 ' A' ' 38' ' ' ILE . . . 84.96 18.92 60.27 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.274 -0.965 . . . . 0.0 111.398 -175.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -67.84 -47.21 69.61 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.989 0.423 . . . . 0.0 110.076 178.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 64.0 m-70 -68.29 -39.59 82.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.753 -172.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.0 tt -62.51 -47.31 93.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.719 0.295 . . . . 0.0 111.775 -178.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.2 ptmm? -81.43 -22.87 37.89 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.924 -177.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -64.81 -39.21 93.22 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 169.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.637 ' HA ' ' CZ ' ' A' ' 51' ' ' PHE . 7.8 tt -61.95 -42.12 98.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.931 177.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.642 ' HA ' HD13 ' A' ' 56' ' ' ILE . 44.0 t -53.98 -34.85 60.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.687 177.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -76.85 -50.96 12.17 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.661 -177.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.637 ' CZ ' ' HA ' ' A' ' 48' ' ' LEU . 2.4 p90 -76.77 -11.42 59.83 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 119.995 -0.682 . . . . 0.0 111.85 -175.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -96.36 -18.53 19.88 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.73 0.3 . . . . 0.0 110.975 176.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.7 t 65.32 34.36 8.35 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.698 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -141.18 168.93 18.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.291 -176.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.665 ' HB2' ' HB ' ' A' ' 74' ' ' THR . 29.9 m -90.71 103.26 15.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.743 0.306 . . . . 0.0 110.679 -178.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.642 HD13 ' HA ' ' A' ' 49' ' ' SER . 2.4 mp -107.21 113.13 42.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.035 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -134.64 157.76 45.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.794 -177.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.693 ' HB ' ' N1 ' ' B' ' 5' ' ' ' A' . 40.8 mm -97.6 135.7 31.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 174.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.864 ' HB2' HG23 ' A' ' 72' ' ' VAL . . . -92.5 140.58 24.08 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-O 120.642 0.258 . . . . 0.0 110.772 -178.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 59' ' ' ALA . 21.9 Cg_exo -65.63 120.8 8.04 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.794 2.33 . . . . 0.0 111.495 175.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -73.5 -176.38 2.48 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.325 2.017 . . . . 0.0 111.733 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -59.61 -61.61 2.5 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.477 0.656 . . . . 0.0 109.715 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.468 ' HB ' ' HD2' ' A' ' 64' ' ' PRO . 32.0 p -143.44 173.86 4.12 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.934 178.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.468 ' HD2' ' HB ' ' A' ' 63' ' ' THR . 39.7 Cg_exo -62.39 -21.5 72.79 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 121.901 1.734 . . . . 0.0 111.421 173.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -92.97 17.08 11.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.095 -177.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.8 t -85.02 143.91 28.61 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -72.65 -24.92 61.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.74 -174.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.754 HG11 ' CE2' ' A' ' 28' ' ' PHE . 7.7 p -137.23 150.99 26.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-O 120.925 0.393 . . . . 0.0 110.602 -175.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.616 ' HB3' HG21 ' A' ' 34' ' ' VAL . 18.6 ttm180 -122.21 121.88 37.86 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 174.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.454 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 44.5 ttp -79.83 148.11 31.51 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.134 -178.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.695 HG22 ' HB ' ' A' ' 27' ' ' VAL . 21.8 m -115.19 145.64 20.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.716 0.293 . . . . 0.0 110.555 175.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.864 HG23 ' HB2' ' A' ' 59' ' ' ALA . 58.3 t -107.8 111.11 34.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.15 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.578 ' O ' HD12 ' A' ' 73' ' ' ILE . 2.7 pp -118.77 125.32 74.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.817 0.818 . . . . 0.0 111.133 176.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.665 ' HB ' ' HB2' ' A' ' 55' ' ' SER . 59.4 m -107.04 106.03 16.35 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.786 176.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.03 134.58 7.4 Favored Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 119.995 -1.098 . . . . 0.0 113.464 -172.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -69.42 151.03 70.95 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.057 1.838 . . . . 0.0 110.247 167.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -38.13 -49.07 2.28 Favored 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 124.862 3.708 . . . . 0.0 115.407 -173.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -71.3 -49.97 37.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.875 0.369 . . . . 0.0 110.132 -178.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.59 -27.19 68.78 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.806 -177.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -53.9 -42.56 68.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.307 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -72.5 -34.65 67.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.844 -177.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 15.4 tppt? -64.99 -47.83 76.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.714 -178.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.0 -53.13 19.06 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.868 -177.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.547 ' O ' HG22 ' A' ' 87' ' ' ILE . 6.5 tt0 -72.18 -30.23 64.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.386 -173.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -56.29 -34.76 63.48 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.508 177.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -76.7 -36.85 56.95 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 1.005 ' HA ' ' HD3' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -70.41 -30.31 42.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.804 -174.492 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.419 ' HA ' HD12 ' A' ' 105' ' ' LEU . 7.4 m-85 -66.94 -30.67 70.87 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.166 0.508 . . . . 0.0 109.752 171.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -61.87 -29.22 71.76 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.867 175.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 1.005 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 5.2 mptp? -60.0 -45.79 91.58 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.909 0.385 . . . . 0.0 109.999 173.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.404 ' HB2' ' O ' ' A' ' 88' ' ' TYR . 3.6 mm? -57.23 -37.67 72.62 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.591 176.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.985 ' HE3' ' HB ' ' A' ' 103' ' ' VAL . 11.4 mmtp -75.26 -24.43 57.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.028 -176.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -69.47 -44.39 71.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.705 0.288 . . . . 0.0 111.407 -176.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.681 ' HB2' ' CE2' ' A' ' 96' ' ' PHE . 22.7 mm-40 -108.2 1.81 22.37 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 52.27 47.9 23.77 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.269 177.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.681 ' CE2' ' HB2' ' A' ' 94' ' ' GLU . 71.8 m-85 -63.52 -27.41 69.24 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.442 -177.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.462 ' HD2' ' HB3' ' A' ' 101' ' ' GLU . 10.9 p90 -72.39 -28.09 62.78 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.217 -177.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 131.95 158.17 8.93 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.11 -178.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -73.78 -30.62 9.24 Favored 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 122.447 2.098 . . . . 0.0 113.149 -178.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -106.13 23.89 13.32 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.953 0.406 . . . . 0.0 111.157 -174.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.462 ' HB3' ' HD2' ' A' ' 97' ' ' PHE . 12.2 tp10 -123.86 157.41 34.24 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.265 -176.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.428 ' O ' ' HG3' ' A' ' 101' ' ' GLU . 46.7 mt-10 -83.29 -174.86 5.53 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 170.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.985 ' HB ' ' HE3' ' A' ' 92' ' ' LYS . 9.8 p -68.12 123.37 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 C-N-CA 118.392 -1.323 . . . . 0.0 109.328 174.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 158' ' ' GLY . 30.3 mmtp -130.75 89.68 2.79 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.43 177.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.419 HD12 ' HA ' ' A' ' 88' ' ' TYR . 0.9 OUTLIER -109.02 115.94 31.04 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -177.473 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.488 ' O ' ' HB3' ' A' ' 28' ' ' PHE . 33.5 tt0 -71.26 116.52 11.67 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.021 -176.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -101.66 144.25 30.61 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.053 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 -124.84 120.98 33.25 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.083 0.468 . . . . 0.0 110.785 -177.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 16.2 pt -121.17 138.15 52.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.144 0.497 . . . . 0.0 111.062 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.618 ' HD3' HG12 ' A' ' 153' ' ' ILE . 9.6 mmt85 -82.66 119.02 23.76 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.442 177.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.956 HG23 HD11 ' A' ' 174' ' ' LEU . 6.0 p -121.69 143.11 37.39 Favored Pre-proline 0 C--N 1.318 -0.783 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.481 ' HD2' ' HG ' ' A' ' 174' ' ' LEU . 50.7 Cg_exo -53.42 140.03 64.16 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.259 1.972 . . . . 0.0 110.111 177.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.68 -28.51 68.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.179 0.514 . . . . 0.0 110.761 -174.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.2 p -75.89 -34.5 59.97 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.461 176.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.525 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -71.89 -20.35 61.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.973 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.421 ' HB2' HG21 ' A' ' 152' ' ' VAL . . . -59.48 -32.65 70.45 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.236 0.541 . . . . 0.0 110.446 176.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -73.43 -39.63 50.17 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.576 175.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.544 ' HD3' HG22 ' A' ' 177' ' ' VAL . 45.5 mtp180 -73.41 -34.64 65.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.486 0.184 . . . . 0.0 111.459 -177.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.546 HG11 HG21 ' A' ' 140' ' ' VAL . 14.0 p -69.73 -36.43 70.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.923 0.392 . . . . 0.0 110.376 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.972 ' HA ' ' HB ' ' A' ' 127' ' ' VAL . 75.5 mt -75.11 -31.4 24.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.651 0.739 . . . . 0.0 109.449 174.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 118.58 -33.75 4.67 Favored Glycine 0 N--CA 1.44 -1.096 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.9 t70 65.48 -72.61 0.07 Allowed 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.548 0.739 . . . . 0.0 110.96 178.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -107.13 -11.32 15.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.957 0.408 . . . . 0.0 110.237 176.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -113.75 -168.96 16.75 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.082 -176.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -109.11 35.94 3.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.884 0.373 . . . . 0.0 110.422 -176.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 11.0 m -60.09 -46.15 90.55 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.246 -175.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.972 ' HB ' ' HA ' ' A' ' 120' ' ' ILE . 9.9 p -68.82 -33.89 61.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.266 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -60.71 -42.56 97.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.346 0.593 . . . . 0.0 109.533 176.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -61.08 -48.89 79.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.844 175.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 91.4 mt -58.6 -49.37 77.73 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.09 -177.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -58.52 -43.88 89.31 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 123.14 0.275 . . . . 0.0 111.575 -174.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -81.13 -33.26 33.33 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 121.061 -0.256 . . . . 0.0 111.344 -178.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.34 -48.74 74.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.098 0.475 . . . . 0.0 110.009 178.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.621 HG21 ' HA ' ' A' ' 166' ' ' ALA . 66.7 p -85.6 -18.06 34.41 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.762 -174.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 63.6 29.32 15.19 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.523 -175.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -127.44 170.17 12.84 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.4 -177.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.448 ' HB3' ' HB ' ' A' ' 157' ' ' ILE . 10.1 tp10 -95.77 113.61 25.26 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 177.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 59.1 t -110.8 105.97 19.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.939 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.637 HG22 ' HD3' ' A' ' 141' ' ' PRO . 6.3 p -125.25 128.34 72.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.348 177.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.894 HG22 HG13 ' A' ' 154' ' ' VAL . 2.3 t -130.75 81.55 67.08 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 121.02 0.438 . . . . 0.0 110.723 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.809 ' HD2' ' HE3' ' A' ' 155' ' ' LYS . 51.6 Cg_exo -57.1 142.18 94.28 Favored 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 123.083 2.522 . . . . 0.0 112.113 176.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -78.17 -19.34 54.15 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.545 -176.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -97.3 16.56 19.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.035 -172.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.966 HE21 ' HB ' ' A' ' 153' ' ' ILE . 14.4 mm100 -50.79 -70.26 0.09 Allowed 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -177.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -137.98 159.94 66.49 Favored Pre-proline 0 C--N 1.311 -1.079 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.587 -174.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -56.44 144.31 84.08 Favored 'Trans proline' 0 C--O 1.238 0.503 0 C-N-CA 123.084 2.523 . . . . 0.0 112.902 -176.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -67.23 -7.45 24.03 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.407 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -49.96 -47.73 52.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.483 169.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . 0.49 ' O ' ' HG2' ' A' ' 150' ' ' GLU . 10.8 t-20 -87.52 -7.16 57.92 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.792 -178.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 149' ' ' ASN . 11.1 pt-20 48.13 33.26 3.46 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.712 1.205 . . . . 0.0 111.457 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -149.55 144.0 25.96 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.436 -173.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.421 HG21 ' HB2' ' A' ' 116' ' ' ALA . 25.2 m -128.47 -176.54 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.965 -178.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.966 ' HB ' HE21 ' A' ' 144' ' ' GLN . 39.3 mt -122.41 131.24 73.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.588 0.233 . . . . 0.0 111.6 -177.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.894 HG13 HG22 ' A' ' 140' ' ' VAL . 32.4 t -92.77 140.2 16.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 172.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.809 ' HE3' ' HD2' ' A' ' 141' ' ' PRO . 0.0 OUTLIER -107.39 126.19 52.16 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 177.397 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 60.2 mt -110.04 111.21 35.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.089 178.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.448 ' HB ' ' HB3' ' A' ' 137' ' ' GLU . 3.8 mp -109.1 119.75 59.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 176.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 104' ' ' LYS . . . 177.53 -157.4 21.95 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 119.62 -1.276 . . . . 0.0 113.1 -174.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.462 ' H ' ' HB3' ' A' ' 162' ' ' ALA . 1.1 m-70 -102.63 173.25 6.42 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 -173.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -59.96 -46.24 90.08 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 121.172 -0.211 . . . . 0.0 111.22 -177.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -60.89 -51.76 67.92 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.931 0.396 . . . . 0.0 110.516 175.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.462 ' HB3' ' H ' ' A' ' 159' ' ' HIS . . . -59.22 -49.04 79.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.259 -174.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.445 ' O ' ' HG3' ' A' ' 167' ' ' GLN . 32.4 t -62.16 -47.44 84.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.058 -175.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -56.41 -37.82 70.7 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.923 0.392 . . . . 0.0 111.001 178.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 89.9 mtp -71.92 -38.72 69.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.653 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.621 ' HA ' HG21 ' A' ' 134' ' ' THR . . . -66.83 -49.53 65.47 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.33 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.445 ' HG3' ' O ' ' A' ' 163' ' ' SER . 75.7 mt-30 -51.87 -52.46 49.44 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.233 -177.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 18.4 ptt180 -66.85 -38.15 85.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.146 -177.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.621 ' HE2' ' HA ' ' A' ' 169' ' ' LYS . 0.1 OUTLIER -68.09 -39.17 82.93 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.706 0.289 . . . . 0.0 111.299 -172.798 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.462 ' O ' HG12 ' A' ' 173' ' ' ILE . 1.9 mp -74.98 -44.19 44.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 177.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 -55.83 -25.59 42.57 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.2 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -60.77 -55.55 31.84 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.463 175.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.497 ' O ' HG23 ' A' ' 177' ' ' VAL . 42.5 pt -67.57 -23.94 30.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.446 -172.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.956 HD11 HG23 ' A' ' 111' ' ' VAL . 10.9 mp -58.33 -37.69 75.65 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.843 176.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -65.74 -34.97 79.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.058 0.456 . . . . 0.0 110.378 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -71.37 -38.1 71.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.508 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.544 HG22 ' HD3' ' A' ' 118' ' ' ARG . 58.0 t -66.7 -37.28 79.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.5 177.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 174' ' ' LEU . 98.2 mttt -66.06 -41.38 90.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.185 176.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -63.3 -37.68 88.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.395 177.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -60.15 -32.09 70.71 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.672 177.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 52.6 m170 -85.21 -25.92 27.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.096 0.474 . . . . 0.0 110.568 178.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -74.94 -41.96 58.62 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.709 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -87.35 73.72 9.57 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.744 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -122.5 137.7 11.49 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.068 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -142.8 143.64 32.25 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.769 0.319 . . . . 0.0 110.352 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 14.9 p -91.28 -10.07 42.79 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.464 -176.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 82.82 -152.3 29.96 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.52 177.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -142.05 140.58 32.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.771 0.319 . . . . 0.0 110.951 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 60.3 tp -104.78 88.37 2.89 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.827 178.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -123.58 152.83 41.46 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.297 -178.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.57 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.593 178.059 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' ' G' . . . . . 0.877 " O2'" ' H6 ' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.426 -0.9 0 C3'-C2'-C1' 105.08 3.978 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . 0.877 ' H6 ' " O2'" ' B' ' 1' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.424 -0.981 0 C3'-C2'-C1' 99.674 -2.029 . 0.0 OUTLIER '7D dist 2a' 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . 0.751 " H1'" ' C5 ' ' B' ' 4' ' ' ' C' . . . . . . . . 0 C2'--C1' 1.517 -1.144 0 C5'-C4'-O4' 112.289 2.207 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' ' C' . . . . . 1.117 ' H41' ' HA2' ' A' ' 35' ' ' GLY . . . . . . . . 0 O5'--C5' 1.429 -0.687 0 C4'-C3'-C2' 105.631 2.931 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.903 " O4'" " H4'" ' B' ' 4' ' ' ' C' . . . . . . . . 0 P--O3' 1.616 0.79 0 O4'-C1'-N19 110.251 2.051 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' ' C' . . . . . 0.616 " O5'" ' H6 ' ' B' ' 6' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.428 -0.723 0 C4'-C3'-C2' 106.409 3.709 OUTLIER-DELTA 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . 0.449 ' H41' ' N4 ' ' B' ' 6' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.425 -0.939 0 C4'-C3'-C2' 103.456 0.756 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.424 -0.981 0 O4'-C1'-N19 108.776 0.576 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.72 0 N-CA-C 111.748 -0.541 . . . . 0.0 111.748 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.78 66.7 9.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.787 0.327 . . . . 0.0 110.716 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 17.1 tpt 62.58 -89.14 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.295 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.463 ' HA2' ' HD3' ' A' ' 5' ' ' PRO . . . 82.25 115.5 0.47 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.012 -177.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.463 ' HD3' ' HA2' ' A' ' 4' ' ' GLY . 2.8 Cg_exo -75.78 51.36 3.02 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.269 2.646 . . . . 0.0 112.506 -179.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.2 m -128.81 140.42 51.71 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 177.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.4 t 59.89 42.52 16.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.612 0.72 . . . . 0.0 109.407 -176.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.4 p -68.64 141.15 17.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.747 -177.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.5 p -74.99 75.53 2.2 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.274 0.559 . . . . 0.0 111.092 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -117.79 -145.92 8.07 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.86 178.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.679 ' HB1' ' HA ' ' A' ' 15' ' ' SER . . . 56.02 37.92 29.38 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.121 0.486 . . . . 0.0 110.595 -177.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.65 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . . . -71.38 -54.4 6.93 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.343 -174.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.65 ' HD3' ' HB3' ' A' ' 12' ' ' ALA . 17.0 Cg_exo -67.98 -32.7 27.88 Favored 'Trans proline' 0 C--N 1.356 0.921 0 C-N-CA 121.982 1.788 . . . . 0.0 111.778 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.403 ' CD1' ' HB2' ' A' ' 13' ' ' PRO . 19.9 p90 -155.72 122.19 5.21 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.495 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.679 ' HA ' ' HB1' ' A' ' 11' ' ' ALA . 16.6 m -95.39 -24.04 16.89 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.414 0.626 . . . . 0.0 109.656 175.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.4 m -112.56 135.71 52.95 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.62 177.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -98.42 113.95 26.14 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.437 -175.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 87.8 mtp 61.0 85.31 0.18 Allowed Pre-proline 0 N--CA 1.466 0.344 0 O-C-N 123.538 0.524 . . . . 0.0 111.097 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.476 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 83.8 Cg_endo -78.75 139.4 15.71 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.364 2.043 . . . . 0.0 112.424 -178.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 19' ' ' PRO . 3.7 Cg_exo -75.49 60.19 5.72 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.935 2.423 . . . . 0.0 110.884 174.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.589 ' HG2' ' HG3' ' A' ' 22' ' ' GLN . 40.0 tt0 -62.02 -75.32 0.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.893 -174.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.589 ' HG3' ' HG2' ' A' ' 21' ' ' GLU . 79.3 mt-30 -133.95 109.73 9.21 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.1 0.476 . . . . 0.0 111.36 -176.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -94.83 102.4 14.25 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.054 174.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 56.1 m -104.59 114.25 28.35 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.214 -177.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.426 HG22 ' HE ' ' A' ' 171' ' ' ARG . 42.1 t -126.42 149.94 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 176.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -108.52 146.45 33.2 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 122.086 -0.384 . . . . 0.0 110.138 -174.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.673 ' HB ' ' CG1' ' A' ' 71' ' ' VAL . 21.1 t -120.76 133.16 68.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.232 -174.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.782 ' CE1' HG11 ' A' ' 68' ' ' VAL . 32.5 t80 -93.56 104.15 16.29 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.483 0.713 . . . . 0.0 110.048 -176.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.496 ' CD1' HG23 ' A' ' 34' ' ' VAL . 8.8 pt -126.74 124.69 24.19 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.283 0.563 . . . . 0.0 111.13 178.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.457 ' HG2' ' HB3' ' A' ' 33' ' ' ALA . 3.0 Cg_endo -45.82 140.65 9.5 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 124.474 3.449 . . . . 0.0 114.064 -174.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.74 -18.71 22.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.958 -176.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -89.71 -29.47 18.72 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.11 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.566 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -96.47 -30.84 13.12 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -175.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.825 HG21 ' HB3' ' A' ' 69' ' ' ARG . 10.6 p -54.09 -29.91 19.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.707 179.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 1.121 ' HA2' ' H41' ' B' ' 4' ' ' ' C' . . . -58.76 -57.0 22.17 Favored Glycine 0 N--CA 1.432 -1.633 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.242 176.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.674 ' HB2' " O2'" ' B' ' 2' ' ' ' C' . . . -77.36 -14.16 59.78 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.552 -0.324 . . . . 0.0 111.201 -174.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.873 HD12 ' HB3' ' A' ' 90' ' ' LYS . 9.5 mm -63.16 -39.29 84.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 172.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.844 HD12 ' C5 ' ' B' ' 4' ' ' ' C' . 38.4 mt -61.83 -52.34 61.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.566 177.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.7 111.87 2.82 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 120.27 -0.967 . . . . 0.0 114.855 170.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.459 ' HD2' ' HA ' ' A' ' 40' ' ' LYS . 27.8 mmmt 59.23 -89.43 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.286 1.034 . . . . 0.0 113.561 173.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.757 ' HA ' ' OP2' ' B' ' 4' ' ' ' C' . 0.0 OUTLIER -129.28 23.94 5.55 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.18 0.514 . . . . 0.0 111.156 -177.478 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.461 ' HA2' ' CG2' ' A' ' 38' ' ' ILE . . . 82.37 28.79 38.78 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.441 -0.885 . . . . 0.0 110.992 -175.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.495 ' HB2' ' CD ' ' A' ' 41' ' ' LYS . 25.4 tm0? -91.02 -47.61 7.46 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.024 0.44 . . . . 0.0 109.855 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -70.52 -32.78 70.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.492 -174.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.616 HG23 ' HG3' ' A' ' 46' ' ' LYS . 6.2 tt -61.04 -44.59 98.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.176 0.512 . . . . 0.0 111.145 177.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.616 ' HG3' HG23 ' A' ' 45' ' ' ILE . 55.0 mtpt -81.41 -30.92 33.41 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.428 -177.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -63.11 -33.46 75.51 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 172.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.815 ' HA ' ' HD1' ' A' ' 51' ' ' PHE . 6.1 tt -62.95 -49.26 75.44 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.422 174.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.639 ' HA ' HD13 ' A' ' 56' ' ' ILE . 14.4 t -55.52 -40.84 72.31 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.704 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.834 ' HA ' ' HE ' ' A' ' 50' ' ' ARG . 0.9 OUTLIER -78.84 -40.54 32.47 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -177.68 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.815 ' HD1' ' HA ' ' A' ' 48' ' ' LEU . 0.4 OUTLIER -74.51 -30.84 61.96 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 121.829 -0.545 . . . . 0.0 110.484 -178.03 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -84.59 -12.96 53.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.529 -177.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.9 m 66.9 30.13 7.88 Favored 'General case' 0 N--CA 1.463 0.223 0 O-C-N 123.644 0.59 . . . . 0.0 110.854 -179.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -134.54 166.95 21.7 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.539 -176.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.45 ' HB2' ' HB ' ' A' ' 74' ' ' THR . 18.4 m -92.53 108.1 19.72 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.567 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.733 HG13 HG22 ' A' ' 73' ' ' ILE . 1.9 mp -110.47 115.03 48.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.224 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -137.66 135.75 36.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.234 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.671 ' HB ' ' N1 ' ' B' ' 5' ' ' ' A' . 37.6 mm -80.38 124.42 38.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 177.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.743 ' HB2' HG23 ' A' ' 72' ' ' VAL . . . -90.05 129.75 44.87 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.606 -177.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.34 140.61 95.29 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 122.942 2.428 . . . . 0.0 111.897 176.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.455 ' HD3' ' HG3' ' A' ' 69' ' ' ARG . 40.2 Cg_endo -67.58 159.71 51.32 Favored 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 122.796 2.33 . . . . 0.0 112.054 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -84.75 -47.16 10.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.384 0.611 . . . . 0.0 109.936 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.2 p -129.5 139.06 34.55 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.782 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.66 -8.31 21.96 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 123.541 2.827 . . . . 0.0 112.9 -178.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -87.46 -4.76 59.0 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.405 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.4 t -87.93 115.56 25.48 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.497 ' O ' ' HD2' ' A' ' 67' ' ' LYS . 1.0 OUTLIER -78.39 33.34 0.2 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.786 0.803 . . . . 0.0 110.578 -176.294 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.782 HG11 ' CE1' ' A' ' 28' ' ' PHE . 11.2 p -146.54 154.64 12.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.798 -175.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.825 ' HB3' HG21 ' A' ' 34' ' ' VAL . 11.7 ttm180 -129.94 129.38 43.75 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 170.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.515 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 42.2 mtt -96.48 134.63 39.42 Favored 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.236 -173.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.673 ' CG1' ' HB ' ' A' ' 27' ' ' VAL . 3.9 p -99.98 140.21 19.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 177.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.743 HG23 ' HB2' ' A' ' 59' ' ' ALA . 63.9 t -101.56 120.5 51.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.112 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.733 HG22 HG13 ' A' ' 56' ' ' ILE . 2.6 pp -114.76 127.31 72.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.499 0.666 . . . . 0.0 110.522 176.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.45 ' HB ' ' HB2' ' A' ' 55' ' ' SER . 91.3 m -125.55 113.21 17.12 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.674 178.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.62 161.14 34.65 Favored Glycine 0 CA--C 1.498 -1.03 0 C-N-CA 119.811 -1.185 . . . . 0.0 113.115 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.31 153.07 71.54 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 122.5 2.133 . . . . 0.0 110.964 169.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.425 ' HA ' ' NH2' ' A' ' 168' ' ' ARG . 35.8 Cg_exo -38.18 -51.59 2.0 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 124.804 3.669 . . . . 0.0 114.85 -176.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -66.61 -36.02 81.61 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.264 0.554 . . . . 0.0 110.994 -177.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.88 -49.82 27.53 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.724 -178.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.563 ' HG3' HD13 ' A' ' 73' ' ' ILE . 19.9 tt0 -63.47 -31.9 73.19 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.955 -178.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -54.21 -54.62 37.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.513 -177.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.6 pttm -72.93 -33.09 65.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.378 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.05 -53.03 62.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.224 177.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.403 ' O ' HG22 ' A' ' 87' ' ' ILE . 35.0 mt-30 -72.76 -31.16 64.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.38 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -54.12 -42.33 71.72 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.957 176.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -81.19 -28.81 34.79 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 178.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.403 HG22 ' O ' ' A' ' 84' ' ' GLN . 0.4 OUTLIER -65.24 -41.25 91.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 120.981 -0.287 . . . . 0.0 110.49 -176.202 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.596 ' HA ' HD23 ' A' ' 91' ' ' LEU . 26.5 m-85 -67.39 -31.67 72.05 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.249 0.547 . . . . 0.0 110.239 176.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.08 -29.38 74.22 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.913 176.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.873 ' HB3' HD12 ' A' ' 37' ' ' ILE . 67.0 mmtt -77.3 -21.06 54.11 Favored 'General case' 0 N--CA 1.442 -0.87 0 O-C-N 122.62 -0.341 . . . . 0.0 110.491 178.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.596 HD23 ' HA ' ' A' ' 88' ' ' TYR . 3.8 mm? -66.05 -33.27 75.43 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.239 0.542 . . . . 0.0 109.847 167.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.823 ' HE2' ' HB2' ' A' ' 97' ' ' PHE . 13.8 mmtp -75.94 -21.8 56.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.117 176.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.523 ' HB2' ' HA ' ' A' ' 90' ' ' LYS . 5.2 tp10 -62.78 -33.05 74.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.772 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.606 ' HG2' ' CE2' ' A' ' 96' ' ' PHE . 6.5 tp10 -88.96 -1.38 58.08 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.957 0.884 . . . . 0.0 109.605 178.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 12.5 m120 65.87 29.09 10.57 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.423 177.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.606 ' CE2' ' HG2' ' A' ' 94' ' ' GLU . 14.2 m-85 -65.01 -51.36 62.08 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.072 0.463 . . . . 0.0 111.149 178.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.823 ' HB2' ' HE2' ' A' ' 92' ' ' LYS . 17.8 m-85 -105.87 34.76 3.16 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.889 -172.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 56.58 -173.42 1.76 Allowed Glycine 0 CA--C 1.525 0.671 0 CA-C-N 115.976 -0.556 . . . . 0.0 113.708 178.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -85.2 -66.51 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.072 2.515 . . . . 0.0 111.975 175.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 53.2 tptt -76.65 -26.71 55.16 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.027 -177.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.657 ' HB3' ' O ' ' A' ' 97' ' ' PHE . 10.4 tp10 -58.15 134.2 56.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.109 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -61.65 130.1 44.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.303 -177.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.804 ' HB ' ' HE3' ' A' ' 92' ' ' LYS . 7.1 p -65.95 122.23 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 175.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -116.79 88.23 2.86 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 174.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.595 ' HG ' ' HG ' ' A' ' 91' ' ' LEU . 1.6 tm? -112.02 124.66 52.87 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.973 -173.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -65.23 118.32 9.09 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.642 -178.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.501 HG21 ' NE2' ' A' ' 167' ' ' GLN . 1.2 m -109.92 136.9 48.47 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -108.0 118.76 37.6 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.286 0.565 . . . . 0.0 111.102 -174.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.523 HG13 ' HB ' ' A' ' 154' ' ' VAL . 12.4 pt -110.76 112.66 41.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.689 175.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.924 ' HG3' ' HG2' ' A' ' 151' ' ' GLN . 5.6 tpt180 -77.96 117.51 19.36 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.673 HG12 HD21 ' A' ' 174' ' ' LEU . 13.0 m -116.2 150.85 45.96 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -177.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -49.44 155.82 3.16 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.864 2.376 . . . . 0.0 111.461 175.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -52.83 -49.92 64.73 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.111 0.482 . . . . 0.0 111.513 -172.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 13.7 m -78.65 -8.26 58.48 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.913 -177.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.24 -29.99 61.95 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 122.215 -0.303 . . . . 0.0 111.453 -175.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.663 ' HB1' HG21 ' A' ' 140' ' ' VAL . . . -65.26 -37.84 88.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.2 0.524 . . . . 0.0 110.684 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -69.41 -28.29 72.65 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.912 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 37.1 mtp85 -92.02 -18.12 24.1 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 111.555 0.206 . . . . 0.0 111.555 -178.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.593 HG12 ' O ' ' A' ' 116' ' ' ALA . 8.4 p -76.64 -29.2 18.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 175.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.853 HG22 ' HA2' ' A' ' 124' ' ' GLY . 69.3 mt -65.79 -40.62 88.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 170.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 117.55 -179.26 17.26 Favored Glycine 0 N--CA 1.441 -0.969 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.931 174.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -42.65 -73.77 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.522 0.729 . . . . 0.0 111.641 178.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -112.12 26.66 10.37 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 122.121 0.963 . . . . 0.0 108.522 171.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.853 ' HA2' HG22 ' A' ' 120' ' ' ILE . . . 88.77 21.39 43.35 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.512 -177.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -83.84 -32.91 25.01 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.989 0.423 . . . . 0.0 110.761 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 15.1 m -64.69 -37.76 88.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.691 -175.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.55 ' HB ' ' HA ' ' A' ' 120' ' ' ILE . 14.0 p -63.24 -33.48 61.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-O 120.872 0.368 . . . . 0.0 110.731 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -65.95 -42.59 89.78 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 177.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -63.93 -40.96 97.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.233 177.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 79.3 mt -57.85 -50.77 72.17 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.202 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -68.4 -35.35 77.54 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.941 0.401 . . . . 0.0 110.881 -177.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -67.36 -36.99 82.51 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.385 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -84.9 -47.72 10.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.099 -175.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.548 ' HB ' ' HB2' ' A' ' 166' ' ' ALA . 76.9 p -79.88 -21.08 44.45 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -172.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 66.17 21.39 11.12 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.53 -174.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -120.13 164.15 16.62 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.002 177.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.501 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 49.0 mt-10 -101.07 113.02 25.65 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.188 0.518 . . . . 0.0 111.033 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 60.0 t -104.85 106.45 20.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.912 -178.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.474 ' O ' ' HD2' ' A' ' 155' ' ' LYS . 7.2 p -128.46 130.88 69.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.065 0.46 . . . . 0.0 111.136 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.688 ' HB ' HG22 ' A' ' 154' ' ' VAL . 8.5 p -125.94 131.04 23.86 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 116.136 -0.483 . . . . 0.0 109.855 178.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.46 ' HB2' ' HB2' ' A' ' 144' ' ' GLN . 36.7 Cg_exo -60.89 121.01 9.03 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.7 2.267 . . . . 0.0 111.631 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.663 ' H ' ' HD2' ' A' ' 142' ' ' ARG . 0.3 OUTLIER -83.19 14.78 3.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.586 0.708 . . . . 0.0 110.102 -175.043 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -117.84 -1.74 11.47 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.346 176.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.46 ' HB2' ' HB2' ' A' ' 141' ' ' PRO . 6.4 tp-100 -98.11 115.11 27.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.07 -172.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.1 t -175.29 70.53 0.27 Allowed Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.381 176.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -91.55 143.96 3.06 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.384 2.056 . . . . 0.0 112.568 -178.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -70.0 -16.62 63.2 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.981 178.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -52.3 -48.67 65.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.974 -1.012 . . . . 0.0 112.204 -178.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . 0.441 ' O ' ' HG2' ' A' ' 150' ' ' GLU . 4.4 t-20 -119.62 -10.4 9.61 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.014 -175.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 149' ' ' ASN . 12.2 pt-20 47.33 29.68 1.33 Allowed 'General case' 0 N--CA 1.475 0.799 0 O-C-N 124.31 1.007 . . . . 0.0 111.097 -173.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.924 ' HG2' ' HG3' ' A' ' 110' ' ' ARG . 30.5 tt0 -155.71 128.31 7.86 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.15 -174.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.401 HG21 ' HB2' ' A' ' 116' ' ' ALA . 33.1 m -114.41 -177.1 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.338 -171.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.411 HG12 ' HD2' ' A' ' 110' ' ' ARG . 53.9 mt -122.16 131.39 73.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -173.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.688 HG22 ' HB ' ' A' ' 140' ' ' VAL . 46.2 t -107.29 140.77 24.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 168.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.474 ' HD2' ' O ' ' A' ' 139' ' ' VAL . 0.0 OUTLIER -104.12 122.39 45.22 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.07 178.898 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.501 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 51.6 mt -102.71 112.67 36.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 173.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.401 ' N ' HD12 ' A' ' 157' ' ' ILE . 4.4 mp -103.6 129.86 54.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.82 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 161.3 -172.07 37.45 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.436 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.512 ' HA ' HG13 ' A' ' 103' ' ' VAL . 6.3 p80 -88.68 153.68 20.91 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.437 ' HB3' ' CG ' ' A' ' 88' ' ' TYR . 10.2 p90 -50.82 -46.59 59.99 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -165.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.411 ' O ' ' HG3' ' A' ' 164' ' ' GLN . 16.8 m-85 -59.67 -48.94 79.7 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 118.85 0.75 . . . . 0.0 111.174 -178.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.59 -42.91 86.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.603 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.475 ' O ' ' HG3' ' A' ' 167' ' ' GLN . 35.7 t -63.59 -50.37 69.68 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.418 -177.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.411 ' HG3' ' O ' ' A' ' 161' ' ' TYR . 5.1 pp0? -59.37 -35.48 73.97 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.478 0.18 . . . . 0.0 111.034 -177.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 49.0 ttp -73.76 -33.45 64.28 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 120.621 -0.431 . . . . 0.0 110.806 177.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.548 ' HB2' ' HB ' ' A' ' 134' ' ' THR . . . -69.96 -43.61 71.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.103 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.501 ' NE2' HG21 ' A' ' 107' ' ' THR . 71.9 mt-30 -51.94 -52.81 47.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.953 -178.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.825 ' HA ' ' HB2' ' A' ' 171' ' ' ARG . 1.3 ptp180 -70.85 -27.36 63.78 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.455 178.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.648 ' HE2' ' HA ' ' A' ' 169' ' ' LYS . 0.1 OUTLIER -67.55 -37.85 83.29 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.753 -178.688 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.486 ' O ' HG13 ' A' ' 173' ' ' ILE . 1.9 mp -75.24 -39.88 42.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 173.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.825 ' HB2' ' HA ' ' A' ' 168' ' ' ARG . 1.1 mpt_? -51.74 -28.0 13.74 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.072 171.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.484 ' HB2' ' O ' ' A' ' 169' ' ' LYS . 1.3 m-20 -68.66 -56.14 9.16 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 122.679 0.392 . . . . 0.0 111.499 178.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.486 HG13 ' O ' ' A' ' 170' ' ' ILE . 2.7 pp -66.59 -18.64 24.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.525 -174.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.673 HD21 HG12 ' A' ' 111' ' ' VAL . 6.7 mp -66.41 -33.86 76.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.093 174.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.99 -31.82 73.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.107 0.48 . . . . 0.0 110.28 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -69.6 -33.45 72.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.923 176.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 173' ' ' ILE . 48.7 t -66.06 -46.4 88.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.796 176.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -61.18 -40.89 95.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.845 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -59.04 -47.04 86.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.016 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -72.67 -35.45 67.69 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.154 0.502 . . . . 0.0 110.431 -178.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 19.8 t60 -73.86 -53.57 9.9 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.406 -175.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -73.04 -51.17 19.17 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 111.59 0.218 . . . . 0.0 111.59 -175.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm 69.72 -61.87 0.43 Allowed 'General case' 0 N--CA 1.468 0.431 0 O-C-N 123.744 0.652 . . . . 0.0 111.429 -177.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 156.38 -100.81 0.2 Allowed Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.033 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -132.42 79.78 1.87 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.259 0.552 . . . . 0.0 110.031 -178.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 40.7 m -101.99 113.08 25.99 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.265 -178.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 120.53 124.34 3.14 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.693 -0.765 . . . . 0.0 113.444 175.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 50.96 71.75 0.41 Allowed 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.326 0.65 . . . . 0.0 112.373 174.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 7.7 mp -83.58 99.02 9.9 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 177.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -121.8 -53.5 1.97 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.761 -175.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.365 -178.355 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' ' G' . . . . . 0.767 HO2' ' H6 ' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.429 -0.698 1 C3'-C2'-C1' 105.218 4.131 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . 0.767 ' H6 ' HO2' ' B' ' 1' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.428 -0.738 0 C3'-C2'-C1' 100.373 -1.252 . 0.0 OUTLIER '7D dist 2a' 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . 0.788 " H1'" ' C5 ' ' B' ' 4' ' ' ' C' . . . . . . . . 0 C2'--C1' 1.516 -1.218 0 C5'-C4'-O4' 113.199 2.857 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' ' C' . . . . . 1.121 ' H41' ' HA2' ' A' ' 35' ' ' GLY . . . . . . . . 0 C4'--C3' 1.516 -0.704 0 C3'-C2'-C1' 104.169 2.965 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.9 " O4'" " H4'" ' B' ' 4' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.431 -0.564 0 O4'-C1'-N19 110.124 1.924 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' ' C' . . . . . 0.53 " O5'" " H2'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.43 -0.645 0 C4'-C3'-C2' 105.114 2.414 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.427 -0.83 0 O4'-C1'-C2' 107.417 0.726 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.427 -0.788 0 C3'-C2'-C1' 99.775 -1.916 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.663 0 N-CA-C 111.688 -0.565 . . . . 0.0 111.688 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.1 84.94 7.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.966 0.412 . . . . 0.0 111.096 -176.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 22.9 ptp -92.88 -16.14 25.58 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.805 176.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -90.62 177.99 42.41 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.117 177.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.0 159.8 47.17 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.692 2.262 . . . . 0.0 112.929 -177.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.4 m -137.19 86.13 2.18 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.825 178.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.436 ' HB2' ' HB3' ' A' ' 11' ' ' ALA . 16.4 p -76.53 -18.79 58.52 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.756 -174.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.8 p -75.48 18.12 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 121.647 0.737 . . . . 0.0 111.405 -177.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.404 ' H ' ' C ' ' A' ' 7' ' ' SER . 46.1 m -131.35 31.06 4.41 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.123 176.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 176.28 -50.31 0.11 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.583 -0.817 . . . . 0.0 112.481 179.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.436 ' HB3' ' HB2' ' A' ' 7' ' ' SER . . . -82.37 83.7 7.39 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.108 0.48 . . . . 0.0 110.96 -178.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -102.02 107.06 51.01 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.388 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -57.9 140.02 92.38 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 123.171 2.581 . . . . 0.0 112.91 -177.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -135.02 46.18 2.46 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.767 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.0 m -78.4 46.51 0.63 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.177 -172.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.1 m -80.89 61.75 4.63 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.209 0.528 . . . . 0.0 109.872 176.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -123.71 -70.72 0.75 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.244 -176.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.546 ' HB3' ' HD3' ' A' ' 19' ' ' PRO . 46.9 ttm -89.14 -48.89 0.41 Allowed Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.615 178.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.546 ' HD3' ' HB3' ' A' ' 18' ' ' MET . 85.0 Cg_exo -50.13 143.0 26.47 Favored 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 122.328 2.019 . . . . 0.0 112.34 176.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 19' ' ' PRO . 6.7 Cg_exo -73.87 59.1 4.22 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.277 2.651 . . . . 0.0 112.864 -176.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -88.74 37.86 0.85 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.507 0.67 . . . . 0.0 109.911 175.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.464 ' HB3' HG22 ' A' ' 74' ' ' THR . 48.5 mt-30 -87.36 98.84 11.58 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.393 177.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.532 ' O ' ' HA ' ' A' ' 74' ' ' THR . 7.1 tp10 -81.05 147.67 30.04 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.399 -0.818 . . . . 0.0 111.101 -174.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.636 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 39.8 m -116.15 107.16 14.54 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.492 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.412 HG13 HG22 ' A' ' 109' ' ' ILE . 37.0 t -119.14 150.02 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.723 -177.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -111.69 125.15 53.66 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-O 120.773 0.32 . . . . 0.0 110.776 -175.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.497 ' HB ' ' HB ' ' A' ' 71' ' ' VAL . 13.6 t -94.09 139.69 17.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.473 ' CZ ' HG11 ' A' ' 68' ' ' VAL . 1.0 OUTLIER -103.54 104.89 15.01 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.406 -175.704 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.443 ' C ' HG23 ' A' ' 68' ' ' VAL . 21.7 pt -129.68 123.36 21.15 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 121.169 0.509 . . . . 0.0 111.291 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.452 ' HA ' ' HA ' ' A' ' 68' ' ' VAL . 50.5 Cg_exo -53.5 149.12 31.86 Favored 'Trans proline' 0 C--O 1.238 0.501 0 C-N-CA 123.439 2.76 . . . . 0.0 112.643 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.671 ' HA ' HG12 ' A' ' 34' ' ' VAL . . . -57.7 -23.57 52.33 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 114.9 -1.046 . . . . 0.0 112.529 -173.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -66.12 -30.01 70.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.235 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.518 ' HB2' ' CE2' ' A' ' 96' ' ' PHE . . . -108.25 -31.07 8.03 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.663 -175.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.753 HG21 ' HB3' ' A' ' 69' ' ' ARG . 13.3 p -53.98 -32.48 22.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-O 120.945 0.402 . . . . 0.0 110.968 -175.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 1.062 ' HA2' ' H41' ' B' ' 4' ' ' ' C' . . . -58.81 -56.36 25.71 Favored Glycine 0 N--CA 1.434 -1.448 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.959 178.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.454 ' HB2' " O2'" ' B' ' 2' ' ' ' C' . . . -77.44 -14.54 59.67 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.621 0.248 . . . . 0.0 111.298 -175.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.998 HD12 ' HB3' ' A' ' 90' ' ' LYS . 2.4 mm -67.44 -36.96 77.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.369 -0.378 . . . . 0.0 109.99 177.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.815 HD12 ' C5 ' ' B' ' 4' ' ' ' C' . 24.6 mt -61.45 -32.72 54.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-O 121.528 0.68 . . . . 0.0 110.337 174.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.18 153.72 30.18 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.627 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.562 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 34.1 mtpt -66.02 131.38 46.08 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -175.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.562 ' HG2' ' O ' ' A' ' 40' ' ' LYS . 19.8 pttt 73.63 4.21 4.69 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.051 1.34 . . . . 0.0 112.198 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.437 ' HA3' " H5'" ' B' ' 4' ' ' ' C' . . . 61.05 38.64 95.88 Favored Glycine 0 CA--C 1.523 0.545 0 CA-C-N 116.253 -0.431 . . . . 0.0 113.607 176.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.447 ' HB3' ' HE2' ' A' ' 41' ' ' LYS . 19.4 tt0 -109.1 -36.65 6.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 117.322 0.561 . . . . 0.0 110.985 175.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 77.7 m-70 -55.87 -41.62 74.67 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.393 0.616 . . . . 0.0 109.778 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.469 ' O ' HG21 ' A' ' 56' ' ' ILE . 4.5 tt -56.52 -44.13 79.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 114.515 -1.221 . . . . 0.0 112.231 176.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.782 ' HE2' " H4'" ' B' ' 6' ' ' ' C' . 28.4 mmmt -81.45 -29.09 33.91 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 121.984 -0.447 . . . . 0.0 110.779 -173.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -60.47 -40.55 91.65 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 172.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.704 HD22 ' HZ ' ' A' ' 51' ' ' PHE . 0.2 OUTLIER -49.72 -47.8 50.35 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.048 175.898 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.838 ' HB2' ' HB ' ' A' ' 56' ' ' ILE . 14.5 t -61.77 -35.88 79.43 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.629 -176.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -78.81 -41.35 30.53 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -169.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.704 ' HZ ' HD22 ' A' ' 48' ' ' LEU . 10.2 p90 -79.56 -17.02 54.89 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 120.167 -0.613 . . . . 0.0 111.609 -177.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -94.09 -16.89 23.38 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.199 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.2 t 67.3 13.97 9.55 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.544 -177.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -108.73 153.57 23.27 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.838 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.495 ' HB2' ' HB ' ' A' ' 74' ' ' THR . 60.4 m -80.27 102.41 9.48 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.018 0.437 . . . . 0.0 110.185 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.838 ' HB ' ' HB2' ' A' ' 49' ' ' SER . 1.5 mp -92.98 117.64 36.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.147 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -144.77 151.13 38.37 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.891 -175.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.648 ' HB ' ' C6 ' ' B' ' 5' ' ' ' A' . 38.8 mm -102.43 129.1 54.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 178.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.599 ' HB3' ' HB2' ' A' ' 70' ' ' MET . . . -95.86 108.55 41.23 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.841 -178.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 59' ' ' ALA . 14.6 Cg_exo -69.59 146.0 59.89 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 123.061 2.507 . . . . 0.0 112.338 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.864 ' HD3' ' HG3' ' A' ' 69' ' ' ARG . 98.6 Cg_endo -84.09 141.53 9.37 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.874 2.383 . . . . 0.0 112.396 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -68.37 -25.97 65.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.989 -177.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.431 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 22.6 p -101.99 132.01 22.07 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.938 -179.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 63' ' ' THR . 15.1 Cg_exo -68.84 -21.19 38.36 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 123.249 2.633 . . . . 0.0 112.335 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.87 17.0 21.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.077 -178.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.5 t -65.74 134.6 53.5 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.196 0.522 . . . . 0.0 110.501 -179.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -81.42 -10.22 59.56 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.417 -178.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.473 HG11 ' CZ ' ' A' ' 28' ' ' PHE . 1.5 p -145.83 150.53 15.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.457 -172.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.864 ' HG3' ' HD3' ' A' ' 61' ' ' PRO . 22.9 ttm180 -127.05 151.3 48.79 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 177.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.599 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 63.6 mtt -100.13 149.41 23.55 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.269 0.557 . . . . 0.0 112.127 -173.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.497 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 86.8 t -105.44 120.34 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 168.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.6 p -109.23 115.54 49.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-O 121.563 0.697 . . . . 0.0 110.451 -176.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.636 ' O ' ' HA ' ' A' ' 24' ' ' THR . 2.1 pp -120.34 140.84 43.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.598 -176.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 58.9 m -123.76 108.77 12.88 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.934 177.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -163.95 162.03 34.8 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.098 -1.049 . . . . 0.0 113.326 -176.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.408 ' HD3' ' HG2' ' A' ' 22' ' ' GLN . 30.7 Cg_endo -64.39 142.61 79.58 Favored 'Trans proline' 0 CA--C 1.533 0.427 0 C-N-CA 123.079 2.519 . . . . 0.0 111.908 175.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.481 ' O ' ' HB2' ' A' ' 80' ' ' GLN . 97.4 Cg_exo -46.14 -35.39 14.89 Favored 'Trans proline' 0 N--CA 1.478 0.565 0 C-N-CA 125.013 3.808 . . . . 0.0 115.298 -174.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.3 -46.87 69.14 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.115 0.483 . . . . 0.0 109.849 177.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.56 -22.44 63.54 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.894 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.481 ' HB2' ' O ' ' A' ' 77' ' ' PRO . 71.3 mm-40 -52.76 -52.0 58.31 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.787 176.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -66.74 -33.15 74.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.832 -179.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 47.1 tttp -61.5 -52.95 62.38 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.189 0.519 . . . . 0.0 110.334 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.4 -53.74 13.07 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.854 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.507 ' O ' HG22 ' A' ' 87' ' ' ILE . 9.5 tt0 -69.15 -31.03 69.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.68 -173.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -58.13 -32.54 67.4 Favored Glycine 0 CA--C 1.518 0.219 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.884 177.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.521 ' NE ' ' HA ' ' A' ' 86' ' ' ARG . 3.5 mmp_? -79.69 -26.83 40.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.654 0.264 . . . . 0.0 111.054 178.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.507 HG22 ' O ' ' A' ' 84' ' ' GLN . 0.4 OUTLIER -66.33 -35.16 74.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.646 -177.307 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.668 ' CE2' ' HB3' ' A' ' 105' ' ' LEU . 10.0 m-85 -68.66 -34.57 75.93 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.361 176.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -62.26 -30.43 75.96 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.524 176.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.998 ' HB3' HD12 ' A' ' 37' ' ' ILE . 75.0 mmtt -59.96 -52.96 63.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.7 0.286 . . . . 0.0 110.612 175.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.895 ' HB3' ' CD1' ' A' ' 97' ' ' PHE . 3.8 mm? -61.35 -39.66 91.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.606 178.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.83 ' HE3' ' HB ' ' A' ' 103' ' ' VAL . 0.3 OUTLIER -61.65 -41.17 97.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.821 0.343 . . . . 0.0 110.92 174.711 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -71.18 -23.45 62.05 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.028 -176.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.509 ' HB3' ' CE2' ' A' ' 96' ' ' PHE . 58.7 mm-40 -88.26 4.23 46.65 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.927 -179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 63.56 21.04 12.56 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.742 172.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.518 ' CE2' ' HB2' ' A' ' 33' ' ' ALA . 78.2 m-85 -85.84 -16.75 37.67 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 168.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.895 ' CD1' ' HB3' ' A' ' 91' ' ' LEU . 67.2 m-85 -135.53 48.82 2.2 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 113.939 -1.482 . . . . 0.0 109.113 -177.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -41.24 157.46 0.04 OUTLIER Glycine 0 CA--C 1.521 0.459 0 O-C-N 124.061 0.851 . . . . 0.0 114.437 -174.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -59.04 -4.57 2.19 Favored 'Trans proline' 0 N--CA 1.478 0.605 0 C-N-CA 123.878 3.052 . . . . 0.0 114.419 -172.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.569 ' HD2' ' N ' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -97.49 -14.5 21.08 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.18 0.514 . . . . 0.0 110.118 -179.862 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -100.33 135.52 41.63 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.491 -172.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -70.28 114.99 8.96 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.362 175.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.83 ' HB ' ' HE3' ' A' ' 92' ' ' LYS . 15.0 p -54.6 123.94 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 CA-C-O 121.819 0.819 . . . . 0.0 111.995 -172.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -123.02 90.81 3.36 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 170.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.668 ' HB3' ' CE2' ' A' ' 88' ' ' TYR . 2.5 tt -117.17 114.89 24.32 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -177.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.877 ' HG3' HG13 ' A' ' 157' ' ' ILE . 1.7 mp0 -71.86 128.73 36.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.694 -175.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.1 m -114.69 128.06 56.1 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 170.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 16.2 m170 -102.26 119.62 39.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.14 0.495 . . . . 0.0 110.064 -178.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.468 HG13 ' HB ' ' A' ' 154' ' ' VAL . 34.8 pt -112.33 157.52 13.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.231 -178.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 110' ' ' ARG . 22.6 mmt180 -102.26 133.64 46.83 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.879 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.777 HG12 HD21 ' A' ' 174' ' ' LEU . 10.4 m -133.15 148.24 68.43 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 173.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.766 ' HD2' ' HG ' ' A' ' 174' ' ' LEU . 51.6 Cg_exo -53.96 146.27 48.01 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.139 1.893 . . . . 0.0 110.596 175.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.15 -27.77 65.95 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.616 -175.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 44.0 t -81.5 -33.11 32.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.3 0.571 . . . . 0.0 110.281 175.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.56 -21.05 61.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.011 -178.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.556 ' O ' HG12 ' A' ' 119' ' ' VAL . . . -61.45 -50.82 71.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.071 0.462 . . . . 0.0 110.59 177.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.93 -29.39 67.14 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.562 177.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.6 ' HD3' HG22 ' A' ' 177' ' ' VAL . 13.7 ttt85 -73.04 -36.1 66.86 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.832 -0.184 . . . . 0.0 111.316 -178.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.556 HG12 ' O ' ' A' ' 116' ' ' ALA . 7.0 p -69.89 -26.21 29.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-O 121.014 0.435 . . . . 0.0 109.905 178.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.921 ' HA ' ' HB ' ' A' ' 127' ' ' VAL . 73.7 mt -68.12 -33.36 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 CA-C-O 121.495 0.664 . . . . 0.0 109.347 171.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.617 ' HA3' ' H ' ' A' ' 126' ' ' THR . . . 127.57 42.57 0.26 Allowed Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.182 176.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.2 t70 65.21 -75.16 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.296 0.638 . . . . 0.0 109.714 -176.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -87.59 -49.69 7.0 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 170.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.774 ' HA2' HG22 ' A' ' 120' ' ' ILE . . . 153.16 101.08 0.2 Allowed Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.78 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 53.2 tptt -173.07 -48.25 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.069 0.461 . . . . 0.0 110.623 -175.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.617 ' H ' ' HA3' ' A' ' 121' ' ' GLY . 21.7 m -60.16 -34.62 73.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.905 -177.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.921 ' HB ' ' HA ' ' A' ' 120' ' ' ILE . 10.2 p -63.11 -29.24 46.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.7 0.286 . . . . 0.0 110.856 -178.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -63.77 -45.49 89.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.149 0.5 . . . . 0.0 109.835 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -72.35 -37.36 68.84 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.946 178.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.635 HD21 HD11 ' A' ' 170' ' ' ILE . 23.1 tp -58.98 -49.43 77.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.937 178.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.504 ' HG3' HG12 ' A' ' 138' ' ' VAL . 16.4 tt0 -63.12 -36.24 82.94 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.195 -178.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -75.11 -37.0 61.63 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.783 -178.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 133' ' ' LEU . 21.8 mt -79.98 -22.08 42.97 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -178.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 38.5 p -96.7 -22.03 17.23 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.747 -177.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 65.25 18.53 11.43 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.623 -178.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -118.95 168.93 10.33 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.585 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.505 ' HB3' ' HB ' ' A' ' 157' ' ' ILE . 21.8 tt0 -105.1 122.05 45.08 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.987 0.423 . . . . 0.0 110.225 -178.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.504 HG12 ' HG3' ' A' ' 131' ' ' GLN . 2.4 p -121.09 122.01 66.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.067 -172.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 13.5 p -130.66 133.23 63.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.54 176.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.818 ' HB ' HG22 ' A' ' 154' ' ' VAL . 6.7 p -137.49 97.68 10.32 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-O 121.824 0.821 . . . . 0.0 111.14 177.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -60.57 166.45 9.75 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 123.427 2.751 . . . . 0.0 112.656 175.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -79.05 -50.31 11.26 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.399 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -94.27 102.19 14.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.438 178.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.762 ' HB2' ' HB ' ' A' ' 152' ' ' VAL . 23.7 mm-40 -127.78 93.23 3.64 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.551 176.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.925 ' HB ' ' HD2' ' A' ' 146' ' ' PRO . 60.8 p 58.67 172.91 0.05 OUTLIER Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 123.615 0.766 . . . . 0.0 111.519 -176.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.925 ' HD2' ' HB ' ' A' ' 145' ' ' THR . 35.1 Cg_endo -65.8 154.71 72.75 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.07 1.847 . . . . 0.0 111.965 178.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -78.88 36.3 0.27 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.527 0.68 . . . . 0.0 110.544 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.422 ' H ' ' C ' ' A' ' 146' ' ' PRO . 37.8 tt0 -63.21 -33.34 75.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.598 -177.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -118.61 22.63 11.94 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 175.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 48.17 31.62 2.66 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 114.104 -1.407 . . . . 0.0 112.716 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -136.35 158.4 44.51 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.503 0.668 . . . . 0.0 112.434 -177.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.762 ' HB ' ' HB2' ' A' ' 144' ' ' GLN . 27.0 m -123.69 -175.78 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.787 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.442 ' HB ' ' OE1' ' A' ' 144' ' ' GLN . 25.2 mt -115.47 136.93 50.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.098 0.475 . . . . 0.0 112.27 -172.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.818 HG22 ' HB ' ' A' ' 140' ' ' VAL . 59.6 t -114.35 141.09 31.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.259 172.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 6.5 mttt -113.22 121.27 43.97 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.333 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.5 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 64.4 mt -104.85 116.34 48.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.177 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.877 HG13 ' HG3' ' A' ' 106' ' ' GLU . 3.9 mp -110.57 133.19 56.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.523 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 153.8 -156.17 26.63 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.114 -1.041 . . . . 0.0 112.757 176.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.642 ' HA ' HG13 ' A' ' 103' ' ' VAL . 74.3 m80 -86.95 160.08 18.8 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -178.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.519 ' HB3' ' CG ' ' A' ' 88' ' ' TYR . 19.7 p90 -68.67 -24.47 64.52 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -170.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -73.26 -41.28 63.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.219 0.533 . . . . 0.0 109.981 172.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -73.27 -39.73 65.15 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.452 -176.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.438 ' O ' ' HG3' ' A' ' 167' ' ' GLN . 29.0 p -65.07 -50.08 67.54 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.223 -177.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -62.23 -34.55 76.71 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.723 0.297 . . . . 0.0 110.627 178.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 26.6 ttt -63.79 -43.46 96.27 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.09 0.472 . . . . 0.0 110.266 177.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.43 ' HB3' HD13 ' A' ' 156' ' ' ILE . . . -68.65 -46.46 69.1 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.02 178.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.438 ' HG3' ' O ' ' A' ' 163' ' ' SER . 72.4 mt-30 -51.52 -51.36 55.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.26 -178.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -70.07 -30.82 68.16 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.151 -178.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -71.49 -40.64 70.07 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.945 0.402 . . . . 0.0 110.92 -178.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.646 ' O ' HD13 ' A' ' 174' ' ' LEU . 1.9 mp -73.01 -51.0 28.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.434 178.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.648 ' HA ' HD22 ' A' ' 174' ' ' LEU . 25.8 mmm180 -56.98 -24.82 56.1 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.727 0.298 . . . . 0.0 110.909 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -69.4 -51.35 37.4 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.638 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.416 ' O ' HG23 ' A' ' 177' ' ' VAL . 34.4 pt -68.5 -19.82 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 121.017 0.437 . . . . 0.0 110.722 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.777 HD21 HG12 ' A' ' 111' ' ' VAL . 3.5 mp -64.08 -29.15 70.3 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.133 178.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.78 -31.89 72.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.26 0.553 . . . . 0.0 110.146 175.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -73.44 -47.09 44.44 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.161 177.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.6 HG22 ' HD3' ' A' ' 118' ' ' ARG . 29.6 t -67.33 -32.51 57.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.657 -178.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -57.25 -49.01 77.4 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 174.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -63.99 -38.37 90.82 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.821 178.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -64.47 -50.81 66.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.107 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 12.4 t-160 -66.78 -25.72 66.61 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.025 0.44 . . . . 0.0 110.423 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -73.56 -36.62 65.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.844 177.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -72.89 -58.05 3.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.212 176.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -136.03 145.07 17.02 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.384 -178.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -126.69 158.82 35.43 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 49.6 m -64.2 109.52 1.89 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.106 0.479 . . . . 0.0 111.207 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -130.52 -126.29 2.78 Favored Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.391 176.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 69.39 152.69 0.1 Allowed 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.31 0.644 . . . . 0.0 111.396 -178.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 8.1 mp 57.78 -161.44 0.23 Allowed 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.783 -178.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -86.3 -48.27 8.66 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 175.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.449 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.502 177.702 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' ' G' . . . . . 0.9 " O2'" ' H6 ' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.426 -0.891 0 C3'-C2'-C1' 105.092 3.991 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . 0.9 ' H6 ' " O2'" ' B' ' 1' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.426 -0.858 0 C3'-C2'-C1' 100.171 -1.476 . 0.0 OUTLIER '7D dist 2a' 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . 0.714 " H1'" ' C5 ' ' B' ' 4' ' ' ' C' . . . . . . . . 0 C2'--C1' 1.517 -1.074 0 C5'-C4'-O4' 112.581 2.415 . 0.0 OUTLIER '7D dist 1z' 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' ' C' . . . . . 1.062 ' H41' ' HA2' ' A' ' 35' ' ' GLY . . . . . . . . 0 O5'--C5' 1.429 -0.697 0 C4'-C3'-C2' 105.929 3.229 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.777 " O4'" " H4'" ' B' ' 4' ' ' ' C' . . . . . . . . 0 O3'--C3' 1.434 0.801 0 P-O3'-C3' 122.273 2.144 OUTLIER-EPSILON 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' ' C' . . . . . 0.782 " H4'" ' HE2' ' A' ' 46' ' ' LYS . . . . . . . . 0 O5'--C5' 1.427 -0.799 0 P-O3'-C3' 123.395 3.079 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . 0.44 HO2' ' H6 ' ' B' ' 8' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.427 -0.789 0 C4'-C3'-C2' 105.241 2.541 . 0.0 OUTLIER '7D dist 1b' 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' ' C' . . . . . 0.44 ' H6 ' HO2' ' B' ' 7' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.428 -0.741 0 O4'-C1'-N19 108.981 0.781 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.958 0 N-CA-C 112.674 -0.171 . . . . 0.0 112.674 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -127.62 151.47 48.88 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 177.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.82 -8.08 56.66 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.358 -175.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -150.13 -160.05 9.06 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.232 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.74 71.69 5.98 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 123.004 2.469 . . . . 0.0 112.833 -178.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.4 t -146.46 99.59 3.24 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.12 178.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 62.2 m -85.7 104.59 15.55 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.428 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.7 p -164.56 148.37 2.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.561 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.9 t -81.99 69.97 8.8 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.564 0.697 . . . . 0.0 109.488 177.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -136.36 36.38 2.01 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.361 178.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.09 165.88 24.29 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.918 0.39 . . . . 0.0 110.981 -177.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -111.83 97.06 36.18 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.401 178.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -81.23 52.3 4.26 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 123.274 2.65 . . . . 0.0 112.0 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -77.93 2.63 16.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.994 0.426 . . . . 0.0 111.221 -177.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 36.9 m -130.34 68.72 1.45 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.233 0.539 . . . . 0.0 110.267 177.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.7 t -80.41 104.95 11.31 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.383 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -93.32 8.36 40.72 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.716 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.4 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 22.5 ptp -100.67 120.17 56.57 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.558 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.483 ' HB2' ' HB2' ' A' ' 22' ' ' GLN . 21.8 Cg_exo -65.84 146.63 83.78 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 123.016 2.477 . . . . 0.0 112.023 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.89 84.78 0.31 Allowed 'Trans proline' 0 C--O 1.237 0.428 0 C-N-CA 122.806 2.337 . . . . 0.0 112.812 -178.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 62.2 56.61 2.17 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.249 176.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.483 ' HB2' ' HB2' ' A' ' 19' ' ' PRO . 94.5 mt-30 -118.67 117.57 29.3 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.759 173.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.61 ' O ' ' HA ' ' A' ' 74' ' ' THR . 22.1 mm-40 -72.64 130.53 40.77 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.255 -174.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.61 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 29.6 m -131.7 109.94 10.54 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.61 -178.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.749 HG22 HD11 ' A' ' 73' ' ' ILE . 14.3 m -127.73 161.24 35.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.237 178.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 10.0 m170 -111.47 127.95 55.85 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 -174.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.621 ' O ' ' HA ' ' A' ' 70' ' ' MET . 10.4 t -105.87 123.87 60.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.821 -174.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.787 ' CZ ' HG11 ' A' ' 68' ' ' VAL . 3.7 t80 -82.33 103.2 11.73 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.313 -174.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.537 ' C ' HG23 ' A' ' 68' ' ' VAL . 39.6 pt -126.52 113.14 23.03 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.701 0.762 . . . . 0.0 110.724 174.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.97 ' HB2' ' HG2' ' A' ' 32' ' ' GLN . 88.8 Cg_exo -50.45 150.95 10.66 Favored 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 123.513 2.808 . . . . 0.0 113.325 -179.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.689 ' HA ' HG12 ' A' ' 34' ' ' VAL . . . -58.73 -18.73 33.98 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.909 -175.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.97 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 3.5 pt20 -51.65 -36.53 46.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.021 176.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.587 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -126.4 -25.35 3.48 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -169.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.689 HG12 ' HA ' ' A' ' 31' ' ' ALA . 14.4 p -49.94 -34.53 9.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.605 0 O-C-N 123.355 0.409 . . . . 0.0 111.622 -173.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.962 ' HA2' ' N4 ' ' B' ' 4' ' ' ' C' . . . -57.22 -55.8 28.42 Favored Glycine 0 N--CA 1.44 -1.084 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.155 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.444 ' HA ' " H5'" ' B' ' 3' ' ' ' A' . . . -71.87 -15.05 62.11 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 120.906 0.384 . . . . 0.0 111.057 -175.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.587 HG12 ' O ' ' A' ' 33' ' ' ALA . 6.5 mm -71.74 -36.0 57.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.683 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.767 HD12 ' C4 ' ' B' ' 4' ' ' ' C' . 8.2 mt -63.51 -32.12 55.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-O 121.41 0.624 . . . . 0.0 110.265 173.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.532 ' HA3' ' HB2' ' A' ' 44' ' ' HIS . . . 86.72 163.48 38.66 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.443 176.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -61.36 128.15 34.94 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 120.927 0.394 . . . . 0.0 110.039 -178.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.419 ' O ' ' HE3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER 72.62 1.84 4.13 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.178 179.149 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.538 ' HA2' HG22 ' A' ' 38' ' ' ILE . . . 69.94 19.86 75.68 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.395 -0.907 . . . . 0.0 110.889 -173.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -73.86 -41.85 61.62 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.427 -0.386 . . . . 0.0 110.227 -178.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.532 ' HB2' ' HA3' ' A' ' 39' ' ' GLY . 18.8 m-70 -64.6 -40.52 95.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.539 -173.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.459 ' HB ' ' HA ' ' A' ' 38' ' ' ILE . 13.8 tt -64.46 -45.45 95.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.887 0.375 . . . . 0.0 111.442 -179.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.418 ' O ' ' HB3' ' A' ' 49' ' ' SER . 13.9 ptmm? -82.26 -22.32 35.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.671 0.272 . . . . 0.0 111.324 -178.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -69.34 -34.78 75.14 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 172.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.865 ' HG ' ' HE1' ' A' ' 51' ' ' PHE . 6.4 tt -60.1 -41.97 93.68 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.052 -0.976 . . . . 0.0 108.983 173.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.638 ' HA ' HD13 ' A' ' 56' ' ' ILE . 34.0 t -54.99 -35.31 64.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.931 178.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -73.53 -51.28 17.55 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.865 ' HE1' ' HG ' ' A' ' 48' ' ' LEU . 1.5 p90 -72.49 -32.18 65.99 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.823 -174.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.53 -19.02 36.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.858 0.361 . . . . 0.0 110.804 179.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.5 m 63.95 31.05 14.03 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.078 178.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -132.4 171.16 14.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.992 -177.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.504 ' HB3' ' HB ' ' A' ' 74' ' ' THR . 33.2 t -93.19 115.85 28.45 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.904 HG13 HG22 ' A' ' 73' ' ' ILE . 3.2 mp -115.58 119.15 61.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.238 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.544 ' HD2' ' O2 ' ' B' ' 6' ' ' ' C' . 37.8 ttpt -148.43 136.69 21.19 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.012 179.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.597 HG12 HG22 ' A' ' 71' ' ' VAL . 10.4 mt -88.8 128.48 40.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.189 0.518 . . . . 0.0 111.224 -177.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.53 ' HB2' HG23 ' A' ' 72' ' ' VAL . . . -71.19 141.79 86.57 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.239 -176.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 59' ' ' ALA . 2.4 Cg_endo -80.36 137.46 11.84 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.933 2.422 . . . . 0.0 111.956 177.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.44 148.54 18.53 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.853 2.369 . . . . 0.0 111.782 176.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -78.39 -32.29 48.77 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.869 -178.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.457 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 9.9 p -122.42 133.4 24.38 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.504 -177.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 63' ' ' THR . 23.8 Cg_exo -65.4 -8.77 19.9 Favored 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 123.441 2.761 . . . . 0.0 112.825 177.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -92.38 17.35 10.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.798 0.332 . . . . 0.0 111.096 176.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 24.9 t -74.73 142.82 44.34 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.164 0.506 . . . . 0.0 110.159 177.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -96.43 2.46 52.6 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.734 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.787 HG11 ' CZ ' ' A' ' 28' ' ' PHE . 3.7 p -154.65 153.64 7.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.788 -167.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.578 ' HB2' HG21 ' A' ' 34' ' ' VAL . 30.4 mtp180 -128.59 130.2 47.02 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 171.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.621 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 4.1 mpp? -92.35 125.88 37.19 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.803 0.335 . . . . 0.0 110.846 -175.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.597 HG22 HG12 ' A' ' 58' ' ' ILE . 93.1 t -84.47 127.11 40.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 120.924 0.393 . . . . 0.0 110.244 178.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.53 HG23 ' HB2' ' A' ' 59' ' ' ALA . 81.9 t -99.29 118.05 45.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.929 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.904 HG22 HG13 ' A' ' 56' ' ' ILE . 2.4 pp -118.58 133.45 65.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.271 0.557 . . . . 0.0 110.938 178.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.61 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 30.0 m -126.08 106.26 9.46 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.068 -179.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.63 164.38 37.29 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.859 -173.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -61.33 138.9 79.83 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 122.488 2.126 . . . . 0.0 111.665 173.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -40.05 -48.36 3.86 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 124.449 3.433 . . . . 0.0 115.316 -173.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -72.9 -32.22 65.2 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 121.031 -0.268 . . . . 0.0 111.617 -175.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.42 -32.21 69.72 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.231 0.539 . . . . 0.0 109.966 177.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -57.85 -41.57 82.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.774 177.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -64.99 -35.03 79.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.409 -175.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.7 mtmt -66.09 -44.02 85.63 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.405 0.621 . . . . 0.0 109.699 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.77 -41.55 75.02 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.058 178.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.494 ' O ' HG22 ' A' ' 87' ' ' ILE . 49.0 tt0 -64.48 -34.44 78.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.242 -177.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -56.79 -42.07 91.37 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.197 177.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 32.7 mmt180 -76.78 -33.38 58.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.788 0.328 . . . . 0.0 111.497 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.494 HG22 ' O ' ' A' ' 84' ' ' GLN . 0.4 OUTLIER -65.53 -37.29 79.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -177.909 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.696 ' HA ' HD23 ' A' ' 91' ' ' LEU . 10.7 m-85 -69.39 -30.66 68.69 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.201 0.524 . . . . 0.0 110.795 174.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -58.02 -33.81 70.38 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.759 175.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.711 ' HG3' HD22 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -61.33 -36.51 80.34 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 117.435 0.617 . . . . 0.0 109.646 177.774 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.752 ' HB3' ' CE1' ' A' ' 97' ' ' PHE . 2.8 mm? -61.79 -44.87 96.02 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.772 175.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 1.075 ' HE3' ' HB ' ' A' ' 103' ' ' VAL . 3.6 mmtp -76.67 -34.96 58.21 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -176.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -63.1 -33.05 74.62 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.768 -171.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.418 ' HB2' ' CE2' ' A' ' 96' ' ' PHE . 8.8 mm-40 -97.68 18.79 14.8 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.169 -0.613 . . . . 0.0 110.763 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 65.8 t30 58.07 40.5 25.24 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.186 174.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.418 ' CE2' ' HB2' ' A' ' 94' ' ' GLU . 27.7 m-85 -80.88 -27.66 36.26 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.591 -0.443 . . . . 0.0 109.986 176.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.752 ' CE1' ' HB3' ' A' ' 91' ' ' LEU . 6.7 m-85 -134.99 28.23 3.5 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.915 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 50.43 -164.67 0.69 Allowed Glycine 0 CA--C 1.523 0.552 0 CA-C-N 115.874 -0.603 . . . . 0.0 113.742 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -87.36 -57.63 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.159 2.572 . . . . 0.0 112.142 173.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.42 ' HE3' ' HB3' ' A' ' 100' ' ' LYS . 21.8 mmmt -80.37 -28.14 38.06 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -175.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.703 ' HB3' ' O ' ' A' ' 97' ' ' PHE . 33.9 tt0 -60.89 128.6 37.29 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 178.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -56.37 119.86 6.7 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.126 -175.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 1.075 ' HB ' ' HE3' ' A' ' 92' ' ' LYS . 13.3 p -60.45 123.3 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 173.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -126.27 89.89 3.09 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.773 0.797 . . . . 0.0 109.335 176.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.2 tt -101.22 126.92 47.99 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.467 -1.242 . . . . 0.0 108.191 -176.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -81.56 103.32 11.19 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.247 0.546 . . . . 0.0 110.383 -177.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.3 m -95.07 130.77 41.63 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.865 0.364 . . . . 0.0 110.036 177.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.405 ' HB3' HG21 ' A' ' 153' ' ' ILE . 11.1 m-70 -103.65 120.18 40.39 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.813 0.34 . . . . 0.0 110.643 -177.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 32.9 pt -115.63 134.41 58.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.174 0.512 . . . . 0.0 110.191 178.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.567 HH11 HD11 ' A' ' 153' ' ' ILE . 12.7 tpt180 -86.84 118.98 26.58 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.254 -174.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.693 HG23 ' CD2' ' A' ' 174' ' ' LEU . 7.1 p -121.51 145.04 41.73 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -177.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.81 ' HA ' ' HG2' ' A' ' 151' ' ' GLN . 32.7 Cg_exo -55.67 144.54 75.08 Favored 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 122.586 2.191 . . . . 0.0 110.871 173.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.21 -32.15 70.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.692 -175.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.5 p -79.75 -26.04 40.86 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.778 178.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.654 ' HB3' HG22 ' A' ' 111' ' ' VAL . . . -75.51 -20.41 58.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.315 -177.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.42 -35.1 79.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.11 0.481 . . . . 0.0 110.098 175.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -81.52 -11.3 83.33 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.909 176.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.426 ' HD2' HG22 ' A' ' 177' ' ' VAL . 18.3 ttm180 -93.09 -38.36 11.65 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.723 0.296 . . . . 0.0 111.037 179.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.6 p -65.66 -29.83 48.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.353 -177.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 1.004 ' HA ' ' HB ' ' A' ' 127' ' ' VAL . 34.9 pt -77.28 -19.48 14.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.005 0.431 . . . . 0.0 110.485 178.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.686 ' HA3' HG22 ' A' ' 126' ' ' THR . . . 84.15 -153.96 29.83 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.213 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.409 ' HB3' ' HD2' ' A' ' 125' ' ' LYS . 16.7 t70 -66.38 92.14 0.19 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.696 0.284 . . . . 0.0 111.104 -176.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 30.3 t70 56.3 33.88 23.06 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.826 0.822 . . . . 0.0 110.582 -179.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.695 ' HA2' ' HB ' ' A' ' 120' ' ' ILE . . . 80.26 72.6 1.2 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.545 -0.836 . . . . 0.0 113.008 177.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.409 ' HD2' ' HB3' ' A' ' 122' ' ' ASP . 64.2 mttp -126.05 -56.24 1.45 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.568 0.223 . . . . 0.0 110.538 176.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.686 HG22 ' HA3' ' A' ' 121' ' ' GLY . 14.4 t -69.24 -14.98 63.26 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.961 -0.295 . . . . 0.0 111.129 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 1.004 ' HB ' ' HA ' ' A' ' 120' ' ' ILE . 12.7 p -66.76 -32.44 58.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.015 0.435 . . . . 0.0 109.964 174.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -66.29 -45.98 78.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.337 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -63.85 -39.06 93.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.242 175.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.715 HD21 HD11 ' A' ' 170' ' ' ILE . 33.4 tp -56.68 -49.44 75.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.147 -176.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.646 ' HG2' ' H ' ' A' ' 138' ' ' VAL . 48.2 mt-30 -61.42 -47.4 85.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.599 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -66.99 -40.09 87.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.855 0.36 . . . . 0.0 111.349 -178.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 34.3 tp -73.13 -42.0 63.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.318 -176.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.427 ' HB ' ' HB2' ' A' ' 166' ' ' ALA . 68.2 p -76.52 -16.26 59.67 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.86 0.362 . . . . 0.0 110.888 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 64.96 26.34 12.74 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.837 -178.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -137.96 162.96 32.71 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.106 -177.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.56 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 8.6 mm-40 -90.23 110.01 21.07 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-O 120.957 0.408 . . . . 0.0 110.395 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.646 ' H ' ' HG2' ' A' ' 131' ' ' GLN . 43.2 t -101.52 104.9 17.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.92 176.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.552 HG13 ' HE3' ' A' ' 155' ' ' LYS . 4.9 p -113.81 111.85 37.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.466 0.65 . . . . 0.0 111.059 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.608 HG12 HG22 ' A' ' 154' ' ' VAL . 9.2 m -90.59 139.14 26.43 Favored Pre-proline 0 N--CA 1.446 -0.631 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 172.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.473 ' HB2' ' H ' ' A' ' 144' ' ' GLN . 67.8 Cg_endo -76.43 122.12 6.37 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 121.845 1.697 . . . . 0.0 112.525 -174.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 11.2 mpt_? -81.53 -13.79 57.67 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 174.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -80.2 -52.13 8.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.933 -1.031 . . . . 0.0 109.44 175.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.515 ' HG2' HG11 ' A' ' 152' ' ' VAL . 40.6 mt-30 73.36 151.1 0.11 Allowed 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 172.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.551 ' HB ' ' HD2' ' A' ' 146' ' ' PRO . 2.2 p -90.95 165.37 22.15 Favored Pre-proline 0 N--CA 1.448 -0.529 0 CA-C-N 114.427 -1.26 . . . . 0.0 110.358 177.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.551 ' HD2' ' HB ' ' A' ' 145' ' ' THR . 20.0 Cg_endo -59.97 159.92 23.88 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.105 2.537 . . . . 0.0 113.601 -177.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -70.83 1.51 5.4 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.096 -0.957 . . . . 0.0 111.207 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -50.13 -35.88 27.58 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.721 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -119.73 7.45 11.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.453 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 44.69 29.86 0.47 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.149 0.98 . . . . 0.0 111.808 -173.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.81 ' HG2' ' HA ' ' A' ' 112' ' ' PRO . 73.9 mt-30 -143.97 153.15 41.96 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 121.069 0.462 . . . . 0.0 111.249 -174.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.515 HG11 ' HG2' ' A' ' 144' ' ' GLN . 33.7 m -126.16 177.91 4.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 176.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.567 HD11 HH11 ' A' ' 110' ' ' ARG . 15.1 mt -121.89 129.62 75.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 O-C-N 121.718 -0.614 . . . . 0.0 111.747 -178.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.608 HG22 HG12 ' A' ' 140' ' ' VAL . 59.4 t -93.1 138.67 19.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 173.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.552 ' HE3' HG13 ' A' ' 139' ' ' VAL . 4.9 mtmt -107.21 123.6 48.53 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.764 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.56 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 52.7 mt -108.0 111.69 36.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 176.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 4.7 mp -107.66 118.45 55.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.904 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 171.7 -165.78 38.69 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.127 -1.035 . . . . 0.0 113.102 178.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.744 ' HA ' HG13 ' A' ' 103' ' ' VAL . 0.3 OUTLIER -77.81 157.24 30.03 Favored 'General case' 0 C--O 1.223 -0.334 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.185 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.507 ' HB3' ' CG ' ' A' ' 88' ' ' TYR . 44.8 p90 -64.24 -23.35 67.27 Favored 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -175.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.569 ' O ' ' HG3' ' A' ' 164' ' ' GLN . 91.1 m-85 -68.73 -51.61 39.55 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.737 0.78 . . . . 0.0 109.543 173.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.15 -41.42 67.11 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.563 -174.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 62.0 p -64.59 -44.28 91.16 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.941 -176.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.613 ' O ' ' HG2' ' A' ' 168' ' ' ARG . 1.2 pp0? -61.09 -38.04 84.84 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.605 177.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.426 ' HG3' ' O ' ' A' ' 161' ' ' TYR . 81.9 mtp -61.24 -42.4 98.56 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.864 0.364 . . . . 0.0 110.818 177.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.427 ' HB2' ' HB ' ' A' ' 134' ' ' THR . . . -70.67 -43.52 68.92 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.748 178.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -51.99 -55.76 18.44 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.728 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.613 ' HG2' ' O ' ' A' ' 164' ' ' GLN . 9.3 ptt180 -65.38 -29.88 70.64 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.824 -179.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -70.96 -51.12 27.65 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.949 -178.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.715 HD11 HD21 ' A' ' 130' ' ' LEU . 2.3 mp -68.09 -44.83 84.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.591 ' HA ' ' HG ' ' A' ' 174' ' ' LEU . 20.3 mmm180 -58.62 -26.27 63.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.811 0.339 . . . . 0.0 111.352 177.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -69.49 -46.4 66.69 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.655 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.519 HG13 HD23 ' A' ' 174' ' ' LEU . 32.7 pt -72.16 -19.74 19.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.691 -179.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.693 ' CD2' HG23 ' A' ' 111' ' ' VAL . 5.6 mt -66.99 -34.5 77.88 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 177.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.4 -31.72 72.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.18 176.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -71.6 -42.27 67.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.988 177.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.426 HG22 ' HD2' ' A' ' 118' ' ' ARG . 88.9 t -67.5 -35.01 71.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.507 176.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -57.48 -46.59 83.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.165 0.507 . . . . 0.0 110.328 175.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.412 ' O ' ' HB3' ' A' ' 183' ' ' LYS . 43.5 mt-30 -64.3 -39.85 94.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.393 177.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.418 ' O ' ' HA3' ' A' ' 184' ' ' GLY . 7.2 tp60 -66.9 -21.48 65.99 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.073 0.463 . . . . 0.0 110.786 178.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -83.68 -42.5 16.56 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.51 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -84.94 -29.19 25.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.097 0.475 . . . . 0.0 111.036 -179.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.463 ' O ' ' HG2' ' A' ' 183' ' ' LYS . 46.2 tttm -114.69 34.76 4.59 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 122.063 0.935 . . . . 0.0 109.254 -177.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.418 ' HA3' ' O ' ' A' ' 180' ' ' GLN . . . -146.61 132.31 4.37 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.567 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -121.45 -39.85 2.63 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.096 0.474 . . . . 0.0 109.73 177.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 11.5 t -100.89 -174.58 2.66 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.759 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 99.34 26.89 8.43 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 -177.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -95.46 49.5 1.19 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.251 0.548 . . . . 0.0 110.894 -176.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 97.8 mt -88.73 57.62 4.25 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.027 178.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -90.25 125.25 35.43 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.07 -177.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.632 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.1 179.75 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' ' G' . . . . . 0.767 HO2' ' H6 ' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.427 -0.789 1 C3'-C2'-C1' 105.289 4.21 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . 0.767 ' H6 ' HO2' ' B' ' 1' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.425 -0.937 0 O4'-C4'-C3' 103.362 -1.527 . 0.0 OUTLIER '7D dist 2a' 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . 0.645 ' C8 ' ' HA3' ' A' ' 35' ' ' GLY . . . . . . . . 0 O5'--C5' 1.424 -1.026 0 O4'-C1'-N19 110.785 2.585 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' ' C' . . . . . 0.962 ' N4 ' ' HA2' ' A' ' 35' ' ' GLY . . . . . . . . 0 O5'--C5' 1.426 -0.866 0 C4'-C3'-C2' 105.774 3.074 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.749 " O5'" " H4'" ' B' ' 4' ' ' ' C' . . . . . . . . 0 P--O3' 1.616 0.782 0 P-O3'-C3' 122.357 2.214 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' ' C' . . . . . 0.544 ' O2 ' ' HD2' ' A' ' 57' ' ' LYS . . . . . . . . 0 P--O3' 1.613 0.505 0 C4'-C3'-C2' 106.555 3.855 OUTLIER-DELTA 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.901 0 O4'-C1'-N19 109.051 0.851 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.425 -0.937 0 C3'-C2'-C1' 100.468 -1.146 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.791 0 N-CA-C 111.967 -0.453 . . . . 0.0 111.967 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.16 86.8 1.86 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.999 0.428 . . . . 0.0 111.114 -177.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 65.4 mtt -99.07 172.3 7.48 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.74 176.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 127.16 -85.59 0.33 Allowed Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 110.991 -0.843 . . . . 0.0 110.991 -176.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -59.76 98.44 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.594 2.196 . . . . 0.0 110.451 172.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.3 m -94.1 118.97 32.3 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.421 0.629 . . . . 0.0 111.847 -169.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.1 m -131.62 -68.31 0.65 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.005 171.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.3 t 50.4 54.12 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-O 121.677 0.751 . . . . 0.0 110.752 177.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.5 m -85.95 -28.68 24.12 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.089 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.11 140.31 6.38 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.043 178.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -127.39 -59.5 1.23 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.027 0.441 . . . . 0.0 110.234 178.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -147.22 89.81 5.46 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.705 178.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -63.94 -49.6 3.82 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.906 2.404 . . . . 0.0 112.645 -177.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -107.77 99.38 8.86 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.8 t 70.1 136.87 0.04 OUTLIER 'General case' 0 C--O 1.235 0.296 0 O-C-N 123.944 0.778 . . . . 0.0 111.064 -177.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.6 t -79.71 65.06 4.75 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.187 -178.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -152.38 -55.98 0.13 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.177 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 27.6 ttt 60.69 91.86 0.07 OUTLIER Pre-proline 0 N--CA 1.465 0.313 0 O-C-N 123.8 0.688 . . . . 0.0 111.071 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -74.68 108.91 2.81 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 123.196 2.598 . . . . 0.0 111.868 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -95.17 14.13 1.25 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.286 2.658 . . . . 0.0 112.905 -176.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 76' ' ' PRO . 37.9 tt0 -144.47 95.51 2.72 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.356 -177.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -122.21 142.46 50.41 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.301 177.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.524 ' O ' ' HA ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -107.65 161.58 14.74 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.663 178.7 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.8 m -139.84 108.63 5.96 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.765 0.317 . . . . 0.0 110.99 -178.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.413 HG22 HD11 ' A' ' 73' ' ' ILE . 35.5 m -127.77 161.02 36.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.128 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -114.97 130.2 56.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.274 -174.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.548 ' HB ' ' HB ' ' A' ' 71' ' ' VAL . 21.4 t -105.06 132.81 50.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.823 -174.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.694 ' CZ ' HG11 ' A' ' 68' ' ' VAL . 5.0 t80 -94.12 104.58 16.6 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.012 0.525 . . . . 0.0 110.846 -174.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.472 ' C ' HG23 ' A' ' 68' ' ' VAL . 26.7 pt -124.66 120.57 25.77 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.391 0.615 . . . . 0.0 110.404 174.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.586 ' HA ' ' HA ' ' A' ' 68' ' ' VAL . 36.5 Cg_endo -64.82 153.1 79.61 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 123.045 2.497 . . . . 0.0 112.541 -174.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.639 ' HA ' HG12 ' A' ' 34' ' ' VAL . . . -60.48 -18.95 54.88 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.052 -176.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -74.09 -13.98 60.92 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.828 177.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.541 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -123.47 -30.75 3.6 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.914 -177.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.639 HG12 ' HA ' ' A' ' 31' ' ' ALA . 11.1 p -54.47 -31.54 23.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -172.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 1.031 ' HA2' ' H41' ' B' ' 4' ' ' ' C' . . . -56.59 -59.26 11.1 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.174 -1.012 . . . . 0.0 111.642 -178.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.609 ' HA ' " H5'" ' B' ' 3' ' ' ' A' . . . -77.4 -13.48 59.92 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 120.788 0.327 . . . . 0.0 111.007 -174.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.816 HD12 ' HB3' ' A' ' 90' ' ' LYS . 2.0 mm -67.79 -34.4 67.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.75 178.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.774 HD12 ' C5 ' ' B' ' 4' ' ' ' C' . 19.2 mt -63.23 -59.45 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.962 177.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.443 ' HA3' ' NE2' ' A' ' 44' ' ' HIS . . . 118.8 90.55 1.34 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 119.761 -1.209 . . . . 0.0 115.311 168.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 43.9 tptt 57.38 -79.13 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.655 1.182 . . . . 0.0 113.805 171.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.534 ' HE2' ' HB3' ' A' ' 43' ' ' GLN . 19.2 pttm -117.36 7.68 12.89 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.749 0.309 . . . . 0.0 111.389 -175.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 62.9 39.25 97.8 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.995 -0.622 . . . . 0.0 112.942 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.534 ' HB3' ' HE2' ' A' ' 41' ' ' LYS . 23.0 tt0 -114.82 -48.79 2.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 117.158 0.479 . . . . 0.0 111.384 178.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.443 ' NE2' ' HA3' ' A' ' 39' ' ' GLY . 4.6 p80 -63.56 -19.19 64.6 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.075 0.464 . . . . 0.0 110.703 178.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.491 HD12 ' HA ' ' A' ' 38' ' ' ILE . 10.2 tt -67.26 -32.2 56.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.385 174.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.448 ' HD3' " C5'" ' B' ' 6' ' ' ' C' . 56.7 mtmt -81.54 -22.25 37.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.287 0.565 . . . . 0.0 110.159 178.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -66.79 -30.57 70.8 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 173.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.645 HD22 ' HE1' ' A' ' 51' ' ' PHE . 0.3 OUTLIER -55.58 -49.31 73.06 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.173 173.822 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.67 ' HA ' HD13 ' A' ' 56' ' ' ILE . 8.6 m -57.87 -37.03 73.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.186 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.8 mtp180 -73.48 -50.92 19.09 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -176.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.645 ' HE1' HD22 ' A' ' 48' ' ' LEU . 0.6 OUTLIER -68.63 -27.46 66.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.938 0.399 . . . . 0.0 110.223 -176.43 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.566 ' O ' ' HB1' ' A' ' 79' ' ' ALA . . . -86.82 -10.64 53.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.892 0.377 . . . . 0.0 110.864 177.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 31.5 m 57.62 38.22 27.7 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.148 178.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -138.65 173.46 11.56 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.623 -174.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.402 ' HB2' ' HB ' ' A' ' 74' ' ' THR . 26.4 m -94.7 101.6 13.45 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.179 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.821 HG13 HG22 ' A' ' 73' ' ' ILE . 1.9 mp -106.14 123.12 60.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.129 178.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -138.65 150.97 46.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.23 176.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.679 ' HB ' ' C6 ' ' B' ' 5' ' ' ' A' . 31.2 mm -89.97 120.83 39.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 169.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.818 ' HB2' HG23 ' A' ' 72' ' ' VAL . . . -65.24 122.45 80.0 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.552 -175.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.41 127.29 19.91 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.987 2.458 . . . . 0.0 111.746 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -49.4 124.62 12.25 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 123.204 2.603 . . . . 0.0 112.56 -177.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -56.66 -39.29 73.46 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.358 177.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.443 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 16.6 p -131.55 144.17 52.25 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 114.812 -1.085 . . . . 0.0 108.81 174.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 63' ' ' THR . 39.0 Cg_exo -61.21 -14.67 35.24 Favored 'Trans proline' 0 N--CA 1.475 0.385 0 C-N-CA 123.137 2.558 . . . . 0.0 113.202 -174.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -116.28 17.66 15.55 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.004 -179.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 27.4 p -49.52 131.47 20.98 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.207 0.527 . . . . 0.0 112.338 -174.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.47 ' O ' ' HD2' ' A' ' 67' ' ' LYS . 24.4 tptp -72.15 -18.96 61.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.282 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.694 HG11 ' CZ ' ' A' ' 28' ' ' PHE . 10.8 p -139.29 148.8 23.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.857 175.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.588 ' HB3' HG21 ' A' ' 34' ' ' VAL . 17.6 ttm180 -127.09 133.8 50.36 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 175.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.548 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 41.0 mtp -100.42 149.33 23.77 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 119.863 -0.735 . . . . 0.0 111.14 -171.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.548 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 89.9 t -99.05 127.95 51.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.953 175.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.818 HG23 ' HB2' ' A' ' 59' ' ' ALA . 92.3 t -103.28 110.0 28.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 177.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.821 HG22 HG13 ' A' ' 56' ' ' ILE . 2.6 pp -117.0 129.23 73.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.307 0.575 . . . . 0.0 111.072 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 35.4 m -125.14 109.44 12.89 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.922 -1.036 . . . . 0.0 109.889 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.45 162.04 35.43 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.363 -0.922 . . . . 0.0 112.601 -177.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.486 ' HG2' ' HB3' ' A' ' 79' ' ' ALA . 19.3 Cg_endo -59.67 137.01 74.53 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.754 2.303 . . . . 0.0 111.339 174.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_exo -40.03 -49.85 3.56 Favored 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 124.314 3.342 . . . . 0.0 114.683 -174.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -68.16 -36.32 79.46 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.888 0.375 . . . . 0.0 111.373 -176.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.566 ' HB1' ' O ' ' A' ' 52' ' ' ALA . . . -74.83 -31.7 61.75 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.425 0.631 . . . . 0.0 110.206 177.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -62.87 -33.45 75.3 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.239 175.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.408 ' HE1' HE22 ' A' ' 164' ' ' GLN . 74.5 t80 -53.75 -54.73 34.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.673 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.564 ' HE2' ' HA ' ' A' ' 79' ' ' ALA . 37.0 pttt -70.9 -33.77 70.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.677 0.275 . . . . 0.0 111.444 -177.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.35 -45.65 86.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.997 0.427 . . . . 0.0 111.011 177.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.654 ' HB3' ' HE1' ' A' ' 160' ' ' PHE . 23.6 tt0 -71.41 -31.69 67.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.318 -177.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -58.0 -32.7 67.11 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.829 176.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -76.65 -27.63 55.72 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.56 0.219 . . . . 0.0 111.197 178.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.524 HG22 ' O ' ' A' ' 84' ' ' GLN . 0.4 OUTLIER -70.26 -39.73 77.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -177.739 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.482 ' HA ' HD12 ' A' ' 105' ' ' LEU . 18.3 m-85 -69.68 -30.81 68.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.095 0.474 . . . . 0.0 109.999 174.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -58.48 -28.6 62.49 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.91 173.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.816 ' HB3' HD12 ' A' ' 37' ' ' ILE . 34.8 mmtp -67.97 -44.39 76.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.082 0.468 . . . . 0.0 109.893 175.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -60.46 -41.71 94.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.851 174.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 1.025 ' HE3' ' HB ' ' A' ' 103' ' ' VAL . 0.6 OUTLIER -65.73 -31.78 72.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.379 178.46 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -52.72 -47.52 67.26 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.575 -176.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.751 ' HB2' ' CE2' ' A' ' 96' ' ' PHE . 10.4 mm-40 -110.14 0.3 18.22 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.665 -177.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 55.72 43.58 27.7 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.751 178.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.751 ' CE2' ' HB2' ' A' ' 94' ' ' GLU . 92.9 m-85 -58.71 -38.92 79.36 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.101 0.477 . . . . 0.0 111.342 -178.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.68 ' CZ ' ' HE2' ' A' ' 92' ' ' LYS . 20.5 p90 -66.24 -33.54 75.98 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.679 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.421 ' HA3' ' HB2' ' A' ' 101' ' ' GLU . . . 150.83 147.22 4.5 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.627 -177.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -58.32 -54.22 3.28 Favored 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 122.743 2.296 . . . . 0.0 113.016 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -105.24 -6.52 19.68 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.708 0.289 . . . . 0.0 111.141 -178.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.421 ' HB2' ' HA3' ' A' ' 98' ' ' GLY . 5.9 mp0 -61.41 152.49 29.55 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.338 -177.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.437 ' HB3' ' NE2' ' A' ' 159' ' ' HIS . 38.5 mt-10 -61.57 146.55 48.43 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.01 172.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 1.025 ' HB ' ' HE3' ' A' ' 92' ' ' LYS . 12.6 p -59.03 129.84 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.149 175.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 74.3 mmtt -136.86 91.25 2.62 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.423 -177.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.482 HD12 ' HA ' ' A' ' 88' ' ' TYR . 2.4 tt -115.88 117.01 29.0 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -76.95 113.93 15.19 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.311 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.5 m -104.99 143.73 32.78 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.463 ' NE2' ' HG2' ' A' ' 155' ' ' LYS . 22.1 m170 -114.41 120.28 39.78 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 120.962 0.411 . . . . 0.0 110.346 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.415 ' CD1' ' HB ' ' A' ' 170' ' ' ILE . 16.6 pt -107.97 138.37 34.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 176.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -90.82 118.68 30.42 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.363 -174.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.653 HG12 HD11 ' A' ' 174' ' ' LEU . 11.1 m -116.95 154.34 49.64 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.769 178.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.658 ' HD2' HD22 ' A' ' 174' ' ' LEU . 38.4 Cg_exo -58.62 146.06 92.98 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.05 1.833 . . . . 0.0 110.891 173.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.455 ' HA ' HG22 ' A' ' 152' ' ' VAL . . . -48.65 -52.21 24.37 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -172.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.5 m -76.34 -17.82 59.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.676 -176.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.19 -24.66 62.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.652 0.263 . . . . 0.0 111.24 -177.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.64 ' HB1' HG11 ' A' ' 140' ' ' VAL . . . -64.17 -29.86 70.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.23 0.538 . . . . 0.0 110.357 177.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -77.01 -23.88 67.95 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.827 177.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.482 ' HD2' HG22 ' A' ' 177' ' ' VAL . 78.8 mtt-85 -83.72 -27.79 28.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.568 0.223 . . . . 0.0 110.592 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.728 HG22 HD11 ' A' ' 130' ' ' LEU . 9.9 p -77.47 -32.34 18.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.086 -178.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.428 ' O ' HG13 ' A' ' 127' ' ' VAL . 47.1 mm -74.34 -38.64 47.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.427 0.632 . . . . 0.0 109.944 177.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 95.54 153.46 30.06 Favored Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.384 -178.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -78.19 115.47 17.93 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 64.77 21.93 12.46 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 123.705 0.628 . . . . 0.0 110.911 -176.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 98.09 -137.45 13.3 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.915 -0.66 . . . . 0.0 111.847 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 23.5 tptm 72.55 -54.39 0.69 Allowed 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.393 0.677 . . . . 0.0 111.834 177.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 26.4 m -68.75 -37.34 79.31 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.891 0.377 . . . . 0.0 110.784 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.428 HG13 ' O ' ' A' ' 120' ' ' ILE . 6.4 m -65.21 -20.95 28.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.669 175.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -63.81 -33.43 75.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.969 0.414 . . . . 0.0 109.954 178.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -79.15 -40.31 31.3 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.642 -0.423 . . . . 0.0 109.957 175.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.728 HD11 HG22 ' A' ' 119' ' ' VAL . 66.4 mt -55.57 -52.01 65.17 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -174.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -84.34 -31.92 24.55 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.361 -0.535 . . . . 0.0 112.233 -173.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -72.26 -38.3 68.89 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.785 0.326 . . . . 0.0 111.083 -178.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.413 HD23 ' HE3' ' A' ' 169' ' ' LYS . 42.7 tp -83.03 -46.59 12.67 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.514 -176.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.577 HG21 ' HA ' ' A' ' 166' ' ' ALA . 39.6 p -75.88 -28.01 57.96 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.526 -174.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 67.36 15.48 9.92 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.546 -175.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -112.59 172.1 7.12 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.75 -178.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.468 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 35.2 tt0 -99.99 110.74 23.06 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 177.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 59.8 t -108.42 106.65 21.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.822 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 6.2 p -119.71 115.82 48.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.288 0.566 . . . . 0.0 111.428 -177.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.64 HG11 ' HB1' ' A' ' 116' ' ' ALA . 86.3 t -93.56 110.82 49.43 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.388 173.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.65 ' HG3' ' HE2' ' A' ' 155' ' ' LYS . 21.1 Cg_exo -67.5 149.9 80.16 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 123.104 2.536 . . . . 0.0 112.639 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.35 118.71 22.23 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.581 177.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 65.93 97.34 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.422 0.629 . . . . 0.0 112.004 -178.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.614 ' OE1' ' HB ' ' A' ' 153' ' ' ILE . 20.8 mm-40 -102.96 -66.94 0.9 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.545 176.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -145.61 144.61 23.11 Favored Pre-proline 0 C--N 1.314 -0.978 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.957 -179.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -67.43 168.33 18.26 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 123.23 2.62 . . . . 0.0 113.531 -174.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -58.84 -15.77 14.07 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.904 -177.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -55.41 -43.17 75.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.9 0.381 . . . . 0.0 110.497 172.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . 0.414 ' O ' ' HG2' ' A' ' 150' ' ' GLU . 0.2 OUTLIER -87.48 -16.75 33.87 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.102 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 149' ' ' ASN . 10.7 pt-20 46.35 28.91 0.77 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.948 1.299 . . . . 0.0 111.731 -178.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -145.29 149.11 34.26 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.381 -174.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.455 HG22 ' HA ' ' A' ' 113' ' ' ALA . 11.2 m -137.59 177.65 5.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 O-C-N 123.362 0.414 . . . . 0.0 110.203 178.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.614 ' HB ' ' OE1' ' A' ' 144' ' ' GLN . 96.7 mt -119.92 144.81 27.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.188 -173.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.625 ' HB ' HG22 ' A' ' 140' ' ' VAL . 1.5 p -135.46 139.43 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-O 121.251 0.548 . . . . 0.0 110.342 168.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.65 ' HE2' ' HG3' ' A' ' 141' ' ' PRO . 19.6 mttm -101.88 133.55 46.46 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.342 -172.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.468 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 68.2 mt -115.3 112.12 38.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.901 177.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.42 HD12 ' N ' ' A' ' 157' ' ' ILE . 4.5 mp -109.63 132.51 57.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.816 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 156.33 -158.43 28.67 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.222 -0.99 . . . . 0.0 112.866 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.844 ' HA ' HG13 ' A' ' 103' ' ' VAL . 13.6 m-70 -76.7 166.08 23.86 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 123.729 0.311 . . . . 0.0 110.64 -177.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.654 ' HE1' ' HB3' ' A' ' 84' ' ' GLN . 10.4 t80 -61.99 -49.04 77.67 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.59 0.233 . . . . 0.0 110.534 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.402 ' HA ' ' HG2' ' A' ' 164' ' ' GLN . 96.5 m-85 -69.46 -33.61 73.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.894 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.06 -49.85 53.79 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.028 0.442 . . . . 0.0 110.672 178.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.538 ' O ' ' HG3' ' A' ' 167' ' ' GLN . 49.7 m -66.49 -38.43 87.24 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.704 -177.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.408 HE22 ' HE1' ' A' ' 81' ' ' PHE . 12.8 pt20 -64.16 -36.67 84.79 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.708 178.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 90.1 mtp -66.01 -34.08 77.27 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.951 0.405 . . . . 0.0 110.357 176.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.577 ' HA ' HG21 ' A' ' 134' ' ' THR . . . -71.68 -44.16 64.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.493 177.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.538 ' HG3' ' O ' ' A' ' 163' ' ' SER . 75.0 mt-30 -52.46 -51.6 58.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.624 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.753 ' O ' ' HB2' ' A' ' 172' ' ' ASP . 5.9 ptm180 -67.05 -31.74 72.46 Favored 'General case' 0 C--O 1.217 -0.651 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.376 -178.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.441 ' N ' ' HG3' ' A' ' 168' ' ' ARG . 16.2 tppt? -65.25 -53.14 48.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.828 0.347 . . . . 0.0 111.208 -176.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.478 ' O ' ' HG ' ' A' ' 174' ' ' LEU . 3.0 mp -72.29 -44.23 63.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.321 -177.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -61.46 -25.5 67.28 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.916 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.753 ' HB2' ' O ' ' A' ' 168' ' ' ARG . 2.1 t0 -71.16 -47.98 54.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.914 -177.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 18.1 pt -70.12 -19.73 22.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.925 -176.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.658 HD22 ' HD2' ' A' ' 112' ' ' PRO . 19.1 mt -57.73 -32.34 67.33 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.883 0.373 . . . . 0.0 110.733 175.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.71 -31.8 73.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.743 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -67.57 -35.69 79.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.998 177.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.482 HG22 ' HD2' ' A' ' 118' ' ' ARG . 42.1 t -74.82 -27.37 20.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.902 177.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 52.1 tptt -65.66 -45.01 84.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.508 172.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -63.54 -33.68 76.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.64 175.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.608 ' HA ' ' HA2' ' A' ' 184' ' ' GLY . 25.5 tp60 -62.72 -33.91 76.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.344 175.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 39.9 m-70 -71.81 -35.82 70.07 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.936 0.398 . . . . 0.0 110.814 174.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -65.09 -48.55 73.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.81 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -161.55 -55.89 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.814 176.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.608 ' HA2' ' HA ' ' A' ' 180' ' ' GLN . . . 142.68 100.92 0.38 Allowed Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.263 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 5.4 tp60 -146.6 110.09 4.84 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.906 0.384 . . . . 0.0 110.369 178.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 16.0 p -105.46 -2.61 23.51 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.686 178.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 109.02 -61.05 0.31 Allowed Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.541 -178.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -103.33 75.47 1.35 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.75 0.309 . . . . 0.0 110.615 178.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 5.1 tt -87.78 99.03 11.8 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 178.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 57.41 35.79 26.35 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.618 -176.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.222 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.236 -177.251 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' ' G' . . . . . 0.933 " O2'" ' H6 ' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.426 -0.849 0 C4'-C3'-C2' 106.626 3.926 OUTLIER-EPSILON 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . 0.933 ' H6 ' " O2'" ' B' ' 1' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.424 -0.996 0 C3'-C2'-C1' 99.605 -2.106 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . 0.703 " H1'" ' C5 ' ' B' ' 4' ' ' ' C' . . . . . . . . 0 C2'--C1' 1.517 -1.084 0 C5'-C4'-O4' 112.524 2.374 . 0.01 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' ' C' . . . . . 1.031 ' H41' ' HA2' ' A' ' 35' ' ' GLY . . . . . . . . 0 O5'--C5' 1.427 -0.787 0 C3'-C2'-C1' 104.196 2.995 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.892 " O4'" " H4'" ' B' ' 4' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.431 -0.579 0 P-O3'-C3' 121.867 1.806 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' ' C' . . . . . 0.511 " O5'" " H2'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.43 -0.656 0 C4'-C3'-C2' 105.523 2.823 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.424 -0.969 0 C4'-C3'-C2' 105.43 2.73 OUTLIER-EPSILON 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.424 -0.989 0 P-O3'-C3' 122.765 2.554 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.649 0 N-CA-C 111.86 -0.496 . . . . 0.0 111.86 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -100.99 -43.26 6.1 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.955 0.407 . . . . 0.0 110.091 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.01 141.91 51.38 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.815 177.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -164.99 77.52 0.14 Allowed Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.164 -177.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.2 72.42 5.38 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 123.26 2.64 . . . . 0.0 111.693 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.9 t 73.47 -46.56 0.64 Allowed 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.608 0.763 . . . . 0.0 110.923 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 35.5 t -122.29 155.55 35.71 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.8 m -120.66 137.06 55.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 176.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.6 m -112.65 13.43 19.92 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.134 0.492 . . . . 0.0 110.677 -177.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -77.11 146.81 32.47 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.156 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.94 117.83 22.48 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.892 0.377 . . . . 0.0 111.326 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.489 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . . . -85.51 133.72 41.56 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.584 175.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 12' ' ' ALA . 13.6 Cg_exo -69.3 111.94 2.86 Favored 'Trans proline' 0 N--CA 1.464 -0.257 0 C-N-CA 122.815 2.343 . . . . 0.0 112.326 -178.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -106.83 18.53 21.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.458 177.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.1 m -74.92 100.64 4.17 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.741 -177.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.5 m -92.97 141.25 28.61 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.372 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 57.71 51.77 8.98 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 123.599 0.562 . . . . 0.0 111.231 178.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.856 ' HB3' ' HD3' ' A' ' 19' ' ' PRO . 22.8 ttt -78.8 -56.04 0.93 Allowed Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.496 176.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.856 ' HD3' ' HB3' ' A' ' 18' ' ' MET . 42.3 Cg_endo -97.96 112.01 0.09 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.877 2.385 . . . . 0.0 112.32 176.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 19' ' ' PRO . 4.7 Cg_exo -78.23 175.48 11.06 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.752 2.301 . . . . 0.0 111.662 176.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -65.83 114.7 5.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.495 177.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -86.4 151.34 23.63 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.872 -177.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.43 110.14 15.6 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.126 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 66.0 m -106.62 107.62 18.72 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 173.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.656 ' HB ' HG22 ' A' ' 109' ' ' ILE . 22.2 m -132.14 160.96 42.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.166 -177.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.511 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 12.8 m-70 -116.96 132.0 56.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.615 0.245 . . . . 0.0 110.777 -173.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.552 ' O ' ' HA ' ' A' ' 70' ' ' MET . 9.6 t -101.52 137.39 29.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.571 -176.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.511 ' CE2' HG11 ' A' ' 68' ' ' VAL . 1.7 t80 -102.05 105.0 15.67 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.253 -177.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.629 HD13 HD11 ' A' ' 87' ' ' ILE . 18.9 pt -132.4 125.83 19.93 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-O 121.288 0.566 . . . . 0.0 111.676 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.538 ' HA ' ' HA ' ' A' ' 68' ' ' VAL . 52.0 Cg_exo -55.85 148.27 57.41 Favored 'Trans proline' 0 C--O 1.239 0.553 0 C-N-CA 123.31 2.674 . . . . 0.0 112.504 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.745 ' HA ' HG12 ' A' ' 34' ' ' VAL . . . -57.83 -23.8 54.41 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.762 -1.108 . . . . 0.0 112.916 -171.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.673 ' HB2' ' HZ ' ' A' ' 96' ' ' PHE . 62.6 mm-40 -64.67 -21.74 66.81 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -175.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.622 ' HB2' ' HE2' ' A' ' 96' ' ' PHE . . . -121.86 -28.97 4.38 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.521 -175.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.745 HG12 ' HA ' ' A' ' 31' ' ' ALA . 14.3 p -57.28 -29.21 32.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-O 121.24 0.543 . . . . 0.0 110.166 -178.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 1.131 ' HA2' ' H41' ' B' ' 4' ' ' ' C' . . . -58.6 -55.32 31.42 Favored Glycine 0 N--CA 1.438 -1.216 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.627 176.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.44 ' HA ' " H5'" ' B' ' 3' ' ' ' A' . . . -73.45 -13.88 61.15 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 120.891 0.377 . . . . 0.0 110.585 -177.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.613 HG12 ' O ' ' A' ' 33' ' ' ALA . 7.8 mm -66.29 -37.38 79.56 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.149 175.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.722 HD12 ' C5 ' ' B' ' 4' ' ' ' C' . 19.6 mt -66.94 -43.9 88.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.628 174.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 83.78 -173.86 51.14 Favored Glycine 0 C--O 1.224 -0.525 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.957 174.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -47.83 91.07 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.509 0.723 . . . . 0.0 112.486 -177.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.602 ' HA ' " C5'" ' B' ' 4' ' ' ' C' . 12.6 ttpt 49.28 37.41 11.34 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.984 0.913 . . . . 0.0 111.544 -175.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.437 ' HA2' HG22 ' A' ' 45' ' ' ILE . . . 83.01 26.85 43.09 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.233 -0.984 . . . . 0.0 112.557 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -56.1 -71.57 0.09 Allowed 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -76.78 -20.6 56.25 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.208 0.448 . . . . 0.0 112.208 -173.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.437 HG22 ' HA2' ' A' ' 42' ' ' GLY . 10.3 tt -68.8 -37.07 76.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.904 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.419 ' HG2' ' O ' ' A' ' 42' ' ' GLY . 1.9 mmmp? -82.23 -22.42 35.89 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 121.939 -0.476 . . . . 0.0 110.679 177.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -69.96 -30.38 67.73 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 172.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.705 ' HA ' ' HE1' ' A' ' 51' ' ' PHE . 0.2 OUTLIER -51.38 -50.46 59.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.996 175.733 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.492 ' HA ' HD13 ' A' ' 56' ' ' ILE . 1.6 p -63.91 -23.26 67.28 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.231 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -74.38 -51.75 14.11 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.705 ' HE1' ' HA ' ' A' ' 48' ' ' LEU . 13.1 p90 -83.97 -22.71 31.35 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.512 -173.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -95.7 -16.53 21.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.85 0.357 . . . . 0.0 111.095 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 73.2 m 56.29 26.46 10.54 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.482 -178.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -106.64 171.55 7.3 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.824 -179.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.5 m -95.7 107.38 19.59 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 178.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.814 HG13 HG22 ' A' ' 73' ' ' ILE . 2.9 mp -108.02 121.31 60.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.782 -176.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -139.51 155.75 47.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.828 175.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.724 ' HB ' ' N6 ' ' B' ' 5' ' ' ' A' . 48.5 mm -99.92 129.56 50.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 173.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.745 ' HB2' HG23 ' A' ' 72' ' ' VAL . . . -81.74 119.08 74.51 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.137 -175.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 59' ' ' ALA . 7.4 Cg_exo -73.25 125.65 10.43 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 123.037 2.491 . . . . 0.0 112.055 176.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.443 ' HD3' ' HG3' ' A' ' 69' ' ' ARG . 72.3 Cg_endo -80.06 163.22 22.99 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.242 1.961 . . . . 0.0 111.658 176.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.418 ' H ' ' CD ' ' A' ' 62' ' ' GLU . 1.7 mp0 -59.48 -57.56 12.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.017 0.437 . . . . 0.0 110.247 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 34.5 p -118.38 146.77 40.33 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.97 -179.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -69.09 0.64 4.86 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.308 2.672 . . . . 0.0 112.663 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -89.01 13.92 11.79 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 121.111 0.482 . . . . 0.0 111.119 178.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 22.9 t -82.17 132.96 35.24 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 174.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -74.0 -16.37 61.07 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.542 0.687 . . . . 0.0 110.171 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.538 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 1.4 p -137.46 148.66 25.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.723 -174.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.443 ' HG3' ' HD3' ' A' ' 61' ' ' PRO . 19.8 ttm180 -126.1 144.35 50.77 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 177.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.552 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 42.0 mtp -98.58 149.45 22.74 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.429 -173.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 26' ' ' HIS . 90.9 t -105.98 137.92 33.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.828 174.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.745 HG23 ' HB2' ' A' ' 59' ' ' ALA . 58.6 t -111.57 109.36 28.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 178.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.814 HG22 HG13 ' A' ' 56' ' ' ILE . 2.0 pp -124.6 140.32 48.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.143 0.497 . . . . 0.0 111.31 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 90.1 m -131.28 113.92 14.39 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.132 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.65 162.75 36.14 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.37 -177.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.47 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 45.3 Cg_endo -68.42 140.44 48.13 Favored 'Trans proline' 0 CA--C 1.531 0.346 0 C-N-CA 122.698 2.265 . . . . 0.0 111.371 175.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 76' ' ' PRO . 80.4 Cg_exo -45.98 -36.37 15.73 Favored 'Trans proline' 0 N--CA 1.477 0.543 0 C-N-CA 124.746 3.631 . . . . 0.0 114.897 -172.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -72.37 -39.37 68.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.84 0.352 . . . . 0.0 110.813 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.56 ' HA ' ' HE2' ' A' ' 82' ' ' LYS . . . -75.44 -29.31 59.65 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.235 0.54 . . . . 0.0 110.186 176.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -64.72 -35.38 80.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.3 178.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -53.34 -51.0 63.84 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.14 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.56 ' HE2' ' HA ' ' A' ' 79' ' ' ALA . 47.2 pttt -72.71 -33.85 66.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.465 -177.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.466 ' HB1' HD11 ' A' ' 48' ' ' LEU . . . -67.14 -53.8 27.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.866 0.365 . . . . 0.0 111.097 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.453 ' O ' HG22 ' A' ' 87' ' ' ILE . 45.1 tt0 -65.82 -29.72 70.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.107 -178.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -53.85 -35.73 53.81 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.737 177.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -75.81 -40.06 55.7 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 120.855 0.36 . . . . 0.0 110.852 178.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.629 HD11 HD13 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -65.33 -38.5 82.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.052 -177.343 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.848 ' HA ' HD22 ' A' ' 91' ' ' LEU . 2.2 m-30 -69.62 -27.34 64.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.763 0.316 . . . . 0.0 111.166 173.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -57.81 -41.14 93.86 Favored Glycine 0 CA--C 1.52 0.402 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.567 177.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.595 ' HG3' ' O ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -65.29 -24.64 67.35 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.68 0.276 . . . . 0.0 111.038 179.171 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.848 HD22 ' HA ' ' A' ' 88' ' ' TYR . 1.6 mp -58.37 -50.57 73.2 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.443 0.639 . . . . 0.0 110.392 177.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.86 ' HE3' ' HB ' ' A' ' 103' ' ' VAL . 0.6 OUTLIER -73.67 -37.89 65.11 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.434 177.711 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.512 ' HB3' ' HA ' ' A' ' 90' ' ' LYS . 3.7 tp10 -58.74 -38.46 78.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.525 -177.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.491 ' CD ' ' H22' ' B' ' 1' ' ' ' G' . 5.1 mm-40 -96.74 8.81 43.43 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -176.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.457 ' OD1' ' HD3' ' A' ' 99' ' ' PRO . 52.0 m-80 54.98 34.61 22.77 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.911 175.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.673 ' HZ ' ' HB2' ' A' ' 32' ' ' GLN . 44.4 m-85 -70.61 -25.08 62.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.404 0.621 . . . . 0.0 109.555 174.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.586 ' HE1' ' HG ' ' A' ' 91' ' ' LEU . 24.1 m-85 -122.31 -44.72 2.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.668 179.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 135.47 146.37 5.29 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 114.902 -1.044 . . . . 0.0 111.057 -178.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.457 ' HD3' ' OD1' ' A' ' 95' ' ' ASN . 30.6 Cg_endo -65.08 -34.9 44.89 Favored 'Trans proline' 0 N--CA 1.464 -0.232 0 C-N-CA 122.682 2.254 . . . . 0.0 112.366 -178.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -108.12 1.99 22.66 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.207 0.527 . . . . 0.0 111.057 -178.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -88.01 156.53 19.26 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.964 -175.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -63.66 132.56 51.47 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.143 177.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.86 ' HB ' ' HE3' ' A' ' 92' ' ' LYS . 7.2 p -79.68 129.65 37.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.177 0.513 . . . . 0.0 110.227 174.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.565 ' HD2' ' HA2' ' A' ' 158' ' ' GLY . 21.1 mmmt -139.14 89.48 2.35 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 174.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.809 ' HG ' HD21 ' A' ' 91' ' ' LEU . 3.4 tm? -110.94 130.48 55.57 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.489 -169.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.446 ' HA ' HG13 ' A' ' 157' ' ' ILE . 6.8 tp10 -64.88 118.91 9.73 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.394 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.0 m -126.39 114.93 18.86 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 177.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 49.9 m170 -99.66 120.42 39.67 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.942 0.401 . . . . 0.0 110.792 -177.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.656 HG22 ' HB ' ' A' ' 25' ' ' VAL . 39.8 pt -110.22 149.38 13.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.063 176.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 13.7 mmt180 -96.76 119.48 35.32 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.336 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.66 HG12 HD21 ' A' ' 174' ' ' LEU . 16.8 m -111.79 152.23 44.01 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 177.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.848 ' HD2' ' HG ' ' A' ' 174' ' ' LEU . 32.4 Cg_exo -56.22 147.73 64.38 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.435 2.09 . . . . 0.0 111.043 176.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -50.11 -52.1 37.63 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -171.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 18.6 m -72.25 -25.4 61.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.795 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.5 -26.52 65.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.798 0.333 . . . . 0.0 110.881 -178.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.798 ' HB1' HG21 ' A' ' 140' ' ' VAL . . . -64.96 -28.84 69.79 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.967 178.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -81.43 -18.97 67.44 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.613 -0.804 . . . . 0.0 111.838 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.59 ' HD3' HG22 ' A' ' 177' ' ' VAL . 17.8 mtp85 -92.38 -19.53 21.99 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 122.733 -0.275 . . . . 0.0 111.23 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.63 HG12 ' O ' ' A' ' 116' ' ' ALA . 7.6 p -69.52 -29.16 40.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.066 0.46 . . . . 0.0 110.236 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.958 ' HA ' ' HB ' ' A' ' 127' ' ' VAL . 7.7 pt -86.5 -33.62 7.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.59 175.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 117.16 155.45 10.22 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.913 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -57.22 -34.49 68.61 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.009 0.433 . . . . 0.0 110.489 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -141.99 47.0 1.64 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.563 0.697 . . . . 0.0 109.485 174.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.454 ' O ' ' HB3' ' A' ' 125' ' ' LYS . . . 79.09 -155.01 39.87 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.019 -179.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.454 ' HB3' ' O ' ' A' ' 124' ' ' GLY . 1.2 tmtp? 73.68 -49.76 0.69 Allowed 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 176.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.403 ' N ' ' HD3' ' A' ' 125' ' ' LYS . 95.1 m -60.16 -46.07 90.95 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -175.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.958 ' HB ' ' HA ' ' A' ' 120' ' ' ILE . 7.1 p -64.62 -40.4 88.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.813 0.34 . . . . 0.0 111.322 -178.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -68.61 -33.96 74.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.258 0.551 . . . . 0.0 109.94 178.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -64.24 -41.71 96.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.864 175.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 127' ' ' VAL . 80.9 mt -59.45 -50.04 75.49 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.567 175.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -62.76 -40.55 97.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.292 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -68.03 -27.69 66.76 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.401 -177.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' A' ' 133' ' ' LEU . 1.9 tm? -93.18 -43.19 8.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.886 0.375 . . . . 0.0 110.961 -176.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 76.1 p -84.66 -20.47 31.22 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -175.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 67.04 20.64 10.37 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 123.724 0.64 . . . . 0.0 110.998 -178.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -118.43 157.46 27.15 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.167 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.57 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 36.4 tt0 -88.35 110.55 20.88 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 59.2 t -108.74 106.8 21.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.321 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.421 ' C ' HG23 ' A' ' 154' ' ' VAL . 6.7 p -132.28 120.74 44.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.38 0.61 . . . . 0.0 111.482 -178.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.798 HG21 ' HB1' ' A' ' 116' ' ' ALA . 2.6 p -99.82 113.16 64.95 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.01 177.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.54 ' HD2' ' O ' ' A' ' 153' ' ' ILE . 36.1 Cg_exo -60.78 125.64 17.74 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.439 2.092 . . . . 0.0 111.55 175.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -83.75 -15.22 49.34 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.26 0.553 . . . . 0.0 109.814 178.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -106.66 59.28 0.64 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.03 172.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.685 ' HG2' ' HB ' ' A' ' 152' ' ' VAL . 57.5 tp60 -100.52 171.75 7.54 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.147 -174.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.432 ' N ' ' HG3' ' A' ' 144' ' ' GLN . 31.7 p -45.21 153.82 0.52 Allowed Pre-proline 0 C--N 1.325 -0.499 0 C-N-CA 123.564 0.746 . . . . 0.0 112.346 174.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -54.61 153.85 22.3 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 123.398 2.732 . . . . 0.0 112.914 -176.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -78.33 9.34 3.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.544 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -53.05 -43.61 66.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.627 175.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . 0.421 ' O ' ' HG2' ' A' ' 150' ' ' GLU . 0.2 OUTLIER -79.74 1.02 28.19 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.668 -175.149 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 149' ' ' ASN . 9.2 pt-20 46.42 29.06 0.81 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.074 0.95 . . . . 0.0 110.484 -171.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -164.5 130.39 2.88 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.17 -169.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.685 ' HB ' ' HG2' ' A' ' 144' ' ' GLN . 23.7 m -128.26 -176.55 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.899 -175.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.54 ' O ' ' HD2' ' A' ' 141' ' ' PRO . 49.2 mt -104.85 142.52 17.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.03 -174.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.421 HG23 ' C ' ' A' ' 139' ' ' VAL . 2.1 p -135.0 140.0 46.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.074 164.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.9 mttt -95.24 145.6 24.94 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.424 -172.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.57 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 70.6 mt -131.42 110.79 18.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.476 174.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.446 HG13 ' HA ' ' A' ' 106' ' ' GLU . 3.8 mp -120.32 118.44 56.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 178.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.565 ' HA2' ' HD2' ' A' ' 104' ' ' LYS . . . -170.87 -170.17 34.77 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.489 -0.863 . . . . 0.0 112.164 -174.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.551 ' HA ' ' O ' ' A' ' 103' ' ' VAL . 24.6 m170 -80.35 169.99 17.0 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -53.26 -45.89 69.01 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -174.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.465 ' O ' ' HG3' ' A' ' 165' ' ' MET . 36.3 p90 -73.88 -33.85 64.21 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.92 0.391 . . . . 0.0 110.762 178.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.79 -50.97 37.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.133 -174.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 26.5 m -58.1 -48.57 79.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.64 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.501 ' O ' ' HG2' ' A' ' 168' ' ' ARG . 65.7 mt-30 -61.74 -32.03 72.24 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.665 -178.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.465 ' HG3' ' O ' ' A' ' 161' ' ' TYR . 77.0 mtp -70.04 -48.54 57.54 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.382 175.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.43 -42.07 98.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.534 -177.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.55 HE21 HG21 ' A' ' 25' ' ' VAL . 39.0 mt-30 -51.4 -54.65 24.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.279 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.501 ' HG2' ' O ' ' A' ' 164' ' ' GLN . 19.4 ptt180 -75.7 -30.81 59.43 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.895 ' HA ' ' HE3' ' A' ' 169' ' ' LYS . 0.1 OUTLIER -70.85 -36.79 73.03 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 122.195 -0.316 . . . . 0.0 111.292 -177.342 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.649 ' O ' HD13 ' A' ' 174' ' ' LEU . 1.8 mp -75.29 -43.04 43.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 174.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.616 ' HA ' HD22 ' A' ' 174' ' ' LEU . 10.7 mmm180 -54.85 -25.74 30.67 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.994 0.426 . . . . 0.0 110.883 175.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.481 ' HB3' ' O ' ' A' ' 169' ' ' LYS . 6.7 t70 -63.13 -55.66 23.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.415 -0.812 . . . . 0.0 111.11 178.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.529 ' O ' HG23 ' A' ' 177' ' ' VAL . 37.8 pt -67.31 -21.95 28.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.882 -176.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.848 ' HG ' ' HD2' ' A' ' 112' ' ' PRO . 6.7 mp -57.18 -41.69 79.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.825 176.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.471 ' O ' ' HG2' ' A' ' 179' ' ' GLN . . . -68.16 -35.59 78.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.321 178.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -67.56 -32.58 73.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.457 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.59 HG22 ' HD3' ' A' ' 118' ' ' ARG . 60.0 t -72.86 -38.21 56.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.881 0.372 . . . . 0.0 110.535 178.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -69.17 -11.14 60.54 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.298 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 175' ' ' ALA . 33.1 mm-40 -68.29 -11.84 60.07 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.143 178.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -57.07 -22.64 40.84 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.829 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -84.71 -24.52 28.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.923 0.392 . . . . 0.0 110.709 -178.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -85.94 -49.93 7.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.927 177.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 52.6 tttm -147.55 131.73 17.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.884 178.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -153.97 164.9 31.5 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.624 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -85.52 60.78 6.45 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.183 0.516 . . . . 0.0 109.788 178.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 4.5 m -66.07 -65.43 0.68 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.065 -175.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -153.98 129.57 2.68 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.213 -177.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -119.14 39.14 3.63 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.449 0.643 . . . . 0.0 110.353 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 86.8 mt -80.99 6.53 13.13 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.588 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -82.76 60.76 5.48 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.178 -178.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.522 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.59 -178.611 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' ' G' . . . . . 1.011 " O2'" ' H6 ' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.425 -0.915 0 C4'-C3'-C2' 105.995 3.295 OUTLIER-EPSILON 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . 1.011 ' H6 ' " O2'" ' B' ' 1' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.426 -0.848 0 P-O3'-C3' 122.393 2.244 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . 0.684 " H1'" ' C5 ' ' B' ' 4' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.422 -1.136 0 O4'-C1'-C2' 103.065 -2.382 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' ' C' . . . . . 1.131 ' H41' ' HA2' ' A' ' 35' ' ' GLY . . . . . . . . 0 O5'--C5' 1.43 -0.643 0 C4'-C3'-C2' 105.753 3.053 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.815 " O5'" " H4'" ' B' ' 4' ' ' ' C' . . . . . . . . 0 P--O3' 1.614 0.608 0 P-O3'-C3' 122.158 2.049 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' ' C' . . . . . 0.554 " O5'" ' H6 ' ' B' ' 6' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.431 -0.568 0 C4'-C3'-C2' 105.232 2.532 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.849 0 C4'-C3'-C2' 105.27 2.57 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.878 0 C3'-C2'-C1' 100.127 -1.526 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.768 0 N-CA-C 111.78 -0.528 . . . . 0.0 111.78 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.72 -36.53 0.43 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.972 0.415 . . . . 0.0 110.776 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 49.0 tpp -93.27 117.85 30.57 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.253 -177.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 85.74 -133.71 12.01 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.621 172.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.56 73.84 5.02 Favored 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 123.137 2.558 . . . . 0.0 113.36 -174.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.2 t -112.35 -51.96 2.81 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.005 174.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 35.4 m -111.51 42.17 1.75 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.167 0.508 . . . . 0.0 110.906 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.4 m -95.24 -3.92 10.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.198 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.5 m -94.76 -2.83 50.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.847 -177.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.57 127.7 9.3 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.942 -0.647 . . . . 0.0 111.589 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -84.83 65.2 9.03 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.173 0.511 . . . . 0.0 110.563 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.72 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . . . -131.98 -56.4 0.03 OUTLIER Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.199 178.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.72 ' HD3' ' HB3' ' A' ' 12' ' ' ALA . 9.2 Cg_exo -72.83 -38.57 2.95 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 122.077 1.851 . . . . 0.0 112.287 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -114.57 167.49 10.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.939 -176.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 48.8 m -148.38 117.16 6.68 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.151 0.5 . . . . 0.0 110.712 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.2 m -93.88 64.16 3.38 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -103.77 -14.62 16.0 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.255 -169.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 48.6 ttm -127.6 76.56 76.88 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -173.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.631 ' HD2' ' HD3' ' A' ' 20' ' ' PRO . 23.0 Cg_exo -65.78 -55.26 0.44 Allowed 'Trans proline' 0 CA--C 1.549 1.257 0 C-N-CA 122.781 2.321 . . . . 0.0 114.632 174.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.631 ' HD3' ' HD2' ' A' ' 19' ' ' PRO . 1.5 Cg_endo -82.47 61.1 7.54 Favored 'Trans proline' 0 C--N 1.361 1.22 0 C-N-CA 122.513 2.142 . . . . 0.0 113.633 -170.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -105.68 -18.98 13.9 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.534 0.683 . . . . 0.0 109.449 172.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -101.99 143.5 31.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.027 -176.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.68 ' OE1' ' HG3' ' A' ' 171' ' ' ARG . 58.4 mt-10 -102.44 132.14 48.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.585 176.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.8 m -100.82 106.73 18.14 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 172.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.717 HG13 HG22 ' A' ' 109' ' ' ILE . 4.6 t -136.08 146.61 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.07 -174.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.456 ' HB2' ' O ' ' A' ' 108' ' ' HIS . 11.5 m170 -104.19 128.58 51.91 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-O 120.932 0.396 . . . . 0.0 110.483 -176.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.5 ' HB ' ' CG1' ' A' ' 71' ' ' VAL . 2.3 t -108.7 142.4 21.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -99.13 112.77 24.83 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -174.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.595 HG22 HD21 ' A' ' 91' ' ' LEU . 6.5 pt -126.81 120.11 22.78 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.846 176.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.619 ' HA ' ' HA ' ' A' ' 68' ' ' VAL . 68.6 Cg_exo -51.46 144.56 31.6 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.395 2.73 . . . . 0.0 112.58 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.711 ' HA ' HG12 ' A' ' 34' ' ' VAL . . . -59.85 -22.94 62.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.974 -1.012 . . . . 0.0 112.218 -173.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -84.2 0.3 49.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.38 -178.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.892 ' HB2' ' HE2' ' A' ' 96' ' ' PHE . . . -125.07 -32.75 2.97 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.594 174.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.711 HG12 ' HA ' ' A' ' 31' ' ' ALA . 11.2 p -57.01 -26.99 25.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-O 121.206 0.527 . . . . 0.0 110.075 -178.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 1.11 ' HA2' ' H41' ' B' ' 4' ' ' ' C' . . . -57.58 -56.95 22.32 Favored Glycine 0 N--CA 1.431 -1.649 0 CA-C-N 115.344 -0.843 . . . . 0.0 111.566 176.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.468 ' HB2' " C1'" ' B' ' 2' ' ' ' C' . . . -78.34 -13.53 59.8 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.826 0.346 . . . . 0.0 111.227 -174.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.661 HD12 ' HG2' ' A' ' 90' ' ' LYS . 3.3 mm -66.35 -39.47 84.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 176.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.782 HD12 ' C5 ' ' B' ' 4' ' ' ' C' . 32.5 mt -64.37 -44.78 97.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 172.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 70.6 104.45 0.04 OUTLIER Glycine 0 CA--C 1.519 0.309 0 N-CA-C 115.706 1.042 . . . . 0.0 115.706 163.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 66.7 mttm 40.54 98.39 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.598 1.159 . . . . 0.0 113.707 167.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.686 ' HE2' ' HB3' ' A' ' 43' ' ' GLN . 24.6 ttpt 76.13 -23.21 0.25 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.209 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.711 ' HA2' HG22 ' A' ' 38' ' ' ILE . . . 92.31 23.06 27.82 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.977 -178.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.686 ' HB3' ' HE2' ' A' ' 41' ' ' LYS . 19.2 pt20 -87.95 -24.71 23.5 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.15 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 81.3 m-70 -66.11 -44.53 84.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.783 0.325 . . . . 0.0 110.775 -178.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.574 ' CD1' HG12 ' A' ' 58' ' ' ILE . 3.0 tt -61.75 -49.06 85.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.242 -177.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -77.55 -21.36 52.67 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.849 0.356 . . . . 0.0 111.033 -175.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -68.43 -36.67 79.4 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 172.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.958 HD23 HG12 ' A' ' 56' ' ' ILE . 1.2 tp -56.73 -40.69 76.15 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.209 177.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.69 ' HA ' HD13 ' A' ' 56' ' ' ILE . 2.1 m -56.85 -38.46 72.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.984 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -70.7 -51.27 28.67 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -175.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.658 ' CZ ' ' HA ' ' A' ' 48' ' ' LEU . 10.6 p90 -79.14 -6.88 57.55 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 120.274 -0.57 . . . . 0.0 111.553 -176.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -97.55 -13.12 21.83 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.863 0.363 . . . . 0.0 110.703 173.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.7 m 56.62 39.61 29.72 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.054 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.441 ' HB1' ' O ' ' A' ' 74' ' ' THR . . . -141.28 174.62 10.36 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.469 -174.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.616 ' HB3' ' HB ' ' A' ' 74' ' ' THR . 32.3 t -92.78 104.34 16.61 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.958 HG12 HD23 ' A' ' 48' ' ' LEU . 1.9 mp -110.97 115.52 50.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.778 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -143.49 151.36 40.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.938 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.644 ' HB ' ' C6 ' ' B' ' 5' ' ' ' A' . 25.1 mm -86.88 134.64 27.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.719 0.295 . . . . 0.0 110.347 178.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.73 ' HB2' HG23 ' A' ' 72' ' ' VAL . . . -95.27 116.77 66.62 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.397 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -62.37 128.61 24.22 Favored 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 122.698 2.265 . . . . 0.0 112.053 178.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.73 ' HD3' ' HG3' ' A' ' 69' ' ' ARG . 57.2 Cg_endo -70.71 157.41 58.6 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 122.449 2.099 . . . . 0.0 111.635 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -64.77 -32.86 74.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.857 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.435 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 11.7 p -131.31 135.68 27.48 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.232 177.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 63' ' ' THR . 20.4 Cg_exo -66.55 -10.16 26.86 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.18 2.587 . . . . 0.0 112.816 -178.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -91.98 -1.64 57.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.056 0.455 . . . . 0.0 110.917 178.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.2 t -56.31 132.75 51.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.257 0.551 . . . . 0.0 110.908 -178.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -71.42 -21.52 61.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.747 -178.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.619 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 2.0 p -134.16 147.15 30.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.192 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.73 ' HG3' ' HD3' ' A' ' 61' ' ' PRO . 27.2 ttm180 -119.18 145.87 45.64 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.617 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 55.3 mtt -87.6 149.07 24.55 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.817 0.342 . . . . 0.0 110.321 -178.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.5 ' CG1' ' HB ' ' A' ' 27' ' ' VAL . 2.8 p -118.5 131.97 69.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 169.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.73 HG23 ' HB2' ' A' ' 59' ' ' ALA . 58.3 t -86.81 102.62 12.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.096 0.474 . . . . 0.0 109.977 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.457 ' HA ' HD13 ' A' ' 73' ' ' ILE . 1.9 mm -94.97 117.63 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.987 175.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.661 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 25.0 m -130.02 106.26 8.52 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.656 175.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.13 162.0 35.31 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.748 -176.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -69.51 155.41 66.83 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.356 2.038 . . . . 0.0 111.144 171.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -38.92 -42.92 2.11 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 124.041 3.161 . . . . 0.0 114.231 -177.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.47 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 30.4 tt0 -55.99 -50.3 71.24 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.149 0.5 . . . . 0.0 110.561 176.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.434 ' HA ' ' CE ' ' A' ' 82' ' ' LYS . . . -63.54 -36.68 84.57 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.689 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -55.96 -35.58 66.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.942 177.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -69.7 -55.66 9.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.767 -174.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.47 ' HD3' ' O ' ' A' ' 78' ' ' GLU . 0.4 OUTLIER -74.62 -34.16 62.74 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 120.119 -0.632 . . . . 0.0 111.879 -176.36 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.31 -52.59 64.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.93 0.395 . . . . 0.0 110.617 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.474 ' HA ' HG22 ' A' ' 87' ' ' ILE . 47.6 mt-30 -76.38 -31.25 57.9 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.216 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.401 ' HA2' ' CE1' ' A' ' 160' ' ' PHE . . . -53.95 -43.65 71.84 Favored Glycine 0 CA--C 1.512 -0.153 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.02 177.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' A' ' 82' ' ' LYS . 12.6 mmt180 -74.84 -43.04 56.73 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.989 0.423 . . . . 0.0 110.076 176.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.903 ' HA ' ' HD3' ' A' ' 90' ' ' LYS . 0.4 OUTLIER -63.8 -35.79 74.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.994 -171.189 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -64.48 -30.51 71.55 Favored 'General case' 0 C--N 1.333 -0.114 0 O-C-N 121.866 -0.522 . . . . 0.0 109.688 176.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -65.0 -29.03 74.31 Favored Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.666 173.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.903 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 4.3 mptp? -68.84 -33.36 73.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.148 0.499 . . . . 0.0 110.103 175.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.735 ' HG ' ' HG ' ' A' ' 105' ' ' LEU . 4.1 mm? -64.55 -40.24 95.21 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.523 172.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.878 ' HE3' ' HB ' ' A' ' 103' ' ' VAL . 0.1 OUTLIER -71.71 -22.0 61.7 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.564 176.659 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -53.52 -47.27 70.06 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.302 178.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -112.81 3.79 16.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.902 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 43.09 59.99 2.7 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 172.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.892 ' HE2' ' HB2' ' A' ' 33' ' ' ALA . 82.8 m-85 -72.55 -46.93 52.09 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.955 179.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.678 ' CZ ' ' HE2' ' A' ' 92' ' ' LYS . 19.1 p90 -64.5 -26.46 68.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.495 -178.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 150.8 154.29 6.45 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 121.164 -0.541 . . . . 0.0 111.918 -178.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -65.07 -64.96 0.05 OUTLIER 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 122.983 2.456 . . . . 0.0 112.896 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -90.85 -10.0 44.29 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.967 0.413 . . . . 0.0 110.737 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -58.77 135.67 57.53 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.906 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.467 ' O ' ' HG2' ' A' ' 104' ' ' LYS . 6.7 mm-40 -61.13 137.56 58.23 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.296 173.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.878 ' HB ' ' HE3' ' A' ' 92' ' ' LYS . 14.9 p -52.39 125.37 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 CA-C-O 121.576 0.703 . . . . 0.0 111.258 -173.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 47.1 mmtm -120.13 91.16 3.47 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.563 -1.198 . . . . 0.0 108.755 178.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.735 ' HG ' ' HG ' ' A' ' 91' ' ' LEU . 1.5 tt -108.27 124.9 51.01 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.658 -173.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -74.5 120.93 20.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.627 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.4 m -107.33 108.47 19.86 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 173.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.456 ' O ' ' HB2' ' A' ' 26' ' ' HIS . 12.1 m-70 -104.01 121.07 42.39 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.159 0.504 . . . . 0.0 109.921 -177.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.717 HG22 HG13 ' A' ' 25' ' ' VAL . 23.0 pt -122.88 152.22 27.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 C-N-CA 120.534 -0.466 . . . . 0.0 112.138 -173.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.713 ' HD3' HG12 ' A' ' 153' ' ' ILE . 1.7 mmt180 -100.05 116.83 32.99 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.435 174.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 151' ' ' GLN . 31.2 m -104.93 162.31 20.15 Favored Pre-proline 0 C--N 1.316 -0.858 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 173.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.421 ' HD2' HD22 ' A' ' 174' ' ' LEU . 51.7 Cg_exo -51.83 139.69 49.25 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 121.442 1.428 . . . . 0.0 109.856 170.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -55.18 -30.5 60.03 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.492 -170.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.5 m -93.02 -15.64 25.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.75 0.31 . . . . 0.0 111.439 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.62 -24.72 61.93 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.913 -172.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.546 ' O ' HG12 ' A' ' 119' ' ' VAL . . . -57.99 -28.84 64.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.145 0.498 . . . . 0.0 110.787 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.92 -27.76 73.52 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.997 -0.62 . . . . 0.0 113.014 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.616 ' HD2' ' OE1' ' A' ' 180' ' ' GLN . 69.3 mtp180 -92.12 -22.79 19.69 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 122.385 -0.479 . . . . 0.0 111.488 -178.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.546 HG12 ' O ' ' A' ' 116' ' ' ALA . 9.8 p -73.31 -27.98 24.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 174.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.943 ' HA ' ' HB ' ' A' ' 127' ' ' VAL . 67.7 mt -78.56 -39.44 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 CA-C-O 121.708 0.766 . . . . 0.0 109.339 171.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.589 ' HA3' ' HB ' ' A' ' 126' ' ' THR . . . 96.44 38.77 4.4 Favored Glycine 0 N--CA 1.442 -0.933 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.312 175.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 66.6 -79.08 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 122.948 0.499 . . . . 0.0 111.296 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -83.92 -24.36 30.77 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.043 0.449 . . . . 0.0 110.238 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.401 ' HA2' HG22 ' A' ' 120' ' ' ILE . . . 121.56 -1.2 11.25 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.499 -0.857 . . . . 0.0 112.47 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 41.3 tptt -57.87 -45.02 86.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.103 0.477 . . . . 0.0 110.621 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.589 ' HB ' ' HA3' ' A' ' 121' ' ' GLY . 84.2 m -65.2 -46.93 78.72 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.306 -176.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.943 ' HB ' ' HA ' ' A' ' 120' ' ' ILE . 11.6 p -67.83 -35.84 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 121.029 -0.268 . . . . 0.0 111.219 -176.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -65.26 -43.57 90.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.2 0.524 . . . . 0.0 109.989 178.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -68.49 -35.68 77.87 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.102 177.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.69 HD21 HD11 ' A' ' 170' ' ' ILE . 39.4 tp -60.74 -49.53 77.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.817 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.541 HE21 ' HA ' ' A' ' 137' ' ' GLU . 39.3 mt-30 -66.65 -32.37 73.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.777 0.322 . . . . 0.0 111.129 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -64.05 -43.6 95.04 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.996 0.427 . . . . 0.0 110.703 175.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 6.7 tt -73.88 -48.11 33.3 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.805 -177.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.671 ' HB ' ' HB2' ' A' ' 166' ' ' ALA . 70.5 p -77.65 -29.98 51.9 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -172.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 65.03 28.17 12.48 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.601 -175.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -121.02 169.37 10.56 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.441 177.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.541 ' HA ' HE21 ' A' ' 131' ' ' GLN . 9.0 tp10 -96.18 111.86 23.78 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.835 -178.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.451 ' H ' ' NE2' ' A' ' 131' ' ' GLN . 45.3 t -113.63 107.33 22.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 O-C-N 123.82 0.7 . . . . 0.0 109.391 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.693 HG13 ' HD3' ' A' ' 155' ' ' LYS . 14.9 p -125.87 126.9 70.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.231 0.539 . . . . 0.0 111.63 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.443 HG22 ' HB ' ' A' ' 154' ' ' VAL . 59.9 t -104.94 112.95 65.26 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.906 176.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.638 ' HG3' ' HE3' ' A' ' 155' ' ' LYS . 34.6 Cg_exo -62.01 156.98 46.32 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 123.1 2.533 . . . . 0.0 112.325 177.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -87.4 -26.1 23.48 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.076 -178.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -120.2 115.97 24.68 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.133 178.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.53 ' OE1' ' HB ' ' A' ' 153' ' ' ILE . 22.4 mm-40 -127.77 -86.9 0.57 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.012 0.434 . . . . 0.0 112.034 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -152.77 154.65 31.65 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.299 -175.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.76 165.17 26.59 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.731 2.288 . . . . 0.0 111.2 175.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -69.98 -3.96 18.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.96 -177.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -53.84 -42.57 68.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.277 0.56 . . . . 0.0 110.239 169.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -84.21 -14.12 50.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.832 -179.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 47.27 23.46 0.33 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.024 1.33 . . . . 0.0 112.058 -175.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.467 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 57.8 mt-30 -143.27 142.26 31.3 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 120.994 0.426 . . . . 0.0 111.16 -175.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 19.7 m -131.93 163.46 37.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 174.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.713 HG12 ' HD3' ' A' ' 110' ' ' ARG . 12.8 mt -107.39 141.71 21.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.365 0.602 . . . . 0.0 112.393 -176.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.443 ' HB ' HG22 ' A' ' 140' ' ' VAL . 2.5 p -128.49 139.44 51.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.379 163.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.693 ' HD3' HG13 ' A' ' 139' ' ' VAL . 0.0 OUTLIER -99.44 137.76 37.48 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -176.27 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.447 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 65.1 mt -113.5 111.18 34.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 169.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 4.7 mp -113.69 140.84 31.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 156.28 -168.52 33.62 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.113 -1.041 . . . . 0.0 112.636 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.405 ' CD2' HG12 ' A' ' 103' ' ' VAL . 12.1 t-80 -75.55 160.85 29.7 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.602 -0.299 . . . . 0.0 110.374 -178.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.535 ' O ' ' HG2' ' A' ' 164' ' ' GLN . 30.4 t80 -49.39 -50.0 42.28 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -172.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -71.47 -47.44 55.63 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.194 -177.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -59.27 -44.62 92.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.911 0.386 . . . . 0.0 110.845 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.659 ' O ' ' HG3' ' A' ' 167' ' ' GLN . 31.9 t -63.79 -52.1 61.79 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.173 -177.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.535 ' HG2' ' O ' ' A' ' 160' ' ' PHE . 4.0 pt20 -66.96 -35.21 79.46 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.406 -177.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 47.1 ttp -64.85 -36.72 85.27 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.068 0.461 . . . . 0.0 109.912 177.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.671 ' HB2' ' HB ' ' A' ' 134' ' ' THR . . . -69.47 -43.11 73.88 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.241 174.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.68 ' O ' ' HG2' ' A' ' 171' ' ' ARG . 80.7 mt-30 -51.47 -56.71 11.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.341 -176.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.401 ' HG3' ' N ' ' A' ' 169' ' ' LYS . 0.1 OUTLIER -58.4 -29.78 66.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.036 -179.102 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.803 ' HE2' ' HA ' ' A' ' 169' ' ' LYS . 0.6 OUTLIER -75.17 -36.39 61.5 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 120.862 0.363 . . . . 0.0 110.399 -172.903 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.69 HD11 HD21 ' A' ' 130' ' ' LEU . 1.8 mp -74.61 -42.46 48.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.469 178.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.68 ' HG3' ' OE1' ' A' ' 23' ' ' GLU . 0.8 OUTLIER -64.25 -25.62 68.14 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.391 0.615 . . . . 0.0 109.419 179.284 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -73.06 -44.24 60.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.583 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.551 HG13 ' O ' ' A' ' 170' ' ' ILE . 2.8 pp -70.95 -19.22 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.904 -178.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 170' ' ' ILE . 39.3 mt -58.82 -34.82 71.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.035 0.445 . . . . 0.0 110.365 174.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.17 -34.53 78.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.767 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -66.44 -39.06 88.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.22 0.533 . . . . 0.0 109.973 176.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.609 HG22 ' HD3' ' A' ' 118' ' ' ARG . 39.6 t -63.53 -38.96 83.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.229 176.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -63.58 -44.49 93.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.271 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -70.42 -29.17 65.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.197 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.616 ' OE1' ' HD2' ' A' ' 118' ' ' ARG . 49.6 tt0 -73.42 -37.22 65.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.087 0.47 . . . . 0.0 110.18 173.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -63.11 -20.84 65.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.143 -178.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -50.87 -41.12 57.86 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.183 173.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt 49.96 77.29 0.12 Allowed 'General case' 0 N--CA 1.465 0.284 0 O-C-N 124.003 0.814 . . . . 0.0 112.145 169.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 142.09 88.02 0.11 Allowed Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.656 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 56.05 55.12 7.15 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -176.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 19.3 m -56.11 106.4 0.27 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.044 -176.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 137.02 -36.52 1.96 Allowed Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.348 -177.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 56.88 -150.72 0.43 Allowed 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 122.59 0.356 . . . . 0.0 111.472 177.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 31.7 tp 62.47 69.5 0.61 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.394 0.616 . . . . 0.0 110.86 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -83.56 67.32 9.36 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.685 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.467 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.754 179.03 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' ' G' . . . . . 0.904 " O2'" ' H6 ' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.427 -0.834 0 C4'-C3'-C2' 106.304 3.604 OUTLIER-EPSILON 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . 0.904 ' H6 ' " O2'" ' B' ' 1' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.422 -1.113 0 P-O3'-C3' 122.133 2.028 OUTLIER-EPSILON 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . 0.741 " H1'" ' C5 ' ' B' ' 4' ' ' ' C' . . . . . . . . 0 C2'--C1' 1.518 -0.999 0 P-O3'-C3' 124.269 3.807 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' ' C' . . . . . 1.11 ' H41' ' HA2' ' A' ' 35' ' ' GLY . . . . . . . . 0 O5'--C5' 1.426 -0.875 0 C4'-C3'-C2' 105.728 3.028 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.875 " O4'" " H4'" ' B' ' 4' ' ' ' C' . . . . . . . . 0 P--O3' 1.616 0.711 0 P-O3'-C3' 121.924 1.853 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' ' C' . . . . . 0.479 ' C5 ' ' C4 ' ' B' ' 7' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.429 -0.674 0 C4'-C3'-C2' 104.859 2.159 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . 0.479 ' C4 ' ' C5 ' ' B' ' 6' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.426 -0.853 0 C3'-C2'-C1' 103.212 1.903 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.847 0 C3'-C2'-C1' 100.7 -0.889 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.73 0 N-CA-C 112.191 -0.364 . . . . 0.0 112.191 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.56 86.89 5.17 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.948 0.404 . . . . 0.0 110.212 178.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 61.5 mtm -115.79 92.17 3.82 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.568 -176.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.42 ' HA2' ' HD3' ' A' ' 5' ' ' PRO . . . 161.19 146.61 4.69 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.093 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.42 ' HD3' ' HA2' ' A' ' 4' ' ' GLY . 40.4 Cg_exo -57.59 115.42 2.5 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.972 2.448 . . . . 0.0 112.041 179.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 53.6 m 60.04 21.21 10.36 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.592 -179.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 43.7 m -96.87 61.39 1.82 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.959 0.409 . . . . 0.0 110.685 -177.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.8 m -70.56 123.66 25.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.368 0.604 . . . . 0.0 111.073 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.5 p -89.31 43.63 1.16 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.506 -176.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 171.69 80.36 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.532 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -91.59 55.88 2.86 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.246 0.546 . . . . 0.0 110.167 177.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.571 ' HB1' ' HD2' ' A' ' 14' ' ' PHE . . . -104.59 114.53 63.95 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.166 -176.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -89.81 31.25 0.38 Allowed 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.974 2.449 . . . . 0.0 112.367 178.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.646 ' HB3' ' HG2' ' A' ' 18' ' ' MET . 88.3 m-85 -92.03 92.93 8.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.811 -177.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 58.0 m -101.98 114.65 28.95 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.342 177.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.1 t 73.11 -56.35 0.66 Allowed 'General case' 0 N--CA 1.465 0.324 0 O-C-N 123.959 0.787 . . . . 0.0 110.991 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -95.39 119.89 34.69 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 177.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.906 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 55.5 mtt -117.79 -60.23 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.114 178.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.906 ' HD3' ' HB2' ' A' ' 18' ' ' MET . 42.4 Cg_exo -57.93 -51.73 7.34 Favored 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 122.203 1.935 . . . . 0.0 114.037 176.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.406 ' HD3' ' HB2' ' A' ' 19' ' ' PRO . 6.3 Cg_exo -73.87 75.23 3.21 Favored 'Trans proline' 0 C--N 1.36 1.141 0 C-N-CA 122.162 1.908 . . . . 0.0 112.723 -177.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.45 ' HG2' ' HE1' ' A' ' 14' ' ' PHE . 47.1 mt-10 -75.09 85.23 2.34 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.472 176.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.409 ' OE1' ' HA ' ' A' ' 22' ' ' GLN . 14.5 mm-40 -72.16 152.33 42.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.223 177.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -98.1 117.74 33.14 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.183 -178.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 48.3 m -110.57 107.72 17.43 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.82 176.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.528 ' HB ' HD11 ' A' ' 73' ' ' ILE . 34.8 t -117.9 147.87 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.438 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 13.8 m-70 -110.04 123.36 49.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.862 0.363 . . . . 0.0 110.71 -173.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.585 ' HB ' ' HB ' ' A' ' 71' ' ' VAL . 44.4 t -90.36 142.03 13.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.59 -176.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.24 105.16 14.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.469 -177.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.555 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 13.9 pt -127.9 123.47 22.81 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 120.938 0.399 . . . . 0.0 110.929 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -48.53 143.53 15.75 Favored 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 123.531 2.821 . . . . 0.0 112.638 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.466 ' HA ' HG12 ' A' ' 34' ' ' VAL . . . -58.08 -18.79 27.14 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.101 -176.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.5 mp0 -65.25 -44.28 88.64 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.401 177.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.746 ' HB2' ' HE2' ' A' ' 96' ' ' PHE . . . -93.71 -29.64 15.3 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.196 -171.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.611 ' HA ' HG12 ' A' ' 37' ' ' ILE . 12.2 p -56.92 -27.64 26.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 O-C-N 123.253 0.346 . . . . 0.0 111.201 -174.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.934 ' HA2' ' H41' ' B' ' 4' ' ' ' C' . . . -56.83 -56.82 22.84 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.235 -0.983 . . . . 0.0 111.076 177.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.431 ' HB2' " C1'" ' B' ' 2' ' ' ' C' . . . -75.95 -15.71 60.13 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.607 -176.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.703 HD12 ' HB3' ' A' ' 90' ' ' LYS . 4.8 mm -61.66 -47.16 94.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.242 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.871 HG22 ' HA2' ' A' ' 42' ' ' GLY . 28.9 mt -63.64 -38.61 82.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.203 177.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 81.83 105.34 0.39 Allowed Glycine 0 CA--C 1.52 0.397 0 N-CA-C 115.554 0.982 . . . . 0.0 115.554 164.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.682 ' HA ' ' OP2' ' B' ' 3' ' ' ' A' . 30.0 mmtp 63.64 -81.29 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 168.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.8 ptmt -123.02 10.12 9.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.931 0.396 . . . . 0.0 110.932 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.871 ' HA2' HG22 ' A' ' 38' ' ' ILE . . . 83.34 16.19 69.67 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.408 -0.901 . . . . 0.0 111.786 -177.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -76.4 -28.6 56.77 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.096 0.474 . . . . 0.0 110.048 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.463 ' HB2' ' O ' ' A' ' 38' ' ' ILE . 38.7 m170 -67.04 -30.67 70.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.699 -173.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.793 HD12 HG12 ' A' ' 58' ' ' ILE . 8.9 tt -76.12 -40.33 36.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -175.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.41 ' HD2' " H5'" ' B' ' 6' ' ' ' C' . 0.0 OUTLIER -79.64 -30.98 41.48 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.124 179.857 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.469 ' OE1' ' HD2' ' A' ' 50' ' ' ARG . 6.3 tp60 -64.48 -33.84 76.83 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 173.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.835 HD12 HG12 ' A' ' 56' ' ' ILE . 0.5 OUTLIER -58.73 -47.14 85.65 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.987 176.407 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.636 ' HA ' HD13 ' A' ' 56' ' ' ILE . 57.1 m -58.26 -31.89 67.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.046 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.469 ' HD2' ' OE1' ' A' ' 47' ' ' GLN . 99.6 mtt180 -73.64 -33.66 64.62 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.584 -178.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.735 ' CD2' ' HA ' ' A' ' 48' ' ' LEU . 24.2 m-85 -62.21 -48.12 81.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.108 0.48 . . . . 0.0 110.761 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.419 ' HB1' ' HB1' ' A' ' 79' ' ' ALA . . . -94.42 -10.58 32.05 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.362 -172.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 75.6 m 60.39 40.22 17.66 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.479 0.657 . . . . 0.0 110.259 -173.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -130.7 174.3 10.07 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.533 -178.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.2 t -95.44 107.01 19.14 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.777 0.322 . . . . 0.0 110.262 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.835 HG12 HD12 ' A' ' 48' ' ' LEU . 2.0 mp -110.12 113.1 43.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.032 179.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.445 ' HA ' HD11 ' A' ' 45' ' ' ILE . 53.2 mtmt -138.14 153.31 49.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.291 -179.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.793 HG12 HD12 ' A' ' 45' ' ' ILE . 44.9 mm -90.44 127.32 43.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.924 0.392 . . . . 0.0 110.25 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.925 ' HB2' HG23 ' A' ' 72' ' ' VAL . . . -92.41 115.8 65.39 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.759 -178.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -67.87 131.18 23.41 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.538 2.159 . . . . 0.0 111.371 176.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.446 ' HD3' ' HD3' ' A' ' 69' ' ' ARG . 18.6 Cg_endo -60.09 138.0 79.04 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.54 2.16 . . . . 0.0 110.814 176.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -62.9 -37.73 88.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.084 -176.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.464 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 4.1 p -119.25 136.76 24.66 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.149 175.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 63' ' ' THR . 13.7 Cg_exo -70.18 1.59 4.57 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.722 2.948 . . . . 0.0 113.649 -174.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -99.71 13.24 34.3 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.184 0.516 . . . . 0.0 110.685 -178.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.7 m -78.48 147.18 34.02 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.283 0.563 . . . . 0.0 110.756 178.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -79.48 -32.08 42.48 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.505 -175.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.555 ' HB ' ' O ' ' A' ' 29' ' ' ILE . 1.3 m -123.35 174.79 7.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 121.191 0.52 . . . . 0.0 110.947 -174.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.574 ' HB3' HG21 ' A' ' 34' ' ' VAL . 2.0 tpp85 -118.19 132.54 56.32 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 174.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.499 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 56.1 mtm -91.14 149.5 21.77 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.891 -175.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.585 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 94.3 t -113.17 132.2 62.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 175.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.925 HG23 ' HB2' ' A' ' 59' ' ' ALA . 77.6 t -99.92 111.83 30.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 177.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.816 HG22 HG13 ' A' ' 56' ' ' ILE . 2.5 pp -110.93 128.51 67.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.746 173.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 83.3 m -128.18 106.0 8.75 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.968 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -166.78 164.39 37.74 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.041 -178.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -56.81 136.84 78.71 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 121.859 1.706 . . . . 0.0 109.987 170.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -49.67 -19.58 3.6 Favored 'Trans proline' 0 N--CA 1.48 0.68 0 C-N-CA 123.897 3.065 . . . . 0.0 114.515 -172.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -70.72 -33.07 70.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.0 0.428 . . . . 0.0 110.563 177.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.419 ' HB1' ' HB1' ' A' ' 52' ' ' ALA . . . -78.4 -21.82 48.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.809 -177.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.51 -36.22 64.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.47 176.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.624 ' HA ' ' NE2' ' A' ' 164' ' ' GLN . 69.1 t80 -59.3 -47.09 86.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.469 177.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 36.0 tptt -63.89 -52.56 59.36 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.048 -176.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.69 -53.64 14.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.474 -174.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -71.38 -29.36 64.85 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -172.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -53.59 -36.81 55.13 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 120.365 -0.922 . . . . 0.0 111.739 175.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.448 ' HD2' ' N ' ' A' ' 86' ' ' ARG . 4.5 mpt_? -80.11 -32.02 39.11 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.532 0.197 . . . . 0.0 111.532 177.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -68.5 -44.43 83.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 121.119 -0.232 . . . . 0.0 110.422 -176.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.699 ' HA ' HD23 ' A' ' 91' ' ' LEU . 6.9 m-85 -66.38 -32.97 74.68 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.189 0.519 . . . . 0.0 110.274 177.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -66.02 -28.66 73.85 Favored Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.051 177.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.703 ' HB3' HD12 ' A' ' 37' ' ' ILE . 30.7 mmtp -78.43 -17.62 56.09 Favored 'General case' 0 N--CA 1.443 -0.787 0 O-C-N 122.388 -0.478 . . . . 0.0 111.332 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.699 HD23 ' HA ' ' A' ' 88' ' ' TYR . 2.6 mm? -65.34 -34.04 77.38 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 120.223 -0.591 . . . . 0.0 109.876 166.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.922 ' HE3' HG22 ' A' ' 103' ' ' VAL . 10.4 mmtp -72.79 -26.07 61.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.37 177.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.441 ' HB2' ' HA ' ' A' ' 90' ' ' LYS . 8.3 tp10 -63.47 -31.29 72.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.394 178.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.49 ' HG3' ' HA ' ' A' ' 33' ' ' ALA . 20.9 mm-40 -97.65 9.22 43.09 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.039 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 65.3 t30 56.8 41.88 27.42 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.654 176.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.746 ' HE2' ' HB2' ' A' ' 33' ' ' ALA . 41.9 m-85 -83.79 -33.08 25.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.04 0.448 . . . . 0.0 110.237 174.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.693 ' HB2' ' HE2' ' A' ' 92' ' ' LYS . 24.2 m-85 -124.58 24.42 7.85 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.272 -176.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 60.19 175.13 1.07 Allowed Glycine 0 CA--C 1.521 0.429 0 CA-C-N 115.659 -0.7 . . . . 0.0 113.717 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -75.32 -52.13 0.11 Allowed 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.667 2.245 . . . . 0.0 112.083 174.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -100.15 -14.35 18.57 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.871 0.322 . . . . 0.0 111.871 -174.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.572 ' HB3' ' O ' ' A' ' 97' ' ' PHE . 10.8 tp10 -67.41 154.99 40.08 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 177.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -65.13 137.59 57.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.402 -176.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.922 HG22 ' HE3' ' A' ' 92' ' ' LYS . 1.0 OUTLIER -73.96 129.08 36.59 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.63 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 172.608 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.6 mmmm -129.4 87.01 2.49 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 172.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.67 ' HB3' ' CE2' ' A' ' 88' ' ' TYR . 2.1 tm? -125.04 141.45 52.12 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -176.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.571 ' H ' HD22 ' A' ' 105' ' ' LEU . 39.8 tt0 -95.47 127.51 41.56 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.578 -170.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.519 HG21 ' NE2' ' A' ' 167' ' ' GLN . 0.1 OUTLIER -108.39 147.66 31.24 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 171.519 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -114.05 119.53 37.48 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.887 0.375 . . . . 0.0 110.088 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.428 ' CG1' ' HB ' ' A' ' 154' ' ' VAL . 23.1 pt -107.43 128.09 62.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.121 177.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.684 ' HD3' HG12 ' A' ' 153' ' ' ILE . 8.8 mmt180 -74.34 123.78 25.25 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.19 177.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.658 HG22 ' HB3' ' A' ' 115' ' ' ALA . 6.4 p -134.07 142.35 42.94 Favored Pre-proline 0 N--CA 1.444 -0.773 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.566 -175.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.442 ' HD2' HG22 ' A' ' 111' ' ' VAL . 31.7 Cg_exo -56.16 149.3 54.78 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 123.114 2.543 . . . . 0.0 111.978 179.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.62 -47.88 69.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.2 0.524 . . . . 0.0 111.066 -178.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.4 m -67.43 -28.9 68.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.661 -177.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.73 ' HB1' HD22 ' A' ' 174' ' ' LEU . . . -67.01 -28.83 68.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.933 -175.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.479 ' HB2' HG21 ' A' ' 152' ' ' VAL . . . -64.66 -27.0 68.63 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.099 0.476 . . . . 0.0 111.225 177.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -79.25 -31.09 43.41 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.664 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.584 ' HD3' HG22 ' A' ' 177' ' ' VAL . 23.1 ttt85 -91.63 -28.63 17.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.081 0.441 . . . . 0.0 111.711 -176.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.2 p -61.14 -24.38 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 121.13 0.491 . . . . 0.0 110.826 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.72 ' HA ' ' HB ' ' A' ' 127' ' ' VAL . 47.1 mm -77.85 -51.43 17.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.158 176.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 71.94 77.66 0.53 Allowed Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.18 -175.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -56.03 -34.51 65.94 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.807 0.336 . . . . 0.0 111.785 -175.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -99.65 22.83 10.35 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.529 -177.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -152.63 -154.95 6.88 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.226 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.546 ' HD2' ' HB2' ' A' ' 129' ' ' GLU . 3.7 pptp? -137.06 25.75 2.99 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.03 0.443 . . . . 0.0 110.048 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.517 ' O ' ' HG ' ' A' ' 130' ' ' LEU . 9.3 t -63.27 -34.58 77.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.022 -173.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.72 ' HB ' ' HA ' ' A' ' 120' ' ' ILE . 9.5 p -67.47 -37.69 79.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-O 121.044 0.449 . . . . 0.0 110.549 177.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.491 ' HA ' ' OE1' ' A' ' 131' ' ' GLN . 3.6 t-20 -74.09 -34.55 64.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.515 0.674 . . . . 0.0 109.579 178.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.546 ' HB2' ' HD2' ' A' ' 125' ' ' LYS . 69.4 tt0 -65.33 -37.46 87.15 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.059 177.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 126' ' ' THR . 87.0 mt -56.78 -48.83 77.0 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.406 173.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.491 ' OE1' ' HA ' ' A' ' 128' ' ' ASN . 80.8 mt-30 -57.35 -45.95 83.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.34 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -71.59 -36.15 70.75 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.834 0.349 . . . . 0.0 111.146 -177.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -73.03 -46.4 52.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.791 -177.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.582 HG21 ' HA ' ' A' ' 166' ' ' ALA . 77.0 p -88.07 -18.07 29.71 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.033 0.382 . . . . 0.0 112.033 -174.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 65.98 22.26 11.26 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 123.847 0.717 . . . . 0.0 110.491 -175.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.576 ' HB2' ' HB1' ' A' ' 162' ' ' ALA . . . -122.3 160.8 24.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.63 -177.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.645 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 10.9 tp10 -88.95 111.73 22.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.487 178.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 54.2 t -104.22 106.04 19.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.582 178.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.464 ' O ' ' HD2' ' A' ' 155' ' ' LYS . 5.0 p -128.7 124.45 61.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.322 0.582 . . . . 0.0 111.156 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.5 ' HB ' HG22 ' A' ' 154' ' ' VAL . 11.2 p -122.14 128.85 25.35 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.71 178.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.648 ' HG3' ' HE3' ' A' ' 155' ' ' LYS . 13.1 Cg_exo -68.24 154.92 71.14 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.552 2.168 . . . . 0.0 111.565 -178.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 -93.8 15.8 15.65 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 176.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.564 ' CG ' ' H ' ' A' ' 144' ' ' GLN . 6.6 p-10 -136.24 -91.06 0.28 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.8 177.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.921 ' HG2' ' H ' ' A' ' 153' ' ' ILE . 6.0 tp-100 58.13 88.88 0.06 Allowed 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.613 0.765 . . . . 0.0 112.351 174.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.636 ' HB ' ' HD2' ' A' ' 146' ' ' PRO . 59.5 p 61.35 161.18 0.11 Allowed Pre-proline 0 N--CA 1.473 0.689 0 C-N-CA 124.225 1.01 . . . . 0.0 112.51 176.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.636 ' HD2' ' HB ' ' A' ' 145' ' ' THR . 57.7 Cg_endo -72.21 157.86 53.03 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.261 1.974 . . . . 0.0 112.285 178.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -73.06 8.87 1.39 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.566 -176.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -57.0 -47.48 80.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.232 0.539 . . . . 0.0 110.143 174.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . 0.499 ' O ' ' HG2' ' A' ' 150' ' ' GLU . 56.1 t30 -90.85 -8.75 48.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.149 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 149' ' ' ASN . 9.9 pt-20 45.03 36.82 2.14 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 114.44 -1.254 . . . . 0.0 111.642 178.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -148.2 138.97 23.02 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.573 -176.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.493 HG23 ' CG1' ' A' ' 111' ' ' VAL . 21.3 m -120.22 -176.15 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.92 -174.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.921 ' H ' ' HG2' ' A' ' 144' ' ' GLN . 49.9 mt -134.45 128.89 52.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.306 -176.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.5 HG22 ' HB ' ' A' ' 140' ' ' VAL . 53.9 t -95.82 140.28 17.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 173.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.648 ' HE3' ' HG3' ' A' ' 141' ' ' PRO . 0.0 OUTLIER -104.13 134.92 46.56 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 177.657 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.645 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 70.6 mt -118.95 112.06 36.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.914 177.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.421 HD12 ' N ' ' A' ' 157' ' ' ILE . 4.4 mp -110.47 138.62 37.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.793 -178.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 149.72 -157.13 27.1 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.372 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -81.45 159.8 24.16 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 -177.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.504 ' HB3' ' CB ' ' A' ' 88' ' ' TYR . 7.6 p90 -57.89 -47.86 81.56 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.719 -175.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.408 ' O ' ' HG3' ' A' ' 165' ' ' MET . 19.0 m-85 -54.37 -49.89 68.78 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.626 0.251 . . . . 0.0 110.721 177.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.576 ' HB1' ' HB2' ' A' ' 136' ' ' ALA . . . -58.25 -53.47 57.88 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.578 -178.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.466 ' O ' ' HG3' ' A' ' 167' ' ' GLN . 30.0 m -59.84 -49.69 76.73 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.979 -179.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.624 ' NE2' ' HA ' ' A' ' 81' ' ' PHE . 21.6 mt-30 -56.51 -30.84 63.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.764 178.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.408 ' HG3' ' O ' ' A' ' 161' ' ' TYR . 91.0 mtp -77.96 -42.67 32.09 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.743 0.306 . . . . 0.0 110.798 175.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.582 ' HA ' HG21 ' A' ' 134' ' ' THR . . . -69.4 -41.56 76.27 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -174.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.519 ' NE2' HG21 ' A' ' 107' ' ' THR . 71.9 mt-30 -51.93 -57.77 8.44 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.961 0.41 . . . . 0.0 111.215 -176.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 21.5 ptt180 -68.21 -28.15 67.0 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.533 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.769 ' HA ' ' HE3' ' A' ' 169' ' ' LYS . 0.1 OUTLIER -69.56 -44.9 69.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.851 0.358 . . . . 0.0 110.393 -177.832 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.588 ' O ' ' HG ' ' A' ' 174' ' ' LEU . 1.8 mp -71.54 -40.46 71.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 177.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 27.2 mmm-85 -58.88 -26.23 64.07 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.147 0.499 . . . . 0.0 110.974 174.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -77.87 -46.55 21.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.966 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.547 HG13 ' O ' ' A' ' 170' ' ' ILE . 2.7 pp -66.28 -18.88 24.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-O 121.0 0.429 . . . . 0.0 110.823 -177.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.73 HD22 ' HB1' ' A' ' 115' ' ' ALA . 17.7 mt -57.37 -27.55 62.39 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.247 175.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.7 ' HA ' ' HD3' ' A' ' 178' ' ' LYS . . . -54.87 -33.46 61.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.515 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -70.22 -33.19 71.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.927 0.394 . . . . 0.0 110.568 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.584 HG22 ' HD3' ' A' ' 118' ' ' ARG . 40.3 t -69.32 -40.39 80.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.389 0.614 . . . . 0.0 109.736 178.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.7 ' HD3' ' HA ' ' A' ' 175' ' ' ALA . 50.9 mtpt -59.95 -50.52 73.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.073 176.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -64.09 -34.67 78.57 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.312 -177.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 23.5 tp60 -60.5 -35.83 76.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.721 -177.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 24.2 m-70 -83.69 -21.13 32.46 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.649 -178.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -85.01 -56.97 3.29 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.003 0.43 . . . . 0.0 110.488 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.41 ' HD2' ' HA ' ' A' ' 183' ' ' LYS . 19.8 tptm -93.5 61.48 3.22 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.729 0.776 . . . . 0.0 110.666 -177.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -73.94 127.9 10.6 Favored Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 169.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -61.18 112.29 2.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.141 0.496 . . . . 0.0 111.268 -175.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 2.0 m -81.81 70.43 8.71 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.154 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -65.48 -62.29 4.96 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.554 -178.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -145.83 101.92 3.6 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 62.7 tp -154.44 -51.62 0.09 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.0 -177.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -111.86 115.55 29.2 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.108 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.584 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.695 177.74 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' ' G' . . . . . 0.541 " H2'" ' C6 ' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.427 -0.825 0 C3'-C2'-C1' 104.445 3.272 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . 0.794 " O2'" " H5'" ' B' ' 3' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.422 -1.119 0 O4'-C4'-C3' 100.87 -3.307 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . 0.794 " H5'" " O2'" ' B' ' 2' ' ' ' C' . . . . . . . . 0 C2'--C1' 1.517 -1.11 1 P-O3'-C3' 125.846 5.122 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' ' C' . . . . . 0.934 ' H41' ' HA2' ' A' ' 35' ' ' GLY . . . . . . . . 0 O5'--C5' 1.426 -0.879 0 C4'-C3'-C2' 105.708 3.008 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.816 " O4'" " H4'" ' B' ' 4' ' ' ' C' . . . . . . . . 0 P--O3' 1.615 0.667 0 P-O3'-C3' 122.518 2.348 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' ' C' . . . . . 0.574 " O5'" " H2'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.429 -0.715 1 C4'-C3'-C2' 106.72 4.02 OUTLIER-DELTA 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.871 0 O4'-C1'-N19 109.134 0.934 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.427 -0.799 0 O4'-C4'-C3' 103.945 -1.111 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.65 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.08 74.58 1.51 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.855 0.359 . . . . 0.0 111.525 -177.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.44 -56.8 4.24 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 171.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -118.68 153.68 16.86 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 174.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.76 122.22 11.1 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 122.5 2.133 . . . . 0.0 111.667 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.3 p -59.99 118.23 6.02 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.627 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 17.2 m -77.67 79.27 4.16 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.763 -177.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.4 m -93.37 152.99 3.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.555 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.4 m -132.03 78.77 1.83 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.604 177.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -128.46 -62.55 0.12 Allowed Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.479 -177.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -146.67 96.08 2.7 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.005 0.431 . . . . 0.0 110.398 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -117.57 107.77 44.24 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.743 -178.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -74.48 159.36 43.16 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.828 2.352 . . . . 0.0 111.759 178.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -88.63 33.42 0.77 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.735 0.779 . . . . 0.0 109.969 -179.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.4 ' O ' ' HD3' ' A' ' 19' ' ' PRO . 4.5 p -84.13 105.55 15.08 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.82 177.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.3 m -70.73 -17.57 62.81 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.326 -0.397 . . . . 0.0 112.022 -173.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -101.12 63.72 1.01 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.55 0.69 . . . . 0.0 110.363 177.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.766 ' H ' ' HD2' ' A' ' 19' ' ' PRO . 27.1 ttt -163.56 -45.49 0.0 OUTLIER Pre-proline 0 CA--C 1.542 0.654 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.852 -178.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.766 ' HD2' ' H ' ' A' ' 18' ' ' MET . 44.5 Cg_exo -37.25 -50.66 1.62 Allowed 'Trans proline' 0 C--N 1.366 1.491 0 C-N-CA 123.432 2.755 . . . . 0.0 116.289 -174.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.47 ' HD3' ' HB2' ' A' ' 19' ' ' PRO . 59.2 Cg_endo -72.56 -28.74 14.05 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 121.323 1.349 . . . . 0.0 113.143 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 66.94 -57.79 0.41 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.911 0.884 . . . . 0.0 112.003 -175.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.524 ' HB2' HG22 ' A' ' 74' ' ' THR . 64.2 mt-30 -132.93 136.49 46.15 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -178.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.442 ' OE1' ' HD3' ' A' ' 77' ' ' PRO . 1.5 mp0 -73.57 113.26 10.48 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.354 0.597 . . . . 0.0 111.619 -174.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 4.9 m -92.66 109.56 20.98 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.134 177.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.8 m -124.14 152.9 30.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 10.2 m170 -113.81 132.03 56.02 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -174.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.713 ' HB ' ' CG1' ' A' ' 71' ' ' VAL . 20.8 t -108.2 141.02 24.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.559 -177.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.674 ' CE2' HG11 ' A' ' 68' ' ' VAL . 47.2 t80 -97.6 104.87 16.94 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 123.531 0.732 . . . . 0.0 110.198 -174.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.544 ' C ' HG23 ' A' ' 68' ' ' VAL . 11.1 pt -124.5 116.58 26.68 Favored Pre-proline 0 C--N 1.326 -0.435 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.264 176.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.515 ' HA ' ' HA ' ' A' ' 68' ' ' VAL . 18.7 Cg_endo -58.9 147.98 86.61 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.57 2.847 . . . . 0.0 112.572 -177.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.636 ' HA ' HG12 ' A' ' 34' ' ' VAL . . . -54.08 -25.71 23.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.579 -1.191 . . . . 0.0 112.854 -175.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -70.3 -23.65 62.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.909 0.385 . . . . 0.0 111.182 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.578 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -114.12 -30.8 6.54 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.577 -177.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.636 HG12 ' HA ' ' A' ' 31' ' ' ALA . 13.0 p -51.95 -33.8 16.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 O-C-N 123.24 0.337 . . . . 0.0 111.661 -173.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 1.058 ' HA2' ' H41' ' B' ' 4' ' ' ' C' . . . -57.65 -56.94 22.43 Favored Glycine 0 N--CA 1.439 -1.129 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.974 -179.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.526 ' HA ' " H5'" ' B' ' 3' ' ' ' A' . . . -78.74 -14.19 59.41 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.79 -0.205 . . . . 0.0 111.318 -175.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.662 HD12 ' HB3' ' A' ' 90' ' ' LYS . 8.3 mm -61.71 -43.01 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 175.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.807 HD12 ' C5 ' ' B' ' 4' ' ' ' C' . 26.3 mt -55.88 -53.48 37.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.532 176.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.32 113.63 0.45 Allowed Glycine 0 CA--C 1.521 0.462 0 C-N-CA 120.515 -0.85 . . . . 0.0 114.942 168.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.413 ' HA ' ' HD2' ' A' ' 40' ' ' LYS . 46.4 tptt 48.82 77.64 0.1 Allowed 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.191 0.996 . . . . 0.0 113.009 170.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.656 ' HA ' ' OP2' ' B' ' 4' ' ' ' C' . 0.0 OUTLIER 62.68 7.81 2.68 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.945 173.893 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.573 ' O ' HG22 ' A' ' 45' ' ' ILE . . . 76.58 8.67 86.15 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.122 -1.037 . . . . 0.0 111.759 -177.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.494 ' HA ' ' HE3' ' A' ' 46' ' ' LYS . 50.8 mt-30 -62.87 -43.55 98.5 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 40.7 m-70 -78.74 -26.62 44.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.695 -177.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.573 HG22 ' O ' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -72.1 -42.52 67.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 120.995 -0.282 . . . . 0.0 110.721 -176.629 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.494 ' HE3' ' HA ' ' A' ' 43' ' ' GLN . 18.9 pttp -81.43 -24.54 36.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.151 0.5 . . . . 0.0 110.425 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -69.26 -30.86 69.07 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.261 174.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.796 ' HA ' ' CE2' ' A' ' 51' ' ' PHE . 6.4 tt -60.77 -38.14 84.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.719 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.635 ' HA ' HD13 ' A' ' 56' ' ' ILE . 22.7 m -62.4 -36.15 81.43 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.035 177.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -69.41 -47.98 62.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.139 -173.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.796 ' CE2' ' HA ' ' A' ' 48' ' ' LEU . 14.2 p90 -71.32 -24.6 62.15 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.235 -174.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -90.78 -9.35 46.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.008 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.2 t 60.58 32.81 20.46 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.724 -178.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -128.17 174.41 9.28 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.305 -176.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.424 ' HB2' ' HB ' ' A' ' 74' ' ' THR . 20.2 m -104.51 101.73 11.38 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.629 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.635 HD13 ' HA ' ' A' ' 49' ' ' SER . 3.2 mp -111.38 122.49 65.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.844 178.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -147.09 142.41 27.36 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.209 178.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.662 ' HB ' ' N1 ' ' B' ' 5' ' ' ' A' . 35.2 mm -75.07 124.45 32.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 177.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.942 ' HB2' HG23 ' A' ' 72' ' ' VAL . . . -77.72 133.64 66.2 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.127 -174.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 59' ' ' ALA . 22.8 Cg_exo -65.33 127.01 17.32 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.817 2.345 . . . . 0.0 112.242 178.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -74.04 168.25 25.24 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.605 2.203 . . . . 0.0 111.6 177.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -79.32 -37.01 38.64 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.875 0.369 . . . . 0.0 110.503 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 68.8 p -127.39 149.38 69.75 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 173.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -69.41 -0.02 6.03 Favored 'Trans proline' 0 CA--C 1.529 0.252 0 C-N-CA 123.001 2.467 . . . . 0.0 113.284 -176.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -116.58 13.89 15.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.687 -0.233 . . . . 0.0 111.235 -178.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 74.8 m -52.96 134.25 37.81 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.247 0.546 . . . . 0.0 111.435 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -70.92 -19.57 62.57 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.697 -177.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.674 HG11 ' CE2' ' A' ' 28' ' ' PHE . 7.4 p -139.01 147.74 24.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 175.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.541 ' HB3' HG21 ' A' ' 34' ' ' VAL . 12.6 ttm180 -123.1 126.62 47.39 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 175.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.848 ' HG3' ' HB3' ' A' ' 59' ' ' ALA . 18.7 ptt? -83.18 146.67 28.49 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.316 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.713 ' CG1' ' HB ' ' A' ' 27' ' ' VAL . 3.5 p -110.08 135.68 48.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 173.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.942 HG23 ' HB2' ' A' ' 59' ' ' ALA . 51.4 t -100.47 110.17 26.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.4 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.417 HG22 HG13 ' A' ' 56' ' ' ILE . 10.0 pt -113.23 142.45 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.802 174.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.524 HG22 ' HB2' ' A' ' 22' ' ' GLN . 20.5 m -137.34 105.95 5.85 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.987 -176.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -166.96 162.51 36.3 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.93 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -59.71 137.26 75.91 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.398 2.065 . . . . 0.0 110.411 172.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.448 ' HA ' ' HB3' ' A' ' 80' ' ' GLN . 63.8 Cg_exo -40.04 -37.99 1.9 Allowed 'Trans proline' 0 N--CA 1.478 0.584 0 C-N-CA 124.352 3.368 . . . . 0.0 115.517 -171.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -72.29 -43.02 64.85 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 121.798 -0.564 . . . . 0.0 111.275 -178.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.38 -27.72 61.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.449 0.643 . . . . 0.0 109.693 175.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.448 ' HB3' ' HA ' ' A' ' 77' ' ' PRO . 35.1 tt0 -61.43 -48.51 80.86 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.012 173.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.772 ' HD1' ' HG3' ' A' ' 164' ' ' GLN . 80.6 t80 -59.16 -39.67 83.17 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.833 176.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.6 tptp -53.42 -53.04 57.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.398 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.524 ' HB1' HD21 ' A' ' 48' ' ' LEU . . . -72.0 -47.36 52.59 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.107 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.584 ' O ' HG22 ' A' ' 87' ' ' ILE . 24.5 tt0 -66.93 -31.95 72.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.552 -172.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -57.38 -36.78 78.19 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.285 175.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.459 ' HD3' ' HA ' ' A' ' 86' ' ' ARG . 27.8 mmt180 -80.4 -27.21 38.16 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.668 -0.266 . . . . 0.0 111.239 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.584 HG22 ' O ' ' A' ' 84' ' ' GLN . 0.3 OUTLIER -67.82 -41.78 85.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 178.941 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.615 ' CE2' ' HB3' ' A' ' 105' ' ' LEU . 7.0 m-85 -68.51 -31.13 70.16 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-O 121.164 0.507 . . . . 0.0 109.889 173.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -61.71 -29.28 71.66 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.474 -0.784 . . . . 0.0 112.119 177.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.662 ' HB3' HD12 ' A' ' 37' ' ' ILE . 73.9 mmtt -66.69 -37.71 85.3 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 177.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.671 ' HB3' ' CE1' ' A' ' 97' ' ' PHE . 3.4 mm? -59.55 -36.75 76.77 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.41 0.624 . . . . 0.0 110.597 174.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.77 ' HE3' ' HB ' ' A' ' 103' ' ' VAL . 0.1 OUTLIER -75.35 -37.82 60.45 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.277 -177.565 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -67.93 -27.48 66.65 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.182 -178.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.449 ' HB3' ' CE2' ' A' ' 96' ' ' PHE . 17.3 mm-40 -89.27 5.27 45.65 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.189 0.519 . . . . 0.0 110.859 178.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 58.69 41.14 22.45 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.986 172.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.449 ' CE2' ' HB3' ' A' ' 94' ' ' GLU . 70.2 m-85 -89.98 -9.51 48.43 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.2 0.524 . . . . 0.0 109.921 172.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.671 ' CE1' ' HB3' ' A' ' 91' ' ' LEU . 60.6 m-85 -133.78 -44.45 0.81 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.423 -178.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 125.98 165.08 11.94 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -178.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.88 -66.66 0.04 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.237 0 C-N-CA 122.688 2.259 . . . . 0.0 112.476 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -94.36 -9.45 35.79 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.133 0.419 . . . . 0.0 112.133 -175.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -62.49 144.63 55.76 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 173.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -65.17 137.64 57.76 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.014 -177.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.77 ' HB ' ' HE3' ' A' ' 92' ' ' LYS . 14.8 p -80.46 138.58 19.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.644 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -128.2 90.81 3.14 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 175.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.615 ' HB3' ' CE2' ' A' ' 88' ' ' TYR . 2.3 tm? -133.38 126.3 30.99 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.261 0.553 . . . . 0.0 110.408 -173.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.782 ' HG3' HG13 ' A' ' 157' ' ' ILE . 41.1 mp0 -66.81 133.52 50.27 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.963 -1.017 . . . . 0.0 113.612 -175.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.534 HG21 ' NE2' ' A' ' 167' ' ' GLN . 0.2 OUTLIER -111.97 140.43 46.64 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.142 165.852 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -121.69 119.8 32.84 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 32.8 pt -125.9 153.64 34.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.112 0.482 . . . . 0.0 111.292 -178.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.48 ' HD3' HG12 ' A' ' 153' ' ' ILE . 59.2 mmt-85 -87.31 132.24 34.0 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.872 -175.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.502 ' O ' ' HG3' ' A' ' 151' ' ' GLN . 5.2 m -129.77 147.09 63.96 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 171.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.72 ' HD2' HD22 ' A' ' 174' ' ' LEU . 31.4 Cg_exo -57.43 145.23 89.2 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.28 1.986 . . . . 0.0 110.911 175.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -51.09 -49.61 60.35 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.787 0.327 . . . . 0.0 111.552 -173.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 36.3 t -65.52 -33.25 75.49 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.137 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.18 -26.69 67.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.007 -178.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.19 -29.18 70.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.268 0.556 . . . . 0.0 110.392 177.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -75.12 -38.21 40.68 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.666 177.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.522 ' HD2' HG22 ' A' ' 177' ' ' VAL . 25.3 ttm180 -74.66 -34.23 62.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.371 0.129 . . . . 0.0 110.997 -178.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.477 HG13 HG21 ' A' ' 140' ' ' VAL . 10.2 p -66.8 -32.17 56.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-O 120.834 0.35 . . . . 0.0 110.579 179.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 76.3 mt -72.43 -43.73 63.37 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 CA-C-O 121.277 0.561 . . . . 0.0 109.656 173.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.904 ' HA3' ' HB ' ' A' ' 126' ' ' THR . . . 69.77 53.07 17.07 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 119.918 -1.134 . . . . 0.0 110.639 -174.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -63.2 -16.62 60.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.35 0.595 . . . . 0.0 110.585 -175.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -76.18 -21.56 56.36 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.698 178.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -164.06 -98.97 0.13 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 119.854 -1.165 . . . . 0.0 114.023 -176.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -142.25 28.72 1.67 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -168.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.904 ' HB ' ' HA3' ' A' ' 121' ' ' GLY . 26.1 m -62.91 -46.51 87.48 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -175.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.0 p -67.85 -29.91 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-O 121.017 0.437 . . . . 0.0 110.663 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -63.72 -40.61 97.19 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 177.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -64.45 -41.56 96.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.003 177.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 73.6 mt -60.13 -49.31 78.13 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.621 178.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -64.2 -30.13 71.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.631 -177.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -72.55 -42.59 64.53 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.886 0.375 . . . . 0.0 110.298 177.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 94.4 mt -68.61 -49.67 57.47 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.27 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 74.1 p -82.26 -35.37 28.16 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.317 -171.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 66.97 27.49 8.82 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 123.894 0.746 . . . . 0.0 109.9 -170.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.695 ' HB2' ' HB1' ' A' ' 162' ' ' ALA . . . -122.92 163.95 19.38 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.707 -178.024 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.486 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 9.7 mm-40 -88.25 111.58 21.83 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.421 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 42.8 t -97.75 105.83 17.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.434 ' O ' ' HD2' ' A' ' 155' ' ' LYS . 54.0 t -112.81 111.6 36.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.232 -175.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.477 HG21 HG13 ' A' ' 119' ' ' VAL . 34.8 t -106.03 126.5 30.46 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 177.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.439 ' HG2' ' HB3' ' A' ' 144' ' ' GLN . 88.1 Cg_endo -83.81 143.23 10.51 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.766 2.311 . . . . 0.0 113.358 -174.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 39.7 mmt180 -94.1 -26.88 16.55 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.467 173.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -69.78 -35.44 74.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.036 -0.983 . . . . 0.0 110.567 178.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.439 ' HB3' ' HG2' ' A' ' 141' ' ' PRO . 60.2 tt0 -92.86 90.83 7.16 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 175.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.429 ' N ' ' HD3' ' A' ' 146' ' ' PRO . 16.0 p -145.98 58.01 4.43 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.75 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.495 ' HB2' ' HB3' ' A' ' 148' ' ' GLU . 49.5 Cg_endo -92.8 133.07 1.03 Allowed 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.548 2.165 . . . . 0.0 112.986 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -71.07 -12.88 61.75 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 172.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.495 ' HB3' ' HB2' ' A' ' 146' ' ' PRO . 30.9 tt0 -44.78 -48.55 10.91 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 114.315 -1.312 . . . . 0.0 112.599 178.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -114.75 -0.07 13.67 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.174 -175.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 44.41 32.45 0.72 Allowed 'General case' 0 N--CA 1.474 0.748 0 O-C-N 124.469 1.105 . . . . 0.0 111.045 -172.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.502 ' HG3' ' O ' ' A' ' 111' ' ' VAL . 28.4 tt0 -157.86 142.74 16.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.402 -174.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.401 HG12 ' HD2' ' A' ' 146' ' ' PRO . 31.0 m -133.88 -177.01 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.792 -178.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.48 HG12 ' HD3' ' A' ' 110' ' ' ARG . 55.8 mt -120.48 137.99 52.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.922 0.391 . . . . 0.0 111.726 -178.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.5 p -104.49 138.41 29.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.565 169.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.468 ' H ' ' HD2' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -101.23 126.31 47.95 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.664 -177.109 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.486 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 58.9 mt -109.24 118.71 57.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.107 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.782 HG13 ' HG3' ' A' ' 106' ' ' GLU . 4.0 mp -114.36 138.33 44.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 143.92 -163.01 27.75 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.525 178.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.543 ' HA ' HG13 ' A' ' 103' ' ' VAL . 10.6 p-80 -83.73 145.1 28.92 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.73 0.3 . . . . 0.0 110.41 178.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.503 ' HD1' HG11 ' A' ' 103' ' ' VAL . 46.0 p90 -57.72 -24.44 56.91 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -168.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.407 ' HB2' ' HD2' ' A' ' 159' ' ' HIS . 94.2 m-85 -61.43 -44.5 97.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.408 0.623 . . . . 0.0 109.625 174.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.695 ' HB1' ' HB2' ' A' ' 136' ' ' ALA . . . -74.6 -40.27 61.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.073 178.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.448 ' O ' ' HG3' ' A' ' 167' ' ' GLN . 19.3 m -55.21 -51.33 66.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.511 178.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.772 ' HG3' ' HD1' ' A' ' 81' ' ' PHE . 7.8 mm100 -57.79 -45.02 86.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.604 177.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 68.8 mtp -61.45 -40.7 95.44 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.8 0.333 . . . . 0.0 110.893 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.464 ' HB3' HD13 ' A' ' 156' ' ' ILE . . . -69.31 -46.2 67.7 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.163 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.534 ' NE2' HG21 ' A' ' 107' ' ' THR . 62.7 mt-30 -55.31 -52.18 64.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.241 -178.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' A' ' 164' ' ' GLN . 6.7 ptp85 -66.42 -32.32 73.63 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.18 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.997 ' HA ' ' HE3' ' A' ' 169' ' ' LYS . 0.6 OUTLIER -77.24 -42.82 35.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.91 0.386 . . . . 0.0 110.965 -173.58 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.518 ' O ' ' HG ' ' A' ' 174' ' ' LEU . 1.8 mp -70.4 -44.71 77.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.923 177.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -59.26 -25.9 64.47 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.819 0.343 . . . . 0.0 110.566 175.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -73.82 -48.29 32.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.175 -179.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.404 ' HA ' HE21 ' A' ' 176' ' ' GLN . 36.1 pt -66.92 -20.53 27.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.112 -177.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.72 HD22 ' HD2' ' A' ' 112' ' ' PRO . 15.5 mt -59.23 -40.5 86.07 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.911 0.386 . . . . 0.0 110.252 176.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.493 ' O ' ' HG2' ' A' ' 179' ' ' GLN . . . -65.91 -37.39 85.95 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.216 178.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . 0.404 HE21 ' HA ' ' A' ' 173' ' ' ILE . 48.4 mt-30 -65.99 -32.19 73.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.887 177.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.522 HG22 ' HD2' ' A' ' 118' ' ' ARG . 75.2 t -73.34 -35.57 46.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.056 0.455 . . . . 0.0 110.207 175.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -64.58 -31.03 72.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.158 0.504 . . . . 0.0 109.904 175.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.493 ' HG2' ' O ' ' A' ' 175' ' ' ALA . 73.3 mm-40 -70.45 -24.35 62.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.622 175.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -68.28 -29.59 68.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.129 0.49 . . . . 0.0 109.843 178.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 -71.26 -31.0 66.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.138 176.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -70.91 -56.65 5.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.645 174.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -159.18 -62.0 0.07 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.763 179.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 87.79 74.71 1.28 Allowed Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.779 -178.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -82.07 147.72 28.96 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 19.8 m 71.14 9.47 6.67 Favored 'General case' 0 N--CA 1.466 0.375 0 O-C-N 123.818 0.698 . . . . 0.0 111.218 -176.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -92.06 157.92 24.5 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.84 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -92.96 103.97 16.24 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 94.5 mt -96.17 137.57 35.05 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.809 -178.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -121.14 62.98 0.88 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.484 0.659 . . . . 0.0 109.536 177.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.514 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.563 179.384 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' ' G' . . . . . 1.017 " O2'" ' H6 ' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.424 -0.981 0 C4'-C3'-C2' 106.576 3.876 OUTLIER-EPSILON 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . 1.017 ' H6 ' " O2'" ' B' ' 1' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.425 -0.945 0 P-O3'-C3' 122.216 2.097 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . 0.694 " H1'" ' C5 ' ' B' ' 4' ' ' ' C' . . . . . . . . 0 C2'--C1' 1.517 -1.081 0 C5'-C4'-O4' 112.522 2.373 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' ' C' . . . . . 1.058 ' H41' ' HA2' ' A' ' 35' ' ' GLY . . . . . . . . 0 O5'--C5' 1.429 -0.712 0 C3'-C2'-C1' 104.362 3.179 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.796 " O4'" " H4'" ' B' ' 4' ' ' ' C' . . . . . . . . 0 P--O3' 1.615 0.689 0 P-O3'-C3' 122.818 2.598 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' ' C' . . . . . 0.605 " O5'" ' H6 ' ' B' ' 6' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.427 -0.828 0 C4'-C3'-C2' 105.04 2.34 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.903 0 C4'-C3'-C2' 105.263 2.563 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.879 0 C3'-C2'-C1' 100.88 -0.688 . 0.0 OUTLIER zeta-1 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.797 0 N-CA-C 112.227 -0.349 . . . . 0.0 112.227 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.57 64.14 4.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.085 0.469 . . . . 0.0 110.784 178.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 82.5 mtp -125.76 123.93 39.9 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.23 -179.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -86.84 159.38 31.52 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.801 -178.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -62.13 156.9 47.4 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.214 2.609 . . . . 0.0 112.118 178.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.1 m 61.04 51.68 4.38 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -174.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 24.8 p -58.7 102.77 0.13 Allowed 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.226 -176.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.457 ' O ' ' HB3' ' A' ' 9' ' ' SER . 27.3 t 58.31 78.41 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.626 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.457 ' HB3' ' O ' ' A' ' 8' ' ' VAL . 42.9 t 76.1 -41.85 0.43 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.853 177.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.92 -19.47 40.96 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.443 -177.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 56.06 51.16 12.37 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 122.946 0.498 . . . . 0.0 111.605 177.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -130.71 80.59 69.55 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.596 -178.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -91.27 116.04 0.45 Allowed 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 123.093 2.529 . . . . 0.0 111.747 174.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -123.36 136.6 54.73 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.153 -177.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 29.1 p -130.72 -76.14 0.53 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.145 178.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.496 ' HB3' ' HG2' ' A' ' 19' ' ' PRO . 70.3 m 58.01 64.39 1.53 Allowed 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 121.095 0.474 . . . . 0.0 110.926 -177.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -85.93 -31.96 21.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.124 -178.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.555 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 70.6 mtm -85.5 -52.69 0.47 Allowed Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -176.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 18' ' ' MET . 4.2 Cg_exo -41.42 -50.3 4.65 Favored 'Trans proline' 0 C--N 1.361 1.202 0 C-N-CA 123.696 2.931 . . . . 0.0 115.777 -178.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.406 ' HD2' ' N ' ' A' ' 19' ' ' PRO . 33.0 Cg_endo -63.06 -27.36 73.74 Favored 'Trans proline' 0 C--N 1.36 1.142 0 C-N-CA 121.918 1.745 . . . . 0.0 113.621 -175.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -106.46 70.54 0.83 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.289 0.566 . . . . 0.0 111.564 -177.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 81.9 mm-40 -110.57 148.3 32.44 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.128 171.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -78.98 141.88 37.12 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.076 -171.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 29.2 m -131.69 112.45 12.56 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.496 -177.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.401 HG21 ' NE2' ' A' ' 167' ' ' GLN . 28.4 m -125.14 161.68 28.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.839 -178.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -117.44 128.1 54.67 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.618 -175.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.562 ' HB ' ' HB ' ' A' ' 71' ' ' VAL . 8.9 t -97.45 143.14 13.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.198 -179.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.429 ' CG ' HG21 ' A' ' 68' ' ' VAL . 0.3 OUTLIER -103.86 106.06 16.45 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 122.623 0.369 . . . . 0.0 111.723 -172.573 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.618 ' C ' ' HB ' ' A' ' 68' ' ' VAL . 8.7 pt -130.4 121.41 19.39 Favored Pre-proline 0 C--N 1.326 -0.433 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.856 176.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.666 ' HB2' ' HG2' ' A' ' 32' ' ' GLN . 10.6 Cg_endo -53.27 147.67 35.14 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.699 2.933 . . . . 0.0 112.485 -176.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.444 ' HA ' HG12 ' A' ' 34' ' ' VAL . . . -57.46 -21.98 40.57 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.509 -0.768 . . . . 0.0 112.096 -175.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.666 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 11.4 pt20 -71.38 -26.2 62.69 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.589 178.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.572 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -111.8 -30.37 7.33 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 121.167 -0.213 . . . . 0.0 111.545 -172.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.663 HG21 ' HB3' ' A' ' 69' ' ' ARG . 9.3 p -52.25 -32.86 16.36 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 O-C-N 123.605 0.566 . . . . 0.0 111.392 -174.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.901 ' HA2' ' N4 ' ' B' ' 4' ' ' ' C' . . . -55.7 -57.93 16.45 Favored Glycine 0 N--CA 1.438 -1.193 0 C-N-CA 120.318 -0.944 . . . . 0.0 111.858 -179.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.402 ' HB2' " O2'" ' B' ' 2' ' ' ' C' . . . -77.32 -14.11 59.8 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 120.744 0.307 . . . . 0.0 111.074 -174.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.637 HD12 ' HB3' ' A' ' 90' ' ' LYS . 7.9 mm -64.71 -38.87 83.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.116 176.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.879 HD12 ' C5 ' ' B' ' 4' ' ' ' C' . 5.0 mt -54.5 -59.42 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -178.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 131.04 77.82 0.17 Allowed Glycine 0 CA--C 1.52 0.357 0 C-N-CA 119.616 -1.278 . . . . 0.0 114.43 175.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.497 ' HA ' ' OP2' ' B' ' 3' ' ' ' A' . 45.9 tttp 54.13 -80.77 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 170.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -101.1 -6.22 24.64 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.821 0.344 . . . . 0.0 111.048 -173.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.55 ' O ' HG22 ' A' ' 45' ' ' ILE . . . 84.86 -1.88 88.57 Favored Glycine 0 C--O 1.229 -0.215 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.152 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -78.78 -32.26 46.39 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 176.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.444 ' HA ' ' HB3' ' A' ' 47' ' ' GLN . 2.2 m-70 -73.62 -22.12 60.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.066 -176.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.556 ' HB ' HG23 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -73.65 -42.89 55.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.728 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.423 ' HD2' " C5'" ' B' ' 6' ' ' ' C' . 7.9 pttp -81.68 -22.5 37.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.286 0.565 . . . . 0.0 109.744 177.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.444 ' HB3' ' HA ' ' A' ' 44' ' ' HIS . 49.2 tt0 -66.44 -33.44 75.72 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 171.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.411 ' HA ' ' HB3' ' A' ' 51' ' ' PHE . 7.0 tt -66.09 -38.5 88.39 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.371 175.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.666 ' HA ' HD13 ' A' ' 56' ' ' ILE . 8.1 t -60.04 -39.17 85.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.628 176.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -68.87 -47.47 65.85 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.062 174.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.411 ' HB3' ' HA ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -58.41 -39.03 78.62 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.984 -1.007 . . . . 0.0 112.007 -178.163 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -91.16 0.89 57.44 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 121.185 -0.206 . . . . 0.0 111.325 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 72.5 p 50.89 31.39 6.1 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.667 0.787 . . . . 0.0 111.964 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -140.14 174.25 10.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.886 -175.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.5 m -86.25 101.29 12.92 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.675 0.274 . . . . 0.0 110.596 -178.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.666 HD13 ' HA ' ' A' ' 49' ' ' SER . 2.2 mp -108.6 117.1 53.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.892 178.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.434 ' HG2' " O2'" ' B' ' 6' ' ' ' C' . 42.2 mtmt -134.28 146.81 50.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.562 -177.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.66 ' HB ' ' N1 ' ' B' ' 5' ' ' ' A' . 40.0 mm -90.17 107.47 18.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 173.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.464 ' HB2' ' CG1' ' A' ' 72' ' ' VAL . . . -86.33 126.4 64.78 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.854 -173.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 59' ' ' ALA . 17.1 Cg_exo -67.65 141.04 53.49 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.879 2.386 . . . . 0.0 110.805 172.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.38 131.24 39.67 Favored 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 122.906 2.404 . . . . 0.0 111.994 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -57.4 -32.42 66.82 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.684 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.6 p -124.06 132.51 24.3 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.55 174.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -64.01 -9.02 17.67 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 123.279 2.652 . . . . 0.0 112.765 -177.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -82.62 -12.27 57.79 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.974 -178.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.7 t -67.97 141.35 56.31 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.81 -9.7 57.9 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.505 -173.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.618 ' HB ' ' C ' ' A' ' 29' ' ' ILE . 1.4 m -127.41 176.08 8.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-O 121.225 0.536 . . . . 0.0 111.316 -172.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.663 ' HB3' HG21 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -120.01 139.79 51.96 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 106.471 -1.678 . . . . 0.0 106.471 172.837 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.542 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 61.4 mtt -97.43 149.15 22.46 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 120.282 -0.567 . . . . 0.0 111.397 -169.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.562 ' HB ' ' HB ' ' A' ' 27' ' ' VAL . 70.1 t -104.35 116.22 47.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 171.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.464 ' CG1' ' HB2' ' A' ' 59' ' ' ALA . 11.1 p -108.73 121.6 62.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.357 0.598 . . . . 0.0 110.472 -177.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 24' ' ' THR . 0.1 OUTLIER -130.63 142.42 43.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.768 0.794 . . . . 0.0 111.135 179.675 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 47.3 m -122.47 111.57 17.0 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.191 -1.368 . . . . 0.0 109.034 176.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.67 162.36 35.78 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 119.845 -1.169 . . . . 0.0 113.158 -175.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.24 148.54 84.91 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.379 2.052 . . . . 0.0 110.824 170.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -38.35 -46.85 2.4 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 124.152 3.235 . . . . 0.0 114.441 -176.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.516 ' HG3' ' N ' ' A' ' 79' ' ' ALA . 7.6 pt-20 -56.8 -43.97 81.48 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.156 0.503 . . . . 0.0 111.203 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.642 ' HA ' ' HD3' ' A' ' 82' ' ' LYS . . . -71.73 -37.64 70.57 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.006 -175.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -68.93 -26.03 64.88 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.946 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.841 ' HA ' HE22 ' A' ' 164' ' ' GLN . 89.8 t80 -64.4 -54.94 24.86 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.709 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.713 ' H ' ' HD2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -70.02 -32.6 70.84 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.459 -0.497 . . . . 0.0 110.726 -177.681 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.3 -51.54 69.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.753 0.311 . . . . 0.0 110.985 177.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.638 ' HA ' HG22 ' A' ' 87' ' ' ILE . 54.1 mt-30 -66.46 -31.89 72.91 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.269 179.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -59.57 -40.04 95.84 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.332 178.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -80.21 -37.83 32.36 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 122.742 -0.269 . . . . 0.0 111.637 -177.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.638 HG22 ' HA ' ' A' ' 84' ' ' GLN . 0.0 OUTLIER -65.21 -43.83 95.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.662 -176.632 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.592 ' CE2' ' HB3' ' A' ' 105' ' ' LEU . 15.2 m-85 -67.13 -30.15 70.07 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.142 0.496 . . . . 0.0 110.148 176.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -60.04 -32.84 76.88 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.213 176.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.637 ' HB3' HD12 ' A' ' 37' ' ' ILE . 31.7 mmtp -72.63 -26.76 61.78 Favored 'General case' 0 N--CA 1.455 -0.213 0 O-C-N 122.541 -0.388 . . . . 0.0 110.624 177.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.601 ' HG ' ' HG ' ' A' ' 105' ' ' LEU . 4.3 mm? -66.35 -38.55 87.85 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.853 0.359 . . . . 0.0 110.156 171.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.89 ' HE3' ' HB ' ' A' ' 103' ' ' VAL . 0.5 OUTLIER -68.78 -26.52 65.25 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.373 176.124 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -64.32 -40.66 96.34 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.995 -176.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.588 ' HB2' ' CE2' ' A' ' 96' ' ' PHE . 10.4 mm-40 -105.94 0.24 25.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.964 0.411 . . . . 0.0 112.079 -178.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.465 ' HB3' ' HD3' ' A' ' 99' ' ' PRO . 37.2 m-80 57.34 47.83 15.96 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.307 -0.86 . . . . 0.0 112.695 171.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.588 ' CE2' ' HB2' ' A' ' 94' ' ' GLU . 80.1 m-85 -69.98 -43.81 70.71 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -176.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.492 ' HE2' ' HB3' ' A' ' 91' ' ' LEU . 23.1 p90 -81.94 -17.86 45.58 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.009 0.433 . . . . 0.0 111.208 -177.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 127.04 122.73 2.57 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.943 -0.646 . . . . 0.0 111.718 -178.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.465 ' HD3' ' HB3' ' A' ' 95' ' ' ASN . 12.2 Cg_endo -57.12 -38.19 96.2 Favored 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 122.981 2.454 . . . . 0.0 113.422 -177.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 39.5 mmtm -87.8 -3.02 58.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.857 0.36 . . . . 0.0 111.419 -178.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.459 ' HG3' ' O ' ' A' ' 102' ' ' GLU . 9.6 tp10 -95.82 141.15 29.61 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.995 -178.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.484 ' HB3' ' CD2' ' A' ' 159' ' ' HIS . 5.2 tt0 -65.06 145.77 55.88 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 171.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.89 ' HB ' ' HE3' ' A' ' 92' ' ' LYS . 11.5 p -54.52 122.84 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.404 0 CA-C-O 121.733 0.778 . . . . 0.0 112.037 -168.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp -117.68 91.29 3.53 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.568 -1.196 . . . . 0.0 108.865 176.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.601 ' HG ' ' HG ' ' A' ' 91' ' ' LEU . 2.0 tm? -128.58 123.81 34.33 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.208 0.527 . . . . 0.0 109.959 -176.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -58.92 129.46 42.26 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.821 -1.081 . . . . 0.0 112.016 -174.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.44 142.51 46.27 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.16 175.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -122.22 120.11 33.2 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.306 0.574 . . . . 0.0 111.546 -179.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.482 HD13 HD11 ' A' ' 156' ' ' ILE . 22.9 pt -114.61 134.16 58.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.872 176.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.594 ' HD3' HG12 ' A' ' 153' ' ' ILE . 6.9 tpp180 -78.48 138.25 38.35 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.249 -176.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.694 HG23 ' CD2' ' A' ' 174' ' ' LEU . 6.4 p -141.93 143.0 26.75 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 177.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.42 ' HD2' HG22 ' A' ' 111' ' ' VAL . 24.6 Cg_exo -59.84 150.1 79.57 Favored 'Trans proline' 0 N--CA 1.465 -0.18 0 C-N-CA 122.399 2.066 . . . . 0.0 111.296 176.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -56.3 -51.06 69.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.022 0.439 . . . . 0.0 111.007 -175.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.7 m -68.54 -12.3 61.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.544 -178.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.642 ' HB2' HG11 ' A' ' 177' ' ' VAL . . . -84.68 -14.87 47.2 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.347 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.458 ' HA ' HG12 ' A' ' 119' ' ' VAL . . . -65.42 -40.96 93.98 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.039 176.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.32 -32.9 83.37 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.615 -0.802 . . . . 0.0 111.55 176.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.447 ' HD2' HG22 ' A' ' 177' ' ' VAL . 15.2 ttm180 -74.2 -42.42 59.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.673 0.273 . . . . 0.0 110.788 -179.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.498 HG22 HD11 ' A' ' 130' ' ' LEU . 7.4 p -68.93 -30.56 47.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.025 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.65 ' HA ' HG23 ' A' ' 127' ' ' VAL . 72.6 mt -69.62 -39.26 78.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.818 0.818 . . . . 0.0 109.558 171.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 97.06 36.71 4.87 Favored Glycine 0 N--CA 1.438 -1.184 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.551 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 67.33 -73.48 0.08 Allowed 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 123.175 0.59 . . . . 0.0 111.541 -176.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -95.26 -27.03 15.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.672 0.272 . . . . 0.0 110.984 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 135.34 5.49 2.32 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.455 -0.878 . . . . 0.0 113.26 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 23.4 pttp -63.72 -26.27 68.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.967 0.413 . . . . 0.0 111.614 -179.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.572 ' O ' ' HG ' ' A' ' 130' ' ' LEU . 50.0 m -88.3 -32.7 18.33 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.268 -174.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.65 HG23 ' HA ' ' A' ' 120' ' ' ILE . 82.0 t -59.81 -37.9 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-O 121.38 0.61 . . . . 0.0 109.809 173.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -56.09 -42.98 77.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.944 177.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.14 -42.83 72.05 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.145 -179.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.572 ' HG ' ' O ' ' A' ' 126' ' ' THR . 77.6 mt -58.29 -52.05 67.23 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.702 -178.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -66.01 -37.97 87.25 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.928 -175.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -65.27 -36.7 84.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.276 -177.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 60.6 tp -88.11 -48.89 7.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.722 0.296 . . . . 0.0 111.525 -176.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.429 HG21 ' HA ' ' A' ' 166' ' ' ALA . 64.2 p -74.67 -25.19 59.01 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.985 -172.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 60.74 20.94 10.98 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.159 -174.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -113.61 173.12 6.57 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.309 -174.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.648 ' HB3' ' HB ' ' A' ' 157' ' ' ILE . 8.6 tp10 -96.95 114.07 25.66 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.04 175.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 57.3 t -114.84 106.98 21.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.758 -176.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.598 HG13 ' HB2' ' A' ' 155' ' ' LYS . 1.5 p -121.22 121.25 64.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.408 0.623 . . . . 0.0 110.991 177.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.642 ' HB ' HG22 ' A' ' 154' ' ' VAL . 7.7 p -127.12 113.01 21.68 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.631 176.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 1.054 ' HG2' ' HB2' ' A' ' 144' ' ' GLN . 96.1 Cg_endo -90.2 138.0 2.71 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.238 2.625 . . . . 0.0 113.526 -174.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -75.41 -23.31 57.02 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 113.636 -1.62 . . . . 0.0 109.418 175.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -97.67 17.29 18.2 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.951 -178.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 1.054 ' HB2' ' HG2' ' A' ' 141' ' ' PRO . 8.9 tp60 -63.83 -63.28 1.21 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.22 0.533 . . . . 0.0 111.54 -177.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.1 p -146.45 150.6 41.15 Favored Pre-proline 0 C--N 1.316 -0.85 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.124 -174.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.57 165.25 32.49 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.189 2.593 . . . . 0.0 112.309 178.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -78.43 23.83 0.29 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.948 -175.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -70.87 -47.6 58.41 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.487 0.661 . . . . 0.0 109.465 176.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -101.82 0.46 35.72 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.744 177.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 44.88 37.86 2.6 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.441 1.096 . . . . 0.0 112.034 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -147.9 141.0 24.98 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.027 0.441 . . . . 0.0 111.779 -174.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.414 HG23 ' CG1' ' A' ' 111' ' ' VAL . 23.3 m -126.95 -176.02 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.186 -178.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.594 HG12 ' HD3' ' A' ' 110' ' ' ARG . 58.2 mt -132.81 134.94 57.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 O-C-N 122.247 -0.283 . . . . 0.0 110.69 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.642 HG22 ' HB ' ' A' ' 140' ' ' VAL . 89.7 t -92.4 139.09 18.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 174.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.719 ' HE3' ' HG3' ' A' ' 141' ' ' PRO . 0.0 OUTLIER -105.57 117.18 33.37 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.997 0.427 . . . . 0.0 109.964 179.258 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.533 HD13 ' HB3' ' A' ' 166' ' ' ALA . 53.4 mt -100.49 116.66 44.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.072 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.648 ' HB ' ' HB3' ' A' ' 137' ' ' GLU . 3.2 mp -107.32 131.8 56.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 175.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 153.36 -152.68 24.27 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.446 -178.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.484 ' CD2' ' HB3' ' A' ' 102' ' ' GLU . 4.1 m80 -102.7 155.12 18.52 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -175.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.435 ' O ' ' HG3' ' A' ' 164' ' ' GLN . 25.0 p90 -56.0 -36.36 67.83 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.037 0.835 . . . . 0.0 111.797 -172.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.461 ' O ' ' HG2' ' A' ' 165' ' ' MET . 35.8 m-85 -60.2 -48.02 83.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.82 0.343 . . . . 0.0 110.746 175.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -70.39 -36.94 74.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.611 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.451 ' HA ' HG21 ' A' ' 156' ' ' ILE . 68.7 m -57.54 -45.78 84.69 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.413 176.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.841 HE22 ' HA ' ' A' ' 81' ' ' PHE . 96.8 mt-30 -64.39 -33.66 76.37 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.777 0.322 . . . . 0.0 111.152 179.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.461 ' HG2' ' O ' ' A' ' 161' ' ' TYR . 95.9 mmm -63.02 -40.57 98.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.173 176.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.533 ' HB3' HD13 ' A' ' 156' ' ' ILE . . . -74.83 -37.99 62.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.826 178.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.401 ' NE2' HG21 ' A' ' 25' ' ' VAL . 32.4 mt-30 -53.33 -56.2 18.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.751 177.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -65.88 -31.45 72.4 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.035 -178.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.726 ' HA ' ' HE3' ' A' ' 169' ' ' LYS . 0.2 OUTLIER -72.95 -54.94 7.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.152 -172.886 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 2.4 mp -72.0 -46.77 58.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.8 0.333 . . . . 0.0 110.424 -177.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.586 ' HA ' ' HG ' ' A' ' 174' ' ' LEU . 24.6 mmm180 -60.99 -24.93 66.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.175 -178.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -71.44 -47.36 56.35 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 111.547 0.203 . . . . 0.0 111.547 177.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.471 HG13 HD23 ' A' ' 174' ' ' LEU . 18.3 pt -66.62 -19.26 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.671 -177.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.694 ' CD2' HG23 ' A' ' 111' ' ' VAL . 6.7 mt -60.92 -28.78 69.18 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.817 177.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.438 ' O ' ' HG3' ' A' ' 179' ' ' GLN . . . -59.0 -43.12 91.45 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.037 176.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 71.3 mm-40 -60.81 -45.43 94.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.656 176.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.642 HG11 ' HB2' ' A' ' 115' ' ' ALA . 46.7 t -61.38 -41.26 89.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.576 179.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -63.0 -44.44 96.0 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.557 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.438 ' HG3' ' O ' ' A' ' 175' ' ' ALA . 96.9 mt-30 -64.2 -43.58 94.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.755 179.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -75.72 -20.82 58.08 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.424 -178.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 -67.59 -32.72 73.65 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.616 0.246 . . . . 0.0 110.954 -178.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -58.8 -28.65 66.19 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.453 0.644 . . . . 0.0 110.373 177.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 42.4 mtmt -122.37 30.33 6.58 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.659 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -82.5 58.13 5.0 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.896 -173.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 54.77 45.66 26.22 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.514 0.673 . . . . 0.0 110.379 177.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 22.8 t -117.34 90.34 3.31 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.804 -178.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -97.67 163.69 21.68 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.953 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -95.09 92.77 6.99 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.788 0.328 . . . . 0.0 110.15 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -143.65 142.71 31.13 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.55 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 52.75 72.91 0.38 Allowed 'General case' 0 N--CA 1.466 0.36 0 O-C-N 123.904 0.752 . . . . 0.0 111.164 177.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.641 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.638 179.048 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' ' G' . . . . . 0.738 " O2'" ' H6 ' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.428 -0.732 0 C4'-C3'-C2' 106.67 3.97 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . 0.738 ' H6 ' " O2'" ' B' ' 1' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.424 -0.982 0 O4'-C4'-C3' 102.061 -2.457 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . 0.643 " H1'" ' C5 ' ' B' ' 4' ' ' ' C' . . . . . . . . 0 C2'--C1' 1.517 -1.096 0 C5'-C4'-O4' 112.728 2.52 OUTLIER-DELTA 0.0 OUTLIER '7D dist 1z' 0.0 . . . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' ' C' . . . . . 0.901 ' N4 ' ' HA2' ' A' ' 35' ' ' GLY . . . . . . . . 0 O5'--C5' 1.427 -0.793 0 C4'-C3'-C2' 105.703 3.003 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.833 " O5'" " H4'" ' B' ' 4' ' ' ' C' . . . . . . . . 0 P--O3' 1.615 0.675 0 P-O3'-C3' 122.439 2.282 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' ' C' . . . . . 0.637 " O5'" ' H6 ' ' B' ' 6' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.429 -0.717 0 C4'-C3'-C2' 104.67 1.97 . 0.0 OUTLIER '7D dist 1m' 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.428 -0.756 0 C4'-C3'-C2' 104.559 1.859 . 0.104 1[ . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.425 -0.925 0 C3'-C2'-C1' 100.151 -1.499 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 stop_ save_